Psyllid ID: psy10462
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 347 | 2.2.26 [Sep-21-2011] | |||||||
| Q9D411 | 328 | Testis-specific serine/th | yes | N/A | 0.458 | 0.484 | 0.491 | 2e-43 | |
| Q6SA08 | 328 | Testis-specific serine/th | yes | N/A | 0.458 | 0.484 | 0.497 | 3e-42 | |
| Q9BXA7 | 367 | Testis-specific serine/th | no | N/A | 0.507 | 0.479 | 0.459 | 3e-42 | |
| O54863 | 358 | Testis-specific serine/th | no | N/A | 0.469 | 0.455 | 0.493 | 4e-42 | |
| Q3SZW1 | 367 | Testis-specific serine/th | no | N/A | 0.463 | 0.438 | 0.5 | 5e-42 | |
| Q61241 | 365 | Testis-specific serine/th | no | N/A | 0.521 | 0.495 | 0.454 | 6e-42 | |
| Q96PF2 | 358 | Testis-specific serine/th | no | N/A | 0.469 | 0.455 | 0.475 | 6e-41 | |
| Q9D2E1 | 268 | Testis-specific serine/th | no | N/A | 0.446 | 0.578 | 0.453 | 2e-37 | |
| Q96PN8 | 268 | Testis-specific serine/th | no | N/A | 0.446 | 0.578 | 0.453 | 3e-37 | |
| Q9BXA6 | 273 | Testis-specific serine/th | no | N/A | 0.446 | 0.567 | 0.457 | 7e-36 |
| >sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus GN=Tssk4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 176 bits (447), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 83/169 (49%), Positives = 112/169 (66%), Gaps = 10/169 (5%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN-----NTD 66
A +WFSQ+A I Y H K +VHRD+K ENLLLD + N+K+SDFGFA+ + +
Sbjct: 125 AGKWFSQMALGIAYLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSSQPVHSSPS 184
Query: 67 YKQ-----NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
Y+Q +LS+T+CGS+AYA PEIL G+PY P SD WSMGV+L+ +V RLPFDDTN
Sbjct: 185 YRQMNSLSHLSQTYCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNL 244
Query: 122 SELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 170
+LL++ QK V FP + +S CK LI +L R + D+ +DPW+
Sbjct: 245 KKLLRETQKEVTFPANLTISQECKNLILQLLRQSTKRATILDVLRDPWM 293
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6SA08|TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (437), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 84/169 (49%), Positives = 110/169 (65%), Gaps = 10/169 (5%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN-----NTD 66
A +WFSQL I Y H KS+VHRD+K ENLLLD N+K+SDFGFA+ N +
Sbjct: 125 AGKWFSQLTLGIAYLHSKSIVHRDLKLENLLLDKWENVKISDFGFAKMVPSNQPVGCSPS 184
Query: 67 YKQ-----NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
Y+Q +LS+T+CGS+AYA PEIL+G+PY P SD WSMGV+L+ +V LPFDDTN
Sbjct: 185 YRQVNCFSHLSQTYCGSFAYACPEILRGLPYNPFLSDTWSMGVILYTLVVAHLPFDDTNL 244
Query: 122 SELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 170
+LL++ QK V FP + +S CK LI +L R + DI +D W+
Sbjct: 245 KKLLRETQKEVTFPANHTISQECKNLILQMLRQATKRATILDIIKDSWV 293
|
May be involved in a signaling pathway during male germ cell development or mature sperm function (By similarity). Phosphorylates CREB1 on Ser-133 and stimulates downstream signaling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA7|TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (436), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 85/185 (45%), Positives = 127/185 (68%), Gaps = 9/185 (4%)
Query: 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
+ D+AR+ F QL+ AI YCH VVHRD+KC+NLLLD +NIKLSDF F+++ + +
Sbjct: 109 HEDEARKKFHQLSLAIKYCHDLDVVHRDLKCDNLLLDKDFNIKLSDFSFSKR-CLRDDSG 167
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK- 126
+ LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+
Sbjct: 168 RMALSKTFCGSPAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRI 227
Query: 127 QVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPE 185
Q + RV FP S L+ CK LI ++L P V R+ +++I W++ K++ +P
Sbjct: 228 QKEHRVNFPRSKHLTGECKDLIYHMLQPDVNRRLHIDEILSHCWMQP------KARGSPS 281
Query: 186 VGIHK 190
V I+K
Sbjct: 282 VAINK 286
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54863|TSSK2_MOUSE Testis-specific serine/threonine-protein kinase 2 OS=Mus musculus GN=Tssk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 172 bits (436), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 82/166 (49%), Positives = 117/166 (70%), Gaps = 3/166 (1%)
Query: 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
+ D AR+ F QL+ A+ YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + +
Sbjct: 109 HEDVARKMFRQLSSAVKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDGSG 167
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK- 126
+ LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD++ ++L+
Sbjct: 168 RIVLSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRI 227
Query: 127 QVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
Q + RV FP S L+ CK LI IL P V R+ +++I WL+
Sbjct: 228 QKEHRVDFPRSKNLTGECKDLIYRILQPDVNRRLHIDEILSHSWLQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus GN=TSSK1B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (435), Expect = 5e-42, Method: Compositional matrix adjust.
Identities = 82/164 (50%), Positives = 116/164 (70%), Gaps = 3/164 (1%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR+ F QL+ AI YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + +
Sbjct: 111 DDARKKFHQLSSAIKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRL 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q
Sbjct: 170 TLSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
+ RV FP S L+ CK LI +L P V R+ +++I W++
Sbjct: 230 EHRVNFPRSKHLTGECKDLIYRMLQPDVTRRLHIDEILSHCWVQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-288' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q61241|TSSK1_MOUSE Testis-specific serine/threonine-protein kinase 1 OS=Mus musculus GN=Tssk1b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 6e-42, Method: Compositional matrix adjust.
Identities = 90/198 (45%), Positives = 127/198 (64%), Gaps = 17/198 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR+ F QL+ AI YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + +
Sbjct: 111 DDARKKFHQLSSAIKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRL 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q
Sbjct: 170 ILSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS--------NPVGK 179
+ RV FP S L+ CK LI +L P V R+ +++I W++ + N G+
Sbjct: 230 EHRVNFPRSKHLTGECKDLIYRMLQPDVNRRLHIDEILNHCWVQPKARGLSSGAINKEGE 289
Query: 180 SKSA------PEVGIHKR 191
S A PE G K+
Sbjct: 290 SSRATEPSWIPEPGADKK 307
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates 'Ser-281' of TSKS. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PF2|TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 168 bits (425), Expect = 6e-41, Method: Compositional matrix adjust.
Identities = 79/166 (47%), Positives = 118/166 (71%), Gaps = 3/166 (1%)
Query: 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
+ D AR+ F QL+ A+ YCH +VHRD+KCENLLLD +NIKLSDFGF+++ + +++
Sbjct: 109 HEDVARKMFRQLSSAVKYCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDSNG 167
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK- 126
+ LS+TFCGS AYA+PE+L+ +PY P+ DIWS+GV+L+ MV G +P+DD++ ++L+
Sbjct: 168 RIILSKTFCGSAAYAAPEVLQSIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIRKMLRI 227
Query: 127 QVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
Q + RV FP S L+ CK LI +L P V R+ +++I WL+
Sbjct: 228 QKEHRVDFPRSKNLTCECKDLIYRMLQPDVSQRLHIDEILSHSWLQ 273
|
Testis-specific serine/threonine-protein kinase required during spermatid development. Phosphorylates TSKS at 'Ser-288' and SPAG16. Involved in the late stages of spermatogenesis, during the reconstruction of the cytoplasm. During spermatogenesis, required for the transformation of a ring-shaped structure around the base of the flagellum originating from the chromatoid body. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9D2E1|TSSK3_MOUSE Testis-specific serine/threonine-protein kinase 3 OS=Mus musculus GN=Tssk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (395), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 73/161 (45%), Positives = 108/161 (67%), Gaps = 6/161 (3%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+A+ F Q+ +AI YCH V HRD+KCEN LL +N+KL+DFGFA+ + ++
Sbjct: 110 RAKALFRQMVEAIRYCHGCGVAHRDLKCENALLQG-FNLKLTDFGFAKVLPKS----RRE 164
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LS+TFCGS AYA+PE+L+G+P+ ++ D+WSMGVVL+ M+ LPFDDT+ ++L Q QK
Sbjct: 165 LSQTFCGSTAYAAPEVLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQK 224
Query: 131 RVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWL 170
V FP +S+ C+ L+ +L P + R +E++ PWL
Sbjct: 225 GVSFPTHLGISTECQDLLKRLLEPDMILRPSIEEVSWHPWL 265
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96PN8|TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (393), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 73/161 (45%), Positives = 108/161 (67%), Gaps = 6/161 (3%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+A+ F Q+ +AI YCH V HRD+KCEN LL +N+KL+DFGFA+ ++ +
Sbjct: 110 RAKALFRQMVEAIRYCHGCGVAHRDLKCENALLQG-FNLKLTDFGFAKVLPKSH----RE 164
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LS+TFCGS AYA+PE+L+G+P+ ++ D+WSMGVVL+ M+ LPFDDT+ ++L Q QK
Sbjct: 165 LSQTFCGSTAYAAPEVLQGIPHDSKKGDVWSMGVVLYVMLCASLPFDDTDIPKMLWQQQK 224
Query: 131 RVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWL 170
V FP +S+ C+ L+ +L P + R +E++ PWL
Sbjct: 225 GVSFPTHLSISADCQDLLKRLLEPDMILRPSIEEVSWHPWL 265
|
May be involved in a signaling pathway during male germ cell development or mature sperm function. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9BXA6|TSSK6_HUMAN Testis-specific serine/threonine-protein kinase 6 OS=Homo sapiens GN=TSSK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 151 bits (381), Expect = 7e-36, Method: Compositional matrix adjust.
Identities = 75/164 (45%), Positives = 110/164 (67%), Gaps = 9/164 (5%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQ 69
+AR F+Q+A A+ Y H +VHRD+KCEN+LL D+ +KL+DFGF R+
Sbjct: 111 QARDLFAQIAGAVRYLHDHHLVHRDLKCENVLLSPDERRVKLTDFGFGRQ-----AHGYP 165
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+LS T+CGS AYASPE+L G+PY P++ D+WSMGVVL+ MV G +PFDD++ + L ++ +
Sbjct: 166 DLSTTYCGSAAYASPEVLLGIPYDPKKYDVWSMGVVLYVMVTGCMPFDDSDIAGLPRRQK 225
Query: 130 KRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLK 171
+ V++PE LS CKALI+ +L SP R + ++ WL+
Sbjct: 226 RGVLYPEGLELSERCKALIAELLQFSP-SARPSAGQVARNCWLR 268
|
Required for sperm production and function. Plays a role in DNA condensation during postmeiotic chromatin remodeling. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 347 | ||||||
| 380027639 | 345 | PREDICTED: testis-specific serine/threon | 0.463 | 0.466 | 0.685 | 6e-63 | |
| 328776257 | 351 | PREDICTED: testis-specific serine/threon | 0.463 | 0.458 | 0.679 | 2e-62 | |
| 270010686 | 327 | hypothetical protein TcasGA2_TC010125 [T | 0.472 | 0.501 | 0.660 | 5e-62 | |
| 91087563 | 340 | PREDICTED: similar to CG9222 CG9222-PA [ | 0.472 | 0.482 | 0.660 | 6e-62 | |
| 357614817 | 329 | putative cAMP-dependent protein kinase c | 0.501 | 0.528 | 0.607 | 5e-61 | |
| 242016558 | 386 | cAMP-dependent protein kinase catalytic | 0.495 | 0.445 | 0.617 | 7e-61 | |
| 383852844 | 364 | PREDICTED: testis-specific serine/threon | 0.458 | 0.436 | 0.656 | 1e-60 | |
| 350401037 | 363 | PREDICTED: testis-specific serine/threon | 0.458 | 0.438 | 0.668 | 1e-60 | |
| 340709608 | 363 | PREDICTED: testis-specific serine/threon | 0.458 | 0.438 | 0.662 | 8e-60 | |
| 332019401 | 361 | Testis-specific serine/threonine-protein | 0.458 | 0.440 | 0.629 | 2e-58 |
| >gi|380027639|ref|XP_003697528.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 247 bits (630), Expect = 6e-63, Method: Compositional matrix adjust.
Identities = 111/162 (68%), Positives = 132/162 (81%), Gaps = 1/162 (0%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
++RRWF QL +AIDYCH + VVHRDIKCENLL+D +NIKLSDFGFAR + +
Sbjct: 136 RSRRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARG-QMKPKNGTNP 194
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LSETFCGSYAYASPEILKGVPY PQ SDIWSMGVVL+AMVYGRLPFDDTNYS+LLKQVQ
Sbjct: 195 LSETFCGSYAYASPEILKGVPYLPQLSDIWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQN 254
Query: 131 RVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKE 172
+VVFP+ P +S +C++LIS IL P + R+ +++IR D WL E
Sbjct: 255 KVVFPKEPNVSQACRSLISRILVPQRIRMNIDNIRNDTWLAE 296
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328776257|ref|XP_395246.3| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 245 bits (626), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 110/162 (67%), Positives = 132/162 (81%), Gaps = 1/162 (0%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
++RRWF QL +AIDYCH + VVHRDIKCENLL+D +NIKLSDFGFAR + +
Sbjct: 142 RSRRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARG-QMKAKNGINP 200
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LSETFCGSYAYASPEILKGVPY PQ SD+WSMGVVL+AMVYGRLPFDDTNYS+LLKQVQ
Sbjct: 201 LSETFCGSYAYASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQN 260
Query: 131 RVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKE 172
+VVFP+ P +S +C++LIS IL P + R+ +++IR D WL E
Sbjct: 261 KVVFPKEPNVSQACRSLISRILVPQRIRMNIDNIRNDTWLAE 302
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270010686|gb|EFA07134.1| hypothetical protein TcasGA2_TC010125 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 244 bits (622), Expect = 5e-62, Method: Compositional matrix adjust.
Identities = 109/165 (66%), Positives = 136/165 (82%), Gaps = 1/165 (0%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
++R+WF QL DA+DYCH++ VVHRDIKCENLLL+ +Y IKLSDFGFAR + + + +
Sbjct: 136 RSRKWFRQLVDAVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGH-MKIKNGQAP 194
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LSETFCGSYAYASPEILKG+PY PQ SDIWSMGVVLFAMVYGRLPFDDTNY +L+KQV
Sbjct: 195 LSETFCGSYAYASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTN 254
Query: 131 RVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSN 175
+VVFP+ P++S CKALI+ IL+P+K RI++ I+ DPW ++N
Sbjct: 255 KVVFPKEPKVSLMCKALINKILAPLKARIRIPGIKTDPWYTYNTN 299
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|91087563|ref|XP_971036.1| PREDICTED: similar to CG9222 CG9222-PA [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 244 bits (622), Expect = 6e-62, Method: Compositional matrix adjust.
Identities = 109/165 (66%), Positives = 136/165 (82%), Gaps = 1/165 (0%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
++R+WF QL DA+DYCH++ VVHRDIKCENLLL+ +Y IKLSDFGFAR + + + +
Sbjct: 136 RSRKWFRQLVDAVDYCHERGVVHRDIKCENLLLNTEYEIKLSDFGFARGH-MKIKNGQAP 194
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LSETFCGSYAYASPEILKG+PY PQ SDIWSMGVVLFAMVYGRLPFDDTNY +L+KQV
Sbjct: 195 LSETFCGSYAYASPEILKGIPYQPQFSDIWSMGVVLFAMVYGRLPFDDTNYRDLVKQVTN 254
Query: 131 RVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSN 175
+VVFP+ P++S CKALI+ IL+P+K RI++ I+ DPW ++N
Sbjct: 255 KVVFPKEPKVSLMCKALINKILAPLKARIRIPGIKTDPWYTYNTN 299
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357614817|gb|EHJ69292.1| putative cAMP-dependent protein kinase catalytic subunit [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 241 bits (614), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 113/186 (60%), Positives = 136/186 (73%), Gaps = 12/186 (6%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY-SVNNTDYKQ 69
+ RRWF QL +A+DYCH++ VVHRDIKCENLL+D NIKLSDFGFAR + N Y
Sbjct: 128 RGRRWFKQLVEAVDYCHERGVVHRDIKCENLLMDHGLNIKLSDFGFARGHMKPKNGVYA- 186
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
LSETFCGSYAYASPEILKGVPY PQ SDIWSMGVVL+A+VYGRLPFDDTNY++LLKQVQ
Sbjct: 187 -LSETFCGSYAYASPEILKGVPYRPQDSDIWSMGVVLYAIVYGRLPFDDTNYTQLLKQVQ 245
Query: 130 KRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKE---------DSNPVGKS 180
+V FP P++S+ C+ LI+ IL+P+K R ++ I DPWL D+NP
Sbjct: 246 NKVSFPREPKVSTECRKLITKILAPLKLRSKIPQILADPWLSPSAPTKDEELDTNPDNAQ 305
Query: 181 KSAPEV 186
S E+
Sbjct: 306 ASKEEI 311
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242016558|ref|XP_002428853.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] gi|212513589|gb|EEB16115.1| cAMP-dependent protein kinase catalytic subunit, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 240 bits (613), Expect = 7e-61, Method: Compositional matrix adjust.
Identities = 108/175 (61%), Positives = 140/175 (80%), Gaps = 3/175 (1%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+AR++F QL DA+DYCH++ VVHRDIKCENLL+D N+KLSDFGFAR + + +
Sbjct: 152 RARKYFRQLIDAVDYCHERGVVHRDIKCENLLMDHDNNVKLSDFGFARGH-MRIKNGVAP 210
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LS+TFCGSYAYASPEILKGVPY PQ SDIWS GVVL+A+VYGRLPFDDTNY++LLKQVQ
Sbjct: 211 LSDTFCGSYAYASPEILKGVPYQPQLSDIWSTGVVLYAIVYGRLPFDDTNYNQLLKQVQS 270
Query: 131 RVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPE 185
++ FP+ P++S++CK+LI+ IL+PVKFR+++ IR DPW + P S + P+
Sbjct: 271 KISFPKEPKISANCKSLITKILAPVKFRLKIPAIRSDPWFVQ--GPSDSSANGPQ 323
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383852844|ref|XP_003701935.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 239 bits (610), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 105/160 (65%), Positives = 130/160 (81%), Gaps = 1/160 (0%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
++RRWF QL +AIDYCH + VVHRD+KCENLL+D +N+KLSDFGFAR + +
Sbjct: 137 RSRRWFRQLLEAIDYCHGRGVVHRDVKCENLLMDSNFNVKLSDFGFARG-QMKPKNGINP 195
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LSETFCGSYAYASPEILKG+PY PQ SD+WSMGVVL+AMVYGRLPFDDTNY++LLKQVQ
Sbjct: 196 LSETFCGSYAYASPEILKGIPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYNQLLKQVQS 255
Query: 131 RVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 170
R+ FP+ P++S SC++LIS IL P + R+ ++ IR D WL
Sbjct: 256 RITFPKDPKVSQSCRSLISRILVPQRTRLHIDRIRNDVWL 295
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350401037|ref|XP_003486034.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 239 bits (610), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 107/160 (66%), Positives = 130/160 (81%), Gaps = 1/160 (0%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
++RRWF QL +AIDYCH + VVHRDIKCENLL+D +NIKLSDFGFAR + + +
Sbjct: 137 RSRRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARG-QMKSKNGIAP 195
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LSETFCGSYAYASPEILKGVPY PQ SD+WSMGVVL+AMVYGRLPFDDTNYS+LLKQVQ
Sbjct: 196 LSETFCGSYAYASPEILKGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQN 255
Query: 131 RVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 170
+V+FP+ P +S +C++LIS IL + R+ ++ IR D WL
Sbjct: 256 KVIFPKEPNVSQACRSLISRILVSQRIRLHIDHIRNDVWL 295
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340709608|ref|XP_003393396.1| PREDICTED: testis-specific serine/threonine-protein kinase 4-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 236 bits (603), Expect = 8e-60, Method: Compositional matrix adjust.
Identities = 106/160 (66%), Positives = 129/160 (80%), Gaps = 1/160 (0%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
++RRWF QL +AIDYCH + VVHRDIKCENLL+D +NIKLSDFGFAR + + +
Sbjct: 137 RSRRWFRQLLEAIDYCHGRGVVHRDIKCENLLMDQNFNIKLSDFGFARG-QMKSKNGIAP 195
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
LSETFCGSYAYASPEIL GVPY PQ SD+WSMGVVL+AMVYGRLPFDDTNYS+LLKQVQ
Sbjct: 196 LSETFCGSYAYASPEILMGVPYLPQLSDVWSMGVVLYAMVYGRLPFDDTNYSQLLKQVQN 255
Query: 131 RVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 170
+V+FP+ P +S +C++LIS IL + R+ ++ IR D WL
Sbjct: 256 KVIFPKEPNVSQACRSLISRILVSQRIRLDIDHIRNDVWL 295
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332019401|gb|EGI59887.1| Testis-specific serine/threonine-protein kinase 4 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 232 bits (591), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 102/162 (62%), Positives = 133/162 (82%), Gaps = 3/162 (1%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR-KYSVNNTDYKQ 69
++RRWF QL +AI+YCH+ +VHRD+KCENLL+D ++NIKLSDFGFAR + + N ++
Sbjct: 140 RSRRWFRQLLEAIEYCHEHGIVHRDVKCENLLMDFRFNIKLSDFGFARGQMKLKNGEWP- 198
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
LS T+CGSYAYASPEIL+G+PY PQ SDIWSMGVVL+AMV+GRLPFDDTNY++LLKQVQ
Sbjct: 199 -LSTTYCGSYAYASPEILRGIPYQPQLSDIWSMGVVLYAMVHGRLPFDDTNYAQLLKQVQ 257
Query: 130 KRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLK 171
RVVFP+ P++S C++LIS IL P R+++ I+ D WL+
Sbjct: 258 NRVVFPKHPKVSQPCRSLISRILVPQFARLRINSIKNDAWLE 299
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 347 | ||||||
| FB|FBgn0031784 | 337 | CG9222 [Drosophila melanogaste | 0.484 | 0.498 | 0.551 | 4.7e-48 | |
| UNIPROTKB|F6RLA2 | 326 | TSSK4 "Uncharacterized protein | 0.458 | 0.487 | 0.520 | 4.6e-41 | |
| UNIPROTKB|E2R1G2 | 358 | TSSK2 "Uncharacterized protein | 0.463 | 0.449 | 0.5 | 7.5e-41 | |
| UNIPROTKB|G3N136 | 358 | G3N136 "Uncharacterized protei | 0.463 | 0.449 | 0.5 | 9.6e-41 | |
| UNIPROTKB|F1RK80 | 364 | TSSK1B "Uncharacterized protei | 0.492 | 0.469 | 0.471 | 1.2e-40 | |
| UNIPROTKB|G3N2D2 | 367 | TSSK1B "Testis-specific serine | 0.492 | 0.465 | 0.482 | 1.2e-40 | |
| UNIPROTKB|Q3SZW1 | 367 | TSSK1B "Testis-specific serine | 0.492 | 0.465 | 0.482 | 1.2e-40 | |
| RGD|1307352 | 365 | Tssk1b "testis-specific serine | 0.463 | 0.441 | 0.5 | 1.2e-40 | |
| UNIPROTKB|H9GWF8 | 368 | TSSK1B "Uncharacterized protei | 0.492 | 0.464 | 0.482 | 1.2e-40 | |
| UNIPROTKB|F1RK79 | 358 | TSSK2 "Uncharacterized protein | 0.463 | 0.449 | 0.506 | 1.2e-40 |
| FB|FBgn0031784 CG9222 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 4.7e-48, P = 4.7e-48
Identities = 97/176 (55%), Positives = 125/176 (71%)
Query: 1 NDILLDYNTDK-------ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSD 53
N LLDY ++ +R F QL A++Y H K VVHRDIKCENLLLD+ +N+KL D
Sbjct: 158 NGTLLDYVRERKFLDEPQSRTLFKQLVSAVEYIHSKGVVHRDIKCENLLLDENWNLKLID 217
Query: 54 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 113
FGFARK +D + LS+TFCGSYAYASPEILKGV Y P SDIW+ GVV +AMV+GR
Sbjct: 218 FGFARK-DTRTSDNQVILSKTFCGSYAYASPEILKGVAYDPFMSDIWACGVVCYAMVFGR 276
Query: 114 LPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPW 169
LP+D +N LLK++ + +VFP+SP SS CK +I +IL+PVK R + +++DPW
Sbjct: 277 LPYDGSNVHILLKRINQSLVFPKSPSASSECKHMIMHILAPVKIRYNIPQVKEDPW 332
|
|
| UNIPROTKB|F6RLA2 TSSK4 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 4.6e-41, P = 4.6e-41
Identities = 88/169 (52%), Positives = 112/169 (66%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR----KYSVNNT-D 66
A +WFSQL I Y H K +VHRD+K ENLLLD + N+K+SDFGFA+ SV N+
Sbjct: 123 AGKWFSQLTLGIAYLHSKGIVHRDLKLENLLLDKRENVKISDFGFAKMVPSNQSVRNSPS 182
Query: 67 YKQ-----NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
Y+Q +LS+T+CGS+AYA PEIL G+PY P SD WSMGV+L+ +V RLPFDDTN
Sbjct: 183 YRQMNCFSHLSQTYCGSFAYACPEILLGLPYNPFLSDTWSMGVILYTLVVARLPFDDTNL 242
Query: 122 SELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWL 170
+LLK+ QK V FP + +S CK LI L R + DI +DPW+
Sbjct: 243 KKLLKETQKEVTFPPNYAISQECKNLILQTLRQAPKRATILDIIKDPWV 291
|
|
| UNIPROTKB|E2R1G2 TSSK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 434 (157.8 bits), Expect = 7.5e-41, P = 7.5e-41
Identities = 82/164 (50%), Positives = 116/164 (70%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D ARR F QL+ AI YCH +VHRD+KCENLLLD +NIKLSDFGF+++ + + +
Sbjct: 111 DDARRKFHQLSSAIKYCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRL 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD++ ++L+ Q
Sbjct: 170 TLSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
+ RV FP S L+ CK LI +L P V R+ +++I WL+
Sbjct: 230 EHRVDFPRSKNLTGECKDLIYRMLQPDVNRRLHIDEILSHSWLQ 273
|
|
| UNIPROTKB|G3N136 G3N136 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 433 (157.5 bits), Expect = 9.6e-41, P = 9.6e-41
Identities = 82/164 (50%), Positives = 116/164 (70%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR+ F QL+ A+ YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + +
Sbjct: 111 DVARKMFRQLSSAVKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDGSGRL 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD++ ++L+ Q
Sbjct: 170 TLSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
+ RV FP S L+ CK LI IL P V R+ +++I WL+
Sbjct: 230 EHRVDFPRSKNLTGECKDLIYRILQPDVTRRLHIDEILSHAWLQ 273
|
|
| UNIPROTKB|F1RK80 TSSK1B "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 432 (157.1 bits), Expect = 1.2e-40, P = 1.2e-40
Identities = 83/176 (47%), Positives = 121/176 (68%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR+ F QL+ AI YCH +VHRD+KCENLLLD +NIKLSDFGF+++ + + +
Sbjct: 111 DDARKKFHQLSSAIKYCHDMDIVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRL 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q
Sbjct: 170 TLSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSA 183
+ RV FP S L+ CK LI +L P V R+ ++++ W++ + G S +A
Sbjct: 230 EHRVNFPRSKHLTGECKDLIYRMLQPDVNRRLHIDEVLSHCWVQPKAR--GLSSAA 283
|
|
| UNIPROTKB|G3N2D2 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 432 (157.1 bits), Expect = 1.2e-40, P = 1.2e-40
Identities = 85/176 (48%), Positives = 121/176 (68%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR+ F QL+ AI YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + +
Sbjct: 111 DDARKKFHQLSSAIKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRL 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q
Sbjct: 170 TLSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSA 183
+ RV FP S L+ CK LI +L P V R+ +++I W++ + G S +A
Sbjct: 230 EHRVNFPRSKHLTGECKDLIYRMLQPDVTRRLHIDEILSHCWVQPKAR--GLSSAA 283
|
|
| UNIPROTKB|Q3SZW1 TSSK1B "Testis-specific serine/threonine-protein kinase 1" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 432 (157.1 bits), Expect = 1.2e-40, P = 1.2e-40
Identities = 85/176 (48%), Positives = 121/176 (68%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR+ F QL+ AI YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + +
Sbjct: 111 DDARKKFHQLSSAIKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRL 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q
Sbjct: 170 TLSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSA 183
+ RV FP S L+ CK LI +L P V R+ +++I W++ + G S +A
Sbjct: 230 EHRVNFPRSKHLTGECKDLIYRMLQPDVTRRLHIDEILSHCWVQPKAR--GLSSAA 283
|
|
| RGD|1307352 Tssk1b "testis-specific serine kinase 1B" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 432 (157.1 bits), Expect = 1.2e-40, P = 1.2e-40
Identities = 82/164 (50%), Positives = 116/164 (70%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR+ F QL+ AI YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + + +
Sbjct: 111 DDARKKFHQLSSAIKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRL 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q
Sbjct: 170 TLSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
+ RV FP S L+ CK LI +L P V R+ +++I W++
Sbjct: 230 EHRVNFPRSKHLTGECKDLIYRMLQPDVNRRLHIDEILSHCWVQ 273
|
|
| UNIPROTKB|H9GWF8 TSSK1B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 432 (157.1 bits), Expect = 1.2e-40, P = 1.2e-40
Identities = 85/176 (48%), Positives = 121/176 (68%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D ARR F QL+ AI YCH +VHRD+KCENLLLD +NIKLSDFGF+++ + + +
Sbjct: 111 DDARRKFHQLSSAIKYCHDLDIVHRDLKCENLLLDKDFNIKLSDFGFSKR-CLRDDSGRL 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD+N ++L+ Q
Sbjct: 170 TLSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSNIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSA 183
+ RV FP S L+ CK LI +L P V R+ +++I W++ + G S +A
Sbjct: 230 EHRVNFPLSKHLTGECKDLIYRMLQPDVNRRLHIDEILSHCWVQPKTR--GLSSAA 283
|
|
| UNIPROTKB|F1RK79 TSSK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 432 (157.1 bits), Expect = 1.2e-40, P = 1.2e-40
Identities = 83/164 (50%), Positives = 116/164 (70%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR+ F QL+ A+ YCH VVHRD+KCENLLLD +NIKLSDFGF+++ + T +
Sbjct: 111 DVARKMFRQLSSAVKYCHDLDVVHRDLKCENLLLDKDFNIKLSDFGFSKRCLRDGTG-RI 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK-QV 128
LS+TFCGS AYA+PE+L+G+PY P+ DIWS+GV+L+ MV G +P+DD++ ++L+ Q
Sbjct: 170 ILSKTFCGSAAYAAPEVLQGIPYQPKVYDIWSLGVILYIMVCGSMPYDDSDIKKMLRIQK 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
+ RV FP S L+ CK LI IL P V R+ +++I WL+
Sbjct: 230 EHRVDFPRSKNLTGECKDLIYRILQPDVNRRLHIDEILSHSWLQ 273
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 347 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-25 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-25 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-24 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-21 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-20 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-20 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-20 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-19 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-19 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-19 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-19 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-19 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-19 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-18 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-18 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-18 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-18 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-17 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-17 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-17 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-16 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-15 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-15 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-15 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-14 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-10 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-06 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-05 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-05 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.001 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.001 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.001 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.001 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.001 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 0.001 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.002 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 0.002 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 0.002 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.002 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 0.003 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.003 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.003 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 59/165 (35%), Positives = 89/165 (53%), Gaps = 11/165 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D+AR + Q+ A++Y H K +VHRD+K EN+LLD+ ++KL+DFG AR+
Sbjct: 97 DEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-- 154
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQV 128
TF G+ Y +PE+L G Y DIWS+GV+L+ ++ G+ PF D EL K++
Sbjct: 155 ----TFVGTPEYMAPEVLLGKGYGK-AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
Query: 129 QKR--VVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWL 170
K P +S K LI +L + R+ E+ Q P+
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 53/169 (31%), Positives = 90/169 (53%), Gaps = 14/169 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D+A++ Q+ ++Y H ++HRD+K EN+LLD+ +K++DFG A+K +++
Sbjct: 98 DEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT- 156
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
TF G+ Y +PE+L G + D+WS+GV+L+ ++ G+ PF N + L+ ++
Sbjct: 157 ----TFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 130 KR------VVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWL 170
+ P+ S K LI L+ P K R E+I Q PW
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSK-RPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 5e-38
Identities = 57/164 (34%), Positives = 94/164 (57%), Gaps = 15/164 (9%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
AR + +++ A++Y H +++RD+K EN+LLD +IKL+DFG A++ S +
Sbjct: 95 ARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN--- 151
Query: 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QK 130
TFCG+ Y +PE+L G Y D WS+GV+L+ M+ G+ PF + E+ +++ +
Sbjct: 152 --TFCGTPEYLAPEVLLGKGYGK-AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208
Query: 131 RVVFPESPRLSSSCKALISNIL--SPVKFRIQ---MEDIRQDPW 169
+ FPE LS + LIS +L P K R+ E+I+ P+
Sbjct: 209 PLRFPEF--LSPEARDLISGLLQKDPTK-RLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 8e-38
Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 7/155 (4%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
WF QL A+ Y H + ++HRDIK +N+ L +KL DFG ++ S + D + T
Sbjct: 108 WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAK----T 162
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 134
G+ Y SPE+ + PY +SDIWS+G VL+ + + PF+ N EL ++ K
Sbjct: 163 VVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP 221
Query: 135 PESPRLSSSCKALISNILSPV-KFRIQMEDIRQDP 168
P + SS + L+S++L + R + I Q P
Sbjct: 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 38/101 (37%), Positives = 64/101 (63%), Gaps = 6/101 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYK 68
D+ R Q+ + ++Y H ++HRD+K EN+LLD D +KL+DFG ++ + +
Sbjct: 92 DEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK---- 147
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM 109
+L +T G+ AY +PE+L G Y ++SDIWS+GV+L+ +
Sbjct: 148 -SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 24/174 (13%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR------KYSVNNTDYKQN 70
+++ A++Y H K ++HRD+K EN+LLD +IK++DFG A+ N D
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 71 LSE---------TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
S+ +F G+ Y SPE+L P SD+W++G +++ M+ G+ PF +N
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNE 227
Query: 122 SELLKQVQKR-VVFPESPRLSSSCKALISNIL--SPVK---FRIQMEDIRQDPW 169
+++ K FP P K LI +L P ++++ P+
Sbjct: 228 YLTFQKILKLEYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 46/171 (26%), Positives = 87/171 (50%), Gaps = 9/171 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR + +++ A++Y H ++HRD+K +N+L+D ++KL+DFG ++ V
Sbjct: 93 DVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152
Query: 70 NLS---ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ + G+ Y +PE++ G ++ D WS+G +L+ + G PF E+ +
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQGHSK-TVDWWSLGCILYEFLVGIPPFHGETPEEIFQ 211
Query: 127 QVQKRVV-FPESPRLSSSCKALISNILSP-VKFRIQM---EDIRQDPWLKE 172
+ + +PE +S LIS +L P + R+ E+I+ P+ K
Sbjct: 212 NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 14 RWFSQLADAIDYCH-----KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 68
R +QL A+ CH +V+HRD+K N+ LD N+KL DFG A+ +
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-----ILGHD 163
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ ++T+ G+ Y SPE L + Y +SDIWS+G +++ + PF N +L ++
Sbjct: 164 SSFAKTYVGTPYYMSPEQLNHMSYDE-KSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
Query: 129 QKRVVFPESPRLSSSCKALISNIL 152
++ R SS +I ++L
Sbjct: 223 KEGKFRRIPYRYSSELNEVIKSML 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 40/203 (19%)
Query: 4 LLDYNT---DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 60
L+ + + AR + ++L A+D HK +HRDIK +N+L+D +IKL+DFG +K
Sbjct: 92 LIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151
Query: 61 -SVNNTDYKQN-----------------------LSETFCGSYAYASPEILKGVPYTPQQ 96
+ +Y N + + G+ Y +PE+L+G PY +
Sbjct: 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE- 210
Query: 97 SDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-------VFPESPRLSSSCKALIS 149
D WS+GV+L+ M+YG PF YS+ L++ ++ FP P +S LI
Sbjct: 211 CDWWSLGVILYEMLYGFPPF----YSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLIC 266
Query: 150 NILSPVKFRI-QMEDIRQDPWLK 171
+L + R+ E+I+ P+ K
Sbjct: 267 RLLCDPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 7/161 (4%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 72
R++ Q+ + + Y H +VHRDIK N+L+D +KL+DFG A++ + + + +
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR--LGDIET-GEGT 160
Query: 73 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKR 131
+ G+ + +PE+++G Y +DIWS+G + M G+ P+ + L ++
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGR-AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS 219
Query: 132 VVFPESP-RLSSSCKALISNILSP-VKFRIQMEDIRQDPWL 170
PE P LS K + L K R +++ Q P+L
Sbjct: 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 51/165 (30%), Positives = 79/165 (47%), Gaps = 9/165 (5%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 72
R + QL + + Y H +VHRDIK N+ LD IKL DFG A K N T + +
Sbjct: 102 RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV- 160
Query: 73 ETFCGSYAYASPEILKGVPYTPQQ--SDIWSMGVVLFAMVYGRLPFD--DTNYSELLKQV 128
++ G+ AY +PE++ G +DIWS+G V+ M G+ P+ D + +
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG 220
Query: 129 QK-RVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWL 170
+ P+S +LS K + L P K R ++ Q P++
Sbjct: 221 AGHKPPIPDSLQLSPEGKDFLDRCLESDPKK-RPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 56/174 (32%), Positives = 94/174 (54%), Gaps = 12/174 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ D A+ + ++L AI H+ VHRDIK EN+L+D +IKL+DFG A + + N
Sbjct: 99 FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN--- 155
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQS-----DIWSMGVVLFAMVYGRLPFDDTNY 121
K S+ G+ Y +PE+L + + + D WS+GV+ + M+YGR PF +
Sbjct: 156 -KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
Query: 122 SELLKQV---QKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKE 172
++ + Q+ + FPE P++SS LI ++L K R+ E + P+ +
Sbjct: 215 AKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 50/147 (34%), Positives = 89/147 (60%), Gaps = 9/147 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ ++AR + +++ A++Y H + VV+RDIK ENL+LD +IK++DFG ++ +
Sbjct: 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
K TFCG+ Y +PE+L+ Y + D W +GVV++ M+ GRLPF + ++ L +
Sbjct: 152 MK-----TFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 205
Query: 127 QV-QKRVVFPESPRLSSSCKALISNIL 152
+ + + FP + LS K+L++ +L
Sbjct: 206 LILMEEIRFPRT--LSPEAKSLLAGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 60/184 (32%), Positives = 96/184 (52%), Gaps = 27/184 (14%)
Query: 2 DILLD---YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 58
IL D ++ AR + + + A +Y H + +++RD+K ENLLLD +KL DFGFA+
Sbjct: 82 TILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
Query: 59 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-- 116
K + TFCG+ Y +PEI+ Y D WS+G++L+ ++ GR PF
Sbjct: 142 KLKSGQKTW------TFCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGE 194
Query: 117 DDTN----YSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQM-----EDIR 165
DD + Y+++LK K + FP + + K LI +L P + R+ +DI+
Sbjct: 195 DDEDPMEIYNDILKGNGK-LEFP--NYIDKAAKDLIKQLLRRNPEE-RLGNLKGGIKDIK 250
Query: 166 QDPW 169
+ W
Sbjct: 251 KHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-24
Identities = 51/149 (34%), Positives = 81/149 (54%), Gaps = 12/149 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ AR + +Q+ A++Y H +V+RD+K ENLLLD IK++DFGFA K T
Sbjct: 98 FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA-KRVKGRT- 155
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
T CG+ Y +PEI+ Y + D W++G++++ M+ G PF D N ++ +
Sbjct: 156 ------YTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208
Query: 127 Q-VQKRVVFPESPRLSSSCKALISNILSP 154
+ ++ +V FP S K LI N+L
Sbjct: 209 KILEGKVRFPSF--FSPDAKDLIRNLLQV 235
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 9e-24
Identities = 52/148 (35%), Positives = 90/148 (60%), Gaps = 9/148 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ +AR + ++L A++ HK +V++RD+K EN+LLD + +I L DFG K ++ + D
Sbjct: 90 FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLC-KLNMKDDD 148
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ TFCG+ Y +PE+L G YT + D W++GV+L+ M+ G PF D N +E+ +
Sbjct: 149 K----TNTFCGTPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR 203
Query: 127 QV-QKRVVFPESPRLSSSCKALISNILS 153
++ Q+ + FP+ K L+ +LS
Sbjct: 204 KILQEPLRFPDG--FDRDAKDLLIGLLS 229
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-23
Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 17/169 (10%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D A+++ +++ ++ H++ ++HRDIK ENLL+D ++KL+DFG +R N
Sbjct: 97 DWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------ 150
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ F G+ Y +PE + GV + SD WS+G V+F ++G PF + +
Sbjct: 151 ---KKFVGTPDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206
Query: 130 KRVV-FPESPRLSSSCKA--LISNILSP-VKFRIQ---MEDIRQDPWLK 171
R + +PE + S +A LI+ +L R+ ++I+ P+ K
Sbjct: 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 7e-23
Identities = 51/148 (34%), Positives = 89/148 (60%), Gaps = 11/148 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-YSVNNT 65
++ D+AR + +++ A+ Y H VV+RD+K ENL+LD +IK++DFG ++ S T
Sbjct: 92 FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 125
+TFCG+ Y +PE+L+ Y + D W +GVV++ M+ GRLPF + ++ +L
Sbjct: 152 ------MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204
Query: 126 KQV-QKRVVFPESPRLSSSCKALISNIL 152
+ + + + FP LS K+L++ +L
Sbjct: 205 ELILMEEIRFPR--TLSPEAKSLLAGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 8e-23
Identities = 50/147 (34%), Positives = 90/147 (61%), Gaps = 9/147 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ D+ R + +++ A+DY H +V+RD+K ENL+LD +IK++DFG ++ +
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
K TFCG+ Y +PE+L+ Y + D W +GVV++ M+ GRLPF + ++ +L +
Sbjct: 152 MK-----TFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205
Query: 127 QV-QKRVVFPESPRLSSSCKALISNIL 152
+ + + FP + LS+ K+L+S +L
Sbjct: 206 LILMEDIKFPRT--LSADAKSLLSGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-23
Identities = 43/134 (32%), Positives = 68/134 (50%), Gaps = 14/134 (10%)
Query: 16 FSQLADAIDYCHKKS-VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
Q+ +DY H K ++HRDIK NLL++ K +K++DFG ++ + NT + N T
Sbjct: 105 ARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCN---T 159
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELLKQVQKR 131
F G+ Y SPE ++G Y +DIWS+G+ L G+ PF + EL++
Sbjct: 160 FVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA---- 214
Query: 132 VVFPESPRLSSSCK 145
+ P L +
Sbjct: 215 ICDGPPPSLPAEEF 228
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.1 bits (240), Expect = 1e-22
Identities = 55/241 (22%), Positives = 93/241 (38%), Gaps = 17/241 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNT 65
+ +A +Q+ A++Y H K ++HRDIK EN+LLD +KL DFG A+ +
Sbjct: 98 LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
Query: 66 DYKQN-LSETFCGSYAYASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
L T G+ Y +PE+L G + Y SDIWS+G+ L+ ++ G PF+ S
Sbjct: 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217
Query: 123 ELLKQVQKRVVFPESPRL------------SSSCKALISNILSPVKF-RIQMEDIRQDPW 169
Q K ++ +P L S + L+ +L+ R+
Sbjct: 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
Query: 170 LKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQA 229
L + + + +++ + + SK A
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELA 337
Query: 230 P 230
P
Sbjct: 338 P 338
|
Length = 384 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 50/169 (29%), Positives = 96/169 (56%), Gaps = 15/169 (8%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+AR + +++ + + H++ +++RD+K +N+LLD + +IK++DFG ++ +
Sbjct: 97 RARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-----V 151
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-Q 129
+ TFCG+ Y +PEIL PY P D W++GV+L+ M+ G+ PF+ + EL + + +
Sbjct: 152 TTSTFCGTPDYIAPEILSYQPYGP-AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
Query: 130 KRVVFPESPRLSSSCKALISNILS--PVK----FRIQMEDIRQDPWLKE 172
V +P LS K+++ + L+ P K +DI+ P+ +E
Sbjct: 211 DEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 42/171 (24%), Positives = 86/171 (50%), Gaps = 16/171 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ ++ + W ++ A++Y H K ++HRDIK +N+LLD++ ++ ++DF A K +
Sbjct: 97 FSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT----- 151
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF---DDTNYSE 123
L+ + G+ Y +PE+L Y+ D WS+GV + + G+ P+ T +
Sbjct: 152 -PDTLTTSTSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209
Query: 124 LL-KQVQKRVVFPESPRLSSSCKALISNILSP---VKFRIQMEDIRQDPWL 170
+ KQ V++P S+ I+ +L + ++D++ P+
Sbjct: 210 IRAKQETADVLYP--ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 54/155 (34%), Positives = 80/155 (51%), Gaps = 14/155 (9%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
R+F Q+ + + H K ++HRDIK NL LD N+K+ D G A+ S N N +
Sbjct: 105 RFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-----NFAN 159
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 133
T G+ Y SPE+ + PY ++SD+W++GVVL+ G+ PFD N L+ ++ + V
Sbjct: 160 TIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF 218
Query: 134 FPESPRLSSSCKALISNILSPVKFRIQMEDIRQDP 168
P S S LI L+ +D RQ P
Sbjct: 219 PPVSQMYSQQLAQLIDQCLT--------KDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-22
Identities = 53/148 (35%), Positives = 93/148 (62%), Gaps = 10/148 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCH-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 65
++ D+AR + +++ A+DY H +K+VV+RD+K ENL+LD +IK++DFG ++ +
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 125
K TFCG+ Y +PE+L+ Y + D W +GVV++ M+ GRLPF + ++ +L
Sbjct: 152 TMK-----TFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 205
Query: 126 KQV-QKRVVFPESPRLSSSCKALISNIL 152
+ + + + FP + LS K+L+S +L
Sbjct: 206 ELILMEEIRFPRT--LSPEAKSLLSGLL 231
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 55/170 (32%), Positives = 94/170 (55%), Gaps = 13/170 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ +AR + +++ + + HKK +++RD+K +N+LLD +IK++DFG ++
Sbjct: 93 FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-----NM 147
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ + TFCG+ Y +PEILKG Y + D WS GV+L+ M+ G+ PF + EL
Sbjct: 148 NGEGKASTFCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206
Query: 127 QVQKRVVFPESPR-LSSSCKALISNIL--SPVKFRIQME-DIRQDPWLKE 172
+ P PR +S K +S + P K R+ ++ DIRQ P+ +
Sbjct: 207 SI--LNDRPHFPRWISKEAKDCLSKLFERDPTK-RLGVDGDIRQHPFFRG 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 32/117 (27%), Positives = 56/117 (47%), Gaps = 8/117 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
++Y H ++HRDIK N+LL +KL DFG + + S T G+ +
Sbjct: 110 GLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS------DTKARNTMVGTPYW 163
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP 138
+PE++ G PY ++DIWS+G+ + G+ P+ + + L ++ P
Sbjct: 164 MAPEVINGKPYDY-KADIWSLGITAIELAEGKPPYSELPPMKALFKI-ATNGPPGLR 218
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-21
Identities = 40/118 (33%), Positives = 64/118 (54%), Gaps = 8/118 (6%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY-SVNNTDYKQNL 71
+ + QL + + Y H ++HRDIK N+L+++ +KL+DFG AR Y N+ DY N
Sbjct: 103 KCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNR 161
Query: 72 SETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
T Y PE+L G Y P + D+WS+G +L + G+ F + E L+++
Sbjct: 162 VITLW----YRPPELLLGATRYGP-EVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-21
Identities = 46/138 (33%), Positives = 77/138 (55%), Gaps = 6/138 (4%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ Q+ A+ Y HK ++HRDIK N+ L IKL DFG ++ ++Y +++ET
Sbjct: 106 YLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL---GSEY--SMAET 160
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 134
G+ Y SPE+ +GV Y +SDIW++G VL+ ++ + FD TN L+ ++ +
Sbjct: 161 VVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT 219
Query: 135 PESPRLSSSCKALISNIL 152
P SS +L+ ++L
Sbjct: 220 PVVSVYSSELISLVHSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-20
Identities = 54/167 (32%), Positives = 93/167 (55%), Gaps = 10/167 (5%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNI-KLSDFGFARKYSVNNT 65
++ D+ WF Q++ + + H + ++HRDIK +N+ L + KL DFG AR +N++
Sbjct: 98 FSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDS 155
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 125
L+ T G+ Y SPEI + PY ++DIWS+G VL+ + + PF+ N +L+
Sbjct: 156 ---MELAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211
Query: 126 KQVQKRVVFPESPRLSSSCKALISNI--LSPVKFRIQMEDIRQDPWL 170
++ + P SP S ++LIS + +SP + R + I + P+L
Sbjct: 212 LKICQGYFAPISPNFSRDLRSLISQLFKVSP-RDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-20
Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 11/157 (7%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNI-KLSDFGFARKYSVNNTDYKQNLSE 73
+F Q+ A+ + H K ++HRD+K +N+LLD + K+ DFG ++ S + Y
Sbjct: 106 FFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY------ 159
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 133
T G+ Y SPE+ +G PY Q+SDIW++G VL+ + + F+ N L+ ++
Sbjct: 160 TVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF 218
Query: 134 FPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDP 168
P S R S + LI ++L+ P K R Q+ I P
Sbjct: 219 APISDRYSPDLRQLILSMLNLDPSK-RPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 55/172 (31%), Positives = 91/172 (52%), Gaps = 15/172 (8%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
AR + +++ A+D H +HRD+K +N+LLD ++KL+DFG K N
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG----MVR 199
Query: 72 SETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDT---NYSEL 124
+T G+ Y SPE+LK G Y ++ D WS+GV L+ M+ G PF D+ YS++
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
Query: 125 LKQVQKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKED 173
+ + + FP+ +S K LI L+ + R+ +++I+ P+ K D
Sbjct: 260 MDH-KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 47/127 (37%), Positives = 78/127 (61%), Gaps = 10/127 (7%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D A+ + ++L A +Y H K +++RD+K ENLLLD+K ++K++DFGFA+K V + +
Sbjct: 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK--VPDRTF-- 173
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQV 128
T CG+ Y +PE+++ + + D W+MGV+L+ + G PF DDT + K +
Sbjct: 174 ----TLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228
Query: 129 QKRVVFP 135
R+ FP
Sbjct: 229 AGRLKFP 235
|
Length = 329 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-20
Identities = 45/144 (31%), Positives = 79/144 (54%), Gaps = 4/144 (2%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 72
R + Q+ ++Y H + ++HRDIK N+L+D+K IK+SDFG ++K N+ K N +
Sbjct: 109 RNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 73 E-TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR 131
+ GS + +PE++K YT ++DIWS+G ++ M+ G+ PF D + + ++ +
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTR-KADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN 227
Query: 132 VVFPESP-RLSSSCKALISNILSP 154
PE P +SS +
Sbjct: 228 AS-PEIPSNISSEAIDFLEKTFEI 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 46/143 (32%), Positives = 84/143 (58%), Gaps = 9/143 (6%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+AR + +++A A+ Y H ++++RD+K EN+LLD + ++ L+DFG ++ ++ +
Sbjct: 97 RARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE----GIEHSKT 152
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-Q 129
S TFCG+ Y +PE+L+ PY + D W +G VL+ M+YG PF + +E+ +
Sbjct: 153 TS-TFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210
Query: 130 KRVVFPESPRLSSSCKALISNIL 152
K + P +S S + L+ +L
Sbjct: 211 KPLRLK--PNISVSARHLLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 6e-20
Identities = 44/130 (33%), Positives = 78/130 (60%), Gaps = 7/130 (5%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ +AR + +++ A+ + H K +++RD+K +N+LLD + + KL+DFG ++ N
Sbjct: 93 FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ TFCG+ Y +PEIL+ + Y P D W+MGV+L+ M+ G PF+ N +L +
Sbjct: 152 ----TTSTFCGTPDYIAPEILQEMLYGP-SVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206
Query: 127 QVQK-RVVFP 135
+ VV+P
Sbjct: 207 AILNDEVVYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 46/138 (33%), Positives = 83/138 (60%), Gaps = 4/138 (2%)
Query: 16 FSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 75
F Q+ A+ + H K ++HRDIK N+LL +KL DFGF++ Y+ +D ++ TF
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD---DVGRTF 205
Query: 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP 135
CG+ Y +PEI + PY+ +++D++S+GV+L+ ++ + PFD N E++ + P
Sbjct: 206 CGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264
Query: 136 ESPRLSSSCKALISNILS 153
P +S + +++ +LS
Sbjct: 265 LPPSISPEMQEIVTALLS 282
|
Length = 496 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 47/142 (33%), Positives = 83/142 (58%), Gaps = 7/142 (4%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+AR + +++A A+ Y H ++V+RD+K EN+LLD + +I L+DFG ++ +N
Sbjct: 97 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-----G 151
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
+ TFCG+ Y +PE+L PY + D W +G VL+ M+YG PF N +E+ +
Sbjct: 152 TTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
Query: 131 RVVFPESPRLSSSCKALISNIL 152
+ + P +++S + L+ +L
Sbjct: 211 KPL-QLKPNITNSARHLLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 38/184 (20%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + YCH ++HRD+K +N+L++ +KL+DFG AR + + Y T
Sbjct: 106 QLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE-VVTLW- 163
Query: 78 SYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPF-------------------D 117
Y +PEIL G Y+ DIWS+G + M+ G+ F
Sbjct: 164 ---YRAPEILLGSKHYST-AVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219
Query: 118 DTNYSELLKQVQKRVVFPES---------PRLSSSCKALISNILS--PVKFRIQMEDIRQ 166
+ ++ + K + FP+ PRL L+S +L P K RI ++ +
Sbjct: 220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RISAKEALK 278
Query: 167 DPWL 170
P+
Sbjct: 279 HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 11/157 (7%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
R F QL + H++ ++HRD+K N+LL +K+ D G ++ K+N+++
Sbjct: 107 RIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL-------KKNMAK 159
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 133
T G+ Y +PE+ KG PY+ +SDIWS+G +L+ M PF+ + +L +VQ+
Sbjct: 160 TQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY 218
Query: 134 FPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDP 168
P P S + I ++L P R + I P
Sbjct: 219 PPIPPIYSQDLQNFIRSMLQVKPKL-RPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 40/130 (30%), Positives = 80/130 (61%), Gaps = 7/130 (5%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ ++R + +++ A+ + H+ V++RD+K +N+LLD + + KL+DFG ++ +N
Sbjct: 93 FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-- 150
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ TFCG+ Y +PEIL+ + Y P D W++GV+++ M+ G+ PF+ N +L +
Sbjct: 151 ---VTTTTFCGTPDYIAPEILQELEYGP-SVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
Query: 127 QV-QKRVVFP 135
+ V++P
Sbjct: 207 SILHDDVLYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 48/144 (33%), Positives = 88/144 (61%), Gaps = 9/144 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ + + + ++LA A+D+ H +++RD+K EN+LLD++ +IKL+DFG + K S+++
Sbjct: 95 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-KESIDH-- 151
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ + +FCG+ Y +PE++ +T Q +D WS GV++F M+ G LPF + E +
Sbjct: 152 --EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMT 208
Query: 127 QVQK-RVVFPE--SPRLSSSCKAL 147
+ K ++ P+ SP S +AL
Sbjct: 209 MILKAKLGMPQFLSPEAQSLLRAL 232
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 43/211 (20%)
Query: 3 ILLDYNT---DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFG---- 55
+L+ +T ++ R + ++ AID HK +HRDIK +NLLLD K +IKLSDFG
Sbjct: 91 LLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150
Query: 56 --------FAR---KYSVNN---------------TDYKQN---LSETFCGSYAYASPEI 86
F R +N +K+N L+ + G+ Y +PE+
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSS 143
Y ++ D WS+GV+++ M+ G PF N E +++ ++ + FP+ LS
Sbjct: 211 FLQTGYN-KECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPE 269
Query: 144 CKALISNILSPVKFRIQ---MEDIRQDPWLK 171
K LI + + R+ + +I+ P+ K
Sbjct: 270 AKDLIKRLCCEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-19
Identities = 49/146 (33%), Positives = 77/146 (52%), Gaps = 6/146 (4%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ D+ WF Q+ A+ + H + ++HRDIK +N+ L IKL DFG AR +N+T
Sbjct: 98 FPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNST- 154
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
L+ T G+ Y SPEI + PY +SDIW++G VL+ M + F+ N L+
Sbjct: 155 --VELARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
Query: 127 QVQKRVVFPESPRLSSSCKALISNIL 152
++ + P S S + L+S +
Sbjct: 212 KIIRGSYPPVSSHYSYDLRNLVSQLF 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 57/172 (33%), Positives = 92/172 (53%), Gaps = 15/172 (8%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
A+ + +++ A+D H ++HRD+K +N+LLD ++KL+DFG K
Sbjct: 144 AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR---- 199
Query: 72 SETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDT---NYSEL 124
+T G+ Y SPE+LK G Y ++ D WS+GV LF M+ G PF D+ YS++
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
Query: 125 LKQVQKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKED 173
+ + + FPE +S K LI L+ + R+ +E+I+Q P+ K D
Sbjct: 260 MDH-KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-19
Identities = 50/131 (38%), Positives = 80/131 (61%), Gaps = 15/131 (11%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ D+A+ + ++L A+++ HK +V+RD+K EN+LLD +I L DFG ++ N TD
Sbjct: 93 FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTD 149
Query: 67 YKQNLSETFCGSYAYASPEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
K + TFCG+ Y +PE+L KG YT + D WS+GV++F M G PF Y+E
Sbjct: 150 NK--TTNTFCGTTEYLAPEVLLDEKG--YT-KHVDFWSLGVLVFEMCCGWSPF----YAE 200
Query: 124 LLKQVQKRVVF 134
+Q+ + + F
Sbjct: 201 DTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 40/151 (26%), Positives = 85/151 (56%), Gaps = 10/151 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ + R + +++ A+D+ H+ +++RDIK EN+LLD + ++ L+DFG ++++ +
Sbjct: 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQS-DIWSMGVVLFAMVYGRLPF----DDTNY 121
+ +FCG+ Y +PE+++G ++ D WS+GV+ F ++ G PF + +
Sbjct: 162 R----AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217
Query: 122 SELLKQVQKRVVFPESPRLSSSCKALISNIL 152
SE+ +++ K P +S+ + I +L
Sbjct: 218 SEISRRILKSKP-PFPKTMSAEARDFIQKLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 6e-19
Identities = 32/91 (35%), Positives = 56/91 (61%), Gaps = 2/91 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V LA + + VAIK+I K + I ++ + REI+++K LKHPN++R E
Sbjct: 11 SFGKVYLARDKKTGKLVAIKVIKKKK--IKKDRERILREIKILKKLKHPNIVRLYDVFED 68
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
++Y++MEY + G L ++++K + ED+A
Sbjct: 69 EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEA 99
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 25/176 (14%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR + +++ AID H+ VHRDIK +N+LLD +I+L+DFG + + T
Sbjct: 102 DMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT---- 157
Query: 70 NLSETFCGSYAYASPEILKGVP-----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
S G+ Y SPEIL+ + Y P + D WS+GV ++ M+YG PF Y+E
Sbjct: 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGP-ECDWWSLGVCMYEMLYGETPF----YAES 212
Query: 125 LKQV-------QKRVVFP-ESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPW 169
L + ++ FP + +S K LI ++ + R+ ++D + P+
Sbjct: 213 LVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-19
Identities = 48/153 (31%), Positives = 81/153 (52%), Gaps = 24/153 (15%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ + S++ A++Y H K +V+RD+K EN+LLD + +IKL+DFGFA+K
Sbjct: 98 FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----- 152
Query: 67 YKQNLSETFCGSYAYASPEIL------KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+ + T CG+ Y +PE++ K V D W++G++++ M+ G PF D N
Sbjct: 153 ---DRTWTLCGTPEYLAPEVIQSKGHNKAV-------DWWALGILIYEMLVGYPPFFDDN 202
Query: 121 YSELL-KQVQKRVVFPESPRLSSSCKALISNIL 152
+ K + ++ FP L K LI +L
Sbjct: 203 PFGIYEKILAGKLEFPRH--LDLYAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 9e-19
Identities = 48/136 (35%), Positives = 82/136 (60%), Gaps = 16/136 (11%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
AR + ++++ A+++ H++ +++RD+K +N+LLD + +IKL+D+G K + D
Sbjct: 98 ARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC-KEGIRPGD----T 152
Query: 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD--------DTNYSE 123
+ TFCG+ Y +PEIL+G Y D W++GV++F M+ GR PFD D N +
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED 211
Query: 124 LLKQV--QKRVVFPES 137
L QV +K++ P S
Sbjct: 212 YLFQVILEKQIRIPRS 227
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-19
Identities = 48/122 (39%), Positives = 69/122 (56%), Gaps = 7/122 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV-NNTDYK 68
+K R + QL AI +CHK +VHRDIK ENLL+ +KL DFGFAR S +N +Y
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ + + Y SPE+L G PY + D+WS+G +L + G+ F + + L +
Sbjct: 160 E-----YVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213
Query: 129 QK 130
QK
Sbjct: 214 QK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 8/129 (6%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+A + +++ + + H K +++RD+K +N++LD +IK++DFG ++ + N
Sbjct: 97 RATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE-----NVFGDN 151
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
+ TFCG+ Y +PEIL+G+ YT D WS GV+L+ M+ G+ PF + EL + +
Sbjct: 152 RASTFCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-- 208
Query: 131 RVVFPESPR 139
RV P PR
Sbjct: 209 RVDTPHYPR 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 6/138 (4%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
WF Q+ + + H+K V+HRDIK +N+ L +KL DFG AR + + T
Sbjct: 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-----SPGAYACT 159
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 134
+ G+ Y PEI + +PY +SDIWS+G +L+ + + PF ++ L+ +V +
Sbjct: 160 YVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK 218
Query: 135 PESPRLSSSCKALISNIL 152
P S ++LI +
Sbjct: 219 PLPSHYSYELRSLIKQMF 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 42/124 (33%), Positives = 73/124 (58%), Gaps = 10/124 (8%)
Query: 22 AIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 80
+ Y H+K ++HRD+K N+L++ + IKL DFG + + VN +L++TF G+ +
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VN------SLAKTFVGTSS 164
Query: 81 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFPESPR 139
Y +PE ++G Y+ +SDIWS+G+ L + GR P+ N + + ++ + +V PR
Sbjct: 165 YMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR 223
Query: 140 LSSS 143
L S
Sbjct: 224 LPSG 227
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 35/194 (18%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDF----------GFARK 59
+ AR + +++ A++Y H +V+RD+K EN+LL + +I LSDF K
Sbjct: 103 EVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162
Query: 60 YSVNNTDYKQNLSET--------------FCGSYAYASPEILKGVPYTPQQSDIWSMGVV 105
+ S F G+ Y +PE++ G + D W++G++
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGIL 221
Query: 106 LFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNILSPVK-------F 157
L+ M+YG PF +N E + K+ V FP SP +SSS + LI +L VK
Sbjct: 222 LYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLL--VKDPSKRLGS 279
Query: 158 RIQMEDIRQDPWLK 171
+ +I+Q P+ +
Sbjct: 280 KRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 53/172 (30%), Positives = 91/172 (52%), Gaps = 19/172 (11%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR + +++ +A+D H+ +HRD+K EN L+D +IKL+DFG ++
Sbjct: 101 DHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-------- 152
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL---- 125
+ + GS Y +PE+L+G Y D WS+G +L+ + G PF + +E
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211
Query: 126 --KQVQKRVVFPESPRLSSSCKA--LISNILSPVKFRIQ-MEDIRQDPWLKE 172
K+ +R V+ + PR + S +A LI+ +++ R +EDI+ P+ KE
Sbjct: 212 YWKETLQRPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 45/138 (32%), Positives = 81/138 (58%), Gaps = 13/138 (9%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+++A + + H K +++RD+K +N++LD + +IK++DFG ++ + TFC
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR-----TFC 162
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FP 135
G+ Y +PEI+ PY + D W+ GV+L+ M+ G+ PFD + EL + + + V +P
Sbjct: 163 GTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221
Query: 136 ESPRLS----SSCKALIS 149
+S LS S CK L++
Sbjct: 222 KS--LSKEAVSICKGLLT 237
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 45/175 (25%), Positives = 93/175 (53%), Gaps = 13/175 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ D+ R + ++ A+++ HK +V+RDIK EN+LLD + ++ L+DFG ++++
Sbjct: 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF----LS 157
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
++ + +FCG+ Y +PEI++G + D WS+G+++F ++ G PF
Sbjct: 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
Query: 127 QVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGKSK 181
+V +R++ C + + P + + +R+DP + + P G S+
Sbjct: 218 EVSRRIL---------KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 54/169 (31%), Positives = 91/169 (53%), Gaps = 11/169 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ +A + +++ + + H K +V+RD+K +N+LLD +IK++DFG ++ + D
Sbjct: 93 FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--D 150
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
K TFCG+ Y +PEIL G Y D WS GV+L+ M+ G+ PF + EL +
Sbjct: 151 AKTC---TFCGTPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206
Query: 127 QVQKRVVFPESPR-LSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKE 172
+ R+ P PR L+ K ++ + P + DIRQ P+ +E
Sbjct: 207 SI--RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 42/104 (40%), Positives = 61/104 (58%), Gaps = 6/104 (5%)
Query: 4 LLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 63
L+ ++ D + + QL + ++YCHKK+ +HRDIKC N+LL++K IKL+DFG AR Y+
Sbjct: 110 LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVL 106
+ N T Y PE+L G Y P D+WS G +L
Sbjct: 170 ESRPYTNKVITLW----YRPPELLLGEERYGP-AIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 45/206 (21%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA--------RKYS 61
D AR + ++L AI+ HK +HRDIK +N+L+D +IKL+DFG KY
Sbjct: 101 DLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 62 VNNTDYKQN------------------------------LSETFCGSYAYASPEILKGVP 91
++Q+ L+ + G+ Y +PE+L
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220
Query: 92 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKALI 148
YT Q D WS+GV+L+ M+ G+ PF +E +V + + P +LS LI
Sbjct: 221 YT-QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLI 279
Query: 149 SNILSPVKFRI---QMEDIRQDPWLK 171
+ + R+ ++I+ P+ K
Sbjct: 280 LRLCCGAEDRLGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 42/136 (30%), Positives = 83/136 (61%), Gaps = 9/136 (6%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
++++ + + H++ +++RD+K +N++LD + +IK++DFG +++ V+ + TFC
Sbjct: 108 AEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-----TTRTFC 162
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFP 135
G+ Y +PEI+ PY + D W+ GV+L+ M+ G+ PFD + EL + + + V +P
Sbjct: 163 GTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221
Query: 136 E--SPRLSSSCKALIS 149
+ S S CK L++
Sbjct: 222 KSLSKEAVSICKGLMT 237
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 39/122 (31%), Positives = 65/122 (53%), Gaps = 7/122 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y K VHRD+ N L+ + +K+SDFG +R V + DY + +
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD--VYDDDYYRKKTGGKL- 169
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK--RVVF 134
+ +PE LK +T +SD+WS GV+L+ G P+ + E+L+ ++K R+
Sbjct: 170 PIRWMAPESLKDGIFTS-KSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK 228
Query: 135 PE 136
PE
Sbjct: 229 PE 230
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-18
Identities = 47/142 (33%), Positives = 83/142 (58%), Gaps = 14/142 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ AR + +++ A+++ H++ +++RD+K +N+LLD +IKL+D+G ++ + D
Sbjct: 96 EHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD--- 151
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD------DTNYSE 123
+ TFCG+ Y +PEIL+G Y D W++GV++F M+ GR PFD D N +
Sbjct: 152 -TTSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209
Query: 124 LLKQV--QKRVVFPESPRLSSS 143
L QV +K + P + +S
Sbjct: 210 YLFQVILEKPIRIPRFLSVKAS 231
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-18
Identities = 48/138 (34%), Positives = 84/138 (60%), Gaps = 16/138 (11%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ AR + ++++ A++Y H++ +++RD+K +N+LLD + +IKL+D+G ++ + D
Sbjct: 96 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD--- 151
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD--------DTNY 121
+ TFCG+ Y +PEIL+G Y D W++GV++F M+ GR PFD D N
Sbjct: 152 -TTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209
Query: 122 SELLKQV--QKRVVFPES 137
+ L QV +K++ P S
Sbjct: 210 EDYLFQVILEKQIRIPRS 227
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 9e-18
Identities = 42/139 (30%), Positives = 79/139 (56%), Gaps = 6/139 (4%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+AR + +++A AI Y H ++++RD+K EN+LLD + ++ L+DFG ++ +
Sbjct: 97 RARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV-----EPEE 151
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
+ TFCG+ Y +PE+L+ PY + D W +G VL+ M+YG PF + S++ +
Sbjct: 152 TTSTFCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
Query: 131 RVVFPESPRLSSSCKALIS 149
+ + + ++C L+
Sbjct: 211 KPLQLPGGKTVAACDLLVG 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 9e-18
Identities = 34/115 (29%), Positives = 60/115 (52%), Gaps = 5/115 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y K+ VHRD+ N L+ + +K+SDFG +R + DY +
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKRGGGKL- 166
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKR 131
+ +PE LK +T +SD+WS GV+L+ + G P+ + E+L+ ++
Sbjct: 167 PIKWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 45/150 (30%), Positives = 84/150 (56%), Gaps = 21/150 (14%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D A + S+++ A+++ H++ +++RD+K EN+LLD + ++KL+DFG ++ T
Sbjct: 100 DTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT---- 155
Query: 70 NLSETFCGSYAYASPEIL------KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
++ TFCG+ Y +PEIL K V D WS+G +++ M+ G PF N +
Sbjct: 156 -VTHTFCGTIEYMAPEILMRSGHGKAV-------DWWSLGALMYDMLTGAPPFTAENRKK 207
Query: 124 LLKQVQK-RVVFPESPRLSSSCKALISNIL 152
+ ++ K ++ P P L+ + L+ +L
Sbjct: 208 TIDKILKGKLNLP--PYLTPEARDLLKKLL 235
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 40/119 (33%), Positives = 73/119 (61%), Gaps = 8/119 (6%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQ 69
+AR + +++A A+ Y H ++V+RD+K EN+LLD + ++ L+DFG ++ + ++T
Sbjct: 97 RARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT---- 152
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ TFCG+ Y +PE+++ PY D W +G VL+ M+YG PF + +E+ +
Sbjct: 153 --TTTFCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 42/136 (30%), Positives = 80/136 (58%), Gaps = 9/136 (6%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+++A + + H K +++RD+K +N++LD + +IK++DFG ++ + K TFC
Sbjct: 108 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-----TFC 162
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFP 135
G+ Y +PEI+ PY + D W+ GV+L+ M+ G+ PF+ + EL + + + V +P
Sbjct: 163 GTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 221
Query: 136 E--SPRLSSSCKALIS 149
+ S + CK L++
Sbjct: 222 KSMSKEAVAICKGLMT 237
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 15/138 (10%)
Query: 4 LLDYNTDKARRWFS---------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDF 54
LLDY + S Q+A ++Y K+ +HRD+ N L+ + +K+SDF
Sbjct: 88 LLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDF 147
Query: 55 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGR 113
G +R + + DY + + +PE LK +T +SD+WS GV+L+ + G
Sbjct: 148 GLSRD--LYDDDYYKVKGGKL--PIRWMAPESLKEGKFTS-KSDVWSFGVLLWEIFTLGE 202
Query: 114 LPFDDTNYSELLKQVQKR 131
P+ + +E+L+ ++K
Sbjct: 203 EPYPGMSNAEVLEYLKKG 220
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 55/174 (31%), Positives = 94/174 (54%), Gaps = 19/174 (10%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
AR + +++ A+D H +HRD+K +N+LLD ++KL+DFG K + K+ +
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN------KEGM 197
Query: 72 --SETFCGSYAYASPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDT---NYS 122
+T G+ Y SPE+LK G Y ++ D WS+GV L+ M+ G PF D+ YS
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
Query: 123 ELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKED 173
+++ + + FP+ +S K LI L+ + R+ +E+I++ + K D
Sbjct: 258 KIMNH-KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 40/126 (31%), Positives = 60/126 (47%), Gaps = 14/126 (11%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D R + QL AI YCH +++HRDIK EN+L+ + +KL DFGFAR
Sbjct: 100 DAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP-- 157
Query: 70 NLSETFCGSYA----YASPEILKG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
Y Y +PE+L G Y D+W++G ++ ++ G F + +
Sbjct: 158 ------LTDYVATRWYRAPELLVGDTNYGK-PVDVWAIGCIMAELLDGEPLFPGDSDIDQ 210
Query: 125 LKQVQK 130
L +QK
Sbjct: 211 LYLIQK 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 46/138 (33%), Positives = 81/138 (58%), Gaps = 4/138 (2%)
Query: 16 FSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 75
F Q+ A+D H + ++HRD+K N+ L IKL DFGF+++YS +++ +F
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS---DSVSLDVASSF 231
Query: 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP 135
CG+ Y +PE+ + Y+ +++D+WS+GV+L+ ++ PF + E+++QV P
Sbjct: 232 CGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290
Query: 136 ESPRLSSSCKALISNILS 153
+SS KAL+ +LS
Sbjct: 291 FPCPVSSGMKALLDPLLS 308
|
Length = 478 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-17
Identities = 49/155 (31%), Positives = 83/155 (53%), Gaps = 13/155 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT---- 65
D AR +F++ A++Y H +VHRD+K +NLL+ +IKL+DFG ++ ++ T
Sbjct: 101 DMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160
Query: 66 ------DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT 119
D ++ L + CG+ Y +PE++ Y + D W+MG++L+ + G +PF
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGD 219
Query: 120 NYSELLKQV-QKRVVFPESPR-LSSSCKALISNIL 152
EL QV + +PE L + + LIS +L
Sbjct: 220 TPEELFGQVISDDIEWPEGDEALPADAQDLISRLL 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-17
Identities = 40/145 (27%), Positives = 77/145 (53%), Gaps = 14/145 (9%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+A + +Q+ +++ H++ +V+RD+K EN+LLDD N+++SD G A +
Sbjct: 96 RAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK------GGK 149
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
+ G+ Y +PE+L+G Y D +++G L+ M+ GR PF +++++
Sbjct: 150 KIKGRAGTPGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208
Query: 131 RVV-----FPE--SPRLSSSCKALI 148
R + +P+ SP C+AL+
Sbjct: 209 RTLEMAVEYPDKFSPEAKDLCEALL 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-17
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 8/94 (8%)
Query: 23 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82
+ Y H + ++HRDIK N+LL K +KL DFG + + VN +L+ TF G+ Y
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VN------SLAGTFTGTSFYM 170
Query: 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
+PE ++G PY+ SD+WS+G+ L + R PF
Sbjct: 171 APERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 56/173 (32%), Positives = 90/173 (52%), Gaps = 17/173 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR + +++ AID H+ VHRDIK +N+L+D +I+L+DFG K + T
Sbjct: 102 DMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-- 159
Query: 70 NLSETFCGSYAYASPEILKGVP-----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
S G+ Y SPEIL+ + Y P + D WS+GV ++ M+YG PF + E
Sbjct: 160 --SSVAVGTPDYISPEILQAMEDGKGKYGP-ECDWWSLGVCMYEMLYGETPFYAESLVET 216
Query: 125 LKQV---QKRVVFP-ESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWL 170
++ ++R FP + +S K LI ++ + R+ +ED +Q P+
Sbjct: 217 YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 1/91 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ TV A + VA+KI+ K + REI +++ L HPN++R + A E
Sbjct: 11 SFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPNIVRLIDAFED 69
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+Y++MEY + G L + + + + ED+A
Sbjct: 70 KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEA 100
|
Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 49/161 (30%), Positives = 83/161 (51%), Gaps = 19/161 (11%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+ Y HK V+HRDIK N+L+ + N+KL DFG A +N K++ TF G+ +
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAA--LLNQNSSKRS---TFVGTPYW 167
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES--PR 139
+PE++ Y ++DIWS+G+ ++ M G P+ D + + + + P+S PR
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV---DAFRAMM---LIPKSKPPR 221
Query: 140 L-----SSSCKALISNILSPV-KFRIQMEDIRQDPWLKEDS 174
L S + ++ L K R+ E++ + W+K S
Sbjct: 222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 1e-16
Identities = 33/115 (28%), Positives = 61/115 (53%), Gaps = 6/115 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y K+ +HRD+ N L+ + +K+SDFG +R + + DY +
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD--LYDDDYYRKRGGKL-- 165
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKR 131
+ +PE LK +T +SD+WS GV+L+ + G P+ + E+L+ ++
Sbjct: 166 PIRWMAPESLKEGKFTS-KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG 219
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 7/136 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ ++Y H ++ VHRDIK N+L+D +KL+DFG A++ + + +++F G
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV------EFSFAKSFKG 163
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 137
S + +PE++ +DIWS+G + M G+ P+ + ++ + P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI 223
Query: 138 P-RLSSSCKALISNIL 152
P LS K I L
Sbjct: 224 PDHLSDEAKDFILKCL 239
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 35/131 (26%), Positives = 65/131 (49%), Gaps = 3/131 (2%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLS 72
+ QL + Y H+ ++HRD+K NLL+D ++++DFG A + + T +
Sbjct: 107 NYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE-FQ 165
Query: 73 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 132
G+ A+ +PE+L+G Y + D+WS+G V+ M + P++ +S L + K
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA 224
Query: 133 VFPESPRLSSS 143
+P +
Sbjct: 225 SATTAPSIPEH 235
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ +A+++ H V+HRD+K N+LL ++KL+DFG + K N Q TF G
Sbjct: 111 QMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAK----NKSTLQKRD-TFIG 165
Query: 78 SYAYASPEIL-----KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 132
+ + +PE++ K PY ++DIWS+G+ L + P + N +L ++ K
Sbjct: 166 TPYWMAPEVVACETFKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS- 223
Query: 133 VFPESPRLSSSCK-------ALISNILSPVKFRIQMEDIRQDPWLKEDSN 175
E P L K L S ++ R ++ + P++ + S+
Sbjct: 224 ---EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 32/96 (33%), Positives = 58/96 (60%), Gaps = 6/96 (6%)
Query: 23 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82
++Y H +HRDIK N+LL+++ KL+DFG + + + +T K+N T G+ +
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--LTDTMAKRN---TVIGTPFWM 166
Query: 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 118
+PE+++ + Y ++DIWS+G+ M G+ P+ D
Sbjct: 167 APEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 54/174 (31%), Positives = 89/174 (51%), Gaps = 17/174 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR + +++ AI H+ VHRDIK +N+LLD +I+L+DFG K + + T
Sbjct: 102 DMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-- 159
Query: 70 NLSETFCGSYAYASPEILKGV-----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
S G+ Y SPEIL+ + Y P + D WS+GV ++ M+YG PF + E
Sbjct: 160 --SSVAVGTPDYISPEILQAMEDGMGKYGP-ECDWWSLGVCMYEMLYGETPFYAESLVET 216
Query: 125 LKQV---QKRVVFPES-PRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLK 171
++ ++R FP +S K LI ++ + R+ +ED ++ + +
Sbjct: 217 YGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 38/118 (32%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
N + + QL ++YCH++ V+HRD+K +NLL++++ +KL+DFG AR S+ Y
Sbjct: 102 NMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 125
+ + Y P+IL G Q D+W +G + + M GR F + E L
Sbjct: 162 SNEVVTLW-----YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 38/101 (37%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 72
+ + QL I YCH V+HRD+K +NLL+D + +KL+DFG AR + V Y +
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV 161
Query: 73 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 113
+ Y +PEIL G DIWS+G + MV R
Sbjct: 162 TLW-----YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-16
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+ + H + V+HRDIK +++LL +KLSDFGF + S K + G+ +
Sbjct: 127 ALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK-----SLVGTPYW 181
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL- 140
+PE++ +PY + DIWS+G+++ MV G P+ ++E Q KR+ P+L
Sbjct: 182 MAPEVISRLPYGT-EVDIWSLGIMVIEMVDGEPPY----FNEPPLQAMKRIRDNLPPKLK 236
Query: 141 -----SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176
S ++ + +L R ++ P+L + P
Sbjct: 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 38/108 (35%), Positives = 58/108 (53%), Gaps = 5/108 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + YCHK+ ++HRD+K +NLL+++K +KL+DFG AR SV Y + +
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLW-- 168
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 125
Y P++L G D+W +G +L+ M GR F + E L
Sbjct: 169 ---YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 5/104 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + +CH ++HRD+K ENLL++ + +KL+DFG AR + Y + +
Sbjct: 106 QLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-- 163
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
Y +PE+L G DIWS+G + ++ R F +
Sbjct: 164 ---YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 7/87 (8%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + + H ++HRD+K NLLL+++ +K+ DFG AR+Y Y Q + +
Sbjct: 114 QLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLW-- 171
Query: 78 SYAYASPEILKGVP-YTPQQSDIWSMG 103
Y +PE+L G Y+ D+WS+G
Sbjct: 172 ---YRAPELLLGAKEYST-AIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ TV LA + + VAIKII K + L + L REIE++K L HPN+++ E
Sbjct: 5 GFGTVYLARDKKTGKKVAIKIIKKEDS--SSLLEELLREIEILKKLNHPNIVKLYGVFED 62
Query: 263 THRVYIIMEYAKNGSLLEVI-RKERYIDEDKAL 294
+ +Y++MEY + GSL +++ E + ED+ L
Sbjct: 63 ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL 95
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + +CH V+HRD+K +NLL++ + IKL+DFG AR + V Y + +
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-- 165
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
Y +PEIL G Y DIWS+G + MV R F
Sbjct: 166 ---YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 9/153 (5%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
++Y H ++V+HRDIK +N+LL ++KL+DFGFA + + +++ + G+ +
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-----EKSKRNSVVGTPYW 182
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPR 139
+PE++K Y P + DIWS+G++ M G P+ L + + + +
Sbjct: 183 MAPEVIKRKDYGP-KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEK 241
Query: 140 LSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
S K ++ L + R E++ Q P+LK
Sbjct: 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
+ Y H+ +V+RD+K +NLLLD + +K++DFG ++ + S TFCG+ +
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE----GMGFGDRTS-TFCGTPEF 167
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF--DD 118
+PE+L YT + D W +GV+++ M+ G PF DD
Sbjct: 168 LAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 8/119 (6%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
++F QL A+++ H K ++HRDIK N+ + +KL D G R +S T +
Sbjct: 110 KYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-----AH 164
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF--DDTNYSELLKQVQK 130
+ G+ Y SPE + Y +SDIWS+G +L+ M + PF D N L K+++K
Sbjct: 165 SLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 40/137 (29%), Positives = 82/137 (59%), Gaps = 12/137 (8%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+++ HK +++RDIK EN+LLD ++ L+DFG ++++ + + + +FCG+ Y
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER----AYSFCGTIEY 172
Query: 82 ASPEILKGVPYTPQQS-DIWSMGVVLFAMVYGRLPF----DDTNYSELLKQVQKRVVFPE 136
+P+I++G ++ D WSMGV+++ ++ G PF + + +E+ +++ K P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PP 230
Query: 137 SPR-LSSSCKALISNIL 152
P+ +S+ K +I +L
Sbjct: 231 YPQEMSALAKDIIQRLL 247
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 51/162 (31%), Positives = 85/162 (52%), Gaps = 18/162 (11%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNI-KLSDFGFARKYSVNNTDYKQNLSE 73
WF QL + Y H++ ++HRD+K +N+ L K N+ K+ DFG +R + + D L+
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSR-LLMGSCD----LAT 163
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 133
TF G+ Y SPE LK Y +SDIWS+G +L+ M F+ N+ V R+V
Sbjct: 164 TFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFL----SVVLRIV 218
Query: 134 FPESPRL----SSSCKALISNILSP-VKFRIQMEDIRQDPWL 170
+P L S +++ ++L+ R +I ++P++
Sbjct: 219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 41/124 (33%), Positives = 68/124 (54%), Gaps = 7/124 (5%)
Query: 5 LDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 64
LD NT K+ + QL I +CH+ V+HRD+K +NLL++ + +KL+DFG AR + +
Sbjct: 97 LDPNTVKSFTY--QLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+ + + Y +P++L G DIWS+G ++ M+ GR F TN +
Sbjct: 155 NTFSNEVVTLW-----YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209
Query: 125 LKQV 128
L ++
Sbjct: 210 LLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNNTDYKQNLSETF 75
Q+ + + Y H +VHRDIK +N+L+ + Y+ +K+SDFG +++ + N +ETF
Sbjct: 116 QILEGLKYLHDNQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINP-----CTETF 169
Query: 76 CGSYAYASPEIL-KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVV 133
G+ Y +PE++ KG +DIWS+G + M G+ PF + + +V +
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI 229
Query: 134 FPESPR-LSSSCKALISNILSP-VKFRIQMEDIRQDPWL 170
PE P LS+ K I P R D+ QDP+L
Sbjct: 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 30/110 (27%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
+ + L + Y H ++HRD+K NLL+ +K++DFG AR + + + +
Sbjct: 101 VKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLAR---LFSEEEPRLY 157
Query: 72 SETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
S + Y +PE+L G Y P D+W++G + ++ G F N
Sbjct: 158 SHQ-VATRWYRAPELLYGARKYDP-GVDLWAVGCIFAELLNGSPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 43/146 (29%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 13 RRW--FSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
R W F Q+ A+ Y HK K +VHRD+ N++L + + ++DFG A++ +
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---- 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ G+ Y+ PEI+K PY +++D+W+ G +L+ M + PF TN L ++
Sbjct: 170 --LTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226
Query: 130 KRVVFP-ESPRLSSSCKALISNILSP 154
+ V P S +I++ L+P
Sbjct: 227 EAVYEPLPEGMYSEDVTDVITSCLTP 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ I +CH + V+HRD+K +NLL+D+K IKL+DFG AR + + Y + +
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW-- 166
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV 110
Y +PE+L G P DIWS+G + M
Sbjct: 167 ---YRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 53/143 (37%), Positives = 71/143 (49%), Gaps = 26/143 (18%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFG---FARKYSVNNTDYKQNLSET 74
QL AIDY H + ++HRDIK EN+L++ +I L DFG FAR Y
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG------ 321
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYG-----------RLPFDDTNYS 122
G+ +PE+L G PYTP DIWS G+V+F A V+ R P+ D
Sbjct: 322 IAGTVDTNAPEVLAGDPYTP-SVDIWSAGLVIFEAAVHTASLFSASRGDERRPY-DAQIL 379
Query: 123 ELLKQVQKRV-VFPESP--RLSS 142
+++Q Q V FP+ RL S
Sbjct: 380 RIIRQAQVHVDEFPQHAGSRLVS 402
|
Length = 461 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + YCH++ V+HRD+K +NLL++++ +KL+DFG AR SV Y + +
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLW-- 169
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
Y P++L G Q D+W +G + F M GR F
Sbjct: 170 ---YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 19/164 (11%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
+ Q+ + Y H++ V+HRDIK N+L +KL+DFG A K + + D
Sbjct: 103 VYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-----DA 157
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK--R 131
+ G+ + +PE+++ + SDIWS+G + ++ G P+ D L + R
Sbjct: 158 SVVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYD------LNPMAALFR 210
Query: 132 VVFPESPRLSSSCKALISNILSP-----VKFRIQMEDIRQDPWL 170
+V + P L + + L R + + + PW+
Sbjct: 211 IVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 35/119 (29%), Positives = 58/119 (48%), Gaps = 4/119 (3%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
+ Q+A+ + Y K +HRD+ N+LL +K+ DFG R N Y
Sbjct: 101 DYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKR 131
+A+ +PE L+ ++ SD+W GV L+ M YG P+ + S++LK++ K
Sbjct: 161 KV--PFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE 216
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + YCH++ V+HRD+K +NLL+ ++ +KL+DFG AR SV + Y + +
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLW-- 168
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
Y P++L G D+W +G + + M GR F
Sbjct: 169 ---YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 43/111 (38%), Positives = 57/111 (51%), Gaps = 13/111 (11%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D AR Q+ I Y H++ +VHRDIK NLL++ N+K++DFG +R + T
Sbjct: 172 DVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR--ILAQTMDPC 225
Query: 70 NLSETFCGSYAYASPEI----LKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
N S G+ AY SPE L Y DIWS+GV + GR PF
Sbjct: 226 NSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 35/108 (32%), Positives = 58/108 (53%), Gaps = 7/108 (6%)
Query: 5 LDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 64
LD + R++ Q+ I++CH +++HRDIK EN+L+ +KL DFGFAR +
Sbjct: 97 LDESR--VRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG 112
Y + + Y +PE+L G + DIW++G ++ M+ G
Sbjct: 155 EVYTD-----YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 23/165 (13%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+ Y H + V+HRDIK +++LL IKLSDFGF + S K + G+ +
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK-----SLVGTPYW 184
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLS 141
+PE++ +PY + DIWS+G+++ M+ G P+ ++E Q +R+ PR+
Sbjct: 185 MAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPY----FNEPPLQAMRRIRDNLPPRVK 239
Query: 142 SSCKALISNIL----------SPVKFRIQMEDIRQDPWLKEDSNP 176
S K +S++L P + R +++ Q P+LK P
Sbjct: 240 DSHK--VSSVLRGFLDLMLVREPSQ-RATAQELLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 42/140 (30%), Positives = 81/140 (57%), Gaps = 13/140 (9%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+ +++ H++ +++RD+K EN+LLD+ N+++SD G A V D Q+ ++ +
Sbjct: 104 AQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA----VELKD-GQSKTKGYA 158
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR----- 131
G+ + +PE+L+G Y D +++GV L+ M+ R PF K++++R
Sbjct: 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS 217
Query: 132 VVFPE--SPRLSSSCKALIS 149
V +P+ SP S C+AL++
Sbjct: 218 VTYPDKFSPASKSFCEALLA 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 41/139 (29%), Positives = 72/139 (51%), Gaps = 6/139 (4%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
WF Q+A A+ Y H+K ++HRD+K +N+ L IK+ D G AR +++ T
Sbjct: 107 WFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-----DMAST 161
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 134
G+ Y SPE+ PY +SD+W++G ++ M + F+ + + L+ ++ + +
Sbjct: 162 LIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220
Query: 135 PESPRLSSSCKALISNILS 153
P S LI+ +LS
Sbjct: 221 PMPKDYSPELGELIATMLS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 37/105 (35%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS-VNNTDYKQNL 71
++ Q+ D + Y H VVHRDIK N++L IKL DFG AR+ + V N+
Sbjct: 105 CKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164
Query: 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
++ G+ + +PE++ Y ++SDIWS+G +F M G+ P
Sbjct: 165 LKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+ Y H + V+HRDIK +++LL +KLSDFGF + S + K + G+ +
Sbjct: 129 ALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK-----SLVGTPYW 183
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLS 141
+PE++ PY + DIWS+G+++ MV G P+ +S+ Q KR+ P+L
Sbjct: 184 MAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPY----FSDSPVQAMKRLRDSPPPKLK 238
Query: 142 SSCKA-------LISNILSPVKFRIQMEDIRQDPWLKEDSNP 176
++ K L + + R +++ P+L + P
Sbjct: 239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 42/124 (33%), Positives = 69/124 (55%), Gaps = 23/124 (18%)
Query: 31 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 90
++HRDIK N+L++ + IKL DFG + + +N ++++TF G+ Y SPE ++G
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-IN------SIADTFVGTSTYMSPERIQGG 177
Query: 91 PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-----------ELLKQVQKRVVFPESPR 139
YT +SD+WS+G+ + + G+ PF +N +LL+Q +V PR
Sbjct: 178 KYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ----IVQEPPPR 232
Query: 140 LSSS 143
L SS
Sbjct: 233 LPSS 236
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 16/159 (10%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS---VNNTDYKQ 69
R++ Q+ + + Y H +VHRDIK N+L D N+KL DFG +++ ++ T K
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK- 167
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ G+ + SPE++ G Y +++DIWS+G + M+ + P+ + E + +
Sbjct: 168 ----SVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEF---EAMAAIF 219
Query: 130 KRVVFPESPRL----SSSCKALISNILSPVKFRIQMEDI 164
K P +P L S C+ + I K R +++
Sbjct: 220 KIATQPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q A+++CHK + +HRD+K EN+L+ + IKL DFGFAR + DY +
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD-----YVA 162
Query: 78 SYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVYG 112
+ Y +PE+L G Y P D+W++G V ++ G
Sbjct: 163 TRWYRAPELLVGDTQYGP-PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 34/142 (23%), Positives = 71/142 (50%), Gaps = 4/142 (2%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
R++ Q+ + ++Y H +VHRDIK N+L D N+KL DFG +++ +
Sbjct: 106 TRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR--LQTICSSGTG 163
Query: 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR 131
++ G+ + SPE++ G Y +++D+WS+G + M+ + P+ + + ++ +
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222
Query: 132 VVFPESP-RLSSSCKALISNIL 152
P+ P +S + +
Sbjct: 223 PTNPQLPSHVSPDARNFLRRTF 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 37/97 (38%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 28 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87
K ++HRD+K N+L++ + IKL DFG + + +++ +F G+ +Y SPE L
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVGTRSYMSPERL 174
Query: 88 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+G Y+ QSDIWSMG+ L M GR P + EL
Sbjct: 175 QGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 195 LIRDKKLSS--YATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 248
L KKL + V T +VA+K + K A +++FL RE +++ L
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFL-REARIMRKL 58
Query: 249 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
HPN+++ L + I+MEY G LL+ +RK R
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR 96
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 8e-14
Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+++ H V+HRDIK +N+LL ++KL+DFGF + + +Q+ T G+ +
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYW 181
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKRVVFPESPR 139
+PE++ Y P + DIWS+G++ MV G P+ + N + L +
Sbjct: 182 MAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240
Query: 140 LSSSCKALISNILS-PVKFRIQMEDIRQDPWLK 171
LS+ + ++ L V+ R +++ Q P+LK
Sbjct: 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS---VNNTDYKQ 69
RR+ Q+ + Y H +VHRDIK N+L D N+KL DFG +++ ++ T K
Sbjct: 109 RRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK- 167
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ G+ + SPE++ G Y +++D+WS+ + M+ + P+ + E + +
Sbjct: 168 ----SVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEY---EAMAAIF 219
Query: 130 KRVVFPESPRL----SSSCKALISNILSPVKFRIQMEDIRQDP 168
K P P L S +C+ + I K R E + + P
Sbjct: 220 KIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 39/102 (38%), Positives = 58/102 (56%), Gaps = 7/102 (6%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+ I + H +V+RD+K EN+LLDD+ N +LSD G A + T ++
Sbjct: 102 AQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR------A 155
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 118
G+ Y +PEILK PY+ D ++MG ++ MV GR PF D
Sbjct: 156 GTNGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 37/97 (38%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 28 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87
K ++HRD+K N+L++ + IKL DFG + + +++ +F G+ +Y SPE L
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVGTRSYMSPERL 170
Query: 88 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+G YT QSDIWS+G+ L M GR P + EL
Sbjct: 171 QGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ ++Y H ++HRD+K NLL+ +KL+DFG AR + N +
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
+ Y +PE+L G + D+WS+G + FA + R+PF
Sbjct: 167 W-----YRAPELLFGARHYGVGVDMWSVGCI-FAELLLRVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 37/139 (26%), Positives = 68/139 (48%), Gaps = 15/139 (10%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR--KYSVNNTDYKQNLSET 74
Q+A+ + Y +++ +HRD+ N+L+ + K++DFG AR K V + K+
Sbjct: 111 CQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---- 166
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVV 133
Y + +PE ++ +SD+WS G++L+ M YG++P+ N E+ Q+
Sbjct: 167 ---PYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR 222
Query: 134 FPESPRLSSSCKALISNIL 152
P + C I I+
Sbjct: 223 MPCPAK----CPQEIYKIM 237
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-13
Identities = 30/98 (30%), Positives = 44/98 (44%), Gaps = 8/98 (8%)
Query: 195 LIRDKKLSS--YATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL 248
L KKL + V T VA+K + K A + ++FL E ++K L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFL-EEASIMKKL 58
Query: 249 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
HPN++R L +YI+ EY G LL+ +RK
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG 96
|
Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 2e-13
Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 11/154 (7%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+D+ H V+HRDIK +N+LL ++KL+DFGF + + +Q+ T G+ +
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYW 181
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SP 138
+PE++ Y P + DIWS+G++ MV G P+ + N L + PE
Sbjct: 182 MAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPE 239
Query: 139 RLSSSCKALISNILS-PVKFRIQMEDIRQDPWLK 171
RLS+ + ++ L V R +++ Q P+LK
Sbjct: 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
AI Y H+ ++HRDIK EN+ ++ ++ L DFG A + V D N + G+ A
Sbjct: 194 AIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPV---DINANKYYGWAGTIAT 249
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 113
+PE+L PY P DIWS G+VLF M
Sbjct: 250 NAPELLARDPYGP-AVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 48/164 (29%), Positives = 87/164 (53%), Gaps = 24/164 (14%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+ +Y ++V+RD+K ENLLLD IK++DFGFA+ V+ Y T C
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTY------TLC 189
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN----YSELLKQVQKRV 132
G+ Y +PEIL V + + +D W++G+ ++ ++ G PF Y ++L+ + +
Sbjct: 190 GTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---I 245
Query: 133 VFPESPRLSSSCKALISNILSP------VKFRIQMEDIRQDPWL 170
FP+ L ++CK L+ +LS + +++++ PW
Sbjct: 246 YFPKF--LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 3e-13
Identities = 25/72 (34%), Positives = 42/72 (58%), Gaps = 2/72 (2%)
Query: 215 HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 274
+ +VA+K + + A + K FL +E V+K L HPN++R L +Y+++EY +
Sbjct: 22 KTTEVAVKTLKE-DASEEERKDFL-KEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79
Query: 275 NGSLLEVIRKER 286
G LL+ +RK R
Sbjct: 80 GGDLLDYLRKSR 91
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 3e-13
Identities = 25/72 (34%), Positives = 41/72 (56%), Gaps = 2/72 (2%)
Query: 215 HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 274
+VA+K + K A +++FL RE +++ L HPN+++ L +YI+MEY +
Sbjct: 27 KKVEVAVKTL-KEDASEQQIEEFL-REARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYME 84
Query: 275 NGSLLEVIRKER 286
G LL +RK R
Sbjct: 85 GGDLLSYLRKNR 96
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 37/193 (19%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFG------------FARK--- 59
+ ++ AID H+ +HRDIK +NLLLD K ++KLSDFG F R
Sbjct: 106 YIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165
Query: 60 -----YSVNNTDYKQ----------NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGV 104
+S N + K+ L+ + G+ Y +PE+ Y + D WS+GV
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGV 224
Query: 105 VLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKALISNILSPVKFRI-- 159
+++ M+ G PF E ++V ++ +VFP +S K LI + + RI
Sbjct: 225 IMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGS 284
Query: 160 -QMEDIRQDPWLK 171
+E+I+ P+ +
Sbjct: 285 NGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 36/107 (33%), Positives = 50/107 (46%), Gaps = 16/107 (14%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + I+Y H+ ++HRDIK N+L+D++ +K++DFG AR Y N G
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY----DGPPPNPKGGGGG 178
Query: 78 SYA----------YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
Y PE+L G YT DIW +G V M R
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTT-AVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 40/111 (36%), Positives = 59/111 (53%), Gaps = 7/111 (6%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNTDYKQNLSETFC 76
Q+ I YCH V+HRD+K +NLL+D + N +KL+DFG AR + + + + +
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW- 168
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLK 126
Y +PEIL G + DIWS+G + MV + F D+ EL K
Sbjct: 169 ----YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215
|
Length = 294 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 38/145 (26%), Positives = 62/145 (42%), Gaps = 20/145 (13%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN----T 65
R Q+ + + HK HRD+K ENLL+ +K++DFG AR + + T
Sbjct: 99 SVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYT 156
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSEL 124
DY + Y +PEIL DIW++G ++ + R F ++ +L
Sbjct: 157 DY--------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL 208
Query: 125 LKQVQ-----KRVVFPESPRLSSSC 144
K + +PE +L+S
Sbjct: 209 YKICSVLGTPTKQDWPEGYKLASKL 233
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 28 KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87
K ++HRD+K N+L++ + IKL DFG + + +++ +F G+ +Y SPE L
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVGTRSYMSPERL 174
Query: 88 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+G Y+ QSDIWSMG+ L + GR P + EL
Sbjct: 175 QGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 37/121 (30%), Positives = 60/121 (49%), Gaps = 5/121 (4%)
Query: 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 68
K + +++AD + Y K VHRD+ N ++ + +K+ DFG R + TDY
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYY 175
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQ 127
+ + + +PE LK +T +SD+WS GVVL+ M P+ + E+LK
Sbjct: 176 RKGGKGLL-PVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233
Query: 128 V 128
V
Sbjct: 234 V 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 35/101 (34%), Positives = 60/101 (59%), Gaps = 6/101 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
++ +DY H + +HRDIK N+LL ++ ++KL+DFG A + + +T K+N TF G
Sbjct: 109 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRN---TFVG 163
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 118
+ + +PE++K Y ++DIWS+G+ + G P D
Sbjct: 164 TPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 39/103 (37%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + + Y H K ++HRD+K +NLL+D K+SDFG ++K S + D QN+S G
Sbjct: 116 QVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQ--G 172
Query: 78 SYAYASPEI--LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 118
S + +PE+ Y+ + DIWS+G V+ M GR P+ D
Sbjct: 173 SVFWMAPEVIHSYSQGYS-AKVDIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 43/133 (32%), Positives = 68/133 (51%), Gaps = 15/133 (11%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ +A+ Y H ++HRD+K N+LL +IKL+DFG + K N Q ++F G
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK----NVKTLQR-RDSFIG 172
Query: 78 SYAYASPEI-----LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 132
+ + +PE+ +K PY ++DIWS+G+ L M P + N +L ++ K
Sbjct: 173 TPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS- 230
Query: 133 VFPESPRLSSSCK 145
E P LS K
Sbjct: 231 ---EPPTLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 46/175 (26%), Positives = 91/175 (52%), Gaps = 22/175 (12%)
Query: 10 DKARRWF--SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
D+ R F +++ ++ H++ +V+RD+K EN+LLDD +I++SD G A + T
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK- 126
+ G+ Y +PE++K YT D W +G +++ M+ G+ PF E +K
Sbjct: 160 GR------VGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPF--RQRKEKVKR 210
Query: 127 -QVQKRVVFPE---SPRLSSSCKALISNILSP-VKFRI-----QMEDIRQDPWLK 171
+V++RV + S + S + +++ +L+ FR+ E+++ P+ +
Sbjct: 211 EEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 16/148 (10%)
Query: 10 DKARRWF--SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
++ R F +++ ++ H++ +V+RD+K EN+LLDD +I++SD G A T
Sbjct: 100 EEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-------TN 120
+ G+ Y +PE++K YT D W++G +L+ M+ G+ PF
Sbjct: 160 GR------VGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212
Query: 121 YSELLKQVQKRVVFPESPRLSSSCKALI 148
L+K+VQ+ SP S CK L+
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLL 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ ++A + +++ ++ H+++ V+RD+K EN+LLDD +I++SD G A K
Sbjct: 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP----- 153
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ G+ Y +PE+L YT D W +G +++ M+ G+ PF +
Sbjct: 154 -EGESIRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE 211
Query: 127 QVQKRVVFPE---SPRLSSSCKALISNILS 153
+V +RV+ E S + S K++ +L+
Sbjct: 212 EVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 32/82 (39%), Positives = 55/82 (67%), Gaps = 1/82 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V + VAIK IS + + LK + +EI+++K LKHPN+++++ +IET
Sbjct: 12 AFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPNIVKYIGSIET 70
Query: 263 THRVYIIMEYAKNGSLLEVIRK 284
+ +YII+EYA+NGSL ++I+K
Sbjct: 71 SDSLYIILEYAENGSLRQIIKK 92
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+++ H V+HRDIK +N+LL ++KL+DFGF + + +Q+ T G+ +
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYW 181
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+PE++ Y P + DIWS+G++ MV G P+ + N
Sbjct: 182 MAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 28/95 (29%), Positives = 54/95 (56%), Gaps = 1/95 (1%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
++Y H +HRDIK N+LL + ++K++DFG + + + D + + +TF G+ +
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA-DGGDRTRKVRKTFVGTPCW 172
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
+PE+++ V ++DIWS G+ + G P+
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 13/126 (10%)
Query: 22 AIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 80
A+ Y +K V+HRD+K N+LLD N+KL DFG + + D K C A
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL----VDSKAKTRSAGCA--A 179
Query: 81 YASPEILKGVPYTPQ---QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 137
Y +PE + P+ ++D+WS+G+ L + G+ P+ + +E +V +++ E
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK-TEF--EVLTKILQEEP 236
Query: 138 PRLSSS 143
P L +
Sbjct: 237 PSLPPN 242
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 42/164 (25%), Positives = 82/164 (50%), Gaps = 16/164 (9%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS---VNNTDYKQ 69
R++ Q+ + + Y H +VHRDIK N+L D N+KL DFG +++ ++ T +
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR- 167
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ G+ + SPE++ G Y +++D+WS+G + M+ + P+ + E + +
Sbjct: 168 ----SVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEY---EAMAAIF 219
Query: 130 KRVVFPESPRL----SSSCKALISNILSPVKFRIQMEDIRQDPW 169
K P +P+L S + + I + R E++ + P+
Sbjct: 220 KIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 37/98 (37%), Positives = 53/98 (54%), Gaps = 4/98 (4%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78
L +A+ Y H + ++HRD+K EN+ LD+ N L DFG A K + D Q + G+
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD-AHPDTPQCYG--WSGT 250
Query: 79 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
SPE+L PY ++DIWS G+VLF M +
Sbjct: 251 LETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 36/115 (31%), Positives = 65/115 (56%), Gaps = 6/115 (5%)
Query: 16 FSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF 75
++ +DY H + +HRDIK N+LL ++ ++KL+DFG A + + +T K+N TF
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRN---TF 161
Query: 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
G+ + +PE+++ Y ++DIWS+G+ + G P D + +L + K
Sbjct: 162 VGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK 215
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 49/209 (23%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS-VNNTDYKQN 70
AR + ++L AI+ HK +HRDIK +N+L+D +IKL+DFG + +N+ Y Q
Sbjct: 103 ARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQK 162
Query: 71 -----------------------------------------LSETFCGSYAYASPEILKG 89
L+ + G+ Y +PE+L
Sbjct: 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 90 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKA 146
YT Q D WS+GV+LF M+ G+ PF +E +V + + P +LS
Sbjct: 223 KGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVD 281
Query: 147 LISNILSPVKFRI---QMEDIRQDPWLKE 172
LI+ + + R+ +DI+ P+ E
Sbjct: 282 LITKLCCSAEERLGRNGADDIKAHPFFSE 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 36/97 (37%), Positives = 55/97 (56%), Gaps = 2/97 (2%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET-FC 76
QL A+ Y H +V+HRD+K N+LL+ +KL+DFG AR S + +N T +
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLTDYV 173
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 113
+ Y +PEIL G + D+WS+G +L M+ G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + Y H+ ++HRD+K NLLL DK +K++DFG AR Y + + +
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW-- 173
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVL 106
Y +PE+L G D+W++G +L
Sbjct: 174 ---YRAPELLLGCTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+ H + V+HRDIK +++LL +KLSDFGF + S K + G+ +
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----SLVGTPYW 182
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
+PE++ +PY P + DIWS+G+++ MV G P+
Sbjct: 183 MAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 9/101 (8%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+ + + QL ++D+ H+ + HRDIK EN+L+ D +KL+DFG S K
Sbjct: 101 RVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFG-----SCRGIYSKPP 154
Query: 71 LSETFCGSYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMV 110
+E + + Y +PE +L Y P+ DIW++G V F ++
Sbjct: 155 YTE-YISTRWYRAPECLLTDGYYGPKM-DIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q +A++Y H+ ++HRD+K N+L +IKL+DFG + K NT Q ++F G
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK----NTRTIQR-RDSFIG 165
Query: 78 SYAYASPEIL-----KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR- 131
+ + +PE++ K PY ++D+WS+G+ L M P + N +L ++ K
Sbjct: 166 TPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE 224
Query: 132 -VVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 175
+ R SS K + L V R + Q P++ +SN
Sbjct: 225 PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 4/148 (2%)
Query: 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 68
+D + + Q+ + Y H ++HRDIK NLL++ +K+ DFG AR V D
Sbjct: 102 SDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR---VEEPDES 158
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+++++ Y Y +PEIL G + DIWS+G + ++ R+ F + + L +
Sbjct: 159 KHMTQEVVTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
Query: 129 QKRVVFPESPRLSSSCKALISNILSPVK 156
+ P + S+C+ ++IL
Sbjct: 218 TDLLGTPSLEAMRSACEGARAHILRGPH 245
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 46/136 (33%), Positives = 67/136 (49%), Gaps = 13/136 (9%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
+ R QL A++Y H K ++HRDIK EN+ L+ I L DFG A + ++
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE----KEREA 323
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTN---YSELLK 126
+ G+ A SPEIL G Y + +DIWS G++L M+ + P D +LLK
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382
Query: 127 QVQKRVV----FPESP 138
+ V FP+ P
Sbjct: 383 IIDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 16/140 (11%)
Query: 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 68
+ + QL +D+ H +VHRD+K +N+L+ +K++DFG AR YS
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF------ 159
Query: 69 QNLSETFC-GSYAYASPEILKGVPY-TPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELL 125
++ T + Y +PE+L Y TP D+WS+G + FA ++ R P F T+ ++ L
Sbjct: 160 -EMALTSVVVTLWYRAPEVLLQSSYATP--VDMWSVGCI-FAELFRRRPLFRGTSEADQL 215
Query: 126 KQVQKRVVFP---ESPRLSS 142
++ + P E PR S
Sbjct: 216 DKIFDVIGLPSEEEWPRNVS 235
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 11/145 (7%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
++F QL A+++ H + V+HRDIK N+ + +KL D G R +S T +
Sbjct: 110 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-----AAH 164
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF--DDTNYSELLKQVQKR 131
+ G+ Y SPE + Y +SDIWS+G +L+ M + PF D N L K++++
Sbjct: 165 SLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ- 222
Query: 132 VVFPESP--RLSSSCKALISNILSP 154
+P P S + L++ ++P
Sbjct: 223 CDYPPLPSDHYSEELRQLVNMCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 50/187 (26%), Positives = 80/187 (42%), Gaps = 46/187 (24%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS-VNNT 65
+ D AR + ++L A++ HK +HRDIK +N+L+D +IKL+DFG + +++
Sbjct: 98 FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 66 DYKQN-----------------------------------------LSETFCGSYAYASP 84
Y Q+ L+ + G+ Y +P
Sbjct: 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217
Query: 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLS 141
E+L YT Q D WS+GV+L+ M+ G+ PF E +V Q + P +LS
Sbjct: 218 EVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLS 276
Query: 142 SSCKALI 148
LI
Sbjct: 277 PEASDLI 283
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 20/157 (12%)
Query: 31 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG- 89
++HRD+K N+L++ +KL DFG + + +L++T G +Y +PE +K
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS-------GNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 90 ----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL----S 141
P QSD+WS+G+ + M GR P+ Y+ + Q+ +V + P L S
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-IVDGDPPTLPSGYS 235
Query: 142 SSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNP 176
+ ++ L+ P + R + + PWL + N
Sbjct: 236 DDAQDFVAKCLNKIPNR-RPTYAQLLEHPWLVKYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 44/145 (30%), Positives = 73/145 (50%), Gaps = 11/145 (7%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
++F QL A+++ H + V+HRDIK N+ + +KL D G R +S T +
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-----AAH 164
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF--DDTNYSELLKQVQKR 131
+ G+ Y SPE + Y +SDIWS+G +L+ M + PF D N L +++++
Sbjct: 165 SLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ- 222
Query: 132 VVFPESPR--LSSSCKALISNILSP 154
+P P S + L+S + P
Sbjct: 223 CDYPPLPTEHYSEKLRELVSMCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 35/177 (19%)
Query: 6 DYNTDKARRWF-SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS-VN 63
D T++ +++ ++ AID H+ +HRDIK +NLLLD K ++KLSDFG +
Sbjct: 96 DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155
Query: 64 NTDYKQNLSETF-----------------------------CGSYAYASPEILKGVPYTP 94
T++ +NL+ + G+ Y +PE+ Y
Sbjct: 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN- 214
Query: 95 QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKALI 148
+ D WS+GV+++ M+ G PF E K+V ++ ++FP +S K LI
Sbjct: 215 KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 33/120 (27%), Positives = 69/120 (57%), Gaps = 6/120 (5%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+A+ + Y +K+ +HRD++ N+L+ + K++DFG AR + + +Y F
Sbjct: 110 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKF- 166
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFP 135
+ +PE + +T +SD+WS G++L+ +V YG++P+ + S+++ +Q+ P
Sbjct: 167 -PIKWTAPEAINFGSFTI-KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 8/124 (6%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H ++HRD+K NL +++ +K+ DFG AR T Y
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY--------VA 179
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 137
+ Y +PEI+ + Q DIWS+G ++ ++ GR F T++ + LK + + V P +
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 138 PRLS 141
L
Sbjct: 240 ELLK 243
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 37/136 (27%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 4 LLDY---NTDKAR-----RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFG 55
LLDY + D W Q+A + Y +K +VHRD+ N+L+ ++K++DFG
Sbjct: 95 LLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFG 154
Query: 56 FARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRL 114
A+ V+ +Y + + + E + YT +SD+WS GV ++ M +G
Sbjct: 155 LAKLLDVDEKEYHAEGGKV---PIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAK 210
Query: 115 PFDDTNYSELLKQVQK 130
P++ E+ ++K
Sbjct: 211 PYEGIPAVEIPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 8/116 (6%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+A+ + Y ++ +HRD+ N+L+ + K++DFG AR + +Y F
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKF- 166
Query: 77 GSYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE G +T +SD+WS G++L +V YGR+P+ E+L+QV++
Sbjct: 167 -PIKWTAPEAANYGR-FT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-12
Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 7/117 (5%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNTDYKQN 70
+ + QL + +CHK V+HRD+K +NLL+D + +K++D G R +S+ Y
Sbjct: 112 IKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLK 126
+ + Y +PE+L G + DIWS+G + M + F D+ +LL
Sbjct: 172 IVTLW-----YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 8e-12
Identities = 33/122 (27%), Positives = 60/122 (49%), Gaps = 11/122 (9%)
Query: 23 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82
+ Y H+ +HRDIK N+LL + ++KL+DFG + + + T K+ +F G+ +
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRK---SFIGTPYWM 168
Query: 83 SPEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR 139
+PE+ + Y + DIW++G+ + + P D + L + K P P+
Sbjct: 169 APEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--PK 225
Query: 140 LS 141
L
Sbjct: 226 LK 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 41/121 (33%), Positives = 66/121 (54%), Gaps = 9/121 (7%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLSETFC 76
Q+A ++Y VHRD+ N L+ + +K+SDFG +R YS DY + S++
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS---ADYYRVQSKSLL 188
Query: 77 GSYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVF 134
+ PE IL G +T +SDIWS GVVL+ + YG P+ + E+++ ++ R +
Sbjct: 189 -PVRWMPPEAILYG-KFTT-ESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL 245
Query: 135 P 135
P
Sbjct: 246 P 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 1e-11
Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+++ H V+HRDIK +N+LL ++KL+DFGF + + +Q+ T G+ +
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYW 182
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+PE++ Y P + DIWS+G++ M+ G P+ + N
Sbjct: 183 MAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 35/118 (29%), Positives = 59/118 (50%), Gaps = 7/118 (5%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 72
R + QL + Y H + ++HRD+K +NLL+ +KL+DFG AR S+ + Y +
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165
Query: 73 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
+ Y P++L G DIW G + M+ G+ F S++ +Q++K
Sbjct: 166 TLW-----YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV--SDVFEQLEK 216
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 39/128 (30%), Positives = 67/128 (52%), Gaps = 16/128 (12%)
Query: 21 DAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79
A++Y ++ ++HRD+K N+LLD NIKL DFG + V++ ++ G
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDSIAKTRD-----AGCR 171
Query: 80 AYASPEILKGVPYTPQ----QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP 135
Y +PE + P +SD+WS+G+ L+ + G+ P+ N + Q+ + VV
Sbjct: 172 PYMAPERID--PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQ-VVKG 226
Query: 136 ESPRLSSS 143
+ P LS+S
Sbjct: 227 DPPILSNS 234
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 5/107 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + + QL + Y H++ ++HRD+K +NLL+ D +KL+DFG AR SV + Y
Sbjct: 103 ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
+ + Y P++L G D+W +G + M+ G F
Sbjct: 163 EVVTLW-----YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 36/113 (31%), Positives = 64/113 (56%), Gaps = 6/113 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
++ +DY H + +HRDIK N+LL + +KL+DFG A + + +T K+N TF G
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRN---TFVG 163
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
+ + +PE++K Y ++DIWS+G+ + G P + + ++L + K
Sbjct: 164 TPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK 215
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK-QNLSETF 75
SQ+ +DY + +HRD+ N+L++ + +K+SDFG A+ + Y + E+
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGR 113
YA PE L+ ++ SD+WS GV L+ + YG
Sbjct: 176 IFWYA---PECLRTSKFS-SASDVWSFGVTLYELFTYGD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 33/97 (34%), Positives = 59/97 (60%), Gaps = 6/97 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
++Y H++ +HRDIK N+LL ++ ++KL+DFG + + +T K+N TF G+ +
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRN---TFVGTPFW 164
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 118
+PE++K Y +++DIWS+G+ + G P D
Sbjct: 165 MAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 19/138 (13%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + + Y H + ++HRD+K EN+ ++D + + D G A+ V G
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG------LAG 218
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDD----------TNYSELLK 126
+ +PE+L Y ++DIWS G+VLF M+ Y F+D + +S LLK
Sbjct: 219 TVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277
Query: 127 QVQKRVVFPES-PRLSSS 143
+ V PE PR S
Sbjct: 278 IISTLKVHPEEFPRDPGS 295
|
Length = 357 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 38/100 (38%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL +D+ H VVHRD+K +N+L+ IKL+DFG AR YS Q +
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF------QMALTSVVV 171
Query: 78 SYAYASPEILKGVPY-TPQQSDIWSMGVVLFAMVYGRLPF 116
+ Y +PE+L Y TP D+WS+G + FA ++ R P
Sbjct: 172 TLWYRAPEVLLQSSYATP--VDLWSVGCI-FAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 10/108 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + Q +D+ H +VHRD+K EN+L+ +KL+DFG AR YS +
Sbjct: 108 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS-----CQM 162
Query: 70 NLSETFCGSYAYASPEILKGVPY-TPQQSDIWSMGVVLFAMVYGRLPF 116
L+ + Y +PE+L Y TP D+WS+G + FA ++ R P
Sbjct: 163 ALTPVVVTLW-YRAPEVLLQSTYATP--VDMWSVGCI-FAEMFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 46/184 (25%), Positives = 89/184 (48%), Gaps = 22/184 (11%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 72
R + +++ +++ H + VV+RD+K N+LLD+ ++++SD G A D+ +
Sbjct: 100 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP 152
Query: 73 ETFCGSYAYASPEIL-KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR 131
G++ Y +PE+L KGV Y +D +S+G +LF ++ G PF + K R
Sbjct: 153 HASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDR 209
Query: 132 VVFPESPRL----SSSCKALISNILS-PVKFRI-----QMEDIRQDPWLKE-DSNPVGKS 180
+ + L S ++L+ +L V R+ +++++ P+ + D V
Sbjct: 210 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269
Query: 181 KSAP 184
K P
Sbjct: 270 KYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 38/118 (32%), Positives = 64/118 (54%), Gaps = 1/118 (0%)
Query: 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 68
+ R + QL + Y H +V+HRD+K NLL+++ +++ DFG AR S + T++K
Sbjct: 106 EEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
++E + + Y +PE+L +P D+WS+G + M+ R F NY LK
Sbjct: 166 YFMTE-YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 35/120 (29%), Positives = 61/120 (50%), Gaps = 10/120 (8%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
Q+A + Y K VHRD+ N+LL +++ K+SDFG +R + Y+ + T
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR---ATT 156
Query: 75 FCGSYA---YASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
G + YA PE + ++ +SD+WS GV L+ YG P+ + +E++ ++
Sbjct: 157 -AGRWPLKWYA-PECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 35/113 (30%), Positives = 63/113 (55%), Gaps = 11/113 (9%)
Query: 31 VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 90
++HRD+K N+L++ + +KL DFG + + VN ++++T+ G+ AY +PE + G
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VN------SIAKTYVGTNAYMAPERISGE 168
Query: 91 PYTPQQSDIWSMGVVLFAMVYGRLPFDD--TNYSELLK-QVQKRVVFPESPRL 140
Y SD+WS+G+ + GR P+ N L+ Q+ + +V + P L
Sbjct: 169 QYGI-HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 40/152 (26%), Positives = 79/152 (51%), Gaps = 14/152 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ +A + ++L ++ ++ +V+RD+K EN+LLDD+ +I++SD G A + T
Sbjct: 99 FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ G+ Y +PE++ YT D W +G +++ M+ G+ PF E +K
Sbjct: 159 RGR------VGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPF--RKRKERVK 209
Query: 127 --QVQKRVVFPE---SPRLSSSCKALISNILS 153
+V +RV + S + S K++ +L+
Sbjct: 210 REEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 31/112 (27%), Positives = 61/112 (54%), Gaps = 10/112 (8%)
Query: 20 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79
+ ++Y +K+ VHRD+ N+L+ + K+SDFG A++ S K + T
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----- 166
Query: 80 AYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+PE L+ ++ +SD+WS G++L+ + +GR+P+ +++ V+K
Sbjct: 167 ---APEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 52/220 (23%)
Query: 3 ILLDYNT---DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK 59
+L+ Y+T D R + ++ AI+ HK +HRDIK +N+L+D +IKLSDFG +
Sbjct: 91 MLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150
Query: 60 Y----------------SVNNTDYKQN--------------------------LSETFCG 77
+ S N +N ++ + G
Sbjct: 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVG 210
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVF 134
+ Y +PEI Y Q+ D WS+G ++F + G PF N E +++ ++ + F
Sbjct: 211 TPDYIAPEIFLQQGYG-QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF 269
Query: 135 PESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLK 171
P+ LS + LI +++ + R+ +I+ P+ +
Sbjct: 270 PDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 39/144 (27%), Positives = 69/144 (47%), Gaps = 13/144 (9%)
Query: 4 LLDYNTDKARR--------WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFG 55
LLDY + W Q+A ++Y ++ +VHRD+ N+L+ ++K++DFG
Sbjct: 95 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFG 154
Query: 56 FARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRL 114
A+ + +Y + + + E + YT QSD+WS GV ++ M +G
Sbjct: 155 LAKLLGADEKEYHAEGGKV---PIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSK 210
Query: 115 PFDDTNYSELLKQVQKRVVFPESP 138
P+D SE+ ++K P+ P
Sbjct: 211 PYDGIPASEISSILEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 32/114 (28%), Positives = 56/114 (49%), Gaps = 6/114 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + +CH +V+HRD+K +NLL++ +KL+DFG AR + + Y + +
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW-- 164
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLKQVQK 130
Y P++L G D+WS G + + P F + + LK++ +
Sbjct: 165 ---YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-11
Identities = 36/115 (31%), Positives = 62/115 (53%), Gaps = 14/115 (12%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR--KYSVNNTDYKQNLSETFC 76
+A+ ++Y K +VHRD+ N+L+ + K+SDFG AR V+N+
Sbjct: 109 VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--------- 159
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE LK ++ +SD+WS GV+L+ + YGR P+ + E+ + V+K
Sbjct: 160 -PVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK 212
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 40/113 (35%), Positives = 64/113 (56%), Gaps = 5/113 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H +V+HRD+K NLL++ +K+ DFG AR +S N + ++E +
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-YVA 171
Query: 78 SYAYASPEI-LKGVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLKQV 128
+ Y +PEI L YT + D+WS+G +L A + GR P F +Y + L Q+
Sbjct: 172 TRWYRAPEIMLSFQSYT-KAIDVWSVGCIL-AELLGRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 7e-11
Identities = 40/127 (31%), Positives = 66/127 (51%), Gaps = 18/127 (14%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
QL +A++ HK +++H DIK EN+L D K I L D+G + +
Sbjct: 117 QLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------IIGTPSCYD 167
Query: 77 GSYAYASPEILKGVPYTPQQS-DIWSMGVVLFAMVYGRLPFDDT-----NYSELLKQVQK 130
G+ Y SPE +KG Y S D W++GV+ + ++ G+ PF + + LLK+ QK
Sbjct: 168 GTLDYFSPEKIKGHNY--DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK 225
Query: 131 RVVFPES 137
++ F ++
Sbjct: 226 KLPFIKN 232
|
Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+A + Y + + VHRD++ N+L+ + K++DFG AR + + +Y F
Sbjct: 109 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKF- 165
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP 135
+ +PE +T +SD+WS G++L + GR+P+ E+L QV++ P
Sbjct: 166 -PIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 223
Query: 136 ESPRLSSSCKALISN 150
P S L+
Sbjct: 224 CPPECPESLHDLMCQ 238
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 32/111 (28%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ + R + +++ +++ H + VV+RD+K N+LLD+ ++++SD G A D
Sbjct: 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------CD 146
Query: 67 YKQNLSETFCGSYAYASPEIL-KGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
+ + G++ Y +PE+L KG Y +D +S+G +LF ++ G PF
Sbjct: 147 FSKKKPHASVGTHGYMAPEVLQKGTAYD-SSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 35/126 (27%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 5 LDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 64
+ DK + Q+ + Y H ++HRD+K NL +++ +K+ DFG AR
Sbjct: 112 HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
T Y + Y +PE++ + Q DIWS+G ++ M+ G+ F +Y +
Sbjct: 172 TGY--------VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 223
Query: 125 LKQVQK 130
L Q+ K
Sbjct: 224 LTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 8/123 (6%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + Y H ++HRD+K N+ +++ +++ DFG AR+ T Y
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY--------VA 177
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES 137
+ Y +PEI+ + Q DIWS+G ++ ++ G+ F +Y + LK++ + V P
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237
Query: 138 PRL 140
L
Sbjct: 238 EVL 240
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 9/101 (8%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
+ Y H+ V+HRDIK +N+LL +KL DFG + + +++T ++N TF G+ +
Sbjct: 125 GLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRN---TFIGTPYW 179
Query: 82 ASPEIL----KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 118
+PE++ + +SD+WS+G+ + G+ P D
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 6/120 (5%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+AD + Y + + +HRD++ N+L+ D K++DFG AR + + +Y F
Sbjct: 109 AQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKF- 165
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP 135
+ +PE +T +SD+WS G++L +V GR+P+ E+L+QV++ P
Sbjct: 166 -PIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 34/127 (26%), Positives = 66/127 (51%), Gaps = 7/127 (5%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
S + +A++Y +HRD+ N L+ + +K+SDFG AR V + Y + F
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR--YVLDDQYTSSQGTKF- 163
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKRVVFP 135
+A PE+ ++ +SD+WS GV+++ + G++P++ + SE+++ V
Sbjct: 164 -PVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY 221
Query: 136 ESPRLSS 142
P+L+
Sbjct: 222 R-PKLAP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 19/126 (15%)
Query: 22 AIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF-CGSY 79
A++Y H K SV+HRD+K N+L++ +KL DFG + Y V+ ++++T G
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVD------SVAKTIDAGCK 167
Query: 80 AYASPEILKGVPYTPQQ-----SDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF 134
Y +PE + P Q+ SD+WS+G+ + + GR P+D ++ +Q+ K+VV
Sbjct: 168 PYMAPERIN--PELNQKGYDVKSDVWSLGITMIELATGRFPYD--SWKTPFQQL-KQVVE 222
Query: 135 PESPRL 140
SP+L
Sbjct: 223 EPSPQL 228
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 36/120 (30%), Positives = 65/120 (54%), Gaps = 6/120 (5%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+A + Y + + +HRD++ N+L+ D K++DFG AR + + +Y F
Sbjct: 109 AQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKF- 165
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP 135
+ +PE +T +SD+WS G++L +V GR+P+ N E+L+QV++ P
Sbjct: 166 -PIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 4 LLDYNTDKARR--------WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFG 55
LLDY + R W Q+A + Y + +VHRD+ N+L+ ++K++DFG
Sbjct: 95 LLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFG 154
Query: 56 FARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRL 114
AR ++ T+Y + + + + E + +T QSD+WS GV ++ M +G
Sbjct: 155 LARLLDIDETEYHADGGKV---PIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAK 210
Query: 115 PFDDTNYSELLKQVQKRVVFPESP 138
P+D E+ ++K P+ P
Sbjct: 211 PYDGIPAREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 6/119 (5%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYKQN 70
R Q+ DA+ H + +VHRD+K +N+++ + + K+ DFG
Sbjct: 83 RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142
Query: 71 LSET--FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 127
L+ T G+ Y +PE L+G P TP SD+++ G++ + G+ + +E+L Q
Sbjct: 143 LTRTTEVLGTPTYCAPEQLRGEPVTP-NSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 22/81 (27%), Positives = 44/81 (54%), Gaps = 3/81 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V A R ++VAIK+I K+ + EI+++K KHPN++++ +
Sbjct: 12 GFGEVYKARHKRTGKEVAIKVIKLESKEK---KEKIINEIQILKKCKHPNIVKYYGSYLK 68
Query: 263 THRVYIIMEYAKNGSLLEVIR 283
++I+ME+ GSL ++++
Sbjct: 69 KDELWIVMEFCSGGSLKDLLK 89
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 3e-10
Identities = 35/119 (29%), Positives = 61/119 (51%), Gaps = 3/119 (2%)
Query: 9 TDKARRWFS-QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
TD ++F Q+ + Y H +V+HRD+K N+L++ ++K+ DFG AR + D
Sbjct: 101 TDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG-VDPDEDE 159
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
K L+E + Y +PE+L + DIWS+G + ++ + F +Y + L
Sbjct: 160 KGFLTEYVVTRW-YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 35/126 (27%), Positives = 62/126 (49%), Gaps = 7/126 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDY- 67
+ AR + QL + Y H +V+HRD+K N+ ++ + +K+ DFG AR + + Y
Sbjct: 114 EHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYS 170
Query: 68 -KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
K LSE + Y SP +L + D+W+ G + M+ G+ F + E ++
Sbjct: 171 HKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229
Query: 127 QVQKRV 132
+ + V
Sbjct: 230 LILESV 235
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 36/124 (29%), Positives = 62/124 (50%), Gaps = 6/124 (4%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
Q+A + Y + VHRD+ N L+ +K+ DFG +R V TDY + T
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYRVGGHTML 186
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKRVVFP 135
+ PE + +T +SD+WS GVVL+ + YG+ P+ + E+++ + + +
Sbjct: 187 -PIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL- 243
Query: 136 ESPR 139
+ PR
Sbjct: 244 QRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 33/123 (26%), Positives = 70/123 (56%), Gaps = 8/123 (6%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+A+ + + +K+ +HRD++ N+L+ + K++DFG AR + + +Y F
Sbjct: 109 AQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKF- 165
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK--RVV 133
+ +PE + +T +SD+WS G++L +V YGR+P+ E+++ +++ R+
Sbjct: 166 -PIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223
Query: 134 FPE 136
P+
Sbjct: 224 RPD 226
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 34/125 (27%), Positives = 63/125 (50%), Gaps = 5/125 (4%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
W Q+A + Y ++ +VHRD+ N+L+ ++K++DFG AR + +Y + +
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSELLKQVQKRVV 133
+ + E + +T QSD+WS GV ++ M +G P+D E+ ++K
Sbjct: 174 ---PIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 229
Query: 134 FPESP 138
P+ P
Sbjct: 230 LPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 31/122 (25%), Positives = 67/122 (54%), Gaps = 6/122 (4%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+A+ + + +++ +HRD++ N+L+ K++DFG AR + + +Y F
Sbjct: 109 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKF- 165
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFP 135
+ +PE + +T +SD+WS G++L +V YGR+P+ + E+++ +++ P
Sbjct: 166 -PIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 223
Query: 136 ES 137
Sbjct: 224 RP 225
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 36/114 (31%), Positives = 61/114 (53%), Gaps = 5/114 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y + +HRD+ N+L+ + +K++DFG AR VNN DY + +
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTTNGRL- 201
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQK 130
+ +PE L YT QSD+WS GV+++ + G P+ EL K +++
Sbjct: 202 PVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 4/105 (3%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H +V+HRD+K NLLL+ ++K+ DFG AR + D+ L+E +
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGFLTE-YVA 171
Query: 78 SYAYASPEI-LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
+ Y +PEI L YT + DIWS+G +L M+ R F +Y
Sbjct: 172 TRWYRAPEIMLNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDY 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 37/120 (30%), Positives = 66/120 (55%), Gaps = 5/120 (4%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+A +++ VVH+D+ N+L+ DK N+K+SD G R+ V DY + + +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE--VYAADYYKLMGNSLL 188
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFP 135
+ SPE + ++ SDIWS GVVL+ + YG P+ + ++++ ++ R V P
Sbjct: 189 -PIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 35/114 (30%), Positives = 59/114 (51%), Gaps = 10/114 (8%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H ++HRD+K NL +++ +K+ DFG AR+ T Y
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY--------VV 177
Query: 78 SYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
+ Y +PE IL + YT Q DIWS+G ++ M+ G+ F ++ + L ++ K
Sbjct: 178 TRWYRAPEVILNWMHYT-QTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 9e-10
Identities = 23/84 (27%), Positives = 44/84 (52%), Gaps = 3/84 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL--QAI 260
S+ +V LA + +A+K + + L+ REI ++ L+HPN++R+ +
Sbjct: 12 SFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE-REIRILSSLQHPNIVRYYGSERD 70
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRK 284
E + + I +EY GSL +++K
Sbjct: 71 EEKNTLNIFLEYVSGGSLSSLLKK 94
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 1e-09
Identities = 25/96 (26%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V L + +K I + L E++++K L HPN+I++ ++ E
Sbjct: 12 SFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL-NEVKILKKLNHPNIIKYYESFEE 70
Query: 263 THRVYIIMEYAKNGSLLEVIRKE----RYIDEDKAL 294
++ I+MEYA G L + I+K+ + E++ L
Sbjct: 71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL 106
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 37/130 (28%), Positives = 71/130 (54%), Gaps = 9/130 (6%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y VH+D+ N+L+ ++ ++K+SD G +R+ + + DY + ++
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE--IYSADYYRVQPKSLL- 188
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPE 136
+ PE + ++ SDIWS GVVL+ + +G P+ + E+++ V+KR + P
Sbjct: 189 PIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 247
Query: 137 S----PRLSS 142
S PR+ S
Sbjct: 248 SEDCPPRMYS 257
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 36/114 (31%), Positives = 61/114 (53%), Gaps = 5/114 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y + +HRD+ N+L+ + +K++DFG AR V+N DY + +
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDYYKKTTNGRL- 198
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQK 130
+ +PE L YT QSD+WS GV+L+ + G P+ EL K +++
Sbjct: 199 PVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 9/112 (8%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A +++ K +HRD+ N+L+ + + +K++DFG AR +++ DY + + G
Sbjct: 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTN---G 194
Query: 78 S--YAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSELLK 126
+ +PE L YT QSD+WS GV+L+ G P+ EL K
Sbjct: 195 RLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 34/112 (30%), Positives = 66/112 (58%), Gaps = 8/112 (7%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78
+ + + Y K +HRD+ N L+DD+ +K+SDFG +R V + +Y ++ F
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSSVGSKF--P 164
Query: 79 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY--GRLPFDDTNYSELLKQV 128
++ PE+L ++ +SD+W+ GV+++ VY G++P++ N SE +++V
Sbjct: 165 VRWSPPEVLLYSKFS-SKSDVWAFGVLMWE-VYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 21/148 (14%)
Query: 4 LLDYNTDKARRWF---------SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDF 54
LL+Y A R +Q+A + Y ++ +HRD+ N+L+ + K++DF
Sbjct: 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADF 147
Query: 55 GFARKYSVNNTDYKQNLSETFCGS---YAYASPEILKGVPYTPQQSDIWSMGVVLFAMV- 110
G AR K+++ E G+ + +PE ++ +SD+WS G++L +V
Sbjct: 148 GLARV-------IKEDIYEAREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVT 199
Query: 111 YGRLPFDDTNYSELLKQVQKRVVFPESP 138
YGR+P+ +E+L+QV + P P
Sbjct: 200 YGRMPYPGMTNAEVLQQVDQGYRMPCPP 227
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 32/112 (28%), Positives = 58/112 (51%), Gaps = 10/112 (8%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H ++HRD+K N+ +++ +K+ DFG AR T Y
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY--------VA 177
Query: 78 SYAYASPEI-LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ Y +PEI L + Y Q DIWS+G ++ ++ G+ F +++ + LK++
Sbjct: 178 TRWYRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 31/112 (27%), Positives = 62/112 (55%), Gaps = 8/112 (7%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78
+ + + Y +V+HRD+ N L+ + +K+SDFG R V + Y + F
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR--FVLDDQYTSSTGTKF--P 164
Query: 79 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY--GRLPFDDTNYSELLKQV 128
++SPE+ Y+ +SD+WS GV+++ V+ G+ P+++ + SE+++ +
Sbjct: 165 VKWSSPEVFSFSKYS-SKSDVWSFGVLMWE-VFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+++AD + Y + K VHRD+ N ++ + +K+ DFG R + TDY + +
Sbjct: 126 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLL 183
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ +PE LK +T SD+WS GVVL+ + P+ + ++LK V
Sbjct: 184 -PVRWMAPESLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 46/203 (22%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 3 ILLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 62
I ++ + ++ Q+ I + H ++HRD+K N+++ +K+ DFG AR
Sbjct: 116 IHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
N + + + Y +PE++ G+ Y + DIWS+G ++ +V G + F T++
Sbjct: 176 N------FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHI 228
Query: 123 ELLKQVQKRVVFPESP---RLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGK 179
+ +V +++ P + RL + + + N P I E++ D W+ + K
Sbjct: 229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN--RPQYPGISFEELFPD-WIFPSESERDK 285
Query: 180 SKSAPEVGIHKRKLKLIRDKKLS 202
K++ + + L + DK++S
Sbjct: 286 LKTSQARDLLSKMLVIDPDKRIS 308
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 5/110 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y + +HRD+ N+L+ + +K++DFG AR V++ DY + S
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTSNGRL- 198
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLK 126
+ +PE L YT QSD+WS G++++ + G P+ EL K
Sbjct: 199 PVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 35/114 (30%), Positives = 61/114 (53%), Gaps = 5/114 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y K +HRD+ N+L+ + +K++DFG AR +++ DY + +
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKTTNGRL- 204
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQK 130
+ +PE L YT QSD+WS GV+L+ + G P+ EL K +++
Sbjct: 205 PVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 5e-09
Identities = 37/130 (28%), Positives = 66/130 (50%), Gaps = 15/130 (11%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
++ + + H+ V+HRDIK +N+LL + +KL DFG + + ++ T ++N TF G
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRN---TFIG 173
Query: 78 SYAYASPEILKGVPYTPQ-----QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV 132
+ + +PE++ P +SD+WS+G+ M G P D + L + +
Sbjct: 174 TPYWMAPEVI-ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN- 231
Query: 133 VFPESPRLSS 142
+PRL S
Sbjct: 232 ---PAPRLKS 238
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 19/52 (36%), Positives = 40/52 (76%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR 58
++ + A ++ S++A A+DY H+ ++HRD+K +N+L+ ++ +IKL+DFG ++
Sbjct: 101 FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 30/109 (27%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
Q+A + Y HK+ V+H+DI N ++D++ +K++D +R + DY L +
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR--DLFPMDY-HCLGDNEN 180
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSEL 124
+ + E L Y+ SD+WS GV+L+ ++ G+ P+ + + E+
Sbjct: 181 RPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 32/133 (24%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 3 ILLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 62
I ++ + ++ Q+ I + H ++HRD+K N+++ +K+ DFG AR
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---- 174
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
T + + + Y +PE++ G+ Y + DIWS+G ++ M+ G + F T++
Sbjct: 175 --TAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHI 231
Query: 123 ELLKQVQKRVVFP 135
+ +V +++ P
Sbjct: 232 DQWNKVIEQLGTP 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 33/114 (28%), Positives = 58/114 (50%), Gaps = 5/114 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
++AD + Y + VHRD+ N ++ + + +K+ DFG R + TDY + +
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLL- 183
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQK 130
+ SPE LK +T SD+WS GVVL+ + P+ + ++L+ V +
Sbjct: 184 PVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V A + + +A+K I ++Q K + E++V++ LKHPNL+++ +E
Sbjct: 12 TFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVKYY-GVEV 69
Query: 263 THR--VYIIMEYAKNGSLLEVIRKERYIDE 290
HR VYI MEY G+L E++ R +DE
Sbjct: 70 -HREKVYIFMEYCSGGTLEELLEHGRILDE 98
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 39/124 (31%), Positives = 68/124 (54%), Gaps = 8/124 (6%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A + Y + VHRD+ N L+ + +K+ DFG +R V +TDY + T
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHTML- 184
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQV-QKRVVFP 135
+ PE + +T +SD+WS+GVVL+ + YG+ P+ + +E+++ + Q RV+
Sbjct: 185 PIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL-- 241
Query: 136 ESPR 139
+ PR
Sbjct: 242 QRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 40/126 (31%), Positives = 68/126 (53%), Gaps = 8/126 (6%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
SQ+A + Y + VHRD+ N L+ +K+ DFG +R V +TDY + T
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGGHTML 187
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQV-QKRVVF 134
+ PE + +T +SD+WS GV+L+ + YG+ P+ + +E+++ + Q RV+
Sbjct: 188 -PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL- 244
Query: 135 PESPRL 140
E PR+
Sbjct: 245 -ERPRV 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 11/106 (10%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN--NTDYKQNLSETF 75
Q+ I + H ++HRD+K N+++ +K+ DFG AR + T Y
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-------V 178
Query: 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
Y Y +PE++ G+ Y + DIWS+G ++ M+ G + F T++
Sbjct: 179 VTRY-YRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDH 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 8/99 (8%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H VVHRD+K N+L+++ ++K+ DFG AR T Y
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY--------VS 167
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
+ Y +PEI+ + DIWS G + M+ G+ F
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 17/111 (15%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK------YSVNN-TDYKQN 70
Q+A ++Y K VHRD+ N +LD+ + +K++DFG AR YSV+N T K
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTN 120
+ + + E L+ +T +SD+WS GV+L+ M G P+ D +
Sbjct: 166 VK--------WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
QL A+ Y H K + HRD+K +NLL+D + +KL DFG A+ N Q C
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----NLLAGQRSVSYIC 232
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG 112
+ Y +PE++ G D+WS+G ++ M+ G
Sbjct: 233 SRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 29/111 (26%), Positives = 60/111 (54%), Gaps = 6/111 (5%)
Query: 21 DAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 80
+ ++Y + S +HRD+ N L+ +K+SDFG R V + +Y + F
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR--YVLDDEYTSSSGAKF--PVK 166
Query: 81 YASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQK 130
++ PE+ Y+ +SD+WS GV+++ + G++PF+ + E+++ + +
Sbjct: 167 WSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 33/115 (28%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q++ A++Y KK+ +HRD+ N L+ + + +K++DFG +R + Y + F
Sbjct: 111 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKF- 167
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPF---DDTNYSELLKQ 127
+ +PE L ++ +SD+W+ GV+L+ + YG P+ D + ELL++
Sbjct: 168 -PIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 220
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 38/110 (34%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + Y H +V+HRD+K NLLL+ ++K+ DFG AR S ++E
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG----DFMTEYVVT 171
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLK 126
+ A +L YT D+WS+G + FA + GR P F +Y LK
Sbjct: 172 RWYRAPELLLNCSEYT-TAIDVWSVGCI-FAELLGRKPLFPGKDYVHQLK 219
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 39/162 (24%), Positives = 77/162 (47%), Gaps = 33/162 (20%)
Query: 18 QLADAIDYCHK-------KSVVHRDIKCENLLL-----------------DDKYNIKLSD 53
QL A+ YCH + V+HRD+K +N+ L + + K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 54 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL-KGVPYTPQQSDIWSMGVVLFAMVYG 112
FG ++ + ++++ + G+ Y SPE+L +SD+W++G +++ + G
Sbjct: 186 FGLSKNIGI------ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 113 RLPFDDT-NYSELLKQVQKRVVFPESPRLSSSCKALISNILS 153
+ PF N+S+L+ ++++ P + S LI N+L+
Sbjct: 240 KTPFHKANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLN 280
|
Length = 1021 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 11/102 (10%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
+ + H V+HRDIK +N+LL + +KL DFG + + ++ T ++N TF G+ +
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRN---TFIGTPYW 187
Query: 82 ASPEILKGVPYTPQ-----QSDIWSMGVVLFAMVYGRLPFDD 118
+PE++ P +SDIWS+G+ M G P D
Sbjct: 188 MAPEVI-ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 5e-08
Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 51/227 (22%)
Query: 3 ILLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV 62
I ++ + ++ Q+ I + H ++HRD+K N+++ +K+ DFG AR
Sbjct: 112 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---- 167
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY- 121
T + + + Y +PE++ G+ Y + DIWS+G ++ MV ++ F +Y
Sbjct: 168 --TAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYI 224
Query: 122 --------------SELLKQVQKRV-----------------VFPES--PRLS------- 141
E +K++Q V +FP+S P S
Sbjct: 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284
Query: 142 SSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEV 186
S + L+S +L P K RI +++ Q P++ +P P++
Sbjct: 285 SQARDLLSKMLVIDPAK-RISVDEALQHPYINVWYDPAEVEAPPPQI 330
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 34/130 (26%), Positives = 67/130 (51%), Gaps = 18/130 (13%)
Query: 2 DILLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 61
D LL ++ D + +A++Y + VHRD+ N+L+ + K+SDFG ++ S
Sbjct: 102 DCLLKFSLD--------VCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153
Query: 62 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTN 120
K + T +PE L+ ++ +SD+WS G++L+ + +GR+P+
Sbjct: 154 STQDTGKLPVKWT--------APEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIP 204
Query: 121 YSELLKQVQK 130
+++ +V+K
Sbjct: 205 LKDVVPRVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 9/106 (8%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNL 71
R+ SQ+A +D+ K+ +HRD+ N+LL D K+ DFG AR +N+++Y K N
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNA 274
Query: 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPF 116
+ +PE + YT QSD+WS G++L+ + G+ P+
Sbjct: 275 RLPV----KWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKK--FLPREIEVVKGLK-HPNLIRFLQA 259
S++TV LA +++ AIKI+ K Q + KK ++ E EV+ L HP +I+
Sbjct: 13 SFSTVVLAKEKETNKEYAIKILDKRQ--LIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT 70
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDED 291
+ +Y ++EYA NG LL+ IRK +DE
Sbjct: 71 FQDEENLYFVLEYAPNGELLQYIRKYGSLDEK 102
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 33/120 (27%), Positives = 57/120 (47%), Gaps = 8/120 (6%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78
+A + Y + VHRD+ N+L++ K+SDFG +R D + T G
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE----DDPEGTYTTSGGK 171
Query: 79 YA--YASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQKRVVFP 135
+ +PE + +T SD+WS G+V++ M +G P+ D + E++K + P
Sbjct: 172 IPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 33/137 (24%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78
+A + Y + + VHRD+ N+L++ K+SDFG +R + +D T+ S
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD------PTYTSS 168
Query: 79 YA------YASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQKR 131
+ +PE + +T SD+WS G+V++ M YG P+ D + +++ +++
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD 227
Query: 132 VVFPESPRLSSSCKALI 148
P ++ L+
Sbjct: 228 YRLPPPMDCPTALHQLM 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 10/131 (7%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
QL+ A+ Y K VHRDI N+L+ +KL DFG +R Y + + YK + +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKL-- 170
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSELLKQVQK--RVV 133
+ +PE + +T SD+W GV ++ ++ G PF ++++ +++ R+
Sbjct: 171 -PIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP 228
Query: 134 FPES--PRLSS 142
P + P L S
Sbjct: 229 MPPNCPPTLYS 239
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 40/114 (35%), Positives = 61/114 (53%), Gaps = 7/114 (6%)
Query: 186 VGIHKRKLKLIRDKKLSSYA--TVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE 243
V I K K R +K+ A TV A Q+VAIK I+ + P K+ + EI
Sbjct: 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEIL 68
Query: 244 VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDK-ALLC 296
V+K LK+PN++ FL + ++++MEY GSL +V+ E +DE + A +C
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVC 121
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
++ + +A ++Y KS +HRD+ N +L++ N+ ++DFG ++K + N DY +
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK--IYNGDYYRQ--- 170
Query: 74 TFCGSYA-----YASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQ 127
G A + + E L YT +SD+WS GV ++ + G+ P+ SE+
Sbjct: 171 ---GRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226
Query: 128 VQKRVVFPESPRLSSSCKALISN--ILSPVKFRIQMEDIRQD 167
+++ + P +L+S+ +L+P K R E +R +
Sbjct: 227 LRQGNRLKQPPDCLDGLYSLMSSCWLLNP-KDRPSFETLRCE 267
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 34/121 (28%), Positives = 59/121 (48%), Gaps = 15/121 (12%)
Query: 25 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84
Y H +++HRDIK N+LL + +KL+DFG A K S N +F G+ + +P
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---------SFVGTPYWMAP 186
Query: 85 EILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSS 142
E++ + + D+WS+G+ + + P + N L + + +SP L S
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----DSPTLQS 242
Query: 143 S 143
+
Sbjct: 243 N 243
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 34/121 (28%), Positives = 58/121 (47%), Gaps = 15/121 (12%)
Query: 25 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84
Y H +++HRDIK N+LL + +KL+DFG A S N +F G+ + +P
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---------SFVGTPYWMAP 190
Query: 85 EILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSS 142
E++ + + D+WS+G+ + + P + N L + + ESP L S
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPTLQS 246
Query: 143 S 143
+
Sbjct: 247 N 247
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 31/83 (37%), Positives = 45/83 (54%), Gaps = 9/83 (10%)
Query: 25 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84
Y H K +HRDIK N+LL D ++KL+DFG A K + K +F G+ + +P
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK-----SFIGTPYWMAP 175
Query: 85 EIL---KGVPYTPQQSDIWSMGV 104
E+ K Y Q DIW++G+
Sbjct: 176 EVAAVEKNGGYN-QLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 34/124 (27%), Positives = 59/124 (47%), Gaps = 3/124 (2%)
Query: 173 DSNPVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID 232
D + K ++ VG K+K + TV A Q+VAIK ++ Q P
Sbjct: 1 DEEILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-- 58
Query: 233 YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDK 292
K+ + EI V++ KHPN++ +L + ++++MEY GSL +V+ + +
Sbjct: 59 -KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 293 ALLC 296
A +C
Sbjct: 118 AAVC 121
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
W Q+A + Y + +VHR++ N+LL ++++DFG A ++ Y + +T
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVV 133
A S IL G YT QSD+WS GV ++ M+ YG P+ E+ ++K
Sbjct: 174 PIKWMALES--ILFG-RYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK--- 226
Query: 134 FPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSN 175
RL+ I + VK + E++R P KE +N
Sbjct: 227 ---GERLAQPQICTIDVYMVMVKCWMIDENVR--PTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 7/114 (6%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLSETFC 76
Q+A + Y ++ VHRD+ N L+ + +K++DFG +R YS DY + SE
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS---ADYYK-ASENDA 193
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQ 129
+ PE + YT +SD+W+ GVVL+ + YG P+ + E++ V+
Sbjct: 194 IPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR 246
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q++ + Y + +VHRD+ N+L+ + +K+SDFG +R ++ K++
Sbjct: 135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI--- 191
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV 110
+ + E L YT QSD+WS GV+L+ +V
Sbjct: 192 PVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 29/114 (25%), Positives = 60/114 (52%), Gaps = 4/114 (3%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q++ + Y + + VHRD+ N+LL ++ K+SDFG ++ + YK +
Sbjct: 103 QVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW-- 160
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 130
+ +PE + ++ +SD+WS GV+++ A YG+ P+ +E+ + ++
Sbjct: 161 PVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 33/115 (28%), Positives = 59/115 (51%), Gaps = 9/115 (7%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG- 77
+A + Y + + VHRD+ N+L++ K+SDFG +R+ + Y T G
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY-----TTKGGK 169
Query: 78 -SYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 130
+ +PE + +T SD+WS G+V++ M YG P+ D + +++K V+
Sbjct: 170 IPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 29/112 (25%), Positives = 61/112 (54%), Gaps = 3/112 (2%)
Query: 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 251
+ ++I+ S+ + LA + S+ IK I + P+ K+ +E+ ++ +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE-KEASKKEVILLAKMKHP 59
Query: 252 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYI--DEDKALLCYSEVS 301
N++ F + + R++I+MEY G L++ I ++R + ED+ L + ++S
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQIS 111
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 22/67 (32%), Positives = 35/67 (52%), Gaps = 4/67 (5%)
Query: 217 QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 276
Q VA+K + FL E V+ L+HPNL++ L + + +YI+ EY G
Sbjct: 30 QKVAVKCLKDDSTAAQ---AFLA-EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85
Query: 277 SLLEVIR 283
SL++ +R
Sbjct: 86 SLVDYLR 92
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 32/123 (26%), Positives = 66/123 (53%), Gaps = 6/123 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q++ + Y K+ VHRD+ N+LL +++ K+SDFG ++ +++ YK + +
Sbjct: 103 QVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW-- 160
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQ--KRVVF 134
+ +PE + ++ +SD+WS G+ ++ A YG+ P+ E++ ++ KR+
Sbjct: 161 PLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC 219
Query: 135 PES 137
P
Sbjct: 220 PAE 222
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 14/114 (12%)
Query: 16 FSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR------------KYSVN 63
F ++ I+Y H K V+HRD+K +N+LL + + D+G A
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 64 NTDYKQ-NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
N Y + G+ Y +PE L GVP + + +DI+++GV+L+ M+ P+
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 27/93 (29%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + + Y H + +HRD+ N+LLD+ +K+ DFG A+ + Y+ + E
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDS 172
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV 110
+ + E LK ++ SD+WS GV L+ ++
Sbjct: 173 PVFWYAVECLKENKFS-YASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 25/81 (30%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 204 YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263
Y V ++S VA+K + + +++FL +E V+K +KHPNL++ L
Sbjct: 19 YGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFL-KEAAVMKEIKHPNLVQLLGVCTRE 74
Query: 264 HRVYIIMEYAKNGSLLEVIRK 284
YII E+ G+LL+ +R+
Sbjct: 75 PPFYIITEFMTYGNLLDYLRE 95
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 40/125 (32%), Positives = 64/125 (51%), Gaps = 8/125 (6%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
SQ+A + Y VHRD+ N L+ +K+ DFG +R + +TDY + T
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTML 186
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQV-QKRVVF 134
+ PE + +T +SDIWS GVVL+ + YG+ P+ + +E ++ + Q R +
Sbjct: 187 -PIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL- 243
Query: 135 PESPR 139
E PR
Sbjct: 244 -ERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 17/130 (13%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+ Y H +HRDIK N+LL + +KL+DFG A S N +F
Sbjct: 122 HGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---------SFV 172
Query: 77 GSYAYASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 133
G+ + +PE++ + Y + D+WS+G+ + + P + N L + +
Sbjct: 173 GTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-- 229
Query: 134 FPESPRLSSS 143
+SP LSS+
Sbjct: 230 --DSPTLSSN 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
L + + Y H+ ++HRD+K N+L+ +KL+DFG AR +S++ K N
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS-KPNRYTNRVV 185
Query: 78 SYAYASPEILKG-VPYTPQQSDIWSMGVVLFAM 109
+ Y PE+L G Y P D+W G ++ M
Sbjct: 186 TLWYRPPELLLGERDYGP-PIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 33/126 (26%), Positives = 63/126 (50%), Gaps = 17/126 (13%)
Query: 20 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-----YSVNNTDYKQNLSET 74
A ++Y K+ +HRD+ N L+ + +K+SDFG +R+ Y+V++ KQ
Sbjct: 103 AAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD-GLKQI---- 157
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK--R 131
+ +PE L YT +SD+WS G++L+ G P+ + + ++++ R
Sbjct: 158 ---PIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR 213
Query: 132 VVFPES 137
+ P+
Sbjct: 214 MPAPQL 219
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 30/108 (27%), Positives = 55/108 (50%), Gaps = 17/108 (15%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ +RW +++ A+D H++ +V RD+ N+LLDD+ +I+L+ F +
Sbjct: 85 ECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV--------- 135
Query: 70 NLSETFCGSYA----YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 113
E C A Y +PE+ G+ + D WS+G +LF ++ G+
Sbjct: 136 ---EDSCDGEAVENMYCAPEV-GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A +++ + +HRD+ N+LL + +K+ DFG AR + DY +
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARL-- 243
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLF 107
+ +PE + YT QSD+WS GV+L+
Sbjct: 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLW 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 22/66 (33%), Positives = 40/66 (60%), Gaps = 6/66 (9%)
Query: 235 KKFLPREIEVVKGLKHPNLIRFLQAI--ETTHRVYIIMEYAKNGSLLEVIRKER----YI 288
K+ L E+ +++ LKHPN++R+ I + +YI+MEY + G L ++I+K + YI
Sbjct: 43 KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI 102
Query: 289 DEDKAL 294
+E+
Sbjct: 103 EEEFIW 108
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 23/76 (30%), Positives = 43/76 (56%), Gaps = 3/76 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V A + VAIK+I K++ D+ + + +EI ++K +HPN++ + +
Sbjct: 15 TYGDVYKARDIATGELVAIKVI-KLEPGDDF--EIIQQEISMLKECRHPNIVAYFGSYLR 71
Query: 263 THRVYIIMEYAKNGSL 278
+++I+MEY GSL
Sbjct: 72 RDKLWIVMEYCGGGSL 87
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A +++ + +HRD+ N+LL + +K+ DFG AR + DY +
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGDARL-- 237
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLF 107
+ +PE + YT QSD+WS GV+L+
Sbjct: 238 PLKWMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 8e-07
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 10/111 (9%)
Query: 25 YCHKKSVVHRDIKCENLLLDDKYN-----IKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79
Y + +HRD+ N L+ +K +K+ DFG AR + +DY + E
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEGEGLL-PV 177
Query: 80 AYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSELLKQVQ 129
+ +PE L +T QSD+WS GV+++ + G+ P+ N E+L+ V
Sbjct: 178 RWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A +++ + +HRD+ N+LL + +K+ DFG AR + DY + S
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI-YKDPDYVRKGSARL-- 238
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLF 107
+ +PE + YT QSD+WS GV+L+
Sbjct: 239 PLKWMAPESIFDKVYT-TQSDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 9/110 (8%)
Query: 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVK 246
I +L +++ + V L R DVAIK+I + + D+++ E +V+
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIE-----EAKVMM 54
Query: 247 GLKHPNLIRFLQAIETTHR-VYIIMEYAKNGSLLEVIRKERYIDEDKALL 295
L HPNL++ L + T R ++I+ EY NG LL +R+ + + LL
Sbjct: 55 KLSHPNLVQ-LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL 103
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 31/120 (25%), Positives = 61/120 (50%), Gaps = 7/120 (5%)
Query: 20 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79
A ++Y K +HRD+ N L+ +K +K+SDFG +R+ + +
Sbjct: 104 AAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI---PV 160
Query: 80 AYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK--RVVFPE 136
+ +PE L Y+ +SD+WS G++L+ A G +P+ + + + + +++ R+ PE
Sbjct: 161 KWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE 219
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 33/116 (28%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLS 72
R+ +A ++Y K+ +HRD+ N +L++ + ++DFG ++K YS + Y+Q
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY--YRQG-- 172
Query: 73 ETFCGS---YAYASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPFDDTNYSEL 124
C S + + E L YT SD+W+ GV ++ M G+ P+ SE+
Sbjct: 173 ---CASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLS- 72
Q+ D I Y H V+HRD+K N+L+ ++ +K++D GFAR + N+ K
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLADL 172
Query: 73 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVL 106
+ ++ Y +PE+L G + + DIW++G +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 49.0 bits (115), Expect = 2e-06
Identities = 24/87 (27%), Positives = 45/87 (51%), Gaps = 4/87 (4%)
Query: 202 SSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP-NLIRFLQAI 260
S+ V LA R + VA+K+++K + REI+++ L HP N+++
Sbjct: 11 GSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERY 287
+ +Y++MEY GSL ++++K
Sbjct: 68 QDEGSLYLVMEYVDGGSLEDLLKKIGR 94
|
Length = 384 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLS- 72
Q+ D I Y H V+HRD+K N+L+ ++ +K++D GFAR + N+ K
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF---NSPLKPLADL 172
Query: 73 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVL 106
+ ++ Y +PE+L G + + DIW++G +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 15/121 (12%)
Query: 25 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84
Y H +++HRD+K N+LL + +KL DFG A + N F G+ + +P
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------XFVGTPYWMAP 180
Query: 85 EILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSS 142
E++ + + D+WS+G+ + + P + N L + + ESP L S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----ESPALQS 236
Query: 143 S 143
Sbjct: 237 G 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 29/113 (25%), Positives = 51/113 (45%), Gaps = 9/113 (7%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
Q+ + ++ HK +HRD+ N+ ++ K K++DFG AR+Y + ET
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 77 G---------SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+ Y +PE+L G D+WS+G + ++ G+ F N
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
Q+A + Y + VHRD+ N L+ + Y IK++DFG +R ++ + DY +
Sbjct: 136 VQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR--NLYSGDYYRIQGRAVL 193
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM 109
A IL G T SD+W+ GV L+ M
Sbjct: 194 PIRWMAWESILLGKFTTA--SDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 13/125 (10%)
Query: 25 YCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84
Y H K +HRDIK N+LL D ++KL+DFG + + + K +F G+ + +P
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK-----SFIGTPYWMAP 175
Query: 85 EIL----KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL 140
E+ KG Y Q DIW++G+ + + P D + L + K P P+L
Sbjct: 176 EVAAVERKG-GYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP--PKL 231
Query: 141 SSSCK 145
K
Sbjct: 232 KDKMK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL A+ Y H +V HRD+K +N+L + +K+ DFG AR + N+T + F
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTP-----TAIFWT 164
Query: 78 SYA----YASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
Y Y +PE+ YTP DIWS+G + ++ G+ F N
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKN 212
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 32/120 (26%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78
+A + Y VHRD+ N+L++ K+SDFG +R D + T G
Sbjct: 115 IASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEAAYTTRGGK 170
Query: 79 YA--YASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQKRVVFP 135
+ +PE + +T SD+WS G+V++ M YG P+ + + +++K +++ P
Sbjct: 171 IPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 19/101 (18%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
Q+ + + Y H V+HRD+K N+L+ ++ +K+ D G AR + N K
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAPLKPLADL 172
Query: 74 -----TFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFA 108
T Y +PE+L G YT DIW++G + FA
Sbjct: 173 DPVVVTIW----YRAPELLLGARHYTK-AIDIWAIGCI-FA 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK-QNLSETF 75
SQ+ ++Y K VHRD+ N+L++ + +K+ DFG + + YK + E+
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLF 107
YA PE L ++ SD+WS GVVL+
Sbjct: 175 IFWYA---PESLTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 30/78 (38%), Positives = 42/78 (53%), Gaps = 9/78 (11%)
Query: 226 KVQAPIDYLKKFLPR--------EIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNG 276
K+ A I LK+F E+EV+ L HPN+I L A E +YI +EYA G
Sbjct: 29 KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYG 88
Query: 277 SLLEVIRKERYIDEDKAL 294
+LL+ +RK R ++ D A
Sbjct: 89 NLLDFLRKSRVLETDPAF 106
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 23/86 (26%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIIS-KVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261
+Y V A + VAIK I + ++ K REI+++K L HPN+I+ L
Sbjct: 11 TYGVVYKARDKLTGEIVAIKKIKLRFESEGI--PKTALREIKLLKELNHPNIIKLLDVFR 68
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERY 287
+Y++ E+ L ++I+ +
Sbjct: 69 HKGDLYLVFEFMDT-DLYKLIKDRQR 93
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 34/115 (29%), Positives = 61/115 (53%), Gaps = 5/115 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A+ +++ K+ VHRD+ N+L+ + +K+ DFG AR + +++Y S TF
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYISKGS-TFL- 303
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKR 131
+ +PE + YT SD+WS G++L+ + G P+ + +E KR
Sbjct: 304 PLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-06
Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 9/127 (7%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
+ + +A +DY +K +HRD+ N+L+ + Y K++DFG +R V K+ +
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGR 172
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRV 132
+ + E L YT SD+WS GV+L+ +V G P+ +EL +++ +
Sbjct: 173 L---PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 228
Query: 133 VFPESPR 139
E P
Sbjct: 229 RL-EKPL 234
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 32/120 (26%), Positives = 58/120 (48%), Gaps = 13/120 (10%)
Query: 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
N + ++ Q+ +DY + VHRD+ N+L++ ++ +K+ DFG + + Y
Sbjct: 107 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 166
Query: 68 --KQNL-SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
K +L S F + +PE L + SD+WS GV L+ + L + D+ S +
Sbjct: 167 TVKDDLDSPVF-----WYAPECLIQSKFY-IASDVWSFGVTLYEL----LTYCDSESSPM 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 20/70 (28%), Positives = 38/70 (54%), Gaps = 2/70 (2%)
Query: 219 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 278
VA+K++ + + + L E ++K + HP++I+ A + +I+EYAK GSL
Sbjct: 33 VAVKMLKENASSSELRD--LLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90
Query: 279 LEVIRKERYI 288
+R+ R +
Sbjct: 91 RSFLRESRKV 100
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 37/126 (29%), Positives = 61/126 (48%), Gaps = 16/126 (12%)
Query: 4 LLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN 63
LL + D AR +DY +K +HRD+ N+L+ + Y K++DFG +R V
Sbjct: 126 LLHFAADVAR--------GMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYS 122
K+ + + + E L YT SD+WS GV+L+ +V G P+ +
Sbjct: 178 ---VKKTMGRL---PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230
Query: 123 ELLKQV 128
EL +++
Sbjct: 231 ELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 24/68 (35%), Positives = 39/68 (57%), Gaps = 2/68 (2%)
Query: 218 DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS 277
+VA+K + P D +KFL +E E++K HPN+++ + +YI+ME GS
Sbjct: 21 EVAVKT-CRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78
Query: 278 LLEVIRKE 285
LL +RK+
Sbjct: 79 LLTFLRKK 86
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 28/78 (35%), Positives = 45/78 (57%), Gaps = 3/78 (3%)
Query: 218 DVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNG 276
D AIK + + + D+ + E+EV+ L HPN+I L A E +Y+ +EYA +G
Sbjct: 24 DAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81
Query: 277 SLLEVIRKERYIDEDKAL 294
+LL+ +RK R ++ D A
Sbjct: 82 NLLDFLRKSRVLETDPAF 99
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 14/114 (12%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNLSET 74
Q+A + + K+ +HRD+ N+LL +K+ DFG AR +N+++Y K N
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDI-MNDSNYVVKGN---A 203
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV------YGRLPFDDTNYS 122
A I V YT +SD+WS G++L+ + Y +P D Y
Sbjct: 204 RLPVKWMAPESIFNCV-YT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 22/97 (22%), Positives = 42/97 (43%)
Query: 204 YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263
Y V LA AIK+I K + E +++ + P +++ + +
Sbjct: 6 YGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK 65
Query: 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
+Y++MEY G L ++ +DED A + +E+
Sbjct: 66 KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEI 102
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 173 DSNPVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID 232
D + K +S VG K+K + TV A Q+VAIK ++ Q P
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-- 58
Query: 233 YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDK 292
K+ + EI V++ K+PN++ +L + ++++MEY GSL +V+ E +DE +
Sbjct: 59 -KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQ 116
Query: 293 -ALLC 296
A +C
Sbjct: 117 IAAVC 121
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 21/80 (26%), Positives = 38/80 (47%), Gaps = 10/80 (12%)
Query: 216 SQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 274
+ VA+K + +P +L+ E +++K L+H L++ +YI+ EY
Sbjct: 30 TTKVAVKTLKPGTMSPEAFLQ-----EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84
Query: 275 NGSLLEVIRKERYIDEDKAL 294
GSLL+ ++ E K L
Sbjct: 85 KGSLLDFLKS----GEGKKL 100
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 36/125 (28%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 173 DSNPVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID 232
D + K +S VG K+K + TV A Q+VAI+ ++ Q P
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-- 59
Query: 233 YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDK 292
K+ + EI V++ K+PN++ +L + ++++MEY GSL +V+ E +DE +
Sbjct: 60 -KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQ 117
Query: 293 -ALLC 296
A +C
Sbjct: 118 IAAVC 122
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 8/117 (6%)
Query: 189 HKRKLKLIRDKKLSSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEV 244
KR LK I+ + V+L + VA+K + + F REIE+
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDF-EREIEI 59
Query: 245 VKGLKHPNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSE 299
++ L H N++++ E + +IMEY +GSL + +++ R K LL +S
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS 116
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 32/116 (27%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
++ S +A + Y +K +HRD+ N+L+ + K++DFG +R V K+ +
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGR 179
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ + E L YT +SD+WS GV+L+ +V G P+ +EL +++
Sbjct: 180 L---PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 19/92 (20%), Positives = 41/92 (44%)
Query: 202 SSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261
+ V+L ++ A+K + K ++ + E E+++ HP +++ + +
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+Y++MEY G L ++R DE A
Sbjct: 64 DKKYIYMLMEYCLGGELWTILRDRGLFDEYTA 95
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 21/89 (23%), Positives = 38/89 (42%), Gaps = 4/89 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLK-KFLPREIEVVKGLKHPNLIRFLQAIE 261
S V + A+K I D K L RE++ ++ + P +++ A
Sbjct: 13 SSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDE 290
+ I++EY GSL ++++K I E
Sbjct: 70 KEGEISIVLEYMDGGSLADLLKKVGKIPE 98
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 3/105 (2%)
Query: 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 251
K + IR ++ V L + V IK I Q D + E +V+K L HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHP 59
Query: 252 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKAL 294
N+I + + + I+MEYA G+L E I+K +DED L
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL 104
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 16/53 (30%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 235 KKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY 287
KK RE++V++ L+H N++ +A R+Y++ EY + +LLE++
Sbjct: 44 KKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPG 95
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 18/67 (26%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 217 QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 276
++VAIK + + + + EI ++K KHPN++ + + ++++MEY G
Sbjct: 45 KEVAIKKMRLRKQNKELIIN----EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100
Query: 277 SLLEVIR 283
SL ++I
Sbjct: 101 SLTDIIT 107
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 21/90 (23%), Positives = 43/90 (47%), Gaps = 5/90 (5%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264
A V A +++ VAIK I + L +E++ + HPN++++ +
Sbjct: 15 AVVYAAICLPNNEKVAIKRIDLEKCQTSV--DELRKEVQAMSQCNHPNVVKYYTSFVVGD 72
Query: 265 RVYIIMEYAKNGSLLEVIR---KERYIDED 291
++++M Y GSLL++++ +DE
Sbjct: 73 ELWLVMPYLSGGSLLDIMKSSYPRGGLDEA 102
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 35/122 (28%), Positives = 60/122 (49%), Gaps = 9/122 (7%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETF----CG 77
++Y H+ +HR+IK ++L+ + LS G + YS+ K + F
Sbjct: 113 GLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTS 170
Query: 78 SYAYASPEILKGVPYTPQ-QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE 136
+ SPE+L+ Y +SDI+S+G+ + GR+PF D +++L +QK P
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPY 228
Query: 137 SP 138
SP
Sbjct: 229 SP 230
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 15/115 (13%)
Query: 16 FS-QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNLS 72
FS Q+A + + K+ +HRD+ N+LL K+ DFG AR N+++Y K N
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR-NDSNYVVKGNAR 277
Query: 73 ETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV------YGRLPFDDTNY 121
+ +PE + YT +SD+WS G++L+ + Y +P D Y
Sbjct: 278 LPV----KWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 24/74 (32%), Positives = 41/74 (55%), Gaps = 9/74 (12%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLIRFLQ 258
+Y V A + + VA+K I +D ++ +P REI ++K LKHPN+++ L
Sbjct: 11 TYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 259 AIETTHRVYIIMEY 272
I T ++Y++ EY
Sbjct: 66 VIHTERKLYLVFEY 79
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 18/57 (31%), Positives = 36/57 (63%), Gaps = 2/57 (3%)
Query: 240 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYI--DEDKAL 294
+E+ V+ +KHPN++++ ++ E +YI+M+Y + G L + I +R + ED+ L
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL----- 257
+Y V A R + VAIK IS V + K+ L REI++++ L+H N+I L
Sbjct: 12 AYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGLLDILRP 70
Query: 258 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED 291
+ E + VYI+ E + L +VI+ + + +D
Sbjct: 71 PSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDD 103
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 32/89 (35%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 218 DVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNG 276
D AIK + + + D+ + E+EV+ L HPN+I L A E +Y+ +EYA +G
Sbjct: 36 DAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 93
Query: 277 SLLEVIRKERYIDEDKAL-LCYSEVSNLS 304
+LL+ +RK R ++ D A + S S LS
Sbjct: 94 NLLDFLRKSRVLETDPAFAIANSTASTLS 122
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 212 SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271
+A VA+K++ + A + + FL +E++++ L PN+ R L + +IME
Sbjct: 42 NADAPVLVAVKVL-RPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTVDPPLCMIME 99
Query: 272 YAKNGSLLEVIRKERYIDEDKALLCYS 298
Y +NG L + ++K ++ E L C S
Sbjct: 100 YMENGDLNQFLQK--HVAETSGLACNS 124
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 33/117 (28%), Positives = 57/117 (48%), Gaps = 16/117 (13%)
Query: 20 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-----YSVNNTDYKQNLSET 74
A + Y K+ +HRD+ N L+ + +K+SDFG +R+ YS ++ KQ
Sbjct: 103 AAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS--SSGLKQI---- 156
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 130
+ +PE L Y+ +SD+WS G++L+ G P+ + +QV+K
Sbjct: 157 ---PIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK 209
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 3e-05
Identities = 22/102 (21%), Positives = 48/102 (47%), Gaps = 8/102 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISK----VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 258
S+ V L + A+K++ K + +++ E ++ + HP +++
Sbjct: 5 SFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL----TERNILSRINHPFIVKLHY 60
Query: 259 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
A +T ++Y+++EYA G L + KE E++A +E+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 27/100 (27%), Positives = 47/100 (47%), Gaps = 4/100 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLK--KFLPREIEVVKGLKHPNLIRFLQAI 260
S+ V L + A+KI+SK A I LK + + E +++ ++HP L+ +
Sbjct: 13 SFGRVMLVRHKGSGKYYALKILSK--AKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF 70
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
+ +Y++MEY G L +RK E A ++V
Sbjct: 71 QDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 31/110 (28%), Positives = 49/110 (44%), Gaps = 7/110 (6%)
Query: 217 QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 276
VA+K + K A K+FL +E ++ HPN+++ L YIIME + G
Sbjct: 27 IRVAVKTLRK-GATDQEKKEFL-KEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGG 84
Query: 277 SLLEVIRKERYIDEDKALLCYSEVSNLSQTFSRCCY---QDHI--QDLSC 321
LL +R R LL E+ ++ ++ C Q H +DL+
Sbjct: 85 DLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAA 134
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 7/112 (6%)
Query: 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 247
I + L +++ + VK R DVAIK+I + D +F+ E +V+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMSED---EFI-EEAKVMMK 55
Query: 248 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALL--CY 297
L H L++ +YI+ EY NG LL +R+ + LL C
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK 107
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 25/69 (36%), Positives = 38/69 (55%), Gaps = 8/69 (11%)
Query: 219 VAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-VYIIMEYAKNG 276
VA+K + P D+L E +++K L+HP LI+ L A+ T +YI+ E K G
Sbjct: 33 VAVKTLKPGTMDPKDFL-----AEAQIMKKLRHPKLIQ-LYAVCTLEEPIYIVTELMKYG 86
Query: 277 SLLEVIRKE 285
SLLE ++
Sbjct: 87 SLLEYLQGG 95
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 26/104 (25%), Positives = 52/104 (50%), Gaps = 15/104 (14%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78
+A ++Y ++ +HRD+ N +L + + ++DFG ++K + + DY + G
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK--IYSGDYYRQ------GR 173
Query: 79 YA-----YASPEILKGVPYTPQQSDIWSMGVVLFA-MVYGRLPF 116
A + + E L YT +SD+W+ GV ++ G+ P+
Sbjct: 174 IAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A +++ K+ VHRD+ N+LL +K+ DFG AR +++++Y S TF
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI-MHDSNYVSKGS-TFL- 301
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAM 109
+ +PE + YT SD+WS G++L+ +
Sbjct: 302 PVKWMAPESIFDNLYT-TLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 247
I + LKL + + V +AT +H++ VA+K + ++ FL E V+K
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE---AFL-AEANVMKT 57
Query: 248 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE 285
L+H L++ L A+ T +YII E+ GSLL+ ++ +
Sbjct: 58 LQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSD 94
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 37/131 (28%), Positives = 55/131 (41%), Gaps = 14/131 (10%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
Q+A + Y + VHRD+ N L+ + IK++DFG +R DY +
Sbjct: 145 LQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG--DYYRIQGRAVL 202
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-------YGRLPFDDT--NYSELLKQ 127
A IL G T SD+W+ GV L+ ++ YG L + N E +
Sbjct: 203 PIRWMAWECILMGKFTT--ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRD 260
Query: 128 VQKRVVFPESP 138
Q R V+ P
Sbjct: 261 -QGRQVYLFRP 270
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 17/105 (16%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
+ + H +HRD+K N+LL + +KL DFG + + + +T ++N S G+ +
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTS---VGTPFW 190
Query: 82 ASPEILKGVPYTPQQ--------SDIWSMGVVLFAMVYGRLPFDD 118
+PE++ QQ D+WS+G+ + G P D
Sbjct: 191 MAPEVIA----CEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 27/101 (26%), Positives = 53/101 (52%), Gaps = 9/101 (8%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
+ + H ++HRD+K N+LL + +KL DFG + + + +T ++N S G+ +
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTS---VGTPFW 194
Query: 82 ASPEIL---KGVPYT-PQQSDIWSMGVVLFAMVYGRLPFDD 118
+PE++ + Y+ + D+WS+G+ + G P D
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 15/47 (31%), Positives = 29/47 (61%)
Query: 238 LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK 284
L +EI ++ L+HPN++++L +YI +E GSL ++++K
Sbjct: 49 LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK 95
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 28/114 (24%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFAR-KYSVNNTDYKQNLSETFC 76
Q+A +D+ VHRD+ N L+ + +K+S ++ Y+ + L
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL-- 182
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQ 129
+ +PE ++ ++ +SD+WS GV+++ + G LPF + E+L ++Q
Sbjct: 183 ---RWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 3/65 (4%)
Query: 219 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 278
VAIKI+ + + F +E++ +K L+H +LI VYII E + GSL
Sbjct: 33 VAIKILK--SDDLLKQQDFQ-KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL 89
Query: 279 LEVIR 283
L +R
Sbjct: 90 LAFLR 94
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 21/76 (27%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 241 EIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED-KALLCYS 298
E+E++K + KH N+I L +Y+++EYA +G+L + +R R E
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 299 EVSNLSQT-FSRCCYQ 313
L+Q YQ
Sbjct: 125 PEETLTQKDLVSFAYQ 140
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 22/82 (26%), Positives = 41/82 (50%), Gaps = 1/82 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
SY +V +Q A+K + + + ++ EI ++ + HPN+I + +A
Sbjct: 12 SYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70
Query: 263 THRVYIIMEYAKNGSLLEVIRK 284
+++ I+MEYA G L + I K
Sbjct: 71 GNKLCIVMEYAPFGDLSKAISK 92
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 16/47 (34%), Positives = 30/47 (63%)
Query: 240 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
+E ++ +KHPN++ F ++ E +YI+MEY G L++ I+ +R
Sbjct: 47 KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR 93
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 8/99 (8%)
Query: 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVK 246
+ + LKL++ + V + H++ VAIK + + +P +L E ++K
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLA-----EANLMK 56
Query: 247 GLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE 285
L+HP L+R L A+ T +YII EY +NGSL++ ++
Sbjct: 57 QLQHPRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTP 94
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 3/95 (3%)
Query: 230 PIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYID 289
P D KFL +E ++K HPN++R + +YI+ME + G L +R E
Sbjct: 33 PPDLKAKFL-QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRL 91
Query: 290 EDKALLCYSE--VSNLSQTFSRCCYQDHIQDLSCF 322
+ K L+ E + + S+ C + +C
Sbjct: 92 KVKELIQMVENAAAGMEYLESKHCIHRDLAARNCL 126
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 31/124 (25%), Positives = 60/124 (48%), Gaps = 11/124 (8%)
Query: 19 LADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78
LA + Y + VH+ + +L++ K+S F ++ D + + T G
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE------DKSEAIYTTMSGK 169
Query: 79 YA--YASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQKRVVFP 135
+A+PE ++ ++ SD+WS G+V++ M YG P+ D + +++K V+ P
Sbjct: 170 SPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP 228
Query: 136 ESPR 139
+PR
Sbjct: 229 -APR 231
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 25/75 (33%), Positives = 38/75 (50%), Gaps = 2/75 (2%)
Query: 220 AIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 278
A+KI+ K V D + L E V++ +HP L + +T R+ +MEYA G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL 82
Query: 279 LEVIRKERYIDEDKA 293
+ +ER ED+A
Sbjct: 83 FFHLSRERVFSEDRA 97
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 24/98 (24%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
SY +V A Q VAIK++ V+ + + K EI ++K P ++++ +
Sbjct: 15 SYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIK----EISILKQCDSPYIVKYYGSYFK 69
Query: 263 THRVYIIMEYAKNGSLLEVIR-KERYIDEDK-ALLCYS 298
++I+MEY GS+ ++++ + + E++ A + Y
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 28/87 (32%), Positives = 44/87 (50%), Gaps = 6/87 (6%)
Query: 203 SYATVKLA---TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 259
S+ V+ TS VA+K + + D + FL +E ++ L H NLIR L
Sbjct: 7 SFGVVRRGEWSTSGGKVIPVAVKCLKSDK-LSDIMDDFL-KEAAIMHSLDHENLIR-LYG 63
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKER 286
+ TH + ++ E A GSLL+ +RK+
Sbjct: 64 VVLTHPLMMVTELAPLGSLLDRLRKDA 90
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 35/148 (23%), Positives = 62/148 (41%), Gaps = 24/148 (16%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLL----DDKYN---IKLSDFGFARKYSVNNTDYKQN 70
QLA A+ Y K +VH ++ +N+L+ ++ IKLSD G +V + + +
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVE 166
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQ-SDIWSMGVVLFAMVY-GRLPFDDTNYSELLK-- 126
+ +PE ++ + +D WS G L + G P + SE +
Sbjct: 167 RI-------PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY 219
Query: 127 QVQKRVVFPESPRLSSSCKALISNILSP 154
Q Q R+ P+ L+ LI+ +
Sbjct: 220 QDQHRLPMPDCAELA----NLINQCWTY 243
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 31/106 (29%), Positives = 51/106 (48%), Gaps = 13/106 (12%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA- 80
A+DY H K +HR +K ++LL + LS ++ S+ +Q + F S
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSV--SMIKHGKRQRVVHDFPKSSVK 170
Query: 81 ---YASPEILK----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT 119
+ SPE+L+ G Y +SDI+S+G+ + G +PF D
Sbjct: 171 NLPWLSPEVLQQNLQG--YNE-KSDIYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 6/97 (6%)
Query: 196 IRDKKLS--SYATVKLATSARHSQDVAIKII--SKVQAPIDYLKKFLPREIEVVKGLKHP 251
+ KKL +YA V A + VAIK I + + D + REI++++ LKHP
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 252 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYI 288
N+I L + ++ E+ + LE + K++ I
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFM--ETDLEKVIKDKSI 97
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 22/94 (23%), Positives = 46/94 (48%), Gaps = 8/94 (8%)
Query: 203 SYATVKLATSARHSQDVAIK-IISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAI 260
++ +V LA + + VAIK + K + + + RE++ ++ L HPN+++ +
Sbjct: 11 TFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL---REVKSLRKLNEHPNIVKLKEVF 67
Query: 261 ETTHRVYIIMEYAKNGSLLEVI--RKERYIDEDK 292
+Y + EY G+L +++ RK + E
Sbjct: 68 RENDELYFVFEYM-EGNLYQLMKDRKGKPFSESV 100
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 7/92 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPID-YLKKFLPREIEVVKGLKHPNLIRFLQAIE 261
+ V + +A+K I + I+ ++K + RE++++ P ++ F A
Sbjct: 13 NSGVVSKVLHRPTGKIMAVKTI---RLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY 69
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERY--IDED 291
+ I MEY GS L+ I KE I E
Sbjct: 70 NNGDISICMEYMDGGS-LDKILKEVQGRIPER 100
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 25/101 (24%), Positives = 51/101 (50%), Gaps = 1/101 (0%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIE 261
S+ V LA + A+K++ K +K + E V+ K +KHP L+ + +
Sbjct: 7 SFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ 66
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSN 302
TT ++Y ++++ G L +++ER E +A +E+++
Sbjct: 67 TTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIAS 107
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 24/84 (28%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 218 DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS 277
+VA+K + + I KK RE V+ L HP ++R L + + ++ME A G
Sbjct: 25 EVAVKTLKQEH--IAAGKKEFLREASVMAQLDHPCIVR-LIGVCKGEPLMLVMELAPLGP 81
Query: 278 LLEVIRKERYIDEDKALLCYSEVS 301
LL+ ++K R I +V+
Sbjct: 82 LLKYLKKRREIPVSDLKELAHQVA 105
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 31/128 (24%), Positives = 59/128 (46%), Gaps = 16/128 (12%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 72
+R ++A + + HK + +H D+ N L +K+ D+G + + YK++
Sbjct: 102 QRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYG------IGPSRYKEDYI 155
Query: 73 ET---FCGSYAYASPEI---LKGVPYTPQQ---SDIWSMGVVLFAMV-YGRLPFDDTNYS 122
ET C + +PE+ G T +Q S++W++GV L+ + P+ +
Sbjct: 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215
Query: 123 ELLKQVQK 130
E+L V K
Sbjct: 216 EVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 2/76 (2%)
Query: 241 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSE- 299
E V++ +HP L A +T R+ +MEYA G L + +ER E++A +E
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 300 VSNLSQTFSR-CCYQD 314
VS L SR Y+D
Sbjct: 105 VSALEYLHSRDVVYRD 120
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 23/68 (33%), Positives = 39/68 (57%), Gaps = 5/68 (7%)
Query: 220 AIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI--ETTHRVYIIMEYAKNGS 277
A+K I+ P L+K + RE+E+ K K P ++++ A E++ + I MEY + GS
Sbjct: 30 ALKTITT--DPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGS 87
Query: 278 LLEVIRKE 285
L+ I K+
Sbjct: 88 -LDSIYKK 94
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 13/143 (9%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+A + Y + VHRD+ N L+ Y IK++DFG +R ++ + DY +
Sbjct: 137 TQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--NLYSGDYYRIQGRAVL 194
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-------YGRLPFDDT--NYSELLKQ 127
+ IL G T SD+W+ GV L+ ++ Y +L + N E +
Sbjct: 195 PIRWMSWESILLGKFTT--ASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRD 252
Query: 128 VQKRVVFPESPRLSSSCKALISN 150
++V P+ S L+ +
Sbjct: 253 QGRQVYLPKPALCPDSLYKLMLS 275
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 25/110 (22%), Positives = 52/110 (47%), Gaps = 3/110 (2%)
Query: 23 IDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN--NTDYKQNLSETFCGSYA 80
++Y H+ + H DIK EN+++D + D+G A + ++ + +Y + + G+
Sbjct: 139 LEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLY 198
Query: 81 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
YA + G T ++ D+ S+G + +LP+ ++ L K
Sbjct: 199 YAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247
|
Length = 294 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 25/101 (24%), Positives = 48/101 (47%), Gaps = 1/101 (0%)
Query: 203 SYATVKLATSARHSQDVAIKIISK-VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261
S+ V LA + A+K++ K V D ++ + + + HP L + +
Sbjct: 7 SFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ 66
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSN 302
T R++ +ME+ G L+ I+K R DE +A +E+++
Sbjct: 67 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITS 107
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 213 ARHSQD---VAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIETTHRVYI 268
ARH + A+K++ K +K + E V+ K +KHP L+ + +T ++Y
Sbjct: 14 ARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 73
Query: 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSN 302
+++Y G L +++ER E +A +E+++
Sbjct: 74 VLDYINGGELFYHLQRERCFLEPRARFYAAEIAS 107
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 17/53 (32%), Positives = 28/53 (52%)
Query: 249 KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS 301
KHP L +T R++ +MEY G L+ I++ R DE ++ +EV+
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVT 106
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 26/100 (26%), Positives = 47/100 (47%), Gaps = 1/100 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIE 261
S+ V LA A+K++ K + + E V+ K LKHP L+ + +
Sbjct: 7 SFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ 66
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS 301
T ++Y +++Y G L +++ER E +A +EV+
Sbjct: 67 TAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 20/70 (28%), Positives = 39/70 (55%), Gaps = 1/70 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V A + + VA+K I ++ + + REI ++K L HPN+++ L I T
Sbjct: 12 TYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 70
Query: 263 THRVYIIMEY 272
+++Y++ E+
Sbjct: 71 ENKLYLVFEF 80
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 217 QDVAIK-IISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 275
Q VAIK + P+ +KK REI ++K LKHPNL+ ++ +++++ EY +
Sbjct: 27 QIVAIKKFVESEDDPV--IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84
Query: 276 GSLLEVIRKERYIDEDK 292
L E+ + R + E
Sbjct: 85 TVLNELEKNPRGVPEHL 101
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 26/92 (28%), Positives = 47/92 (51%), Gaps = 10/92 (10%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQA--PIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260
S+ V A R +Q VAIK+I +A I+ + +EI+ + + P + ++ +
Sbjct: 13 SFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE----DIQQEIQFLSQCRSPYITKYYGSF 68
Query: 261 ETTHRVYIIMEYAKNGSLLEVIR----KERYI 288
+++IIMEY GS L++++ E YI
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYI 100
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 24/84 (28%), Positives = 44/84 (52%), Gaps = 2/84 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V AT++ ++ VA+K +S + + + +E++ ++ LKHPN I +
Sbjct: 33 SFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92
Query: 263 THRVYIIMEY--AKNGSLLEVIRK 284
H +++MEY LLEV +K
Sbjct: 93 EHTAWLVMEYCLGSASDLLEVHKK 116
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 24/77 (31%), Positives = 45/77 (58%), Gaps = 9/77 (11%)
Query: 219 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKH---PNLIRFLQAIETTHRVYIIMEYAKN 275
VA+KII+ + P D + + RE+ ++ L+ PN+ ++ + R++IIMEYA+
Sbjct: 29 VALKIIN-LDTPDDDVSD-IQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG 86
Query: 276 GSLLEVIR----KERYI 288
GS+ +++ E+YI
Sbjct: 87 GSVRTLMKAGPIAEKYI 103
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 22/96 (22%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 203 SYATVKLATSARHSQDVAIKI--ISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260
S V +AT + VA+K + K Q ++ L E+ +++ +HPN++ +
Sbjct: 31 STGIVCIATDKSTGRQVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLC 296
++++ME+ + G+L +++ R +E A +C
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVC 121
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 203 SYATVKLATSARHSQDVAIK-------IISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR 255
+Y V LA + + +A+K I + + + K L EIE +K L H N+++
Sbjct: 13 TYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72
Query: 256 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED 291
+L T + I +EY GS+ +R +E
Sbjct: 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ 108
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 25/98 (25%), Positives = 46/98 (46%), Gaps = 5/98 (5%)
Query: 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 247
I + +KL++ + V + +S VA+K + + + FL E ++K
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSV---QAFL-EEANLMKT 57
Query: 248 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE 285
L+H L+R + +YII EY GSLL+ ++ +
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD 95
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 7/109 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA- 80
A+DY H VHR +K ++L+ + LS G S+ N + + F
Sbjct: 113 ALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVK 170
Query: 81 ---YASPEILK-GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 125
+ SPE+L+ + +SDI+S+G+ + G +PF D +++L
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 41/152 (26%), Positives = 62/152 (40%), Gaps = 35/152 (23%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDK-------YNIKLSDFG-----FARKYSVNNT 65
QLA A+ Y K++VH ++ +N+LL IKLSD G +R+ V
Sbjct: 125 QLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI 184
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSEL 124
+ +PE + G +D WS G L + + G +P + SE
Sbjct: 185 --------------PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230
Query: 125 LKQVQKRVVFPESPRLSSSCK---ALISNILS 153
+ +K+ PE SCK LIS L+
Sbjct: 231 ERFYEKKHRLPE-----PSCKELATLISQCLT 257
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 31/109 (28%), Positives = 50/109 (45%), Gaps = 10/109 (9%)
Query: 25 YCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
Y + +HRDI N LL K K++DFG AR + Y + +
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKGGRAML-PIKW 187
Query: 82 ASPE-ILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQV 128
PE L G+ +T ++D+WS GV+L+ G +P+ E+++ V
Sbjct: 188 MPPEAFLDGI-FT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 2/91 (2%)
Query: 196 IRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIR 255
+R+ S+ V A R+S+ VAIK +S + + + +E+ ++ L+HPN I+
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 256 FLQAIETTHRVYIIMEY--AKNGSLLEVIRK 284
+ H +++MEY LLEV +K
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKK 110
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-YSVNNTDYKQNLSETFC 76
Q+A + Y + VHRD+ N L+ Y IK++DFG +R YS +DY +
Sbjct: 138 QIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS---SDYYRVQGRAPL 194
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVL 106
A +L G +T +SD+W+ GV L
Sbjct: 195 PIRWMAWESVLLG-KFT-TKSDVWAFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 23/80 (28%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 219 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 278
VA+K K P + KFL E ++K HPN+++ + +YI+ME G
Sbjct: 22 VAVKT-CKEDLPQELKIKFL-SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79
Query: 279 LEVIRKERYIDEDKALLCYS 298
L +RK++ + K L+ ++
Sbjct: 80 LSFLRKKKDELKTKQLVKFA 99
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 33/141 (23%), Positives = 64/141 (45%), Gaps = 23/141 (16%)
Query: 22 AIDYC------HKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ-NLSE 73
AID C +K + ++++ + L+ + Y +K+ G + S + +K N
Sbjct: 128 AIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS--SPPFKNVNFM- 184
Query: 74 TFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR 131
Y S ++L + YT + DI+S+GVVL+ + G++PF++ E+ + +
Sbjct: 185 ------VYFSYKMLNDIFSEYT-IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK 237
Query: 132 VVFPESPRLSSSCKALISNIL 152
S +L C I I+
Sbjct: 238 NN---SLKLPLDCPLEIKCIV 255
|
Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 31/128 (24%), Positives = 52/128 (40%), Gaps = 26/128 (20%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNL 71
+ Q+ A+D H +VHRD+K +N++ + + K+ D G A V +Y +
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRV-GINY---I 313
Query: 72 SETFCGSYAYASPE--ILK----GVPYT---------------PQQSDIWSMGVVLFAMV 110
+ F YA+PE I+ P P + DI+S G++ M
Sbjct: 314 PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373
Query: 111 YGRLPFDD 118
+ L D
Sbjct: 374 FPNLRSDS 381
|
Length = 566 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 31/130 (23%), Positives = 61/130 (46%), Gaps = 26/130 (20%)
Query: 18 QLADAIDYCHKK-SVVHRDIKCENLLLD----------------DKYNIKLSDFGFARKY 60
Q A+DY H + ++H D+K EN+L++ D +++ D G
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG----- 293
Query: 61 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
D + + + + Y SPE++ G+ + +D+WSMG +++ + G+L +D +
Sbjct: 294 --GCCDERHSRT-AIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHD 349
Query: 121 YSELLKQVQK 130
E L ++K
Sbjct: 350 NLEHLHLMEK 359
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 347 | |||
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0590|consensus | 601 | 99.98 | ||
| KOG0592|consensus | 604 | 99.98 | ||
| KOG0600|consensus | 560 | 99.98 | ||
| KOG0663|consensus | 419 | 99.98 | ||
| KOG0605|consensus | 550 | 99.97 | ||
| KOG0604|consensus | 400 | 99.97 | ||
| KOG0659|consensus | 318 | 99.97 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032|consensus | 382 | 99.97 | ||
| KOG0594|consensus | 323 | 99.97 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0582|consensus | 516 | 99.97 | ||
| KOG0986|consensus | 591 | 99.97 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0597|consensus | 808 | 99.97 | ||
| KOG0581|consensus | 364 | 99.97 | ||
| KOG0658|consensus | 364 | 99.97 | ||
| KOG0612|consensus | 1317 | 99.97 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| KOG0690|consensus | 516 | 99.97 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0580|consensus | 281 | 99.97 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| KOG0583|consensus | 370 | 99.97 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0201|consensus | 467 | 99.97 | ||
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0192|consensus | 362 | 99.97 | ||
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0580|consensus | 281 | 99.97 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0610|consensus | 459 | 99.97 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0591|consensus | 375 | 99.97 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| KOG0589|consensus | 426 | 99.97 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| KOG1035|consensus | 1351 | 99.97 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0600|consensus | 560 | 99.97 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0603|consensus | 612 | 99.96 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0593|consensus | 396 | 99.96 | ||
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| KOG0614|consensus | 732 | 99.96 | ||
| KOG0197|consensus | 468 | 99.96 | ||
| KOG0659|consensus | 318 | 99.96 | ||
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0607|consensus | 463 | 99.96 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0696|consensus | 683 | 99.96 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0579|consensus | 1187 | 99.96 | ||
| KOG0586|consensus | 596 | 99.96 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0585|consensus | 576 | 99.96 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| KOG0667|consensus | 586 | 99.96 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0983|consensus | 391 | 99.96 | ||
| KOG0596|consensus | 677 | 99.96 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG0588|consensus | 786 | 99.96 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| KOG0032|consensus | 382 | 99.95 | ||
| KOG0658|consensus | 364 | 99.95 | ||
| KOG0661|consensus | 538 | 99.95 | ||
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| KOG4721|consensus | 904 | 99.95 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4645|consensus | 1509 | 99.95 | ||
| KOG0584|consensus | 632 | 99.95 | ||
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0198|consensus | 313 | 99.95 | ||
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG4279|consensus | 1226 | 99.95 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| KOG0192|consensus | 362 | 99.95 | ||
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0663|consensus | 419 | 99.95 | ||
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0695|consensus | 593 | 99.95 | ||
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| KOG0694|consensus | 694 | 99.95 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0597|consensus | 808 | 99.95 | ||
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0612|consensus | 1317 | 99.95 | ||
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0197|consensus | 468 | 99.95 | ||
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| KOG0594|consensus | 323 | 99.95 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0608|consensus | 1034 | 99.95 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG0033|consensus | 355 | 99.95 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0586|consensus | 596 | 99.94 | ||
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.94 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0665|consensus | 369 | 99.94 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| KOG0662|consensus | 292 | 99.94 | ||
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| KOG0193|consensus | 678 | 99.94 | ||
| KOG4717|consensus | 864 | 99.94 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0577|consensus | 948 | 99.94 | ||
| KOG0669|consensus | 376 | 99.94 | ||
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.94 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.94 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.94 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.94 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.94 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.94 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.94 | |
| KOG4236|consensus | 888 | 99.94 | ||
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0194|consensus | 474 | 99.94 | ||
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0666|consensus | 438 | 99.94 | ||
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG4250|consensus | 732 | 99.94 | ||
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| KOG0582|consensus | 516 | 99.94 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| KOG1035|consensus | 1351 | 99.94 | ||
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.93 | |
| KOG2345|consensus | 302 | 99.93 | ||
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0671|consensus | 415 | 99.93 | ||
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| KOG0607|consensus | 463 | 99.93 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.93 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| KOG0608|consensus | 1034 | 99.93 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.93 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.93 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.93 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.93 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| KOG0660|consensus | 359 | 99.93 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.93 | |
| KOG0589|consensus | 426 | 99.93 | ||
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0690|consensus | 516 | 99.93 | ||
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0574|consensus | 502 | 99.93 | ||
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| KOG0662|consensus | 292 | 99.93 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.93 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| KOG0599|consensus | 411 | 99.92 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| KOG0664|consensus | 449 | 99.92 | ||
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG1989|consensus | 738 | 99.92 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.92 | |
| KOG1187|consensus | 361 | 99.92 | ||
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.92 | |
| KOG4236|consensus | 888 | 99.92 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| KOG0668|consensus | 338 | 99.92 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| KOG1151|consensus | 775 | 99.92 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.92 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.92 | |
| KOG0986|consensus | 591 | 99.92 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.92 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.92 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.92 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.92 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.92 | |
| KOG1027|consensus | 903 | 99.92 | ||
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.92 | |
| KOG1152|consensus | 772 | 99.92 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| KOG0578|consensus | 550 | 99.92 | ||
| KOG1006|consensus | 361 | 99.92 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| KOG1095|consensus | 1025 | 99.91 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.91 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.91 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.91 | |
| KOG0574|consensus | 502 | 99.91 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| KOG0194|consensus | 474 | 99.91 |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=325.06 Aligned_cols=293 Identities=26% Similarity=0.426 Sum_probs=238.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
|.+..++.+...++.|++++|+.+|++||+|++||+++.+|++++.|||+++..... +..|||..|||||+
T Consensus 94 f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~---------~~~cgt~eymApEI 164 (612)
T KOG0603|consen 94 FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE---------KIACGTYEYRAPEI 164 (612)
T ss_pred hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh---------hhcccchhhhhhHh
Confidence 455788889999999999999999999999999999999999999999998765431 12289999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC-----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ----- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~----- 160 (347)
+.+. . ..+|+||+|+++++|+||..||.. ++..+|.+. .++.+..++..+++++..++ .+|.+|..
T Consensus 165 ~~gh--~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~ 236 (612)
T KOG0603|consen 165 INGH--L-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDG 236 (612)
T ss_pred hhcc--C-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcch
Confidence 9843 2 458999999999999999999987 556666542 24567789999999999988 67777653
Q ss_pred HHHHhcCCCCCCCCCCC--C-------CC--------------------C-------C-------------CCcc-----
Q psy10462 161 MEDIRQDPWLKEDSNPV--G-------KS--------------------K-------S-------------APEV----- 186 (347)
Q Consensus 161 ~~eil~~p~~~~~~~~~--~-------~~--------------------~-------~-------------~~~~----- 186 (347)
..++.+|+++....+.. . ++ . + .+.+
T Consensus 237 ~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~il~~~~ 316 (612)
T KOG0603|consen 237 VDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPGVLEDAV 316 (612)
T ss_pred hHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChHHhhccc
Confidence 57888888877554210 0 00 0 0 0000
Q ss_pred c-hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCC
Q psy10462 187 G-IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 264 (347)
Q Consensus 187 ~-~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 264 (347)
. ...+.|++...+|.|+|+.|..+.+..+++.+|+|++.+.. ....+|+.++... +||||+++++++.++.
T Consensus 317 ~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 317 TAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred cCCcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCc
Confidence 0 12567788888999999999999999999999999997652 2223677777766 8999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQE 324 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~ 324 (347)
+.|+|||++.||.|.+.+...+.++ .++..|+++++ ++.|+|++|||||||||+|||++
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~ 449 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD 449 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence 9999999999999999998776666 88888888766 99999999999999999999996
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.42 Aligned_cols=168 Identities=44% Similarity=0.738 Sum_probs=153.9
Q ss_pred CCccCCCCH-------HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcc
Q psy10462 1 NDILLDYNT-------DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73 (347)
Q Consensus 1 ~~~l~~~~~-------~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 73 (347)
||+||+|.. .||.++|+||+.|+.|||..+|+|||+||+|+|+|..+++||+|||+|..... ....+
T Consensus 96 gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~------gklLe 169 (786)
T KOG0588|consen 96 GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP------GKLLE 169 (786)
T ss_pred CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC------Ccccc
Confidence 688888654 99999999999999999999999999999999999999999999999975433 34456
Q ss_pred cccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-
Q psy10462 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL- 152 (347)
Q Consensus 74 ~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l- 152 (347)
+-||+|.|.|||++.|.+|++.++||||+|+++|.++||+.||++++...++.+++++. |..|..+|+++++|+++||
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-f~MPs~Is~eaQdLLr~ml~ 248 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-FEMPSNISSEAQDLLRRMLD 248 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-ccCCCcCCHHHHHHHHHHhc
Confidence 78999999999999999999999999999999999999999999999999999999986 4567899999999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 153 SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 153 ~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.||..|+|++||++|||+.....
T Consensus 249 VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 249 VDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred cCccccccHHHHhhCchhhcCCC
Confidence 79999999999999999986543
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=284.74 Aligned_cols=165 Identities=31% Similarity=0.614 Sum_probs=147.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.|+|+.|+.|+.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+|+..... .....++|||+.|||||
T Consensus 121 ~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-----~~~t~tfcGT~eYmAPE 195 (357)
T KOG0598|consen 121 RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-----GDATRTFCGTPEYMAPE 195 (357)
T ss_pred CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-----CCccccccCCccccChH
Confidence 4778999999999999999999999999999999999999999999999999865432 22345789999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC----C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI----Q 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~----~ 160 (347)
++.+.+|+ ..+|+||+|+++|+|++|..||.+.+..+..+.|.++.....+..++.+++++++.+| .+|+.|. .
T Consensus 196 il~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d 274 (357)
T KOG0598|consen 196 ILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGD 274 (357)
T ss_pred HHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCC
Confidence 99999888 6799999999999999999999999999999999887644445569999999999999 7999995 6
Q ss_pred HHHHhcCCCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDSNP 176 (347)
Q Consensus 161 ~~eil~~p~~~~~~~~ 176 (347)
++++.+||||...++.
T Consensus 275 ~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 275 AEEIKRHPFFKGINWE 290 (357)
T ss_pred hHHhhcCcccccCCHH
Confidence 8999999999988764
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=293.91 Aligned_cols=169 Identities=33% Similarity=0.564 Sum_probs=144.0
Q ss_pred CCccCCCCH-------HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC---CcEEEeccCCceecccCCcccccc
Q psy10462 1 NDILLDYNT-------DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQN 70 (347)
Q Consensus 1 ~~~l~~~~~-------~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~ 70 (347)
||+|+++.. +..+-+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+.... ..
T Consensus 260 GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~------~s 333 (475)
T KOG0615|consen 260 GGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE------GS 333 (475)
T ss_pred CccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc------ce
Confidence 688877543 7788899999999999999999999999999999766 6799999999987642 34
Q ss_pred CcccccCCccccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcc---CCCCCCCCCHHH
Q psy10462 71 LSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE-LLKQVQKRV---VFPESPRLSSSC 144 (347)
Q Consensus 71 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~-~~~~i~~~~---~~~~~~~~s~~~ 144 (347)
...++||||.|.|||++.+. .+++.++|+||+||++|-+++|.+||++..... +.++|.++- ..+.+.++|.++
T Consensus 334 fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea 413 (475)
T KOG0615|consen 334 FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEA 413 (475)
T ss_pred ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHH
Confidence 45789999999999999765 355568999999999999999999999876555 667776653 234567899999
Q ss_pred HHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 145 KALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 145 ~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
++||+.|| .+|++|+++.|+++|||++....
T Consensus 414 ~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 414 LDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred HHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 99999999 79999999999999999987553
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=286.96 Aligned_cols=163 Identities=28% Similarity=0.596 Sum_probs=144.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.++|+||+.+++||+.||.|||+++|+|||||..|++++++.++||+|||+|.....+ .+...+.||||.|.|||
T Consensus 114 ~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-----~Erk~TlCGTPNYIAPE 188 (592)
T KOG0575|consen 114 PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-----GERKKTLCGTPNYIAPE 188 (592)
T ss_pred CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc-----ccccceecCCCcccChh
Confidence 4678999999999999999999999999999999999999999999999999877532 23345789999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
++.....+ ..+||||+||+||.|+.|++||+..+..+.+.+|.... +..|..+|.++++||+.+| .+|..||+++++
T Consensus 189 Vl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~v 266 (592)
T KOG0575|consen 189 VLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEV 266 (592)
T ss_pred HhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-cccccccCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 99977766 67999999999999999999999999999999987653 3344589999999999999 799999999999
Q ss_pred hcCCCCCCCCC
Q psy10462 165 RQDPWLKEDSN 175 (347)
Q Consensus 165 l~~p~~~~~~~ 175 (347)
+.|+||.....
T Consensus 267 L~h~Ff~~g~~ 277 (592)
T KOG0575|consen 267 LDHPFFKSGFT 277 (592)
T ss_pred hcCHhhhCCCc
Confidence 99999965543
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=285.15 Aligned_cols=161 Identities=42% Similarity=0.829 Sum_probs=142.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC-CcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.|++|+++|+||+.|++|||++||+||||||+|+|++.+ +++||+|||++..... ......++|||+.|+|||
T Consensus 117 l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~-----~~~~l~t~cGsp~Y~aPE 191 (370)
T KOG0583|consen 117 LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG-----EDGLLKTFCGSPAYAAPE 191 (370)
T ss_pred CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC-----CCCcccCCCCCcccCCHH
Confidence 3457999999999999999999999999999999999999 9999999999976521 123456889999999999
Q ss_pred cccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCC-CHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRL-SSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~-~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
++.+.. |++.++||||+|+++|.|++|+.||.+.+...+...+.++. +..+..+ |++++.|+++|| .+|..|+++.
T Consensus 192 vl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~ 270 (370)
T KOG0583|consen 192 VLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-FKIPSYLLSPEARSLIEKMLVPDPSTRITLL 270 (370)
T ss_pred HhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-ccCCCCcCCHHHHHHHHHHcCCCcccCCCHH
Confidence 999988 99899999999999999999999999988888888876552 3334555 999999999999 7999999999
Q ss_pred HHhcCCCCCCC
Q psy10462 163 DIRQDPWLKED 173 (347)
Q Consensus 163 eil~~p~~~~~ 173 (347)
+++.|||++..
T Consensus 271 ~i~~h~w~~~~ 281 (370)
T KOG0583|consen 271 EILEHPWFQKE 281 (370)
T ss_pred HHhhChhhccC
Confidence 99999999983
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=255.79 Aligned_cols=161 Identities=35% Similarity=0.641 Sum_probs=142.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC---CcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
|+|..|..+++||++||.|||.+||+|||+||+|+|+... ..+||+|||+|..+.. ...-..++|||.|||
T Consensus 107 ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~------g~~~~G~~GtP~fma 180 (355)
T KOG0033|consen 107 YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND------GEAWHGFAGTPGYLS 180 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC------ccccccccCCCcccC
Confidence 7788999999999999999999999999999999999643 4599999999988763 222345789999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||+++..+|+ ..+|+||.|+++|-++.|.+||.+.+...+.++|.++. ..|.++.+++++++|+++|| .+|.+|+
T Consensus 181 PEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI 259 (355)
T KOG0033|consen 181 PEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI 259 (355)
T ss_pred HHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhc
Confidence 9999999988 78999999999999999999999999999999997753 33467889999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ~~~eil~~p~~~~~~ 174 (347)
|+.|.++|||+++..
T Consensus 260 ta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 260 TADEALKHPWICNRE 274 (355)
T ss_pred cHHHHhCCchhcchH
Confidence 999999999988754
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=279.78 Aligned_cols=168 Identities=28% Similarity=0.543 Sum_probs=145.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc-----c---cccCcccccCC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD-----Y---KQNLSETFCGS 78 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~---~~~~~~~~~gt 78 (347)
|++..+|.|+.||+.||+|||++|||||||||+|||+|.++++||+|||.|+.+...... . .......++||
T Consensus 171 fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGT 250 (604)
T KOG0592|consen 171 FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGT 250 (604)
T ss_pred chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeee
Confidence 567889999999999999999999999999999999999999999999999877543221 1 11112569999
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 79 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
..|.+||++.....+ ..+|+|+|||++|+|+.|.+||.+.+.--++++|.+.. ++-++.+++.+++|++++| .+|..
T Consensus 251 AeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~-y~fp~~fp~~a~dLv~KLLv~dp~~ 328 (604)
T KOG0592|consen 251 AEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD-YEFPEGFPEDARDLIKKLLVRDPSD 328 (604)
T ss_pred ecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc-ccCCCCCCHHHHHHHHHHHccCccc
Confidence 999999999988766 57999999999999999999999999988999887642 3445778899999999999 79999
Q ss_pred CCCHHHHhcCCCCCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 158 R~~~~eil~~p~~~~~~~~ 176 (347)
|++.++|.+||||....+.
T Consensus 329 Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 329 RLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred cccHHHHhhCcccccCChh
Confidence 9999999999999987653
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=269.32 Aligned_cols=160 Identities=28% Similarity=0.495 Sum_probs=141.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.|....+++.+++.||.|||+ ++||||||||+|+|++..|.+||||||.++.... ....+++||..|||||
T Consensus 175 i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn-------S~a~tfvGT~~YMsPE 247 (364)
T KOG0581|consen 175 IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN-------SIANTFVGTSAYMSPE 247 (364)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh-------hhcccccccccccChh
Confidence 6778889999999999999995 9999999999999999999999999999987653 2356889999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhccCCCCCC-CCCHHHHHHHHhcc-CCCCCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-----NYSELLKQVQKRVVFPESP-RLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~-~~s~~~~~li~~~l-~~~~~R 158 (347)
.+.+..|+ .++||||||++++|+++|++||... +..+++..|..+.....+. ..|+++++|+.+|| .+|.+|
T Consensus 248 Ri~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R 326 (364)
T KOG0581|consen 248 RISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSER 326 (364)
T ss_pred hhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccC
Confidence 99999888 6799999999999999999999874 6678888887765444444 49999999999999 899999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
++++++++|||++...
T Consensus 327 ~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 327 PSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCHHHHhcCHHHhhcc
Confidence 9999999999988644
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.47 Aligned_cols=167 Identities=33% Similarity=0.577 Sum_probs=144.4
Q ss_pred CccCCCC-------HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCccc
Q psy10462 2 DILLDYN-------TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74 (347)
Q Consensus 2 ~~l~~~~-------~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 74 (347)
|+||||. +.+++++++|+++|+.|||.++|+||||||+|||++++.++||+|||+|+....+ .....
T Consensus 108 GELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G------ekLre 181 (411)
T KOG0599|consen 108 GELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG------EKLRE 181 (411)
T ss_pred chHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc------hhHHH
Confidence 6777764 4899999999999999999999999999999999999999999999999987642 22456
Q ss_pred ccCCccccccccccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCCCCCCCHHHHH
Q psy10462 75 FCGSYAYASPEILKGV-----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPESPRLSSSCKA 146 (347)
Q Consensus 75 ~~gt~~y~aPE~~~~~-----~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~~~~ 146 (347)
.||||+|+|||.+... +.++..+|.||+|++||.++.|..||......-++..|.++. .-|++..+|...++
T Consensus 182 lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~Kd 261 (411)
T KOG0599|consen 182 LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKD 261 (411)
T ss_pred hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHH
Confidence 8999999999998643 333367999999999999999999999887777777777653 35677889999999
Q ss_pred HHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 147 LISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 147 li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
|++++| .||.+|+|.+|+++||||.+..
T Consensus 262 LIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 262 LISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred HHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 999999 7999999999999999996543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=258.98 Aligned_cols=160 Identities=34% Similarity=0.633 Sum_probs=143.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.|+++.|+.|+.||+.||+|||+.+|++||+||+|||+|.+|.+||+|||+|+..... .-+.||||.|+|||
T Consensus 140 rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--------T~TlCGTPeYLAPE 211 (355)
T KOG0616|consen 140 RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--------TWTLCGTPEYLAPE 211 (355)
T ss_pred CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--------EEEecCCccccChH
Confidence 5788999999999999999999999999999999999999999999999999987532 34689999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCHHHHHHHHhcc-CCCCCC-----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNIL-SPVKFR----- 158 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~l-~~~~~R----- 158 (347)
+++..++. ..+|+||||+++|||+.|..||.+.+..++.++|.++ +.+ |..+++++++|++++| .|...|
T Consensus 212 ii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~f--P~~fs~~~kdLl~~LL~vD~t~R~gnlk 288 (355)
T KOG0616|consen 212 IIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKF--PSYFSSDAKDLLKKLLQVDLTKRFGNLK 288 (355)
T ss_pred HhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccC--CcccCHHHHHHHHHHHhhhhHhhhcCcC
Confidence 99999887 7899999999999999999999999999999988765 334 4678999999999999 687777
Q ss_pred CCHHHHhcCCCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~~~ 176 (347)
...+++.+||||+...+.
T Consensus 289 nG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 289 NGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred CCccccccCcccccccHH
Confidence 356899999999987654
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=273.13 Aligned_cols=136 Identities=26% Similarity=0.411 Sum_probs=126.6
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
..+|...+.||+|+||+||+|+++.++..||||.+.+.... ....+.+..|++||++++|||||++++++++++.+|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 56788899999999999999999999999999999877553 34466778999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
||||+||||.+||++++.++|..++.+++|++ |+.++|+++||||||||+||||...
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~ 145 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTT 145 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccC
Confidence 99999999999999999999999999999987 8999999999999999999999875
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=267.59 Aligned_cols=171 Identities=32% Similarity=0.547 Sum_probs=145.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccC--------------------Ccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN--------------------NTD 66 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~--------------------~~~ 66 (347)
+.++.|+.|+.+++.|++-+|+.|+|||||||+|+|||..|++||+|||||...... ..+
T Consensus 238 L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (550)
T KOG0605|consen 238 LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSD 317 (550)
T ss_pred CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcc
Confidence 567999999999999999999999999999999999999999999999998533210 000
Q ss_pred ccc----------------------cCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy10462 67 YKQ----------------------NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124 (347)
Q Consensus 67 ~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~ 124 (347)
... ......+|||-|+|||++.+..|+ ..+|+||+||+|||||.|.+||.+.++.+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T 396 (550)
T KOG0605|consen 318 FPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGCIMYEMLVGYPPFCSETPQET 396 (550)
T ss_pred ccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 000 000125799999999999999877 679999999999999999999999999999
Q ss_pred HHHHHh---ccCCCCCCCCCHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCCCCCCCC
Q psy10462 125 LKQVQK---RVVFPESPRLSSSCKALISNILSPVKFRIQ---MEDIRQDPWLKEDSNPVG 178 (347)
Q Consensus 125 ~~~i~~---~~~~~~~~~~s~~~~~li~~~l~~~~~R~~---~~eil~~p~~~~~~~~~~ 178 (347)
.++|.. ...+|....+++++++||.+||.+|..|.. ++||.+||||+...+..-
T Consensus 397 ~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l 456 (550)
T KOG0605|consen 397 YRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHL 456 (550)
T ss_pred HHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchh
Confidence 988854 567888889999999999999999999985 899999999999887543
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=264.68 Aligned_cols=168 Identities=31% Similarity=0.647 Sum_probs=145.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+|+.|++.++.||+|||.+|||||||||+|+|++.+|++||+|||.+..................+|||.|+|||.
T Consensus 207 ls~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~ 286 (576)
T KOG0585|consen 207 LSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL 286 (576)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence 56799999999999999999999999999999999999999999999999987643322111122233679999999999
Q ss_pred ccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 87 LKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 87 ~~~---~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
+.+ ..+.+.+.||||+|+++|.|+.|+.||.+....++..+|.. .+.+|..+.+.+..++||.+|| .||..|+++
T Consensus 287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l 366 (576)
T KOG0585|consen 287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL 366 (576)
T ss_pred hcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeeh
Confidence 987 44666788999999999999999999999988888888854 6678888899999999999999 799999999
Q ss_pred HHHhcCCCCCCCC
Q psy10462 162 EDIRQDPWLKEDS 174 (347)
Q Consensus 162 ~eil~~p~~~~~~ 174 (347)
.++..|||.....
T Consensus 367 ~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 367 PDIKLHPWVTRDG 379 (576)
T ss_pred hhheecceeccCC
Confidence 9999999998763
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=264.39 Aligned_cols=138 Identities=23% Similarity=0.379 Sum_probs=125.3
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhh----hhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDY----LKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
..+.|.+.+.+|+|+||.|.+|..++||+.||||++++....... -...+++|++||++|+|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 567888999999999999999999999999999999875533211 2334679999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
..||||||++||+|++++-..+.+.|...+.++.|++ ++.|+|++||+||||||+|||++++
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~ 312 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND 312 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC
Confidence 9999999999999999999999999999999988877 9999999999999999999999887
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=261.19 Aligned_cols=167 Identities=28% Similarity=0.491 Sum_probs=135.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.++.++++.+||++||.|||++||+||||||+|||++. ++.+||+|||+++........ ........||+.|||||
T Consensus 114 l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~--~~~~~~~~Gtp~~maPE 191 (313)
T KOG0198|consen 114 LPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK--SDSELSVQGTPNYMAPE 191 (313)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc--ccccccccCCccccCch
Confidence 678999999999999999999999999999999999999 799999999999876531111 12234578999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHH-hccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQ-KRVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~-~~~~~~~~~i~-~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
++........++||||+||++.||+||+.||.. ....+..-.+. .....+.+..+|+++++++..|+ .+|..||+++
T Consensus 192 vi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~ 271 (313)
T KOG0198|consen 192 VIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAE 271 (313)
T ss_pred hhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHH
Confidence 999633332479999999999999999999987 34444333443 33222345679999999999999 7999999999
Q ss_pred HHhcCCCCCCCCC
Q psy10462 163 DIRQDPWLKEDSN 175 (347)
Q Consensus 163 eil~~p~~~~~~~ 175 (347)
+++.|||......
T Consensus 272 eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 272 ELLEHPFLKQNSI 284 (313)
T ss_pred HHhhChhhhcccc
Confidence 9999999887655
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=259.02 Aligned_cols=141 Identities=15% Similarity=0.297 Sum_probs=132.1
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|++.+.||+|+||+|++++.++|++.||+|+++|.........+....|..||.+++||+||+++..|++.+.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 45789999999999999999999999999999999999887766655667789999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
+|+||+.||+|+..|++.+.|+|+.|++|+++|+ |+.|||++||||||||||||||+..++
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH 163 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH 163 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc
Confidence 9999999999999999999999999999999765 999999999999999999999999883
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=267.90 Aligned_cols=163 Identities=27% Similarity=0.566 Sum_probs=146.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.|++..|+.|+..++.||.|||++|||+||||.+|||+|..|++||+|||+|+..... .....++||||.|||||
T Consensus 464 ~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-----g~~TsTfCGTpey~aPE 538 (694)
T KOG0694|consen 464 VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-----GDRTSTFCGTPEFLAPE 538 (694)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC-----CCccccccCChhhcChh
Confidence 4889999999999999999999999999999999999999999999999999865422 23457899999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCHHHHHHHHhcc-CCCCCCCC---
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNIL-SPVKFRIQ--- 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~l-~~~~~R~~--- 160 (347)
++.+..|+ ..+|+|||||+||||+.|..||++.+.+++...|... +.+ |..+|.++.++++++| .+|.+|..
T Consensus 539 il~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y--P~~ls~ea~~il~~ll~k~p~kRLG~~e 615 (694)
T KOG0694|consen 539 VLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY--PRFLSKEAIAIMRRLLRKNPEKRLGSGE 615 (694)
T ss_pred hhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--CCcccHHHHHHHHHHhccCcccccCCCC
Confidence 99999988 6799999999999999999999999999999998653 334 4678999999999999 79999985
Q ss_pred --HHHHhcCCCCCCCCCC
Q psy10462 161 --MEDIRQDPWLKEDSNP 176 (347)
Q Consensus 161 --~~eil~~p~~~~~~~~ 176 (347)
.+++..||||+...+.
T Consensus 616 ~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 616 RDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred CCchhhhhCCccccCCHH
Confidence 5899999999998753
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=260.89 Aligned_cols=160 Identities=26% Similarity=0.504 Sum_probs=141.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.... ....+.+|||+|||||+
T Consensus 366 ~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-----~KR~TmVGTPYWMAPEV 440 (550)
T KOG0578|consen 366 MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-----SKRSTMVGTPYWMAPEV 440 (550)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc-----CccccccCCCCccchhh
Confidence 4568889999999999999999999999999999999999999999999998876532 23567889999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--VVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.....|+ .++||||||++.+||+.|++||-..++-..+..|... .....++.+|+.+++|+.+|| .|+.+|+++.|
T Consensus 441 vtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 441 VTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred hhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 9998888 6899999999999999999999987776666666443 344567889999999999999 79999999999
Q ss_pred HhcCCCCCC
Q psy10462 164 IRQDPWLKE 172 (347)
Q Consensus 164 il~~p~~~~ 172 (347)
+++|||++.
T Consensus 520 LL~HpFl~~ 528 (550)
T KOG0578|consen 520 LLEHPFLKM 528 (550)
T ss_pred HhcChhhhh
Confidence 999999954
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=245.77 Aligned_cols=168 Identities=27% Similarity=0.492 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.++.++.||+.||+|+||.+|+||||||+|+|++.+..+||+|||+|+..... ......+..+.|.+|.|||+
T Consensus 122 L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~---~~~~~mTeYVaTRWYRAPEl 198 (359)
T KOG0660|consen 122 LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF---FEDGFMTEYVATRWYRAPEL 198 (359)
T ss_pred ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc---CcccchhcceeeeeecCHHH
Confidence 566888999999999999999999999999999999999999999999999877532 11222345677999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------------------------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------------------------ 136 (347)
+......+...|+||+||++.||++|+..|++.+.-..+..|..-...|+
T Consensus 199 ll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~ 278 (359)
T KOG0660|consen 199 LLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSI 278 (359)
T ss_pred HhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHH
Confidence 87665555789999999999999999999999876555544433222221
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~~ 177 (347)
-+..++.+.+|+.+|| .||.+|+|++|+++|||+..=..+.
T Consensus 279 fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 279 FPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred cCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 1456789999999999 7999999999999999988655443
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=251.52 Aligned_cols=163 Identities=24% Similarity=0.412 Sum_probs=139.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
|++.+++.|+.||+.||+|+|++|+.|||+||+|||+..+..+||+|||+|+.... ..+.+..+.|.||.|||+
T Consensus 107 fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S------kpPYTeYVSTRWYRAPEv 180 (538)
T KOG0661|consen 107 FSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS------KPPYTEYVSTRWYRAPEV 180 (538)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc------CCCcchhhhcccccchHH
Confidence 77899999999999999999999999999999999999989999999999998764 233456788999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--------------------CCC---------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--------------------FPE---------S 137 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--------------------~~~---------~ 137 (347)
+....+++.+.|+||+||+++|+.+-+..|++.+..+.+-+|.+-+. +|. -
T Consensus 181 LLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~ 260 (538)
T KOG0661|consen 181 LLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLL 260 (538)
T ss_pred hhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhC
Confidence 98877777899999999999999999999999887666555543222 221 1
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
+..++++..++.+|+ -||.+|||+.++++||||.....
T Consensus 261 p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 261 PNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred cccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 336789999999999 79999999999999999987654
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=238.70 Aligned_cols=150 Identities=30% Similarity=0.473 Sum_probs=133.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHh--CC--CeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHK--KS--VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~--~~--iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y 81 (347)
-+.|..+++++.|++.||..||+ .. |+||||||.||+++++|.+||+|||+++.+.... ....+++|||.|
T Consensus 120 ~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~-----tfA~S~VGTPyY 194 (375)
T KOG0591|consen 120 LIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT-----TFAHSLVGTPYY 194 (375)
T ss_pred cCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh-----HHHHhhcCCCcc
Confidence 36679999999999999999999 45 9999999999999999999999999999876432 224568899999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC-CCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES-PRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
|+||.+.+.+|+ .++||||+||++|||+.-+.||.+++..++-++|..+...|.| ...|.+...++..|+ .++..||
T Consensus 195 MSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP 273 (375)
T KOG0591|consen 195 MSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRP 273 (375)
T ss_pred cCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCC
Confidence 999999999998 6899999999999999999999999999999999888655555 568999999999999 7999999
Q ss_pred CH
Q psy10462 160 QM 161 (347)
Q Consensus 160 ~~ 161 (347)
+.
T Consensus 274 ~t 275 (375)
T KOG0591|consen 274 DT 275 (375)
T ss_pred Cc
Confidence 74
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=244.00 Aligned_cols=143 Identities=18% Similarity=0.266 Sum_probs=134.8
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
..-++|+..+.+|.|+||+|.+++++.+|..+|+|++++....+..+.+-..+|..+|+.+.||+++++++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 44678999999999999999999999999999999999888777777888889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccce
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYS 330 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~ 330 (347)
|||||.+||+|+.++++.++|+|..|++|++|+. ++.|+|+++|++|||||||||||++|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iK 184 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIK 184 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEE
Confidence 9999999999999999999999999999999765 99999999999999999999999999753
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=244.51 Aligned_cols=180 Identities=29% Similarity=0.563 Sum_probs=152.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCC---------------------
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN--------------------- 64 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--------------------- 64 (347)
.|+++.|+.|+.+++.||+|||-.|||.|||||+|||+.++|++.|+||.++.......
T Consensus 175 ~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~ 254 (459)
T KOG0610|consen 175 RFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQ 254 (459)
T ss_pred ccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccccccc
Confidence 47889999999999999999999999999999999999999999999999864321100
Q ss_pred ------------c------------------cccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCC
Q psy10462 65 ------------T------------------DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRL 114 (347)
Q Consensus 65 ------------~------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~ 114 (347)
. +.....+..++||-.|.|||+++|...+ .++|+|+||+.+|||++|..
T Consensus 255 ~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg-sAVDWWtfGIflYEmLyG~T 333 (459)
T KOG0610|consen 255 PSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG-SAVDWWTFGIFLYEMLYGTT 333 (459)
T ss_pred ccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC-chhhHHHHHHHHHHHHhCCC
Confidence 0 0001122457899999999999998776 68999999999999999999
Q ss_pred CCCCCCHHHHHHHHH-hccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC----HHHHhcCCCCCCCCCCCCCCCCCCcc
Q psy10462 115 PFDDTNYSELLKQVQ-KRVVFPESPRLSSSCKALISNIL-SPVKFRIQ----MEDIRQDPWLKEDSNPVGKSKSAPEV 186 (347)
Q Consensus 115 pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~----~~eil~~p~~~~~~~~~~~~~~~~~~ 186 (347)
||.+.+..+.+..|. +.+.+|..+.+|..+++||+++| .||.+|.. +.||.+||||+...+........|..
T Consensus 334 PFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~i 411 (459)
T KOG0610|consen 334 PFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEI 411 (459)
T ss_pred CcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcC
Confidence 999999988888875 46778888899999999999999 89999998 99999999999998876555444443
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=248.18 Aligned_cols=163 Identities=41% Similarity=0.784 Sum_probs=145.7
Q ss_pred CCccCCC-------CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcc
Q psy10462 1 NDILLDY-------NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73 (347)
Q Consensus 1 ~~~l~~~-------~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 73 (347)
||+|+|| ++.||+.+|+||..|+.|||+++++|||||.+|||+|.++++||+|||++..+.. .....
T Consensus 137 ~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~------~kfLq 210 (668)
T KOG0611|consen 137 GGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD------KKFLQ 210 (668)
T ss_pred CccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc------ccHHH
Confidence 5777665 4589999999999999999999999999999999999999999999999977654 33456
Q ss_pred cccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-
Q psy10462 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL- 152 (347)
Q Consensus 74 ~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l- 152 (347)
+|||+|.|.+||+..|.+|.+..+|.||+|+++|.++.|..||++.+...+.++|..+-.+. + .-++++..||+.||
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE-P-~~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE-P-ETPSDASGLIRWMLM 288 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC-C-CCCchHHHHHHHHHh
Confidence 89999999999999999999889999999999999999999999999999999998876543 2 23567889999999
Q ss_pred CCCCCCCCHHHHhcCCCCC
Q psy10462 153 SPVKFRIQMEDIRQDPWLK 171 (347)
Q Consensus 153 ~~~~~R~~~~eil~~p~~~ 171 (347)
.+|.+|.|++++.+|=|++
T Consensus 289 VNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWWVN 307 (668)
T ss_pred cCcccchhHHHHhhhheee
Confidence 8999999999999998875
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=254.07 Aligned_cols=172 Identities=38% Similarity=0.697 Sum_probs=151.6
Q ss_pred CCccCCCC--------HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc-CCCcEEEeccCCceecccCCccccccC
Q psy10462 1 NDILLDYN--------TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNL 71 (347)
Q Consensus 1 ~~~l~~~~--------~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 71 (347)
||+|+||. |+-|++||.||+.|+.|||+..++||||||+|+++- .-|.+||.|||++..+..+ ..
T Consensus 101 ~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG------~k 174 (864)
T KOG4717|consen 101 GGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG------KK 174 (864)
T ss_pred CchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc------ch
Confidence 57888765 377999999999999999999999999999999875 5689999999998776542 23
Q ss_pred cccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q psy10462 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNI 151 (347)
Q Consensus 72 ~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 151 (347)
.++.||+..|.|||++.|..|+...+||||+|+++|-+++|+.||...+..+.+..|.... +.-|..+|.+|++||..|
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-YtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-YTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-ccCchhhhHHHHHHHHHH
Confidence 4678999999999999999999999999999999999999999999999889888887654 445678999999999999
Q ss_pred c-CCCCCCCCHHHHhcCCCCCCCCCCCCC
Q psy10462 152 L-SPVKFRIQMEDIRQDPWLKEDSNPVGK 179 (347)
Q Consensus 152 l-~~~~~R~~~~eil~~p~~~~~~~~~~~ 179 (347)
| .+|++|.+.++|..++|++....+...
T Consensus 254 LvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred HhcCchhhccHHHHhccccccCCCCCccc
Confidence 9 799999999999999999988765544
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=237.97 Aligned_cols=156 Identities=31% Similarity=0.612 Sum_probs=131.7
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccccc
Q psy10462 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 88 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 88 (347)
.+.++.++.|++.|+.|||++++|||||||+|||+..+|.+||||||+|+.....+..+ +..+.|.||.|||.+.
T Consensus 100 ~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y-----TDYVATRWYRaPELLv 174 (396)
T KOG0593|consen 100 SELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY-----TDYVATRWYRAPELLV 174 (396)
T ss_pred HHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh-----hhhhhhhhccChhhhc
Confidence 37789999999999999999999999999999999999999999999999876544333 3467899999999999
Q ss_pred C-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------------------ccCCCCC----------
Q psy10462 89 G-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK--------------------RVVFPES---------- 137 (347)
Q Consensus 89 ~-~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~--------------------~~~~~~~---------- 137 (347)
| .+|+ ..+||||+||++.||++|...|++.+.-+.+..|.+ ++.+|++
T Consensus 175 GDtqYG-~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~ 253 (396)
T KOG0593|consen 175 GDTQYG-KPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKY 253 (396)
T ss_pred ccCcCC-CcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhc
Confidence 8 4555 789999999999999999999999877665554432 2234433
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
+.++....++++.|| -||..|++.++++.||+|
T Consensus 254 p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 254 PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred ccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 345667889999999 699999999999999998
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=262.97 Aligned_cols=137 Identities=23% Similarity=0.339 Sum_probs=131.0
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
..+|+..+.+|+|+|++||.+++..||+.||+|++++.......+.+.+.+|++|++.|+|||||+++++|++.+++|||
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 36799999999999999999999999999999999988777788888999999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
+|+|+.|+|.+++++++.++|.+|++++.||+ |+.|+|+++|||||||..|+||+++
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~ 154 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN 154 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc
Confidence 99999999999999999999999999999876 9999999999999999999999887
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=247.74 Aligned_cols=167 Identities=34% Similarity=0.610 Sum_probs=142.2
Q ss_pred CCccCC-------CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC------CcEEEeccCCceecccCCccc
Q psy10462 1 NDILLD-------YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK------YNIKLSDFGFARKYSVNNTDY 67 (347)
Q Consensus 1 ~~~l~~-------~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~------~~~kl~Dfg~a~~~~~~~~~~ 67 (347)
||||-+ .+++.++.++.||+.||++||+++||||||||.||||... -.+||+|||+|+....
T Consensus 93 gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~----- 167 (429)
T KOG0595|consen 93 GGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP----- 167 (429)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc-----
Confidence 566643 4568899999999999999999999999999999999765 4589999999998763
Q ss_pred cccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCHHHH
Q psy10462 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--PESPRLSSSCK 145 (347)
Q Consensus 68 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~~~ 145 (347)
.....+.||+|.|||||++....|+ .|+|+||+|+++|+|++|+.||...+..+++..++++... ..+..++..+.
T Consensus 168 -~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 168 -GSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred -hhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence 3345688999999999999988898 5799999999999999999999999999999988775432 23345778888
Q ss_pred HHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 146 ALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 146 ~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
+++...+ .++..|....+-+.|+++....
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8888888 6888999999999998876554
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=248.82 Aligned_cols=139 Identities=23% Similarity=0.373 Sum_probs=131.7
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
.+.+|++.+.+|+|.||+|.+|+...+|+.||||.|++....++...-.+.||++||+.|+||||+++|++|+..+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 46789999999999999999999999999999999999888776666667899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+.+|+|++|+.+++.++|.+|+.+|+||. ++.|+|.++|+|||||.+|||||++.
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~ 190 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN 190 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC
Confidence 999999999999999999999999999999876 89999999999999999999999987
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-34 Score=278.15 Aligned_cols=315 Identities=23% Similarity=0.361 Sum_probs=241.0
Q ss_pred HHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEEcCCC-cEEEeccCCceeccc-CCccccccCcccccC-Ccccccc
Q psy10462 9 TDKARRWFSQLADAIDYCH-KKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSV-NNTDYKQNLSETFCG-SYAYASP 84 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH-~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~~~~~~~g-t~~y~aP 84 (347)
...+.+++.|+..|+.|+| ..++.|+|+||+|.+++..+ .++++|||+|..+.. ++.. ......+| ++.|+||
T Consensus 122 ~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~---~~~~~~~g~s~~y~a~ 198 (601)
T KOG0590|consen 122 SSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAE---RSLKDRCGSSPPYGAP 198 (601)
T ss_pred CcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcc---eeeecccCCCCCCCCc
Confidence 3778999999999999999 99999999999999999999 999999999987754 3322 22344578 9999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHhcc--CCCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE--LLKQVQKRV--VFPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~--~~~~i~~~~--~~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
|...+..+.....|+||.|+++..+++|..||....... ....+.... ....+..++....+++..++ .++..|.
T Consensus 199 E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~ 278 (601)
T KOG0590|consen 199 EHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRL 278 (601)
T ss_pred ccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcc
Confidence 999987666678999999999999999999997543322 112222211 23456678899999999999 6899999
Q ss_pred CHHHHhcCCCCCC-CCCCCCCC-CC------CCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhcc---C
Q psy10462 160 QMEDIRQDPWLKE-DSNPVGKS-KS------APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKV---Q 228 (347)
Q Consensus 160 ~~~eil~~p~~~~-~~~~~~~~-~~------~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~---~ 228 (347)
+.+++..+||+.. ........ .. ..........-.....+|.|+||.|+.+......+.++.|..... .
T Consensus 279 s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~ 358 (601)
T KOG0590|consen 279 SIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPT 358 (601)
T ss_pred ccccccccccccccccccccccccccccccccCccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCc
Confidence 9999999999988 22111111 00 011111222335667899999998888877666666666654411 1
Q ss_pred CchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHh
Q psy10462 229 APIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTF 307 (347)
Q Consensus 229 ~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h 307 (347)
.........+..|..+-..+.|||++.....+++....+-.||||++ ||+.++...+.++..++..+++|+. |+.|+|
T Consensus 359 ~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h 437 (601)
T KOG0590|consen 359 ESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH 437 (601)
T ss_pred ccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH
Confidence 11111122266777888889999999988888777666666999999 9999998878899999999999887 999999
Q ss_pred hcCccccCCCCccccccccc
Q psy10462 308 SRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 308 ~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.||-||||||+|+++..++
T Consensus 438 ~~GiahrdlK~enll~~~~g 457 (601)
T KOG0590|consen 438 SMGLAHRDLKLENLLVTENG 457 (601)
T ss_pred hcCceeccCccccEEEecCC
Confidence 99999999999999998885
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-33 Score=257.89 Aligned_cols=139 Identities=24% Similarity=0.360 Sum_probs=131.1
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 267 (347)
...+|.+.+.+|.|+|++|++|+.+.|++.||||++.+.-...+.-...+.+|-.+|..| .||.||+|+..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 457899999999999999999999999999999999987766666677788999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+||+++|||.++|++.+.|+|..+++|+++|. ++.|+|++|||||||||||||||.++
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG 211 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC
Confidence 9999999999999999999999999999999776 99999999999999999999999987
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=248.47 Aligned_cols=167 Identities=25% Similarity=0.445 Sum_probs=141.2
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 5 LDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 5 ~~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+|++++++.|++||++||.|||++||+|||||.+|||||.+|.+||+|||+|+++...... ..+..+-|.+|.||
T Consensus 213 vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~----~~T~rVvTLWYRpP 288 (560)
T KOG0600|consen 213 VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA----PYTSRVVTLWYRPP 288 (560)
T ss_pred cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc----ccccceEEeeccCh
Confidence 46889999999999999999999999999999999999999999999999999987653321 12344569999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC----------------------------
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---------------------------- 136 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------- 136 (347)
|++.|...++..+|+||+||+|.||++|+..|++.+.-+.+..|.+....|.
T Consensus 289 ELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~ 368 (560)
T KOG0600|consen 289 ELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET 368 (560)
T ss_pred HHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH
Confidence 9999987666789999999999999999999999998888887765332221
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
...+++.+-+|+..|| -||.+|.|+.++++++||.....
T Consensus 369 ~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~ 408 (560)
T KOG0600|consen 369 FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL 408 (560)
T ss_pred hccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence 1235678899999999 69999999999999999955443
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=235.70 Aligned_cols=168 Identities=25% Similarity=0.398 Sum_probs=142.5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 5 LDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 5 ~~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+|...+++-++.|++.|++|||++.|+||||||+|+|+...|.+||+|||+|+.+.+.... .+..+-|.+|.||
T Consensus 172 q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~-----~T~lVVTLWYRaP 246 (419)
T KOG0663|consen 172 QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP-----YTPLVVTLWYRAP 246 (419)
T ss_pred CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc-----CcceEEEeeecCH
Confidence 46888999999999999999999999999999999999999999999999999988754322 2345678999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC----------------------------
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---------------------------- 136 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------- 136 (347)
|++.|...++...|+||+||++.||+++++.|++.+..+.+.+|-+....|.
T Consensus 247 ELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~ 326 (419)
T KOG0663|consen 247 ELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRK 326 (419)
T ss_pred HHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhh
Confidence 9999987666789999999999999999999999988777777754332221
Q ss_pred ---CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy10462 137 ---SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 137 ---~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~~ 177 (347)
...+|....+|++.+| .||.+|.|+++.++|+||.+...+.
T Consensus 327 kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 327 KFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred hccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 0115577889999999 7999999999999999999876554
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=254.35 Aligned_cols=146 Identities=16% Similarity=0.263 Sum_probs=134.9
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
.-++|++++.||+|+||.||+|+-+.||..+|+|+++++.+....+.+-+..|-.||...++|+||+|+.+|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 46789999999999999999999999999999999999887777777788899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHH-HHHHHHHhhcCccccCCCCcccccccccc--ceeEEE
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSE-VSNLSQTFSRCCYQDHIQDLSCFQEQATY--YSTIVV 334 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~-~~~~~~~h~~~iiHRDlKp~Nil~~~~~~--~~~~~~ 334 (347)
||||++|||+..+|.+.+.|+|+.|++|+++ ++|+..+|..|+|||||||+|+|||+.|+ .|-++|
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccc
Confidence 9999999999999999999999999999885 56999999999999999999999999994 444444
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=235.69 Aligned_cols=162 Identities=29% Similarity=0.557 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
|+|.+|..+++||+.|+.|||+.+|.||||||+|+|... +..+||+|||+|+..... ....+.|-||+|.|
T Consensus 158 fTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~------~~L~TPc~TPyYva 231 (400)
T KOG0604|consen 158 FTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP------GDLMTPCFTPYYVA 231 (400)
T ss_pred chHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC------ccccCCcccccccC
Confidence 889999999999999999999999999999999999964 456999999999875432 22346688999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhc-cCCC--CCCCCCHHHHHHHHhcc-CCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQKR-VVFP--ESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~----~~~~~~i~~~-~~~~--~~~~~s~~~~~li~~~l-~~~ 155 (347)
||++....|+ ..+|+||+|+++|-|++|.+||-.... ..+..+|..+ +.|| ++..+|++++++|+++| .+|
T Consensus 232 Pevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~P 310 (400)
T KOG0604|consen 232 PEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEP 310 (400)
T ss_pred HHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCc
Confidence 9999888887 678999999999999999999975432 2334455443 3344 45679999999999999 799
Q ss_pred CCCCCHHHHhcCCCCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~~~~ 175 (347)
+.|.|++++++|||+.....
T Consensus 311 teRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 311 TERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred hhheeHHHhhcCchhccccc
Confidence 99999999999999987654
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=226.37 Aligned_cols=165 Identities=25% Similarity=0.418 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..+++.|+.|++.|++|||++.|+|||+||.|+|++.+|.+||+|||+|+.+........ ..+-|.+|.|||.
T Consensus 98 l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~-----~~V~TRWYRAPEL 172 (318)
T KOG0659|consen 98 LSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT-----HQVVTRWYRAPEL 172 (318)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc-----cceeeeeccChHH
Confidence 34478999999999999999999999999999999999999999999999998865433222 2256899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---------------------C------CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---------------------S------PR 139 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------~------~~ 139 (347)
+-|...++..+|+||.||++.||+-|.+-|++.+.-+.+..|-+....|. + +.
T Consensus 173 LfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~a 252 (318)
T KOG0659|consen 173 LFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPA 252 (318)
T ss_pred hccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccccccc
Confidence 99876555789999999999999999999999888777777755443321 1 22
Q ss_pred CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 140 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 140 ~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.++++-+|+.+|+ .+|.+|+++.|+++|+||.....+
T Consensus 253 as~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 253 ASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred ccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 4567899999999 799999999999999999975544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=248.64 Aligned_cols=168 Identities=29% Similarity=0.496 Sum_probs=136.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc--------------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD-------------------- 66 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------------------- 66 (347)
+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 98 l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (363)
T cd05628 98 LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177 (363)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccc
Confidence 567899999999999999999999999999999999999999999999998754321000
Q ss_pred ----------ccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---ccC
Q psy10462 67 ----------YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVV 133 (347)
Q Consensus 67 ----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~---~~~ 133 (347)
.........+||+.|+|||++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.. ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 256 (363)
T cd05628 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI 256 (363)
T ss_pred cccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc
Confidence 000011245799999999999887777 689999999999999999999999888887777754 334
Q ss_pred CCCCCCCCHHHHHHHHhccCCCC---CCCCHHHHhcCCCCCCCCC
Q psy10462 134 FPESPRLSSSCKALISNILSPVK---FRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 134 ~~~~~~~s~~~~~li~~~l~~~~---~R~~~~eil~~p~~~~~~~ 175 (347)
+|+...+++++++++.+++.++. .||+++++++||||....+
T Consensus 257 ~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 257 FPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred CCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 55555689999999999875443 4689999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=245.98 Aligned_cols=161 Identities=34% Similarity=0.546 Sum_probs=141.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC----CcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
|++.+|..+++|++.|+.|||+.||+|||+||+|+|+... +.+|++|||++..... .......+||+.|+
T Consensus 132 ~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~------~~~~~~~~Gtp~y~ 205 (382)
T KOG0032|consen 132 YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP------GERLHTIVGTPEYV 205 (382)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC------CceEeeecCCcccc
Confidence 8899999999999999999999999999999999999643 4799999999987653 22245679999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||++...+|+ ..+|+||+|+++|.|++|..||.+.+..+....+..+. ..+.++.+|..++++++++| .+|..|
T Consensus 206 APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R 284 (382)
T KOG0032|consen 206 APEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKR 284 (382)
T ss_pred CchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccC
Confidence 99999988887 57999999999999999999999999888888886653 34566789999999999999 799999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
+++.++++|||+....
T Consensus 285 ~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 285 LTAAQALQHPWIKSIG 300 (382)
T ss_pred CCHHHHhcCccccCCc
Confidence 9999999999988753
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=235.07 Aligned_cols=162 Identities=26% Similarity=0.425 Sum_probs=135.1
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccC
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 89 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 89 (347)
..++.+++||+.||+|||+++|+||||||.|+|++.+|.+||+|||+|+....+... .....+|.+|.|||++.|
T Consensus 120 ~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~-----yt~evvTlWYRaPEvLlG 194 (323)
T KOG0594|consen 120 RLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT-----YTPEVVTLWYRAPEVLLG 194 (323)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCccc-----ccccEEEeeccCHHHhcC
Confidence 568999999999999999999999999999999999999999999999866543322 234467899999999999
Q ss_pred CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-------------------C----------CCC
Q psy10462 90 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-------------------S----------PRL 140 (347)
Q Consensus 90 ~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------------------~----------~~~ 140 (347)
....+..+|+||+||+++||++++..|++.+..+.+.+|-+....|. + +..
T Consensus 195 s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~ 274 (323)
T KOG0594|consen 195 STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKL 274 (323)
T ss_pred CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhcccc
Confidence 86555779999999999999999999999988877777754333221 1 122
Q ss_pred CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 141 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 141 s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
+++..+++..|| .+|.+|.+++.++.||||.+...+
T Consensus 275 ~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 275 DPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred CccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 347889999999 799999999999999999887554
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=240.05 Aligned_cols=157 Identities=27% Similarity=0.433 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .......|++.|+|||.
T Consensus 107 ~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~ 180 (290)
T cd07862 107 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALTSVVVTLWYRAPEV 180 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC------cccccccccccccChHH
Confidence 466889999999999999999999999999999999999999999999999765421 12234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--------------------------CCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE--------------------------SPRL 140 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~ 140 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+.+..+......|. .+.+
T Consensus 181 ~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (290)
T cd07862 181 LLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 259 (290)
T ss_pred HhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCC
Confidence 9887766 579999999999999999999998877666665543221111 1346
Q ss_pred CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 141 SSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 141 s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
++.+++++.+|| .+|++||++.++++||||
T Consensus 260 ~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 260 DELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 778899999999 799999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=239.18 Aligned_cols=159 Identities=31% Similarity=0.560 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... .......|++.|+|||.
T Consensus 100 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 174 (288)
T cd07871 100 MSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-----KTYSNEVVTLWYRPPDV 174 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-----ccccCceecccccChHH
Confidence 4568889999999999999999999999999999999999999999999987543211 11123467899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--------------------CCC---------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--------------------FPE---------S 137 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--------------------~~~---------~ 137 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+.+..+..... +|. .
T Consensus 175 ~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (288)
T cd07871 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHA 254 (288)
T ss_pred hcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhC
Confidence 87644334789999999999999999999998877665554432211 111 1
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
+.+++++++++++|| .+|.+|+|++|+++||||
T Consensus 255 ~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 255 PRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 346789999999999 699999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=239.66 Aligned_cols=169 Identities=22% Similarity=0.394 Sum_probs=137.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.|.-+.-++++++.||.|||.+|.||||||+.||||+.+|.+||+|||.+..+...+.....+. .++.||+.|||||+
T Consensus 123 l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf-~tfvgtp~wmAPEv 201 (516)
T KOG0582|consen 123 LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRF-NTFVGTPCWMAPEV 201 (516)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEee-ccccCcccccChHH
Confidence 45577788999999999999999999999999999999999999999998877665553332222 67899999999999
Q ss_pred c-cCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhccCCCC--------CCCCCHHHHHHHHhcc-CCC
Q psy10462 87 L-KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL-KQVQKRVVFPE--------SPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 87 ~-~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~--------~~~~s~~~~~li~~~l-~~~ 155 (347)
+ +....+..|+||||||++..|+.+|..||....+.+++ ..++..+..+. ....+...+.++..|| .||
T Consensus 202 l~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP 281 (516)
T KOG0582|consen 202 LMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDP 281 (516)
T ss_pred hhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCc
Confidence 4 33333348999999999999999999999988766654 44444443222 2346678999999999 899
Q ss_pred CCCCCHHHHhcCCCCCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+||+++++++|+||+.....
T Consensus 282 ~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 282 SKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred ccCCCHHHHhccHHHhhccch
Confidence 999999999999999987643
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=241.87 Aligned_cols=163 Identities=25% Similarity=0.479 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
|++.+|+.|+.||+.||++||+.+||.||+||+|||+|+.|+++|+|+|+|..+....+ -...+||.+|||||+
T Consensus 284 F~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~------~~~rvGT~GYMAPEv 357 (591)
T KOG0986|consen 284 FDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP------IRGRVGTVGYMAPEV 357 (591)
T ss_pred CchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc------cccccCcccccCHHH
Confidence 67899999999999999999999999999999999999999999999999988765322 223479999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCCCCCCCHHHHHHHHhcc-CCCCCCC---
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPESPRLSSSCKALISNIL-SPVKFRI--- 159 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~~~~li~~~l-~~~~~R~--- 159 (347)
+.+..|+ ..+|+||+||++|+|+.|+.||.....+.-.+.+.+.. .-.-+..+|++++++.+.+| .+|++|.
T Consensus 358 l~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 358 LQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 9998877 67899999999999999999998765443333333221 11224789999999999999 7898876
Q ss_pred --CHHHHhcCCCCCCCCCC
Q psy10462 160 --QMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 160 --~~~eil~~p~~~~~~~~ 176 (347)
...++.+||+|+...+.
T Consensus 437 g~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 437 GEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred CcCcchhhhCcccccCCHh
Confidence 46799999999987654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=245.17 Aligned_cols=161 Identities=31% Similarity=0.590 Sum_probs=136.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... ......+||+.|+|||+
T Consensus 92 ~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~gt~~y~aPE~ 166 (323)
T cd05571 92 FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTPEYLAPEV 166 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-----CcccceecCccccChhh
Confidence 5678899999999999999999999999999999999999999999999987532211 11234679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+.......+.... ...+..+++++++++++|| .+|.+|+ +
T Consensus 167 ~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (323)
T cd05571 167 LEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPED 244 (323)
T ss_pred hcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCC
Confidence 9887776 67999999999999999999999888777766665432 2334678999999999999 7999999 8
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
+.++++||||....
T Consensus 245 ~~~ll~h~~f~~~~ 258 (323)
T cd05571 245 AKEIMEHRFFASIN 258 (323)
T ss_pred HHHHHcCCCcCCCC
Confidence 99999999997754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=246.44 Aligned_cols=161 Identities=30% Similarity=0.554 Sum_probs=142.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
..|+.++.+..|++.||.|||+.+|+|||+||.|||++..+.+|+||||+|+.+..+ ........|||.|||||.
T Consensus 97 lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-----t~vltsikGtPlYmAPEl 171 (808)
T KOG0597|consen 97 LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-----TSVLTSIKGTPLYMAPEL 171 (808)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-----ceeeeeccCcccccCHHH
Confidence 456899999999999999999999999999999999999999999999999877642 222345679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
..+.+|+ ..+|+||+||++||+.+|++||-..+..++.+.|......| +...|+.+..++..+| .||..|+++.+++
T Consensus 172 v~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~-p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 172 VEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP-PSTASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred HcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-cccccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 9999998 67999999999999999999999988888888887655433 3488999999999999 8999999999999
Q ss_pred cCCCCCCCC
Q psy10462 166 QDPWLKEDS 174 (347)
Q Consensus 166 ~~p~~~~~~ 174 (347)
.|||.+...
T Consensus 250 ~HpF~k~~~ 258 (808)
T KOG0597|consen 250 GHPFWKGKI 258 (808)
T ss_pred cChHHhhhh
Confidence 999987553
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=238.03 Aligned_cols=140 Identities=21% Similarity=0.205 Sum_probs=127.0
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
..+..++++..+.||+|..|+||+++|+.|++.+|+|+|... .++...+++.+|++|+++++||+||++|++|..++.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 346677899999999999999999999999999999999533 345567778899999999999999999999999994
Q ss_pred -EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHh-hcCccccCCCCccccccccc
Q psy10462 266 -VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTF-SRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 -~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h-~~~iiHRDlKp~Nil~~~~~ 327 (347)
++|+||||++|+|.+++++.++++|.....++.++. ||.|+| +++||||||||+|||++..+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG 216 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG 216 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC
Confidence 999999999999999999989999999998888665 999999 59999999999999998877
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=234.75 Aligned_cols=161 Identities=27% Similarity=0.412 Sum_probs=136.3
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC-CcEEEeccCCceecccCCccccccCcccccCCcccccccccc
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 88 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 88 (347)
-+++-|..||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+....+. ...+...|..|.|||.+.
T Consensus 125 ~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e------pniSYicSRyYRaPELif 198 (364)
T KOG0658|consen 125 LEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE------PNISYICSRYYRAPELIF 198 (364)
T ss_pred eeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC------CceeEEEeccccCHHHHc
Confidence 4567788999999999999999999999999999976 899999999999876532 234556789999999999
Q ss_pred CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC----------------------------CCCC
Q psy10462 89 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------------------------SPRL 140 (347)
Q Consensus 89 ~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------~~~~ 140 (347)
|....+.+.||||.||++.||+-|+..|++.+..+.+..|.+....|. ....
T Consensus 199 ga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~ 278 (364)
T KOG0658|consen 199 GATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRL 278 (364)
T ss_pred CccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCC
Confidence 987666889999999999999999999999988777766655433331 2346
Q ss_pred CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 141 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 141 s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
+++.-+|+.++| .+|.+|.++.+++.||||.+-..+
T Consensus 279 ~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 279 PPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 789999999999 799999999999999999877655
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=260.66 Aligned_cols=172 Identities=33% Similarity=0.529 Sum_probs=147.8
Q ss_pred CCcc------CC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcc
Q psy10462 1 NDIL------LD-YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73 (347)
Q Consensus 1 ~~~l------~~-~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 73 (347)
|||| ++ +.++=|+.|+.+|+.||.-+|+.|+|||||||+|||+|..|++||+|||.|-.+..+++. .+.
T Consensus 159 GGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V----~s~ 234 (1317)
T KOG0612|consen 159 GGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV----RSS 234 (1317)
T ss_pred CchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE----Eec
Confidence 6777 34 567889999999999999999999999999999999999999999999999877654432 245
Q ss_pred cccCCccccccccccCC----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---hccCCCCCCCCCHHHHH
Q psy10462 74 TFCGSYAYASPEILKGV----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ---KRVVFPESPRLSSSCKA 146 (347)
Q Consensus 74 ~~~gt~~y~aPE~~~~~----~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~s~~~~~ 146 (347)
..+|||-|.+||+++.. ..++..+|+||+|+++|||+.|..||.+.+..+.+.+|. ....||+...+|..+++
T Consensus 235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakd 314 (1317)
T KOG0612|consen 235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKD 314 (1317)
T ss_pred cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHH
Confidence 67899999999999732 223367999999999999999999999988887777773 46778877889999999
Q ss_pred HHHhccCCCCCCCC---HHHHhcCCCCCCCCCC
Q psy10462 147 LISNILSPVKFRIQ---MEDIRQDPWLKEDSNP 176 (347)
Q Consensus 147 li~~~l~~~~~R~~---~~eil~~p~~~~~~~~ 176 (347)
||..++.+++.|.. ++++.+||||....+.
T Consensus 315 LI~~ll~~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 315 LIEALLCDREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred HHHHHhcChhhhcccccHHHHHhCccccCCChh
Confidence 99999999988887 9999999999988763
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=251.47 Aligned_cols=163 Identities=26% Similarity=0.426 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-cEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...... ......||+.|+|||
T Consensus 167 l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~------~~~~~~~t~~y~aPE 240 (440)
T PTZ00036 167 LPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ------RSVSYICSRFYRAPE 240 (440)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC------CcccCCCCcCccCHH
Confidence 45678899999999999999999999999999999998664 69999999997654211 122456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC------------------CCC----------C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV------------------FPE----------S 137 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------~~~----------~ 137 (347)
++.+....+.++|+||+||++|+|++|..||.+.+..+.+..+.+... +|. +
T Consensus 241 ~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p 320 (440)
T PTZ00036 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFP 320 (440)
T ss_pred HhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhc
Confidence 987654334789999999999999999999998876655544432111 111 1
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
...++++++|+++|| .+|.+|+++.++++||||.....
T Consensus 321 ~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 321 KGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 235789999999999 79999999999999999976544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=242.63 Aligned_cols=158 Identities=28% Similarity=0.565 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ....+||+.|+|||.
T Consensus 115 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~ 186 (329)
T PTZ00263 115 FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--------TFTLCGTPEYLAPEV 186 (329)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--------cceecCChhhcCHHH
Confidence 466888999999999999999999999999999999999999999999999765321 123579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC-----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ----- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~----- 160 (347)
+.+..++ .++|+|||||++|+|++|..||.+.+..+....+..+. .+.+..++..+++++++|| .+|.+|++
T Consensus 187 ~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 264 (329)
T PTZ00263 187 IQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGG 264 (329)
T ss_pred HcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence 9887766 68999999999999999999999888877777776543 3334568899999999999 79999986
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++||||....
T Consensus 265 ~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 265 VADVKNHPYFHGAN 278 (329)
T ss_pred HHHHhcCCccCCCC
Confidence 79999999998754
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=230.37 Aligned_cols=162 Identities=32% Similarity=0.627 Sum_probs=142.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
|+++.++.|-.+|+.||.|||+++|+.||+|.+|.++|.+|++||+|||+|+.--..+ ....++||||.|+|||+
T Consensus 265 FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g-----~t~kTFCGTPEYLAPEV 339 (516)
T KOG0690|consen 265 FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG-----DTTKTFCGTPEYLAPEV 339 (516)
T ss_pred ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc-----ceeccccCChhhcCchh
Confidence 6779999999999999999999999999999999999999999999999998644322 23568999999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQ---- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~---- 160 (347)
+....|+ ..+|+|.+|++||||++|+.||.+.+...++..|.. .+.|| ..+|++++.|+..+| .||.+|..
T Consensus 340 leDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP--r~ls~eAktLLsGLL~kdP~kRLGgGpd 416 (516)
T KOG0690|consen 340 LEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP--RTLSPEAKTLLSGLLKKDPKKRLGGGPD 416 (516)
T ss_pred hcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC--ccCCHHHHHHHHHHhhcChHhhcCCCch
Confidence 9998887 689999999999999999999999999888887754 44554 679999999999999 79999874
Q ss_pred -HHHHhcCCCCCCCCCC
Q psy10462 161 -MEDIRQDPWLKEDSNP 176 (347)
Q Consensus 161 -~~eil~~p~~~~~~~~ 176 (347)
+.|+.+|+||....+.
T Consensus 417 DakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 417 DAKEIMRHRFFASVDWE 433 (516)
T ss_pred hHHHHHhhhhhccCCHH
Confidence 7899999999887653
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=240.88 Aligned_cols=166 Identities=25% Similarity=0.422 Sum_probs=128.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ........||+.|+|||+
T Consensus 100 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~t~~y~aPE~ 177 (338)
T cd07859 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT--AIFWTDYVATRWYRAPEL 177 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc--cccccCCCCCCCcCCHHH
Confidence 567889999999999999999999999999999999999999999999999754321111 111234568999999999
Q ss_pred ccC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------------------------cCCC--
Q psy10462 87 LKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---------------------------VVFP-- 135 (347)
Q Consensus 87 ~~~--~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~---------------------------~~~~-- 135 (347)
+.+ ..++ .++|+||+||++|+|++|+.||.+.+....+..+... ...+
T Consensus 178 ~~~~~~~~~-~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 256 (338)
T cd07859 178 CGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFS 256 (338)
T ss_pred HhccccccC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchH
Confidence 875 3444 6899999999999999999999876643332222111 0000
Q ss_pred -CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 136 -ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 136 -~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
..+..++.+.+++.+|| .+|..||+++++++||||.....
T Consensus 257 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 257 QKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 01346778899999999 79999999999999999976544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=220.31 Aligned_cols=158 Identities=33% Similarity=0.637 Sum_probs=141.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.|++..+..|+.|++.||.|||.++++||||||+|+|++..+.+|++|||.+..... ....+.|||.-|.+||
T Consensus 120 ~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-------~kR~tlcgt~dyl~pE 192 (281)
T KOG0580|consen 120 RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-------NKRKTLCGTLDYLPPE 192 (281)
T ss_pred cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC-------CCceeeecccccCCHh
Confidence 477889999999999999999999999999999999999999999999999865431 2245789999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
...+...+ ..+|+|++|++.||++.|..||...+..+..++|.+... ..+..+|.+++++|.+|+ .+|..|....++
T Consensus 193 mv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v 270 (281)
T KOG0580|consen 193 MVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-KFPSTISGGAADLISRLLVKNPIERLALTEV 270 (281)
T ss_pred hcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-cCCcccChhHHHHHHHHhccCccccccHHHH
Confidence 99998887 679999999999999999999999999999999876432 234789999999999999 799999999999
Q ss_pred hcCCCCCC
Q psy10462 165 RQDPWLKE 172 (347)
Q Consensus 165 l~~p~~~~ 172 (347)
+.|||...
T Consensus 271 ~~hpwI~a 278 (281)
T KOG0580|consen 271 MDHPWIVA 278 (281)
T ss_pred hhhHHHHh
Confidence 99999754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=239.53 Aligned_cols=161 Identities=30% Similarity=0.599 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||.
T Consensus 93 l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 167 (320)
T cd05590 93 FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-----KTTSTFCGTPDYIAPEI 167 (320)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-----CcccccccCccccCHHH
Confidence 5678899999999999999999999999999999999999999999999987532211 11234579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM---- 161 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~---- 161 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+..... ..+..++.+++++++.|| .+|.+|++.
T Consensus 168 ~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 245 (320)
T cd05590 168 LQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLG 245 (320)
T ss_pred HcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCC
Confidence 9887776 579999999999999999999999988888777765432 334568999999999999 799999998
Q ss_pred --HHHhcCCCCCCCC
Q psy10462 162 --EDIRQDPWLKEDS 174 (347)
Q Consensus 162 --~eil~~p~~~~~~ 174 (347)
+++++||||....
T Consensus 246 ~~~~~~~h~~f~~~~ 260 (320)
T cd05590 246 GEEAILRHPFFKELD 260 (320)
T ss_pred CHHHHHcCCCcCCCC
Confidence 9999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=239.23 Aligned_cols=160 Identities=31% Similarity=0.579 Sum_probs=136.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......+||+.|+|||+
T Consensus 90 ~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 164 (312)
T cd05585 90 FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-----DKTNTFCGTPEYLAPEL 164 (312)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-----CccccccCCcccCCHHH
Confidence 5678899999999999999999999999999999999999999999999987532211 11234679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC---CHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI---QME 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~---~~~ 162 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... ...+..+++.+++++..|| .+|.+|+ ++.
T Consensus 165 ~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~ 242 (312)
T cd05585 165 LLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQ 242 (312)
T ss_pred HcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHH
Confidence 9887776 67999999999999999999999888877777665542 2334678999999999999 7999997 579
Q ss_pred HHhcCCCCCCC
Q psy10462 163 DIRQDPWLKED 173 (347)
Q Consensus 163 eil~~p~~~~~ 173 (347)
++++|||+.+.
T Consensus 243 e~l~hp~~~~~ 253 (312)
T cd05585 243 EIKNHPFFSQL 253 (312)
T ss_pred HHHcCCCcCCC
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=235.92 Aligned_cols=158 Identities=30% Similarity=0.558 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ....+||+.|+|||+
T Consensus 98 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~ 169 (291)
T cd05612 98 FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--------TWTLCGTPEYLAPEV 169 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--------cccccCChhhcCHHH
Confidence 466888999999999999999999999999999999999999999999998765321 123568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC-----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ----- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~----- 160 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+..+. .+.+...++.+++++++|| .+|.+|++
T Consensus 170 ~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 247 (291)
T cd05612 170 IQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNG 247 (291)
T ss_pred HcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCCCHHHccCCccCC
Confidence 9887766 68999999999999999999999988877777776543 2234567899999999999 79999995
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++|||+....
T Consensus 248 ~~~~l~h~~~~~~~ 261 (291)
T cd05612 248 ADDVKNHRWFKSVD 261 (291)
T ss_pred HHHHhcCccccCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=236.71 Aligned_cols=162 Identities=23% Similarity=0.412 Sum_probs=126.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+++++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++........ ......|++.|+|||+
T Consensus 100 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 174 (303)
T cd07869 100 LHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-----TYSNEVVTLWYRPPDV 174 (303)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-----cCCCCcccCCCCChHH
Confidence 45688999999999999999999999999999999999999999999999875432111 1123467899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhccCCC------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKRVVFP------------------------------ 135 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~------------------------------ 135 (347)
+.+....+.++|+||+||++|+|++|..||.+.. ..+.+..+......|
T Consensus 175 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (303)
T cd07869 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQA 254 (303)
T ss_pred HcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHH
Confidence 8765444468999999999999999999998753 233333332111000
Q ss_pred -CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 136 -ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 136 -~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
.....++.++++++.|| .+|.+|++++++++||||...
T Consensus 255 ~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 255 WNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred hhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00123567899999999 799999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=235.78 Aligned_cols=162 Identities=25% Similarity=0.447 Sum_probs=132.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....... ......||+.|+|||.
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~------~~~~~~g~~~y~aPE~ 172 (285)
T cd05631 99 FDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE------TVRGRVGTVGYMAPEV 172 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC------eecCCCCCCCccCHhh
Confidence 5678899999999999999999999999999999999999999999999997653211 1123468999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC--
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNIL-SPVKFRIQ-- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~-- 160 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+.......+.. ....+.+..+++++.+++++|| .+|.+|++
T Consensus 173 ~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05631 173 INNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCR 251 (285)
T ss_pred hcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCC
Confidence 9987776 679999999999999999999987654332222222 2222334568999999999999 79999987
Q ss_pred ---HHHHhcCCCCCCCCC
Q psy10462 161 ---MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 ---~~eil~~p~~~~~~~ 175 (347)
++++++||||.....
T Consensus 252 ~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 252 GNGAAGVKQHPIFKNINF 269 (285)
T ss_pred CCCHHHHhcCHhhcCCCH
Confidence 899999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=244.16 Aligned_cols=163 Identities=28% Similarity=0.533 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ......+||+.|+|||+
T Consensus 93 ~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE~ 167 (330)
T cd05586 93 FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-----KTTNTFCGTTEYLAPEV 167 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-----CCccCccCCccccCHHH
Confidence 5678999999999999999999999999999999999999999999999986532211 12235679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC----CH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI----QM 161 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~----~~ 161 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+....+..+....+...+++++++++++|| .+|.+|+ ++
T Consensus 168 ~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 247 (330)
T cd05586 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDA 247 (330)
T ss_pred HcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCH
Confidence 876543346899999999999999999999998888777777654333333457999999999999 7899998 79
Q ss_pred HHHhcCCCCCCCC
Q psy10462 162 EDIRQDPWLKEDS 174 (347)
Q Consensus 162 ~eil~~p~~~~~~ 174 (347)
+++++|||+....
T Consensus 248 ~~ll~h~~~~~~~ 260 (330)
T cd05586 248 VELKEHPFFADID 260 (330)
T ss_pred HHHhcCccccCCC
Confidence 9999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=241.45 Aligned_cols=158 Identities=27% Similarity=0.542 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....+||+.|+|||+
T Consensus 128 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--------~~~~~gt~~y~aPE~ 199 (340)
T PTZ00426 128 FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--------TYTLCGTPEYIAPEI 199 (340)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--------cceecCChhhcCHHH
Confidence 566888999999999999999999999999999999999999999999999764321 224579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+..++ .++|+||+||++|+|++|..||.+.+.......+..+.. ..+..+++.+++++++|| .+|.+|+ +
T Consensus 200 ~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 277 (340)
T PTZ00426 200 LLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKG 277 (340)
T ss_pred HhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCC
Confidence 9887666 679999999999999999999999887777777765543 234568999999999999 6888885 8
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++|||+....
T Consensus 278 ~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 278 AQNVKEHPWFGNID 291 (340)
T ss_pred HHHHHcCCCcCCCC
Confidence 99999999998754
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=246.83 Aligned_cols=140 Identities=28% Similarity=0.471 Sum_probs=126.3
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCc-h-hhhhhchHHHHHHHhcCC-CcchhhhheeeeeCC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP-I-DYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH 264 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~-~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~ 264 (347)
.....|.+.+.+|+|+||+|++|.+..+|+.||+|++++.... . ....+.+.+|+.+|++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999999999999999988765322 1 134556679999999998 999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+|||||.||+|++++.++++++|.+|+.+++|+. |+.|+|++||+|||||||||||+.++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~ 157 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE 157 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC
Confidence 9999999999999999999899999999999999876 99999999999999999999999884
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=237.51 Aligned_cols=162 Identities=28% Similarity=0.590 Sum_probs=136.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... .......+||+.|+|||
T Consensus 92 ~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE 166 (316)
T cd05620 92 RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-----DNRASTFCGTPDYIAPE 166 (316)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-----CCceeccCCCcCccCHH
Confidence 3567889999999999999999999999999999999999999999999998643211 11223567999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH-HH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM-ED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~-~e 163 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+..... ..+..++.+++++++.|| .+|.+|+++ ++
T Consensus 167 ~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~ 244 (316)
T cd05620 167 ILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP-HYPRWITKESKDILEKLFERDPTRRLGVVGN 244 (316)
T ss_pred HHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 99887776 679999999999999999999998888777777654432 234468999999999999 799999997 68
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
+++|||+....
T Consensus 245 ~~~h~~f~~~~ 255 (316)
T cd05620 245 IRGHPFFKTIN 255 (316)
T ss_pred HHcCCCcCCCC
Confidence 99999997754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=237.46 Aligned_cols=162 Identities=25% Similarity=0.423 Sum_probs=122.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----cCCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++......... ........||+.|+
T Consensus 105 l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~t~~y~ 182 (317)
T cd07868 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LADLDPVVVTFWYR 182 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCcc--ccccCCcccccccc
Confidence 5678899999999999999999999999999999999 45678999999999765432111 11123457899999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---------HHHHHHHHhccCCC------------------
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---------SELLKQVQKRVVFP------------------ 135 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~---------~~~~~~i~~~~~~~------------------ 135 (347)
|||++.+....+.++|+||+||++|+|++|+.||..... .+.+..+......|
T Consensus 183 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T cd07868 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLM 262 (317)
T ss_pred CCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhh
Confidence 999998755444789999999999999999999964321 11111111111000
Q ss_pred -------------------CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 136 -------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 136 -------------------~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.....+..+.+++.+|| .||.+|+|++|+++||||
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 263 KDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01123457889999999 799999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=241.03 Aligned_cols=160 Identities=24% Similarity=0.452 Sum_probs=136.1
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
.+.++.-++++++.||.|||+++.+|||||+.|||+..+|.+|++|||++.+.... .....+++|||.|||||++
T Consensus 109 ~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~-----~~rr~tfvGTPfwMAPEVI 183 (467)
T KOG0201|consen 109 DEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT-----VKRRKTFVGTPFWMAPEVI 183 (467)
T ss_pred ccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech-----hhccccccccccccchhhh
Confidence 45667778899999999999999999999999999999999999999999877542 2223689999999999999
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 88 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 88 ~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
.+..|+ .++||||||++.+||++|.+||.+..+..++..|-+..+.......|+.+++|+..|| .+|+.||++.++++
T Consensus 184 ~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 184 KQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 987887 6899999999999999999999988775555444343322223468899999999999 79999999999999
Q ss_pred CCCCCCC
Q psy10462 167 DPWLKED 173 (347)
Q Consensus 167 ~p~~~~~ 173 (347)
|+|++..
T Consensus 263 h~FIk~a 269 (467)
T KOG0201|consen 263 HKFIKRA 269 (467)
T ss_pred hHHHHhc
Confidence 9999873
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=238.61 Aligned_cols=161 Identities=29% Similarity=0.572 Sum_probs=137.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......+||+.|+|||+
T Consensus 93 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 167 (321)
T cd05591 93 FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-----VTTTTFCGTPDYIAPEI 167 (321)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-----ccccccccCccccCHHH
Confidence 5678899999999999999999999999999999999999999999999987543211 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI------ 159 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~------ 159 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+..... ..+..+++++.+++++|| .+|..|+
T Consensus 168 ~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~ 245 (321)
T cd05591 168 LQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQ 245 (321)
T ss_pred HcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCC
Confidence 9887776 579999999999999999999999988888777765432 234568999999999999 7999999
Q ss_pred -CHHHHhcCCCCCCCC
Q psy10462 160 -QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 -~~~eil~~p~~~~~~ 174 (347)
+++++++|||+....
T Consensus 246 ~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 246 GGEDAIKQHPFFKEID 261 (321)
T ss_pred CCHHHHhcCCccCCCC
Confidence 899999999996643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=245.83 Aligned_cols=168 Identities=30% Similarity=0.533 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCc---------------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT--------------------- 65 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--------------------- 65 (347)
+.++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 98 ~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (382)
T cd05625 98 FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177 (382)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccc
Confidence 45688999999999999999999999999999999999999999999999753210000
Q ss_pred ---------------------cccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy10462 66 ---------------------DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124 (347)
Q Consensus 66 ---------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~ 124 (347)
..........+||+.|+|||++.+..++ .++|+||+||++|+|++|+.||.+.+..+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 256 (382)
T cd05625 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLAQTPLET 256 (382)
T ss_pred cccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHHHHHhCCCCCCCCCHHHH
Confidence 0000011235799999999999888777 679999999999999999999998877666
Q ss_pred HHHHHh---ccCCCCCCCCCHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCCCCC
Q psy10462 125 LKQVQK---RVVFPESPRLSSSCKALISNILSPVKFRIQ---MEDIRQDPWLKEDSN 175 (347)
Q Consensus 125 ~~~i~~---~~~~~~~~~~s~~~~~li~~~l~~~~~R~~---~~eil~~p~~~~~~~ 175 (347)
...+.. ....|....+++++++++.+|+.+|..|++ ++++++|||+.....
T Consensus 257 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 257 QMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 555543 334555567899999999998888988887 999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=233.50 Aligned_cols=159 Identities=35% Similarity=0.538 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........ .......|++.|+|||+
T Consensus 97 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~ 172 (287)
T cd07848 97 VPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN----ANYTEYVATRWYRSPEL 172 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc----ccccccccccccCCcHH
Confidence 56788999999999999999999999999999999999999999999999976532211 11223568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------------CCCC----------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--------------------VFPE---------- 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------~~~~---------- 136 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... ..|.
T Consensus 173 ~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07848 173 LLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERR 251 (287)
T ss_pred HcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHh
Confidence 9887766 68999999999999999999999876544433332211 0111
Q ss_pred -CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 -~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
...+|.++++++++|| .+|.+|++++++++||||
T Consensus 252 ~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 252 YLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1136788999999999 799999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=236.79 Aligned_cols=154 Identities=27% Similarity=0.523 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC-CeecCCCCCcEEEcCCC-cEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS-VVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~-iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
+....+.+++.||+.||.|||+++ ||||||||+|+|++.++ ++||+|||+++...... .......||+.||||
T Consensus 139 l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-----~~~~~~~GT~~wMAP 213 (362)
T KOG0192|consen 139 LPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-----TSMTSVAGTYRWMAP 213 (362)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-----ccccCCCCCccccCh
Confidence 445778999999999999999999 99999999999999997 99999999998765321 112235799999999
Q ss_pred ccccC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-CCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 85 EILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-SPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 85 E~~~~--~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
|++.+ ..++ .|+||||||+++|||+||+.||.+....++...+......|. +...++....++..|+ .+|..||+
T Consensus 214 Ev~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~ 292 (362)
T KOG0192|consen 214 EVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPS 292 (362)
T ss_pred hhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCC
Confidence 99994 4676 789999999999999999999999988777777754444444 5558999999999999 79999999
Q ss_pred HHHHhc
Q psy10462 161 MEDIRQ 166 (347)
Q Consensus 161 ~~eil~ 166 (347)
+.++..
T Consensus 293 f~ei~~ 298 (362)
T KOG0192|consen 293 FLEIVS 298 (362)
T ss_pred HHHHHH
Confidence 998864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=239.13 Aligned_cols=161 Identities=30% Similarity=0.598 Sum_probs=135.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||.
T Consensus 92 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 166 (328)
T cd05593 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-----ATMKTFCGTPEYLAPEV 166 (328)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-----cccccccCCcCccChhh
Confidence 5678999999999999999999999999999999999999999999999987532211 11234579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... .+.+..+++++++++++|| .+|..|+ +
T Consensus 167 ~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (328)
T cd05593 167 LEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDD 244 (328)
T ss_pred hcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCC
Confidence 9887766 67999999999999999999999888777666654332 2344678999999999999 7999997 8
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++|||+....
T Consensus 245 ~~~il~h~~~~~~~ 258 (328)
T cd05593 245 AKEIMRHSFFTGVN 258 (328)
T ss_pred HHHHhcCCCcCCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=240.42 Aligned_cols=160 Identities=24% Similarity=0.450 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .......||+.|+|||+
T Consensus 123 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~~~~~t~~y~aPE~ 196 (364)
T cd07875 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPEV 196 (364)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC------CcccCCcccCCcCCHHH
Confidence 456788899999999999999999999999999999999999999999999754321 11234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------------------------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------------------------ 136 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+......|.
T Consensus 197 ~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (364)
T cd07875 197 ILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF 275 (364)
T ss_pred HhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhC
Confidence 9887776 579999999999999999999998776555444432111100
Q ss_pred -----------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 137 -----------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 137 -----------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
....++.+++++.+|| .+|.+||+++++++|||+..-
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 276 PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred ccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0113467899999999 799999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=223.76 Aligned_cols=143 Identities=23% Similarity=0.326 Sum_probs=132.1
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
....-++|++.+.+|+|.||.||+|+.++++-.||+|++.+++.........+.||++|-+.|+||||.++|++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 34567889999999999999999999999999999999998887777778889999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHH--hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIR--KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~--~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
+|+++||+++|+|+..|+ +.+.++|..+..|..|++ ++.|+|.++||||||||+|+|++-++.
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~ 162 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE 162 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC
Confidence 999999999999999998 556899999998888877 999999999999999999999987764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=250.05 Aligned_cols=162 Identities=31% Similarity=0.561 Sum_probs=140.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....... .......+||+.|+|||.
T Consensus 140 l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~---~~~~~~~~Gt~~Y~aPE~ 216 (496)
T PTZ00283 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS---DDVGRTFCGTPYYVAPEI 216 (496)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeecccccc---ccccccccCCcceeCHHH
Confidence 56788999999999999999999999999999999999999999999999976543211 112345679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|||||||++|+|++|+.||.+.+..+....+..+...+.++.+++++++++..|| .+|..||++.+++
T Consensus 217 ~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 217 WRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred hCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 9987776 6899999999999999999999998888888777766555667788999999999999 7999999999999
Q ss_pred cCCCCCC
Q psy10462 166 QDPWLKE 172 (347)
Q Consensus 166 ~~p~~~~ 172 (347)
+|||++.
T Consensus 296 ~~p~~~~ 302 (496)
T PTZ00283 296 NMPICKL 302 (496)
T ss_pred hCHHHHH
Confidence 9999764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=237.19 Aligned_cols=161 Identities=27% Similarity=0.562 Sum_probs=136.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+++++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||+
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 171 (323)
T cd05584 97 FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-----TVTHTFCGTIEYMAPEI 171 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-----CcccccCCCccccChhh
Confidence 4567888999999999999999999999999999999999999999999987543211 11234579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+..+. .+.++.+++.+++++++|| .+|.+|+ +
T Consensus 172 ~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 249 (323)
T cd05584 172 LMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGD 249 (323)
T ss_pred ccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCC
Confidence 9887665 67999999999999999999999988777777765543 3445678999999999999 7999999 8
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++|||+....
T Consensus 250 ~~~l~~h~~~~~~~ 263 (323)
T cd05584 250 AAEVQSHPFFRHVN 263 (323)
T ss_pred HHHHhcCCCcCCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=242.07 Aligned_cols=167 Identities=31% Similarity=0.561 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc-------------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY------------------- 67 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~------------------- 67 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 98 l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (364)
T cd05599 98 FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177 (364)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccc
Confidence 5678999999999999999999999999999999999999999999999987543211000
Q ss_pred --------------cccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--
Q psy10462 68 --------------KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-- 131 (347)
Q Consensus 68 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-- 131 (347)
........+||+.|+|||++.+..++ .++|+||+||++|+|++|..||.+.+..+....+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~ 256 (364)
T cd05599 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKE 256 (364)
T ss_pred cccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 00011134699999999999887776 6799999999999999999999998877776666442
Q ss_pred -cCCCCCCCCCHHHHHHHHhccCCCCCCCC---HHHHhcCCCCCCCC
Q psy10462 132 -VVFPESPRLSSSCKALISNILSPVKFRIQ---MEDIRQDPWLKEDS 174 (347)
Q Consensus 132 -~~~~~~~~~s~~~~~li~~~l~~~~~R~~---~~eil~~p~~~~~~ 174 (347)
..+|....+++++++++++|+.+|..|++ ++++++|||+....
T Consensus 257 ~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 257 TLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred ccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCC
Confidence 33455556899999999999988888887 99999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=241.93 Aligned_cols=164 Identities=31% Similarity=0.530 Sum_probs=135.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||.
T Consensus 139 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~----~~~~~~~gt~~y~aPE~ 214 (370)
T cd05596 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM----VRCDTAVGTPDYISPEV 214 (370)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc----ccCCCCCCCcCeECHHH
Confidence 45688899999999999999999999999999999999999999999999976532211 11234579999999999
Q ss_pred ccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cCCCCCCCCCHHHHHHHHhcc-CCCCC--
Q psy10462 87 LKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESPRLSSSCKALISNIL-SPVKF-- 157 (347)
Q Consensus 87 ~~~~~---~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~s~~~~~li~~~l-~~~~~-- 157 (347)
+.+.. ..+.++|+||+||++|+|++|+.||.+.+.......+... ..+|....+|.++++++++|| .+|.+
T Consensus 215 ~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~ 294 (370)
T cd05596 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLG 294 (370)
T ss_pred hccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccC
Confidence 87542 2236799999999999999999999998887777777543 345555678999999999999 46665
Q ss_pred CCCHHHHhcCCCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 158 R~~~~eil~~p~~~~~~ 174 (347)
|++++++++|||+....
T Consensus 295 R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 295 RNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred CCCHHHHhcCcccCCCC
Confidence 99999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=237.46 Aligned_cols=162 Identities=22% Similarity=0.428 Sum_probs=130.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....||+.|+|||
T Consensus 114 ~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~t~~y~aPE 185 (343)
T cd07878 114 KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--------MTGYVATRWYRAPE 185 (343)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC--------cCCccccccccCch
Confidence 3677899999999999999999999999999999999999999999999999765321 22456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC------------------------C-----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------------------E----- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------------------~----- 136 (347)
++.+....+.++|+||+||++|+|++|+.||.+.+..+.+..+.+....+ .
T Consensus 186 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (343)
T cd07878 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKK 265 (343)
T ss_pred HhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHH
Confidence 99874434468999999999999999999998876555444432211110 0
Q ss_pred -CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 137 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 137 -~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
....++.+.+++.+|| .+|.+||+++++++||||.+...
T Consensus 266 ~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 266 IFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0134567889999999 79999999999999999986543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=232.13 Aligned_cols=157 Identities=26% Similarity=0.447 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ......|++.|+|||.
T Consensus 105 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~ 178 (288)
T cd07863 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM------ALTPVVVTLWYRAPEV 178 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcc------cCCCccccccccCchH
Confidence 5778999999999999999999999999999999999999999999999987653211 1223467899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------------------------CCCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--------------------------ESPRL 140 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------------------------~~~~~ 140 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+.+..+......+ ..+.+
T Consensus 179 ~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (288)
T cd07863 179 LLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEI 257 (288)
T ss_pred hhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCc
Confidence 9887766 67999999999999999999998877665555443211100 01346
Q ss_pred CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 141 SSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 141 s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
+..+++++.+|| .+|.+||++++++.||||
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 258 EESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 778899999999 699999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=234.89 Aligned_cols=144 Identities=19% Similarity=0.205 Sum_probs=130.3
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
....+..+.+++.+.+|.|.-|+||+|+...++..+|+|+|.+...........++-|-+||+.++||.++.||..|+++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 34456788999999999999999999999999999999999987766555555667899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
...|+|||||+||||+.+.+++ +.|+|..|++|++++. ||.|||-.|||.|||||||||+.++|
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG 216 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG 216 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC
Confidence 9999999999999999998664 5899999999999655 99999999999999999999999998
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=238.70 Aligned_cols=163 Identities=28% Similarity=0.553 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||.
T Consensus 102 ~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~----~~~~~~~gt~~y~aPE~ 177 (332)
T cd05614 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK----ERTYSFCGTIEYMAPEI 177 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC----CccccccCCccccCHHH
Confidence 56788999999999999999999999999999999999999999999999876432211 11224579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC--
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN----YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-- 159 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-- 159 (347)
+.+....+.++|+|||||++|+|++|+.||.... .......+.. ...+.+..+++.+++++.+|| .+|.+|+
T Consensus 178 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 256 (332)
T cd05614 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGA 256 (332)
T ss_pred hcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence 9875433467999999999999999999996432 2233333332 223344678999999999999 7999999
Q ss_pred ---CHHHHhcCCCCCCCC
Q psy10462 160 ---QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ---~~~eil~~p~~~~~~ 174 (347)
+++++++|||+....
T Consensus 257 ~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 257 GPQGASEIKEHPFFKGLD 274 (332)
T ss_pred CCCCHHHHHcCCCcCCCC
Confidence 889999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=238.62 Aligned_cols=160 Identities=24% Similarity=0.476 Sum_probs=127.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .......||+.|+|||.
T Consensus 120 ~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~ 193 (359)
T cd07876 120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN------FMMTPYVVTRYYRAPEV 193 (359)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC------ccCCCCcccCCCCCchh
Confidence 466888999999999999999999999999999999999999999999998654321 11233568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------------CCC--------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-----------------------VFP-------- 135 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-----------------------~~~-------- 135 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+....+..+.+.. ..+
T Consensus 194 ~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (359)
T cd07876 194 ILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELF 272 (359)
T ss_pred ccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhc
Confidence 9888777 57999999999999999999998776543332221110 000
Q ss_pred ------C----CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 136 ------E----SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 136 ------~----~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
. ....++.+++++.+|| .+|.+||++.|+++|||+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 273 PDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred cccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 0 0123578899999999 799999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=236.44 Aligned_cols=161 Identities=27% Similarity=0.556 Sum_probs=136.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||+
T Consensus 98 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 172 (324)
T cd05587 98 FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-----KTTRTFCGTPDYIAPEI 172 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-----CceeeecCCccccChhh
Confidence 5678899999999999999999999999999999999999999999999986432111 11234579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM---- 161 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~---- 161 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... .+.+..+++++.+++++|| .+|..|++.
T Consensus 173 ~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~ 250 (324)
T cd05587 173 IAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTG 250 (324)
T ss_pred hcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCC
Confidence 9988776 67999999999999999999999988887777776543 2334568999999999999 799999976
Q ss_pred -HHHhcCCCCCCCC
Q psy10462 162 -EDIRQDPWLKEDS 174 (347)
Q Consensus 162 -~eil~~p~~~~~~ 174 (347)
+++++|||+....
T Consensus 251 ~~~~~~hp~~~~~~ 264 (324)
T cd05587 251 ERDIREHAFFRRID 264 (324)
T ss_pred HHHHhcCCCcCCCC
Confidence 8999999998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=227.33 Aligned_cols=139 Identities=19% Similarity=0.262 Sum_probs=121.5
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhhe-eeeeCC-e
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ-AIETTH-R 265 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~-~~~~~~-~ 265 (347)
.+..+|++.+.||+|+||+||++.+..+|..+|.|.++-. ..+....+....|+.+|++|+|||||++++ .|.++. .
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 4567899999999999999999999999999999999843 344555667779999999999999999998 555544 4
Q ss_pred EEEEEEecCCCChHHHHHh----CCCCCHHHHHHHHHHHH-HHHHHhh--cC--ccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRK----ERYIDEDKALLCYSEVS-NLSQTFS--RC--CYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~----~~~l~e~~~~~~~~~~~-~~~~~h~--~~--iiHRDlKp~Nil~~~~~ 327 (347)
++||||||.+|||.+.|+. ++.++|..++.++.|++ ++..+|+ .+ |+||||||.||+|+.++
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g 165 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG 165 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC
Confidence 9999999999999999953 56899999999988887 8999998 56 99999999999999887
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=236.93 Aligned_cols=162 Identities=26% Similarity=0.530 Sum_probs=137.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||+
T Consensus 98 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 172 (323)
T cd05616 98 FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-----VTTKTFCGTPDYIAPEI 172 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-----CccccCCCChhhcCHHH
Confidence 5668899999999999999999999999999999999999999999999987543211 11234679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC-----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ----- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~----- 160 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+..... ..+..++.++++++.+|| .+|.+|++
T Consensus 173 ~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~ 250 (323)
T cd05616 173 IAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEG 250 (323)
T ss_pred hcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCC
Confidence 9988776 679999999999999999999999888887777765432 234568999999999999 79999997
Q ss_pred HHHHhcCCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 ~~eil~~p~~~~~~~ 175 (347)
.+++++|||++...+
T Consensus 251 ~~~i~~h~~~~~~~~ 265 (323)
T cd05616 251 ERDIKEHAFFRYIDW 265 (323)
T ss_pred HHHHhcCCCcCCCCH
Confidence 489999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=241.12 Aligned_cols=168 Identities=32% Similarity=0.616 Sum_probs=139.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc--------------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD-------------------- 66 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------------------- 66 (347)
+.+.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 98 l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (350)
T cd05573 98 FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177 (350)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccc
Confidence 566889999999999999999999999999999999999999999999998765432200
Q ss_pred ----ccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---ccCCCCCCC
Q psy10462 67 ----YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPR 139 (347)
Q Consensus 67 ----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~ 139 (347)
..........||+.|+|||++.+..++ .++|+|||||++|+|++|+.||.+.+..+....+.. ...+|....
T Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 256 (350)
T cd05573 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPP 256 (350)
T ss_pred cccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCC
Confidence 000112345689999999999988776 679999999999999999999998887776666654 344555566
Q ss_pred CCHHHHHHHHhccCCCCCCCC-HHHHhcCCCCCCCCC
Q psy10462 140 LSSSCKALISNILSPVKFRIQ-MEDIRQDPWLKEDSN 175 (347)
Q Consensus 140 ~s~~~~~li~~~l~~~~~R~~-~~eil~~p~~~~~~~ 175 (347)
+++++++++..|+.+|..|++ ++++++|||+.....
T Consensus 257 ~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 257 VSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred CCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCH
Confidence 899999999999999999999 999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=240.06 Aligned_cols=161 Identities=32% Similarity=0.628 Sum_probs=148.4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 5 LDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 5 ~~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
..|.++.+.+|+.|++.|+.|||+++|+|||||+.||++..++.+||.|||+|+..... .....+..|||.||+|
T Consensus 101 ~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-----~~~a~tvvGTp~YmcP 175 (426)
T KOG0589|consen 101 VLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-----DSLASTVVGTPYYMCP 175 (426)
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc-----hhhhheecCCCcccCH
Confidence 34778999999999999999999999999999999999999999999999999987542 1234578899999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
|++.+.+|. .|+|+||+||++|||++-+.+|.+.+...+..+|.+....|.+...|.+.+.+++.|| .+|..||++.+
T Consensus 176 Eil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~ 254 (426)
T KOG0589|consen 176 EILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALE 254 (426)
T ss_pred HHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHH
Confidence 999999998 7899999999999999999999999999999999998888999999999999999999 79999999999
Q ss_pred HhcCCCCC
Q psy10462 164 IRQDPWLK 171 (347)
Q Consensus 164 il~~p~~~ 171 (347)
++.+|.+.
T Consensus 255 LL~~P~l~ 262 (426)
T KOG0589|consen 255 LLRRPHLL 262 (426)
T ss_pred HhhChhhh
Confidence 99998776
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=242.94 Aligned_cols=168 Identities=30% Similarity=0.524 Sum_probs=136.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc--------------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD-------------------- 66 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------------------- 66 (347)
+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 98 l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (360)
T cd05627 98 LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177 (360)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccc
Confidence 566889999999999999999999999999999999999999999999998654221000
Q ss_pred ----------ccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---ccC
Q psy10462 67 ----------YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVV 133 (347)
Q Consensus 67 ----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~---~~~ 133 (347)
.........+||+.|+|||++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.. ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~ 256 (360)
T cd05627 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLV 256 (360)
T ss_pred cccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCcee
Confidence 000111245799999999999888777 679999999999999999999999888777776654 233
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCCC---CHHHHhcCCCCCCCCC
Q psy10462 134 FPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKEDSN 175 (347)
Q Consensus 134 ~~~~~~~s~~~~~li~~~l~~~~~R~---~~~eil~~p~~~~~~~ 175 (347)
+|+...+++++++++.+++.+|..|+ +++++++||||....+
T Consensus 257 ~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 257 FPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred cCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 45555689999999999888888887 5899999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=235.41 Aligned_cols=162 Identities=31% Similarity=0.598 Sum_probs=136.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......+||+.|+|||
T Consensus 92 ~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aPE 166 (316)
T cd05592 92 RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-----GKASTFCGTPDYIAPE 166 (316)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----CccccccCCccccCHH
Confidence 35678899999999999999999999999999999999999999999999997543211 1223567999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH-HH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM-ED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~-~e 163 (347)
.+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... ...+..++.++.++++.|| .+|..|++. ++
T Consensus 167 ~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 167 ILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-PHFPRWISKEAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred HHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHHHcCCChHH
Confidence 99887776 67999999999999999999999988877777765532 2334568899999999999 789999986 58
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
+++|||+....
T Consensus 245 l~~h~~~~~~~ 255 (316)
T cd05592 245 IRQHPFFRGID 255 (316)
T ss_pred HHcCcccCCCC
Confidence 88999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=254.02 Aligned_cols=303 Identities=17% Similarity=0.250 Sum_probs=207.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC---cEEEcCCCcEEEe--ccCCceecccCCccccccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCE---NLLLDDKYNIKLS--DFGFARKYSVNNTDYKQNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y 81 (347)
.+.+.++.+..++++||+|+|+....|.-+..+ +...+..+....+ ||+............ ....+..+
T Consensus 283 i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~------~~~~~~~~ 356 (1351)
T KOG1035|consen 283 IPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF------SDLLAEIR 356 (1351)
T ss_pred cCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccch------hhcCcccc
Confidence 344788899999999999999986555544444 3333445555655 887776554322211 11123456
Q ss_pred cccccccCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 82 ASPEILKGVPYTP-QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 82 ~aPE~~~~~~~~~-~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
-+||......... ...|+|.+|.....+..|..+-.-. .+...+. +........++...|+ .+++.|+
T Consensus 357 ~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l-------~~~~~~~~~d~~~~~~~~~~~~Rl 426 (1351)
T KOG1035|consen 357 NADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLL-------DVLSTSELLDALPKCLDEDSEERL 426 (1351)
T ss_pred ccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhh-------ccccchhhhhhhhhhcchhhhhcc
Confidence 6777776544432 2369999999999888776543211 0011110 0111114555666666 6889999
Q ss_pred CHHHHhcCCCCCCCCCCCCCC--------------CC-------CCccchhhhhhhhhhhcccccchhhhhhcccccccc
Q psy10462 160 QMEDIRQDPWLKEDSNPVGKS--------------KS-------APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQD 218 (347)
Q Consensus 160 ~~~eil~~p~~~~~~~~~~~~--------------~~-------~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~ 218 (347)
...+++.|++.+......... .. .........+|+..+.+|+||||.||+++++-+|+.
T Consensus 427 ~~~~ll~~~f~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~~r~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~ 506 (1351)
T KOG1035|consen 427 SALELLTHPFLRFPTDNESSEFAPNDETSVPQFRLRFSGAMSPLQRQFSRYLNDFEELELLGKGGFGSVVKVRNKLDGRE 506 (1351)
T ss_pred chhhhhhchhcccccccccccccCccccccCccCCCCccccCccccchhhHhhhhHHHHHhcCCCCceEEEEeecccchh
Confidence 999999999887654321100 00 001122456788889999999999999999999999
Q ss_pred hhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee-------------------------------------
Q psy10462 219 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE------------------------------------- 261 (347)
Q Consensus 219 ~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~------------------------------------- 261 (347)
||||+|+... ++ ..-....+|+.+|++|+|||||+++.++.
T Consensus 507 YAIKKIpl~~-s~-~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~ 584 (1351)
T KOG1035|consen 507 YAIKKIPLKA-SD-KLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTS 584 (1351)
T ss_pred hhhhhccCch-HH-HHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCC
Confidence 9999998664 33 33445569999999999999999986550
Q ss_pred -----------------------------------------eC-------------------------------------
Q psy10462 262 -----------------------------------------TT------------------------------------- 263 (347)
Q Consensus 262 -----------------------------------------~~------------------------------------- 263 (347)
+.
T Consensus 585 ~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~ 664 (1351)
T KOG1035|consen 585 SPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVP 664 (1351)
T ss_pred CcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccc
Confidence 00
Q ss_pred ----CeEEEEEEecCCCChHHHHHhCCCC-CHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 ----HRVYIIMEYAKNGSLLEVIRKERYI-DEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ----~~~~iv~E~~~~G~L~~~l~~~~~l-~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..+||-||||+.-.|.+++++.... ....++.++++|. |++|+|++|||||||||.||+|+.+.
T Consensus 665 ~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~ 734 (1351)
T KOG1035|consen 665 VQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN 734 (1351)
T ss_pred cccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC
Confidence 2489999999997777777665544 4677888899876 99999999999999999999998543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=249.09 Aligned_cols=158 Identities=22% Similarity=0.388 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCC----------------cEEEeccCCceecccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKY----------------NIKLSDFGFARKYSVNNTDYKQ 69 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~----------------~~kl~Dfg~a~~~~~~~~~~~~ 69 (347)
+.+.+++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||.+.....
T Consensus 228 l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------- 300 (467)
T PTZ00284 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------- 300 (467)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-------
Confidence 5668899999999999999998 5999999999999998765 499999998754221
Q ss_pred cCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-------------
Q psy10462 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------- 136 (347)
Q Consensus 70 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------- 136 (347)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+..+.+....++
T Consensus 301 -~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~ 378 (467)
T PTZ00284 301 -SRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEAR 378 (467)
T ss_pred -ccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHH
Confidence 12346799999999999988877 689999999999999999999988776555444433211000
Q ss_pred --------------C--------------CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 137 --------------S--------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 137 --------------~--------------~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
+ ...++.+.+||.+|| .||.+|++++|+++||||..-
T Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 379 LLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred HHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0 001345679999999 799999999999999999863
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=235.98 Aligned_cols=161 Identities=30% Similarity=0.597 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||.
T Consensus 92 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 166 (323)
T cd05595 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTPEYLAPEV 166 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-----CccccccCCcCcCCccc
Confidence 5678999999999999999999999999999999999999999999999986532211 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... ...+..+++++++++++|| .+|..|+ +
T Consensus 167 ~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (323)
T cd05595 167 LEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 244 (323)
T ss_pred ccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCC
Confidence 9887776 67999999999999999999999888777766664432 2234578999999999999 7999998 8
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
+.++++|||+....
T Consensus 245 ~~~~l~h~~~~~~~ 258 (323)
T cd05595 245 AKEVMEHRFFLSIN 258 (323)
T ss_pred HHHHHcCCCcCCCC
Confidence 99999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=248.35 Aligned_cols=162 Identities=30% Similarity=0.535 Sum_probs=139.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+||+.|+|||+
T Consensus 166 l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~---~~~~~~~~gt~~y~aPE~ 242 (478)
T PTZ00267 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS---LDVASSFCGTPYYLAPEL 242 (478)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc---cccccccCCCccccCHhH
Confidence 67788999999999999999999999999999999999999999999999986543211 112345679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+.+..+..+...+.+..++.++++++..|| .+|..||++++++
T Consensus 243 ~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 243 WERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred hCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 9887776 6899999999999999999999998888887777665554555678999999999999 7999999999999
Q ss_pred cCCCCCC
Q psy10462 166 QDPWLKE 172 (347)
Q Consensus 166 ~~p~~~~ 172 (347)
.++|+..
T Consensus 322 ~~~~~~~ 328 (478)
T PTZ00267 322 HTEFLKY 328 (478)
T ss_pred hCHHHHH
Confidence 9998764
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=234.52 Aligned_cols=162 Identities=30% Similarity=0.587 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||+
T Consensus 93 ~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 167 (316)
T cd05619 93 FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-----AKTCTFCGTPDYIAPEI 167 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-----CceeeecCCccccCHHH
Confidence 5668899999999999999999999999999999999999999999999987532211 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH-HH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME-DI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~-ei 164 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+..... ..+..++.++++++.+|| .+|.+|+++. ++
T Consensus 168 ~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 168 LLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP-CYPRWLTREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred HcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHHHhccCHhhcCCChHHH
Confidence 9887776 679999999999999999999999888887777755432 233468899999999999 7999999996 89
Q ss_pred hcCCCCCCCCC
Q psy10462 165 RQDPWLKEDSN 175 (347)
Q Consensus 165 l~~p~~~~~~~ 175 (347)
++|||+.....
T Consensus 246 ~~h~~~~~~~~ 256 (316)
T cd05619 246 RQHPFFREIDW 256 (316)
T ss_pred HcCcccCCCCH
Confidence 99999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=237.31 Aligned_cols=160 Identities=24% Similarity=0.462 Sum_probs=127.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+.|+|||+
T Consensus 116 l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~t~~y~aPE~ 189 (355)
T cd07874 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPEV 189 (355)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc------cccCCccccCCccCHHH
Confidence 456788899999999999999999999999999999999999999999999754321 11234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-------------------------------- 134 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------------------------------- 134 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.+....
T Consensus 190 ~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (355)
T cd07874 190 ILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF 268 (355)
T ss_pred HcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhc
Confidence 9887776 6799999999999999999999887654433322111000
Q ss_pred -----C----CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 135 -----P----ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 135 -----~----~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
+ .....+..+++++.+|| .+|.+||+++++++|||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 01123567899999999 799999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=240.79 Aligned_cols=164 Identities=32% Similarity=0.532 Sum_probs=134.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........ ......+||+.|+|||+
T Consensus 139 ~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~----~~~~~~~gt~~Y~aPE~ 214 (370)
T cd05621 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM----VRCDTAVGTPDYISPEV 214 (370)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc----eecccCCCCcccCCHHH
Confidence 45688999999999999999999999999999999999999999999999976532211 11235679999999999
Q ss_pred ccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cCCCCCCCCCHHHHHHHHhccCCCC---C
Q psy10462 87 LKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESPRLSSSCKALISNILSPVK---F 157 (347)
Q Consensus 87 ~~~~~---~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~s~~~~~li~~~l~~~~---~ 157 (347)
+.+.. ..+.++|+||+||++|+|++|+.||.+.+.......+... ..+|....++..+++++.+||.++. .
T Consensus 215 ~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~ 294 (370)
T cd05621 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLG 294 (370)
T ss_pred HhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccC
Confidence 87643 2236799999999999999999999988877777776542 3445555789999999999995433 3
Q ss_pred CCCHHHHhcCCCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 158 R~~~~eil~~p~~~~~~ 174 (347)
|++++++++|||+....
T Consensus 295 R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 295 RNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred CCCHHHHhcCcccCCCC
Confidence 88999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=235.12 Aligned_cols=161 Identities=26% Similarity=0.546 Sum_probs=136.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ......+|++.|+|||.
T Consensus 98 l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~g~~~y~aPE~ 172 (324)
T cd05589 98 FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-----DRTSTFCGTPEFLAPEV 172 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-----CcccccccCccccCHhH
Confidence 5678999999999999999999999999999999999999999999999986432211 11235679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+..++ .++|+|||||++|+|++|+.||.+.+..+....+..... ..+..++..+.+++++|| .+|.+|+ +
T Consensus 173 ~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 250 (324)
T cd05589 173 LTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRLLRRNPERRLGSGEKD 250 (324)
T ss_pred hcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 9887766 679999999999999999999999888877777655432 234568999999999999 7999999 6
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++|||+....
T Consensus 251 ~~~l~~~~~f~~~~ 264 (324)
T cd05589 251 AEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHhhCCCcCCCC
Confidence 99999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=236.99 Aligned_cols=161 Identities=29% Similarity=0.595 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+||+.|+|||+
T Consensus 93 ~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE~ 167 (323)
T cd05575 93 FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-----SKTTSTFCGTPEYLAPEV 167 (323)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-----CCccccccCChhhcChhh
Confidence 567888999999999999999999999999999999999999999999998653221 112234579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM---- 161 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~---- 161 (347)
+.+..++ .++|+|||||++|+|++|..||.+.+..+....+.... ...++.++..+.+++++|| .+|.+|++.
T Consensus 168 ~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 168 LRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred hcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCH
Confidence 9887776 67999999999999999999999988887777775543 2334567999999999999 799999987
Q ss_pred HHHhcCCCCCCCC
Q psy10462 162 EDIRQDPWLKEDS 174 (347)
Q Consensus 162 ~eil~~p~~~~~~ 174 (347)
+++++|||+....
T Consensus 246 ~~il~~~~~~~~~ 258 (323)
T cd05575 246 LEIKNHVFFSSIN 258 (323)
T ss_pred HHHHcCCCcCCCC
Confidence 6999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=238.83 Aligned_cols=139 Identities=17% Similarity=0.253 Sum_probs=125.4
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC--C
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--H 264 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~ 264 (347)
....+.|+.++.||+|+||.||+|++..||+.||+|+++.... ++....+..|||.||++|+|||||+|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 3467889999999999999999999999999999999986543 445567778999999999999999999988776 7
Q ss_pred eEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|||+|||+. ||.-++... -.|++.++..|++|+. |+.|+|++||+|||||.+|||+|+++
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G 255 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG 255 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC
Confidence 89999999998 999999763 4799999999999876 99999999999999999999999998
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=236.99 Aligned_cols=159 Identities=31% Similarity=0.552 Sum_probs=134.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... .....+||+.|+|||.
T Consensus 98 l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--------~~~~~~gt~~y~aPE~ 169 (333)
T cd05600 98 LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--------YANSVVGSPDYMAPEV 169 (333)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--------ccCCcccCccccChhH
Confidence 45688999999999999999999999999999999999999999999999875432 1234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCCC----CCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPES----PRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~----~~~s~~~~~li~~~l-~~~~~R 158 (347)
+.+..++ .++|+||+||++|+|++|..||.+.+..+....+.... ..|.. ..+++++.+++.+|| .+|.+|
T Consensus 170 ~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr 248 (333)
T cd05600 170 LRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRF 248 (333)
T ss_pred hcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhc
Confidence 9888766 67999999999999999999999988877766664321 22222 256899999999999 678889
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
++++++++|||+....
T Consensus 249 ~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 249 GSLEDIKNHPFFKEVD 264 (333)
T ss_pred CCHHHHHhCcccCCCC
Confidence 9999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=239.10 Aligned_cols=163 Identities=34% Similarity=0.575 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... ......||+.|+|||+
T Consensus 99 l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~----~~~~~~gt~~y~aPE~ 174 (330)
T cd05601 99 FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV----NSKLPVGTPDYIAPEV 174 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce----eeecccCCccccCHHH
Confidence 567888999999999999999999999999999999999999999999999765432211 1223468999999999
Q ss_pred ccC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cCCCCCCCCCHHHHHHHHhccCCCCC
Q psy10462 87 LKG------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESPRLSSSCKALISNILSPVKF 157 (347)
Q Consensus 87 ~~~------~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~s~~~~~li~~~l~~~~~ 157 (347)
+.+ ..++ .++|+||+||++|+|++|+.||.+.+..+....+... ..+|..+.++++++++++.||.+|.+
T Consensus 175 ~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~ 253 (330)
T cd05601 175 LTTMNGDGKGTYG-VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKE 253 (330)
T ss_pred hccccccccCCCC-CcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhh
Confidence 863 3333 6799999999999999999999988877766666442 34556667899999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 158 R~~~~eil~~p~~~~~~ 174 (347)
|++++++++|||+....
T Consensus 254 R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 254 RLGYEGLCCHPFFSKID 270 (330)
T ss_pred CCCHHHHhCCCCcCCCC
Confidence 99999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=242.99 Aligned_cols=167 Identities=31% Similarity=0.554 Sum_probs=134.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCc---------------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT--------------------- 65 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--------------------- 65 (347)
+.++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.....
T Consensus 98 ~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (376)
T cd05598 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177 (376)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccc
Confidence 35688899999999999999999999999999999999999999999999753210000
Q ss_pred -----------------cccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q psy10462 66 -----------------DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128 (347)
Q Consensus 66 -----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i 128 (347)
..........+||+.|+|||++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 256 (376)
T cd05598 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256 (376)
T ss_pred cccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhhCCCCCCCCCHHHHHHHH
Confidence 0000011235799999999999887776 6799999999999999999999988877666655
Q ss_pred Hh---ccCCCCCCCCCHHHHHHHHhccCCCCCCC---CHHHHhcCCCCCCCC
Q psy10462 129 QK---RVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKEDS 174 (347)
Q Consensus 129 ~~---~~~~~~~~~~s~~~~~li~~~l~~~~~R~---~~~eil~~p~~~~~~ 174 (347)
.. ....|....+++++++++.+|+.+|..|+ +++++++|||+....
T Consensus 257 ~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 257 INWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred hccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 43 22344455789999999999888999999 999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=235.85 Aligned_cols=162 Identities=29% Similarity=0.591 Sum_probs=130.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......+||+.|+|||
T Consensus 92 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-----~~~~~~~~gt~~y~aPE 166 (329)
T cd05588 92 KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-----GDTTSTFCGTPNYIAPE 166 (329)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-----CCccccccCCccccCHH
Confidence 3567899999999999999999999999999999999999999999999998643211 11223467999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--------HHH-HHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--------YSE-LLKQVQKRVVFPESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~--------~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~ 155 (347)
++.+..++ .++|+||+||++|+|++|+.||.... ..+ ..+.+... ..+.+..++..+++++++|| .+|
T Consensus 167 ~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP 244 (329)
T cd05588 167 ILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKASSVLKGFLNKDP 244 (329)
T ss_pred HHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhccCH
Confidence 99987776 67999999999999999999996321 111 22333222 23344678999999999999 799
Q ss_pred CCCCC------HHHHhcCCCCCCCC
Q psy10462 156 KFRIQ------MEDIRQDPWLKEDS 174 (347)
Q Consensus 156 ~~R~~------~~eil~~p~~~~~~ 174 (347)
.+|++ ++++++|||+....
T Consensus 245 ~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 245 KERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred HHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 99987 79999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=238.52 Aligned_cols=164 Identities=30% Similarity=0.522 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||+
T Consensus 139 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~----~~~~~~~gt~~y~aPE~ 214 (371)
T cd05622 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM----VRCDTAVGTPDYISPEV 214 (371)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc----ccccCcccCccccCHHH
Confidence 45678899999999999999999999999999999999999999999999976542211 11235679999999999
Q ss_pred ccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cCCCCCCCCCHHHHHHHHhccCCCCC---
Q psy10462 87 LKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESPRLSSSCKALISNILSPVKF--- 157 (347)
Q Consensus 87 ~~~~~---~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~s~~~~~li~~~l~~~~~--- 157 (347)
+.+.. ..+.++|+||+||++|+|++|..||.+.+.......+... ..+|....++..+++++..||.++..
T Consensus 215 l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~ 294 (371)
T cd05622 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLG 294 (371)
T ss_pred HhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcC
Confidence 87543 2236799999999999999999999998887777776543 34556667999999999999965433
Q ss_pred CCCHHHHhcCCCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 158 R~~~~eil~~p~~~~~~ 174 (347)
|++++++++|||+....
T Consensus 295 r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 295 RNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred CCCHHHHhcCcccCCCC
Confidence 78999999999997754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=237.38 Aligned_cols=161 Identities=34% Similarity=0.612 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++++++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++........ .....+||+.|+|||
T Consensus 92 l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE 166 (325)
T cd05594 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-----TMKTFCGTPEYLAPE 166 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-----ccccccCCcccCCHH
Confidence 5678899999999999999997 7999999999999999999999999999875432111 123457999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI----- 159 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~----- 159 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... ...+..+++++.+++++|| .+|.+|+
T Consensus 167 ~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 244 (325)
T cd05594 167 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPD 244 (325)
T ss_pred HHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCC
Confidence 99887776 67999999999999999999999888777766664432 2234568999999999999 7999997
Q ss_pred CHHHHhcCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ~~~eil~~p~~~~~~ 174 (347)
++.++++|||+....
T Consensus 245 ~~~~il~h~~~~~~~ 259 (325)
T cd05594 245 DAKEIMQHKFFAGIV 259 (325)
T ss_pred CHHHHhcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=231.27 Aligned_cols=163 Identities=28% Similarity=0.542 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ ......+++.|+|||.
T Consensus 101 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 175 (309)
T cd07872 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-----TYSNEVVTLWYRPPDV 175 (309)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-----ccccccccccccCCHH
Confidence 45688899999999999999999999999999999999999999999999875432111 1123457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--------------------CC---------CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--------------------FP---------ES 137 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--------------------~~---------~~ 137 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+....+.+... ++ ..
T Consensus 176 ~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (309)
T cd07872 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHA 255 (309)
T ss_pred HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhc
Confidence 87654334789999999999999999999988776555444432111 11 11
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
+.++.++++++.+|| .+|.+|++++|+++|||++...
T Consensus 256 ~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 256 PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 356889999999999 6999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=232.54 Aligned_cols=162 Identities=29% Similarity=0.606 Sum_probs=137.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... ......+|++.|+|||
T Consensus 92 ~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~g~~~y~aPE 166 (318)
T cd05570 92 RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-----VTTSTFCGTPDYIAPE 166 (318)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-----CcccceecCccccCHH
Confidence 36678899999999999999999999999999999999999999999999986532211 1123457899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH---
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM--- 161 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~--- 161 (347)
.+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+..... ..+..++..+++++++|| .+|..|+++
T Consensus 167 ~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~ 244 (318)
T cd05570 167 ILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV-RYPRWLSKEAKSILKSFLTKNPEKRLGCLPT 244 (318)
T ss_pred HhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHccCCHHHcCCCCCC
Confidence 99988776 679999999999999999999998887777776654432 234568999999999999 799999999
Q ss_pred --HHHhcCCCCCCCC
Q psy10462 162 --EDIRQDPWLKEDS 174 (347)
Q Consensus 162 --~eil~~p~~~~~~ 174 (347)
.++++|||+....
T Consensus 245 ~~~~ll~~~~~~~~~ 259 (318)
T cd05570 245 GEQDIKGHPFFREID 259 (318)
T ss_pred CHHHHhcCCCcCCCC
Confidence 9999999997754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=228.98 Aligned_cols=161 Identities=24% Similarity=0.489 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ ......||+.|+|||.
T Consensus 94 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~g~~~y~aPE~ 168 (280)
T cd05608 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-----KTKGYAGTPGFMAPEL 168 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----cccccCCCcCccCHHH
Confidence 56788999999999999999999999999999999999999999999999876543211 1234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC--
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS----ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-- 159 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-- 159 (347)
+.+..++ .++|+||+||++|+|++|+.||...+.. +....+... ....+..++..+++++.+|| .+|..|+
T Consensus 169 ~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 169 LQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred hcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 9988776 6799999999999999999999865432 222222111 12234568999999999999 7999999
Q ss_pred ---CHHHHhcCCCCCCCC
Q psy10462 160 ---QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ---~~~eil~~p~~~~~~ 174 (347)
+++++++||||+...
T Consensus 247 ~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 247 RDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred CCCCHHHHhcChhhhcCC
Confidence 889999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=240.56 Aligned_cols=167 Identities=29% Similarity=0.533 Sum_probs=133.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCc-----------ccc-------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT-----------DYK------- 68 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-----------~~~------- 68 (347)
+.++.++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+..... ...
T Consensus 98 ~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (377)
T cd05629 98 FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177 (377)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccc
Confidence 45688999999999999999999999999999999999999999999999863321000 000
Q ss_pred ------------------------ccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy10462 69 ------------------------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124 (347)
Q Consensus 69 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~ 124 (347)
.......+||+.|+|||++.+..++ .++|+||+||++|+|++|..||.+.+..+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 256 (377)
T cd05629 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMFECLIGWPPFCSENSHET 256 (377)
T ss_pred ccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhhhhhcCCCCCCCCCHHHH
Confidence 0000124699999999999887776 679999999999999999999998887776
Q ss_pred HHHHHh---ccCCCCCCCCCHHHHHHHHhccCCCCC---CCCHHHHhcCCCCCCCC
Q psy10462 125 LKQVQK---RVVFPESPRLSSSCKALISNILSPVKF---RIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 125 ~~~i~~---~~~~~~~~~~s~~~~~li~~~l~~~~~---R~~~~eil~~p~~~~~~ 174 (347)
...+.. ...+|....++.++++++++||.+|.. |+++.+++.|||+....
T Consensus 257 ~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 257 YRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred HHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCC
Confidence 666653 334555557899999999999976554 56999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=234.38 Aligned_cols=163 Identities=29% Similarity=0.548 Sum_probs=131.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||
T Consensus 92 ~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE 166 (327)
T cd05617 92 KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-----DTTSTFCGTPNYIAPE 166 (327)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-----CceecccCCcccCCHH
Confidence 36678999999999999999999999999999999999999999999999987532111 1123467999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC------CHHH-HHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT------NYSE-LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~------~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
.+.+..++ .++|+||+||++|+|++|+.||... +..+ ....+.. ...+.+..++..+++++++|| .+|..
T Consensus 167 ~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~li~~~L~~dP~~ 244 (327)
T cd05617 167 ILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPRFLSVKASHVLKGFLNKDPKE 244 (327)
T ss_pred HHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 99887776 6899999999999999999999532 2222 2333322 233345668999999999999 79999
Q ss_pred CCC------HHHHhcCCCCCCCCC
Q psy10462 158 RIQ------MEDIRQDPWLKEDSN 175 (347)
Q Consensus 158 R~~------~~eil~~p~~~~~~~ 175 (347)
|++ ++++++||||....+
T Consensus 245 R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 245 RLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred cCCCCCCCCHHHHHcCCCCCCCCH
Confidence 987 579999999987653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=238.94 Aligned_cols=167 Identities=32% Similarity=0.536 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc--c-----------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD--Y----------------- 67 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~----------------- 67 (347)
+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .
T Consensus 98 ~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (381)
T cd05626 98 FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177 (381)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccc
Confidence 456888999999999999999999999999999999999999999999997543110000 0
Q ss_pred -----------------------cccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q psy10462 68 -----------------------KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124 (347)
Q Consensus 68 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~ 124 (347)
........+||+.|+|||.+.+..++ .++|+||+||++|+|++|+.||...+..+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~ 256 (381)
T cd05626 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFLAPTPTET 256 (381)
T ss_pred ccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHHHHhCCCCCcCCCHHHH
Confidence 00011245799999999999887776 679999999999999999999998877665
Q ss_pred HHHHHh---ccCCCCCCCCCHHHHHHHHhccC---CCCCCCCHHHHhcCCCCCCCC
Q psy10462 125 LKQVQK---RVVFPESPRLSSSCKALISNILS---PVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 125 ~~~i~~---~~~~~~~~~~s~~~~~li~~~l~---~~~~R~~~~eil~~p~~~~~~ 174 (347)
...+.. ....|....+++++++++.+|+. ++..|++++++++||||.+..
T Consensus 257 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 257 QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 555542 23455556789999999999763 344599999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=238.05 Aligned_cols=165 Identities=27% Similarity=0.361 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|....... .......+||+.|+|||+
T Consensus 179 l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~----~~~~~~~~gt~~y~aPE~ 254 (391)
T PHA03212 179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN----ANKYYGWAGTIATNAPEL 254 (391)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc----ccccccccCccCCCChhh
Confidence 4568899999999999999999999999999999999999999999999986532211 112234679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcc---------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-------YSELLKQVQKRV--------------------------- 132 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-------~~~~~~~i~~~~--------------------------- 132 (347)
+.+..++ .++|+||+||++|+|++|..||.... ....+..+....
T Consensus 255 ~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 333 (391)
T PHA03212 255 LARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSS 333 (391)
T ss_pred hcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccC
Confidence 9887776 68999999999999999998875321 111111111100
Q ss_pred CCCC-------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 133 VFPE-------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 133 ~~~~-------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
..+. ...++.++.+++.+|| .+|.+||+++|+++||||.+...+
T Consensus 334 ~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 334 RKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred CCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0000 0124567899999999 799999999999999999875443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=235.90 Aligned_cols=164 Identities=26% Similarity=0.418 Sum_probs=131.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ .......+++.|+|||.
T Consensus 100 l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~----~~~~~~~~~~~y~aPE~ 175 (372)
T cd07853 100 LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES----KHMTQEVVTQYYRAPEI 175 (372)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc----ccCCCCCcCCCcCCHHH
Confidence 56788999999999999999999999999999999999999999999999976532211 11123457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC------------------------CC-------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV------------------------FP------- 135 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------------~~------- 135 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+.+..+..... .+
T Consensus 176 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (372)
T cd07853 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYT 255 (372)
T ss_pred HcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcc
Confidence 98755434689999999999999999999998776655544432111 11
Q ss_pred CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 136 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 136 ~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.....++++.+++.+|| .+|.+||+++++++|||+....
T Consensus 256 ~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 256 LSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 12345788999999999 6999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=238.47 Aligned_cols=149 Identities=32% Similarity=0.593 Sum_probs=128.7
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE-cCCCcEEEeccCCceecccCCccccccCcccccCCcccccccccc
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL-DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 88 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 88 (347)
.++..|++||+.|+.|||++|++|||+||+|||+ +..++++|+|||.++..... ..+.|-|..|.|||++.
T Consensus 415 ~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--------~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 415 SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--------CDTPALTLQYVAPEVLA 486 (612)
T ss_pred HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--------hcccchhhcccChhhhc
Confidence 6788899999999999999999999999999999 68999999999999876532 22345688999999999
Q ss_pred CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 89 GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 89 ~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
...|+ ..+||||+|+++|+|++|+.||...... ++..++..+ +....+|.++++|++.|| .+|..|+++.++..
T Consensus 487 ~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 487 IQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 88887 6799999999999999999999876555 555555433 234789999999999999 79999999999999
Q ss_pred CCCC
Q psy10462 167 DPWL 170 (347)
Q Consensus 167 ~p~~ 170 (347)
|||+
T Consensus 563 h~w~ 566 (612)
T KOG0603|consen 563 HPWF 566 (612)
T ss_pred Ccch
Confidence 9999
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=234.26 Aligned_cols=161 Identities=30% Similarity=0.613 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||+
T Consensus 93 ~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~gt~~y~aPE~ 167 (325)
T cd05602 93 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-----GTTSTFCGTPEYLAPEV 167 (325)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-----CCcccccCCccccCHHH
Confidence 5578889999999999999999999999999999999999999999999987532211 12235679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH---
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME--- 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~--- 162 (347)
+.+..++ .++|+||+||++|+|++|..||.+.+..+....+.... ...++.+++.+++++++|| .+|.+|++..
T Consensus 168 ~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 168 LHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 9887776 67999999999999999999999988877777765442 2334578999999999999 7899999765
Q ss_pred -HHhcCCCCCCCC
Q psy10462 163 -DIRQDPWLKEDS 174 (347)
Q Consensus 163 -eil~~p~~~~~~ 174 (347)
++.+|+|+....
T Consensus 246 ~~i~~~~~~~~~~ 258 (325)
T cd05602 246 MEIKNHIFFSPIN 258 (325)
T ss_pred HHHhcCcccCCCC
Confidence 899999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=234.08 Aligned_cols=162 Identities=30% Similarity=0.582 Sum_probs=129.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......+||+.|+|||
T Consensus 92 ~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-----~~~~~~~gt~~y~aPE 166 (329)
T cd05618 92 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-----DTTSTFCGTPNYIAPE 166 (329)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-----CccccccCCccccCHH
Confidence 35678899999999999999999999999999999999999999999999986532211 1123467999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC--------C-HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT--------N-YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~--------~-~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~ 155 (347)
++.+..++ .++|+||+||++|+|++|+.||... . .......+.. .....+..++..+++++++|| .+|
T Consensus 167 ~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~~~~~~~ll~~~L~~dP 244 (329)
T cd05618 167 ILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDP 244 (329)
T ss_pred HHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCH
Confidence 99887776 5799999999999999999999521 1 1122233322 222334578899999999999 799
Q ss_pred CCCCC------HHHHhcCCCCCCCC
Q psy10462 156 KFRIQ------MEDIRQDPWLKEDS 174 (347)
Q Consensus 156 ~~R~~------~~eil~~p~~~~~~ 174 (347)
..|++ ++++++||||....
T Consensus 245 ~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 245 KERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred HHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 99998 58999999997754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=231.38 Aligned_cols=162 Identities=26% Similarity=0.557 Sum_probs=136.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||
T Consensus 97 ~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE 171 (323)
T cd05615 97 KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-----VTTRTFCGTPDYIAPE 171 (323)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-----ccccCccCCccccCHH
Confidence 35779999999999999999999999999999999999999999999999987532211 1123457899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ---- 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~---- 160 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... ...+..++.++.+++.+|| .+|.+|++
T Consensus 172 ~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~ 249 (323)
T cd05615 172 IIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPE 249 (323)
T ss_pred HHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHcccCHhhCCCCCCC
Confidence 99887776 67999999999999999999999988877777765532 2334568899999999999 79999997
Q ss_pred -HHHHhcCCCCCCCC
Q psy10462 161 -MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 -~~eil~~p~~~~~~ 174 (347)
.+++++|||+....
T Consensus 250 ~~~~i~~h~~f~~~~ 264 (323)
T cd05615 250 GERDIREHAFFRRID 264 (323)
T ss_pred CHHHHhcCcccCCCC
Confidence 58999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=231.58 Aligned_cols=164 Identities=27% Similarity=0.424 Sum_probs=129.6
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......||..|+|||.+
T Consensus 166 ~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-----~~~~~~~gt~~y~aPE~~ 240 (353)
T PLN00034 166 DEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-----DPCNSSVGTIAYMSPERI 240 (353)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-----ccccccccCccccCcccc
Confidence 457778899999999999999999999999999999999999999999987653211 112345689999999987
Q ss_pred cCC----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 88 KGV----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 88 ~~~----~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
... .+...++|||||||++|+|++|+.||..... ......+........+...+.++++++..|| .+|.+||
T Consensus 241 ~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 320 (353)
T PLN00034 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRW 320 (353)
T ss_pred ccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCc
Confidence 532 2333579999999999999999999974332 2233333333333344568899999999999 7999999
Q ss_pred CHHHHhcCCCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 160 ~~~eil~~p~~~~~~~~ 176 (347)
+++|+++|||+......
T Consensus 321 t~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 321 SAMQLLQHPFILRAQPG 337 (353)
T ss_pred CHHHHhcCcccccCCcc
Confidence 99999999999886543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=234.43 Aligned_cols=162 Identities=28% Similarity=0.587 Sum_probs=135.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .......+||+.|+|||
T Consensus 92 ~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-----~~~~~~~~gt~~y~aPE 166 (325)
T cd05604 92 SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-----SDTTTTFCGTPEYLAPE 166 (325)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-----CCCcccccCChhhCCHH
Confidence 3567889999999999999999999999999999999999999999999998643211 11123467999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH---
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM--- 161 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~--- 161 (347)
.+.+..++ .++|+||+||++|+|++|..||.+.+..+....+.... ...++..+..+.+++++|| .+|.+|++.
T Consensus 167 ~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 167 VIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred HHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 99887776 67999999999999999999999988877777765543 2234568899999999999 688888865
Q ss_pred -HHHhcCCCCCCCC
Q psy10462 162 -EDIRQDPWLKEDS 174 (347)
Q Consensus 162 -~eil~~p~~~~~~ 174 (347)
.++++|||+....
T Consensus 245 ~~~i~~h~~f~~~~ 258 (325)
T cd05604 245 FLEIQEHPFFESLS 258 (325)
T ss_pred HHHHhcCCCcCCCC
Confidence 6999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=222.29 Aligned_cols=135 Identities=19% Similarity=0.284 Sum_probs=117.3
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|+....+|+|+||+|++|+++.||+.||||++..+. .++..++-.+||+++|++|+|||+|.+.++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 57889999999999999999999999999999986443 34566677789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhC-CCCCHHHHHHHHHH-HHHHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKE-RYIDEDKALLCYSE-VSNLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~-~~~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||+. ++.+-|.+. ..++++.+..|..| +.|+.|+|+++||||||||||||+.+++
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g 138 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG 138 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC
Confidence 99998 666666553 46777777766555 5599999999999999999999998876
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=229.09 Aligned_cols=162 Identities=25% Similarity=0.426 Sum_probs=121.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----cCCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++........ ........||+.|+
T Consensus 105 l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~t~~y~ 182 (317)
T cd07867 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LADLDPVVVTFWYR 182 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCccc--ccccCcceeccccc
Confidence 5678889999999999999999999999999999999 45678999999999765432111 11123456899999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHHhccCCC------------------
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---------ELLKQVQKRVVFP------------------ 135 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~---------~~~~~i~~~~~~~------------------ 135 (347)
|||.+.+....+.++|+||+||++|+|+||+.||...... .....+......+
T Consensus 183 aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T cd07867 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQ 262 (317)
T ss_pred CcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhh
Confidence 9999987544447899999999999999999999743211 1111111100000
Q ss_pred -------------------CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 136 -------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 136 -------------------~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.....+..+.+++.+|| .+|.+|||++|+++||||
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 263 KDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 01123567889999999 799999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=230.46 Aligned_cols=164 Identities=27% Similarity=0.539 Sum_probs=143.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.|.+..++.|+.-+++|++|||++|||.|||||+|++++.+|.+||.|||+|+....+.. .-++||||.|.|||
T Consensus 516 ~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K------TwTFcGTpEYVAPE 589 (732)
T KOG0614|consen 516 SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK------TWTFCGTPEYVAPE 589 (732)
T ss_pred CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc------eeeecCCcccccch
Confidence 366688999999999999999999999999999999999999999999999998865432 34799999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-CCCCCCHHHHHHHHhcc-CCCCCCCC---
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQ--- 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~~l-~~~~~R~~--- 160 (347)
++.+...+ ..+|.||+|+++||+++|++||++.++......|.+++..- -|.+++..+.+|++++. ..|..|..
T Consensus 590 IILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~ 668 (732)
T KOG0614|consen 590 IILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQK 668 (732)
T ss_pred hhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhcccc
Confidence 99988777 67999999999999999999999999999988888876422 24678999999999988 67888765
Q ss_pred --HHHHhcCCCCCCCCCC
Q psy10462 161 --MEDIRQDPWLKEDSNP 176 (347)
Q Consensus 161 --~~eil~~p~~~~~~~~ 176 (347)
+.++.+|.||..-.+.
T Consensus 669 ~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 669 GGINDIKKHRWFEGFDWE 686 (732)
T ss_pred CChHHHHhhhhhhcCChh
Confidence 7999999999876653
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=233.27 Aligned_cols=151 Identities=25% Similarity=0.502 Sum_probs=132.2
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccC
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 89 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 89 (347)
.+-..++.|||+||+||+++++|||||...|||++++..+||+|||+|+....+ .+....... -...|.|||.+..
T Consensus 303 ~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~--~Y~~~~~~k--fPIkWtAPEa~~~ 378 (468)
T KOG0197|consen 303 PQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD--EYTASEGGK--FPIKWTAPEALNY 378 (468)
T ss_pred HHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC--ceeecCCCC--CCceecCHHHHhh
Confidence 677889999999999999999999999999999999999999999999944332 221111111 1356999999998
Q ss_pred CCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 90 VPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 90 ~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
..++ .+|||||||++|||++| |+.||++.+..++++.+.++.+.|.|+..++..-+++..|+ .+|+.|||++.+.
T Consensus 379 ~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 379 GKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 8887 68999999999999996 99999999999999999999999999999999999999999 7999999998765
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=216.83 Aligned_cols=135 Identities=19% Similarity=0.264 Sum_probs=120.4
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|...+.+|+|+||.||+|++..||+.||||+|+..... +.......||+++|+.++||||+++.++|-..+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5788899999999999999999999999999999866443 333445569999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhC-CCCCHHHHHHHHHHH-HHHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKE-RYIDEDKALLCYSEV-SNLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~-~~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||+. ||+..|+.. ..++...++.|+.++ .|++|+|++.|+||||||.|+|++.++
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g 138 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG 138 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC
Confidence 99997 999999764 478999988887765 499999999999999999999998877
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=218.26 Aligned_cols=158 Identities=27% Similarity=0.546 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.|++|||++|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 99 l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 173 (257)
T cd08223 99 LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-----DMASTLIGTPYYMSPEL 173 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-----CccccccCCcCccChhH
Confidence 5678899999999999999999999999999999999999999999999987654321 11234568899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||+|++++++++|+.||...+.......+..+...+.+...++.+.+++..|+ .+|..||++.+++
T Consensus 174 ~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 252 (257)
T cd08223 174 FSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252 (257)
T ss_pred hcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 9887766 5799999999999999999999988776666665555443445678899999999999 7999999999999
Q ss_pred cCCCC
Q psy10462 166 QDPWL 170 (347)
Q Consensus 166 ~~p~~ 170 (347)
+|||+
T Consensus 253 ~~~~~ 257 (257)
T cd08223 253 RQPYI 257 (257)
T ss_pred cCCCC
Confidence 99996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=216.64 Aligned_cols=171 Identities=30% Similarity=0.567 Sum_probs=137.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc---EEEeccCCceecccCCc--cccccCcccccCCcc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNT--DYKQNLSETFCGSYA 80 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~--~~~~~~~~~~~gt~~ 80 (347)
.|++.||.++.++|+.||.|||.+||.|||+||+|||-..... +|||||.++.....+.. ....+...+.+|+..
T Consensus 172 ~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAE 251 (463)
T KOG0607|consen 172 HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAE 251 (463)
T ss_pred hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchh
Confidence 4889999999999999999999999999999999999876544 79999988754332221 112222346789999
Q ss_pred cccccccc---C-CCCCCChhhHHHHHHHHHHHHcCCCCCCCC-------C--------HHHHHHHHHhcc-CCCC--CC
Q psy10462 81 YASPEILK---G-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-------N--------YSELLKQVQKRV-VFPE--SP 138 (347)
Q Consensus 81 y~aPE~~~---~-~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-------~--------~~~~~~~i~~~~-~~~~--~~ 138 (347)
|||||+.. + ..++.+++|.||+|+++|-|+.|..||.+. + ...+++.|+++. .||+ +.
T Consensus 252 fMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWa 331 (463)
T KOG0607|consen 252 FMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWA 331 (463)
T ss_pred hcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhH
Confidence 99999863 2 223347899999999999999999999653 1 356788888764 4665 45
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+|.+++++++++| .++..|.++.++++|||++.....
T Consensus 332 hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 332 HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 69999999999999 799999999999999999877654
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=230.52 Aligned_cols=161 Identities=27% Similarity=0.548 Sum_probs=134.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......+||+.|+|||.
T Consensus 93 ~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 167 (321)
T cd05603 93 FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-----ETTSTFCGTPEYLAPEV 167 (321)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-----CccccccCCcccCCHHH
Confidence 5678899999999999999999999999999999999999999999999986532111 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM---- 161 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~---- 161 (347)
+.+..++ .++|+||+||++|+|++|..||.+.+..+....+.... .+.++..+..+.+++..|| .+|..|++.
T Consensus 168 ~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (321)
T cd05603 168 LRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADF 245 (321)
T ss_pred hcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCH
Confidence 9887776 57999999999999999999999988777777765543 2334567889999999999 789999864
Q ss_pred HHHhcCCCCCCCC
Q psy10462 162 EDIRQDPWLKEDS 174 (347)
Q Consensus 162 ~eil~~p~~~~~~ 174 (347)
.++++|+|+....
T Consensus 246 ~~~~~~~~~~~~~ 258 (321)
T cd05603 246 LEIKNHVFFSPIN 258 (321)
T ss_pred HHHhCCCCcCCCC
Confidence 6999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=223.21 Aligned_cols=163 Identities=29% Similarity=0.587 Sum_probs=142.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.|.|+.|..|+.+|+-||-|||++|||.||||.+|++++.+|++||+|||+++.-..+ .....++||||.|+|||
T Consensus 446 kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-----~~TTkTFCGTPdYiAPE 520 (683)
T KOG0696|consen 446 KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-----GVTTKTFCGTPDYIAPE 520 (683)
T ss_pred ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-----CcceeeecCCCcccccc
Confidence 4677899999999999999999999999999999999999999999999999753221 23356899999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC---
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQ--- 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~--- 160 (347)
++.-.+|+ ..+|+||+|+++|||+.|+.||++.+..++++.|.+ .+.+| ..+|.++.++.+.+| ..|.+|..
T Consensus 521 Ii~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP--KslSkEAv~ickg~ltK~P~kRLGcg~ 597 (683)
T KOG0696|consen 521 IIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP--KSLSKEAVAICKGLLTKHPGKRLGCGP 597 (683)
T ss_pred eEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc--ccccHHHHHHHHHHhhcCCccccCCCC
Confidence 99998887 779999999999999999999999999999998865 44454 578999999999999 67888764
Q ss_pred --HHHHhcCCCCCCCCCC
Q psy10462 161 --MEDIRQDPWLKEDSNP 176 (347)
Q Consensus 161 --~~eil~~p~~~~~~~~ 176 (347)
-+++..||||+...+.
T Consensus 598 ~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 598 EGERDIREHPFFRRIDWE 615 (683)
T ss_pred ccccchhhCcchhhccHH
Confidence 4789999999988764
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=232.18 Aligned_cols=161 Identities=29% Similarity=0.571 Sum_probs=136.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......+|++.|+|||.
T Consensus 95 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~g~~~y~aPE~ 169 (318)
T cd05582 95 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-----KKAYSFCGTVEYMAPEV 169 (318)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-----CceecccCChhhcCHHH
Confidence 5678999999999999999999999999999999999999999999999987543211 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC-----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ----- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~----- 160 (347)
+.+..++ .++|+|||||++|+|++|+.||.+.+..+....+.+.. ...+..+++.++++++.|| .+|..|++
T Consensus 170 ~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~ 247 (318)
T cd05582 170 VNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDG 247 (318)
T ss_pred HcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 9887665 67999999999999999999999888777777665432 2344568999999999999 79999999
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
.+++++|||+....
T Consensus 248 ~~~~~~~~~~~~~~ 261 (318)
T cd05582 248 VEEIKRHPFFSTID 261 (318)
T ss_pred HHHHhCCCCcCCCC
Confidence 78899999998653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=224.38 Aligned_cols=163 Identities=30% Similarity=0.554 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.
T Consensus 101 ~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~~PE~ 175 (301)
T cd07873 101 INMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-----TYSNEVVTLWYRPPDI 175 (301)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-----cccccceeecccCcHH
Confidence 45688999999999999999999999999999999999999999999999865432111 1122346889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--------------------CCC---------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--------------------FPE---------S 137 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--------------------~~~---------~ 137 (347)
+.+....+.++|+||+|+++|+|++|+.||.+.+..+....+..... .|. .
T Consensus 176 ~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (301)
T cd07873 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHA 255 (301)
T ss_pred HhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhc
Confidence 87654344689999999999999999999998776655444332111 110 1
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
+.+++.+++++.+|| .+|.+||+++++++||||..-.
T Consensus 256 ~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 256 PRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 346888999999999 6999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=233.48 Aligned_cols=165 Identities=28% Similarity=0.453 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ ........||+.|+|||+
T Consensus 182 l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~ 258 (392)
T PHA03207 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD---TPQCYGWSGTLETNSPEL 258 (392)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc---cccccccccccCccCHhH
Confidence 56789999999999999999999999999999999999999999999999976543211 111234579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccC----------------------------CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---SELLKQVQKRVV----------------------------FP 135 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~---~~~~~~i~~~~~----------------------------~~ 135 (347)
+.+..++ .++|+||+||++|+|++|+.||.+... ...+..+.+... ++
T Consensus 259 ~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (392)
T PHA03207 259 LALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYT 337 (392)
T ss_pred hcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCcc
Confidence 9887776 679999999999999999999976532 111222211100 00
Q ss_pred CC-----CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 136 ES-----PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 136 ~~-----~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.+ ...+.++++++++|| .+|.+||++.++++||||.....
T Consensus 338 ~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 338 IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00 124567889999999 79999999999999999987544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=226.70 Aligned_cols=160 Identities=26% Similarity=0.478 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.+..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...... ......|++.|+|||
T Consensus 100 ~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~g~~~y~aPE 172 (331)
T cd06649 100 IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------MANSFVGTRSYMSPE 172 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-------ccccCCCCcCcCCHh
Confidence 45678899999999999999986 6999999999999999999999999998755321 123456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---------------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--------------------------------- 132 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------------------- 132 (347)
.+.+..++ .++|+||+||++|+|++|+.||...+..+....+....
T Consensus 173 ~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T cd06649 173 RLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAM 251 (331)
T ss_pred HhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccch
Confidence 99887776 68999999999999999999998766544432221100
Q ss_pred ------------CCC--CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 133 ------------VFP--ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 133 ------------~~~--~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
..+ .....++++++++++|| .+|+.||+++++++|||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 252 AIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred hHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 001 11246789999999999 7999999999999999997643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=230.73 Aligned_cols=162 Identities=25% Similarity=0.478 Sum_probs=139.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+++++-++.|++.||.|||+++|||||||..|||+.-+|.++|+|||.+..... +.....+|.|||+|||||+
T Consensus 127 LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-----t~qkRDsFIGTPYWMAPEV 201 (1187)
T KOG0579|consen 127 LTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-----TRQKRDSFIGTPYWMAPEV 201 (1187)
T ss_pred cchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-----HHhhhccccCCcccccchh
Confidence 45789999999999999999999999999999999999999999999998754321 2334567899999999998
Q ss_pred c-----cCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 L-----KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~-----~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
. ...+|+ .++||||||+++.+|..+.+|-...++..++-.|.+..+ .-.|...|..+++++.+|| .+|..|
T Consensus 202 vmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~R 280 (1187)
T KOG0579|consen 202 VMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNR 280 (1187)
T ss_pred eeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccC
Confidence 6 456777 789999999999999999999999999988888876432 2345678999999999999 799999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
|++.++++|||+....
T Consensus 281 p~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 281 PPAAQLLKHPFVQNAP 296 (1187)
T ss_pred CCHHHHhhCcccccCC
Confidence 9999999999998543
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=238.21 Aligned_cols=168 Identities=40% Similarity=0.729 Sum_probs=147.6
Q ss_pred CCccCCCCH-------HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcc
Q psy10462 1 NDILLDYNT-------DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73 (347)
Q Consensus 1 ~~~l~~~~~-------~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 73 (347)
||++++|.. .+|+.+|.|+..|++|||+++|+|||||.+|+||+.+.++||+|||++..+.. .....
T Consensus 139 ~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~------~~~lq 212 (596)
T KOG0586|consen 139 GGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY------GLMLQ 212 (596)
T ss_pred CchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc------ccccc
Confidence 466666654 78999999999999999999999999999999999999999999999987753 23456
Q ss_pred cccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-
Q psy10462 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL- 152 (347)
Q Consensus 74 ~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l- 152 (347)
++||++.|.|||++.+..|+...+|+||+|+++|.++.|..||++.+..++..++..+. +..+..++.+|+++|+++|
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-YRIPFYMSCDCEDLLRKFLV 291 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-ecccceeechhHHHHHHhhc
Confidence 88999999999999999999999999999999999999999999998887777765543 3345678999999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 153 SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 153 ~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.+|.+|++++++..|.|......
T Consensus 292 l~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred cCccccCCHHHhhhhcccchhhh
Confidence 79999999999999999886544
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=221.68 Aligned_cols=161 Identities=30% Similarity=0.444 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... ......|++.|+|||.
T Consensus 92 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~ 165 (277)
T cd05607 92 LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK------TITQRAGTNGYMAPEI 165 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc------eeeccCCCCCccCHHH
Confidence 4557788899999999999999999999999999999999999999999987654211 1123468899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
+.+..++ .++|+||+||++|+|++|+.||.+... .++...............++++++++++.|| .+|.+|+++
T Consensus 166 ~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~ 244 (277)
T cd05607 166 LKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGS 244 (277)
T ss_pred HccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCC
Confidence 9887766 679999999999999999999976533 2222222221111122467899999999999 799999998
Q ss_pred ----HHHhcCCCCCCCC
Q psy10462 162 ----EDIRQDPWLKEDS 174 (347)
Q Consensus 162 ----~eil~~p~~~~~~ 174 (347)
++++.||||+...
T Consensus 245 ~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 245 REKNDDPRKHEFFKTIN 261 (277)
T ss_pred ccchhhhhcChhhcCCC
Confidence 7788999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=231.45 Aligned_cols=139 Identities=21% Similarity=0.342 Sum_probs=118.7
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCch-------hhh----hhchHHHHHHHhcCCCcchhhh
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI-------DYL----KKFLPREIEVVKGLKHPNLIRF 256 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~-------~~~----~~~~~~E~~il~~l~HpnIv~l 256 (347)
..-..|++.+.||+|+||+|.+|++..+++.||||++++..... ... .+.+.+|+.||++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44578999999999999999999999999999999998754321 111 2467899999999999999999
Q ss_pred heeeeeC--CeEEEEEEecCCCChHHHHHhCCC-CCHHHHHHHHH-HHHHHHHHhhcCccccCCCCccccccccc
Q psy10462 257 LQAIETT--HRVYIIMEYAKNGSLLEVIRKERY-IDEDKALLCYS-EVSNLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 257 ~~~~~~~--~~~~iv~E~~~~G~L~~~l~~~~~-l~e~~~~~~~~-~~~~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+++..++ +.+|||+|||..|.+... ...++ +++.+|+.|++ .++||.|||.+|||||||||+|+||+.++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 9999876 679999999999997643 23345 99999999999 55699999999999999999999998876
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=227.08 Aligned_cols=164 Identities=31% Similarity=0.528 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... .....+||+.|+|||+
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~gt~~y~aPE~ 174 (331)
T cd05597 99 LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV----QSNVAVGTPDYISPEI 174 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc----cccceeccccccCHHH
Confidence 456889999999999999999999999999999999999999999999998765432211 1123468999999999
Q ss_pred ccCC----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cCCC-CCCCCCHHHHHHHHhccCCC---
Q psy10462 87 LKGV----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFP-ESPRLSSSCKALISNILSPV--- 155 (347)
Q Consensus 87 ~~~~----~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~-~~~~~s~~~~~li~~~l~~~--- 155 (347)
+.+. ...+.++|+||+||++|+|++|+.||.+.+..+....+... ..++ ....++..+++++++||..+
T Consensus 175 ~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r 254 (331)
T cd05597 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETR 254 (331)
T ss_pred HhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccc
Confidence 8742 22236799999999999999999999988777766666432 2222 23457999999999998433
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~~~ 174 (347)
..|++++++++|||+....
T Consensus 255 ~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 255 LGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred cCCCCHHHHhcCCCCCCCC
Confidence 3378999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=225.27 Aligned_cols=168 Identities=26% Similarity=0.464 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......... ........|++.|+|||.
T Consensus 103 l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~ 180 (336)
T cd07849 103 LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH--TGFLTEYVATRWYRAPEI 180 (336)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc--cCCcCCcCcCCCccChHH
Confidence 677889999999999999999999999999999999999999999999998765432111 111234568999999998
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---------------------C---------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---------------------P---------E 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------------~---------~ 136 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+.......+...... + .
T Consensus 181 ~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T cd07849 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKL 260 (336)
T ss_pred hhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHH
Confidence 765433346899999999999999999999876544333322111100 0 0
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+..++++.+++.+|| .+|.+||++.++++|||+..-..+
T Consensus 261 ~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 261 FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 1345788999999999 699999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=232.65 Aligned_cols=160 Identities=28% Similarity=0.428 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC--CcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
++...++.+.+||+.||.+||+.||||+||||+||||... ..+||+|||.|+..... ..+.+.+..|.||
T Consensus 286 lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~--------vytYiQSRfYRAP 357 (586)
T KOG0667|consen 286 LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR--------VYTYIQSRFYRAP 357 (586)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc--------ceeeeeccccccc
Confidence 4558899999999999999999999999999999999754 36999999999876432 1255678999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC----------------------------
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---------------------------- 136 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------- 136 (347)
|++.|.+|+ .+.|+|||||+++||++|.+.|++.+..+.+..|.+-...|+
T Consensus 358 EVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~ 436 (586)
T KOG0667|consen 358 EVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETS 436 (586)
T ss_pred hhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeec
Confidence 999999998 679999999999999999999999988777776654332221
Q ss_pred ----------------------CC-C-------C----CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 137 ----------------------SP-R-------L----SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 137 ----------------------~~-~-------~----s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.+ . + -....+++++|| .||..|+|..++++|||+.....
T Consensus 437 ~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 437 APRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred ccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 00 0 0 024578999999 69999999999999999996543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=222.29 Aligned_cols=162 Identities=24% Similarity=0.495 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||+.|++||||||+||++++++.++|+|||++....... ......|++.|+|||.
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~ 172 (285)
T cd05605 99 FDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE------TIRGRVGTVGYMAPEV 172 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC------ccccccCCCCccCcHH
Confidence 5678899999999999999999999999999999999999999999999987653211 1123468999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---ccCCCCCCCCCHHHHHHHHhcc-CCCCCCC---
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNIL-SPVKFRI--- 159 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~l-~~~~~R~--- 159 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+.......+.. ......+..++..+++++.+|+ .+|..|+
T Consensus 173 ~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 173 VKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred hcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCC
Confidence 9887766 578999999999999999999998765443333322 1122234568899999999999 7999999
Q ss_pred --CHHHHhcCCCCCCCCC
Q psy10462 160 --QMEDIRQDPWLKEDSN 175 (347)
Q Consensus 160 --~~~eil~~p~~~~~~~ 175 (347)
+++++++|||+.....
T Consensus 252 ~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 252 GEGAEEVKAHPFFRTANF 269 (285)
T ss_pred CCCHHHHhcCcCccCCCH
Confidence 8999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=220.28 Aligned_cols=159 Identities=26% Similarity=0.535 Sum_probs=124.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++......... .....+++.|+|||.
T Consensus 96 ~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~ 170 (284)
T cd07839 96 IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-----YSAEVVTLWYRPPDV 170 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-----cCCCccccCCcChHH
Confidence 567889999999999999999999999999999999999999999999998755322111 123356889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHhccC------------------CC----------CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQVQKRVV------------------FP----------ES 137 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf-~~~~~~~~~~~i~~~~~------------------~~----------~~ 137 (347)
+.+....+.++|+||+||++|+|++|..|| .+.+..+.+..+.+... ++ ..
T Consensus 171 ~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (284)
T cd07839 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVV 250 (284)
T ss_pred HhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhc
Confidence 877554346899999999999999998885 44444443333322110 00 11
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
+.+++++++++.+|| .+|.+||+++++++||||
T Consensus 251 ~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 251 PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 346889999999999 799999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=226.27 Aligned_cols=156 Identities=20% Similarity=0.362 Sum_probs=125.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++.+++.+++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ......+++.|+|||.
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~---~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---RKGSARLPLKWMAPES 247 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh---cccCCCCCccccCcHH
Confidence 6678899999999999999999999999999999999999999999999997653221111 1122345678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSE-LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|||||||++|+|++ |..||.+....+ ....+..+...+.+...++++++++..|+ .+|..||++.+
T Consensus 248 ~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 248 IFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSA 326 (338)
T ss_pred hhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9887776 67999999999999996 999998765433 34444444444445677899999999999 79999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+++
T Consensus 327 l~~ 329 (338)
T cd05102 327 LVE 329 (338)
T ss_pred HHH
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=208.19 Aligned_cols=159 Identities=25% Similarity=0.492 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.|.-+-++...++.||.||-+ +||+|||+||+|||+|..|++|+||||.+.++.++... +.-.|.+.|||||
T Consensus 188 iPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh------trsAGC~~YMaPE 261 (391)
T KOG0983|consen 188 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH------TRSAGCAAYMAPE 261 (391)
T ss_pred chHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc------ccccCCccccCcc
Confidence 3344455666778899999975 68999999999999999999999999999887653221 2346899999999
Q ss_pred cccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhc--cCCCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 86 ILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKR--VVFPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 86 ~~~~~---~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
.+.-. .|+ -++||||||++++|+.||+.||.+.+ .-+++..+... ...|....+|+...+++..|| .|+..|
T Consensus 262 Ridp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~R 340 (391)
T KOG0983|consen 262 RIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKR 340 (391)
T ss_pred ccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccC
Confidence 98643 344 67999999999999999999999843 34556665443 233444558999999999999 799999
Q ss_pred CCHHHHhcCCCCCC
Q psy10462 159 IQMEDIRQDPWLKE 172 (347)
Q Consensus 159 ~~~~eil~~p~~~~ 172 (347)
|.-.++++|||...
T Consensus 341 P~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 341 PKYNKLLEHPFIKR 354 (391)
T ss_pred cchHHHhcCcceee
Confidence 99999999999765
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=228.19 Aligned_cols=159 Identities=29% Similarity=0.532 Sum_probs=125.5
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccCC
Q psy10462 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 90 (347)
Q Consensus 11 ~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 90 (347)
..+.|..|++.|+.++|.+||||.||||.|+|+- .|.+||+|||.|.....+.+.. .....+||+.||+||.+...
T Consensus 461 ~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI---~kdsQvGT~NYMsPEAl~~~ 536 (677)
T KOG0596|consen 461 FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSI---VKDSQVGTVNYMSPEALTDM 536 (677)
T ss_pred HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccce---eeccccCcccccCHHHHhhc
Confidence 7889999999999999999999999999999986 5789999999998887654443 34567899999999998755
Q ss_pred CCC----------CChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhc---cCCCCCCCCCHHHHHHHHhcc-CCC
Q psy10462 91 PYT----------PQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKR---VVFPESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 91 ~~~----------~~~~Dvws~G~~l~~ll~g~~pf~~~~-~~~~~~~i~~~---~~~~~~~~~s~~~~~li~~~l-~~~ 155 (347)
.++ ..++||||+||++|+|+.|+.||.... ...-+..|... +.||..+. ..++.+++++|| .||
T Consensus 537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdP 615 (677)
T KOG0596|consen 537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDP 615 (677)
T ss_pred cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCc
Confidence 433 257899999999999999999997643 22223333222 23443332 223899999999 799
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~~~ 174 (347)
.+|++..++++|||+....
T Consensus 616 kkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 616 KKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred ccCCCcHHHhcCccccccc
Confidence 9999999999999987633
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=227.41 Aligned_cols=163 Identities=33% Similarity=0.527 Sum_probs=130.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.++.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||+
T Consensus 99 l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~----~~~~~~~gt~~y~aPE~ 174 (332)
T cd05623 99 LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT----VQSSVAVGTPDYISPEI 174 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc----ceecccccCccccCHHH
Confidence 45678899999999999999999999999999999999999999999999876532211 11223579999999999
Q ss_pred ccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCC-CCCCCHHHHHHHHhccCCC--
Q psy10462 87 LKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPE-SPRLSSSCKALISNILSPV-- 155 (347)
Q Consensus 87 ~~~-----~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~-~~~~s~~~~~li~~~l~~~-- 155 (347)
+.+ ..++ .++|+|||||++|+|++|+.||.+.+..+....+.... .+|. ...+++++++++++||..+
T Consensus 175 ~~~~~~~~~~~~-~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~ 253 (332)
T cd05623 175 LQAMEDGKGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREH 253 (332)
T ss_pred HhccccCCCCCC-CcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhh
Confidence 863 2333 67999999999999999999999988877777765432 2222 2457999999999999432
Q ss_pred -CCCCCHHHHhcCCCCCCCC
Q psy10462 156 -KFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 156 -~~R~~~~eil~~p~~~~~~ 174 (347)
..|++++++++||||....
T Consensus 254 r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 254 RLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred hcCCCCHHHHhCCCCcCCCC
Confidence 3368999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=235.50 Aligned_cols=138 Identities=22% Similarity=0.318 Sum_probs=124.0
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
.-|++.+.+|+|+-|.|.+|++..||+.+|||++.+.....+.....+.+|+-||+.+.||||+++|++++++..+|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34678899999999999999999999999999998764334445667889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHH-HHHHHHhhcCccccCCCCcccccccccc
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEV-SNLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~-~~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
||++||+|+++|.++++++|.+|..+++|+ .|+.|+|+.+|+||||||||+|||....
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n 150 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN 150 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC
Confidence 999999999999999999999988777655 5999999999999999999999976543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=221.55 Aligned_cols=161 Identities=27% Similarity=0.493 Sum_probs=129.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ......|++.|+|||
T Consensus 98 ~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~g~~~y~aPE 171 (285)
T cd05630 98 GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ------TIKGRVGTVGYMAPE 171 (285)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc------cccCCCCCccccChH
Confidence 35678899999999999999999999999999999999999999999999986543211 112346899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC-
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ- 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~- 160 (347)
.+.+..++ .++|+||+|+++|+|++|+.||...... +....+........+...+++.+++++.|| .+|.+|++
T Consensus 172 ~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 172 VVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred HHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCC
Confidence 99887766 6799999999999999999999865422 222222222222234567899999999999 69999999
Q ss_pred ----HHHHhcCCCCCCC
Q psy10462 161 ----MEDIRQDPWLKED 173 (347)
Q Consensus 161 ----~~eil~~p~~~~~ 173 (347)
++++++|||+.+.
T Consensus 251 ~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 251 QGGGAREVKEHPLFKQI 267 (285)
T ss_pred CCCchHHHHcChhhhcc
Confidence 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=218.42 Aligned_cols=159 Identities=27% Similarity=0.491 Sum_probs=124.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.
T Consensus 98 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 172 (285)
T cd07861 98 MDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-----VYTHEVVTLWYRAPEV 172 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-----cccCCcccccccChHH
Confidence 56788999999999999999999999999999999999999999999999875432211 1122346889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------------------CC---------CCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-------------------VF---------PESP 138 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-------------------~~---------~~~~ 138 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+.......+.... .. ....
T Consensus 173 ~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T cd07861 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVK 252 (285)
T ss_pred hcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcC
Confidence 8765433468999999999999999999998765433222211100 00 0123
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.+++++++++++|| .+|.+||++++++.||||
T Consensus 253 ~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 253 NLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 47889999999999 799999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=214.74 Aligned_cols=161 Identities=22% Similarity=0.433 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .........|+..|+|||.
T Consensus 101 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~ 178 (263)
T cd06625 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS--SGTGMKSVTGTPYWMSPEV 178 (263)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc--ccccccCCCcCccccCcce
Confidence 45678899999999999999999999999999999999999999999999876532111 0111123467889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|++++|+.||.+.+..+....+... ...+.+...+..+.+++++|+ .+|..||+++++
T Consensus 179 ~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 257 (263)
T cd06625 179 ISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEEL 257 (263)
T ss_pred eccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 9887765 6899999999999999999999876655544444332 223334567899999999999 689999999999
Q ss_pred hcCCCC
Q psy10462 165 RQDPWL 170 (347)
Q Consensus 165 l~~p~~ 170 (347)
++||||
T Consensus 258 l~~~~~ 263 (263)
T cd06625 258 LRHFFV 263 (263)
T ss_pred hhCCCC
Confidence 999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-29 Score=231.47 Aligned_cols=153 Identities=21% Similarity=0.270 Sum_probs=135.6
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-CcchhhhheeeeeCCeE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRV 266 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~ 266 (347)
.....|++.+.+|.|+||.||+|+.+.||+.+|+|++.+.........+.+.+|+.||+++. |||||+++++|++...+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567899999999999999999999999999999998776544434567889999999997 99999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccce-eEEEEEeeeeE
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYS-TIVVVHLQYNI 341 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~-~~~~~~~~~~~ 341 (347)
|+|||+|.||+|++.|.+. .++|..+..++.|++ ++.|+|+.||+||||||||+|+......+ ++.++.-|-.+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999999776 499999999988877 89999999999999999999998887654 78777766444
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-30 Score=226.01 Aligned_cols=148 Identities=22% Similarity=0.310 Sum_probs=129.1
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC--C---e
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--H---R 265 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~---~ 265 (347)
-.|+..+.+|.|+||.||.|....+++.||||.+-... +.-.+|+.||+.++|||||+|..+|... . .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 45667789999999999999999999999999885432 2234899999999999999999988653 2 5
Q ss_pred EEEEEEecCCCChHHHHHh----CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc-------cceeEE
Q psy10462 266 VYIIMEYAKNGSLLEVIRK----ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT-------YYSTIV 333 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~----~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~-------~~~~~~ 333 (347)
+.+|||||+. +|.++++. +..++.-.++.|+.|+. |+.|+|+.||+||||||+|||+|+.+ ++|..+
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 7899999997 99999974 56889888887777765 99999999999999999999999996 999999
Q ss_pred EEEeeeeEEEEEe
Q psy10462 334 VVHLQYNIIIITI 346 (347)
Q Consensus 334 ~~~~~~~~~~~~~ 346 (347)
+|...-||-|||.
T Consensus 176 L~~~epniSYicS 188 (364)
T KOG0658|consen 176 LVKGEPNISYICS 188 (364)
T ss_pred eccCCCceeEEEe
Confidence 9999999999994
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=228.03 Aligned_cols=134 Identities=19% Similarity=0.312 Sum_probs=119.6
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-CcchhhhheeeeeCC-eE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH-RV 266 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~-~~ 266 (347)
-.++|...+.+|.|+||.||+|+.+.+|+.||||.|++.-...+... -.||++-|++|. |||||++++++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~--nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM--NLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH--HHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 45789999999999999999999999999999999987655543322 249999999997 999999999999887 99
Q ss_pred EEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
|+|||||+. +|+++++. ++.|+|..++.|+.|+. ||+++|.+|+.|||+||||||+..
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~ 145 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG 145 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc
Confidence 999999997 99999975 46899999999888776 999999999999999999999974
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=226.75 Aligned_cols=159 Identities=26% Similarity=0.427 Sum_probs=120.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++++++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......||+.|+|||+
T Consensus 154 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~ 227 (357)
T PHA03209 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA------PAFLGLAGTVETNAPEV 227 (357)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC------cccccccccccccCCee
Confidence 567889999999999999999999999999999999999999999999998643221 11224568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCC-CCCCHH---------HHHHHHHhcc-----CCC----------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYS---------ELLKQVQKRV-----VFP---------------- 135 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf-~~~~~~---------~~~~~i~~~~-----~~~---------------- 135 (347)
+.+..++ .++|+||+||++|+|+++..|+ .+.... ..+..+.... .++
T Consensus 228 ~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (357)
T PHA03209 228 LARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYAS 306 (357)
T ss_pred cCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcc
Confidence 9887776 6899999999999999865554 332110 1111111110 011
Q ss_pred ------------CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCC
Q psy10462 136 ------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 136 ------------~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~ 172 (347)
....++.++.+++..|| .+|.+||+++|+++||||++
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 307 LERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 01134567788999999 79999999999999999975
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=215.02 Aligned_cols=163 Identities=27% Similarity=0.537 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcccc-ccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK-QNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~gt~~y~aPE 85 (347)
+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++........... ........|++.|+|||
T Consensus 103 l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe 182 (267)
T cd06628 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182 (267)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChh
Confidence 45678889999999999999999999999999999999999999999999876642211100 11122356888999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
.+.+..++ .++|+||+||++|+|++|+.||.+.+.......+........+...+..++++++.|+ .+|..||++.++
T Consensus 183 ~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 261 (267)
T cd06628 183 VVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261 (267)
T ss_pred HhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHH
Confidence 99877665 5799999999999999999999887665555554444333344567899999999999 689999999999
Q ss_pred hcCCCC
Q psy10462 165 RQDPWL 170 (347)
Q Consensus 165 l~~p~~ 170 (347)
++|||+
T Consensus 262 l~~~~~ 267 (267)
T cd06628 262 LKHPFL 267 (267)
T ss_pred hhCCCC
Confidence 999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=231.20 Aligned_cols=162 Identities=27% Similarity=0.413 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......+||+.|+|||+
T Consensus 257 l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~~~GT~~Y~APE~ 333 (461)
T PHA03211 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS---TPFHYGIAGTVDTNAPEV 333 (461)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc---cccccccCCCcCCcCHHH
Confidence 56788999999999999999999999999999999999999999999999976532211 111224579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhcc----CCCC------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT--------NYSELLKQVQKRV----VFPE------------------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~--------~~~~~~~~i~~~~----~~~~------------------ 136 (347)
+.+..++ .++|||||||++|||++|..|+... ...++...+.... .++.
T Consensus 334 ~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 412 (461)
T PHA03211 334 LAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNR 412 (461)
T ss_pred HcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhccc
Confidence 9888776 6899999999999999987655321 1223333332211 0110
Q ss_pred --------C---CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCC
Q psy10462 137 --------S---PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 137 --------~---~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~ 172 (347)
+ ..++..+++|+..|| .||.+||++.|+++||||..
T Consensus 413 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 413 RPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 134568999999999 69999999999999999964
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=220.09 Aligned_cols=165 Identities=27% Similarity=0.441 Sum_probs=132.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......... .....+++.|+|||.
T Consensus 105 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~ 179 (309)
T cd07845 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP-----MTPKVVTLWYRAPEL 179 (309)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC-----CCcccccccccChhh
Confidence 567889999999999999999999999999999999999999999999998765432111 112235778999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------------------C---------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--------------------E---------S 137 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------------------~---------~ 137 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+....+......+ . .
T Consensus 180 ~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (309)
T cd07845 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKF 259 (309)
T ss_pred hcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhc
Confidence 8764433478999999999999999999999888777666554421110 0 0
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
...++.+.+++++|| .+|.+||++++++.||||.....+
T Consensus 260 ~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 260 PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 125788999999999 799999999999999999876655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-29 Score=232.66 Aligned_cols=151 Identities=28% Similarity=0.553 Sum_probs=130.2
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccC
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 89 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 89 (347)
.-...|..+|+.||.|||.+.|||||||..||||..+..+||+|||-++..... .....|+||..|||||++++
T Consensus 212 ~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~------STkMSFaGTVaWMAPEvIrn 285 (904)
T KOG4721|consen 212 SLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK------STKMSFAGTVAWMAPEVIRN 285 (904)
T ss_pred HHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh------hhhhhhhhhHhhhCHHHhhc
Confidence 456789999999999999999999999999999999999999999998876542 23457899999999999999
Q ss_pred CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcC
Q psy10462 90 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQD 167 (347)
Q Consensus 90 ~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~ 167 (347)
.+.+ .|+|||||||+||||+||..||.+.+...++--+ ...+..|.+...+..++-|++.|+ ..|..||++.+++.|
T Consensus 286 ePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 286 EPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred CCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 9987 7899999999999999999999887654333222 223456777888999999999999 789999999999998
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=216.45 Aligned_cols=157 Identities=27% Similarity=0.448 Sum_probs=125.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||+|||++|++||||+|+||+++. +.+||+|||++........ .....+++.|+|||.
T Consensus 97 ~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~ 169 (282)
T cd07831 97 LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP------YTEYISTRWYRAPEC 169 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC------cCCCCCCcccCChhH
Confidence 567889999999999999999999999999999999999 9999999999876532211 123457889999998
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-------------------CCC---------CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------------------FPE---------SP 138 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------------~~~---------~~ 138 (347)
+.+....+.++|+||+||++|+|++|..||.+.+..+....+..... +|. .+
T Consensus 170 ~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (282)
T cd07831 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLP 249 (282)
T ss_pred hhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcc
Confidence 76544444689999999999999999999988776554443322110 111 12
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
..+..+++++.+|| .+|.+||+++++++||||
T Consensus 250 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 250 NASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 46789999999999 699999999999999996
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=212.42 Aligned_cols=158 Identities=34% Similarity=0.563 Sum_probs=133.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+....+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 98 ~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 172 (256)
T cd08529 98 LPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-----NFANTIVGTPYYLSPEL 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-----chhhccccCccccCHHH
Confidence 4557788899999999999999999999999999999999999999999987654321 11234568899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||||+++|+|++|+.||...+..+....+..+...+.+..++.++.+++.+|+ .+|+.||++.+++
T Consensus 173 ~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 173 CEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251 (256)
T ss_pred hcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence 9887765 6799999999999999999999988877777766665544444478899999999999 6899999999999
Q ss_pred cCCCC
Q psy10462 166 QDPWL 170 (347)
Q Consensus 166 ~~p~~ 170 (347)
.|||+
T Consensus 252 ~~~~~ 256 (256)
T cd08529 252 RNPSL 256 (256)
T ss_pred hCCCC
Confidence 99995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=216.26 Aligned_cols=162 Identities=27% Similarity=0.485 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++....... .......+++.|+|||.
T Consensus 100 l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 174 (282)
T cd06643 100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-----QRRDSFIGTPYWMAPEV 174 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-----cccccccccccccCHhh
Confidence 5678899999999999999999999999999999999999999999999986543211 11234568899999999
Q ss_pred ccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~~-----~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
+.. ..++ .++|+||+||++|+|++|+.||.+.+..+....+.... ..+.+..++.++++++.+|+ .+|..|
T Consensus 175 ~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (282)
T cd06643 175 VMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDAR 253 (282)
T ss_pred ccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence 842 2333 57999999999999999999998877666555554332 22334567899999999999 799999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
|+++++++|||+....
T Consensus 254 p~~~~il~~~~~~~~~ 269 (282)
T cd06643 254 WTTTQLLQHPFVTVNS 269 (282)
T ss_pred cCHHHHhcCCCEeccC
Confidence 9999999999988643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=220.13 Aligned_cols=172 Identities=31% Similarity=0.556 Sum_probs=138.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc-------------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY------------------- 67 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~------------------- 67 (347)
+.+..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 100 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (316)
T cd05574 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchh
Confidence 5668888999999999999999999999999999999999999999999986543211100
Q ss_pred -----cccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCC
Q psy10462 68 -----KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLS 141 (347)
Q Consensus 68 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s 141 (347)
.......+.|+..|+|||.+.+..++ .++|+||||+++|+|++|+.||.+.+..+.+..+.. ...++....++
T Consensus 180 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (316)
T cd05574 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVS 258 (316)
T ss_pred hhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccC
Confidence 00111235688899999999887665 689999999999999999999998877666655543 33444444579
Q ss_pred HHHHHHHHhcc-CCCCCCCC----HHHHhcCCCCCCCCCCCCC
Q psy10462 142 SSCKALISNIL-SPVKFRIQ----MEDIRQDPWLKEDSNPVGK 179 (347)
Q Consensus 142 ~~~~~li~~~l-~~~~~R~~----~~eil~~p~~~~~~~~~~~ 179 (347)
..+++++..|+ .+|..||+ ++++++|||+....++...
T Consensus 259 ~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 259 SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred HHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence 99999999999 79999999 9999999999887655433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=215.43 Aligned_cols=158 Identities=24% Similarity=0.417 Sum_probs=126.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 108 l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~g~~~y~aPE~ 182 (272)
T cd06637 108 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEV 182 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc-----ccCCcccccccccCHhH
Confidence 4567888999999999999999999999999999999999999999999987543211 11234568999999999
Q ss_pred ccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 87 LKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 87 ~~~-----~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
+.+ ..++ .++|+||+||++|+|++|..||.+.........+... .........+.++++++..|+ .+|..||
T Consensus 183 ~~~~~~~~~~~~-~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 261 (272)
T cd06637 183 IACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP 261 (272)
T ss_pred hccccCcCCCCC-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCC
Confidence 863 2344 5799999999999999999999876554443333222 122233467889999999999 6999999
Q ss_pred CHHHHhcCCCC
Q psy10462 160 QMEDIRQDPWL 170 (347)
Q Consensus 160 ~~~eil~~p~~ 170 (347)
++++++.||||
T Consensus 262 t~~~il~~~~~ 272 (272)
T cd06637 262 TTEQLMKHPFI 272 (272)
T ss_pred CHHHHhhCCCC
Confidence 99999999996
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=249.51 Aligned_cols=164 Identities=28% Similarity=0.428 Sum_probs=136.1
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccCC
Q psy10462 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV 90 (347)
Q Consensus 11 ~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 90 (347)
..+.|..|++.|++|||++|||||||||+||+++.+|.+|++|||.|.....+--+.. .......|||.|||||++.+.
T Consensus 1335 vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~-~el~~~~GT~~YMAPEvit~t 1413 (1509)
T KOG4645|consen 1335 VTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP-GELQSMMGTPMYMAPEVITGT 1413 (1509)
T ss_pred HHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC-HHHHhhcCCchhcCchhhccc
Confidence 3567889999999999999999999999999999999999999999988764321222 223456799999999999875
Q ss_pred CC--CCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 91 PY--TPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 91 ~~--~~~~~Dvws~G~~l~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
.. ...+.||||+||++.||+||+.||...+ .-+++-.+..+...+.|.++|++.++++.+|| .||+.|.++.|++.
T Consensus 1414 ~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1414 KGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 42 2346899999999999999999998654 34666777777666677789999999999999 79999999999999
Q ss_pred CCCCCCCCC
Q psy10462 167 DPWLKEDSN 175 (347)
Q Consensus 167 ~p~~~~~~~ 175 (347)
|.|-+.+..
T Consensus 1494 ~~f~~~~~d 1502 (1509)
T KOG4645|consen 1494 HAFGKSCTD 1502 (1509)
T ss_pred hhccccccc
Confidence 988765543
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=231.13 Aligned_cols=157 Identities=22% Similarity=0.534 Sum_probs=133.1
Q ss_pred HHHHHHHHHHHHHHHHHHhC--CCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 10 DKARRWFSQLADAIDYCHKK--SVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~--~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
.-.+.|++||+.||.|||++ .|||||||.+||++++ .|.+||+|+|+|..... .......|||.|||||.
T Consensus 143 kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-------s~aksvIGTPEFMAPEm 215 (632)
T KOG0584|consen 143 KAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-------SHAKSVIGTPEFMAPEM 215 (632)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc-------cccceeccCccccChHH
Confidence 67899999999999999998 5999999999999976 58999999999976542 22334689999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccCCCCCCC-CCHHHHHHHHhccCCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPR-LSSSCKALISNILSPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~-~s~~~~~li~~~l~~~~~R~~~~ei 164 (347)
+. ..|+ ..+||||||++|.||+|+.+||.. .++.++++++..+.....-.+ -.++.+++|.+||...+.|+++.|+
T Consensus 216 YE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~~~~R~sa~eL 293 (632)
T KOG0584|consen 216 YE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLATKSERLSAKEL 293 (632)
T ss_pred Hh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcCchhccCHHHH
Confidence 98 4566 789999999999999999999985 567888999988875322222 2578999999999779999999999
Q ss_pred hcCCCCCCCCC
Q psy10462 165 RQDPWLKEDSN 175 (347)
Q Consensus 165 l~~p~~~~~~~ 175 (347)
+.||||.....
T Consensus 294 L~d~Ff~~d~g 304 (632)
T KOG0584|consen 294 LKDPFFDEDGG 304 (632)
T ss_pred hhChhhccccc
Confidence 99999998643
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=217.69 Aligned_cols=161 Identities=26% Similarity=0.489 Sum_probs=132.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ......|++.|+|||.
T Consensus 99 ~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~------~~~~~~g~~~~~aPE~ 172 (285)
T cd05632 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE------SIRGRVGTVGYMAPEV 172 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC------cccCCCCCcCccChHH
Confidence 5678899999999999999999999999999999999999999999999986543211 1123468999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCCCCCCCHHHHHHHHhcc-CCCCCCCC--
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPESPRLSSSCKALISNIL-SPVKFRIQ-- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~s~~~~~li~~~l-~~~~~R~~-- 160 (347)
+.+..++ .++|+||+|+++|+|++|..||.+.+.......+.... ....+..+++++.+++..|+ .+|..|++
T Consensus 173 ~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 173 LNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred hcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 9887766 57999999999999999999998876654444443322 11234567889999999999 79999999
Q ss_pred ---HHHHhcCCCCCCCC
Q psy10462 161 ---MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ---~~eil~~p~~~~~~ 174 (347)
+++++.|+|++.-.
T Consensus 252 ~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 252 EEGAGEVKRHPFFRNMN 268 (285)
T ss_pred ccChHHHHcChhhhcCC
Confidence 88999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=218.50 Aligned_cols=165 Identities=27% Similarity=0.527 Sum_probs=136.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++++..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 115 l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 189 (292)
T cd06658 115 MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-----PKRKSLVGTPYWMAPEV 189 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----ccCceeecCccccCHHH
Confidence 4678899999999999999999999999999999999999999999999986543211 11223568899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+|+++|+|++|..||.+.+..+....+..... .+.....+..+++++..|+ .+|.+||++++
T Consensus 190 ~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 268 (292)
T cd06658 190 ISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQE 268 (292)
T ss_pred HccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHH
Confidence 9877666 679999999999999999999998776666555544322 2233457889999999999 79999999999
Q ss_pred HhcCCCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSNPV 177 (347)
Q Consensus 164 il~~p~~~~~~~~~ 177 (347)
+++|||+.....+.
T Consensus 269 il~~~~~~~~~~~~ 282 (292)
T cd06658 269 LLQHPFLKLAGPPS 282 (292)
T ss_pred HhhChhhhccCCcc
Confidence 99999998766554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=221.63 Aligned_cols=174 Identities=28% Similarity=0.509 Sum_probs=133.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .........|+..|+|||.
T Consensus 104 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~ 182 (334)
T cd07855 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE-HKYFMTEYVATRWYRAPEL 182 (334)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC-CCcccccccccccccChHH
Confidence 567899999999999999999999999999999999999999999999999765432211 1111234568899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---------------------CC---C------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---------------------FP---E------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------------~~---~------ 136 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+....+..+..... ++ .
T Consensus 183 ~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (334)
T cd07855 183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKI 262 (334)
T ss_pred hcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHH
Confidence 86643334679999999999999999999987765433322221100 00 0
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVGKSK 181 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~~~~~~ 181 (347)
.+..+.++++++++|| .+|.+||++++++.|||+..-..+.....
T Consensus 263 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~ 308 (334)
T cd07855 263 FPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPT 308 (334)
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccccc
Confidence 1346789999999999 79999999999999999987665554433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=216.87 Aligned_cols=160 Identities=24% Similarity=0.473 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++....... .....|++.|+|||.
T Consensus 94 l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~y~aPE~ 166 (279)
T cd05633 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEV 166 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-------ccCcCCCcCccCHHH
Confidence 5678899999999999999999999999999999999999999999999986543211 123468999999999
Q ss_pred ccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC---
Q psy10462 87 LKG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY--SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI--- 159 (347)
Q Consensus 87 ~~~-~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~--- 159 (347)
+.+ ..++ .++|+||+||++|+|++|..||..... ...............+..++.+++++++.|| .+|.+|+
T Consensus 167 ~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 245 (279)
T cd05633 167 LQKGTAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCL 245 (279)
T ss_pred hcCCCCCC-chhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCC
Confidence 864 3344 679999999999999999999975432 1222222222222334568899999999999 7999999
Q ss_pred --CHHHHhcCCCCCCCC
Q psy10462 160 --QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 --~~~eil~~p~~~~~~ 174 (347)
+++++++|||++...
T Consensus 246 ~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 246 GRGAQEVKEHVFFKGID 262 (279)
T ss_pred CCCHHHHHhCccccCCC
Confidence 699999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=216.46 Aligned_cols=161 Identities=27% Similarity=0.423 Sum_probs=127.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++......... .....+++.|+||
T Consensus 106 ~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~aP 180 (295)
T cd07837 106 PLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-----YTHEIVTLWYRAP 180 (295)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccc-----cCCcccccCCCCh
Confidence 3577899999999999999999999999999999999998 889999999998765321111 1123467889999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC---------------------------CC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP---------------------------ES 137 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------------------------~~ 137 (347)
|.+.+......++|+||+|+++|+|++|..||.+.+..+....+......| ..
T Consensus 181 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (295)
T cd07837 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAV 260 (295)
T ss_pred HHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhc
Confidence 988764433468999999999999999999998776554444332211100 01
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 171 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~ 171 (347)
+.++..+.+++.+|| .+|..||++++++.|||++
T Consensus 261 ~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 261 PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 357888999999999 7999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=216.11 Aligned_cols=160 Identities=23% Similarity=0.471 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++...... ......|+..|+|||.
T Consensus 94 l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~ 166 (278)
T cd05606 94 FSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------KPHASVGTHGYMAPEV 166 (278)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-------CCcCcCCCcCCcCcHH
Confidence 567899999999999999999999999999999999999999999999998654321 1123468999999999
Q ss_pred ccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC--
Q psy10462 87 LKGV-PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-- 159 (347)
Q Consensus 87 ~~~~-~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-- 159 (347)
+.+. .++ .++|+||+|+++|+|++|+.||.+.. ........ .....+.+...+..+.+++.+|+ .+|..|+
T Consensus 167 ~~~~~~~~-~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~ 244 (278)
T cd05606 167 LQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 244 (278)
T ss_pred hcCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCC
Confidence 8754 344 67999999999999999999998763 22222222 22223334557899999999999 7899999
Q ss_pred ---CHHHHhcCCCCCCCCC
Q psy10462 160 ---QMEDIRQDPWLKEDSN 175 (347)
Q Consensus 160 ---~~~eil~~p~~~~~~~ 175 (347)
+++++++|||++....
T Consensus 245 ~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 245 LGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred CCCCHHHHHhCccccCCCc
Confidence 9999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=224.71 Aligned_cols=163 Identities=31% Similarity=0.512 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......... .....+||+.|+|||.
T Consensus 99 l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~gt~~y~aPE~ 174 (331)
T cd05624 99 LPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV----QSSVAVGTPDYISPEI 174 (331)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce----eeccccCCcccCCHHH
Confidence 456789999999999999999999999999999999999999999999999765432111 1223579999999999
Q ss_pred ccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCC-CCCCCHHHHHHHHhccCCCCC
Q psy10462 87 LKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPE-SPRLSSSCKALISNILSPVKF 157 (347)
Q Consensus 87 ~~~-----~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~-~~~~s~~~~~li~~~l~~~~~ 157 (347)
+.+ ..++ .++|+||+||++|+|++|+.||.+.+..+....+.... .+|. ...++.++++++.+||..+..
T Consensus 175 ~~~~~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~ 253 (331)
T cd05624 175 LQAMEDGMGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRER 253 (331)
T ss_pred HhccccCCCCCC-CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchh
Confidence 875 2333 57999999999999999999999888777766664422 2222 235789999999999954333
Q ss_pred ---CCCHHHHhcCCCCCCCC
Q psy10462 158 ---RIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 158 ---R~~~~eil~~p~~~~~~ 174 (347)
|++++++++|||+....
T Consensus 254 ~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 254 RLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred hcCCCCHHHHhcCCCcCCCC
Confidence 56899999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=214.29 Aligned_cols=162 Identities=23% Similarity=0.481 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+...++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++......... ........++..|+|||.
T Consensus 103 l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~ 180 (266)
T cd06651 103 LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS--GTGIRSVTGTPYWMSPEV 180 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc--CCccccCCccccccCHHH
Confidence 456788899999999999999999999999999999999999999999998754321110 111123457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-CCCCCHHHHHHHHhccCCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-SPRLSSSCKALISNILSPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~~~~li~~~l~~~~~R~~~~eil 165 (347)
+.+...+ .++|+||+||++|++++|+.||.+.+..+...........|. +..+++.+++++++++.+|.+||++++++
T Consensus 181 ~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 181 ISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELL 259 (266)
T ss_pred hCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHHHHhcCChhhCcCHHHHh
Confidence 9887665 679999999999999999999987765554444433222222 34568889999976668999999999999
Q ss_pred cCCCCC
Q psy10462 166 QDPWLK 171 (347)
Q Consensus 166 ~~p~~~ 171 (347)
+|||++
T Consensus 260 ~hp~~~ 265 (266)
T cd06651 260 RHPFAQ 265 (266)
T ss_pred cCcccc
Confidence 999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=220.74 Aligned_cols=134 Identities=21% Similarity=0.284 Sum_probs=119.2
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC--eEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--RVY 267 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~ 267 (347)
..++...+.+|+|+||+||++.+.++|+..|+|.+..... .. .+.+.+|+.+|++++|||||+++|.....+ .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 4568889999999999999999999999999999976521 11 556789999999999999999999755544 699
Q ss_pred EEEEecCCCChHHHHHhCC-CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
|.|||+++|+|.+++++.+ .++|+.++.+.+|++ |+.|+|++|||||||||+|||+++.
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~ 153 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS 153 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC
Confidence 9999999999999998866 899999999999877 9999999999999999999999984
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=223.01 Aligned_cols=159 Identities=24% Similarity=0.475 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... ......+++.|+|||.
T Consensus 115 l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~ 188 (353)
T cd07850 115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF------MMTPYVVTRYYRAPEV 188 (353)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC------CCCCCcccccccCHHH
Confidence 4668889999999999999999999999999999999999999999999997653211 1223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------------------------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------------------------ 136 (347)
+.+..++ .++|+||+||++|+|++|+.||...+.......+......|.
T Consensus 189 ~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (353)
T cd07850 189 ILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELF 267 (353)
T ss_pred HhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhC
Confidence 9887776 679999999999999999999987765444333322111100
Q ss_pred ------------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCC
Q psy10462 137 ------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 137 ------------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~ 172 (347)
+...++.+++++.+|| .+|.+||++++++.|||+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 268 PDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred cccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 1123557899999999 79999999999999998863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=231.58 Aligned_cols=161 Identities=30% Similarity=0.509 Sum_probs=133.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+|.....|-+||++||.|||++.|+|||||-+|+|++. .|.+||+|||-++.+..- .+..+++.||..|||||+
T Consensus 673 NEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-----nP~TETFTGTLQYMAPEv 747 (1226)
T KOG4279|consen 673 NESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-----NPCTETFTGTLQYMAPEV 747 (1226)
T ss_pred chhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-----CccccccccchhhhChHh
Confidence 55777889999999999999999999999999999974 688999999999877543 344678999999999999
Q ss_pred ccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 87 LKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 87 ~~~~~-~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
+..++ .++.++|||||||++.||.||++||-..... ..+-++.- ..-.|.|..+|.+++++|.+|. .+|..||++.
T Consensus 748 IDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~ 827 (1226)
T KOG4279|consen 748 IDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAK 827 (1226)
T ss_pred hccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHH
Confidence 97554 3347899999999999999999999765432 22333321 2335667789999999999999 7899999999
Q ss_pred HHhcCCCCCCC
Q psy10462 163 DIRQDPWLKED 173 (347)
Q Consensus 163 eil~~p~~~~~ 173 (347)
+++.+||+...
T Consensus 828 ~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 828 DLLQDPFLQHN 838 (1226)
T ss_pred HhccCcccccC
Confidence 99999999876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=215.70 Aligned_cols=157 Identities=24% Similarity=0.388 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......... .......+++.|+|||.
T Consensus 121 l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 197 (283)
T cd05048 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEA 197 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccc---cccCCCcccccccCHHH
Confidence 456788899999999999999999999999999999999999999999998754322110 11123346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+.++...+.+...+.++.+++..|+ .+|..||++.++
T Consensus 198 ~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 198 ILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred hccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 8877766 68999999999999998 99999998888888888776666666788999999999999 689999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
.++
T Consensus 277 ~~~ 279 (283)
T cd05048 277 HTR 279 (283)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=220.24 Aligned_cols=169 Identities=25% Similarity=0.453 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+++++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......... ........|++.|+|||.
T Consensus 102 ~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~g~~~y~aPE~ 180 (332)
T cd07857 102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN-AGFMTEYVATRWYRAPEI 180 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccc-cccccCcccCccccCcHH
Confidence 5678899999999999999999999999999999999999999999999997654322111 111233568999999998
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC------------------------------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------------------------E 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------------------------~ 136 (347)
+.+....+.++|+||+|+++|++++|..||.+.+....+..+......| .
T Consensus 181 ~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (332)
T cd07857 181 MLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESI 260 (332)
T ss_pred HhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhh
Confidence 7664323368999999999999999999998776544433322211100 1
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+..+..+++++.+|| .+|..||++++++.|||+.+-..+
T Consensus 261 ~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 261 FPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 1235788999999999 699999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=217.31 Aligned_cols=157 Identities=17% Similarity=0.299 Sum_probs=122.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc--cccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~gt~~y~aP 84 (347)
+.+..++.++.|++.||+|||+++|+||||||+|||++.++.++|+|||+|+....+.... .........||+.|+||
T Consensus 123 ~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ap 202 (294)
T PHA02882 123 KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGL 202 (294)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCH
Confidence 4567788999999999999999999999999999999999999999999998764322111 11122345799999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHH--------HHHHHhccCCCCCCCCCHHHHHHHHhcc-CC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SEL--------LKQVQKRVVFPESPRLSSSCKALISNIL-SP 154 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~--------~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~ 154 (347)
|++.+..++ .++|+||+||++|+|++|+.||.+.+. .+. ..++..+. ...+..++.+.++++.|+ .+
T Consensus 203 e~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 279 (294)
T PHA02882 203 DAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLS 279 (294)
T ss_pred HHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCC
Confidence 999988776 689999999999999999999987632 221 12222211 122345788999999999 79
Q ss_pred CCCCCCHHHHhc
Q psy10462 155 VKFRIQMEDIRQ 166 (347)
Q Consensus 155 ~~~R~~~~eil~ 166 (347)
|..||+.+++.+
T Consensus 280 ~~~rp~~~~l~~ 291 (294)
T PHA02882 280 YEEKPDYDALIK 291 (294)
T ss_pred CCCCCCHHHHHH
Confidence 999999999864
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=224.84 Aligned_cols=142 Identities=23% Similarity=0.308 Sum_probs=125.2
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccccc-hhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQD-VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~-~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
.+.+.+....+...+.+|+|+||+||+|.+. |+. ||+|++......... .+.|.+|+.+|++++|||||+|+|++.
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3556677778888888999999999999886 555 999999866544444 678889999999999999999999999
Q ss_pred eCC-eEEEEEEecCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhcC-ccccCCCCccccccccc
Q psy10462 262 TTH-RVYIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSRC-CYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ~~~-~~~iv~E~~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~~-iiHRDlKp~Nil~~~~~ 327 (347)
++. .++||||||++|+|.+++.. .+.++...+..++-+++ |+.|+|+++ ||||||||+|||++...
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~ 180 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG 180 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC
Confidence 887 79999999999999999976 67899999998888776 999999999 99999999999999886
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=214.59 Aligned_cols=161 Identities=25% Similarity=0.443 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........ .......|+..|+|||.
T Consensus 96 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~ 171 (286)
T cd07832 96 LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP----RLYSHQVATRWYRAPEL 171 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----CccccccCcccccCcee
Confidence 56789999999999999999999999999999999999999999999999876543211 11223468899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------------------C---------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--------------------E---------S 137 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------------------~---------~ 137 (347)
+.+....+.++|+||+|+++|+|++|..||.+.+..+....+......+ . .
T Consensus 172 ~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (286)
T cd07832 172 LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIF 251 (286)
T ss_pred eeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhC
Confidence 8765544478999999999999999999998776555544443321111 0 1
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 171 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~ 171 (347)
+..+..+.++++.|| .+|.+||+++++++||||.
T Consensus 252 ~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 252 PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 245688999999999 6999999999999999973
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=214.08 Aligned_cols=159 Identities=30% Similarity=0.493 Sum_probs=125.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||+|||+.+++|+||+|+||+++.++.+||+|||++......... .....+++.|+|||.
T Consensus 97 l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~ 171 (284)
T cd07860 97 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-----YTHEVVTLWYRAPEI 171 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-----cccccccccccCCeE
Confidence 567889999999999999999999999999999999999999999999998754322111 122346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-------------------C---------CCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-------------------P---------ESP 138 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------------------~---------~~~ 138 (347)
+.+....+.++|+||||+++|+|+||+.||.+.+......++.+.... + ..+
T Consensus 172 ~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (284)
T cd07860 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVP 251 (284)
T ss_pred EecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcc
Confidence 877554446799999999999999999999876654433332221110 0 013
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.+++++++++.+|+ .+|.+||+++++++||||
T Consensus 252 ~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 252 PLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 46788999999999 699999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=230.78 Aligned_cols=145 Identities=11% Similarity=0.221 Sum_probs=126.8
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|+..+.||+|+||+||+|.+..+++.||+|++++...........+.+|+.++++++||||+++++++++.+.+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36788899999999999999999999999999997654333344556778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|||+||+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~---~vkL~DFG 146 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG---HVKLSDFG 146 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC---CEEEeecc
Confidence 9999999999998888999999998888766 99999999999999999999998765 34555444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=213.87 Aligned_cols=163 Identities=24% Similarity=0.433 Sum_probs=134.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||++........ ......|++.|+|||
T Consensus 94 ~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~y~~PE 168 (274)
T cd06609 94 KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-----KRNTFVGTPFWMAPE 168 (274)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-----ccccccCCccccChh
Confidence 356788999999999999999999999999999999999999999999999977653211 123456788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCC-CCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPR-LSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+||||+++|+|++|+.||...+..+....+........... .+.++.+++.+|+ .+|..||++++
T Consensus 169 ~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~ 247 (274)
T cd06609 169 VIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKE 247 (274)
T ss_pred hhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 99887765 689999999999999999999988776665555554433222233 7889999999999 79999999999
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
+++|||+....
T Consensus 248 il~~~~~~~~~ 258 (274)
T cd06609 248 LLKHKFIKKAK 258 (274)
T ss_pred HhhChhhcCCC
Confidence 99999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=212.37 Aligned_cols=162 Identities=24% Similarity=0.505 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.|++.||+|||+++++|+||||+||+++.++.++|+|||++......... ........|+..|+|||.
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~ 180 (265)
T cd06652 103 LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS--GTGMKSVTGTPYWMSPEV 180 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccccc--ccccccCCCCccccChhh
Confidence 355778999999999999999999999999999999999999999999998754321110 111223458889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-CCCCCCHHHHHHHHhccCCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSSSCKALISNILSPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~~l~~~~~R~~~~eil 165 (347)
+.+...+ .++|+||||+++|+|++|+.||.+.+.......+......+ .+..++..+.+++++|+.+|..||++++++
T Consensus 181 ~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~p~~Rp~~~~il 259 (265)
T cd06652 181 ISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADELL 259 (265)
T ss_pred hcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcChhhCCCHHHHh
Confidence 9876665 67999999999999999999998765554444443332222 234678899999999998899999999999
Q ss_pred cCCCCC
Q psy10462 166 QDPWLK 171 (347)
Q Consensus 166 ~~p~~~ 171 (347)
+|||+.
T Consensus 260 ~~~~~~ 265 (265)
T cd06652 260 RHTFVH 265 (265)
T ss_pred cCcccC
Confidence 999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=214.10 Aligned_cols=137 Identities=14% Similarity=0.235 Sum_probs=121.4
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC--CeE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT--HRV 266 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~ 266 (347)
+.++|+....|++|+||.||+|+++.|++.||+|.++... ..+...-...|||.+|.+++|||||.+.++.... +.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 5678999999999999999999999999999999997654 3333444567999999999999999999987654 679
Q ss_pred EEEEEecCCCChHHHHHhCC-CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||||+. ||..+|...+ +|++.+++.++.|++ |+.|+|+..|+||||||+|+|+...+
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G 214 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG 214 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC
Confidence 999999998 9999997754 999999999988876 99999999999999999999998877
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=214.16 Aligned_cols=160 Identities=23% Similarity=0.459 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ......|+..|+|||.
T Consensus 92 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~ 164 (279)
T cd06619 92 IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-------IAKTYVGTNAYMAPER 164 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-------cccCCCCChhhcCcee
Confidence 466888999999999999999999999999999999999999999999998755321 1234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-------SELLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-------~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
+.+..++ .++|+||+|+++|+|++|+.||..... .+....+..... .......++++++++.+|+ .+|..
T Consensus 165 ~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 243 (279)
T cd06619 165 ISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKE 243 (279)
T ss_pred ecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhh
Confidence 9887665 679999999999999999999965321 122222222211 1123457889999999999 78999
Q ss_pred CCCHHHHhcCCCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 158 R~~~~eil~~p~~~~~~ 174 (347)
||+++++++|||+....
T Consensus 244 Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 244 RPAPENLMDHPFIVQYN 260 (279)
T ss_pred CCCHHHHhcCccccccc
Confidence 99999999999997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=208.18 Aligned_cols=165 Identities=30% Similarity=0.550 Sum_probs=135.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.++.|+.|..+|+.||.|||++|||.||+|.+|+|+|..|++||.|+|+++.--.+ ....+++||||.|.|||
T Consensus 347 klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~-----gd~tstfcgtpnyiape 421 (593)
T KOG0695|consen 347 KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-----GDTTSTFCGTPNYIAPE 421 (593)
T ss_pred cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC-----CcccccccCCCcccchh
Confidence 3567899999999999999999999999999999999999999999999999754322 33457899999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD-------DTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~-------~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
+++|..|. ..+|+|++|++|+||+.|+.||+ +.+.++.+-++.-..+...+..+|-.+...++..| .||..
T Consensus 422 ilrgeeyg-fsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~e 500 (593)
T KOG0695|consen 422 ILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKE 500 (593)
T ss_pred hhcccccC-ceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHH
Confidence 99999887 78999999999999999999996 23445555444332233345567777888888888 68877
Q ss_pred CC------CHHHHhcCCCCCCCCCC
Q psy10462 158 RI------QMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 158 R~------~~~eil~~p~~~~~~~~ 176 (347)
|. .+.++..|+||+...+.
T Consensus 501 rlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 501 RLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred hcCCCcccchhhhhcchhhhhCCHH
Confidence 64 46899999999977654
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=231.42 Aligned_cols=160 Identities=28% Similarity=0.467 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccccc
Q psy10462 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 88 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 88 (347)
..+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||++.
T Consensus 266 ~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~ 341 (501)
T PHA03210 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE----AFDYGWVGTVATNSPEILA 341 (501)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc----cccccccCCcCCCCchhhc
Confidence 467888999999999999999999999999999999999999999999976543211 1123457999999999999
Q ss_pred CCCCCCChhhHHHHHHHHHHHHcCCCC-CCCC--CHHHHHHHHHhccC-----CCC------------------------
Q psy10462 89 GVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDT--NYSELLKQVQKRVV-----FPE------------------------ 136 (347)
Q Consensus 89 ~~~~~~~~~Dvws~G~~l~~ll~g~~p-f~~~--~~~~~~~~i~~~~~-----~~~------------------------ 136 (347)
+..++ .++|||||||++|+|++|..+ |.+. +....+..+..... +|.
T Consensus 342 ~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~ 420 (501)
T PHA03210 342 GDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPL 420 (501)
T ss_pred CCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhH
Confidence 88776 689999999999999998764 4322 12222222211110 110
Q ss_pred --CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 137 --SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 137 --~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
...++.+..+++..|| .||.+||++.|++.||||...
T Consensus 421 ~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 421 IRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 1124556778899999 799999999999999999764
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=234.30 Aligned_cols=141 Identities=18% Similarity=0.190 Sum_probs=128.0
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCe
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 265 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 265 (347)
.+..++|.+.+.+|+|+||+|+++..+.+++.||||+++|...-.....+..+.|.+|+... +||++++++.+|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 45678899999999999999999999999999999999988776666678888999999887 69999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
+|+||||+.||| .-.+++.+.|+|..|++|++++. ||.|+|++|||+||||.+|||||+.|+
T Consensus 444 l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 444 LFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred EEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc
Confidence 999999999999 44455668999999999999765 999999999999999999999999985
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=230.86 Aligned_cols=144 Identities=12% Similarity=0.198 Sum_probs=127.0
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
.|+..+.||+|+||+||+|++..+++.||+|++++...........+.+|+.++++++|||||+++++|.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 47788999999999999999999999999999976544444445667899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||+||+|.+++.+.+.+++..++.++.|++ ++.|+|++||+||||||+|||++.++ ++.+...|
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~---~~kL~DFG 146 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG---HIKLTDFG 146 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC---CEEEeeCc
Confidence 999999999998888999999998888776 99999999999999999999997654 45555554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=225.55 Aligned_cols=135 Identities=21% Similarity=0.309 Sum_probs=123.6
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|.+.+.+|+|+||.||+|+.+.|.+.||+|.+.|....+. ..+.+.+|++|+++++|||||.++++|++..++++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 467888999999999999999999999999999988765433 3456789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||.| ||+.+|...+.++|+.++.++.++. |+.|+|+.+|+|||+||.||||+.++
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~ 137 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG 137 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC
Confidence 99997 9999999999999999999988655 99999999999999999999998766
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=211.65 Aligned_cols=157 Identities=23% Similarity=0.410 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++......... .......+++.|+|||.
T Consensus 109 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~ 185 (272)
T cd05075 109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY---RQGRIAKMPVKWIAIES 185 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccce---ecCCcccCCcccCCHHH
Confidence 456788999999999999999999999999999999999999999999999765432211 11122345678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |+.||.+....+....+..+...+.++..+..+++++.+|+ .+|..||+++++
T Consensus 186 ~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 264 (272)
T cd05075 186 LADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264 (272)
T ss_pred ccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 9877666 67999999999999999 89999988877777777776655566678899999999999 699999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 265 ~~~ 267 (272)
T cd05075 265 RCE 267 (272)
T ss_pred HHH
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=242.70 Aligned_cols=143 Identities=16% Similarity=0.236 Sum_probs=132.6
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
......++|++.+.||+|+||.|.+++++.|++.||+|++++..+.......+|..|-.||.-.+.+-||+++.+|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34567899999999999999999999999999999999999866655556778999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++|+||||++||||..+|.+..++||+.|+||++.+. ++.-+|+.|.|||||||+|||||..|
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC
Confidence 9999999999999999999888999999999988654 99999999999999999999999988
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=214.91 Aligned_cols=162 Identities=26% Similarity=0.463 Sum_probs=133.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++++..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 186 (296)
T cd06655 112 MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEV 186 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-----cCCCcCCCccccCcch
Confidence 46688999999999999999999999999999999999999999999999876543211 1223468889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+...+ .++|+|||||++|++++|+.||.+.+.......+.... ....+..+++.+++++++|+ .+|..||++++
T Consensus 187 ~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 265 (296)
T cd06655 187 VTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKE 265 (296)
T ss_pred hcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHH
Confidence 9876665 67999999999999999999998877655544443322 22344568899999999999 68999999999
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
++.|||+....
T Consensus 266 il~~~~~~~~~ 276 (296)
T cd06655 266 LLQHPFLKLAK 276 (296)
T ss_pred HhhChHhhhcc
Confidence 99999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=229.99 Aligned_cols=144 Identities=14% Similarity=0.213 Sum_probs=125.2
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|++.+.||.|+||+||+|.+..+++.||+|++.+.........+.+.+|++++++++|||||+++++|++++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 57788999999999999999999999999999865433333334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||+||+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++ ++.+...|
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~---~~kl~DfG 146 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG---HIKLSDFG 146 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC---CEEEeecc
Confidence 999999999998888999999998888766 99999999999999999999997655 34444443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=212.02 Aligned_cols=156 Identities=28% Similarity=0.577 Sum_probs=126.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-cEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+.++++..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...... ....|+..|+||
T Consensus 105 ~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---------~~~~~~~~y~aP 175 (267)
T PHA03390 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---------SCYDGTLDYFSP 175 (267)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---------ccCCCCCcccCh
Confidence 467799999999999999999999999999999999999988 9999999998755321 123578899999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHh--ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL-LKQVQK--RVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~-~~~i~~--~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
|.+.+..++ .++|+||+|+++|+|++|+.||........ ...+.. ....+.....++.+++++..|| .+|.+|++
T Consensus 176 E~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 254 (267)
T PHA03390 176 EKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT 254 (267)
T ss_pred hhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCc
Confidence 999887776 679999999999999999999985543221 111111 1122334468999999999999 68999996
Q ss_pred -HHHHhcCCCCC
Q psy10462 161 -MEDIRQDPWLK 171 (347)
Q Consensus 161 -~~eil~~p~~~ 171 (347)
.+++++|||+.
T Consensus 255 ~~~~~l~h~~~~ 266 (267)
T PHA03390 255 NYNEIIKHPFLK 266 (267)
T ss_pred hHHHHhcCCccc
Confidence 69999999986
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=213.34 Aligned_cols=168 Identities=22% Similarity=0.365 Sum_probs=132.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.++++++..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ......+++.|+|||
T Consensus 98 ~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE 172 (298)
T cd07841 98 VLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-----KMTHQVVTRWYRAPE 172 (298)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-----cccccccceeeeCHH
Confidence 366788999999999999999999999999999999999999999999999876543211 112234678899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---------------------------CC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---------------------------SP 138 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------~~ 138 (347)
.+.+....+.++|+||+||++|+|++|..||.+.+..+....+......|. ..
T Consensus 173 ~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T cd07841 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFP 252 (298)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcc
Confidence 986544334689999999999999999888887665544444432211110 12
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 178 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~~~ 178 (347)
..+..+.+++.+|+ .+|..||++.+++.||||.+...+..
T Consensus 253 ~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 253 AASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 34678999999999 79999999999999999999776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=230.09 Aligned_cols=144 Identities=13% Similarity=0.237 Sum_probs=127.0
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
.|+..+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++++++|||||+++++|.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 47788999999999999999999999999999976543334445667899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||++|+|.+++.+.+.+++..++.++.|++ ++.|+|++||+||||||+|||++.++ ++.++..|
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g---~~kL~DFG 146 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG---HIKLTDFG 146 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC---CEEEeECC
Confidence 999999999998888899999999888766 99999999999999999999998765 35555554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=209.52 Aligned_cols=157 Identities=20% Similarity=0.337 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.+.+++.|++.||+|||++|++||||||+||+++.++.+||+|||++............ .....++..|+|||.
T Consensus 92 ~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--~~~~~~~~~y~aPE~ 169 (257)
T cd05116 92 VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA--KTHGKWPVKWYAPEC 169 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee--cCCCCCCccccCHhH
Confidence 567889999999999999999999999999999999999999999999999765432211111 112234578999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+.++...+.+...+++++++++.|+ .+|..||++.++
T Consensus 170 ~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i 248 (257)
T cd05116 170 MNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248 (257)
T ss_pred hccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence 8776655 57999999999999997 99999988888888888776655566778999999999999 699999999988
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
..
T Consensus 249 ~~ 250 (257)
T cd05116 249 EL 250 (257)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=219.35 Aligned_cols=160 Identities=26% Similarity=0.452 Sum_probs=125.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.+..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... ......|++.|+|||
T Consensus 100 ~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-------~~~~~~~~~~y~aPE 172 (333)
T cd06650 100 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------MANSFVGTRSYMSPE 172 (333)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-------ccccCCCCccccCHH
Confidence 34577889999999999999985 7999999999999999999999999998654321 123456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------------------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ------------------------------------ 129 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~------------------------------------ 129 (347)
.+.+..++ .++|+||+||++|+|++|+.||......+....+.
T Consensus 173 ~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (333)
T cd06650 173 RLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAI 251 (333)
T ss_pred HhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccH
Confidence 99887666 67999999999999999999998655433322110
Q ss_pred --------hccC-CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 130 --------KRVV-FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 130 --------~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.... .......+.++++++.+|| .+|.+||++++++.|||++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 252 FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred HHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000 0011235788999999999 7999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=221.86 Aligned_cols=239 Identities=18% Similarity=0.219 Sum_probs=169.2
Q ss_pred cccccccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 80 AYASPEILKGVPY-TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 80 ~y~aPE~~~~~~~-~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
.+++||...|.-. -...++-|+|+.++++-..+. +=....... ......+...+ ..-.....+.+..|+ ..+..
T Consensus 96 ~ll~p~~~~G~flvR~se~~~g~yslsv~~~~~~~-~~~~v~hyr-i~~~~~~~~~~--~~~~~~~F~~l~~lv~~~~~~ 171 (468)
T KOG0197|consen 96 QLLAPENKEGAFLVRESESDKGDYSLSVREGDSGG-LGAKVKHYR-IRQLDGGGLYP--YIDERELFSSLQQLVNYYSKN 171 (468)
T ss_pred hhcCCCCCccceeeecccCCcCCeeEEEEeccccC-Cccceeeee-eeEcCCCCeec--CCCHHHhhhhHHHHHhhhhcc
Confidence 5677877655432 112367888888888776554 000000000 00000110110 001123344455555 45666
Q ss_pred CCCHHHHhcCCCCCCC-CCCCCCCCCCCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhh
Q psy10462 158 RIQMEDIRQDPWLKED-SNPVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKK 236 (347)
Q Consensus 158 R~~~~eil~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~ 236 (347)
++.....+..|-.... ..|.........|.++++.+++.+.||+|.||.|++|.+..+ ..||+|.++...+. .+
T Consensus 172 ~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~----~~ 246 (468)
T KOG0197|consen 172 ADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS----PE 246 (468)
T ss_pred CcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC----hh
Confidence 6666666666654332 223333333678899999999999999999999999998643 36999999754333 35
Q ss_pred chHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhcCccc
Q psy10462 237 FLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSRCCYQ 313 (347)
Q Consensus 237 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~~iiH 313 (347)
.|.+|++||++|+|+|||++++++..++++|||||||+.|+|.++|+. ++.+.-.+...+++||+ |++||.++++||
T Consensus 247 ~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IH 326 (468)
T KOG0197|consen 247 AFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIH 326 (468)
T ss_pred HHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccc
Confidence 566999999999999999999999999999999999999999999986 56788899889999888 899999999999
Q ss_pred cCCCCccccccccc
Q psy10462 314 DHIQDLSCFQEQAT 327 (347)
Q Consensus 314 RDlKp~Nil~~~~~ 327 (347)
|||.++|||++++.
T Consensus 327 RDLAARNiLV~~~~ 340 (468)
T KOG0197|consen 327 RDLAARNILVDEDL 340 (468)
T ss_pred hhhhhhheeeccCc
Confidence 99999999998876
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=215.09 Aligned_cols=162 Identities=25% Similarity=0.450 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+...++..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 113 ~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 187 (296)
T cd06654 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYWMAPEV 187 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-----cccCcccCCccccCHHH
Confidence 4557889999999999999999999999999999999999999999999987543211 11223468899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+...+ .++|+|||||++|+|++|+.||...+.......+.... ..+.+..++..+.+++.+|+ .+|..||++++
T Consensus 188 ~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 266 (296)
T cd06654 188 VTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266 (296)
T ss_pred HcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHH
Confidence 9876665 67999999999999999999998776544433332221 12234567889999999999 69999999999
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
+++|||+....
T Consensus 267 il~~~~~~~~~ 277 (296)
T cd06654 267 LLQHQFLKIAK 277 (296)
T ss_pred HhhChhhhccC
Confidence 99999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=212.23 Aligned_cols=162 Identities=24% Similarity=0.446 Sum_probs=130.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .......+++.|+|||.
T Consensus 107 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 181 (292)
T cd06644 107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-----QRRDSFIGTPYWMAPEV 181 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-----cccceecCCccccCcee
Confidence 5678899999999999999999999999999999999999999999999986543211 11123457889999999
Q ss_pred ccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~~-----~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
+.+ ..++ .++|+|||||++|+|++|..||.+.+..+....+..... .+.+..++.++.+++++|+ .+|..|
T Consensus 182 ~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 260 (292)
T cd06644 182 VMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR 260 (292)
T ss_pred eccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccC
Confidence 853 2233 579999999999999999999988776655555543322 2234567889999999999 699999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
|+++++++|||+....
T Consensus 261 p~~~~il~~~~~~~~~ 276 (292)
T cd06644 261 PSAAQLLEHPFVSSVT 276 (292)
T ss_pred cCHHHHhcCccccccc
Confidence 9999999999986544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=229.14 Aligned_cols=136 Identities=13% Similarity=0.238 Sum_probs=122.9
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|+..+.||.|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||++++++|++++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 57888999999999999999999999999999976443333445567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||++|+|.+++...+.+++..++.++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~ 138 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG 138 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC
Confidence 999999999998888999999999988776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=212.77 Aligned_cols=163 Identities=24% Similarity=0.490 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++++..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 112 ~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 186 (285)
T cd06648 112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-----PRRKSLVGTPYWMAPEV 186 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-----cccccccCCccccCHHH
Confidence 4568889999999999999999999999999999999999999999999876543211 11223468899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--PESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+|+++|+|++|+.||.+.+..+....+...... ..+...+..+.++++.|+ .+|..||++++
T Consensus 187 ~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 187 ISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred hcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 9877665 6799999999999999999999887776666666554221 122347889999999999 78999999999
Q ss_pred HhcCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSN 175 (347)
Q Consensus 164 il~~p~~~~~~~ 175 (347)
+++|||+.....
T Consensus 266 il~~~~~~~~~~ 277 (285)
T cd06648 266 LLNHPFLAKAGP 277 (285)
T ss_pred HccCcccccCCC
Confidence 999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=213.50 Aligned_cols=160 Identities=20% Similarity=0.347 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.++.++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++........ ......|+..|+|||.
T Consensus 125 ~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 199 (291)
T cd06639 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEV 199 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc-----cccCccCCccccChhh
Confidence 56688899999999999999999999999999999999999999999999876532111 1123457889999999
Q ss_pred ccCCCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 87 LKGVPY----TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 87 ~~~~~~----~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
+..... ...++|+||+||++|+|++|+.||...+..+....+.+... ...+...+..+++++.+|+ .+|..||
T Consensus 200 ~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 279 (291)
T cd06639 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARP 279 (291)
T ss_pred hcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCc
Confidence 865321 23679999999999999999999988776555555543322 1224457788999999999 7999999
Q ss_pred CHHHHhcCCCCC
Q psy10462 160 QMEDIRQDPWLK 171 (347)
Q Consensus 160 ~~~eil~~p~~~ 171 (347)
++.++++|||++
T Consensus 280 s~~~il~~~~~~ 291 (291)
T cd06639 280 SVTHLLEHPFIK 291 (291)
T ss_pred CHHHHhcCcccC
Confidence 999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=211.79 Aligned_cols=160 Identities=26% Similarity=0.486 Sum_probs=127.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........ ......++..|+|||
T Consensus 96 ~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE 170 (286)
T cd07847 96 GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-----DYTDYVATRWYRAPE 170 (286)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-----cccCcccccccCCHH
Confidence 356788999999999999999999999999999999999999999999999976543211 112345778999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------------------cCCCC---------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--------------------VVFPE--------- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~--------------------~~~~~--------- 136 (347)
.+.+....+.++|+||+|+++|+|++|+.||.+.+..+....+... ...|.
T Consensus 171 ~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T cd07847 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLES 250 (286)
T ss_pred HHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHH
Confidence 9876443346899999999999999999999887655444333221 01111
Q ss_pred -CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 -~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.+.++..+.+++.+|+ .+|.+||++.+++.||||
T Consensus 251 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 251 KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 1245788999999999 699999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=215.13 Aligned_cols=164 Identities=21% Similarity=0.358 Sum_probs=126.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+++++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......... ........++..|+|||
T Consensus 115 ~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~y~aPE 193 (310)
T cd07865 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK-PNRYTNRVVTLWYRPPE 193 (310)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccC-CCCccCcccCccccCcH
Confidence 35778999999999999999999999999999999999999999999999997654322111 11122345788899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--------------------CCC---------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--------------------FPE--------- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--------------------~~~--------- 136 (347)
.+.+......++|+||+|+++|+|++|+.||.+.+.......+..... .+.
T Consensus 194 ~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (310)
T cd07865 194 LLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKER 273 (310)
T ss_pred HhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHh
Confidence 987654333679999999999999999999988766544433332110 000
Q ss_pred --CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 --SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 --~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
....++.+++++..|| .+|.+||+++++++||||
T Consensus 274 l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 274 LKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0112567889999999 799999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=212.87 Aligned_cols=161 Identities=25% Similarity=0.468 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 100 l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~y~~PE~ 174 (280)
T cd06611 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-----QKRDTFIGTPYWMAPEV 174 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-----cccceeecchhhcCHHH
Confidence 5678999999999999999999999999999999999999999999999876543211 11224568899999999
Q ss_pred ccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~~-----~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
+.. .+++ .++|+||+|+++|+|++|+.||.+.+..+....+..... ...+..++.++.+++..|+ .+|..|
T Consensus 175 ~~~~~~~~~~~~-~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (280)
T cd06611 175 VACETFKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDR 253 (280)
T ss_pred HhhcccCCCCCC-ccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhC
Confidence 753 2233 579999999999999999999998877666666655432 2334567899999999999 789999
Q ss_pred CCHHHHhcCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKED 173 (347)
Q Consensus 159 ~~~~eil~~p~~~~~ 173 (347)
|+++++++|||+...
T Consensus 254 ps~~~il~~~~~~~~ 268 (280)
T cd06611 254 PTAAELLKHPFVSDQ 268 (280)
T ss_pred cCHHHHhcChhhccc
Confidence 999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=209.69 Aligned_cols=158 Identities=31% Similarity=0.555 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~ 172 (256)
T cd08218 98 FPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-----LARTCIGTPYYLSPEI 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-----hhhhccCCccccCHHH
Confidence 45678899999999999999999999999999999999999999999999876533211 1123457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+...+ .++|+||||+++++|++|+.||...+..+....+..+...+.+...+.+.++++.+|+ .+|..||++.+++
T Consensus 173 ~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 173 CENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred hCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 9877655 6799999999999999999999988877777776665554556678999999999999 7899999999999
Q ss_pred cCCCC
Q psy10462 166 QDPWL 170 (347)
Q Consensus 166 ~~p~~ 170 (347)
+|||+
T Consensus 252 ~~~~~ 256 (256)
T cd08218 252 EKNFI 256 (256)
T ss_pred hCcCC
Confidence 99996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=213.36 Aligned_cols=158 Identities=36% Similarity=0.661 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+....... .......+++.|+|||.
T Consensus 95 ~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 169 (260)
T PF00069_consen 95 LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-----ENFNPFVGTPEYMAPEV 169 (260)
T ss_dssp BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-----SEBSSSSSSGGGSCHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccccccccccc
Confidence 5668899999999999999999999999999999999999999999999987642111 12234568999999999
Q ss_pred cc-CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc----C--CCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LK-GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV----V--FPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~-~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~----~--~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
+. +...+ .++|+||+|+++|+|++|..||.+.+.......+.+.. . .......++.+.+++..|| .+|++|
T Consensus 170 ~~~~~~~~-~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 248 (260)
T PF00069_consen 170 LQQGKKYT-RKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQR 248 (260)
T ss_dssp HTTTSSBS-THHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGS
T ss_pred cccccccc-ccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHC
Confidence 98 54444 78999999999999999999999874333333222211 1 1111223489999999999 799999
Q ss_pred CCHHHHhcCCCC
Q psy10462 159 IQMEDIRQDPWL 170 (347)
Q Consensus 159 ~~~~eil~~p~~ 170 (347)
|+++++++||||
T Consensus 249 ~~~~~l~~~~~~ 260 (260)
T PF00069_consen 249 PSAEELLKHPWF 260 (260)
T ss_dssp TTHHHHHTSGGG
T ss_pred cCHHHHhcCCCC
Confidence 999999999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=213.79 Aligned_cols=151 Identities=17% Similarity=0.246 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
++...+.+++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... .....|++.|+|||
T Consensus 119 ~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~y~aPE 190 (283)
T PHA02988 119 LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--------PFKNVNFMVYFSYK 190 (283)
T ss_pred CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--------cccccCcccccCHH
Confidence 44577889999999999999984 9999999999999999999999999998754321 11345788999999
Q ss_pred cccC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 86 ILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 86 ~~~~--~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
.+.+ ..++ .++|+|||||++|+|++|+.||.+.+..+....+.. ....+.+...++.+++++.+|+ .+|..||++
T Consensus 191 ~~~~~~~~~~-~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~ 269 (283)
T PHA02988 191 MLNDIFSEYT-IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNI 269 (283)
T ss_pred Hhhhcccccc-chhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCH
Confidence 9976 4455 689999999999999999999999888877777643 3334444468899999999999 799999999
Q ss_pred HHHhc
Q psy10462 162 EDIRQ 166 (347)
Q Consensus 162 ~eil~ 166 (347)
+++++
T Consensus 270 ~ell~ 274 (283)
T PHA02988 270 KEILY 274 (283)
T ss_pred HHHHH
Confidence 99975
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=214.10 Aligned_cols=137 Identities=18% Similarity=0.204 Sum_probs=121.5
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcc-hhhhheeeeeCC----
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN-LIRFLQAIETTH---- 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~---- 264 (347)
.+.|+..+.+|+|+||+||+|+.+.+|+.||+|+++.... ++.......||+.+|++|+|+| ||.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 6778889999999999999999999999999999986532 2445666789999999999999 999999999877
Q ss_pred --eEEEEEEecCCCChHHHHHhCC----CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 265 --RVYIIMEYAKNGSLLEVIRKER----YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 265 --~~~iv~E~~~~G~L~~~l~~~~----~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
.+++|+||++. ||..+++... .++...++.++.|++ |++|||++||+||||||+|||+++.+.
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV 158 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc
Confidence 89999999997 9999997754 588888888888776 999999999999999999999998763
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=229.33 Aligned_cols=144 Identities=12% Similarity=0.244 Sum_probs=126.1
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+++|++++||||+++++.|++++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 57889999999999999999999999999999975433333334567799999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||++|+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++ .+.+...|
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~---~ikL~DFG 146 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG---HIKLTDFG 146 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC---CEEEEeCC
Confidence 999999999998888999999998887765 99999999999999999999998765 35555554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=211.07 Aligned_cols=163 Identities=21% Similarity=0.407 Sum_probs=130.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++.......... ........|+..|+|||.
T Consensus 99 ~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~y~~Pe~ 177 (267)
T cd06610 99 LDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT-RKVRKTFVGTPCWMAPEV 177 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc-ccccccccCChhhcChHH
Confidence 5678899999999999999999999999999999999999999999999987665332211 112234568899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCC---CCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPES---PRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~---~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
+......+.++|+||+|+++|+|++|+.||...+..+.......... .+.. ..+++...+++..|+ .+|..||+
T Consensus 178 ~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (267)
T cd06610 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257 (267)
T ss_pred HccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC
Confidence 87763344689999999999999999999988766555444433321 1111 256889999999999 68999999
Q ss_pred HHHHhcCCCC
Q psy10462 161 MEDIRQDPWL 170 (347)
Q Consensus 161 ~~eil~~p~~ 170 (347)
++++++||||
T Consensus 258 ~~~ll~~p~~ 267 (267)
T cd06610 258 AEELLKHKFF 267 (267)
T ss_pred HHHHhhCCCC
Confidence 9999999996
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=218.44 Aligned_cols=161 Identities=25% Similarity=0.475 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.++++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... .....+++.|+|||.
T Consensus 114 ~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--------~~~~~~~~~y~aPE~ 185 (342)
T cd07879 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--------MTGYVVTRWYRAPEV 185 (342)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--------CCCceeeecccChhh
Confidence 567889999999999999999999999999999999999999999999998654211 123457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC------------------------CCC------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV------------------------FPE------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------------~~~------ 136 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+....+..+..... .+.
T Consensus 186 ~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (342)
T cd07879 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTL 265 (342)
T ss_pred hcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHH
Confidence 87643334689999999999999999999998765444433322111 010
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.+..+..+.+++++|| .+|.+||++++++.||||.....
T Consensus 266 ~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 266 FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 1245778999999999 69999999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=208.51 Aligned_cols=157 Identities=32% Similarity=0.542 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-cEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.+.++..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++....... ......|++.|+|||
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~y~aPE 171 (256)
T cd08220 98 LDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS------KAYTVVGTPCYISPE 171 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc------cccccccCCcccCch
Confidence 46688899999999999999999999999999999998654 57999999997654321 122346788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
.+.+...+ .++|+||+|+++|+|++|..||.+.+.......+......+.+...+..+++++.+|+ .+|..||+++++
T Consensus 172 ~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 250 (256)
T cd08220 172 LCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250 (256)
T ss_pred hccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99876655 6799999999999999999999988877776666665555555678999999999999 699999999999
Q ss_pred hcCCCC
Q psy10462 165 RQDPWL 170 (347)
Q Consensus 165 l~~p~~ 170 (347)
++|||+
T Consensus 251 l~~p~~ 256 (256)
T cd08220 251 MAQPIC 256 (256)
T ss_pred hhCCCC
Confidence 999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=212.63 Aligned_cols=157 Identities=24% Similarity=0.379 Sum_probs=130.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+...++.+++.|++.||.|||++||+||||||+||++++++.+||+|||+++........ .......+++.|+|||.
T Consensus 121 ~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 197 (283)
T cd05091 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEA 197 (283)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchhe---eeccCccCCccccCHHH
Confidence 455778899999999999999999999999999999999999999999998765322110 11122345778999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+||++|+|++ |..||.+....+....+......+.+...+....+++..|+ .+|..||++.++
T Consensus 198 ~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 198 IMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred HhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 9876665 57999999999999998 89999988888888888776655556778999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 277 ~~~ 279 (283)
T cd05091 277 HSR 279 (283)
T ss_pred HHH
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=213.15 Aligned_cols=154 Identities=22% Similarity=0.371 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++....... . ......+..|+|||.
T Consensus 116 l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----~--~~~~~~~~~y~aPE~ 189 (297)
T cd05089 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV----K--KTMGRLPVRWMAIES 189 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCcccccee----c--cCCCCcCccccCchh
Confidence 5567889999999999999999999999999999999999999999999985422110 0 111123457999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+..+...+.+..++..+++++.+|+ .+|..||+++++
T Consensus 190 ~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 190 LNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred hccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9877766 68999999999999997 99999998888888777766655556678999999999999 789999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 269 ~~~ 271 (297)
T cd05089 269 SVQ 271 (297)
T ss_pred HHH
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=210.81 Aligned_cols=156 Identities=19% Similarity=0.354 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++........ .......++..|+|||.
T Consensus 106 ~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~~pE~ 182 (279)
T cd05111 106 LDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK---YFYSEHKTPIKWMALES 182 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc---cccCCCCCcccccCHHH
Confidence 456788999999999999999999999999999999999999999999999765432111 11223456778999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |..||.+....+....+.++...+.+...+.++..++..|+ .+|..||++.++
T Consensus 183 ~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 183 ILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred hccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 9877766 67999999999999998 99999988877766666666555555567788999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 262 ~~ 263 (279)
T cd05111 262 AN 263 (279)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=211.16 Aligned_cols=156 Identities=22% Similarity=0.457 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||++........... .....+++.|+|||.
T Consensus 106 ~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~---~~~~~~~~~y~~PE~ 182 (279)
T cd05109 106 IGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH---ADGGKVPIKWMALES 182 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceee---cCCCccchhhCCHHH
Confidence 45678899999999999999999999999999999999999999999999986643221110 111234678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |..||...........+......+.+...+....+++..|+ .+|..||++.++
T Consensus 183 ~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l 261 (279)
T cd05109 183 ILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFREL 261 (279)
T ss_pred hccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9877766 68999999999999998 99999888777777767666555666778999999999999 699999999999
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
+.
T Consensus 262 ~~ 263 (279)
T cd05109 262 VD 263 (279)
T ss_pred HH
Confidence 84
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=216.11 Aligned_cols=169 Identities=24% Similarity=0.463 Sum_probs=134.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++......... ........+++.|+|||
T Consensus 99 ~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE 176 (330)
T cd07834 99 PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE--KGFLTEYVVTRWYRAPE 176 (330)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc--cccccccccccCcCCce
Confidence 3567888999999999999999999999999999999999999999999999876432110 01122345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-----------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------------------------- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------- 136 (347)
.+.+....+.++|+||+|+++|+|++|+.||.+.+..+....+......+.
T Consensus 177 ~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (330)
T cd07834 177 LLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSK 256 (330)
T ss_pred eeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHH
Confidence 998873334689999999999999999999998877665555443221111
Q ss_pred -CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 -~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+.+++.+.+++.+|| .+|..||+++++++|||+.....+
T Consensus 257 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 257 LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 1236788999999999 699999999999999999876544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=216.31 Aligned_cols=157 Identities=23% Similarity=0.449 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+....+.+++.||+.||+|||++||+||||||+||+++.++.+||+|||++........... .....++..|+|||.
T Consensus 106 ~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~---~~~~~~~~~y~apE~ 182 (316)
T cd05108 106 IGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH---AEGGKVPIKWMALES 182 (316)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCccee---ccCCccceeecChHH
Confidence 34567789999999999999999999999999999999999999999999986643222111 112234668999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |..||.+.+..+....+......|.++..+.+..+++..|+ .+|..||++.++
T Consensus 183 ~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l 261 (316)
T cd05108 183 ILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 261 (316)
T ss_pred hccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9887766 68999999999999997 99999988877766666666666667778899999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+.+
T Consensus 262 ~~~ 264 (316)
T cd05108 262 IIE 264 (316)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=214.32 Aligned_cols=165 Identities=26% Similarity=0.422 Sum_probs=127.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcccc------ccCcccccCCc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK------QNLSETFCGSY 79 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~~~~gt~ 79 (347)
.+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........... ........+++
T Consensus 111 ~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (311)
T cd07866 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190 (311)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceecc
Confidence 467789999999999999999999999999999999999999999999999876543221110 01112335688
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-----------------------
Q psy10462 80 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------------------- 136 (347)
Q Consensus 80 ~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------- 136 (347)
.|+|||.+.+......++|+||+||++|+|++|+.||.+.+.......+......+.
T Consensus 191 ~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (311)
T cd07866 191 WYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP 270 (311)
T ss_pred CcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCC
Confidence 899999887644333679999999999999999999988776555444432111000
Q ss_pred ------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 ------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 ------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
....++.+.+++.+|| .+|.+||++.+++.||||
T Consensus 271 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 271 RTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0234467889999999 799999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=209.45 Aligned_cols=163 Identities=25% Similarity=0.409 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc-ccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD-YKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~gt~~y~aPE 85 (347)
+.++.+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++......... ..........|+..|+|||
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe 178 (265)
T cd06631 99 LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChh
Confidence 456888999999999999999999999999999999999999999999998754321111 0111223456889999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--VVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+..++ .++|+||+|+++|++++|..||...+.......+... ...+.+...+.++.+++++|+ .+|..||+++
T Consensus 179 ~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 257 (265)
T cd06631 179 VINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSAL 257 (265)
T ss_pred hhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHH
Confidence 99887766 6799999999999999999999876654443333322 222334568899999999999 6899999999
Q ss_pred HHhcCCCC
Q psy10462 163 DIRQDPWL 170 (347)
Q Consensus 163 eil~~p~~ 170 (347)
++++|||+
T Consensus 258 ~~l~~~~~ 265 (265)
T cd06631 258 QLLRHDFL 265 (265)
T ss_pred HHhcCCCC
Confidence 99999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=208.26 Aligned_cols=158 Identities=30% Similarity=0.508 Sum_probs=134.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-----hCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCH-----KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH-----~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y 81 (347)
+++.++..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++........ ......|++.|
T Consensus 102 l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~ 176 (265)
T cd08217 102 IEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-----FAKTYVGTPYY 176 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc-----cccccccCCCc
Confidence 456788999999999999999 89999999999999999999999999999876543211 12234688999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
+|||.+.+..++ .++|+||||+++|+|++|+.||...+..+..+.+..+...+.+...+..+.+++..|+ .+|..||+
T Consensus 177 ~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~ 255 (265)
T cd08217 177 MSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPS 255 (265)
T ss_pred cChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCC
Confidence 999999877655 6799999999999999999999988877777777666544455678899999999999 69999999
Q ss_pred HHHHhcCCCC
Q psy10462 161 MEDIRQDPWL 170 (347)
Q Consensus 161 ~~eil~~p~~ 170 (347)
++++++|||+
T Consensus 256 ~~~il~~~~~ 265 (265)
T cd08217 256 TEELLQLPLI 265 (265)
T ss_pred HHHHhhCCCC
Confidence 9999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=217.96 Aligned_cols=163 Identities=24% Similarity=0.431 Sum_probs=131.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... .....++..|+|||
T Consensus 114 ~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--------~~~~~~~~~y~aPE 185 (343)
T cd07851 114 KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--------MTGYVATRWYRAPE 185 (343)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc--------ccCCcccccccCHH
Confidence 3577899999999999999999999999999999999999999999999998765321 12345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-----------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------------------------- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------- 136 (347)
.+.+....+.++|+||+|+++|++++|+.||.+.+..+....+......+.
T Consensus 186 ~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (343)
T cd07851 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKE 265 (343)
T ss_pred HHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHH
Confidence 986543334689999999999999999999988776555554433221111
Q ss_pred -CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 -~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
....+..+.+++++|| .+|.+||+++++++|||+.+-..+
T Consensus 266 ~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 266 VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 1235889999999999 799999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=224.72 Aligned_cols=170 Identities=31% Similarity=0.536 Sum_probs=137.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecc--cCCcccc----------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS--VNNTDYK---------------- 68 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~--~~~~~~~---------------- 68 (347)
|.|+-|+.|+.++.+|+++.|+.|+|||||||+|||||.+|++||.|||||..+. -+...+.
T Consensus 726 FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~ 805 (1034)
T KOG0608|consen 726 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEW 805 (1034)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhh
Confidence 5568899999999999999999999999999999999999999999999985321 1111100
Q ss_pred -------------------ccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy10462 69 -------------------QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129 (347)
Q Consensus 69 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~ 129 (347)
.-....++||+.|+|||++....+. ..+|+||.|++||||+.|+.||.+..+.+...++.
T Consensus 806 ~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~ 884 (1034)
T KOG0608|consen 806 ADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVI 884 (1034)
T ss_pred ccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeee
Confidence 0001125799999999999887776 67899999999999999999999887766554443
Q ss_pred ---hccCCCCCCCCCHHHHHHHHhccCCCCCCC---CHHHHhcCCCCCCCCCCC
Q psy10462 130 ---KRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 130 ---~~~~~~~~~~~s~~~~~li~~~l~~~~~R~---~~~eil~~p~~~~~~~~~ 177 (347)
..+.++....+|++|.++|.++..+++.|. ..+++..||||+..+...
T Consensus 885 nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 885 NWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred ehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 345567778899999999999998887776 467899999999877543
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=218.13 Aligned_cols=166 Identities=26% Similarity=0.465 Sum_probs=129.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.++++..++.|++.||.|||+++++||||||+||+++.++.+||+|||++....... .......++..|+|||
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE 178 (337)
T cd07858 104 TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-----DFMTEYVVTRWYRAPE 178 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-----ccccccccccCccChH
Confidence 35678999999999999999999999999999999999999999999999987653221 1122345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----------------------C-CC------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-----------------------V-FP------ 135 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-----------------------~-~~------ 135 (347)
.+.+......++|+||+||++|+|++|+.||.+.+.......+.... . .+
T Consensus 179 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (337)
T cd07858 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR 258 (337)
T ss_pred HHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH
Confidence 88653323367999999999999999999998765433322221100 0 00
Q ss_pred CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 136 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 136 ~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
..+.+++++++++++|| .+|.+||+++++++|||+.....+
T Consensus 259 ~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 259 LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 12357889999999999 699999999999999999765443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=215.73 Aligned_cols=187 Identities=20% Similarity=0.320 Sum_probs=146.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++..... .....|++.|+|||.
T Consensus 112 l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~y~aPE~ 182 (308)
T cd06634 112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---------ANXFVGTPYWMAPEV 182 (308)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---------cccccCCccccCHHH
Confidence 56788899999999999999999999999999999999999999999999865432 123457889999999
Q ss_pred ccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 87 LKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 87 ~~~---~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
+.+ ...+ .++|+|||||++|+|++|..||.+.+..+....+..... .......+..+++++++|| .+|.+||++
T Consensus 183 ~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~ 261 (308)
T cd06634 183 ILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTS 261 (308)
T ss_pred HhhcccCCCC-cccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCH
Confidence 753 2333 579999999999999999999988766555554444332 2233467889999999999 689999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCCCCccchhhhhhhhhhhcccccchhhhh
Q psy10462 162 EDIRQDPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKL 209 (347)
Q Consensus 162 ~eil~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~fg~V~~ 209 (347)
+++++|||+.....+... .......++..+.++.+.|+.+..
T Consensus 262 ~~ll~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 303 (308)
T cd06634 262 EVLLKHRFVLRERPPTVI------MDLIQRTKDAVRELDNLQYRKMKK 303 (308)
T ss_pred HHHhhCccccccCChhHH------HHHHHHHHHHHHHHHHHHHHHHHh
Confidence 999999999885433211 222344466777888888888664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=216.74 Aligned_cols=168 Identities=23% Similarity=0.373 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.+..++.++.||+.||.|||+.|++||||||+||+++. ++.++++|||++......... ........++..|+|||
T Consensus 111 l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE 188 (342)
T cd07854 111 LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH--KGYLSEGLVTKWYRSPR 188 (342)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccc--ccccccccccccccCHH
Confidence 567899999999999999999999999999999999974 557899999998754321110 11112235788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----------------------------C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-----------------------------E 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----------------------------~ 136 (347)
.+.+......++|+||+||++|+|++|+.||.+.+..+....+......+ .
T Consensus 189 ~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (342)
T cd07854 189 LLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDL 268 (342)
T ss_pred HHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHH
Confidence 87654334468999999999999999999998776544433332211100 0
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+.++.++.++++.|| .+|.+||++++++.|||++.-..+
T Consensus 269 ~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 269 LPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred ccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 1346788999999999 699999999999999999864443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=204.73 Aligned_cols=139 Identities=17% Similarity=0.294 Sum_probs=125.0
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
-.+.|++...||+|.|+.|+++.+..||+.+|+|+++....... ..+.+.+|++|-+.|+|||||++++.+.+....||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 35789999999999999999999999999999999986554433 34567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
|+|+|+||+|..-|-++-.++|..|..+++|++ ++.|+|.+||||||+||+|+||.....
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~ 148 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAK 148 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccC
Confidence 999999999988886667899999999999987 899999999999999999999965543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=216.58 Aligned_cols=168 Identities=27% Similarity=0.433 Sum_probs=129.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...................|++.|+|||.
T Consensus 104 ~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 183 (337)
T cd07852 104 LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183 (337)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCcee
Confidence 45677788999999999999999999999999999999999999999999876543221111122234568999999998
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC------------------------------CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF------------------------------PE 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~------------------------------~~ 136 (347)
+.+......++|+||||+++|+|++|+.||.+....+....+...... ..
T Consensus 184 ~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (337)
T cd07852 184 LLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL 263 (337)
T ss_pred eeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhh
Confidence 866443346799999999999999999999876654433333221100 00
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.+..+.++.+++..|+ .+|..||++.++++|||+..-.
T Consensus 264 ~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 264 LPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred ccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 1236788999999999 6999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=211.28 Aligned_cols=157 Identities=20% Similarity=0.392 Sum_probs=130.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........ ........+++.|+|||
T Consensus 116 ~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE 192 (288)
T cd05093 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPE 192 (288)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCce---eecCCCCCccccccCHH
Confidence 367788999999999999999999999999999999999999999999999875432111 11112334577899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+|||||++|+|++ |..||...+..+....+..+...+.+...+.++.+++.+|+ .+|..||++++
T Consensus 193 ~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 271 (288)
T cd05093 193 SIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKE 271 (288)
T ss_pred HhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99877666 68999999999999998 99999988877777777766555555668899999999999 68999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+.+
T Consensus 272 v~~ 274 (288)
T cd05093 272 IHS 274 (288)
T ss_pred HHH
Confidence 854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=211.95 Aligned_cols=158 Identities=25% Similarity=0.401 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
..+..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 118 ~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 192 (282)
T cd06636 118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEV 192 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc-----cCCCcccccccccCHhh
Confidence 3456788899999999999999999999999999999999999999999986543211 11234568899999999
Q ss_pred ccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 87 LKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 87 ~~~-----~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
+.. ..++ .++|+||+||++|+|++|..||.+....+....+..... .......+....+++++|| .+|..||
T Consensus 193 l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (282)
T cd06636 193 IACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRP 271 (282)
T ss_pred cCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCc
Confidence 863 2344 579999999999999999999987665444433333221 1223457889999999999 6899999
Q ss_pred CHHHHhcCCCC
Q psy10462 160 QMEDIRQDPWL 170 (347)
Q Consensus 160 ~~~eil~~p~~ 170 (347)
++.++++|||+
T Consensus 272 ~~~ell~~~~~ 282 (282)
T cd06636 272 STEQLLKHPFI 282 (282)
T ss_pred CHHHHhcCCCC
Confidence 99999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=219.44 Aligned_cols=144 Identities=18% Similarity=0.283 Sum_probs=125.5
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 57788999999999999999999999999999975433333345567799999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+++|+|.+++++.+.+++..+..++.|++ |+.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~---~~kl~Dfg 146 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG---HIKLTDFG 146 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---CEEEEecC
Confidence 999999999999888999999998888766 99999999999999999999998765 34455444
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=207.82 Aligned_cols=158 Identities=22% Similarity=0.461 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||.
T Consensus 96 l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~~PE~ 170 (256)
T cd06612 96 LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-----KRNTVIGTPFWMAPEV 170 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-----ccccccCCccccCHHH
Confidence 46788999999999999999999999999999999999999999999999876543211 1223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+|+++|+|++|+.||...+..+....+.... ....+..++..+.+++.+|+ .+|..||++++
T Consensus 171 ~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~ 249 (256)
T cd06612 171 IQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQ 249 (256)
T ss_pred HhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHH
Confidence 9887665 68999999999999999999998776554443332221 12233457789999999999 69999999999
Q ss_pred HhcCCCC
Q psy10462 164 IRQDPWL 170 (347)
Q Consensus 164 il~~p~~ 170 (347)
++.|||+
T Consensus 250 il~~~~~ 256 (256)
T cd06612 250 LLQHPFI 256 (256)
T ss_pred HhcCCCC
Confidence 9999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-27 Score=209.93 Aligned_cols=160 Identities=31% Similarity=0.489 Sum_probs=125.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++......... .....+++.|+|||
T Consensus 95 ~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~aPE 169 (283)
T cd07835 95 GLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-----YTHEVVTLWYRAPE 169 (283)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-----cCccccccCCCCCc
Confidence 3567889999999999999999999999999999999999999999999998654321111 11224678899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-------------------C---------CCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------------------F---------PES 137 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------------~---------~~~ 137 (347)
.+.+......++|+||+|+++|+|++|+.||.+.+.......+.+... + ...
T Consensus 170 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T cd07835 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVV 249 (283)
T ss_pred eeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhc
Confidence 887654333689999999999999999999987665443333221100 0 012
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
+.++..+.+++.+|+ .+|.+||++++++.||||
T Consensus 250 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 250 PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 456789999999999 699999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=213.05 Aligned_cols=165 Identities=25% Similarity=0.500 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 114 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 188 (297)
T cd06659 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-----KRKSLVGTPYWMAPEV 188 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-----cccceecCccccCHHH
Confidence 56688899999999999999999999999999999999999999999999865432211 1223568899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+||++|+|++|+.||...+..+....+..... .......+....++++.|+ .+|..||++++
T Consensus 189 ~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ 267 (297)
T cd06659 189 ISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQE 267 (297)
T ss_pred HccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 9887765 679999999999999999999988776666666544321 1223457889999999999 79999999999
Q ss_pred HhcCCCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSNPV 177 (347)
Q Consensus 164 il~~p~~~~~~~~~ 177 (347)
+++|||+.+...+.
T Consensus 268 ll~~~~~~~~~~~~ 281 (297)
T cd06659 268 LLDHPFLLQTGLPE 281 (297)
T ss_pred HhhChhhccCCCcc
Confidence 99999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-27 Score=209.15 Aligned_cols=157 Identities=25% Similarity=0.381 Sum_probs=124.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 103 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 177 (267)
T cd06645 103 LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-----AKRKSFIGTPYWMAPEV 177 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-----cccccccCcccccChhh
Confidence 5678899999999999999999999999999999999999999999999987653211 11234568999999998
Q ss_pred cc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCC---CCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFP---ESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~---~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~---~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
+. ...++ .++|+||+||++|+|++|..||............... ...+ ....++..+++++.+|+ .+|..|
T Consensus 178 ~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 256 (267)
T cd06645 178 AAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR 256 (267)
T ss_pred hccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhC
Confidence 74 33344 5799999999999999999999765543333322222 2111 12346788999999999 789999
Q ss_pred CCHHHHhcCCC
Q psy10462 159 IQMEDIRQDPW 169 (347)
Q Consensus 159 ~~~~eil~~p~ 169 (347)
|+++++++|||
T Consensus 257 ~~~~~ll~~~~ 267 (267)
T cd06645 257 PTAEKLLQHPF 267 (267)
T ss_pred cCHHHHhcCCC
Confidence 99999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=211.55 Aligned_cols=162 Identities=26% Similarity=0.437 Sum_probs=127.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.++++.+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....... ......|+..|+||
T Consensus 99 ~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aP 172 (283)
T cd06617 99 TIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV------AKTIDAGCKPYMAP 172 (283)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc------ccccccCCccccCh
Confidence 356788999999999999999997 99999999999999999999999999987653211 11224578899999
Q ss_pred ccccCC----CCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhccCC-CCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 85 EILKGV----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKRVVF-PESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 85 E~~~~~----~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
|.+.+. .++ .++|+||+||++|+|++|+.||.... ..+....+...... .+...++.++.+++..|| .+|..
T Consensus 173 E~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 251 (283)
T cd06617 173 ERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKE 251 (283)
T ss_pred hhcCCcccccccC-ccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhh
Confidence 988652 233 57899999999999999999997532 22223333332221 122457899999999999 79999
Q ss_pred CCCHHHHhcCCCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 158 R~~~~eil~~p~~~~~~ 174 (347)
||+++++++|||+....
T Consensus 252 Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 252 RPNYPELLQHPFFELHL 268 (283)
T ss_pred CcCHHHHhcCchhhhcc
Confidence 99999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=206.22 Aligned_cols=158 Identities=30% Similarity=0.526 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ ......|++.|+|||.
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-----~~~~~~~~~~y~ape~ 172 (256)
T cd08221 98 FEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-----MAETVVGTPYYMSPEL 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-----cccccCCCccccCHhh
Confidence 56688899999999999999999999999999999999999999999999876543221 1234568899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+...+ .++|+||+|+++|+|++|..||...+..+....+..+...+.....+.++.+++..|+ .+|..||++++++
T Consensus 173 ~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll 251 (256)
T cd08221 173 CQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251 (256)
T ss_pred cCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 9877655 5799999999999999999999988887777777665554555667899999999999 6899999999999
Q ss_pred cCCCC
Q psy10462 166 QDPWL 170 (347)
Q Consensus 166 ~~p~~ 170 (347)
++||+
T Consensus 252 ~~~~l 256 (256)
T cd08221 252 DQPLL 256 (256)
T ss_pred hCcCC
Confidence 99985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=225.21 Aligned_cols=140 Identities=26% Similarity=0.427 Sum_probs=128.6
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
+.....|.+.+.||+|.|++|.+|++..|+..||||.++++......... +-+|+++|+.|.|||||+++.+.+.+..+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k-~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQK-LGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHH-HHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34566788999999999999999999999999999999988766555444 66999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+||||+.+|++++++.+.+++.|..|+.++.|+. ++.|+|+++|+|||||++||||+++.
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m 192 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM 192 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc
Confidence 99999999999999999999999999999988876 99999999999999999999999886
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=212.21 Aligned_cols=159 Identities=25% Similarity=0.412 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++......... .....+++.|+|||.
T Consensus 103 l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~aPE~ 177 (293)
T cd07843 103 FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-----YTQLVVTLWYRAPEL 177 (293)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc-----cccccccccccCchh
Confidence 577899999999999999999999999999999999999999999999998765432111 122346888999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC------------------------------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------------------------E 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------------------------~ 136 (347)
+.+......++|+||+|+++|+|++|..||.+.+..+...++......| -
T Consensus 178 ~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (293)
T cd07843 178 LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKF 257 (293)
T ss_pred hcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccc
Confidence 8765543467999999999999999999998877655544433211100 0
Q ss_pred CCC-CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 SPR-LSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 ~~~-~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
+.. +++..++++++|| .+|++||+++|++.||||
T Consensus 258 ~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 258 PALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011 4788999999999 699999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=214.90 Aligned_cols=163 Identities=21% Similarity=0.359 Sum_probs=123.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC----CCcEEEeccCCceecccCCccccccCcccccCCccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD----KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y 81 (347)
.+.+..++.++.|++.||.|||+++|+||||||+||+++. ++.+||+|||++......... ........+++.|
T Consensus 104 ~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y 181 (316)
T cd07842 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP--LADLDPVVVTIWY 181 (316)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccc--ccccCCccccccc
Confidence 3567889999999999999999999999999999999999 899999999998765432211 1112344678899
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHHhc---------------------
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE---------LLKQVQKR--------------------- 131 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~---------~~~~i~~~--------------------- 131 (347)
+|||.+.+......++|+||+|+++|+|++|+.||.+.+... .+..+...
T Consensus 182 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (316)
T cd07842 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL 261 (316)
T ss_pred cCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhh
Confidence 999988765433468999999999999999999997654321 11111000
Q ss_pred ------cCCC---------CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 132 ------VVFP---------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 132 ------~~~~---------~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
..++ .....+..+.+++.+|| .+|..||+++++++||||
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 262 MKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0011 00145678999999999 699999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=211.24 Aligned_cols=158 Identities=32% Similarity=0.586 Sum_probs=133.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... ....+|++.|+|||.
T Consensus 98 l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~y~aPE~ 169 (290)
T cd05580 98 FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--------TYTLCGTPEYLAPEI 169 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--------CCCCCCCccccChhh
Confidence 456888899999999999999999999999999999999999999999998765321 224468899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+...+ .++|+||+|+++|+|++|+.||...+..+..+.+..+. .+.+...++..++++++|| .+|.+|+ +
T Consensus 170 ~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~ 247 (290)
T cd05580 170 ILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK-VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNG 247 (290)
T ss_pred hcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-ccCCccCCHHHHHHHHHHccCCHHHccCcccCC
Confidence 9876655 67999999999999999999998887666666655432 3344567899999999999 7899998 8
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++|||+....
T Consensus 248 ~~~l~~~~~~~~~~ 261 (290)
T cd05580 248 VNDIKNHPWFAGID 261 (290)
T ss_pred HHHHHcCcccccCC
Confidence 99999999997755
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=208.46 Aligned_cols=158 Identities=17% Similarity=0.331 Sum_probs=131.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||+++......... ......++..|+|||
T Consensus 109 ~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~~pe 185 (273)
T cd05035 109 KLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR---QGRIAKMPVKWIAIE 185 (273)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeecccccccc---ccccccCCccccCHh
Confidence 45668889999999999999999999999999999999999999999999998664322211 111223467899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+..+...+.+...+..+.+++.+|+ .+|.+||++.+
T Consensus 186 ~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 264 (273)
T cd05035 186 SLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTK 264 (273)
T ss_pred hcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 98776665 67999999999999999 99999988888888777766655566778999999999999 68999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 265 ~~~~ 268 (273)
T cd05035 265 LREV 268 (273)
T ss_pred HHHH
Confidence 8754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=209.17 Aligned_cols=156 Identities=21% Similarity=0.373 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++........ ........+++.|+|||.
T Consensus 119 l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~y~aPE~ 195 (280)
T cd05049 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY---YRVGGHTMLPIRWMPPES 195 (280)
T ss_pred ccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcc---eecCCCCcccceecChhh
Confidence 45678899999999999999999999999999999999999999999999875432111 011122345678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+||++|+|++ |..||.+.+..+....+..+...+.+...+...++++++|+ .+|..||+++|+
T Consensus 196 ~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 196 IMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred hccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 9887776 57999999999999998 99999988888877777766555555678999999999999 689999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 275 l~ 276 (280)
T cd05049 275 HE 276 (280)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=206.41 Aligned_cols=158 Identities=23% Similarity=0.373 Sum_probs=134.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........ ........+++.|+|||
T Consensus 101 ~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE 177 (262)
T cd00192 101 TLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWMAPE 177 (262)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc---cccccCCCcCccccCHH
Confidence 357789999999999999999999999999999999999999999999999976643221 01122345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+||+|+++|+|++ |..||.+.+..+....+......+.+...++++.+++..|+ .+|..||++++
T Consensus 178 ~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 256 (262)
T cd00192 178 SLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSE 256 (262)
T ss_pred HhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHH
Confidence 99877655 67999999999999998 69999999888888888776666667778999999999999 68999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 257 l~~~ 260 (262)
T cd00192 257 LVER 260 (262)
T ss_pred HHHh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-27 Score=210.68 Aligned_cols=159 Identities=29% Similarity=0.536 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.++++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ ......+++.|++||.
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~y~~PE~ 171 (284)
T cd07836 97 LDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-----TFSNEVVTLWYRAPDV 171 (284)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-----ccccccccccccChHH
Confidence 57789999999999999999999999999999999999999999999999865432111 1123356889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC----------------------------CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------------------------SP 138 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------~~ 138 (347)
+.+....+.++|+||+|+++|++++|+.||.+.+..+....+.+....|. .+
T Consensus 172 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (284)
T cd07836 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFP 251 (284)
T ss_pred hcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhh
Confidence 87655444789999999999999999999998776555444332111000 12
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
..+..+++++.+|+ .+|.+||++.++++||||
T Consensus 252 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 252 HADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 45778899999999 799999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=207.85 Aligned_cols=158 Identities=29% Similarity=0.553 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..... .....|++.|+|||.
T Consensus 94 ~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------~~~~~~~~~y~~pe~ 164 (260)
T cd05611 94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------NKKFVGTPDYLAPET 164 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---------cccCCCCcCccChhh
Confidence 45688999999999999999999999999999999999999999999999865422 123457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-CCC--CCCCCCHHHHHHHHhcc-CCCCCCC---
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFP--ESPRLSSSCKALISNIL-SPVKFRI--- 159 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~--~~~~~s~~~~~li~~~l-~~~~~R~--- 159 (347)
+.+..++ .++|+||+|+++|+|++|..||...+..+....+.... .++ ....+++.+.+++.+|+ .+|..||
T Consensus 165 ~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 165 ILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred hcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCC
Confidence 9887654 68999999999999999999999888777766664432 222 22357899999999999 7999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ~~~eil~~p~~~~~~ 174 (347)
+++|++.|||+....
T Consensus 244 ~~~~~l~~~~~~~~~ 258 (260)
T cd05611 244 GYQEIKSHPFFKSIN 258 (260)
T ss_pred cHHHHHcChHhhcCC
Confidence 558999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=208.12 Aligned_cols=160 Identities=31% Similarity=0.593 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||++....... ......|++.|++||.
T Consensus 90 l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~~PE~ 163 (262)
T cd05572 90 FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------KTWTFCGTPEYVAPEI 163 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------ccccccCCcCccChhH
Confidence 4568888999999999999999999999999999999999999999999987654321 1223467889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhc-cCCCCCCCCCHHHHHHHHhcc-CCCCCCCC--
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKR-VVFPESPRLSSSCKALISNIL-SPVKFRIQ-- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~--~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~l-~~~~~R~~-- 160 (347)
+.+..++ .++|+||+|+++|++++|..||.... ..+....+..+ ...+.+...++.+++++.+|+ .+|..|++
T Consensus 164 ~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 242 (262)
T cd05572 164 ILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNL 242 (262)
T ss_pred hcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCc
Confidence 8876665 67999999999999999999998776 55555555532 222333455899999999999 79999999
Q ss_pred ---HHHHhcCCCCCCC
Q psy10462 161 ---MEDIRQDPWLKED 173 (347)
Q Consensus 161 ---~~eil~~p~~~~~ 173 (347)
++|+++||||.+-
T Consensus 243 ~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 243 KGGIKDIKKHKWFNGF 258 (262)
T ss_pred ccCHHHHhcChhhhCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=210.76 Aligned_cols=156 Identities=20% Similarity=0.363 Sum_probs=129.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........ ........++..|+|||.
T Consensus 120 ~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~ 196 (291)
T cd05094 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWMPPES 196 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCce---eecCCCCCcceeecChHH
Confidence 45678899999999999999999999999999999999999999999999875532211 111223446788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |..||...+..+....+..+.....+...+..+.+++.+|+ .+|.+||+++++
T Consensus 197 ~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 197 IMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred hccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 9887766 57999999999999998 99999888877777777665544445567889999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 276 ~~ 277 (291)
T cd05094 276 YK 277 (291)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=209.19 Aligned_cols=159 Identities=24% Similarity=0.423 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 110 ~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 184 (275)
T cd06608 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-----GRRNTFIGTPYWMAPEV 184 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch-----hhhcCccccccccCHhH
Confidence 5678889999999999999999999999999999999999999999999987653211 11223568889999998
Q ss_pred ccCCC----CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 87 LKGVP----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 87 ~~~~~----~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
+.... ....++|+||+|+++|+|++|+.||.+.........+..... ...+...+.++++++++|| .+|..||
T Consensus 185 ~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 264 (275)
T cd06608 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRP 264 (275)
T ss_pred hcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCc
Confidence 75432 122578999999999999999999987665555555544322 1222346789999999999 7999999
Q ss_pred CHHHHhcCCCC
Q psy10462 160 QMEDIRQDPWL 170 (347)
Q Consensus 160 ~~~eil~~p~~ 170 (347)
+++++++|||+
T Consensus 265 t~~~ll~~~~~ 275 (275)
T cd06608 265 FMEELLEHPFI 275 (275)
T ss_pred CHHHHhcCCCC
Confidence 99999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=219.62 Aligned_cols=156 Identities=24% Similarity=0.385 Sum_probs=124.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++++.+++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......+++.|+|||+
T Consensus 209 l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~ 285 (374)
T cd05106 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY---VVKGNARLPVKWMAPES 285 (374)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce---eeccCCCCccceeCHHH
Confidence 567889999999999999999999999999999999999999999999998765322111 11112234567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL-KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+|||||++|+|++ |+.||......+.. ..+..+...+.+...++++++++.+|+ .+|..||++++
T Consensus 286 ~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~ 364 (374)
T cd05106 286 IFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQ 364 (374)
T ss_pred hcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9877766 67999999999999997 99999876544333 333344444445567899999999999 69999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+.+
T Consensus 365 l~~ 367 (374)
T cd05106 365 ISQ 367 (374)
T ss_pred HHH
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=204.52 Aligned_cols=155 Identities=24% Similarity=0.479 Sum_probs=126.6
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccC
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 89 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 89 (347)
+..+.++.|+++|++|||+.||+||||||+||++..+..+||.|||+|+....+ ...+..+.+..|.|||++.+
T Consensus 118 ~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~------~~mtpyVvtRyyrapevil~ 191 (369)
T KOG0665|consen 118 ETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD------FMMTPYVVTRYYRAPEVILG 191 (369)
T ss_pred HHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc------cccCchhheeeccCchheec
Confidence 667888999999999999999999999999999999999999999999754321 12345678899999999999
Q ss_pred CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------------------------------CC
Q psy10462 90 VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--------------------------------ES 137 (347)
Q Consensus 90 ~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------------------------------~~ 137 (347)
..+. ..+|+||+||++.||++|+..|++.+..+.+.++.+....| +.
T Consensus 192 ~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~ 270 (369)
T KOG0665|consen 192 MGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDS 270 (369)
T ss_pred cCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcc
Confidence 8876 57999999999999999999999877555444443322211 11
Q ss_pred ---------CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCC
Q psy10462 138 ---------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 171 (347)
Q Consensus 138 ---------~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~ 171 (347)
+.-+..+++++.+|| -+|+.|.+++++++||+++
T Consensus 271 ~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 271 LFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred cccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 122356899999999 7999999999999999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-28 Score=222.28 Aligned_cols=140 Identities=16% Similarity=0.253 Sum_probs=125.3
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
....+|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34578899999999999999999999999999999997543333334456779999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+||||+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~ 155 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG 155 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC
Confidence 9999999999999999888999999998888776 99999999999999999999998765
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=207.43 Aligned_cols=158 Identities=22% Similarity=0.364 Sum_probs=127.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... .......++..|+|||
T Consensus 97 ~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~~y~~Pe 171 (262)
T cd06613 97 PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-----AKRKSFIGTPYWMAPE 171 (262)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-----hccccccCCccccCch
Confidence 35678899999999999999999999999999999999999999999999987653211 1122346788999999
Q ss_pred cccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-C---CCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 86 ILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-V---FPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 86 ~~~~~---~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-~---~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
.+.+. .++ .++|+||+|+++|+|++|..||.+.+..+....+.... . .......+.++++++++|+ .+|..
T Consensus 172 ~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 250 (262)
T cd06613 172 VAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKK 250 (262)
T ss_pred hhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhh
Confidence 98766 555 67999999999999999999998877655544443331 1 1123345778999999999 68999
Q ss_pred CCCHHHHhcCCC
Q psy10462 158 RIQMEDIRQDPW 169 (347)
Q Consensus 158 R~~~~eil~~p~ 169 (347)
||++++++.|+|
T Consensus 251 Rpt~~~il~~~~ 262 (262)
T cd06613 251 RPTATKLLQHPF 262 (262)
T ss_pred CCCHHHHhcCCC
Confidence 999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=212.47 Aligned_cols=160 Identities=27% Similarity=0.453 Sum_probs=125.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+.+..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ......|++.|+||
T Consensus 103 ~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aP 176 (288)
T cd06616 103 VIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI------AKTRDAGCRPYMAP 176 (288)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC------ccccccCccCccCH
Confidence 356788999999999999999975 99999999999999999999999999987553211 11233578899999
Q ss_pred ccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccC--C--CCCCCCCHHHHHHHHhcc-CCC
Q psy10462 85 EILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVV--F--PESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 85 E~~~~~---~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~~~~--~--~~~~~~s~~~~~li~~~l-~~~ 155 (347)
|.+.+. .++ .++|+||+||++|+|++|+.||...+. .+...++..... . ..+..++.++.+|++.|+ .+|
T Consensus 177 E~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 255 (288)
T cd06616 177 ERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDE 255 (288)
T ss_pred HHhccccccCCc-chhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCCh
Confidence 999765 344 679999999999999999999976542 122222222111 1 112347889999999999 799
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~ 172 (347)
..||++++++.|||+..
T Consensus 256 ~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 256 SKRPKYKELLEHPFIKD 272 (288)
T ss_pred hhCcCHHHHhcChhhhc
Confidence 99999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=209.68 Aligned_cols=163 Identities=25% Similarity=0.455 Sum_probs=130.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...... ......+++.|+||
T Consensus 98 ~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~y~aP 170 (286)
T cd06622 98 GIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-------LAKTNIGCQSYMAP 170 (286)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-------ccccCCCccCccCc
Confidence 46778999999999999999997 59999999999999999999999999998655321 12234578899999
Q ss_pred ccccCCCC-----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HhccCCCCCCCCCHHHHHHHHhcc-CCC
Q psy10462 85 EILKGVPY-----TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 85 E~~~~~~~-----~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~s~~~~~li~~~l-~~~ 155 (347)
|.+.+... .+.++|+||+||++|+|++|+.||...........+ ........++.++++++++++.|+ .+|
T Consensus 171 E~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 250 (286)
T cd06622 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIP 250 (286)
T ss_pred chhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCc
Confidence 99865432 135799999999999999999999876555444433 233333334568999999999999 799
Q ss_pred CCCCCHHHHhcCCCCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~~~~ 175 (347)
..||+++++++|||+.....
T Consensus 251 ~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 251 NRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred ccCCCHHHHhcChhhhhccC
Confidence 99999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=215.42 Aligned_cols=166 Identities=19% Similarity=0.303 Sum_probs=123.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc--cccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~gt~~y~aP 84 (347)
+++.+++.++.|++.||+|||++||+||||||+||+++.++.++++||+.+.......... .........++..|+||
T Consensus 98 l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (327)
T cd08227 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177 (327)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccCh
Confidence 4568889999999999999999999999999999999999999999998654332111100 01111223467789999
Q ss_pred ccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-C----------------------------
Q psy10462 85 EILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-V---------------------------- 133 (347)
Q Consensus 85 E~~~~~--~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-~---------------------------- 133 (347)
|.+.+. .++ .++|+||+||++|+|++|+.||.+....+......... .
T Consensus 178 E~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T cd08227 178 EVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGE 256 (327)
T ss_pred HHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCc
Confidence 998763 344 67999999999999999999998765433322221110 0
Q ss_pred ----------------CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 134 ----------------FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 134 ----------------~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
.+....+++.+++++++|| .+|.+||+++++++||||++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 257 STTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred ccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0011234678999999999 799999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=207.71 Aligned_cols=155 Identities=30% Similarity=0.556 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.+..++.|++.||.|||++|++|+||||+||+++.++.++++|||++........ ......|++.|+|||.
T Consensus 97 ~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE~ 171 (255)
T cd08219 97 FPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-----YACTYVGTPYYVPPEI 171 (255)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-----ccccccCCccccCHHH
Confidence 46788899999999999999999999999999999999999999999999876542211 1223568889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+...+ .++|+||+|+++|+|++|..||...+.......+..+...+.+..++...++++++|| .+|.+||++++++
T Consensus 172 ~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 250 (255)
T cd08219 172 WENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250 (255)
T ss_pred HccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHh
Confidence 9887665 6799999999999999999999988877777776665555556678899999999999 7999999999998
Q ss_pred cC
Q psy10462 166 QD 167 (347)
Q Consensus 166 ~~ 167 (347)
+.
T Consensus 251 ~~ 252 (255)
T cd08219 251 SR 252 (255)
T ss_pred hc
Confidence 64
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=206.03 Aligned_cols=155 Identities=21% Similarity=0.350 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+....+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ......++..|+|||.
T Consensus 101 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~----~~~~~~~~~~y~aPE~ 176 (263)
T cd05052 101 VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT----AHAGAKFPIKWTAPES 176 (263)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee----ccCCCCCccccCCHHH
Confidence 455777889999999999999999999999999999999999999999998765421110 1112234567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+......+.+...+++..+++.+|+ .+|++||++.++
T Consensus 177 ~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 255 (263)
T cd05052 177 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255 (263)
T ss_pred hccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 9877766 57999999999999998 99999998888888887776665666778999999999999 699999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 256 ~~ 257 (263)
T cd05052 256 HQ 257 (263)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=209.03 Aligned_cols=163 Identities=27% Similarity=0.475 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||.
T Consensus 98 l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 172 (277)
T cd06917 98 IAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-----KRSTFVGTPYWMAPEV 172 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-----ccccccCCcceeCHHH
Confidence 45688899999999999999999999999999999999999999999999977643221 1223468889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC-CCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES-PRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+....+.++|+||+|+++|+|++|..||.+.+.......+........+ ...+.+..+++.+|+ .+|..||++.++
T Consensus 173 ~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~i 252 (277)
T cd06917 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEEL 252 (277)
T ss_pred hccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 876443346799999999999999999999877655444333222111111 237889999999999 689999999999
Q ss_pred hcCCCCCCCC
Q psy10462 165 RQDPWLKEDS 174 (347)
Q Consensus 165 l~~p~~~~~~ 174 (347)
+.|+|+++..
T Consensus 253 l~~~~~~~~~ 262 (277)
T cd06917 253 LKSKWIKAHS 262 (277)
T ss_pred hhChHhhccc
Confidence 9999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=212.39 Aligned_cols=163 Identities=27% Similarity=0.472 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........ ......+++.|+|||.
T Consensus 112 ~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 186 (297)
T cd06656 112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEV 186 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-----CcCcccCCccccCHHH
Confidence 34578889999999999999999999999999999999999999999999876533211 1223468889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+||++|++++|..||.+.+.......+.... ....+..++...++++.+|+ .+|..||++++
T Consensus 187 ~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (297)
T cd06656 187 VTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKE 265 (297)
T ss_pred HcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9887665 67999999999999999999998765433322222211 11234567888999999999 68999999999
Q ss_pred HhcCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSN 175 (347)
Q Consensus 164 il~~p~~~~~~~ 175 (347)
+++|||+.....
T Consensus 266 il~~~~~~~~~~ 277 (297)
T cd06656 266 LLQHPFLKLAKP 277 (297)
T ss_pred HhcCchhccccc
Confidence 999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=207.53 Aligned_cols=155 Identities=18% Similarity=0.335 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||+|||++|++||||||+||+++.++.++++|||.+........ .......++..|+|||.
T Consensus 104 l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~ 179 (266)
T cd05064 104 LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI----YTTMSGKSPVLWAAPEA 179 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch----hcccCCCCceeecCHHH
Confidence 46688999999999999999999999999999999999999999999998754322110 01112335678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+||++|+++ +|..||.+.+..+..+.+..+...|.+...+..+.+++..|+ .+|..||+++++
T Consensus 180 ~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i 258 (266)
T cd05064 180 IQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258 (266)
T ss_pred HhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 9887776 6899999999999977 499999998888888888777666777788999999999999 689999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 259 ~~ 260 (266)
T cd05064 259 HS 260 (266)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=208.50 Aligned_cols=162 Identities=23% Similarity=0.371 Sum_probs=131.5
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccccc
Q psy10462 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 88 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 88 (347)
...+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus 118 ~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~~pE~~~ 194 (288)
T cd05061 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLK 194 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccc---cccCCCcccccccCHHHhc
Confidence 3567889999999999999999999999999999999999999999998754322111 1112234567899999998
Q ss_pred CCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 89 GVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 89 ~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
+..++ .++|+|||||++|+|++ |..||.+.+..+....+..+...+.+...++..++++..|+ .+|..||++.++++
T Consensus 195 ~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 195 DGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred cCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77766 68999999999999998 79999988877777766555444445567899999999999 79999999999986
Q ss_pred ------CCCCCCCC
Q psy10462 167 ------DPWLKEDS 174 (347)
Q Consensus 167 ------~p~~~~~~ 174 (347)
|||++..+
T Consensus 274 ~l~~~~~~~~~~~~ 287 (288)
T cd05061 274 LLKDDLHPSFPEVS 287 (288)
T ss_pred HHHhhcCCCCCCCC
Confidence 88887643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=209.76 Aligned_cols=159 Identities=28% Similarity=0.531 Sum_probs=121.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ......++..|+|||.
T Consensus 100 ~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE~ 174 (291)
T cd07844 100 LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-----TYSNEVVTLWYRPPDV 174 (291)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-----cccccccccccCCcHH
Confidence 45688999999999999999999999999999999999999999999999865422111 1112346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhccCCC-----------------------------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKRVVFP-----------------------------E 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~-----------------------------~ 136 (347)
+.+....+.++|+||+|+++|+|++|+.||.+.. ..+....+.+....+ .
T Consensus 175 ~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd07844 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINH 254 (291)
T ss_pred hhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHh
Confidence 8764433468999999999999999999997655 333332221110000 0
Q ss_pred CCCCC--HHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 SPRLS--SSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 ~~~~s--~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.+.++ ..+.+++.+|| .+|..||++.++++||||
T Consensus 255 ~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 255 APRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11334 78899999999 689999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=187.73 Aligned_cols=162 Identities=28% Similarity=0.541 Sum_probs=134.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
..+.++.++.|++.||.|||++++.|||+||.|.|++.+|.+|++|||+++.+......+. .-+-|.+|.+|.++
T Consensus 99 d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys-----aevvtlwyrppdvl 173 (292)
T KOG0662|consen 99 DPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS-----AEVVTLWYRPPDVL 173 (292)
T ss_pred CHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee-----ceeeeeeccCccee
Confidence 3477899999999999999999999999999999999999999999999987765433332 23458899999999
Q ss_pred cCCCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHhccCCCC----------------------------CC
Q psy10462 88 KGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPE----------------------------SP 138 (347)
Q Consensus 88 ~~~~~~~~~~Dvws~G~~l~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------~~ 138 (347)
-|....+...|+||.||++.|+. .|++.|++.+..+.+.+|-.....|. .+
T Consensus 174 fgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp 253 (292)
T KOG0662|consen 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVP 253 (292)
T ss_pred eeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhh
Confidence 98876657789999999999998 68889999988888877754322211 13
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
++++.-+++++++| ..|..|+++++.++||+|.+.+
T Consensus 254 ~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 254 KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred hhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 44556789999999 7999999999999999998754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=215.68 Aligned_cols=163 Identities=24% Similarity=0.413 Sum_probs=128.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.++++.++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... .....+++.|+|||
T Consensus 116 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~y~aPE 187 (345)
T cd07877 116 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--------MTGYVATRWYRAPE 187 (345)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc--------ccccccCCCccCHH
Confidence 3667889999999999999999999999999999999999999999999998654221 12345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC------------------------CCC-----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV------------------------FPE----- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------------~~~----- 136 (347)
.+.+....+.++|+||+||++|+|++|+.||.+.+.......+..... .+.
T Consensus 188 ~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (345)
T cd07877 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN 267 (345)
T ss_pred HHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh
Confidence 987633233679999999999999999999987665444333322110 010
Q ss_pred -CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 -~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
....++.+++++.+|| .+|.+|++..+++.||||.+-..+
T Consensus 268 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 268 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 0134778999999999 799999999999999999875544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=208.78 Aligned_cols=157 Identities=23% Similarity=0.400 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... .......++..|+|||.
T Consensus 121 ~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 197 (283)
T cd05090 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEA 197 (283)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcce---ecccCCCccceecChHH
Confidence 456778889999999999999999999999999999999999999999999765322111 11223345678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |..||.+.+..+....+......+.+...++..++++..|+ .+|..||++.++
T Consensus 198 ~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 276 (283)
T cd05090 198 IMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276 (283)
T ss_pred hccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 9877666 67999999999999998 99999988877777777766666666778999999999999 699999999998
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
.++
T Consensus 277 ~~~ 279 (283)
T cd05090 277 HTR 279 (283)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=205.47 Aligned_cols=157 Identities=19% Similarity=0.362 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.|++.||.|||++|++||||||+||+++.++.+||+|||++........... ......+++.|+|||.
T Consensus 92 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~ 169 (257)
T cd05115 92 ITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPEC 169 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee--ccCCCCCCcccCCHHH
Confidence 46688999999999999999999999999999999999999999999999875543221111 1111223568999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|++++ |..||.+.+..+....+..+...+.+...++++.+++.+|+ .+|..||++.++
T Consensus 170 ~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i 248 (257)
T cd05115 170 INFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248 (257)
T ss_pred HccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 8876665 67999999999999996 99999998888887777776655556677899999999999 689999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 249 ~~ 250 (257)
T cd05115 249 EE 250 (257)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=207.61 Aligned_cols=156 Identities=22% Similarity=0.362 Sum_probs=127.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
+...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......... ......+++.|+|||.+
T Consensus 117 ~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~ 193 (277)
T cd05062 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESL 193 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceee---cCCCCccCHhhcChhHh
Confidence 446778899999999999999999999999999999999999999999987543221110 11123457789999999
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 88 KGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 88 ~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
.+..++ .++|+|||||++|+|++ |..||.+.+..+....+......+.+...++.+++++.+|+ .+|..||++.+++
T Consensus 194 ~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 272 (277)
T cd05062 194 KDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272 (277)
T ss_pred hcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 887766 67999999999999998 79999988887777776665444455678889999999999 6999999999997
Q ss_pred cC
Q psy10462 166 QD 167 (347)
Q Consensus 166 ~~ 167 (347)
++
T Consensus 273 ~~ 274 (277)
T cd05062 273 SS 274 (277)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=210.14 Aligned_cols=160 Identities=24% Similarity=0.455 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..++.++.|++.|+.|||++|++|+||+|+||+++.++.++++|||++........ ......|+..|+|||.
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 172 (277)
T cd06642 98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-----KRNTFVGTPFWMAPEV 172 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-----hhhcccCcccccCHHH
Confidence 45688899999999999999999999999999999999999999999999876543211 1123457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||||+++|+|++|+.||.+.........+............+.++.+++.+|+ .+|..||++.+++
T Consensus 173 ~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06642 173 IKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELL 251 (277)
T ss_pred hCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 9887665 6799999999999999999999877655555444433322233457788999999999 7999999999999
Q ss_pred cCCCCCC
Q psy10462 166 QDPWLKE 172 (347)
Q Consensus 166 ~~p~~~~ 172 (347)
+|||+..
T Consensus 252 ~~~~~~~ 258 (277)
T cd06642 252 KHKFITR 258 (277)
T ss_pred HhHHHHH
Confidence 9999765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=206.19 Aligned_cols=150 Identities=23% Similarity=0.420 Sum_probs=121.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++||||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 82 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------~~~~~~~~~y~aPE~ 153 (237)
T cd05576 82 IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------CDGEAVENMYCAPEV 153 (237)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--------cccCCcCccccCCcc
Confidence 456888999999999999999999999999999999999999999999987554321 112345678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM---- 161 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~---- 161 (347)
+.+..++ .++|+||+|+++|+|++|+.||...... +........+..+++.+++++++|+ .+|.+|+++
T Consensus 154 ~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 227 (237)
T cd05576 154 GGISEET-EACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAG 227 (237)
T ss_pred cCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccc
Confidence 8776665 5799999999999999999988653221 1111122334568899999999999 799999985
Q ss_pred -HHHhcCCCC
Q psy10462 162 -EDIRQDPWL 170 (347)
Q Consensus 162 -~eil~~p~~ 170 (347)
+++++|||+
T Consensus 228 ~~~~~~h~~~ 237 (237)
T cd05576 228 VEDIKSHPFF 237 (237)
T ss_pred hHHHHcCCCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=212.10 Aligned_cols=160 Identities=29% Similarity=0.523 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.+..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...... ......|++.|+|||
T Consensus 96 ~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~aPE 168 (308)
T cd06615 96 IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------MANSFVGTRSYMSPE 168 (308)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-------ccccCCCCcCccChh
Confidence 4567889999999999999998 59999999999999999999999999998654321 123457899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--------------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------------------------------- 133 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------------------------- 133 (347)
.+.+..++ .++|+||||+++|+|++|+.||...+.......+.....
T Consensus 169 ~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (308)
T cd06615 169 RLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIV 247 (308)
T ss_pred HhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHh
Confidence 99877665 679999999999999999999976554333322211100
Q ss_pred ---CC--CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 134 ---FP--ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 134 ---~~--~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.| +...++.++++++.+|| .+|++||+++++++|||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 248 NEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred cCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 00 01135778999999999 7999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=208.34 Aligned_cols=157 Identities=25% Similarity=0.475 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.
T Consensus 104 l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~~PE~ 177 (287)
T cd07838 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM------ALTSVVVTLWYRAPEV 177 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc------ccccccccccccChHH
Confidence 5678899999999999999999999999999999999999999999999987654321 1123347889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----------------C---------CCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-----------------E---------SPRL 140 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----------------~---------~~~~ 140 (347)
+.+...+ .++|+||+||++|+|++|..||.+.+..+...++......+ . .+.+
T Consensus 178 ~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T cd07838 178 LLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEI 256 (287)
T ss_pred hccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhh
Confidence 9887765 67999999999999999999999887666555553321110 0 1234
Q ss_pred CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 141 SSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 141 s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
++.+.+++.+|| .+|..||++++++.||||
T Consensus 257 ~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 257 CEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 577899999999 799999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=208.85 Aligned_cols=158 Identities=27% Similarity=0.423 Sum_probs=120.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
...+++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .......+++.|+|||.+
T Consensus 101 ~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~ 175 (291)
T cd07870 101 HPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-----QTYSSEVVTLWYRPPDVL 175 (291)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-----CCCCCccccccccCCcee
Confidence 457888999999999999999999999999999999999999999999986543211 111233568899999998
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccCCC----------------------C--------
Q psy10462 88 KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFP----------------------E-------- 136 (347)
Q Consensus 88 ~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~----------------------~-------- 136 (347)
.+....+.++|+||+|+++|+|++|..||.+.+. .+.+..+......| .
T Consensus 176 ~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (291)
T cd07870 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVW 255 (291)
T ss_pred ecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhc
Confidence 7644333679999999999999999999976543 22222221100000 0
Q ss_pred -CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 -~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
....+..+.+++.+|+ .+|.+||++++++.||||
T Consensus 256 ~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 256 KRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0112568899999999 799999999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=205.62 Aligned_cols=155 Identities=22% Similarity=0.430 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++.++...++.|++.||+|||+.+++||||||+||+++.++.++|+|||++......... ......++..|+|||.
T Consensus 100 ~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~ 175 (261)
T cd05072 100 VLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT----AREGAKFPIKWTAPEA 175 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee----ccCCCccceecCCHHH
Confidence 445778889999999999999999999999999999999999999999999765422111 1122335678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+......+.....+.++.+++.+|+ .+|..||+++++
T Consensus 176 ~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (261)
T cd05072 176 INFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYL 254 (261)
T ss_pred hccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 9877665 57999999999999998 99999988887888877777666666678999999999999 689999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 255 ~~ 256 (261)
T cd05072 255 QS 256 (261)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-27 Score=208.05 Aligned_cols=159 Identities=26% Similarity=0.492 Sum_probs=127.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+.+..+.+++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+....... .....++..|+||
T Consensus 96 ~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-------~~~~~~~~~y~~P 168 (265)
T cd06605 96 RIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-------AKTFVGTSSYMAP 168 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-------hhcccCChhccCH
Confidence 34567888999999999999999 999999999999999999999999999986543211 1125678899999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhccCCCCCCC-CCHHHHHHHHhcc-CCCCC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-----YSELLKQVQKRVVFPESPR-LSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~-~s~~~~~li~~~l-~~~~~ 157 (347)
|.+.+..++ .++|+||+|+++|+|++|..||...+ ..+..+.+........+.. +++++++++..|+ .+|.+
T Consensus 169 E~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 247 (265)
T cd06605 169 ERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRE 247 (265)
T ss_pred HHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchh
Confidence 999887666 67999999999999999999997642 2233333333322222222 7889999999999 69999
Q ss_pred CCCHHHHhcCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKE 172 (347)
Q Consensus 158 R~~~~eil~~p~~~~ 172 (347)
||++.+++.||||..
T Consensus 248 Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 248 RPSYKELLEHPFIKK 262 (265)
T ss_pred CcCHHHHhhCchhhc
Confidence 999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=214.75 Aligned_cols=158 Identities=19% Similarity=0.357 Sum_probs=126.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.++.+.+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......... ......++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~---~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---RKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh---hccCCCCCccccCcH
Confidence 45678899999999999999999999999999999999999999999999997653221111 112334567899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSE-LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+..++ .++|+||+||++|+|++ |..||.+....+ ....+..+.....+...++++.+++.+|+ .+|..||+++
T Consensus 246 ~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 324 (337)
T cd05054 246 SIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFS 324 (337)
T ss_pred HhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99887777 57999999999999997 999998755433 33444444444445567889999999999 6999999999
Q ss_pred HHhcC
Q psy10462 163 DIRQD 167 (347)
Q Consensus 163 eil~~ 167 (347)
+++++
T Consensus 325 ell~~ 329 (337)
T cd05054 325 ELVEI 329 (337)
T ss_pred HHHHH
Confidence 99865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=204.89 Aligned_cols=158 Identities=32% Similarity=0.607 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc-EEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++..+..++.|++.||.|||+.+++|+||||+||+++.++. ++|+|||.+....... .......|++.|+|||
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~ape 172 (257)
T cd08225 98 FSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-----ELAYTCVGTPYYLSPE 172 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-----ccccccCCCccccCHH
Confidence 456888999999999999999999999999999999988754 6999999987653211 1122345888999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
.+.+..++ .++|+||+|+++|+|++|..||...+..+....+......+..+..+.++++++++|+ .+|++||+++++
T Consensus 173 ~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 251 (257)
T cd08225 173 ICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSI 251 (257)
T ss_pred HHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 98876665 6799999999999999999999887776666555554444455677899999999999 689999999999
Q ss_pred hcCCCC
Q psy10462 165 RQDPWL 170 (347)
Q Consensus 165 l~~p~~ 170 (347)
++|||+
T Consensus 252 l~~~~~ 257 (257)
T cd08225 252 LKRPFL 257 (257)
T ss_pred hhCCCC
Confidence 999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=212.16 Aligned_cols=170 Identities=22% Similarity=0.378 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc---------ccccCcccccC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD---------YKQNLSETFCG 77 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~~~~~~g 77 (347)
++++.+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......... ..........+
T Consensus 116 ~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (335)
T PTZ00024 116 LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195 (335)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccccccccc
Confidence 567889999999999999999999999999999999999999999999998765411100 00111123346
Q ss_pred CccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---------------------
Q psy10462 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE--------------------- 136 (347)
Q Consensus 78 t~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------- 136 (347)
++.|+|||.+.+....+.++|+||+||++|+|++|..||.+.+..+.+..+......|.
T Consensus 196 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (335)
T PTZ00024 196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKP 275 (335)
T ss_pred ccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCc
Confidence 78899999987654444789999999999999999999998876665555433211010
Q ss_pred ------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 ------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
....+..+.+++.+|| .+|..||++++++.|||++....+
T Consensus 276 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 276 KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred ccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 1234678899999999 699999999999999999876544
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=222.00 Aligned_cols=155 Identities=25% Similarity=0.474 Sum_probs=125.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
.....+.+++||+.||.|||.++|||||||..||++.+++.|||+|||++..-..- ..........|+.-|||||++
T Consensus 486 dm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w---~g~~q~~qp~gsilwmAPEvI 562 (678)
T KOG0193|consen 486 DMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW---SGEQQLEQPHGSLLWMAPEVI 562 (678)
T ss_pred hHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee---ccccccCCCccchhhhcHHHH
Confidence 33677899999999999999999999999999999999999999999998532210 111223345688899999999
Q ss_pred cCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC----CCCHHHHHHHHhcc-CCCCCCC
Q psy10462 88 KGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP----RLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 88 ~~~---~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~s~~~~~li~~~l-~~~~~R~ 159 (347)
+.. +|+ ..+|||||||++|||+||..||...+.++++-.+-+++..|... ..+.+.++|+..|+ .+++.||
T Consensus 563 Rmqd~nPfS-~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP 641 (678)
T KOG0193|consen 563 RMQDDNPFS-FQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERP 641 (678)
T ss_pred hhcccCCCC-cccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCc
Confidence 743 455 67999999999999999999999877777777777776555432 34458899999999 7999999
Q ss_pred CHHHHhc
Q psy10462 160 QMEDIRQ 166 (347)
Q Consensus 160 ~~~eil~ 166 (347)
.+.+++.
T Consensus 642 ~F~~il~ 648 (678)
T KOG0193|consen 642 LFPQLLS 648 (678)
T ss_pred cHHHHHH
Confidence 9998876
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=217.75 Aligned_cols=142 Identities=24% Similarity=0.365 Sum_probs=125.5
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
..-|.+.+.+|+|.|++|.+|+|.-||+.||+|+++++...... ...+.+|+++|+..+|||||+||++..++..+|+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34578899999999999999999999999999999988765443 34455999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEe
Q psy10462 270 MEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHL 337 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~ 337 (347)
+|+-++|||++||-+ ...+.|+-+++||+||. ++.|+|...||||||||||+.+++ |+++|.|
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-----KlGlVKL 160 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-----KLGLVKL 160 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-----ecCceEe
Confidence 999999999999954 56899999999999887 999999999999999999998754 5555554
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=204.49 Aligned_cols=157 Identities=20% Similarity=0.375 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||++............ .....++..|+|||.
T Consensus 92 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~--~~~~~~~~~y~aPE~ 169 (257)
T cd05060 92 IPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA--TTAGRWPLKWYAPEC 169 (257)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc--ccCccccccccCHHH
Confidence 567889999999999999999999999999999999999999999999998765432221110 111123457999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |..||...+..+....+......+.+...+...++++.+|+ .+|.+||++.++
T Consensus 170 ~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l 248 (257)
T cd05060 170 INYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248 (257)
T ss_pred hcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9877766 67999999999999998 99999988887777777666555666778899999999999 689999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 249 ~~ 250 (257)
T cd05060 249 ES 250 (257)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=234.10 Aligned_cols=162 Identities=27% Similarity=0.502 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-------CCeecCCCCCcEEEcC-----------------CCcEEEeccCCceeccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK-------SVVHRDIKCENLLLDD-----------------KYNIKLSDFGFARKYSV 62 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~-------~iiH~dlkp~Nill~~-----------------~~~~kl~Dfg~a~~~~~ 62 (347)
+.+..++.++.||+.||.|||+. +|+||||||+|||++. .+.+||+|||++.....
T Consensus 115 L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccc
Confidence 56788999999999999999984 5999999999999954 23489999999976532
Q ss_pred CCccccccCcccccCCccccccccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccCCCCCCC
Q psy10462 63 NNTDYKQNLSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFPESPR 139 (347)
Q Consensus 63 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 139 (347)
. .......||+.|+|||++.+. .++ .++|||||||++|+|++|..||...+. .+++..+......| ...
T Consensus 195 ~------s~~~s~vGTp~YmAPEvL~ge~~~~s-~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp-i~~ 266 (1021)
T PTZ00266 195 E------SMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP-IKG 266 (1021)
T ss_pred c------ccccccCCCccccCHHHHhccCCCCC-chhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC-cCC
Confidence 1 112345789999999998653 244 679999999999999999999976543 34444444443322 345
Q ss_pred CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 140 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 140 ~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+.++.+||..|| .+|..||++.+++.|||+.....+
T Consensus 267 ~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 267 KSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 6899999999999 799999999999999999865443
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=205.11 Aligned_cols=151 Identities=21% Similarity=0.423 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.++.+.+++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... .....++..|+|||.
T Consensus 99 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~y~aPE~ 170 (256)
T cd05082 99 LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--------QDTGKLPVKWTAPEA 170 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--------CCCCccceeecCHHH
Confidence 455788899999999999999999999999999999999999999999998754321 112234567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+||++|+|++ |+.||...+..+....+.+......++..++..++++.+|+ .+|..||++.++
T Consensus 171 ~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 249 (256)
T cd05082 171 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQL 249 (256)
T ss_pred HccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9877666 57999999999999997 99999988888887777766555555678899999999999 699999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 250 ~~ 251 (256)
T cd05082 250 RE 251 (256)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=207.54 Aligned_cols=161 Identities=26% Similarity=0.472 Sum_probs=128.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........ .......++..|+|||
T Consensus 96 ~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~y~~PE 171 (287)
T cd07840 96 KFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS----ADYTNRVITLWYRPPE 171 (287)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc----ccccccccccccCCce
Confidence 466788999999999999999999999999999999999999999999999876643221 0112234678899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------C----------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------S---------------------- 137 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------~---------------------- 137 (347)
.+.+....+.++|+||||+++|+|++|+.||.+.+.......+.+....+. .
T Consensus 172 ~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07840 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREF 251 (287)
T ss_pred eeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHH
Confidence 887644334689999999999999999999998776665555543221110 0
Q ss_pred -CC-CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 138 -PR-LSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 138 -~~-~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.. .++.+.+++++|+ .+|.+||++++++.|||+
T Consensus 252 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 252 FKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 11 2788999999999 689999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=223.58 Aligned_cols=144 Identities=11% Similarity=0.226 Sum_probs=126.1
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|+..+.||+|+||+||+|.+..+++.||+|++++...........+.+|+.++..++||||++++++|++++.+|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 57788999999999999999999999999999975433333345567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||+||+|.+++.+.+.+++..++.++.|++ ++.|+|++||+||||||+|||++.++ .+.++..|
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~---~vkL~DfG 146 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG---HVKLSDFG 146 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC---CEEEeecc
Confidence 999999999998888999999999988776 99999999999999999999997765 34555544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=218.78 Aligned_cols=139 Identities=20% Similarity=0.237 Sum_probs=120.2
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 276 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G 276 (347)
+.||+|+||.||+|++..+|+.||+|++++...........+.+|+.++++++||||++++++|+.++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999997543333333445668999999999999999999999999999999999999
Q ss_pred ChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 277 SLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 277 ~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~---~~kl~DfG 140 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG---HIKITDFG 140 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC---CEEEeeCC
Confidence 9999998888999999999888776 99999999999999999999998765 34454444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=204.15 Aligned_cols=158 Identities=34% Similarity=0.597 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 100 ~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~y~~pe~ 174 (258)
T cd08215 100 FPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-----DLAKTVVGTPYYLSPEL 174 (258)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-----ceecceeeeecccChhH
Confidence 5678889999999999999999999999999999999999999999999987654321 12234568899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+...+ .++|+||+|+++++|++|..||...+..+...........+.+...+..+.++++.|| .+|..||++++++
T Consensus 175 ~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 253 (258)
T cd08215 175 CQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQIL 253 (258)
T ss_pred hccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 8877665 6799999999999999999999988877777766655544555678899999999999 6899999999999
Q ss_pred cCCCC
Q psy10462 166 QDPWL 170 (347)
Q Consensus 166 ~~p~~ 170 (347)
+|||+
T Consensus 254 ~~~~~ 258 (258)
T cd08215 254 QSPFI 258 (258)
T ss_pred cCCCC
Confidence 99996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=209.26 Aligned_cols=163 Identities=28% Similarity=0.442 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.+..++.++.||+.||+|||+++++|+||+|+||+++. ++.+||+|||++........ ......+++.|+|||
T Consensus 99 ~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~~PE 173 (294)
T PLN00009 99 KNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-----TFTHEVVTLWYRAPE 173 (294)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-----ccccCceeecccCHH
Confidence 456778899999999999999999999999999999985 55799999999865432111 112235688999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC----------------------C------CC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF----------------------P------ES 137 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~----------------------~------~~ 137 (347)
.+.+......++|+||+|+++|+|++|..||.+.+..+...++...... + ..
T Consensus 174 ~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (294)
T PLN00009 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVV 253 (294)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhC
Confidence 9876443346899999999999999999999877655444433221100 0 02
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
+..++.+.+++.+|+ .+|.+||++++++.||||.+..
T Consensus 254 ~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 254 PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 356788999999999 6999999999999999997643
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=205.26 Aligned_cols=161 Identities=24% Similarity=0.443 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+++++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ .........|+..|+|||.
T Consensus 103 l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~ 180 (264)
T cd06653 103 LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM--SGTGIKSVTGTPYWMSPEV 180 (264)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc--cCccccccCCcccccCHhh
Confidence 45678899999999999999999999999999999999999999999999876532110 0111223468899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCHHHHHHHHhccCCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNILSPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l~~~~~R~~~~eil 165 (347)
+.+...+ .++|+|||||++|++++|+.||.+....+...++..... ...+..+++.++++++.|+.++..||+..+++
T Consensus 181 ~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~~~~~r~~~~~~~ 259 (264)
T cd06653 181 ISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLL 259 (264)
T ss_pred hcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhcCcccCccHHHHh
Confidence 9876655 679999999999999999999987765554444433222 22355688999999999998889999999999
Q ss_pred cCCCC
Q psy10462 166 QDPWL 170 (347)
Q Consensus 166 ~~p~~ 170 (347)
.|||.
T Consensus 260 ~~~~~ 264 (264)
T cd06653 260 RHPFV 264 (264)
T ss_pred cCCCC
Confidence 99984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=220.09 Aligned_cols=142 Identities=15% Similarity=0.229 Sum_probs=124.0
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccc-cchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHS-QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~-~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
.....++|++.+.+|+|+||.||+|.+..++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4456778999999999999999999876654 679999986544333333455778999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+|||||++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~ 168 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG 168 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC
Confidence 9999999999999999999888999999999888776 99999999999999999999997765
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=204.56 Aligned_cols=167 Identities=27% Similarity=0.538 Sum_probs=134.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc---ccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD---YKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~gt~~y~ 82 (347)
.+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......... ..........++..|+
T Consensus 89 ~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (265)
T cd05579 89 SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCcccc
Confidence 3567888999999999999999999999999999999999999999999998654322110 0001122345788999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
|||...+...+ .++|+||+|+++|++++|..||...+..+....+..+. .++.....+..+.++++.|+ .+|..||+
T Consensus 169 ~Pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt 247 (265)
T cd05579 169 APEVILGQGHS-KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLG 247 (265)
T ss_pred CHHHhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCC
Confidence 99998876654 67999999999999999999999888877777765532 23333345899999999999 78999999
Q ss_pred H---HHHhcCCCCCCC
Q psy10462 161 M---EDIRQDPWLKED 173 (347)
Q Consensus 161 ~---~eil~~p~~~~~ 173 (347)
+ .++++||||...
T Consensus 248 ~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 248 AKSIEEIKNHPFFKGI 263 (265)
T ss_pred CccHHHHhcCccccCC
Confidence 9 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=205.11 Aligned_cols=158 Identities=20% Similarity=0.336 Sum_probs=125.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
...++..++.|++.||+|||+.+++||||||+|||++.++.+||+|||++......... .........+++.|+|||.+
T Consensus 96 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~ 174 (262)
T cd05058 96 TVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY-SVHNHTGAKLPVKWMALESL 174 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce-eecccccCcCCccccChhHh
Confidence 34667888999999999999999999999999999999999999999998754321110 00111123456789999998
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 88 KGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 88 ~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
.+..++ .++|+|||||++|+|++ |..||...+..+....+..+...+.+...++.+.+++..|+ .+|+.||++.+++
T Consensus 175 ~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il 253 (262)
T cd05058 175 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELV 253 (262)
T ss_pred ccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 877665 68999999999999999 56778877777776666665555555567889999999999 6999999999997
Q ss_pred cC
Q psy10462 166 QD 167 (347)
Q Consensus 166 ~~ 167 (347)
+.
T Consensus 254 ~~ 255 (262)
T cd05058 254 SR 255 (262)
T ss_pred HH
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=209.34 Aligned_cols=161 Identities=30% Similarity=0.534 Sum_probs=128.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.++.|++.||+|||+.||+|+||||+||++++++.+||+|||++........ .......++..|+|||
T Consensus 112 ~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~y~~PE 187 (302)
T cd07864 112 HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES----RPYTNKVITLWYRPPE 187 (302)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc----cccccceeccCccChH
Confidence 467789999999999999999999999999999999999999999999999876543211 1112234577899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----------------------------C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-----------------------------E 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----------------------------~ 136 (347)
.+.+....+.++|+||+||++|+|++|+.||...+..+.+..+.+....+ .
T Consensus 188 ~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd07864 188 LLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE 267 (302)
T ss_pred HhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh
Confidence 88754433467999999999999999999998776665555554321111 1
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
...++..+.+++..|| .+|..||++++++.|||+
T Consensus 268 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 268 FSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 1246789999999999 799999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=207.04 Aligned_cols=156 Identities=22% Similarity=0.357 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.||+.|++|||++|++||||||+||++++++.+||+|||++........ ........+++.|+|||.
T Consensus 119 l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~ 195 (280)
T cd05092 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPES 195 (280)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCce---eecCCCccccccccCHHH
Confidence 55688899999999999999999999999999999999999999999999875532111 011122335678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |..||......+....+..+...+.+...++.+.+++.+|+ .+|..||+++++
T Consensus 196 ~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 274 (280)
T cd05092 196 ILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274 (280)
T ss_pred hccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9887766 67999999999999998 99999888777777777666555556678899999999999 699999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
..
T Consensus 275 ~~ 276 (280)
T cd05092 275 HS 276 (280)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=207.51 Aligned_cols=162 Identities=24% Similarity=0.466 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||+|||+.+++|+||+|+||+++.++.++++|||++....... .......++..|+|||.
T Consensus 98 l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~apE~ 172 (277)
T cd06640 98 FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-----IKRNTFVGTPFWMAPEV 172 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-----cccccccCcccccCHhH
Confidence 4567888999999999999999999999999999999999999999999987654321 11223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+...+ .++|+||||+++|+|++|..||.+.+.......+............+..+.+++.+|+ .+|..||++++++
T Consensus 173 ~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06640 173 IQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELL 251 (277)
T ss_pred hccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHH
Confidence 9877665 6799999999999999999999887766655544333322233456788999999999 7899999999999
Q ss_pred cCCCCCCCC
Q psy10462 166 QDPWLKEDS 174 (347)
Q Consensus 166 ~~p~~~~~~ 174 (347)
+|+|+....
T Consensus 252 ~~~~~~~~~ 260 (277)
T cd06640 252 KHKFIVKNA 260 (277)
T ss_pred hChHhhhcc
Confidence 999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=218.28 Aligned_cols=157 Identities=21% Similarity=0.353 Sum_probs=135.1
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccccc
Q psy10462 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 88 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 88 (347)
+.++..+..+.+.||+|||+.+.||||||..|||+.+.|.+||+|||.|.... +..+|+|||+|||||++.
T Consensus 125 EvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---------PAnsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 125 EVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---------PANSFVGTPYWMAPEVIL 195 (948)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---------chhcccCCccccchhHhe
Confidence 46778889999999999999999999999999999999999999999986543 345789999999999986
Q ss_pred C---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-CCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 89 G---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 89 ~---~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
. +.|+ -++||||+|++..|+..+++|+..++....+..|.... +.-.....|..++.|+..|| ..|..||+.++
T Consensus 196 AMDEGqYd-gkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ 274 (948)
T KOG0577|consen 196 AMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEE 274 (948)
T ss_pred eccccccC-CccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHH
Confidence 4 4566 57999999999999999999999999887777775433 22335667899999999999 78999999999
Q ss_pred HhcCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSN 175 (347)
Q Consensus 164 il~~p~~~~~~~ 175 (347)
++.|+|+..+..
T Consensus 275 ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 275 LLKHRFVLRERP 286 (948)
T ss_pred HhhcchhccCCC
Confidence 999999876653
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=194.68 Aligned_cols=172 Identities=22% Similarity=0.364 Sum_probs=136.3
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 4 LLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 4 l~~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
...|+..+++++++++++||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.++....... ......+-|.+|.+
T Consensus 118 ~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~k-prytnrvvTLwYrp 196 (376)
T KOG0669|consen 118 KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVK-PRYTNRVVTLWYRP 196 (376)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCC-CCcccceeeeecCC
Confidence 35677899999999999999999999999999999999999999999999999976654322221 11223445899999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc------CCCC---------------C-----
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV------VFPE---------------S----- 137 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~------~~~~---------------~----- 137 (347)
||.+.|....+.+.|+|..||++.+|+||.+-|.+.+..+.+..|..-. ..|. +
T Consensus 197 pEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~r 276 (376)
T KOG0669|consen 197 PELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKR 276 (376)
T ss_pred HHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhh
Confidence 9999987666678999999999999999999999887766666554211 0110 0
Q ss_pred --------CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 138 --------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 138 --------~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
-.-.+++.+|+..+| .||.+|+...++++|.||-.+..+
T Consensus 277 kv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 277 KVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred hhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 001236778999999 799999999999999999877655
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=206.80 Aligned_cols=160 Identities=26% Similarity=0.447 Sum_probs=127.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||+++++|+||||+||+++.++.++|+|||.+........ ......++..|+|||
T Consensus 94 ~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~~PE 168 (283)
T cd05118 94 GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-----PYTHYVVTRWYRAPE 168 (283)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----cccCccCcccccCcH
Confidence 456788999999999999999999999999999999999999999999999876643221 111234778899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----------------------------C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-----------------------------E 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----------------------------~ 136 (347)
.+.+....+.++|+||+|+++|+|++|+.||.+.+..+....+......+ .
T Consensus 169 ~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T cd05118 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKL 248 (283)
T ss_pred HHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHh
Confidence 98876334478999999999999999999998877655444432211110 1
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.+.++.++++++..|+ .+|.+||+++++++|||+
T Consensus 249 ~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 249 FPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1236788999999999 699999999999999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=208.42 Aligned_cols=157 Identities=21% Similarity=0.362 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......... ......+++.|+|||.
T Consensus 134 ~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~---~~~~~~~~~~y~aPE~ 210 (304)
T cd05101 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK---KTTNGRLPVKWMAPEA 210 (304)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccc---cccCCCCCceeeCchh
Confidence 3456788899999999999999999999999999999999999999999997654321111 1112335678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |..||.+.+..+....+........+...+..+++++.+|+ .+|..||++.++
T Consensus 211 ~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 211 LFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred hccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 9877666 67999999999999998 89999998888888887766655556678899999999999 689999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 290 l~~ 292 (304)
T cd05101 290 VED 292 (304)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=205.83 Aligned_cols=163 Identities=23% Similarity=0.472 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-cEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.......... ........|+..|+|||
T Consensus 100 ~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~~PE 178 (268)
T cd06630 100 FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA-GEFQGQLLGTIAFMAPE 178 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccC-CccccccccccceeCHh
Confidence 45688899999999999999999999999999999998776 59999999987664321111 11123346788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE---LLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~---~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
.+.+..++ .++|+||+|+++|++++|..||...+... ....+..... ...+..+++++.+++..|+ .+|..||+
T Consensus 179 ~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 257 (268)
T cd06630 179 VLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP 257 (268)
T ss_pred HhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC
Confidence 99876665 67999999999999999999997544322 2222222222 2233467899999999999 79999999
Q ss_pred HHHHhcCCCCC
Q psy10462 161 MEDIRQDPWLK 171 (347)
Q Consensus 161 ~~eil~~p~~~ 171 (347)
+.++++||||+
T Consensus 258 ~~~ll~~~~~~ 268 (268)
T cd06630 258 SRELLKHPVFR 268 (268)
T ss_pred HHHHhcCcccC
Confidence 99999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=204.66 Aligned_cols=157 Identities=22% Similarity=0.408 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++.+++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++........... .....+++.|+|||.
T Consensus 103 ~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~---~~~~~~~~~y~~Pe~ 179 (266)
T cd05033 103 FTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT---TKGGKIPIRWTAPEA 179 (266)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccccee---ccCCCCCccccChhh
Confidence 56788999999999999999999999999999999999999999999999987642111111 112234678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |..||......+....+......+.+...++.+.+++..|+ .+|..||+++++
T Consensus 180 ~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei 258 (266)
T cd05033 180 IAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQI 258 (266)
T ss_pred hccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 9877666 57999999999999997 99999988888888888776666667778999999999999 699999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 259 ~~~ 261 (266)
T cd05033 259 VST 261 (266)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=207.60 Aligned_cols=156 Identities=22% Similarity=0.334 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||++.......... ......++..|+|||.
T Consensus 124 l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~apE~ 200 (290)
T cd05045 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV---KRSKGRIPVKWMAIES 200 (290)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchh---cccCCCCCccccCHHH
Confidence 4567889999999999999999999999999999999999999999999987553222111 1122345678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |..||.+....++...+.+....+.+...+.++.+++..|+ .+|..||++.++
T Consensus 201 ~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 201 LFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred HccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 8776665 68999999999999998 99999998888888877776666666778999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 280 ~~ 281 (290)
T cd05045 280 SK 281 (290)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=207.15 Aligned_cols=159 Identities=27% Similarity=0.489 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.
T Consensus 97 ~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~ 171 (286)
T cd07846 97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-----YTDYVATRWYRAPEL 171 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-----cCcccceeeccCcHH
Confidence 567889999999999999999999999999999999999999999999998765432211 123457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------------------ccCCCC----------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK--------------------RVVFPE---------- 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~--------------------~~~~~~---------- 136 (347)
+.+....+.++|+||||+++|+|++|+.||...+..+....+.. ....+.
T Consensus 172 ~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (286)
T cd07846 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKR 251 (286)
T ss_pred hccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHh
Confidence 87654444689999999999999999999987664433333221 011111
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.+.++..+++++.+|+ .+|.+||++.++++||||
T Consensus 252 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 252 FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 2356788999999999 699999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=206.45 Aligned_cols=157 Identities=25% Similarity=0.363 Sum_probs=123.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+|||+||+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~~PE~ 177 (267)
T cd06646 103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-----KRKSFIGTPYWMAPEV 177 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-----ccCccccCccccCHhH
Confidence 46688899999999999999999999999999999999999999999999976532111 1223468889999998
Q ss_pred ccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCC---CCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFP---ESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~~---~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~---~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
+.+ ..++ .++|+||+||++|+|++|..||...+..+....+... ...+ ....++..+.+++++|| .+|.+|
T Consensus 178 ~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 256 (267)
T cd06646 178 AAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256 (267)
T ss_pred cccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhC
Confidence 853 2233 5799999999999999999999765543332222221 1111 12346889999999999 799999
Q ss_pred CCHHHHhcCCC
Q psy10462 159 IQMEDIRQDPW 169 (347)
Q Consensus 159 ~~~~eil~~p~ 169 (347)
|+++++++|+|
T Consensus 257 p~~~~il~~l~ 267 (267)
T cd06646 257 PTAERLLTHLF 267 (267)
T ss_pred cCHHHHhcCCC
Confidence 99999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=203.39 Aligned_cols=156 Identities=21% Similarity=0.380 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ .......++..|+|||.
T Consensus 97 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~y~~Pe~ 172 (256)
T cd05059 97 LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKFPVKWAPPEV 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc----cccCCCCCCccccCHHH
Confidence 45678899999999999999999999999999999999999999999999876532111 00111123457999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |+.||...+..+....+......+.+...+....+++.+|+ .+|..||+++++
T Consensus 173 ~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~ 251 (256)
T cd05059 173 FDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251 (256)
T ss_pred hccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9887766 67999999999999998 89999888777777777766555556678999999999999 699999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 252 l~~ 254 (256)
T cd05059 252 LSQ 254 (256)
T ss_pred HHH
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=202.58 Aligned_cols=155 Identities=23% Similarity=0.380 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......... .......+..|+|||.
T Consensus 100 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~ 175 (261)
T cd05068 100 LKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE----AREGAKFPIKWTAPEA 175 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc----ccCCCcCceeccCccc
Confidence 556888999999999999999999999999999999999999999999999766421111 0111223457999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |+.||.+.+..+....+......+.+...+..+.+++.+|+ .+|..||+++++
T Consensus 176 ~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l 254 (261)
T cd05068 176 ALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254 (261)
T ss_pred cccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 8877665 67999999999999999 99999998888888777766555666678899999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 255 ~~ 256 (261)
T cd05068 255 QW 256 (261)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=202.49 Aligned_cols=155 Identities=19% Similarity=0.379 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+........ .......++..|+|||.
T Consensus 97 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~~~~y~aPE~ 172 (256)
T cd05114 97 LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY----TSSSGAKFPVKWSPPEV 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce----eccCCCCCchhhCChhh
Confidence 45678899999999999999999999999999999999999999999999875432111 01112234568999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |+.||...+..+....+..+...+.+...+..+.+++.+|+ .+|..||+++++
T Consensus 173 ~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l 251 (256)
T cd05114 173 FNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAEL 251 (256)
T ss_pred cccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 9877665 68999999999999999 99999998888888888776555455667889999999999 789999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 252 ~~ 253 (256)
T cd05114 252 LR 253 (256)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=202.95 Aligned_cols=157 Identities=21% Similarity=0.398 Sum_probs=129.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+......... . .....++..|+|||
T Consensus 96 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~--~~~~~~~~~y~~pe 171 (256)
T cd05113 96 RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT--S--SVGSKFPVRWSPPE 171 (256)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee--e--cCCCccChhhCCHH
Confidence 3567889999999999999999999999999999999999999999999998765322110 0 11123456799999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+||||+++|+|++ |..||...+..+....+......+.+...+...++++.+|+ .+|.+||++.+
T Consensus 172 ~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 250 (256)
T cd05113 172 VLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQ 250 (256)
T ss_pred HHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 99876666 67999999999999998 99999988877777777666555555667899999999999 68999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++.+
T Consensus 251 ll~~ 254 (256)
T cd05113 251 LLSS 254 (256)
T ss_pred HHHh
Confidence 9754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=218.84 Aligned_cols=144 Identities=16% Similarity=0.226 Sum_probs=125.8
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|++.+.||+|+||.||+|++..+++.||+|++++...........+.+|+.+++.++||||+++++++++.+.+|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 57888999999999999999999999999999976533333334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|++||+|.+++.+.+.+++..++.++.|++ ++.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kL~Dfg 146 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG---HIKLTDFG 146 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---CEEEEeCc
Confidence 999999999998888999999998888776 99999999999999999999997765 35555544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=206.10 Aligned_cols=157 Identities=20% Similarity=0.300 Sum_probs=127.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC---cEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++.+++.||+.||+|||+++++||||||+||+++.++ .+||+|||++......... . ......+++.|+|
T Consensus 113 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~-~~~~~~~~~~y~a 189 (277)
T cd05036 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY--R-KGGRAMLPIKWMP 189 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccce--e-cCCCCCccHhhCC
Confidence 56688889999999999999999999999999999998654 5899999998765321110 0 0112223567999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
||.+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+......+.+..++....+++.+|+ .+|..||++
T Consensus 190 PE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~ 268 (277)
T cd05036 190 PEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNF 268 (277)
T ss_pred HHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 9999877766 68999999999999996 99999988877777776655444455678899999999999 689999999
Q ss_pred HHHhcC
Q psy10462 162 EDIRQD 167 (347)
Q Consensus 162 ~eil~~ 167 (347)
.++++|
T Consensus 269 ~~vl~~ 274 (277)
T cd05036 269 ATILER 274 (277)
T ss_pred HHHHHH
Confidence 999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=206.75 Aligned_cols=158 Identities=20% Similarity=0.350 Sum_probs=125.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 121 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 195 (286)
T cd06638 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEV 195 (286)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC-----ccccccCCCcccChhh
Confidence 44577888999999999999999999999999999999999999999999876542111 1223468899999999
Q ss_pred ccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LKGV-----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~~~-----~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
+... .++ .++|+||+||++|+|++|+.||.+.+.......+..... ...+...+..+++++.+|+ .+|.+|
T Consensus 196 ~~~~~~~~~~~~-~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 274 (286)
T cd06638 196 IACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274 (286)
T ss_pred hchhhhcccccc-chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccC
Confidence 8532 233 579999999999999999999987765444444333221 1223446788999999999 699999
Q ss_pred CCHHHHhcCCCC
Q psy10462 159 IQMEDIRQDPWL 170 (347)
Q Consensus 159 ~~~~eil~~p~~ 170 (347)
|+++++++|+|+
T Consensus 275 ps~~ell~~~~~ 286 (286)
T cd06638 275 PTVSDLLQHVFI 286 (286)
T ss_pred CCHHHHhhcccC
Confidence 999999999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=207.77 Aligned_cols=168 Identities=30% Similarity=0.516 Sum_probs=132.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc----------ccccCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD----------YKQNLSETFC 76 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~~~~ 76 (347)
++++.+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........ ..........
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (305)
T cd05609 98 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177 (305)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCc
Confidence 456788899999999999999999999999999999999999999999998632111000 0000112345
Q ss_pred CCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-CCCCC-CCCCHHHHHHHHhcc-C
Q psy10462 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-VFPES-PRLSSSCKALISNIL-S 153 (347)
Q Consensus 77 gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~-~~~s~~~~~li~~~l-~ 153 (347)
|+..|+|||.+.+..++ .++|+|||||++|++++|..||.+.+..+....+.... ..|.. ..++.++++++++|+ .
T Consensus 178 ~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 256 (305)
T cd05609 178 GTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQ 256 (305)
T ss_pred cCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhcc
Confidence 78899999998876665 67999999999999999999999888777777665442 22322 357889999999999 7
Q ss_pred CCCCCCC---HHHHhcCCCCCCCCC
Q psy10462 154 PVKFRIQ---MEDIRQDPWLKEDSN 175 (347)
Q Consensus 154 ~~~~R~~---~~eil~~p~~~~~~~ 175 (347)
+|..||+ +.++++|||+.....
T Consensus 257 ~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 257 NPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred ChhhccCccCHHHHHhCccccCCCH
Confidence 9999997 799999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=203.26 Aligned_cols=155 Identities=25% Similarity=0.391 Sum_probs=129.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......... ......++..|+|||.
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~ 174 (260)
T cd05070 99 LKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT----ARQGAKFPIKWTAPEA 174 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc----cccCCCCCccccChHH
Confidence 566889999999999999999999999999999999999999999999999765432111 0112234567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |..||.+.+..+....+......+.+...+..+++++.+|+ .+|.+||++.++
T Consensus 175 ~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 253 (260)
T cd05070 175 ALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYL 253 (260)
T ss_pred HhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 8776665 67999999999999999 99999988888888877766666666678899999999999 689999999988
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 254 ~~ 255 (260)
T cd05070 254 QS 255 (260)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=238.63 Aligned_cols=164 Identities=16% Similarity=0.239 Sum_probs=117.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC-------------------CcEEEeccCCceecccCCc--
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-------------------YNIKLSDFGFARKYSVNNT-- 65 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~~-- 65 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.. +.+|++|||+++.......
T Consensus 77 ~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~ 156 (793)
T PLN00181 77 VDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERR 156 (793)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccc
Confidence 5678999999999999999999999999999999999654 4456666666643211000
Q ss_pred --cccc-------cCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC
Q psy10462 66 --DYKQ-------NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE 136 (347)
Q Consensus 66 --~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 136 (347)
.... .......||++|||||++.+..++ .++|||||||++|||++|..|+.... .....+......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (793)
T PLN00181 157 IEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSN-CASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQ 233 (793)
T ss_pred hhhhhccccCCCcccccccCCCcceEChhhhccCCCC-chhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChh
Confidence 0000 000124588999999999988876 68999999999999999998876432 22223322222121
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
.....+...+++..|| .+|..||++.++++|||+.+.
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 1223456678888899 789999999999999999764
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=207.58 Aligned_cols=158 Identities=22% Similarity=0.354 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
.++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....+++.|+|||.
T Consensus 112 l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---------~~~~~~~~~y~aPE~ 182 (307)
T cd06607 112 LQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---------ANSFVGTPYWMAPEV 182 (307)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---------CCCccCCccccCcee
Confidence 46688899999999999999999999999999999999999999999999865432 123457889999998
Q ss_pred ccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 87 LKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-PESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 87 ~~~---~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
+.+ ..++ .++|+||||+++|+|++|+.||.+.+.......+...... ......+..+++++.+|+ .+|..||++
T Consensus 183 ~~~~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 261 (307)
T cd06607 183 ILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSS 261 (307)
T ss_pred eeccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCH
Confidence 742 2334 5799999999999999999999887766555444432211 122346788999999999 699999999
Q ss_pred HHHhcCCCCCCCC
Q psy10462 162 EDIRQDPWLKEDS 174 (347)
Q Consensus 162 ~eil~~p~~~~~~ 174 (347)
.+++.|||+....
T Consensus 262 ~~il~~~~~~~~~ 274 (307)
T cd06607 262 EELLKHRFVLRER 274 (307)
T ss_pred HHHhcChhhcccC
Confidence 9999999988744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=202.00 Aligned_cols=157 Identities=26% Similarity=0.491 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++....... ......|++.|++||.
T Consensus 99 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~------~~~~~~~~~~y~~pe~ 172 (258)
T cd06632 99 FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS------FAKSFKGSPYWMAPEV 172 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc------cccccCCCcceeCHHH
Confidence 4567888899999999999999999999999999999999999999999987653221 1234568889999999
Q ss_pred ccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-CCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-PESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~-~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.... ++ .++|+||+|+++|++++|+.||......+....+...... ..+..+++.+++++++|+ .+|..||++++
T Consensus 173 ~~~~~~~~-~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 251 (258)
T cd06632 173 IAQQGGYG-LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAE 251 (258)
T ss_pred hcCCCCCC-chhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHH
Confidence 87655 44 6799999999999999999999877654444444432222 234567899999999999 69999999999
Q ss_pred HhcCCCC
Q psy10462 164 IRQDPWL 170 (347)
Q Consensus 164 il~~p~~ 170 (347)
++.|||+
T Consensus 252 ~l~~~~~ 258 (258)
T cd06632 252 LLEHPFV 258 (258)
T ss_pred HhcCCCC
Confidence 9999995
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-28 Score=221.73 Aligned_cols=158 Identities=30% Similarity=0.605 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC---CcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.-.+.++.||+.||+|||.++|+|+||||+|+|+... -.+||||||+|+.... .......+|||.|+|
T Consensus 661 L~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE------ksFRrsVVGTPAYLa 734 (888)
T KOG4236|consen 661 LPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE------KSFRRSVVGTPAYLA 734 (888)
T ss_pred chHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch------hhhhhhhcCCccccC
Confidence 4456677888999999999999999999999999999754 3589999999998764 334557789999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCC--CCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFP--ESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~--~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||+++...|. ..-|+||+|+++|--+.|..||... +++..+|+.. .-+| ++..+|+.+.+||.++| ....+|.
T Consensus 735 PEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRy 811 (888)
T KOG4236|consen 735 PEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRY 811 (888)
T ss_pred HHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhc
Confidence 9999998887 5679999999999999999999764 3445566543 2233 45679999999999999 6788999
Q ss_pred CHHHHhcCCCCCCC
Q psy10462 160 QMEDIRQDPWLKED 173 (347)
Q Consensus 160 ~~~eil~~p~~~~~ 173 (347)
+.+..+.|||+++-
T Consensus 812 svdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 812 SVDKSLSHPWLQDY 825 (888)
T ss_pred chHhhccchhhhcc
Confidence 99999999998763
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=214.73 Aligned_cols=157 Identities=21% Similarity=0.344 Sum_probs=125.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++++.+++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .......++..|+|||.
T Consensus 211 l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~~~~y~aPE~ 287 (375)
T cd05104 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY---VVKGNARLPVKWMAPES 287 (375)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc---cccCCCCCCcceeChhH
Confidence 567889999999999999999999999999999999999999999999999765432111 11112334667999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYS-ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+|||||++|+|++ |..||...... ...+.+..+...+.+...+.++++++..|+ .+|.+||++.+
T Consensus 288 ~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 366 (375)
T cd05104 288 IFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQ 366 (375)
T ss_pred hcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9887776 67999999999999997 89999876543 344444545444445567889999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
+++.
T Consensus 367 il~~ 370 (375)
T cd05104 367 IVQL 370 (375)
T ss_pred HHHH
Confidence 9754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=202.37 Aligned_cols=155 Identities=26% Similarity=0.398 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++.+.+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......... ......++..|+|||.
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~y~~Pe~ 174 (260)
T cd05069 99 LKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT----ARQGAKFPIKWTAPEA 174 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc----ccCCCccchhhCCHHH
Confidence 456778899999999999999999999999999999999999999999999765322111 1112235678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
..+...+ .++|+||+|+++|+|++ |+.||.+....+....+......+.+...+..++++++.|+ .+|.+||+++++
T Consensus 175 ~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 253 (260)
T cd05069 175 ALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYI 253 (260)
T ss_pred hccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 8776655 68999999999999999 99999988877777777666555556678899999999999 699999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 254 ~~ 255 (260)
T cd05069 254 QS 255 (260)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=207.18 Aligned_cols=163 Identities=25% Similarity=0.460 Sum_probs=129.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||
T Consensus 91 ~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~y~~PE 164 (277)
T cd05577 91 GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK------KIKGRAGTPGYMAPE 164 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC------ccccccCCCCcCCHH
Confidence 35678899999999999999999999999999999999999999999999986543211 112335778899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---ccCCCCCCCCCHHHHHHHHhcc-CCCCCCC--
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNIL-SPVKFRI-- 159 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-- 159 (347)
.+.+..++ .++|+||+|+++|+|++|+.||...+.......+.. ....+.+...++.+++++++|| .+|..||
T Consensus 165 ~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 243 (277)
T cd05577 165 VLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGC 243 (277)
T ss_pred HhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCC
Confidence 99877655 679999999999999999999977543211222221 1122334567899999999999 7999999
Q ss_pred ---CHHHHhcCCCCCCCCC
Q psy10462 160 ---QMEDIRQDPWLKEDSN 175 (347)
Q Consensus 160 ---~~~eil~~p~~~~~~~ 175 (347)
++.++++|||+.+-..
T Consensus 244 ~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 244 RGGSADEVREHPLFKDLNW 262 (277)
T ss_pred CcccHHHHHhChhhhcCCh
Confidence 8888999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=205.40 Aligned_cols=156 Identities=24% Similarity=0.345 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++........ .......++..|+|||.
T Consensus 116 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 192 (277)
T cd05032 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPES 192 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCccc---ccCCCCCccccccCHHH
Confidence 345678899999999999999999999999999999999999999999998755322110 11123346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|++++ |..||.+.+..+....+......+.+...+..+.+++.+|+ .+|..||++.++
T Consensus 193 ~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 271 (277)
T cd05032 193 LKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271 (277)
T ss_pred HhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 8876665 67999999999999998 99999988888877777755545556667899999999999 799999999999
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 272 ~~ 273 (277)
T cd05032 272 VS 273 (277)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=208.54 Aligned_cols=157 Identities=22% Similarity=0.378 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++......... . ......++..|+|||.
T Consensus 129 l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~-~~~~~~~~~~y~aPE~ 205 (293)
T cd05053 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY--R-KTTNGRLPVKWMAPEA 205 (293)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccce--e-ccCCCCCCccccCHHH
Confidence 556788899999999999999999999999999999999999999999999765321110 0 0111234567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|++++ |..||.+.+..+....+......+.+...+..+.+++.+|+ .+|..||+++++
T Consensus 206 ~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ei 284 (293)
T cd05053 206 LFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284 (293)
T ss_pred hccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 8877666 67999999999999997 99999998888888877776655556678899999999999 689999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 285 l~~ 287 (293)
T cd05053 285 VED 287 (293)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=201.19 Aligned_cols=158 Identities=25% Similarity=0.459 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
.+++.+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......... .....++..|+|||.
T Consensus 96 l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~y~~pe~ 170 (254)
T cd06627 96 FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-----DASVVGTPYWMAPEV 170 (254)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-----ccccccchhhcCHhh
Confidence 567888999999999999999999999999999999999999999999999766432211 223467889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+...+ .++|+||+|+++|+|++|..||.+.+.......+......+.+..++..+++++.+|| .+|+.||++++++
T Consensus 171 ~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 171 IEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred hcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence 8876654 6799999999999999999999877655545444444444455678899999999999 6999999999999
Q ss_pred cCCCC
Q psy10462 166 QDPWL 170 (347)
Q Consensus 166 ~~p~~ 170 (347)
.||||
T Consensus 250 ~~~~~ 254 (254)
T cd06627 250 KHPWI 254 (254)
T ss_pred cCCCC
Confidence 99996
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=202.29 Aligned_cols=162 Identities=31% Similarity=0.520 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+++++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......... ........+++.|+|||.
T Consensus 96 ~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~ 174 (264)
T cd06626 96 LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM-GEEVQSLAGTPAYMAPEV 174 (264)
T ss_pred CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc-cccccCCcCCcCccChhh
Confidence 4568889999999999999999999999999999999999999999999987654322211 110123467889999999
Q ss_pred ccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhc--cCCCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 87 LKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQKR--VVFPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 87 ~~~~~---~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
+.+.. .. .++|+||||+++|++++|+.||...+ .......+... ...|.....+....+++.+|+ .+|.+||
T Consensus 175 ~~~~~~~~~~-~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 253 (264)
T cd06626 175 ITGGKGKGHG-RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP 253 (264)
T ss_pred ccCCCCCCCC-cccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCC
Confidence 88654 33 67999999999999999999997653 22233233322 223444455899999999999 7899999
Q ss_pred CHHHHhcCCCC
Q psy10462 160 QMEDIRQDPWL 170 (347)
Q Consensus 160 ~~~eil~~p~~ 170 (347)
++++++.|||+
T Consensus 254 ~~~~i~~~~~~ 264 (264)
T cd06626 254 TASELLQHPFV 264 (264)
T ss_pred CHHHHhcCCCC
Confidence 99999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=203.72 Aligned_cols=161 Identities=29% Similarity=0.521 Sum_probs=132.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++......... .....++..|+|||
T Consensus 96 l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~y~~pE 170 (264)
T cd06623 96 IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-----CNTFVGTVTYMSPE 170 (264)
T ss_pred CCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-----ccceeecccccCHh
Confidence 4668889999999999999999 99999999999999999999999999998765432111 12345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhccCCCCCCC-CCHHHHHHHHhcc-CCCCCCCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRVVFPESPR-LSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~-~s~~~~~li~~~l-~~~~~R~~ 160 (347)
.+.+..++ .++|+||||+++|+|++|+.||... ...+....+......+.+.. .+..+.++++.|+ .+|..||+
T Consensus 171 ~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~ 249 (264)
T cd06623 171 RIQGESYS-YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249 (264)
T ss_pred hhCCCCCC-chhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCC
Confidence 99877655 6799999999999999999999876 44555555555444444445 7899999999999 68999999
Q ss_pred HHHHhcCCCCCCC
Q psy10462 161 MEDIRQDPWLKED 173 (347)
Q Consensus 161 ~~eil~~p~~~~~ 173 (347)
++++++|||++..
T Consensus 250 ~~~ll~~~~~~~~ 262 (264)
T cd06623 250 AAELLQHPFIKKA 262 (264)
T ss_pred HHHHHhCHHHHhc
Confidence 9999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=210.04 Aligned_cols=155 Identities=23% Similarity=0.372 Sum_probs=126.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.+++.++.|++.|++|||++|++||||||+|||++.++.+||+|||++....... ......++..|+|||
T Consensus 120 ~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE 193 (303)
T cd05088 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIE 193 (303)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhh------hcccCCCcccccCHH
Confidence 35678899999999999999999999999999999999999999999999985322100 011122456799999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+|||||++|+|+| |..||.+.+..+....+......+.+...+++..+++.+|+ .+|..||++++
T Consensus 194 ~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 272 (303)
T cd05088 194 SLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 272 (303)
T ss_pred HHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 98777665 67999999999999998 99999988877777666555444445567889999999999 78999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++..
T Consensus 273 il~~ 276 (303)
T cd05088 273 ILVS 276 (303)
T ss_pred HHHH
Confidence 9865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=202.44 Aligned_cols=155 Identities=25% Similarity=0.401 Sum_probs=128.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||.+......... ......++..|+|||.
T Consensus 99 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~----~~~~~~~~~~y~~PE~ 174 (262)
T cd05071 99 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT----ARQGAKFPIKWTAPEA 174 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc----cccCCcccceecCHhH
Confidence 355788999999999999999999999999999999999999999999999765422111 1112335678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
..+..++ .++|+||+|+++|++++ |..||.+....+....+......+.+...+..+.+++.+|+ .+|..||++.++
T Consensus 175 ~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~ 253 (262)
T cd05071 175 ALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 253 (262)
T ss_pred hccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 8777665 68999999999999999 89999988877777777666555556678899999999999 699999999988
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 254 ~~ 255 (262)
T cd05071 254 QA 255 (262)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=204.38 Aligned_cols=153 Identities=23% Similarity=0.375 Sum_probs=125.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+..+++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... .......+..|+|||.
T Consensus 109 l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~------~~~~~~~~~~y~apE~ 182 (270)
T cd05047 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIES 182 (270)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhh------hccCCCCccccCChHH
Confidence 4567889999999999999999999999999999999999999999999985322110 0111223567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |..||.+.+..+....+......+.+...+.+..+++.+|+ .+|..||++.++
T Consensus 183 ~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 183 LNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred HccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 8776665 67999999999999997 99999988877777777665554555567889999999999 789999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
+.
T Consensus 262 l~ 263 (270)
T cd05047 262 LV 263 (270)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=208.08 Aligned_cols=156 Identities=19% Similarity=0.327 Sum_probs=122.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++.+++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .......++..|+|||.
T Consensus 135 ~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 211 (304)
T cd05096 135 ISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWEC 211 (304)
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCcee---EecCcCCCCccccCHHH
Confidence 344678899999999999999999999999999999999999999999999765322111 11123345778999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHHhc-------cCCCCCCCCCHHHHHHHHhcc-CCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY--GRLPFDDTNYSELLKQVQKR-------VVFPESPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~--g~~pf~~~~~~~~~~~i~~~-------~~~~~~~~~s~~~~~li~~~l-~~~~ 156 (347)
+.+..++ .++|+|||||++|+|++ +..||.+.+..+....+... .....++..+..+.+++.+|+ .+|.
T Consensus 212 ~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 290 (304)
T cd05096 212 ILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR 290 (304)
T ss_pred HhcCCCC-chhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCch
Confidence 8877766 68999999999999986 67889887766655544321 112234567889999999999 6999
Q ss_pred CCCCHHHHhc
Q psy10462 157 FRIQMEDIRQ 166 (347)
Q Consensus 157 ~R~~~~eil~ 166 (347)
.||+++++.+
T Consensus 291 ~RPs~~~i~~ 300 (304)
T cd05096 291 ERPSFSDIHA 300 (304)
T ss_pred hCcCHHHHHH
Confidence 9999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=221.09 Aligned_cols=149 Identities=17% Similarity=0.259 Sum_probs=126.1
Q ss_pred CCCCCCccchhhhhhhhhhhcccccchhhhhhccccccc---c-hhheehhccCCchhhhhhchHHHHHHHhcCCCcchh
Q psy10462 179 KSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQ---D-VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI 254 (347)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~---~-~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv 254 (347)
.+...+.|.+.-++..+.+.+|+|+||.||+|+.+..+. . ||+|...............+.+|+++|+.++|||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 344566788888999999999999999999999865422 3 899998753333344566677999999999999999
Q ss_pred hhheeeeeCCeEEEEEEecCCCChHHHHHhCC-CCCHHHHHHHHHHH-HHHHHHhhcCccccCCCCccccccccc
Q psy10462 255 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEV-SNLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 255 ~l~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~-~~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+++|+....+++|||||+|+||+|.++|++.+ .++..+...+..++ .|+.|+|++++|||||..+|||+....
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG 299 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC
Confidence 99999999999999999999999999998866 58888877665555 599999999999999999999998744
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=205.27 Aligned_cols=157 Identities=20% Similarity=0.345 Sum_probs=130.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||+|||+++++|+||||+||+++.++.+||+|||+++.+...... .......++..|+|||
T Consensus 113 ~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~apE 189 (280)
T cd05043 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH---CLGDNENRPVKWMALE 189 (280)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE---EeCCCCCcchhccCHH
Confidence 3567888999999999999999999999999999999999999999999999765332111 0111223566799999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+||+||++|++++ |+.||.+.+..+....+......+.+...++++.+++.+|+ .+|+.||++.+
T Consensus 190 ~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 268 (280)
T cd05043 190 SLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQ 268 (280)
T ss_pred HHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 99877665 67999999999999998 99999988877777777666655556677899999999999 79999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+++
T Consensus 269 ~~~ 271 (280)
T cd05043 269 LVQ 271 (280)
T ss_pred HHH
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=205.88 Aligned_cols=160 Identities=30% Similarity=0.545 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++........ .......++..|+|||.
T Consensus 97 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~~~~~~~PE~ 172 (288)
T cd07833 97 LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA----SPLTDYVATRWYRAPEL 172 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----ccccCcccccCCcCCch
Confidence 56788999999999999999999999999999999999999999999999876543221 11223567889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------------CCCC----------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--------------------VFPE---------- 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------~~~~---------- 136 (347)
+.+....+.++|+||+|+++|+|++|+.||.+.+..+....+.... .+++
T Consensus 173 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (288)
T cd07833 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERR 252 (288)
T ss_pred hcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHh
Confidence 9877333478999999999999999999998765544333222100 0111
Q ss_pred -CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 -~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
+..++.+++++++.|+ .+|.+||+++++++||||
T Consensus 253 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 253 YPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 1234788999999999 689999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=221.13 Aligned_cols=139 Identities=16% Similarity=0.252 Sum_probs=122.2
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997543333333455778999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||++|+|.+++... .+++..++.++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~ 179 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG 179 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC
Confidence 999999999999999654 689999998888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=201.77 Aligned_cols=157 Identities=27% Similarity=0.545 Sum_probs=129.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++........ ......|++.|+|||.
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~~~pe~ 176 (260)
T cd08222 103 LSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD-----LATTFTGTPYYMSPEA 176 (260)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcc-----cccCCCCCcCccCHHH
Confidence 567889999999999999999999999999999999975 5699999999876533211 1223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||+|+++|+|++|..||.+.+..+....+..+.....+...+.++.+++.+|+ .+|..||++++++
T Consensus 177 ~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 177 LKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255 (260)
T ss_pred HccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 8876665 5799999999999999999999877766665555544333334567889999999999 7999999999999
Q ss_pred cCCCC
Q psy10462 166 QDPWL 170 (347)
Q Consensus 166 ~~p~~ 170 (347)
+|||+
T Consensus 256 ~~~~~ 260 (260)
T cd08222 256 RNPFI 260 (260)
T ss_pred hCCCC
Confidence 99996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=208.40 Aligned_cols=157 Identities=22% Similarity=0.364 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++.+++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......... ......+++.|+|||.
T Consensus 137 l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~---~~~~~~~~~~y~aPE~ 213 (307)
T cd05098 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK---KTTNGRLPVKWMAPEA 213 (307)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhh---ccccCCCccceeChHH
Confidence 4557888999999999999999999999999999999999999999999987543211100 0111224568999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+||++|+|++ |..||.+.+..+....+......+.+...+.++++++.+|+ .+|..||++.++
T Consensus 214 ~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 214 LFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred hccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 9877665 68999999999999998 99999988887777777666555556678899999999999 689999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 293 l~~ 295 (307)
T cd05098 293 VED 295 (307)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=216.84 Aligned_cols=131 Identities=22% Similarity=0.253 Sum_probs=116.3
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 276 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G 276 (347)
+.||+|+||.||++++..+|+.||+|++++...........+.+|+.+++.++||||++++++|...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899999999999999999999999997543323333445668999999999999999999999999999999999999
Q ss_pred ChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 277 SLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 277 ~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 132 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 132 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC
Confidence 9999998888999999999888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-26 Score=202.45 Aligned_cols=157 Identities=22% Similarity=0.378 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.|++.|+.|||+.|++|+||||+||+++.++.+|++|||++.......... ........++.|+|||.
T Consensus 104 ~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~ 181 (268)
T cd05063 104 FSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT--YTTSGGKIPIRWTAPEA 181 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc--eeccCCCcCceecCHHH
Confidence 4567889999999999999999999999999999999999999999999987654321110 00111123457999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|++++ |+.||...+..+....+......|.+...++++.+++.+|+ .+|..||++.++
T Consensus 182 ~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 182 IAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred hhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 9876665 68999999999999997 99999988888888888776666666778899999999999 699999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 261 ~~ 262 (268)
T cd05063 261 VN 262 (268)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=203.72 Aligned_cols=157 Identities=24% Similarity=0.535 Sum_probs=129.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|+..|+|||
T Consensus 96 ~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~y~~PE 169 (258)
T cd05578 96 KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT------LTTSTSGTPGYMAPE 169 (258)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc------cccccCCChhhcCHH
Confidence 45678899999999999999999999999999999999999999999999987654321 112345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
.+.+...+ .++|+||+|+++|+|++|+.||...+. .+....... ...+.+...+..+.+++++|+ .+|..|++.
T Consensus 170 ~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 170 VLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred HHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCc
Confidence 99876655 679999999999999999999997763 333333222 233445668899999999999 799999999
Q ss_pred --HHHhcCCCC
Q psy10462 162 --EDIRQDPWL 170 (347)
Q Consensus 162 --~eil~~p~~ 170 (347)
+++++||||
T Consensus 248 ~~~~l~~~~~~ 258 (258)
T cd05578 248 NLKDLKNHPYF 258 (258)
T ss_pred cHHHHhcCCCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=200.45 Aligned_cols=156 Identities=30% Similarity=0.517 Sum_probs=133.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++...... ......+++.|+|||.
T Consensus 100 ~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~~~~Pe~ 172 (256)
T cd08530 100 IPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-------MAKTQIGTPHYMAPEV 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-------CcccccCCccccCHHH
Confidence 556788899999999999999999999999999999999999999999998765432 1123457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||+|+++|+|++|+.||...+..+....+......+.+...+.++++++.+|+ .+|..||++++++
T Consensus 173 ~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 173 WKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred HCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 9887766 5799999999999999999999988877776666665544455678899999999999 6899999999999
Q ss_pred cCCCC
Q psy10462 166 QDPWL 170 (347)
Q Consensus 166 ~~p~~ 170 (347)
+||++
T Consensus 252 ~~p~~ 256 (256)
T cd08530 252 ASPAV 256 (256)
T ss_pred cCCCC
Confidence 99974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=214.64 Aligned_cols=129 Identities=13% Similarity=0.186 Sum_probs=115.3
Q ss_pred cccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCCCh
Q psy10462 199 KKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 278 (347)
Q Consensus 199 ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G~L 278 (347)
||+|+||.||+|++..+++.||+|++++...........+.+|+.++++++||||++++++|.+++.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999754333333345567899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 279 LEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 279 ~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+++.+.+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~ 130 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG 130 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC
Confidence 99998888999999998888776 99999999999999999999997765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=211.37 Aligned_cols=162 Identities=23% Similarity=0.424 Sum_probs=128.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.++++.++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...... .....+++.|+|||
T Consensus 114 ~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~y~aPE 185 (343)
T cd07880 114 KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--------MTGYVVTRWYRAPE 185 (343)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC--------ccccccCCcccCHH
Confidence 3567889999999999999999999999999999999999999999999998754321 12345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---------------------CC---------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---------------------FP--------- 135 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~---------------------~~--------- 135 (347)
.+.+....+.++|+||+|+++|++++|+.||.+.+.......+.+... .+
T Consensus 186 ~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (343)
T cd07880 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS 265 (343)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHH
Confidence 987643334689999999999999999999987765433332221100 00
Q ss_pred CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 136 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 136 ~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
..+.+++.+.+++.+|| .+|.+||++.+++.||||.....
T Consensus 266 ~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 266 LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 11356788999999999 69999999999999999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=200.54 Aligned_cols=156 Identities=21% Similarity=0.364 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......... .......++..|+|||.
T Consensus 91 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 167 (252)
T cd05084 91 LKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA---STGGMKQIPVKWTAPEA 167 (252)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc---ccCCCCCCceeecCchh
Confidence 456888999999999999999999999999999999999999999999998654321100 00011123456999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |..||...+..+....+......+.+...+..+.+++.+|+ .+|.+||++.++
T Consensus 168 ~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 246 (252)
T cd05084 168 LNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246 (252)
T ss_pred hcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9887766 67999999999999997 99999888777776766665555556677899999999999 689999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 247 ~~ 248 (252)
T cd05084 247 HQ 248 (252)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=198.77 Aligned_cols=165 Identities=22% Similarity=0.374 Sum_probs=127.2
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC----CcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.-++.++-||+.|+.|||++-|+||||||.|||+..+ |.+||+|||+|+.+...-... ......+-|.+|.|||
T Consensus 132 ~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl--~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 132 SMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPL--ASLDPVVVTIWYRAPE 209 (438)
T ss_pred HHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccccc--ccCCceEEEEEecChH
Confidence 5578889999999999999999999999999999877 899999999998875432111 1123456689999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---------HHHHHHHHhccCCCCC-------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---------SELLKQVQKRVVFPES------------------- 137 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~---------~~~~~~i~~~~~~~~~------------------- 137 (347)
.+.|....+.+.|+||.||++.||+|-++.|.+... .+.+.+|-+-..+|..
T Consensus 210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f 289 (438)
T KOG0666|consen 210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF 289 (438)
T ss_pred HhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHh
Confidence 999987777889999999999999999888865321 1233344333322210
Q ss_pred -----------------CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 138 -----------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 138 -----------------~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
..-++.+-+|+..|| .||.+|+++++.++|+||.+...+
T Consensus 290 ~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 290 RRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred HHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 112334778999999 799999999999999999988655
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=207.81 Aligned_cols=156 Identities=21% Similarity=0.353 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++.+++.||+.||.|||++|++||||||+||+++.++.+||+|||+++........ . ......++..|+|||.
T Consensus 131 l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~-~~~~~~~~~~y~aPE~ 207 (314)
T cd05099 131 LSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY--K-KTSNGRLPVKWMAPEA 207 (314)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccc--c-ccccCCCCccccCHHH
Confidence 456778899999999999999999999999999999999999999999999755321111 0 0111234467999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |..||.+.+..+....+......+.+...+.+.++++.+|+ .+|..||++.++
T Consensus 208 ~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 286 (314)
T cd05099 208 LFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286 (314)
T ss_pred HccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 9877666 67999999999999998 99999998888888777766544445677889999999999 699999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 287 l~ 288 (314)
T cd05099 287 VE 288 (314)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=205.87 Aligned_cols=163 Identities=25% Similarity=0.490 Sum_probs=134.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.++.++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 113 ~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~~pE~ 187 (292)
T cd06657 113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-----RRKSLVGTPYWMAPEL 187 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-----cccccccCccccCHHH
Confidence 46688899999999999999999999999999999999999999999999875532111 1123467889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+|+++|+|++|..||.+.+..+....+..... .+....++..+.+++..|+ .+|.+||++++
T Consensus 188 ~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ 266 (292)
T cd06657 188 ISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 266 (292)
T ss_pred hcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHH
Confidence 8776665 679999999999999999999998776666555544332 2233457889999999999 79999999999
Q ss_pred HhcCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSN 175 (347)
Q Consensus 164 il~~p~~~~~~~ 175 (347)
++.|||+.....
T Consensus 267 ll~~~~~~~~~~ 278 (292)
T cd06657 267 LLKHPFLAKAGP 278 (292)
T ss_pred HhcChHHhccCC
Confidence 999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-26 Score=206.54 Aligned_cols=157 Identities=22% Similarity=0.430 Sum_probs=128.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......... ......++..|+|||.
T Consensus 106 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~~PE~ 182 (303)
T cd05110 106 IGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY---NADGGKMPIKWMALEC 182 (303)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccccc---ccCCCccccccCCHHH
Confidence 4567889999999999999999999999999999999999999999999997654322111 1112335678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |..||.+....+....+......+.++..+....+++..|+ .+|..||+++++
T Consensus 183 ~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l 261 (303)
T cd05110 183 IHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261 (303)
T ss_pred hccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9877766 67999999999999997 99999887777766666666666666677889999999999 689999999998
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 262 ~~~ 264 (303)
T cd05110 262 AAE 264 (303)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=221.65 Aligned_cols=140 Identities=20% Similarity=0.234 Sum_probs=119.5
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC------e
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH------R 265 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~ 265 (347)
.+...+.+|+|+||.||+++++.||+.||||..++..... ..+.-.+|+++|++|+|||||++.++=++.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3456678999999999999999999999999998754322 2445569999999999999999999876544 5
Q ss_pred EEEEEEecCCCChHHHHHh---CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEE
Q psy10462 266 VYIIMEYAKNGSLLEVIRK---ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIV 333 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~---~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~ 333 (347)
..+|||||+||||..+|++ ...++|.+.+.+...++ |+.|+|+.||+||||||.||++.+..+..+|+
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEE
Confidence 7899999999999999964 45899999998888665 99999999999999999999999988766654
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-26 Score=202.69 Aligned_cols=158 Identities=29% Similarity=0.496 Sum_probs=121.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
.+..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++........ ......|++.|+|||.
T Consensus 106 ~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~aPE~ 180 (268)
T cd06624 106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-----CTETFTGTLQYMAPEV 180 (268)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-----ccccCCCCccccChhh
Confidence 45677888999999999999999999999999999976 67899999999875532111 1223457889999999
Q ss_pred ccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH-hccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 87 LKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE-LLKQVQ-KRVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 87 ~~~~~-~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~-~~~~i~-~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
+.+.. ..+.++|+||+|+++|+|++|..||....... ...... .......+..+++++++++++|+ .+|..||+++
T Consensus 181 ~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 260 (268)
T cd06624 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAH 260 (268)
T ss_pred hccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHH
Confidence 86543 12367999999999999999999997643221 111111 11122234567889999999999 6899999999
Q ss_pred HHhcCCCC
Q psy10462 163 DIRQDPWL 170 (347)
Q Consensus 163 eil~~p~~ 170 (347)
+++.|||+
T Consensus 261 ~ll~~~~~ 268 (268)
T cd06624 261 DLLQDPFL 268 (268)
T ss_pred HHHhCCCC
Confidence 99999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=215.73 Aligned_cols=131 Identities=20% Similarity=0.233 Sum_probs=116.8
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 276 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G 276 (347)
+.||+|+||.||++++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999997643333333455678999999999999999999999999999999999999
Q ss_pred ChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 277 SLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 277 ~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|.+++...+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 132 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG 132 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC
Confidence 9999998888999999998888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-26 Score=202.66 Aligned_cols=157 Identities=20% Similarity=0.400 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCccccc--CCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC--GSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~--gt~~y~aP 84 (347)
++..++..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......... ....... .+..|+||
T Consensus 103 ~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~y~~P 180 (269)
T cd05065 103 FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP--TYTSSLGGKIPIRWTAP 180 (269)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc--ccccccCCCcceeecCH
Confidence 4567889999999999999999999999999999999999999999999987553321111 0111111 24579999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
|.+.+..++ .++|+||+||++|++++ |..||.+.+..+....+......|.+...+..+.+++..|+ .+|..||+++
T Consensus 181 E~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (269)
T cd05065 181 EAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFG 259 (269)
T ss_pred hHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999877766 67999999999999886 99999988888887777766666666778899999999999 6899999999
Q ss_pred HHhc
Q psy10462 163 DIRQ 166 (347)
Q Consensus 163 eil~ 166 (347)
+++.
T Consensus 260 ~i~~ 263 (269)
T cd05065 260 QIVS 263 (269)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=216.69 Aligned_cols=145 Identities=16% Similarity=0.240 Sum_probs=124.7
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||++++..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|++++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999999999999999999999999997543333334455778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 271 EYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 271 E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||+++|+|.+++.+ ...+++..++.++.|++ ++.|+|++||+||||||+|||++.++ .+.++..|
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg 147 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG---HIRLADFG 147 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC---CEEEEECC
Confidence 99999999999976 56799999998888776 99999999999999999999997765 34444444
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=202.97 Aligned_cols=160 Identities=28% Similarity=0.484 Sum_probs=126.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++.+++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......... .....++..|+|||
T Consensus 94 ~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-----~~~~~~~~~~~aPE 168 (282)
T cd07829 94 PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-----YTHEVVTLWYRAPE 168 (282)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-----cCccccCcCcCChH
Confidence 4567889999999999999999999999999999999999999999999998765432111 12234577899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-------------------CC---------CC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-------------------FP---------ES 137 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-------------------~~---------~~ 137 (347)
.+.+....+.++|+||+|+++|++++|+.||...+..+....+.+... ++ ..
T Consensus 169 ~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd07829 169 ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL 248 (282)
T ss_pred HhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc
Confidence 987663334679999999999999999999988765554444332111 00 01
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
+..+..+.+++++|| .+|..||+++++++||||
T Consensus 249 ~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 249 PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 234678999999999 799999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=200.14 Aligned_cols=157 Identities=24% Similarity=0.446 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.........+.. .....++..|+|||.
T Consensus 94 ~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~--~~~~~~~~~y~~pE~ 171 (257)
T cd05040 94 FLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM--EEHLKVPFAWCAPES 171 (257)
T ss_pred CcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec--ccCCCCCceecCHHH
Confidence 566888999999999999999999999999999999999999999999999876432221111 123456788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+|||||++|+|++ |..||...+..+....+.. ....+.+...+....+++..|+ .+|..||++.+
T Consensus 172 ~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 250 (257)
T cd05040 172 LRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAA 250 (257)
T ss_pred hcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 8877766 57999999999999998 9999988887777766654 2233344567889999999999 79999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+.+
T Consensus 251 ~~~ 253 (257)
T cd05040 251 LRE 253 (257)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=199.54 Aligned_cols=157 Identities=24% Similarity=0.494 Sum_probs=128.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||
T Consensus 94 ~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~PE 167 (253)
T cd05122 94 TLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA------RNTMVGTPYWMAPE 167 (253)
T ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc------ccceecCCcccCHH
Confidence 346788899999999999999999999999999999999999999999999876543211 23456788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+...+ .++|+||+|+++|+|++|+.||...+..+.......... .+.....+..+.+++.+|+ .+|..||++.
T Consensus 168 ~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ 246 (253)
T cd05122 168 VINGKPYD-YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAE 246 (253)
T ss_pred HHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHH
Confidence 99876654 679999999999999999999988765554444433221 2223334889999999999 7999999999
Q ss_pred HHhcCCC
Q psy10462 163 DIRQDPW 169 (347)
Q Consensus 163 eil~~p~ 169 (347)
++++|||
T Consensus 247 ~~l~~~~ 253 (253)
T cd05122 247 QLLKHPF 253 (253)
T ss_pred HHhcCCC
Confidence 9999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=210.09 Aligned_cols=145 Identities=20% Similarity=0.290 Sum_probs=131.2
Q ss_pred CCCCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 181 KSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
.+...+....++|++...||.|..++||+|+...+++.||||+++....... .+.+.+|+..|+.++||||++++..|
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 3445677888999999999999999999999999999999999987654433 56788999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..+..+|+||.||.+|++.+.++.. ..++|..+..+.++++ ||.|+|.+|.||||||+.|||++.+|
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG 163 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG 163 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC
Confidence 9999999999999999999999763 4699999999999766 99999999999999999999999887
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=222.29 Aligned_cols=161 Identities=22% Similarity=0.334 Sum_probs=115.1
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCcccccccccc
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 88 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 88 (347)
..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+|........ .....+++++.|+|||.+.
T Consensus 255 ~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~----~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 255 KIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred HHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc----cCCcccccCCCccChHHhh
Confidence 346789999999999999999999999999999986 57899999999976533211 1223567899999999764
Q ss_pred CCCCC---------------------CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-------------cCC
Q psy10462 89 GVPYT---------------------PQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-------------VVF 134 (347)
Q Consensus 89 ~~~~~---------------------~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-------------~~~ 134 (347)
..... +.++||||+||++|+|+++..|+... .......+... ...
T Consensus 331 ~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~ 409 (566)
T PLN03225 331 MSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRAS 409 (566)
T ss_pred ccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccc
Confidence 32211 13469999999999999987775432 11111111110 000
Q ss_pred C-------CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 135 P-------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 135 ~-------~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
+ ..........+|+..|| .+|.+||+++++++||||.....
T Consensus 410 ~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 410 PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred hhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 0 00112234568999999 79999999999999999987654
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-26 Score=201.10 Aligned_cols=155 Identities=23% Similarity=0.428 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......... ......++..|+|||.
T Consensus 99 ~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~y~~pe~ 174 (260)
T cd05067 99 LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT----AREGAKFPIKWTAPEA 174 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc----cccCCcccccccCHHH
Confidence 456788999999999999999999999999999999999999999999998765421111 1112335678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |+.||.+.+..+....+......+.+...+.+..+++.+|+ .+|..||+++++
T Consensus 175 ~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 253 (260)
T cd05067 175 INYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYL 253 (260)
T ss_pred hccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9877665 67999999999999998 99999988888877777766666666778899999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 254 ~~ 255 (260)
T cd05067 254 RS 255 (260)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=226.77 Aligned_cols=161 Identities=26% Similarity=0.477 Sum_probs=122.9
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceeccc----------CCc---cccccCccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSV----------NNT---DYKQNLSET 74 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~----------~~~---~~~~~~~~~ 74 (347)
..++++++|+||++||.|+|++|||||||||.||+++.++.+||+|||+|..... ... .......+.
T Consensus 695 ~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts 774 (1351)
T KOG1035|consen 695 QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTS 774 (1351)
T ss_pred hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccc
Confidence 4689999999999999999999999999999999999999999999999976210 000 001112245
Q ss_pred ccCCccccccccccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhccCCCCC----CCCCHHHHHH
Q psy10462 75 FCGSYAYASPEILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFPES----PRLSSSCKAL 147 (347)
Q Consensus 75 ~~gt~~y~aPE~~~~~~--~~~~~~Dvws~G~~l~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~----~~~s~~~~~l 147 (347)
.+||..|+|||++.+.. ....|+|+||+|++++||+ +||... ....++..+.+ ...|.+ ..--+..+.+
T Consensus 775 ~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~-g~iP~~~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 775 QVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRK-GSIPEPADFFDPEHPEEASL 850 (1351)
T ss_pred ccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhccc-CCCCCCcccccccchHHHHH
Confidence 68999999999998766 2337899999999999998 567532 23334444443 333433 1223566789
Q ss_pred HHhcc-CCCCCCCCHHHHhcCCCCCC
Q psy10462 148 ISNIL-SPVKFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 148 i~~~l-~~~~~R~~~~eil~~p~~~~ 172 (347)
|+.|+ .+|.+|||+.|++++.|+.+
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhhccCCCc
Confidence 99999 69999999999999999885
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=198.13 Aligned_cols=157 Identities=34% Similarity=0.635 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.
T Consensus 90 l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~~Pe~ 164 (250)
T cd05123 90 FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-----SRTNTFCGTPEYLAPEV 164 (250)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----CcccCCcCCccccChHH
Confidence 5678899999999999999999999999999999999999999999999987654321 11234567889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH---H
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM---E 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~---~ 162 (347)
+.+...+ .++|+||||+++|++++|..||...+..+....+.. ...+.+...+....+++++|+ .+|..||++ +
T Consensus 165 ~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~ 242 (250)
T cd05123 165 LLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAE 242 (250)
T ss_pred hCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHH
Confidence 8876654 679999999999999999999988776666666554 334555667899999999999 789999999 9
Q ss_pred HHhcCCCC
Q psy10462 163 DIRQDPWL 170 (347)
Q Consensus 163 eil~~p~~ 170 (347)
++++||||
T Consensus 243 ~l~~~~~f 250 (250)
T cd05123 243 EIKAHPFF 250 (250)
T ss_pred HHHhCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-27 Score=219.22 Aligned_cols=148 Identities=16% Similarity=0.248 Sum_probs=126.3
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
....++|++.+.||+|+||+||+|++..+++.||+|++++...........+.+|+.+++.++||||+++++++++++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34567899999999999999999999999999999999754333333345567899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|||||+||+|.+++.. ..+++..+..++.|++ |+.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~---~~kL~DfG 187 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG---HLKLADFG 187 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC---CEEEEecc
Confidence 999999999999999865 4689999988887766 99999999999999999999998765 34444444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=205.73 Aligned_cols=159 Identities=25% Similarity=0.490 Sum_probs=125.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++.++..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++........ .....+++.|+|||
T Consensus 111 l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~------~~~~~~~~~y~aPE 184 (296)
T cd06618 111 IPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA------KTRSAGCAAYMAPE 184 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc------ccCCCCCccccCHh
Confidence 5567788999999999999997 5999999999999999999999999999875532111 12234678899999
Q ss_pred cccCCC----CCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcc--CCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 86 ILKGVP----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRV--VFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 86 ~~~~~~----~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~~~--~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
.+.+.. ++ .++|+||||+++|+|++|+.||..... .+.+..+.... ..+.....+.++.+++.+|+ .+|..
T Consensus 185 ~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 263 (296)
T cd06618 185 RIDPPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRK 263 (296)
T ss_pred hcCCCCCccccc-cchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence 987653 33 579999999999999999999976432 23333333222 22333357889999999999 69999
Q ss_pred CCCHHHHhcCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKE 172 (347)
Q Consensus 158 R~~~~eil~~p~~~~ 172 (347)
||++++++.|||+..
T Consensus 264 Rp~~~~il~~~~~~~ 278 (296)
T cd06618 264 RPKYRELLQHPFIRR 278 (296)
T ss_pred CCCHHHHhcChhhhc
Confidence 999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=200.36 Aligned_cols=154 Identities=21% Similarity=0.408 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+..+++.+++.||+.||.|||++|++|+||||+||+++.++.+||+|||++......... .....++..|+|||.
T Consensus 101 ~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~~PE~ 175 (261)
T cd05148 101 LPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-----SSDKKIPYKWTAPEA 175 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-----ccCCCCceEecCHHH
Confidence 456788999999999999999999999999999999999999999999998765321111 112235678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |+.||...+..+....+......+.+...++...+++..|+ .+|..||++.++
T Consensus 176 ~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (261)
T cd05148 176 ASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKAL 254 (261)
T ss_pred HccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 8876665 67999999999999998 89999988887888877776666667788999999999999 699999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 255 ~~ 256 (261)
T cd05148 255 RE 256 (261)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=201.72 Aligned_cols=159 Identities=25% Similarity=0.374 Sum_probs=124.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||
T Consensus 95 ~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~aPE 168 (283)
T cd07830 95 PFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP------PYTDYVSTRWYRAPE 168 (283)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC------CcCCCCCcccccCce
Confidence 35678899999999999999999999999999999999999999999999987653211 112345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----------------------------C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-----------------------------E 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----------------------------~ 136 (347)
.+.+....+.++|+||||+++|+|++|+.||...+..+....+......+ .
T Consensus 169 ~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T cd07830 169 ILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQL 248 (283)
T ss_pred eeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHH
Confidence 88654433467999999999999999999998766544433332211100 0
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.+..+..+++++++|+ .+|..||+++|++.|||+
T Consensus 249 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 249 IPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 1123678999999999 699999999999999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=207.17 Aligned_cols=167 Identities=20% Similarity=0.380 Sum_probs=124.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc--ccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD--YKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~gt~~y~aP 84 (347)
+.+..++.++.|++.||+|||+++|+||||||+||+++.++.+|++|||.+......... ..........++..|+||
T Consensus 98 ~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (314)
T cd08216 98 LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177 (314)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCH
Confidence 456788999999999999999999999999999999999999999999988755322110 001111234567889999
Q ss_pred ccccCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHhccC----------------------------
Q psy10462 85 EILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL-KQVQKRVV---------------------------- 133 (347)
Q Consensus 85 E~~~~~--~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~-~~i~~~~~---------------------------- 133 (347)
|.+.+. .++ .++|+||+||++|+|++|..||.+....... ..+.....
T Consensus 178 E~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
T cd08216 178 EVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNR 256 (314)
T ss_pred HHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchh
Confidence 998763 344 5799999999999999999999876543322 22211100
Q ss_pred ----CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 134 ----FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 134 ----~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.+....++.++.++++.|| .+|..||+++++++|||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 257 DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0001123467889999999 6999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-27 Score=195.56 Aligned_cols=160 Identities=26% Similarity=0.429 Sum_probs=122.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEcCCCcEEEeccCCceecccC---Cccc--cccCcccccCCc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVN---NTDY--KQNLSETFCGSY 79 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~--iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~---~~~~--~~~~~~~~~gt~ 79 (347)
++|.++..|+.+|++||++||+.. .+||||||.|||+.+.+.+++.|||.+...... ..+. .+...+. ..|.
T Consensus 124 ~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e-~Ct~ 202 (302)
T KOG2345|consen 124 VSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEE-RCTI 202 (302)
T ss_pred cCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHH-hCCC
Confidence 567899999999999999999998 999999999999999999999999998654321 1000 0111112 3578
Q ss_pred cccccccccCCCCC--CChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHH-HhccCCCCCCCCCHHHHHHHHhcc-C
Q psy10462 80 AYASPEILKGVPYT--PQQSDIWSMGVVLFAMVYGRLPFDDTNY--SELLKQV-QKRVVFPESPRLSSSCKALISNIL-S 153 (347)
Q Consensus 80 ~y~aPE~~~~~~~~--~~~~Dvws~G~~l~~ll~g~~pf~~~~~--~~~~~~i-~~~~~~~~~~~~s~~~~~li~~~l-~ 153 (347)
.|.|||.+.-.... +.++|||||||++|+|+.|..||+-.-. ..+.-.+ .....+|...+.|+....+++.|| .
T Consensus 203 pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqv 282 (302)
T KOG2345|consen 203 PYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQV 282 (302)
T ss_pred cccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcC
Confidence 89999998654322 3689999999999999999999963110 0011112 224567888889999999999999 7
Q ss_pred CCCCCCCHHHHhcC
Q psy10462 154 PVKFRIQMEDIRQD 167 (347)
Q Consensus 154 ~~~~R~~~~eil~~ 167 (347)
||..||+..+++.+
T Consensus 283 dP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 283 DPNQRPTIPELLSK 296 (302)
T ss_pred CcccCCCHHHHHHH
Confidence 99999999999864
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=205.17 Aligned_cols=158 Identities=22% Similarity=0.390 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.||+.|+.|||++|++|+||+|+||+++.++.+||+|||++..... .....|+..|+|||.
T Consensus 118 l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---------~~~~~~~~~y~aPE~ 188 (313)
T cd06633 118 LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---------ANSFVGTPYWMAPEV 188 (313)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---------CCCccccccccChhh
Confidence 45678888999999999999999999999999999999999999999998854321 123568889999999
Q ss_pred ccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 87 LKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 87 ~~~---~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
+.+ ..++ .++|+||+|+++|+|++|..||.+.+.......+..... .......+...++++.+|| .+|..||++
T Consensus 189 ~~~~~~~~~~-~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~ 267 (313)
T cd06633 189 ILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPAS 267 (313)
T ss_pred ccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCH
Confidence 853 3344 579999999999999999999988776555555443322 1223456788999999999 789999999
Q ss_pred HHHhcCCCCCCCC
Q psy10462 162 EDIRQDPWLKEDS 174 (347)
Q Consensus 162 ~eil~~p~~~~~~ 174 (347)
.+++.|||+....
T Consensus 268 ~~~l~~~~~~~~~ 280 (313)
T cd06633 268 AELLRHDFVRRDR 280 (313)
T ss_pred HHHhcCcccCCCc
Confidence 9999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-27 Score=206.87 Aligned_cols=161 Identities=24% Similarity=0.410 Sum_probs=125.5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC--------------------CCcEEEeccCCceecccCC
Q psy10462 5 LDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--------------------KYNIKLSDFGFARKYSVNN 64 (347)
Q Consensus 5 ~~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~--------------------~~~~kl~Dfg~a~~~~~~~ 64 (347)
..|..+.++.+..|++++++|||+.+++|-||||+|||+-. ...++|+|||.|.....
T Consensus 187 ~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-- 264 (415)
T KOG0671|consen 187 IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-- 264 (415)
T ss_pred cccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc--
Confidence 34666899999999999999999999999999999999831 23589999999865432
Q ss_pred ccccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCC-------
Q psy10462 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPE------- 136 (347)
Q Consensus 65 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~------- 136 (347)
.-.+.+.|..|.|||++.+.+++ .++||||+||+++|+.||...|..-+..|-+..++.... +|.
T Consensus 265 ------~hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~ 337 (415)
T KOG0671|consen 265 ------HHSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR 337 (415)
T ss_pred ------CcceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh
Confidence 12456789999999999999988 679999999999999999999987665553333332221 110
Q ss_pred -----------CCC--------------------------CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 137 -----------SPR--------------------------LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 137 -----------~~~--------------------------~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
++. --..+.+|+++|| .||.+|+|+.|++.||||....
T Consensus 338 ~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 338 KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 000 0024678999999 7999999999999999997643
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=201.49 Aligned_cols=158 Identities=20% Similarity=0.392 Sum_probs=129.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+....+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......... .......+++.|++||
T Consensus 109 ~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe 185 (273)
T cd05074 109 TLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY---RQGCASKLPVKWLALE 185 (273)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcce---ecCCCccCchhhcCHh
Confidence 4566788999999999999999999999999999999999999999999998765322111 0112234567899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+|||||++|+|++ |+.||.+.+..+....+......+.++..+..+.+++..|+ .+|..||++.+
T Consensus 186 ~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~ 264 (273)
T cd05074 186 SLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQH 264 (273)
T ss_pred HHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 98877665 67999999999999998 99999988877777777665544555667899999999999 78999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++..
T Consensus 265 ~~~~ 268 (273)
T cd05074 265 LRDQ 268 (273)
T ss_pred HHHH
Confidence 8753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=201.01 Aligned_cols=141 Identities=21% Similarity=0.317 Sum_probs=124.1
Q ss_pred hhhhhhhh-hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeE
Q psy10462 189 HKRKLKLI-RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 189 ~~~~~~~~-~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 266 (347)
-.+.|++. ..+|+|+||.|--|....||..||+|+|.+.... .+..+-||++++..+ .|+||++|+++|+++..+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 35666665 5699999999999999999999999999876432 245566999999999 799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeE
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTI 332 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~ 332 (347)
|+|||-|.||.|.+.|.+++.|+|.+|+.+.+.++ +|.++|.+||.||||||+|||-.....-|-+
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPv 218 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPV 218 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCce
Confidence 99999999999999999999999999999999776 9999999999999999999998655544433
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=201.30 Aligned_cols=161 Identities=25% Similarity=0.461 Sum_probs=125.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..++.++.|++.||.|||+++++|+||+|+||+++.++.++++|||++....... .........|+..|+|||.
T Consensus 105 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~ 181 (272)
T cd06629 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY---DNDQNMSMQGSVFWMAPEV 181 (272)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccc---cccccccccCCccccCHHH
Confidence 4567888999999999999999999999999999999999999999999986543211 1111234467889999999
Q ss_pred ccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc---CCCC--CCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 87 LKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV---VFPE--SPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 87 ~~~~~-~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~--~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
+.+.. ..+.++|+||+|+++|++++|..||...+..+....+.... .++. ...++..+++++..|+ .+|..||
T Consensus 182 ~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 261 (272)
T cd06629 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP 261 (272)
T ss_pred hccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC
Confidence 87654 22367999999999999999999998765544443332211 1221 1346889999999999 7999999
Q ss_pred CHHHHhcCCCC
Q psy10462 160 QMEDIRQDPWL 170 (347)
Q Consensus 160 ~~~eil~~p~~ 170 (347)
+++++++|||+
T Consensus 262 s~~~il~~~~~ 272 (272)
T cd06629 262 TARELLQHPFI 272 (272)
T ss_pred CHHHHhhCCCC
Confidence 99999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=198.91 Aligned_cols=151 Identities=25% Similarity=0.434 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ......+..|+|||.
T Consensus 97 ~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~~y~~pe~ 168 (254)
T cd05083 97 VSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--------VDNSKLPVKWTAPEA 168 (254)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--------CCCCCCCceecCHHH
Confidence 456778889999999999999999999999999999999999999999998654221 111223567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |+.||.+.+..+....+.++...+.+...+..+.+++..|+ .+|..||++.++
T Consensus 169 ~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 247 (254)
T cd05083 169 LKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKL 247 (254)
T ss_pred hccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 8877666 67999999999999997 99999998888877777776655556678899999999999 689999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
+.
T Consensus 248 ~~ 249 (254)
T cd05083 248 RE 249 (254)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=201.91 Aligned_cols=156 Identities=19% Similarity=0.350 Sum_probs=118.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
.++.+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......... .......+++.|+|||.+
T Consensus 98 ~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05042 98 QKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY---ITKDCHAVPLRWLAPELV 174 (269)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe---eccCCCCCcccccCHHHH
Confidence 34667889999999999999999999999999999999999999999998653321110 011223456789999987
Q ss_pred cCC------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccC--CCC---CCCCCHHHHHHHHhccCCC
Q psy10462 88 KGV------PYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVV--FPE---SPRLSSSCKALISNILSPV 155 (347)
Q Consensus 88 ~~~------~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~--~~~---~~~~s~~~~~li~~~l~~~ 155 (347)
... ...+.++|+||+||++|+|++ |..||......+.+..+..... .+. ....+...+.++..|+.+|
T Consensus 175 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dp 254 (269)
T cd05042 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLDP 254 (269)
T ss_pred hhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhcCc
Confidence 531 122368999999999999998 8899988776665555433221 121 2357788899999998899
Q ss_pred CCCCCHHHHhc
Q psy10462 156 KFRIQMEDIRQ 166 (347)
Q Consensus 156 ~~R~~~~eil~ 166 (347)
..||+++++++
T Consensus 255 ~~Rpt~~~v~~ 265 (269)
T cd05042 255 ETRPTAEEVHE 265 (269)
T ss_pred ccccCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=213.04 Aligned_cols=139 Identities=20% Similarity=0.251 Sum_probs=119.2
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 276 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G 276 (347)
+.+|+|+||+||++.+..+|+.||+|++.+...........+.+|+++++.++||||++++++|..++.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999997643333333445668999999999999999999999999999999999999
Q ss_pred ChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhh-cCccccCCCCccccccccccceeEEEEEee
Q psy10462 277 SLLEVIRKERYIDEDKALLCYSEVS-NLSQTFS-RCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 277 ~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~-~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+|.+++.+.+.+++..+..++.|++ |+.|+|+ +||+||||||+|||++.++ .+.++..|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~---~~kL~Dfg 141 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG---HIKITDFG 141 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC---CEEEecCC
Confidence 9999998888999999999988776 9999996 8999999999999998765 34444443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=202.70 Aligned_cols=161 Identities=24% Similarity=0.443 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~y~~PE~ 172 (277)
T cd06641 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-----KRNTFVGTPFWMAPEV 172 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-----hhccccCCccccChhh
Confidence 45688899999999999999999999999999999999999999999999876532111 1223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+...+ .++|+||+||++|+|++|..||...+.......+............+.++.+++..|+ .+|..||++.+++
T Consensus 173 ~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 251 (277)
T cd06641 173 IKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 251 (277)
T ss_pred hccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9876655 5799999999999999999999887766555555443322233467889999999999 6899999999999
Q ss_pred cCCCCCCC
Q psy10462 166 QDPWLKED 173 (347)
Q Consensus 166 ~~p~~~~~ 173 (347)
+|||+.+.
T Consensus 252 ~~~~~~~~ 259 (277)
T cd06641 252 KHKFIVRF 259 (277)
T ss_pred hCHHHhhh
Confidence 99998774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=206.50 Aligned_cols=162 Identities=26% Similarity=0.471 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+...++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~y~~PE~ 186 (293)
T cd06647 112 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEV 186 (293)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-----ccccccCChhhcCchh
Confidence 35678899999999999999999999999999999999999999999998865543211 1223468889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--VVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||||+++|++++|+.||...+..+....+... ..++.+..++...++++++|+ .+|..||++++
T Consensus 187 ~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 265 (293)
T cd06647 187 VTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 265 (293)
T ss_pred hccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 9876665 5799999999999999999999876654433333221 223334557889999999999 69999999999
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
++.|+|+....
T Consensus 266 il~h~~~~~~~ 276 (293)
T cd06647 266 LLQHPFLKIAK 276 (293)
T ss_pred HhcCHHHhcCc
Confidence 99999998655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=200.65 Aligned_cols=150 Identities=22% Similarity=0.298 Sum_probs=117.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc-------EEEeccCCceecccCCccccccCcccccCCc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-------IKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~ 79 (347)
+++.++.+++.||+.||+|||++||+||||||+|||++.++. ++++|||++..... .....++.
T Consensus 102 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~---------~~~~~~~~ 172 (262)
T cd05077 102 LTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS---------RQECVERI 172 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC---------cccccccc
Confidence 566888999999999999999999999999999999986654 89999999865432 12235778
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 80 AYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 80 ~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
.|+|||.+.+....+.++|||||||++|+|+ +|..||.+....+........ .+.....+.++++++.+|+ .+|.+
T Consensus 173 ~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~ 250 (262)
T cd05077 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ--CMLVTPSCKELADLMTHCMNYDPNQ 250 (262)
T ss_pred cccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC--ccCCCCChHHHHHHHHHHcCCChhh
Confidence 8999999874433346899999999999997 699999876654443322222 1222334678999999999 79999
Q ss_pred CCCHHHHhcC
Q psy10462 158 RIQMEDIRQD 167 (347)
Q Consensus 158 R~~~~eil~~ 167 (347)
||++.+++.+
T Consensus 251 Rp~~~~il~~ 260 (262)
T cd05077 251 RPFFRAIMRD 260 (262)
T ss_pred CcCHHHHHHh
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=218.72 Aligned_cols=140 Identities=13% Similarity=0.237 Sum_probs=129.0
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
.+..|..++.||-|+||+|.+++...|...||+|.+++...-...+..-+.-|-.||..-+.+-||+||..|++++.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 45667778899999999999999999999999999998776666666678889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHH-HHHHHHhhcCccccCCCCcccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEV-SNLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~-~~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
||||.+|||+..+|.+.+.|+|+.|+||.+++ +++.+.|..|.|||||||.|||+|+++.
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH 767 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH 767 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc
Confidence 99999999999999999999999999998876 5999999999999999999999999984
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=214.44 Aligned_cols=145 Identities=16% Similarity=0.217 Sum_probs=124.2
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|..+++.++||||+++++++++++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999999999999999987543333333455778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 271 EYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 271 E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||++||+|.+++.+ ...+++..+..++.|++ ++.|+|++||+||||||+|||++.++ .+.++..|
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~---~~kl~DfG 147 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG---HIRLADFG 147 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC---CEEEEecc
Confidence 99999999999976 56899999998888766 99999999999999999999998765 24444444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=214.13 Aligned_cols=131 Identities=21% Similarity=0.293 Sum_probs=117.5
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|++..+++.||+|++++...........+.+|..+++.+ +||||++++++|++.+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999999999999999765444444455677899999998 799999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~ 133 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG 133 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC
Confidence 99999998888999999999988776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-27 Score=217.49 Aligned_cols=136 Identities=15% Similarity=0.269 Sum_probs=122.5
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|++.+.||.|+||+||+|++..+|+.||+|++++...........+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 57888999999999999999999999999999976543333345567799999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+++|+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~ 138 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG 138 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC
Confidence 999999999998888999999999888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=203.31 Aligned_cols=162 Identities=26% Similarity=0.488 Sum_probs=132.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.++..++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||
T Consensus 112 ~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~y~~PE 186 (286)
T cd06614 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-----KRNSVVGTPYWMAPE 186 (286)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-----hhccccCCcccCCHh
Confidence 466788899999999999999999999999999999999999999999998865432111 112345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+..++ .++|+||||+++|+|++|+.||...+.......+..... .+....++..+++++++|+ .+|..||++.
T Consensus 187 ~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 265 (286)
T cd06614 187 VIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAE 265 (286)
T ss_pred HhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHH
Confidence 99877766 679999999999999999999988776555554433222 2223347889999999999 7899999999
Q ss_pred HHhcCCCCCCC
Q psy10462 163 DIRQDPWLKED 173 (347)
Q Consensus 163 eil~~p~~~~~ 173 (347)
+++.|+|+...
T Consensus 266 ~il~~~~~~~~ 276 (286)
T cd06614 266 ELLQHPFLKKA 276 (286)
T ss_pred HHhhChHhhcc
Confidence 99999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=201.88 Aligned_cols=160 Identities=29% Similarity=0.507 Sum_probs=126.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.
T Consensus 102 l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~y~~pE~ 174 (287)
T cd06621 102 IGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-------AGTFTGTSFYMAPER 174 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-------cccccCCccccCHHH
Confidence 4567788999999999999999999999999999999999999999999986543211 123457888999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhccC--CCCC----CCCCHHHHHHHHhcc-CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-----YSELLKQVQKRVV--FPES----PRLSSSCKALISNIL-SP 154 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-----~~~~~~~i~~~~~--~~~~----~~~s~~~~~li~~~l-~~ 154 (347)
+.+..++ .++|+||+||++|+|++|..||.... ..+....+..... .+.. ...++.+++++..|+ .+
T Consensus 175 ~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 253 (287)
T cd06621 175 IQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKD 253 (287)
T ss_pred hcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCC
Confidence 9877766 57999999999999999999998652 2333333332111 1111 234678999999999 69
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q psy10462 155 VKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 155 ~~~R~~~~eil~~p~~~~~~ 174 (347)
|.+||++.|++.|||+....
T Consensus 254 p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 254 PTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred cccCCCHHHHHhCccccccc
Confidence 99999999999999986543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=217.12 Aligned_cols=140 Identities=16% Similarity=0.256 Sum_probs=122.8
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
....++|++.+.+|+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34568899999999999999999999999999999998754333333345577899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|||||+||+|.++++.. .+++..++.++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC
Confidence 9999999999999998654 689999998888766 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=201.58 Aligned_cols=156 Identities=22% Similarity=0.323 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||+++++||||||+||+++.++.++|+|||++......... .......++..|+|||.
T Consensus 127 l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 203 (288)
T cd05050 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPES 203 (288)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccc---cccCCCccChhhcCHHH
Confidence 456788999999999999999999999999999999999999999999998754321110 00112234567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|+|++ |..||.+.+..+....+..+...+.+...+.++.+++.+|+ .+|..||+++|+
T Consensus 204 ~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 204 IFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred HhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 8877766 68999999999999997 88999988888877777666555555678899999999999 689999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 283 ~~ 284 (288)
T cd05050 283 NR 284 (288)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=212.47 Aligned_cols=140 Identities=17% Similarity=0.274 Sum_probs=116.3
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcc-----cccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhhee
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA 259 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~ 259 (347)
|.++.++|++.+.||+|+||.||+|.+ ..+++.||+|+++.... ......+.+|+.+|+.+ +|||||+++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 567788999999999999999999974 34567899999874321 22245577999999999 89999999998
Q ss_pred eeeC-CeEEEEEEecCCCChHHHHHhC-----------------------------------------------------
Q psy10462 260 IETT-HRVYIIMEYAKNGSLLEVIRKE----------------------------------------------------- 285 (347)
Q Consensus 260 ~~~~-~~~~iv~E~~~~G~L~~~l~~~----------------------------------------------------- 285 (347)
+... +.+|+|||||++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 5699999999999999999642
Q ss_pred ---------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 286 ---------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 286 ---------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.++++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~ 211 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN 211 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC
Confidence 2477788887877776 99999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=196.23 Aligned_cols=156 Identities=21% Similarity=0.356 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|+|++|++|+||||+||+++.++.+||+|||++........ .......+++.|+|||.
T Consensus 90 ~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~y~aPE~ 165 (250)
T cd05085 90 LKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY----SSSGLKQIPIKWTAPEA 165 (250)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc----ccCCCCCCcccccCHHH
Confidence 45688899999999999999999999999999999999999999999999865432111 01112234567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |..||.+.........+........+..++..+.+++.+|+ .+|..||++.++
T Consensus 166 ~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 244 (250)
T cd05085 166 LNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244 (250)
T ss_pred hccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 9876655 67999999999999998 99999988877777777666555555678899999999999 799999999998
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
.+.
T Consensus 245 ~~~ 247 (250)
T cd05085 245 QKE 247 (250)
T ss_pred HHH
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=202.21 Aligned_cols=157 Identities=26% Similarity=0.472 Sum_probs=128.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.++..+...++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++......... .......+...|+|||
T Consensus 99 ~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~---~~~~~~~~~~~~~aPE 175 (259)
T PF07714_consen 99 PLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY---KNDSSQQLPLRYLAPE 175 (259)
T ss_dssp TSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE---EESTTSESGGGGS-HH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccc
Confidence 4567888999999999999999999999999999999999999999999999776321111 1112234567899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++||||||+++||+++ |+.||.+.+..+....+.++...+.+...+....+++..|+ .+|..||++++
T Consensus 176 ~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~ 254 (259)
T PF07714_consen 176 VLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQE 254 (259)
T ss_dssp HHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHH
T ss_pred cccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHH
Confidence 99877655 78999999999999999 78999999888888888777766667778999999999999 79999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+++
T Consensus 255 i~~ 257 (259)
T PF07714_consen 255 ILQ 257 (259)
T ss_dssp HHH
T ss_pred HHh
Confidence 874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=208.83 Aligned_cols=168 Identities=21% Similarity=0.323 Sum_probs=123.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcccc--ccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK--QNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~gt~~y~aP 84 (347)
+.+..++.++.|++.||+|||++|++||||||+||+++.++.++++||+.+........... ........++..|+||
T Consensus 98 ~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (328)
T cd08226 98 MSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177 (328)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccCh
Confidence 45678889999999999999999999999999999999999999999986543321111000 0001112346679999
Q ss_pred ccccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC------------------------------
Q psy10462 85 EILKGVPY-TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV------------------------------ 133 (347)
Q Consensus 85 E~~~~~~~-~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~------------------------------ 133 (347)
|.+.+... .+.++|+||+||++|+|++|+.||.+....+..........
T Consensus 178 E~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (328)
T cd08226 178 ELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGES 257 (328)
T ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccc
Confidence 99976421 23679999999999999999999987655443332221110
Q ss_pred ----------------CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 134 ----------------FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 134 ----------------~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.+.+...++.+.+++++|| .+|..||+++++++|||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 258 VVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 1112235677899999999 7999999999999999987644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=199.83 Aligned_cols=157 Identities=20% Similarity=0.364 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++.+++.|++.||+|||++|++||||||+||+++.++.++++|||++.......... .......++..|+|||.
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~y~~pe~ 180 (267)
T cd05066 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWTAPEA 180 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee--eecCCCccceeecCHhH
Confidence 4567889999999999999999999999999999999999999999999997654321111 00111223567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |..||.+.+..+....+.+....|.+...++.+.+++.+|+ .+|..||+++++
T Consensus 181 ~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (267)
T cd05066 181 IAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI 259 (267)
T ss_pred hccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence 9876665 67999999999999886 99999988877777777776666666778899999999999 699999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 260 ~~ 261 (267)
T cd05066 260 VS 261 (267)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=200.38 Aligned_cols=156 Identities=22% Similarity=0.441 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+.+++.|++.||+|||++|++||||||+||+++.++.+||+|||++........... .....++..|+|||.
T Consensus 106 ~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~---~~~~~~~~~y~~PE~ 182 (279)
T cd05057 106 IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH---AEGGKVPIKWMALES 182 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccccee---cCCCcccccccCHHH
Confidence 45788999999999999999999999999999999999999999999999976543221111 111223567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |+.||.+.+..+....+..+...+.+...+..+.+++..|+ .+|..||++.++
T Consensus 183 ~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 183 ILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred hhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 8776665 67999999999999998 99999998888887777776666666778899999999999 799999999988
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 262 ~~ 263 (279)
T cd05057 262 IN 263 (279)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=203.72 Aligned_cols=158 Identities=22% Similarity=0.365 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... .....|++.|+|||.
T Consensus 122 l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---------~~~~~~~~~y~aPE~ 192 (317)
T cd06635 122 LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---------ANSFVGTPYWMAPEV 192 (317)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---------cccccCCccccChhh
Confidence 45688889999999999999999999999999999999999999999998864321 123467889999999
Q ss_pred ccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 87 LKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 87 ~~~---~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
+.+ ..++ .++|+||+||++|+|++|..||.+.+.......+..... .......++.+++++..|+ .+|..||++
T Consensus 193 ~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 271 (317)
T cd06635 193 ILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTS 271 (317)
T ss_pred hhcCCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCH
Confidence 742 3344 579999999999999999999988776665555544332 2334567889999999999 689999999
Q ss_pred HHHhcCCCCCCCC
Q psy10462 162 EDIRQDPWLKEDS 174 (347)
Q Consensus 162 ~eil~~p~~~~~~ 174 (347)
.++++|+|+....
T Consensus 272 ~~il~~~~~~~~~ 284 (317)
T cd06635 272 EELLKHMFVLRER 284 (317)
T ss_pred HHHHhChhhhccC
Confidence 9999999986544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=206.17 Aligned_cols=156 Identities=22% Similarity=0.355 Sum_probs=128.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
...++..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......... ......++..|+|||.+
T Consensus 132 ~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~ 208 (334)
T cd05100 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK---KTTNGRLPVKWMAPEAL 208 (334)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccc---cccCCCcCceEcCHHHh
Confidence 446778899999999999999999999999999999999999999999987653211110 01122345679999999
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 88 KGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 88 ~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
.+..++ .++|+||||+++|+|++ |..||.+.+..+....+......+.+...+..+.+++.+|+ .+|..||++.+++
T Consensus 209 ~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell 287 (334)
T cd05100 209 FDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287 (334)
T ss_pred ccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 887766 67999999999999998 89999998888888777766655556677899999999999 6999999999998
Q ss_pred cC
Q psy10462 166 QD 167 (347)
Q Consensus 166 ~~ 167 (347)
.+
T Consensus 288 ~~ 289 (334)
T cd05100 288 ED 289 (334)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=200.37 Aligned_cols=163 Identities=28% Similarity=0.583 Sum_probs=132.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc---------------ccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY---------------KQN 70 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---------------~~~ 70 (347)
.+.+.++..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||++.......... ...
T Consensus 98 ~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (280)
T cd05581 98 SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177 (280)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccccc
Confidence 35668899999999999999999999999999999999999999999999987654322100 011
Q ss_pred CcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q psy10462 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISN 150 (347)
Q Consensus 71 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 150 (347)
......++..|+|||...+...+ .++|+||+|++++++++|+.||...+.......+... ....+..+++.+.+++.+
T Consensus 178 ~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 255 (280)
T cd05581 178 RFASFVGTAEYVSPELLNEKPAG-KSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-EYSFPPNFPPDAKDLIEK 255 (280)
T ss_pred ccccccCCccccCHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-CCCCCCccCHHHHHHHHH
Confidence 22345678899999998876554 6799999999999999999999988766655555432 233446778999999999
Q ss_pred cc-CCCCCCCCH----HHHhcCCCC
Q psy10462 151 IL-SPVKFRIQM----EDIRQDPWL 170 (347)
Q Consensus 151 ~l-~~~~~R~~~----~eil~~p~~ 170 (347)
|| .+|..||++ +++++||||
T Consensus 256 ~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 256 LLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhcCCHhhCCCcccCHHHHhcCCCC
Confidence 99 789999999 999999996
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=201.87 Aligned_cols=157 Identities=22% Similarity=0.391 Sum_probs=120.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......... .......++..|+|||.
T Consensus 104 l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~~PE~ 181 (283)
T cd05080 104 LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY--RVREDGDSPVFWYAVEC 181 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhh--ccCCCCCCCceeeCHhH
Confidence 5678899999999999999999999999999999999999999999999987654321111 11122345667999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---------------ELLKQVQKRVVFPESPRLSSSCKALISNI 151 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 151 (347)
+.+...+ .++|+||||+++|+|++|..||...... .....+......+.+...+..+++++..|
T Consensus 182 ~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 260 (283)
T cd05080 182 LKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNC 260 (283)
T ss_pred hcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHH
Confidence 9876665 6799999999999999999998653211 11111222233344556788999999999
Q ss_pred c-CCCCCCCCHHHHhc
Q psy10462 152 L-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 152 l-~~~~~R~~~~eil~ 166 (347)
+ .+|+.||+++++++
T Consensus 261 l~~~p~~Rps~~~i~~ 276 (283)
T cd05080 261 WETEAKFRPTFRSLIP 276 (283)
T ss_pred hccChhhCCCHHHHHH
Confidence 9 69999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=204.10 Aligned_cols=162 Identities=23% Similarity=0.409 Sum_probs=125.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|+++||+|||++|++||||+|+||+++.++.++|+|||++...... .....+++.|+|||.
T Consensus 105 ~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~y~aPE~ 176 (328)
T cd07856 105 LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--------MTGYVSTRYYRAPEI 176 (328)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--------cCCCcccccccCcee
Confidence 455778889999999999999999999999999999999999999999998653211 123456888999998
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---------------------------cCCCC---
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---------------------------VVFPE--- 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~---------------------------~~~~~--- 136 (347)
+.+....+.++|+||+|+++|+|++|+.||...........+.+. ...|.
T Consensus 177 ~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (328)
T cd07856 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEK 256 (328)
T ss_pred eeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHH
Confidence 866333347899999999999999999999876543322211110 00110
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+.++..+++++++|+ .+|.+||++++++.|||+..-..+
T Consensus 257 ~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 257 FKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred cCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 1346789999999999 799999999999999999765544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=199.07 Aligned_cols=156 Identities=22% Similarity=0.351 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-----cEEEeccCCceecccCCccccccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-----NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y 81 (347)
+...++..++.|++.||.|||+++++|+||||+||+++.++ .++++|||++......... .......++..|
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y 179 (269)
T cd05044 103 LTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGLLPVRW 179 (269)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccccccccc---ccCcccCCCccc
Confidence 34577888999999999999999999999999999999877 8999999998755321110 111123456789
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
+|||.+.+...+ .++|+|||||++|+|++ |+.||...+..+....+........+...+..+.+++.+|| .+|..||
T Consensus 180 ~aPE~~~~~~~~-~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 180 MAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred cCHHHHccCCcc-cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCC
Confidence 999999887765 67999999999999998 99999988777777776655555556678899999999999 6899999
Q ss_pred CHHHHhc
Q psy10462 160 QMEDIRQ 166 (347)
Q Consensus 160 ~~~eil~ 166 (347)
+++++.+
T Consensus 259 ~~~~i~~ 265 (269)
T cd05044 259 TFDRIQE 265 (269)
T ss_pred CHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=196.88 Aligned_cols=151 Identities=21% Similarity=0.426 Sum_probs=127.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........ ...++..|+|||.
T Consensus 99 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--------~~~~~~~~~ape~ 170 (256)
T cd05039 99 ITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--------SGKLPVKWTAPEA 170 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--------cCCCcccccCchh
Confidence 56688999999999999999999999999999999999999999999999876532111 1223567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|++++ |..||...+..+....+........+...++.+.+++++|+ .+|.+||+++++
T Consensus 171 ~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 249 (256)
T cd05039 171 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQL 249 (256)
T ss_pred hcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 8876665 67999999999999997 99999998888877777766554455667899999999999 689999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 250 ~~ 251 (256)
T cd05039 250 RE 251 (256)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=211.09 Aligned_cols=131 Identities=21% Similarity=0.235 Sum_probs=115.3
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|++..+++.||+|++.+.........+.+..|.++++.+ +||||++++++|++++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999999999999999999764333333344566899999876 899999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|.+++.+.+.+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~ 133 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG 133 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC
Confidence 99999998888999999998888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=189.55 Aligned_cols=146 Identities=19% Similarity=0.221 Sum_probs=116.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ...||+.|+|||+
T Consensus 14 l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----------~~~g~~~y~aPE~ 75 (176)
T smart00750 14 LNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----------QSRVDPYFMAPEV 75 (176)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------cCCCcccccChHH
Confidence 678999999999999999999998 999999999999999 9998765321 1257899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccCCC------CCCCCCH--HHHHHHHhcc-CCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFP------ESPRLSS--SCKALISNIL-SPVK 156 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~------~~~~~s~--~~~~li~~~l-~~~~ 156 (347)
+.+..++ .++||||+||++|+|++|+.||..... ......+....... ....++. .+++++++|+ .+|.
T Consensus 76 ~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~ 154 (176)
T smart00750 76 IQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQ 154 (176)
T ss_pred hcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccc
Confidence 9988877 689999999999999999999976543 23333333222111 1122333 6899999999 7999
Q ss_pred CCCCHHHHhcCCCCC
Q psy10462 157 FRIQMEDIRQDPWLK 171 (347)
Q Consensus 157 ~R~~~~eil~~p~~~ 171 (347)
.||++.++++|+|..
T Consensus 155 ~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 155 RREAANHYLAHCRAL 169 (176)
T ss_pred cccCHHHHHHHHHHH
Confidence 999999999998854
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=197.49 Aligned_cols=155 Identities=24% Similarity=0.415 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++.+++..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++......... ......++..|+|||.
T Consensus 100 ~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~~~~y~~PE~ 175 (261)
T cd05034 100 LRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT----AREGAKFPIKWTAPEA 175 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh----hhhccCCCccccCHHH
Confidence 456788999999999999999999999999999999999999999999998765421110 0112224567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+...+ .++|+||+|+++|++++ |+.||.+.+.......+......+.+...+.+..+++.+|+ .+|.+||+++++
T Consensus 176 ~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 254 (261)
T cd05034 176 ANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYL 254 (261)
T ss_pred hccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 9877665 67999999999999998 99999988888888888777666666777899999999999 789999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 255 ~~ 256 (261)
T cd05034 255 QS 256 (261)
T ss_pred HH
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=196.47 Aligned_cols=156 Identities=21% Similarity=0.378 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.++.+..++.|++.|++|||+.+++|+||||+||+++.++.++|+|||++......... ......++..|+|||.
T Consensus 97 ~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~~~~~~aPe~ 172 (256)
T cd05112 97 FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT----SSTGTKFPVKWSSPEV 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc----ccCCCccchhhcCHhH
Confidence 456788999999999999999999999999999999999999999999998755321110 0112234568999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |..||......+....+.++.....+...+..+.+++..|+ .+|..||+++++
T Consensus 173 ~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~ 251 (256)
T cd05112 173 FSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLL 251 (256)
T ss_pred hccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 9876665 68999999999999998 99999988888878777766554445567899999999999 689999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 252 l~~ 254 (256)
T cd05112 252 LHQ 254 (256)
T ss_pred HHh
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=200.80 Aligned_cols=160 Identities=25% Similarity=0.465 Sum_probs=125.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+....++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...... ......|+..|+|||
T Consensus 100 ~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-------~~~~~~~~~~~~aPE 172 (284)
T cd06620 100 IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-------IADTFVGTSTYMSPE 172 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-------ccCccccCcccCCHH
Confidence 4567889999999999999997 69999999999999999999999999998654221 112356899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHHhccCCC-CCCCCCHHHHHHHHhcc-
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-----------ELLKQVQKRVVFP-ESPRLSSSCKALISNIL- 152 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-----------~~~~~i~~~~~~~-~~~~~s~~~~~li~~~l- 152 (347)
.+.+...+ .++|+||+||++|++++|+.||...+.. +....+....... .....+..+.+++..|+
T Consensus 173 ~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 251 (284)
T cd06620 173 RIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLL 251 (284)
T ss_pred HHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhc
Confidence 98876655 5799999999999999999999865431 1222222211111 12236788999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 153 SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 153 ~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.+|..||+++++++|+|+.+..
T Consensus 252 ~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 252 KDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CCcccCcCHHHHhcCccccccc
Confidence 6899999999999999986643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=202.22 Aligned_cols=156 Identities=19% Similarity=0.333 Sum_probs=125.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||+++++|+||||+||+++.++.++++|||++......... .......+++.|+|||.
T Consensus 138 l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 214 (302)
T cd05055 138 LTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY---VVKGNARLPVKWMAPES 214 (302)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCce---eecCCCCcccccCCHhh
Confidence 466888999999999999999999999999999999999999999999998765432111 01122345778999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH-HHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLK-QVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+||++|+|++ |..||.+.+..+... .+..+...+.+...++.+.+++.+|+ .+|.+||++.+
T Consensus 215 ~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 293 (302)
T cd05055 215 IFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQ 293 (302)
T ss_pred hccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9887766 68999999999999998 999998776554433 33334444445567899999999999 68999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+++
T Consensus 294 ll~ 296 (302)
T cd05055 294 IVQ 296 (302)
T ss_pred HHH
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=196.06 Aligned_cols=161 Identities=27% Similarity=0.477 Sum_probs=129.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||
T Consensus 97 ~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~y~~pE 173 (260)
T cd06606 97 KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG---EGTGSVRGTPYWMAPE 173 (260)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc---ccccCCCCCccccCHh
Confidence 4567888999999999999999999999999999999999999999999998776542210 0122346788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+...+ .++|+||+|++++++++|..||...+ .......+.. ....+.+...+...++++.+|+ .+|..||++.
T Consensus 174 ~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~ 252 (260)
T cd06606 174 VIRGEEYG-RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTAD 252 (260)
T ss_pred hhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHH
Confidence 99877654 67999999999999999999998765 3333333332 1222334567899999999999 7899999999
Q ss_pred HHhcCCCC
Q psy10462 163 DIRQDPWL 170 (347)
Q Consensus 163 eil~~p~~ 170 (347)
++++|||+
T Consensus 253 ~ll~~~~~ 260 (260)
T cd06606 253 ELLQHPFL 260 (260)
T ss_pred HHhhCCCC
Confidence 99999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=207.67 Aligned_cols=143 Identities=13% Similarity=0.126 Sum_probs=120.7
Q ss_pred hhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEe
Q psy10462 193 LKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 272 (347)
Q Consensus 193 ~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~ 272 (347)
|+..+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.++++++||||++++++|.+++.+|+||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 56678899999999999999999999999998755433333344567899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 273 AKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 273 ~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|++|+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||++.++ .+.+...|
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~---~~kl~Dfg 147 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG---HIRISDLG 147 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC---CEEEeeCC
Confidence 9999999888543 3689999998888766 99999999999999999999997654 24444444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=211.07 Aligned_cols=139 Identities=19% Similarity=0.239 Sum_probs=118.6
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|+++.+++.||+|++++.........+.+.+|..+++.+ +||||++++++|.+.+.+|+|||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999999754332333344556888888876 799999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++ ++.++..|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~---~~kL~DfG 141 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG---HCKLADFG 141 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC---cEEEeeCC
Confidence 99999998888999999999888776 99999999999999999999998765 34444444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=204.65 Aligned_cols=137 Identities=21% Similarity=0.276 Sum_probs=117.0
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee-----CCe
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-----THR 265 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 265 (347)
..|...+.+|+|+||.|+.|.++.||+.||||++......... .+...||+++|+.++|+|||.+++++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~-akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID-AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH-HHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3455578999999999999999999999999999743333333 3444599999999999999999999865 357
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYY 329 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~ 329 (347)
+|+|+|+|+. ||...|+.+..+++..+.++..|+. |+.|+|+.+|+||||||+|+|++.+-..
T Consensus 101 vYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred eEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCE
Confidence 9999999965 9999999988899999998877665 9999999999999999999999887654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=211.70 Aligned_cols=136 Identities=21% Similarity=0.211 Sum_probs=118.7
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCC-cchhhhheeeeeCCeEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-PNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~iv~ 270 (347)
+|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+..|.++++.+.| ++|++++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 36778899999999999999999999999999976433333334556789999999965 46889999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||+++|+|.+++...+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 138 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG 138 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC
Confidence 9999999999998888999999999888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=212.90 Aligned_cols=136 Identities=15% Similarity=0.255 Sum_probs=121.6
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|++.+.||+|+||+||+|++..+|+.||+|++++...........+.+|+.+++.++||||+++++++++.+.+|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 57788999999999999999999999999999976543333445667899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 272 YAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 272 ~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+++|+|.+++++. +.+++..++.++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~ 139 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG 139 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC
Confidence 99999999999775 6899999998887766 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-25 Score=195.96 Aligned_cols=156 Identities=21% Similarity=0.324 Sum_probs=127.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+....+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++......... .......++..|+|||.
T Consensus 90 ~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~~y~~PE~ 166 (251)
T cd05041 90 LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT---VSDGLKQIPIKWTAPEA 166 (251)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce---eccccCcceeccCChHh
Confidence 455778889999999999999999999999999999999999999999998754321110 00111223567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |..||...........+......+.+...+....+++.+|+ .+|.+||+++++
T Consensus 167 ~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~el 245 (251)
T cd05041 167 LNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEI 245 (251)
T ss_pred hccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 8877665 67999999999999998 89999888877777777665555556678899999999999 789999999999
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 246 l~ 247 (251)
T cd05041 246 YN 247 (251)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=195.46 Aligned_cols=155 Identities=23% Similarity=0.402 Sum_probs=130.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......... . ....+++.|+|||.
T Consensus 100 ~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~---~~~~~~~~y~~Pe~ 175 (258)
T smart00219 100 LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-K---KGGKLPIRWMAPES 175 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc-c---ccCCCcccccChHH
Confidence 5678889999999999999999999999999999999999999999999997664321111 1 01236788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |..||...+..+....+......+.+...+.++.+++.+|+ .+|..||++.++
T Consensus 176 ~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (258)
T smart00219 176 LKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSEL 254 (258)
T ss_pred hccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 8766555 67999999999999998 89999988888888887776665666678999999999999 699999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 255 l~ 256 (258)
T smart00219 255 VE 256 (258)
T ss_pred Hh
Confidence 75
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=210.52 Aligned_cols=131 Identities=21% Similarity=0.304 Sum_probs=116.5
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++.++ +||||+++++++.+.+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999765433333445567899988877 899999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|..++.+.+.+++..++.++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~ 133 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 133 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC
Confidence 99999998888999999999988776 99999999999999999999998775
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=198.42 Aligned_cols=155 Identities=27% Similarity=0.440 Sum_probs=124.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 103 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~~~~aPE~ 177 (267)
T cd08228 103 IPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-----AAHSLVGTPYYMSPER 177 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH-----HHhcCCCCccccChhh
Confidence 45678899999999999999999999999999999999999999999999876543211 1123468889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhccCCCC-CCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKRVVFPE-SPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~-~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
+.+...+ .++|+||+|+++|+|++|+.||.... ..+....+......+. ....+...+++++.|+ .+|..||+++
T Consensus 178 ~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 256 (267)
T cd08228 178 IHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIG 256 (267)
T ss_pred hccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHH
Confidence 9877665 67999999999999999999996543 2344444444332222 2357788999999999 6999999999
Q ss_pred HHhcC
Q psy10462 163 DIRQD 167 (347)
Q Consensus 163 eil~~ 167 (347)
++++.
T Consensus 257 ~vl~~ 261 (267)
T cd08228 257 YVHQI 261 (267)
T ss_pred HHHHH
Confidence 99864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=196.65 Aligned_cols=154 Identities=22% Similarity=0.426 Sum_probs=127.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
+..++..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||.+........ .......++..|+|||.+
T Consensus 100 ~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~ 175 (260)
T cd05073 100 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAI 175 (260)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc----ccccCCcccccccCHhHh
Confidence 4467888999999999999999999999999999999999999999999876532211 111122356679999999
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 88 KGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 88 ~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
.+..++ .++|+||||+++|++++ |+.||.+.+..+....+......+.+...+.++.+++.+|+ .+|.+||++.++.
T Consensus 176 ~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 176 NFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred ccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 876655 57999999999999998 99999988877777777776665666778899999999999 6999999998876
Q ss_pred c
Q psy10462 166 Q 166 (347)
Q Consensus 166 ~ 166 (347)
+
T Consensus 255 ~ 255 (260)
T cd05073 255 S 255 (260)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-26 Score=211.27 Aligned_cols=143 Identities=22% Similarity=0.231 Sum_probs=121.4
Q ss_pred hhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEE
Q psy10462 193 LKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 193 ~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
|+..+.||+|+||+||+|++..+|+.||+|++++.........+.+..|..+++.+ +||+|+++++++++.+.+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56678999999999999999999999999999754332233344566899999888 56788899999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+++|+|.+++.+.+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++ .+.+...|
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~---~ikL~Dfg 146 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG---HIKIADFG 146 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC---CEEEeccc
Confidence 999999999998888999999999988776 99999999999999999999998765 34444444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=210.00 Aligned_cols=137 Identities=15% Similarity=0.311 Sum_probs=122.0
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe-EEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-VYI 268 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~i 268 (347)
.++|...+.+|+|+||.+++++++..++.+++|.+........ .++...+|+.+++++.|||||.+++.|+.++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4678999999999999999999999999999999987765443 34466799999999999999999999999888 999
Q ss_pred EEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||+||||.+.|++. ..|+|+.+..|+-|++ ++.|+|+++|+|||||++|||+..+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~ 143 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK 143 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC
Confidence 99999999999999654 4799999888877766 99999999999999999999997765
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=198.25 Aligned_cols=154 Identities=27% Similarity=0.447 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 103 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~ape~ 177 (267)
T cd08229 103 IPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-----AAHSLVGTPYYMSPER 177 (267)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc-----ccccccCCcCccCHHH
Confidence 46678899999999999999999999999999999999999999999999876532211 1223468889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhccCCCC-CCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY--SELLKQVQKRVVFPE-SPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~-~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
+.+...+ .++|+||+|+++|+|++|..||.+... .+..+.+......+. +...++.+++++.+|+ .+|.+||+++
T Consensus 178 ~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 256 (267)
T cd08229 178 IHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDIT 256 (267)
T ss_pred hcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHH
Confidence 9877665 679999999999999999999976543 333444443332222 2357889999999999 7999999999
Q ss_pred HHhc
Q psy10462 163 DIRQ 166 (347)
Q Consensus 163 eil~ 166 (347)
++++
T Consensus 257 ~i~~ 260 (267)
T cd08229 257 YVYD 260 (267)
T ss_pred HHHH
Confidence 8764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=201.33 Aligned_cols=142 Identities=20% Similarity=0.256 Sum_probs=127.6
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
.+..++|++.+.+|+|.||+|-+++.+.||+.||+|++++..........--..|-++|+..+||++..+...|+..+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45678899999999999999999999999999999999877544333333334799999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHH-HHHHHHhhcCccccCCCCcccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV-SNLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~-~~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
|+||||+.||+|+-+|.+.+.|+|+.+++|-++| ++|.|+|+++||.||||.+|+|||.++.
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH 306 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH 306 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc
Confidence 9999999999999999999999999999998855 5999999999999999999999999985
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=197.23 Aligned_cols=156 Identities=22% Similarity=0.418 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+....+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........ .. .....+++.|+|||.
T Consensus 104 ~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~---~~~~~~~~~y~aPE~ 179 (270)
T cd05056 104 LDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YK---ASKGKLPIKWMAPES 179 (270)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc-ee---cCCCCccccccChhh
Confidence 45678889999999999999999999999999999999999999999999876543211 10 112234567999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|++++ |..||.+.+..+....+..+...+.+...+....+++.+|+ .+|..||++.++
T Consensus 180 ~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 258 (270)
T cd05056 180 INFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258 (270)
T ss_pred hccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 8776665 67999999999999885 99999988877777777776666667788999999999999 789999999998
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+..
T Consensus 259 ~~~ 261 (270)
T cd05056 259 KAQ 261 (270)
T ss_pred HHH
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=200.76 Aligned_cols=157 Identities=19% Similarity=0.340 Sum_probs=125.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......... .......+++.|+|||
T Consensus 126 ~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE 202 (296)
T cd05051 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWE 202 (296)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcce---eecCcCCCCceecCHH
Confidence 3567888999999999999999999999999999999999999999999998754322111 1122334677899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHHhc-------cCCCCCCCCCHHHHHHHHhcc-CCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY--GRLPFDDTNYSELLKQVQKR-------VVFPESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~--g~~pf~~~~~~~~~~~i~~~-------~~~~~~~~~s~~~~~li~~~l-~~~ 155 (347)
.+.+..++ .++|+|||||++|+|++ |..||...+..+.+...... ...+.+...+.++.+++.+|+ .+|
T Consensus 203 ~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 281 (296)
T cd05051 203 SVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDE 281 (296)
T ss_pred HhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccCh
Confidence 98876665 67999999999999998 78899887766666555432 112334456789999999999 799
Q ss_pred CCCCCHHHHhc
Q psy10462 156 KFRIQMEDIRQ 166 (347)
Q Consensus 156 ~~R~~~~eil~ 166 (347)
.+||++.++++
T Consensus 282 ~~Rpt~~el~~ 292 (296)
T cd05051 282 EDRPTFREIHL 292 (296)
T ss_pred hcCCCHHHHHH
Confidence 99999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=209.61 Aligned_cols=139 Identities=19% Similarity=0.210 Sum_probs=116.4
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|++..+++.||+|++++.........+....|..++..+ +||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999999754332222334445677777754 899999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|.++++..+.+++..+..++.|++ |+.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~---~~kL~Dfg 141 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG---HIKIADFG 141 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC---CEEEccCc
Confidence 99999998888999999998888776 99999999999999999999998765 34444443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=209.55 Aligned_cols=139 Identities=19% Similarity=0.296 Sum_probs=116.7
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHH-HHhcCCCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||++++++|+.++.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999999999999999997543222222334445655 56778999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~---~~kL~DfG 141 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG---HVVLTDFG 141 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---CEEEeecC
Confidence 99999998888999999999888776 99999999999999999999998776 34555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-27 Score=202.61 Aligned_cols=163 Identities=23% Similarity=0.417 Sum_probs=135.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.++++|+..+++..+.||+|||...=||||||..|||++.+|..||+|||.|..+... ....++..|||.|||||
T Consensus 125 ~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-----MAKRNTVIGTPFWMAPE 199 (502)
T KOG0574|consen 125 PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-----MAKRNTVIGTPFWMAPE 199 (502)
T ss_pred CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-----HHhhCccccCcccccHH
Confidence 3567999999999999999999999999999999999999999999999999877542 22345778999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--VVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
++....|+ .++|+||+|++..||..|++||.+..+...+-.|-.. ..|..+...|++.-++++.|| ..|+.|-|+.
T Consensus 200 VI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~ 278 (502)
T KOG0574|consen 200 VIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTAL 278 (502)
T ss_pred HHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHH
Confidence 99988888 6799999999999999999999886554332222111 112234557889999999999 8999999999
Q ss_pred HHhcCCCCCCCC
Q psy10462 163 DIRQDPWLKEDS 174 (347)
Q Consensus 163 eil~~p~~~~~~ 174 (347)
++++|||.+...
T Consensus 279 ~L~~H~FiknA~ 290 (502)
T KOG0574|consen 279 RLCEHTFIKNAP 290 (502)
T ss_pred HHhhhhhhcCCC
Confidence 999999988654
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=209.38 Aligned_cols=131 Identities=20% Similarity=0.301 Sum_probs=112.4
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHH-HHhcCCCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++++++.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999999999999999997543322222233445554 56789999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|.+++.+.+.+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~ 133 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG 133 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC
Confidence 99999998888999999998888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=209.66 Aligned_cols=139 Identities=21% Similarity=0.284 Sum_probs=120.9
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|++..+++.||+|++++.........+.+.+|+.++.++ +||||++++++|++.+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3689999999999999999999999999865444444455677999999888 799999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||+++++. +.+...|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~---~kl~Dfg 141 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH---IKLTDYG 141 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC---EEEeccc
Confidence 99999998888999999999988876 999999999999999999999987652 4444443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=185.00 Aligned_cols=136 Identities=16% Similarity=0.212 Sum_probs=119.8
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
.+|+..+.||+|.||+||+|++..|++.||+|.++... .++.......||+.+|+.|+|.|||+++++..++..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35778899999999999999999999999999998654 34555666779999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-CCCCCHHHHHHHHHH-HHHHHHHhhcCccccCCCCcccccccccc
Q psy10462 271 EYAKNGSLLEVIRK-ERYIDEDKALLCYSE-VSNLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 271 E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~-~~~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
|||.. +|..+... .+.+..+.++.++-| +.|+.++|+++++||||||.|+|+..++.
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge 139 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE 139 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc
Confidence 99986 99998865 567888888855554 55999999999999999999999999884
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=209.26 Aligned_cols=139 Identities=18% Similarity=0.196 Sum_probs=117.3
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||.||+|+++.+|+.||+|++++..............|..++..+ +||||++++++|.+++.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4689999999999999999999999999754322222234456788888765 999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|.+++.+.+.+++..+..++.|++ |+.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~---~~kl~Dfg 141 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG---HIKIADFG 141 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---CEEeCccC
Confidence 99999998888899999998888776 99999999999999999999998765 34444443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=199.91 Aligned_cols=163 Identities=26% Similarity=0.565 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++........ .......|+..|+|||.
T Consensus 102 l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~ 177 (290)
T cd05613 102 FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV----ERAYSFCGTIEYMAPDI 177 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc----cccccccCCcccCChhh
Confidence 45688888999999999999999999999999999999999999999999876533211 11224568899999999
Q ss_pred ccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-
Q psy10462 87 LKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI- 159 (347)
Q Consensus 87 ~~~~~-~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~- 159 (347)
+.+.. ....++|+||+|+++|+|++|..||...+. .+....+... ..+.+..+++...+++++|+ .+|..|+
T Consensus 178 ~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred ccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 87532 223578999999999999999999974322 2233333222 22344568899999999999 7899997
Q ss_pred ----CHHHHhcCCCCCCCC
Q psy10462 160 ----QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ----~~~eil~~p~~~~~~ 174 (347)
++++++.|||+....
T Consensus 257 ~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 257 CGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCCCCHHHHHcCcccccCC
Confidence 899999999997754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=211.57 Aligned_cols=136 Identities=15% Similarity=0.238 Sum_probs=120.1
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|++.+.||+|+||+||++++..+++.+|+|++.+...........+.+|+.++..++||||+++++++++++.+|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 57888999999999999999999999999999865433333334557789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 272 YAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 272 ~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+++|+|.+++.+ ...+++..++.++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~ 139 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 139 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC
Confidence 9999999999976 46899999999888776 99999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-26 Score=209.09 Aligned_cols=131 Identities=20% Similarity=0.291 Sum_probs=112.5
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHH-HHhcCCCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||.|+||.||+|++..+|+.||+|++.+...........+.+|.. +++.++||||++++++|.+.+.+|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999997543322222333445554 67889999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|.+.+.+.+.+++..++.++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~ 133 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG 133 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC
Confidence 99999998888899999998888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=195.50 Aligned_cols=150 Identities=23% Similarity=0.299 Sum_probs=117.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc--------EEEeccCCceecccCCccccccCcccccCC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--------IKLSDFGFARKYSVNNTDYKQNLSETFCGS 78 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt 78 (347)
+.+..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..... .....++
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~---------~~~~~~~ 167 (258)
T cd05078 97 INISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---------KEILLER 167 (258)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC---------chhcccc
Confidence 456778889999999999999999999999999999987654 69999998764421 1234578
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCC
Q psy10462 79 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~ 156 (347)
+.|+|||.+.+....+.++|+||+|+++|+|++| ..||...+............. .+...+.+..+++..|+ .+|.
T Consensus 168 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~ 245 (258)
T cd05078 168 IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQ--LPAPKWTELANLINQCMDYEPD 245 (258)
T ss_pred CCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcccc--CCCCCcHHHHHHHHHHhccChh
Confidence 8999999998754334679999999999999998 567766655444333333322 23345688999999999 7999
Q ss_pred CCCCHHHHhcC
Q psy10462 157 FRIQMEDIRQD 167 (347)
Q Consensus 157 ~R~~~~eil~~ 167 (347)
.||+++++++.
T Consensus 246 ~Rps~~~il~~ 256 (258)
T cd05078 246 FRPSFRAIIRD 256 (258)
T ss_pred hCCCHHHHHHh
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-26 Score=195.98 Aligned_cols=137 Identities=12% Similarity=0.213 Sum_probs=120.9
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCc-----hhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCC
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP-----IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 264 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 264 (347)
..|.-.+.+|.|..++|.++.++.||+.+|+|+|...... .....+.-.+|+.||+++ .||+|+++.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3455667899999999999999999999999999644321 122345567999999998 8999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+++|+|+|+.|+|+|+|...-.++|.+++.+++|+. |+.|+|.++||||||||+|||++.+.
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM 160 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc
Confidence 9999999999999999998888899999999999886 99999999999999999999998764
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=207.73 Aligned_cols=157 Identities=20% Similarity=0.332 Sum_probs=126.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++.+++.|++.||+|||+++|+||||||+||+++.++.+||+|||++......... .......+++.|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY---VSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccc---cccCCcCCCcceEChh
Confidence 3667888999999999999999999999999999999999999999999999765322111 1112334678899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYS-ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+..++ .++|||||||++|+|++ |..||...... .....+..+...+.+...+.++++++..|+ .+|..||++.
T Consensus 310 ~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 310 SIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred hhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 99887766 68999999999999996 99999876543 334445555555555678899999999999 7999999998
Q ss_pred HHhc
Q psy10462 163 DIRQ 166 (347)
Q Consensus 163 eil~ 166 (347)
++.+
T Consensus 389 ~l~~ 392 (400)
T cd05105 389 HLSD 392 (400)
T ss_pred HHHH
Confidence 8864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=199.08 Aligned_cols=164 Identities=27% Similarity=0.556 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++........ .......|+..|+|||.
T Consensus 102 ~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~ 177 (288)
T cd05583 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE----ERAYSFCGTIEYMAPEV 177 (288)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc----cccccccCCccccCHHH
Confidence 45688899999999999999999999999999999999999999999999876543211 11123468889999999
Q ss_pred ccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 87 LKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 87 ~~~~~-~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
+.+.. ....++|+||+|+++|+|++|..||...+. .+..+.+... ..+.+..++..+++++.+|+ .+|+.||+
T Consensus 178 ~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~t 256 (288)
T cd05583 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKTMSAEARDFIQKLLEKDPKKRLG 256 (288)
T ss_pred hcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCCCCcccCHHHHHHHHHHhcCCHhhccC
Confidence 87643 223679999999999999999999964322 2222333222 23445567899999999999 79999998
Q ss_pred ---HHHHhcCCCCCCCCC
Q psy10462 161 ---MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 ---~~eil~~p~~~~~~~ 175 (347)
+.++++|||++...+
T Consensus 257 ~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 257 ANGADEIKNHPFFQGIDW 274 (288)
T ss_pred cchHHHHhcCcccccCCH
Confidence 567799999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-25 Score=196.00 Aligned_cols=155 Identities=18% Similarity=0.346 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccccc
Q psy10462 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 88 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 88 (347)
...+++++.|++.||.|||+++++|+||||+||+++.++.++|+|||++......... .......+++.|+|||.+.
T Consensus 99 ~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~ 175 (269)
T cd05087 99 PTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY---VTPDQLWVPLRWIAPELVD 175 (269)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee---ecCCCcCCcccccCHhHhc
Confidence 3567789999999999999999999999999999999999999999998643321111 1122345778899999986
Q ss_pred CCCC------CCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc--cCCCCC---CCCCHHHHHHHHhccCCCC
Q psy10462 89 GVPY------TPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKR--VVFPES---PRLSSSCKALISNILSPVK 156 (347)
Q Consensus 89 ~~~~------~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~--~~~~~~---~~~s~~~~~li~~~l~~~~ 156 (347)
+... .+.++|+||||+++|+|++ |+.||......+........ ...+.+ ...+...+++++.|+.+|.
T Consensus 176 ~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~ 255 (269)
T cd05087 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPE 255 (269)
T ss_pred cccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHhcCcc
Confidence 4321 1357999999999999996 99999877666554433222 112221 2467889999999998899
Q ss_pred CCCCHHHHhc
Q psy10462 157 FRIQMEDIRQ 166 (347)
Q Consensus 157 ~R~~~~eil~ 166 (347)
+||+++++..
T Consensus 256 ~Rpt~~~l~~ 265 (269)
T cd05087 256 QRPSAEEVHL 265 (269)
T ss_pred cCCCHHHHHH
Confidence 9999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.4e-26 Score=192.50 Aligned_cols=164 Identities=24% Similarity=0.420 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++.+.++-++.||++||+|||+.+|.||||||.|.|++.+..+||||||+|+-...+... ....-+-|.+|.|||+
T Consensus 153 Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~----hMTqEVVTQYYRAPEi 228 (449)
T KOG0664|consen 153 LTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL----NMTHEVVTQYYRAPEL 228 (449)
T ss_pred CCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh----hhHHHHHHHHhccHHH
Confidence 455788889999999999999999999999999999999999999999999865432211 1112245789999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC------------------------CCC----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------------------ESP---- 138 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------------------~~~---- 138 (347)
+.|....+..+||||+||++.|++.++..|...++.+.++.|..-...| ..+
T Consensus 229 LMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYt 308 (449)
T KOG0664|consen 229 LMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYK 308 (449)
T ss_pred hhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceee
Confidence 9997766678999999999999999999999888777666554332222 111
Q ss_pred -----CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 139 -----RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 139 -----~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.-..+.-.++..++ .+|.+|++.++.+.|++..+..
T Consensus 309 lsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 309 IASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred ecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 11234566777777 6899999999999999877654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=195.04 Aligned_cols=154 Identities=29% Similarity=0.458 Sum_probs=123.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.++++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.
T Consensus 103 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~y~apE~ 177 (267)
T cd08224 103 IPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-----AAHSLVGTPYYMSPER 177 (267)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc-----ccceecCCccccCHHH
Confidence 45688899999999999999999999999999999999999999999999876532211 1223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhccCCCCCC-CCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKRVVFPESP-RLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~-~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
+.+..++ .++|+||+|+++|+|++|+.||.... ..+....+..+...+.+. ..+...++++..|+ .+|..||++.
T Consensus 178 ~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~ 256 (267)
T cd08224 178 IHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDIS 256 (267)
T ss_pred hccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence 9877666 67999999999999999999996543 334444544444333333 67889999999999 6899999999
Q ss_pred HHhc
Q psy10462 163 DIRQ 166 (347)
Q Consensus 163 eil~ 166 (347)
++++
T Consensus 257 ~il~ 260 (267)
T cd08224 257 YVLQ 260 (267)
T ss_pred HHHH
Confidence 8864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=203.24 Aligned_cols=138 Identities=12% Similarity=0.098 Sum_probs=116.5
Q ss_pred cccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCCCh
Q psy10462 199 KKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 278 (347)
Q Consensus 199 ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G~L 278 (347)
||+|+||+||++.+..+|+.||+|.+.+.........+.+..|+++++.++||||+++.++|..+..+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999999999999999999999999755433333334566899999999999999999999999999999999999999
Q ss_pred HHHHHh----CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEeee
Q psy10462 279 LEVIRK----ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQY 339 (347)
Q Consensus 279 ~~~l~~----~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~~ 339 (347)
.+++.. ...+++..+..++.|++ ++.|+|++||+||||||+|||+++++ .+.++..|.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~~l~dfg~ 143 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG---NVRISDLGL 143 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---CEEEeeCcc
Confidence 988743 34699999998888776 99999999999999999999997754 355555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=198.73 Aligned_cols=156 Identities=21% Similarity=0.354 Sum_probs=122.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++.+++.|++.||+|||++|++|+||||+||+++.++.++|+|||++......... .......+++.|++||.
T Consensus 127 ~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~ 203 (296)
T cd05095 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWES 203 (296)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcce---eccCcCcCccccCCHHH
Confidence 345678999999999999999999999999999999999999999999998765322111 11112234578999998
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHHh-------ccCCCCCCCCCHHHHHHHHhcc-CCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY--GRLPFDDTNYSELLKQVQK-------RVVFPESPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~--g~~pf~~~~~~~~~~~i~~-------~~~~~~~~~~s~~~~~li~~~l-~~~~ 156 (347)
..+..++ .++|+|||||++|+|++ |..||...+..+....... ....+.+...++...+++..|+ .+|.
T Consensus 204 ~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 282 (296)
T cd05095 204 ILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAK 282 (296)
T ss_pred HhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 8777666 68999999999999998 7899987766555443321 2223445667899999999999 7999
Q ss_pred CCCCHHHHhc
Q psy10462 157 FRIQMEDIRQ 166 (347)
Q Consensus 157 ~R~~~~eil~ 166 (347)
.||++.++.+
T Consensus 283 ~Rp~~~~i~~ 292 (296)
T cd05095 283 ERPSFQEIHA 292 (296)
T ss_pred cCCCHHHHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=203.11 Aligned_cols=157 Identities=19% Similarity=0.355 Sum_probs=124.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++.+++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......... ......+++.|+|||.
T Consensus 176 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~ 252 (343)
T cd05103 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---RKGDARLPLKWMAPET 252 (343)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh---hcCCCCCCcceECcHH
Confidence 4567888999999999999999999999999999999999999999999987653221111 1112235667999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYS-ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||||+++|+|++ |..||.+.... +....+..+...+.+...+++..+++.+|+ .+|..||++.+
T Consensus 253 ~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~e 331 (343)
T cd05103 253 IFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 331 (343)
T ss_pred hcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9877666 67999999999999996 99999875433 334444444444445567889999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 332 il~~ 335 (343)
T cd05103 332 LVEH 335 (343)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=218.41 Aligned_cols=156 Identities=29% Similarity=0.509 Sum_probs=125.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccc-cC---cccccCCcc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ-NL---SETFCGSYA 80 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~--iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~---~~~~~gt~~ 80 (347)
|+++|+.+||.|+++|+++||... |||||||-+||||..+++.||||||.|.......+...+ .. .-....|+.
T Consensus 141 lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~ 220 (738)
T KOG1989|consen 141 LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQ 220 (738)
T ss_pred CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCcc
Confidence 567999999999999999999987 999999999999999999999999998643221110000 00 001246899
Q ss_pred ccccccc---cCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCC
Q psy10462 81 YASPEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 81 y~aPE~~---~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~ 156 (347)
|+|||.+ .+.+.+ .|+|||||||+||-+++...||++... +..+...+.+|+.+..+..+++||+.|| .+|.
T Consensus 221 YRsPEMIDlysg~pI~-eKsDIWALGclLYkLCy~t~PFe~sg~---laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~ 296 (738)
T KOG1989|consen 221 YRSPEMIDLYSGLPIG-EKSDIWALGCLLYKLCYFTTPFEESGK---LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPD 296 (738)
T ss_pred ccChHHHhhhcCCCCc-chhHHHHHHHHHHHHHHhCCCcCcCcc---eeEEeccccCCCCccHHHHHHHHHHHHhccCcc
Confidence 9999986 466666 789999999999999999999987632 2334556778888999999999999999 7999
Q ss_pred CCCCHHHHhc
Q psy10462 157 FRIQMEDIRQ 166 (347)
Q Consensus 157 ~R~~~~eil~ 166 (347)
.||.+-+++.
T Consensus 297 ~RPnI~Qv~~ 306 (738)
T KOG1989|consen 297 ERPNIYQVLE 306 (738)
T ss_pred cCCCHHHHHH
Confidence 9999988763
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=207.75 Aligned_cols=139 Identities=20% Similarity=0.294 Sum_probs=114.3
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHH-HHHhcCCCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI-EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++++.+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3689999999999999999999999999754322222222333444 456788999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++ .+.++..|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~---~~kl~DfG 141 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG---HIVLTDFG 141 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC---CEEEccCC
Confidence 99999998888899999998888766 99999999999999999999998765 34444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-26 Score=208.77 Aligned_cols=136 Identities=21% Similarity=0.223 Sum_probs=118.8
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
+|++.+.||+|+||+||+|++..+++.||+|++.+.........+....|..++..+ +||+|+++++++++.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 367788999999999999999999999999999765333333344456788888877 6899999999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~ 138 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG 138 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC
Confidence 9999999999998888999999999988776 99999999999999999999998775
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=208.89 Aligned_cols=137 Identities=18% Similarity=0.200 Sum_probs=115.0
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC-e
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH-R 265 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~ 265 (347)
....++|.-...+|+|+||.||+|.... |+.||||.+....... ...|.+|+.++.+++|||+|+|+|+|.+.+ .
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 3345667777899999999999998754 4789999876543221 233789999999999999999999999988 5
Q ss_pred EEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhc---CccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSR---CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~---~iiHRDlKp~Nil~~~~~ 327 (347)
.+||+|||++|+|.++|..+. +++|.....|+..++ |+.|||+. .||||||||+|||||++-
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~ 214 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF 214 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence 999999999999999996544 899999999988776 99999954 499999999999999654
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-26 Score=208.65 Aligned_cols=142 Identities=18% Similarity=0.206 Sum_probs=117.9
Q ss_pred hhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHH---hcCCCcchhhhheeeeeCCeEEEE
Q psy10462 193 LKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV---KGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 193 ~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il---~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
|++.+.||+|+||.||+|.+..+|+.||+|++++.........+.+.+|++++ +.++||||+++++++++.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45678899999999999999999999999999754332233344566776665 567899999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|||+++|+|..++.. +.+++..+..++.|++ |+.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~---~~kL~Dfg 146 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG---FVKIADFG 146 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC---cEEeCccc
Confidence 999999999988854 5799999998888776 99999999999999999999998775 34444443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=200.97 Aligned_cols=138 Identities=14% Similarity=0.177 Sum_probs=118.8
Q ss_pred hhhhhhhhhhhcccccchhhhhhccc---ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSA---RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
+...+|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.++++++||||+++++++..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34677899999999999999999764 456689999987542 2223456779999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..|+||||+++|+|.+++.+. ..+++..+..++.+++ |+.|+|++|++||||||+|||+++++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~ 144 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL 144 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC
Confidence 999999999999999999764 5799999998888776 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=205.77 Aligned_cols=144 Identities=19% Similarity=0.322 Sum_probs=126.5
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNG 276 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G 276 (347)
+.+|+|.||+||-|++++||+.||||+|++..... .....+..|+.||+.++||.||.+--.|++++.++.|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 67999999999999999999999999998766543 2346788999999999999999999999999999999999975
Q ss_pred ChHHHH--HhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEeeeeEE
Q psy10462 277 SLLEVI--RKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQYNII 342 (347)
Q Consensus 277 ~L~~~l--~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~~~~~ 342 (347)
|+.+.| .+.++++|....++..||+ +|.|+|.++|+|+|||||||||..+..++.+-+-..|+-=+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 888877 4578999999998877765 99999999999999999999999999888877776666443
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=206.87 Aligned_cols=139 Identities=18% Similarity=0.283 Sum_probs=116.8
Q ss_pred hhcccccchhhhhhccc---ccccchhheehhccCCc-hhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEe
Q psy10462 197 RDKKLSSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 272 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~---~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~ 272 (347)
+.||+|+||.||+++.. .+++.||+|++++.... .......+.+|+.+|+.++||||++++++|+.++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999763 57888999998754321 122234466899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 273 AKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 273 ~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++ .+.+...|
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg 145 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG---HVKLTDFG 145 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC---CEEEeeCc
Confidence 99999999998888999999998887766 99999999999999999999998765 34444443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=197.01 Aligned_cols=156 Identities=21% Similarity=0.348 Sum_probs=122.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+...++.+++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......... .......++..|+|||.
T Consensus 126 ~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 202 (295)
T cd05097 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWES 202 (295)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcce---eccCcCcCceeecChhh
Confidence 455778889999999999999999999999999999999999999999998755322111 11122345678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHHh-------ccCCCCCCCCCHHHHHHHHhcc-CCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY--GRLPFDDTNYSELLKQVQK-------RVVFPESPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~--g~~pf~~~~~~~~~~~i~~-------~~~~~~~~~~s~~~~~li~~~l-~~~~ 156 (347)
+.+..++ .++|+|||||++|+|++ |..||...+..+....+.+ ......++..++.+++++.+|+ .+|.
T Consensus 203 ~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 203 ILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred hccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCch
Confidence 8877665 68999999999999987 7789988776665544422 1112234557889999999999 6999
Q ss_pred CCCCHHHHhc
Q psy10462 157 FRIQMEDIRQ 166 (347)
Q Consensus 157 ~R~~~~eil~ 166 (347)
.||+++++++
T Consensus 282 ~RPs~~~i~~ 291 (295)
T cd05097 282 DRPTFNKIHH 291 (295)
T ss_pred hCcCHHHHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=183.97 Aligned_cols=162 Identities=25% Similarity=0.493 Sum_probs=124.2
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC-CcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+..+++.++.|++.||.||||.||+|||+||.|+++|.. ..++|+|+|+|.++... .++ +..+.+..|--||.
T Consensus 130 ~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-~eY-----nVRVASRyfKGPEL 203 (338)
T KOG0668|consen 130 TDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY-----NVRVASRYFKGPEL 203 (338)
T ss_pred chhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-cee-----eeeeehhhcCCchh
Confidence 347789999999999999999999999999999999864 46999999999887642 222 23456778899999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhc--------------cC------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQVQKR--------------VV------------------ 133 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~-~~~~~~~~~~i~~~--------------~~------------------ 133 (347)
+..-+.....-|+|||||++..|+..+.||- +.+..+.+-+|.+- ..
T Consensus 204 LVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~ 283 (338)
T KOG0668|consen 204 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWS 283 (338)
T ss_pred eeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHH
Confidence 9887655577899999999999999999985 32222222111110 00
Q ss_pred -C--CCC-CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 134 -F--PES-PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 134 -~--~~~-~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
| ++. .-.++++.+|+.++| .|...|+|+.|++.||||.....
T Consensus 284 ~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 284 RFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 0 111 224689999999999 79999999999999999976543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=194.23 Aligned_cols=155 Identities=26% Similarity=0.513 Sum_probs=128.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......|+..|+||
T Consensus 109 ~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~~~P 182 (269)
T cd08528 109 RFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES------KLTSVVGTILYSCP 182 (269)
T ss_pred CCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc------ccccccCcccCcCh
Confidence 35668889999999999999996 789999999999999999999999999997654321 12344678899999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC-CCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP-RLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
|.+.+..++ .++|+||||+++|+|++|+.||...+.......+......|... ..++.+.++++.|+ .+|..||++.
T Consensus 183 e~~~~~~~~-~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ 261 (269)
T cd08528 183 EIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDII 261 (269)
T ss_pred hhhcCCCCc-hHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHH
Confidence 999877665 68999999999999999999998887776666666554444333 67899999999999 7999999999
Q ss_pred HHhcC
Q psy10462 163 DIRQD 167 (347)
Q Consensus 163 eil~~ 167 (347)
++..+
T Consensus 262 e~~~~ 266 (269)
T cd08528 262 QVSAM 266 (269)
T ss_pred HHHHH
Confidence 98754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=195.00 Aligned_cols=150 Identities=26% Similarity=0.315 Sum_probs=117.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-------cEEEeccCCceecccCCccccccCcccccCCc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-------NIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~ 79 (347)
+.+..+.+++.||+.||+|||++||+||||||+||+++..+ .+|++|||++...... ....++.
T Consensus 114 ~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---------~~~~~~~ 184 (274)
T cd05076 114 VPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---------EERVERI 184 (274)
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---------cccccCC
Confidence 45678889999999999999999999999999999997543 3799999987543211 1234678
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHH-HcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 80 AYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 80 ~y~aPE~~~~~~~~~~~~Dvws~G~~l~~l-l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
.|+|||.+.+......++|+||||+++|++ ++|..||.+....+...........| ...++...+++.+|+ .+|..
T Consensus 185 ~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~ 262 (274)
T cd05076 185 PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLP--EPSCKELATLISQCLTYEPTQ 262 (274)
T ss_pred cccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCCC--CCCChHHHHHHHHHcccChhh
Confidence 899999987643334689999999999998 47999998876655544444433333 335678999999999 68999
Q ss_pred CCCHHHHhcC
Q psy10462 158 RIQMEDIRQD 167 (347)
Q Consensus 158 R~~~~eil~~ 167 (347)
||++++++++
T Consensus 263 Rps~~~il~~ 272 (274)
T cd05076 263 RPSFRTILRD 272 (274)
T ss_pred CcCHHHHHHh
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=199.76 Aligned_cols=167 Identities=29% Similarity=0.526 Sum_probs=135.3
Q ss_pred CHHHHHHHHHHHHHHHHHHHhC--CCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCc--cccccCcccccCCcc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKK--SVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNT--DYKQNLSETFCGSYA 80 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~--~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~~gt~~ 80 (347)
++.||+.++-||+.||.||.+. .|||.||||.|||+-. .|.+||.|||+++.+..+.. .....+.+...||.|
T Consensus 566 SEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYW 645 (775)
T KOG1151|consen 566 SEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYW 645 (775)
T ss_pred hHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceee
Confidence 4699999999999999999975 6999999999999953 47899999999998765432 223455667899999
Q ss_pred ccccccccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHH----HhccCCCCCCCCCHHHHHHHHhcc
Q psy10462 81 YASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQV----QKRVVFPESPRLSSSCKALISNIL 152 (347)
Q Consensus 81 y~aPE~~~~~---~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i----~~~~~~~~~~~~s~~~~~li~~~l 152 (347)
|++||.+.-. +--+.++||||+|+++|.++.|+.||...-. .++++.. ...+.||..+.+|++++++|++||
T Consensus 646 YLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCL 725 (775)
T KOG1151|consen 646 YLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCL 725 (775)
T ss_pred ecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHH
Confidence 9999998643 3334689999999999999999999976533 2232211 135679999999999999999999
Q ss_pred -CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 153 -SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 153 -~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.....|....++..||++.+..
T Consensus 726 aYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 726 AYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred HhhhhhhhhHHHHccCccccchh
Confidence 6777899999999999998754
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=192.91 Aligned_cols=148 Identities=24% Similarity=0.265 Sum_probs=116.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-------cEEEeccCCceecccCCccccccCcccccCCc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-------NIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~ 79 (347)
+....+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..... .....++.
T Consensus 98 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~ 168 (259)
T cd05037 98 VSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---------REERVERI 168 (259)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc---------ccccccCC
Confidence 45677889999999999999999999999999999999887 799999999875432 12234667
Q ss_pred cccccccccCC--CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCC
Q psy10462 80 AYASPEILKGV--PYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 80 ~y~aPE~~~~~--~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~ 155 (347)
.|+|||.+.+. .++ .++|+||+|+++|++++ |..||...+..+...........+. ..+..+.+++..|+ .+|
T Consensus 169 ~y~aPE~~~~~~~~~~-~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p 245 (259)
T cd05037 169 PWIAPECIRNGQASLT-IAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM--PDCAELANLINQCWTYDP 245 (259)
T ss_pred CccChhhhcCCCCCcc-hhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC--CCchHHHHHHHHHhccCh
Confidence 89999999876 344 67999999999999999 6888877754443333332222222 22478999999999 699
Q ss_pred CCCCCHHHHhc
Q psy10462 156 KFRIQMEDIRQ 166 (347)
Q Consensus 156 ~~R~~~~eil~ 166 (347)
..||++.++++
T Consensus 246 ~~Rpt~~~il~ 256 (259)
T cd05037 246 TKRPSFRAILR 256 (259)
T ss_pred hhCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-25 Score=205.41 Aligned_cols=146 Identities=16% Similarity=0.156 Sum_probs=125.4
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
+..++|++.+.+|.|+||.||++.+..+++.+|+|.+.... .......+.+|++++++++||||++++++|.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34578999999999999999999999999999999886542 2233456779999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhc-CccccCCCCccccccccccceeEEEEEee
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSR-CCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~-~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+||||+++|+|.+++++.+.+++..+..++.+++ ++.|+|++ +|+||||||+|||+++++. +.+...|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~---~kL~Dfg 149 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFG 149 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC---EEEeeCC
Confidence 9999999999999998888899999988877665 99999974 7999999999999987652 4444443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-26 Score=206.95 Aligned_cols=141 Identities=14% Similarity=0.170 Sum_probs=127.3
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
......|...+.+|+|+||.|+-++.+.||+.||+|.+.+.......-.....+|..||.+.+.|+||.+-.+|++++.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34567788889999999999999999999999999999887665555555667999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+||..|+||||.-+|-+.+ .|+|..+++|+++|. ||.++|+++||.|||||+|||||..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G 324 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG 324 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC
Confidence 99999999999999997655 899999999999765 99999999999999999999998877
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=207.64 Aligned_cols=144 Identities=15% Similarity=0.238 Sum_probs=121.2
Q ss_pred hhhhhhhcccccchhhhhhccc---ccccchhheehhccCCc-hhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~---~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 266 (347)
+|++.+.||+|+||+||+++.. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||++++++|+.++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 3677889999999999998763 57889999998654321 222344567899999999 699999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|||||++|+|.+++.+++.+++..++.++.|++ ++.|+|++||+||||||+|||+++++ ++.+...|
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~---~~kl~DfG 150 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG---HVVLTDFG 150 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC---CEEEeeCc
Confidence 99999999999999998888999999998888766 99999999999999999999998775 34454444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=202.76 Aligned_cols=143 Identities=13% Similarity=0.141 Sum_probs=121.3
Q ss_pred hhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEe
Q psy10462 193 LKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 272 (347)
Q Consensus 193 ~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~ 272 (347)
|+..+.||+|+||+||++.+..+++.||+|++.............+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 67788999999999999999999999999999754433333344566899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 273 AKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 273 ~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+++|+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||+++++ .+.+...|
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~~l~Dfg 147 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG---HIRISDLG 147 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC---CEEEeeCC
Confidence 9999999988653 4699999998887766 99999999999999999999997654 34455544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=206.59 Aligned_cols=131 Identities=21% Similarity=0.242 Sum_probs=116.0
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||.|+||+||+|.+..+++.||+|++++...........+.+|..+++.+ +||||+++++++++.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999999765433333345566899999888 799999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~ 133 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG 133 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC
Confidence 99999998888999999998888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=196.46 Aligned_cols=158 Identities=18% Similarity=0.376 Sum_probs=122.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......... ........++..|+|||.
T Consensus 106 ~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~apE~ 183 (284)
T cd05079 106 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YTVKDDLDSPVFWYAPEC 183 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccc--eeecCCCCCCccccCHHH
Confidence 456888999999999999999999999999999999999999999999998765432111 111223456778999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---------------NYSELLKQVQKRVVFPESPRLSSSCKALISNI 151 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~---------------~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 151 (347)
+.+..++ .++|+||+|+++|+|+++..|+... ........+......+.+...+..+.+++..|
T Consensus 184 ~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 262 (284)
T cd05079 184 LIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKC 262 (284)
T ss_pred hccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHH
Confidence 8877666 5799999999999999987765321 11122233334444555667899999999999
Q ss_pred c-CCCCCCCCHHHHhcC
Q psy10462 152 L-SPVKFRIQMEDIRQD 167 (347)
Q Consensus 152 l-~~~~~R~~~~eil~~ 167 (347)
+ .+|..||+++++++.
T Consensus 263 l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 263 WEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCcccCcCHHHHHHH
Confidence 9 699999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=206.39 Aligned_cols=131 Identities=21% Similarity=0.191 Sum_probs=113.4
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|++..+++.||+|++++..............|..+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3689999999999999999999999999754322222234455788888764 999999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|.+++++...+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~ 133 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG 133 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC
Confidence 99999998888899999998888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=210.65 Aligned_cols=142 Identities=20% Similarity=0.303 Sum_probs=119.4
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhcc-----cccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 257 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 257 (347)
..+.++.++|++.+.||+|+||.||+|++ ..++..||+|+++..... ...+.+.+|+.+|+.+ +|||||+++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeee
Confidence 35667788999999999999999999864 346778999998644322 2245677999999999 899999999
Q ss_pred eeeeeCCeEEEEEEecCCCChHHHHHhCC---------------------------------------------------
Q psy10462 258 QAIETTHRVYIIMEYAKNGSLLEVIRKER--------------------------------------------------- 286 (347)
Q Consensus 258 ~~~~~~~~~~iv~E~~~~G~L~~~l~~~~--------------------------------------------------- 286 (347)
++|.+.+..|+|||||++|||.+++++.+
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 99999999999999999999999996432
Q ss_pred ------------------------CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 287 ------------------------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 287 ------------------------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~ 251 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR 251 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC
Confidence 467777787877766 99999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=205.51 Aligned_cols=138 Identities=17% Similarity=0.287 Sum_probs=116.8
Q ss_pred hhcccccchhhhhhcc---cccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEec
Q psy10462 197 RDKKLSSYATVKLATS---ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 273 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~---~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~ 273 (347)
+.||+|+||.||++++ ..+|+.||+|++.+..... .....+.+|+++|++++||||++++++|.+++.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5689999999999876 3578899999997543221 12334568999999999999999999999999999999999
Q ss_pred CCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 274 KNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 274 ~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
++|+|.+++.+...+++..+..++.|++ ++.|+|++||+||||||+|||+++++ .+.+...|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kL~Dfg 143 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG---HIKLTDFG 143 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC---cEEEeecc
Confidence 9999999998888899999999988776 99999999999999999999998765 34444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=206.70 Aligned_cols=137 Identities=15% Similarity=0.202 Sum_probs=114.8
Q ss_pred cccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC---CCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 199 KKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL---KHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 199 ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
||+|+||+||+|++..+++.||+|++.+.............+|..++..+ +||||++++++|++++.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999654332222223344677777665 799999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|.+++.+.+.+++..++.++.|++ ++.|+|++||+||||||+|||++.++ ++.++..|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~---~~kl~Dfg 141 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG---HIALCDFG 141 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC---CEEEecCC
Confidence 99999998888999999999888776 99999999999999999999998765 34444444
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=192.80 Aligned_cols=154 Identities=18% Similarity=0.337 Sum_probs=116.8
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccC
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 89 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 89 (347)
..++.++.||+.||+|||+++++||||||+|||++.++.++|+|||++....... . .......+++..|+|||.+.+
T Consensus 99 ~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~-~--~~~~~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 99 LLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-Y--IETEDDKCVPLRWLAPELVGE 175 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch-h--hhcccCCcCcccccCchhccc
Confidence 4567889999999999999999999999999999999999999999975432111 0 011224567889999998753
Q ss_pred CC------CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccC--C--C-CCCCCCHHHHHHHHhccCCCCC
Q psy10462 90 VP------YTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVV--F--P-ESPRLSSSCKALISNILSPVKF 157 (347)
Q Consensus 90 ~~------~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~--~--~-~~~~~s~~~~~li~~~l~~~~~ 157 (347)
.. ..+.++|+||||+++|+|++ |..||...+..+.+..+..... . | .....++...+++..|+.+|.+
T Consensus 176 ~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~ 255 (268)
T cd05086 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEK 255 (268)
T ss_pred ccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCccc
Confidence 21 11357899999999999996 5789987777666655433211 1 1 1234788899999999988999
Q ss_pred CCCHHHHhc
Q psy10462 158 RIQMEDIRQ 166 (347)
Q Consensus 158 R~~~~eil~ 166 (347)
||+++++++
T Consensus 256 Rp~~~~i~~ 264 (268)
T cd05086 256 RATAEEVHR 264 (268)
T ss_pred CCCHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=218.43 Aligned_cols=154 Identities=22% Similarity=0.356 Sum_probs=117.0
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc-------------ccccCcccc
Q psy10462 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD-------------YKQNLSETF 75 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------------~~~~~~~~~ 75 (347)
...+.+++.||+.||+|||++||+||||||+||+++.++.++|+|||++......... .........
T Consensus 112 v~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~ 191 (932)
T PRK13184 112 VGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI 191 (932)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCC
Confidence 3567889999999999999999999999999999999999999999999765211100 000111235
Q ss_pred cCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HhccCCCCCCCCCHHHHHHHHhcc-
Q psy10462 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV--QKRVVFPESPRLSSSCKALISNIL- 152 (347)
Q Consensus 76 ~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~s~~~~~li~~~l- 152 (347)
+||+.|+|||.+.+..++ .++|+||+||++|+|+||+.||...+..+..... .......+...+++.+.+++.+|+
T Consensus 192 vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~ 270 (932)
T PRK13184 192 VGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALA 270 (932)
T ss_pred CCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHcc
Confidence 799999999999887776 6899999999999999999999876544332221 111112223467889999999999
Q ss_pred CCCCCCCCHHH
Q psy10462 153 SPVKFRIQMED 163 (347)
Q Consensus 153 ~~~~~R~~~~e 163 (347)
.+|.+|++..+
T Consensus 271 ~DP~kR~ss~e 281 (932)
T PRK13184 271 VDPAERYSSVQ 281 (932)
T ss_pred CChhhCcCHHH
Confidence 79999986433
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=209.98 Aligned_cols=139 Identities=14% Similarity=0.164 Sum_probs=121.7
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
++....|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++|++++|||||+++++|..+...
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3456779999999999999999999999999999997542 2345899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
++|||++. |+|.+++...+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++ .+.++..|
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~---~vkL~DFG 227 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG---DVCLGDFG 227 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC---CEEEEeCC
Confidence 99999996 69999998888899999999988776 99999999999999999999997765 34455544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=203.02 Aligned_cols=135 Identities=18% Similarity=0.195 Sum_probs=116.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|+..+.+|.|+||+||+|.+..+++.||+|.++.... ......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 3568889999999999999999999999999999865422 11233456899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||+++ +|.+++... ..+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~ 140 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG 140 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC
Confidence 999985 999999764 4689999998888766 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=205.35 Aligned_cols=137 Identities=16% Similarity=0.165 Sum_probs=122.3
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
..++|+..+.+|+|+||.||++++..+|..+|+|.+.... .......+.+|+++|++++||||+++++++.+++.+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4678999999999999999999999999999999987532 23345567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhc-CccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSR-CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~-~iiHRDlKp~Nil~~~~~ 327 (347)
||||+++|+|.+++...+.+++..+..++.|++ ++.|+|++ +|+||||||+|||+++++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~ 141 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG 141 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC
Confidence 999999999999998888899999998888766 99999975 699999999999998765
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=216.08 Aligned_cols=158 Identities=26% Similarity=0.419 Sum_probs=123.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---C--CcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---K--YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 11 ~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.+..+.|++.||++||+.+||||||||.||||.. + ..++|+|||+++.+..+...+.. .....||-+|+|||
T Consensus 607 ~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r--~s~~sGt~GW~APE 684 (903)
T KOG1027|consen 607 DPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSR--LSGGSGTSGWQAPE 684 (903)
T ss_pred cHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhc--ccCCCCcccccCHH
Confidence 45778999999999999999999999999999975 2 46899999999999876665544 45667999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccCC--CCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQVQKRVVF--PESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
++...... .++|++|+||++|+.++| .+||.+.-..+ ..|..+... ...+....++++||.+|+ .+|..||++
T Consensus 685 ~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa 761 (903)
T KOG1027|consen 685 QLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSA 761 (903)
T ss_pred HHhccccC-cccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCH
Confidence 99876544 579999999999998876 99998754332 233332210 011111228999999999 799999999
Q ss_pred HHHhcCCCCCCC
Q psy10462 162 EDIRQDPWLKED 173 (347)
Q Consensus 162 ~eil~~p~~~~~ 173 (347)
.+++.||+|=..
T Consensus 762 ~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 762 TDVLNHPLFWDS 773 (903)
T ss_pred HHHhCCCccCCh
Confidence 999999987543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=208.44 Aligned_cols=150 Identities=20% Similarity=0.292 Sum_probs=123.2
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhcccc-----cccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 257 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 257 (347)
..|.++.++|++.+.+|+|+||.||+|.+.. +++.||+|.++..... .....+.+|+.+++.+ +|||||+++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEe
Confidence 3567888999999999999999999998643 3457999999754322 2245677999999999 899999999
Q ss_pred eeeeeCCeEEEEEEecCCCChHHHHHhC----------------------------------------------------
Q psy10462 258 QAIETTHRVYIIMEYAKNGSLLEVIRKE---------------------------------------------------- 285 (347)
Q Consensus 258 ~~~~~~~~~~iv~E~~~~G~L~~~l~~~---------------------------------------------------- 285 (347)
++|...+.+|+|||||++|+|.++++..
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999999998542
Q ss_pred ------------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 286 ------------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 286 ------------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
.++++..+..++.|++ ++.|+|++||+||||||+|||++.++ .+.+...|
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~---~~kL~DfG 257 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR---VAKICDFG 257 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC---eEEEeece
Confidence 2477888888888776 99999999999999999999997654 34444444
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=202.75 Aligned_cols=157 Identities=19% Similarity=0.352 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++......... .......+++.|+|||.
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~ 312 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPES 312 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHH
Confidence 556788999999999999999999999999999999999999999999999764322111 11123356788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH-HHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSEL-LKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||||+++|+|++ |..||......+. ...+..+...+.+...+.++.+++.+|+ .+|..||++.+
T Consensus 313 ~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 313 IFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred hcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9877665 67999999999999998 8999987655443 3444445445555678899999999999 69999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
+++.
T Consensus 392 ll~~ 395 (401)
T cd05107 392 LVHL 395 (401)
T ss_pred HHHH
Confidence 9753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=193.67 Aligned_cols=157 Identities=22% Similarity=0.380 Sum_probs=120.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........... ......++..|+|||.
T Consensus 105 l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~ 182 (284)
T cd05081 105 LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK--VREPGESPIFWYAPES 182 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCccee--ecCCCCCceEeeCHHH
Confidence 34577889999999999999999999999999999999999999999999986543221111 1111223456999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHhccCCCCCCCCCHHHHHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS----------------ELLKQVQKRVVFPESPRLSSSCKALISN 150 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~s~~~~~li~~ 150 (347)
+.+..++ .++|+||+|+++|+|++|..|+...... .....+......+.+...+..+.+++..
T Consensus 183 ~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (284)
T cd05081 183 LTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKE 261 (284)
T ss_pred hccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHH
Confidence 9877665 6899999999999999988776433211 1122233334445566788999999999
Q ss_pred cc-CCCCCCCCHHHHhc
Q psy10462 151 IL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 151 ~l-~~~~~R~~~~eil~ 166 (347)
|+ .+|..||+++++.+
T Consensus 262 cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 262 CWNNDPSQRPSFSELAL 278 (284)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99 79999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=206.83 Aligned_cols=140 Identities=21% Similarity=0.350 Sum_probs=124.1
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhh-----hhchHHHHHHHhcCC---Ccchhhhheee
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYL-----KKFLPREIEVVKGLK---HPNLIRFLQAI 260 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~-----~~~~~~E~~il~~l~---HpnIv~l~~~~ 260 (347)
...+|...+.+|.|+||+|++|.++.+...|++|.|.|.+.-.+.. ...+-.|+.||..|+ ||||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4566889999999999999999999998899999998876432222 234678999999996 99999999999
Q ss_pred eeCCeEEEEEEecCCC-ChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 261 ETTHRVYIIMEYAKNG-SLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G-~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
++++++||+||--..| ||+++|..+..++|.+|..++.|++ |+.++|++||||||||-||+.++.+++
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF 708 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe
Confidence 9999999999976544 9999999999999999999999887 899999999999999999999999884
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=203.65 Aligned_cols=135 Identities=21% Similarity=0.248 Sum_probs=116.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||.|+||+||+|++..+++.||+|+++..... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 46789999999999999999999999999999998754321 1223456899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||++ |+|.+++.+ .+.+++..++.++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 140 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG 140 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 99996 588888865 35789999998888766 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=192.18 Aligned_cols=157 Identities=20% Similarity=0.322 Sum_probs=126.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.++..++.|++.||+|||+++|+||||||+||+++.++.++++|||++......... ......++..|+|||
T Consensus 113 ~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~y~~PE 188 (275)
T cd05046 113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY----KLRNALIPLRWLAPE 188 (275)
T ss_pred CCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCccccc----ccCCceeEEeecChh
Confidence 4677889999999999999999999999999999999999999999999998644221110 112234567799999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+.... .++|+||+|+++|++++ |..||.+....+....+... ...+.+...+..+.+++.+|+ .+|..||++.
T Consensus 189 ~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~ 267 (275)
T cd05046 189 AVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFS 267 (275)
T ss_pred hhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 98876655 67999999999999998 88999887766666666533 234445668899999999999 7999999999
Q ss_pred HHhcC
Q psy10462 163 DIRQD 167 (347)
Q Consensus 163 eil~~ 167 (347)
++++.
T Consensus 268 ~~l~~ 272 (275)
T cd05046 268 ELVSA 272 (275)
T ss_pred HHHHH
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=206.39 Aligned_cols=137 Identities=24% Similarity=0.345 Sum_probs=122.7
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
-+...|+....+|.|+.|.||.|+...+++.||||++....... ++.+.+|+.+|+..+|||||++++.|...+.+|
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence 46778889999999999999999999999999999998654433 556779999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHH-HHHHHHhhcCccccCCCCcccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV-SNLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~-~~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
+|||||+||+|-+.+.. ..++|.++..+.+++ .||.|||.+||+|||||.+||||..++.
T Consensus 347 VVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~ 407 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS 407 (550)
T ss_pred EEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc
Confidence 99999999999998865 359999988888855 5999999999999999999999988775
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=190.77 Aligned_cols=149 Identities=28% Similarity=0.428 Sum_probs=115.2
Q ss_pred HHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccCC--CCC
Q psy10462 17 SQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV--PYT 93 (347)
Q Consensus 17 ~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~ 93 (347)
.-.+.||.||-. ..|||||+||+|||++..|.+||||||.+..+..+-. .+.-+|...|||||.+... .|+
T Consensus 174 vatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA------kT~daGCrpYmAPERi~p~~~gyD 247 (361)
T KOG1006|consen 174 VATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA------KTVDAGCRPYMAPERIDPSDKGYD 247 (361)
T ss_pred eeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH------hhhccCCccccChhccCCccCCcc
Confidence 345679999975 4899999999999999999999999999976643211 1223588899999998643 344
Q ss_pred CChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccCC--CC---CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 94 PQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVF--PE---SPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 94 ~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~~~~~--~~---~~~~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
-++|+||+|++|||..||+.||...+. -+.+.++..+.+. .. ....|.....++..|| .+.+.||...++.+
T Consensus 248 -iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 248 -IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 689999999999999999999987653 2333334333211 11 1347889999999999 78899999999999
Q ss_pred CCCCCC
Q psy10462 167 DPWLKE 172 (347)
Q Consensus 167 ~p~~~~ 172 (347)
+||.+.
T Consensus 327 ~~fyr~ 332 (361)
T KOG1006|consen 327 FPFYRM 332 (361)
T ss_pred Cchhhh
Confidence 999765
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=200.03 Aligned_cols=135 Identities=15% Similarity=0.211 Sum_probs=117.4
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|++.+.+|+|+||+||+|++..+++.||+|++...... ....+.+.+|+.++++++||||++++++|..++.+|+|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 578889999999999999999999999999998754322 2334556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+++|.|..+.+....+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~ 137 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND 137 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC
Confidence 999987766655556899999998888776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-25 Score=197.20 Aligned_cols=138 Identities=12% Similarity=0.149 Sum_probs=115.6
Q ss_pred cccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCCCCh
Q psy10462 199 KKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 278 (347)
Q Consensus 199 ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~G~L 278 (347)
||+|+||.||++..+.+|+.||+|.+................|++++++++||||++++++|+++..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999754333222334455799999999999999999999999999999999999999
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEeee
Q psy10462 279 LEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQY 339 (347)
Q Consensus 279 ~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~~ 339 (347)
.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||+++++ .+.++..|.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~---~~~l~Dfg~ 141 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG---NCRLSDLGL 141 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC---CEEEeecee
Confidence 9988543 3688888888877765 99999999999999999999997754 355555553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=221.16 Aligned_cols=145 Identities=17% Similarity=0.283 Sum_probs=128.1
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||.|+||+||+|.+..+++.||+|++++...........+.+|+.+++.++||||+++++++...+.+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999999999999999997655444445567789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||+.||+|.+++...+.+++..++.++.|++ +|.|+|++|||||||||+|||++.++ .+.++..|
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g---~vkL~DFG 149 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG---HIKLTDFG 149 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC---CEEEEeCC
Confidence 9999999999998888899999999988776 99999999999999999999998764 35555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-25 Score=202.39 Aligned_cols=132 Identities=16% Similarity=0.200 Sum_probs=115.8
Q ss_pred hhhhcccc--cchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEe
Q psy10462 195 LIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 272 (347)
Q Consensus 195 ~~~~ig~G--~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~ 272 (347)
+.+.||+| +||+||++.+..+|+.||+|.++..... ....+.+.+|+.+++.++||||++++++|.+++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 7889999999999999999999754332 23455677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 273 AKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 273 ~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+++|+|.+++.. .+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~ 138 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 138 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC
Confidence 999999999965 34699999998888776 99999999999999999999997765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-25 Score=218.33 Aligned_cols=153 Identities=25% Similarity=0.398 Sum_probs=130.1
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccC
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 89 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 89 (347)
.+...++.|||.|+.||+++++|||||..+|+|++....+||+|||+|+...... .+ ....+ .--...|||||.+..
T Consensus 802 ~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~-yy-r~~~~-a~lPvkWm~PEsl~d 878 (1025)
T KOG1095|consen 802 RDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKD-YY-RKHGE-AMLPVKWMPPESLKD 878 (1025)
T ss_pred HHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhch-he-eccCc-cccceecCCHHHHhh
Confidence 5678889999999999999999999999999999999999999999998433211 11 11111 111357999999998
Q ss_pred CCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 90 VPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 90 ~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
..++ .|+|||||||++||++| |..||.+.+..+++..+.++-+.+++...+...-+++..|+ .+|+.||++..+++
T Consensus 879 ~iFt-skSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 879 GIFT-SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cccc-cccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 7777 68999999999999996 89999999999999977776688999999999999999999 79999999999886
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-25 Score=206.65 Aligned_cols=150 Identities=19% Similarity=0.251 Sum_probs=122.9
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhccccc-----ccchhheehhccCCchhhhhhchHHHHHHHhcCC-Ccchhhhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARH-----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFL 257 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~-----~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~ 257 (347)
..+..+.++|++.+.||+|+||.||+|.+... +..||+|+++... .....+.+.+|+++|+++. |||||+++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 45778889999999999999999999986432 3469999996542 2233456789999999995 99999999
Q ss_pred eeeeeCCeEEEEEEecCCCChHHHHHhC----------------------------------------------------
Q psy10462 258 QAIETTHRVYIIMEYAKNGSLLEVIRKE---------------------------------------------------- 285 (347)
Q Consensus 258 ~~~~~~~~~~iv~E~~~~G~L~~~l~~~---------------------------------------------------- 285 (347)
+++.+.+.+|||||||++|+|.++|.+.
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 9999999999999999999999998542
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcc
Q psy10462 286 --------------------------------------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLS 320 (347)
Q Consensus 286 --------------------------------------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~N 320 (347)
+.+++..+..++.|++ ++.|+|+++|+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 2367777788888776 9999999999999999999
Q ss_pred ccccccccceeEEEEEee
Q psy10462 321 CFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 321 il~~~~~~~~~~~~~~~~ 338 (347)
||+++++ .+.+...|
T Consensus 268 ill~~~~---~~kL~DfG 282 (400)
T cd05105 268 VLLAQGK---IVKICDFG 282 (400)
T ss_pred EEEeCCC---EEEEEeCC
Confidence 9998754 34454544
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-25 Score=200.14 Aligned_cols=138 Identities=18% Similarity=0.269 Sum_probs=115.0
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccc----------------cccchhheehhccCCchhhhhhchHHHHHHHhcCCCc
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSAR----------------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP 251 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~----------------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp 251 (347)
++..+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|++++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence 356788999999999999999997532 34469999986532 223345677999999999999
Q ss_pred chhhhheeeeeCCeEEEEEEecCCCChHHHHHhCC-------------------CCCHHHHHHHHHHHH-HHHHHhhcCc
Q psy10462 252 NLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-------------------YIDEDKALLCYSEVS-NLSQTFSRCC 311 (347)
Q Consensus 252 nIv~l~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~-------------------~l~e~~~~~~~~~~~-~~~~~h~~~i 311 (347)
||+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.|++ |+.|+|++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999999996432 356777777877776 9999999999
Q ss_pred cccCCCCccccccccc
Q psy10462 312 YQDHIQDLSCFQEQAT 327 (347)
Q Consensus 312 iHRDlKp~Nil~~~~~ 327 (347)
+||||||+|||++.++
T Consensus 160 vH~dlkp~Nill~~~~ 175 (304)
T cd05096 160 VHRDLATRNCLVGENL 175 (304)
T ss_pred cccCcchhheEEcCCc
Confidence 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-25 Score=198.90 Aligned_cols=144 Identities=19% Similarity=0.282 Sum_probs=126.0
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+|++.+.+|.|+||.||++.+..+++.||+|++.+.........+.+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 57788999999999999999999999999999876544334445667899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 272 YAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 272 ~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~---~~kl~dfg 146 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG---YIKITDFG 146 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC---CEEEeeCC
Confidence 999999999998888999999998888766 99999999999999999999998765 24444443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=202.58 Aligned_cols=144 Identities=16% Similarity=0.239 Sum_probs=120.2
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
.....++|+..+.||+|+||.||+|++..+|+.||+|++.... .......+.+|+++++.++||||++++++++..+.
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 3445678899999999999999999999999999999986432 23345567799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+|+|||||++|+|.+. ...++..+..++.|++ ++.|+|++||+||||||+|||++.++ ++.++..|
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kL~DfG 213 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK---NVKIADFG 213 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC---CEEEcccc
Confidence 9999999999998653 3567777777777766 99999999999999999999998764 34444443
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-25 Score=190.08 Aligned_cols=135 Identities=15% Similarity=0.216 Sum_probs=120.9
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
.+.+-|.+...+|+|+||.||+|.|+.+|+.+|||.+.-.. ..+...+|+.||++++.|+||++||.|.....+|
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW 104 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW 104 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence 45678999999999999999999999999999999986431 1345669999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-CCCCCHHHHHHHHH-HHHHHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRK-ERYIDEDKALLCYS-EVSNLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~-~~~~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||||..|+..+.++. +++++|+++.-+.+ .+.||.|+|..+-||||||..||||.-++
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G 166 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG 166 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc
Confidence 99999999999999975 56899999998888 56699999999999999999999997766
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=184.92 Aligned_cols=157 Identities=36% Similarity=0.659 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++...+..++.+++.++.|||+.+++|+||+|+||+++.++.++++|||.+....... ......++..|++||.
T Consensus 84 ~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 84 LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTTFVGTPEYMAPEV 157 (244)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc------ccccccCCcCCCCHHH
Confidence 4567888999999999999999999999999999999999999999999987664321 1223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccCCCCCCC--CCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPR--LSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~--~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
+.+...+ .++|+||+|++++++++|..||.. .+.......+........... ++.++.+++..|+ .+|..||++.
T Consensus 158 ~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 236 (244)
T smart00220 158 LLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE 236 (244)
T ss_pred HccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence 9876666 489999999999999999999987 555555555554433222222 8889999999999 6999999999
Q ss_pred HHhcCCCC
Q psy10462 163 DIRQDPWL 170 (347)
Q Consensus 163 eil~~p~~ 170 (347)
++++|||+
T Consensus 237 ~~~~~~~~ 244 (244)
T smart00220 237 EALQHPFF 244 (244)
T ss_pred HHhhCCCC
Confidence 99999996
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-25 Score=203.98 Aligned_cols=134 Identities=17% Similarity=0.277 Sum_probs=114.8
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC-----CeE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----HRV 266 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 266 (347)
+|++.+.+|+|+||.||+|++..+|+.||+|.+...... ......+.+|+.++++++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 467788999999999999999999999999998643222 12234567999999999999999999988643 358
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|||||. |+|.+++.+.+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~ 140 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC 140 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC
Confidence 99999996 69999998888899999999988776 99999999999999999999998765
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=218.33 Aligned_cols=146 Identities=18% Similarity=0.218 Sum_probs=121.9
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
.+|++.+.+|+|+||.||+|.+..+|+.||+|+++......+...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46788899999999999999999999999999997654344445566789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhC-----------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 271 EYAKNGSLLEVIRKE-----------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 271 E~~~~G~L~~~l~~~-----------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||++||+|.+++... ..++...+..++.|++ |+.|+|++||+||||||+|||+++++. +.++..|
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~---vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE---VVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC---EEEEecC
Confidence 999999999998641 1344556667777766 999999999999999999999977653 4455544
Q ss_pred e
Q psy10462 339 Y 339 (347)
Q Consensus 339 ~ 339 (347)
.
T Consensus 159 L 159 (932)
T PRK13184 159 A 159 (932)
T ss_pred c
Confidence 3
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=202.54 Aligned_cols=161 Identities=20% Similarity=0.258 Sum_probs=118.5
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL 87 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 87 (347)
..+.++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++....... .. ......+++.|+|||.+
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~---~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NF---NPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-cc---CccccCCCcceeChhhh
Confidence 346788899999999999999999999999999999999999999999986543211 10 01122347899999988
Q ss_pred cCCCC--------------------C-CChhhHHHHHHHHHHHHcCCC-CCCCCCHH-----------HHHHHHH-hccC
Q psy10462 88 KGVPY--------------------T-PQQSDIWSMGVVLFAMVYGRL-PFDDTNYS-----------ELLKQVQ-KRVV 133 (347)
Q Consensus 88 ~~~~~--------------------~-~~~~Dvws~G~~l~~ll~g~~-pf~~~~~~-----------~~~~~i~-~~~~ 133 (347)
..... . +.+.|+||+||++++|++|.. ||.+.... ..+..+. ....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 64321 1 124699999999999999986 77543211 1111111 2233
Q ss_pred CCCCCCCCHHHHHHHHhccC-CC---CCCCCHHHHhcCCCCCC
Q psy10462 134 FPESPRLSSSCKALISNILS-PV---KFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 134 ~~~~~~~s~~~~~li~~~l~-~~---~~R~~~~eil~~p~~~~ 172 (347)
++.....++.+++++.+||. ++ .+|++++|+++||||..
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 55556789999999999994 33 67999999999999965
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=196.78 Aligned_cols=143 Identities=13% Similarity=0.137 Sum_probs=121.2
Q ss_pred hhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEe
Q psy10462 193 LKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 272 (347)
Q Consensus 193 ~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~ 272 (347)
|+..+.||+|+||+||+|.+..+++.+|+|.+.+...........+.+|+++|+.++||||+.+++++.+++.+|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 45667899999999999999999999999999765443333345567899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 273 AKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 273 ~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+++|+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||+++++ .+.++..|
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~---~~kl~Dfg 147 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG---HIRISDLG 147 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC---CEEEecCC
Confidence 9999999988543 3699999998888776 99999999999999999999997764 34455444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=196.55 Aligned_cols=143 Identities=13% Similarity=0.133 Sum_probs=121.0
Q ss_pred hhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEe
Q psy10462 193 LKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEY 272 (347)
Q Consensus 193 ~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~ 272 (347)
|+..+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.++++++||||+.+++.+.+.+.+|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 56678899999999999999999999999998765433333344566899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 273 AKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 273 ~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+++|+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||++.++ .+.++..|
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~---~~~l~Dfg 147 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG---HIRISDLG 147 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC---CEEEeecc
Confidence 9999999998543 3689999998888766 99999999999999999999998654 34555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=209.96 Aligned_cols=143 Identities=15% Similarity=0.219 Sum_probs=120.0
Q ss_pred hhhhhhhhhcccccchhhhhhccccc-ccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARH-SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~-~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
...|.+.+.+|+|+||.||+|....+ ++.||+|.+... +......+.+|+.+|+.++|||||+++++|+.++.+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44588999999999999999988777 778999977433 22334556789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh----CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 269 IMEYAKNGSLLEVIRK----ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~----~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||||++||+|.++|.+ ..++++.++..++.|++ ++.|+|++||+||||||+|||++.++ .+.++..|
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~---~~kL~DFg 214 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG---IIKLGDFG 214 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC---cEEEEeCc
Confidence 9999999999988853 45799999998888776 99999999999999999999998765 34444443
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-25 Score=205.08 Aligned_cols=152 Identities=24% Similarity=0.392 Sum_probs=128.4
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccccc
Q psy10462 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILK 88 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 88 (347)
..+-.+++.+.+.||+|||++++|||||-.+|+|+..++.+||+|||+++.-.. +..... ...-...|+|||.+.
T Consensus 261 ~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~----~~~~~~-~~klPirWLAPEtl~ 335 (474)
T KOG0194|consen 261 TLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ----YVMKKF-LKKLPIRWLAPETLN 335 (474)
T ss_pred HHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc----eeeccc-cccCcceecChhhhc
Confidence 467788999999999999999999999999999999999999999999865431 111000 011246899999999
Q ss_pred CCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH-HhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 89 GVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQV-QKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 89 ~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
...++ .++|||||||++||+++ |..||.+.+..++..+| ..+.+.+.+...+.+...++..|. .+|+.|+++.++.
T Consensus 336 ~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 336 TGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred cCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 88776 68999999999999998 89999999999999999 667777777888889999999999 7999999999886
Q ss_pred c
Q psy10462 166 Q 166 (347)
Q Consensus 166 ~ 166 (347)
+
T Consensus 415 ~ 415 (474)
T KOG0194|consen 415 K 415 (474)
T ss_pred H
Confidence 4
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 347 | ||||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-33 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-32 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-32 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-32 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-32 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-32 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-31 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-31 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-31 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-31 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-30 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-30 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-30 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-30 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-30 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-29 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-27 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-26 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-24 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-24 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-24 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-24 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-24 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-24 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-24 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-24 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-24 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-24 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-24 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-24 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-24 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-24 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-23 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-23 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-21 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-21 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-21 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-21 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-21 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-21 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-21 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-20 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-20 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-20 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-19 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-18 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-18 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-18 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-18 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-17 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-17 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-17 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-17 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-17 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-17 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-17 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-17 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-17 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-17 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-17 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-17 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-17 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-17 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-17 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-17 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-17 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-17 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-17 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-16 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-16 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-16 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-16 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-16 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-16 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-16 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-16 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-16 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-16 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-14 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-14 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-14 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-14 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-13 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-12 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-09 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 3e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-04 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 9e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-06 |
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-66
Identities = 66/182 (36%), Positives = 101/182 (55%), Gaps = 17/182 (9%)
Query: 4 LLDY-------NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGF 56
+ DY +AR F Q+ A+ YCH+K +VHRD+K ENLLLD NIK++DFGF
Sbjct: 101 VFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF 160
Query: 57 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
+ +++ + FCG+ YA+PE+ +G Y + D+WS+GV+L+ +V G LPF
Sbjct: 161 SNEFT------VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
Query: 117 DDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDS 174
D N EL ++V R + +S+ C+ L+ L P+K R +E I +D W+
Sbjct: 215 DGQNLKELRERV-LRGKYRIPFYMSTDCENLLKRFLVLNPIK-RGTLEQIMKDRWINAGH 272
Query: 175 NP 176
Sbjct: 273 EE 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 1/91 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++A VKLA ++VAIKII K Q L+K L RE+ ++K L HPN+++ + IET
Sbjct: 27 NFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPNIVKLFEVIET 85
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+Y+IMEYA G + + + + E +A
Sbjct: 86 EKTLYLIMEYASGGEVFDYLVAHGRMKEKEA 116
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 7e-65
Identities = 52/167 (31%), Positives = 93/167 (55%), Gaps = 11/167 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D+AR +F L I+Y H + ++HRDIK NLL+ + +IK++DFG + ++ ++
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA---- 192
Query: 70 NLSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 127
L G+ A+ +PE L ++ + D+W+MGV L+ V+G+ PF D L +
Sbjct: 193 -LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251
Query: 128 VQK-RVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLK 171
++ + FP+ P ++ K LI+ +L +P RI + +I+ PW+
Sbjct: 252 IKSQALEFPDQPDIAEDLKDLITRMLDKNPES-RIVVPEIKLHPWVT 297
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 26/116 (22%), Positives = 49/116 (42%), Gaps = 26/116 (22%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----------------------- 239
SY VKLA + + A+K++SK + P
Sbjct: 25 SYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY 84
Query: 240 REIEVVKGLKHPNLIRFLQAIE--TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+EI ++K L HPN+++ ++ ++ +Y++ E G ++EV + ED+A
Sbjct: 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPL-SEDQA 139
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 4e-64
Identities = 68/169 (40%), Positives = 98/169 (57%), Gaps = 10/169 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ARR F Q+ A+DYCH+ VVHRD+K EN+LLD N K++DFG + S
Sbjct: 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----- 165
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
T CGS YA+PE++ G Y + DIWS GV+L+A++ G LPFDD + L K++
Sbjct: 166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI- 223
Query: 130 KRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSNP 176
+ VF L+ S L+ ++L P+K R ++DIR+ W K+D
Sbjct: 224 RGGVFYIPEYLNRSVATLLMHMLQVDPLK-RATIKDIREHEWFKQDLPS 271
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 25/91 (27%), Positives = 48/91 (52%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ VK+ VA+KI+++ + + + REI+ +K +HP++I+ Q I T
Sbjct: 23 TFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+++MEY G L + I K ++E +A
Sbjct: 83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEA 113
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-63
Identities = 59/168 (35%), Positives = 94/168 (55%), Gaps = 8/168 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
A+R+F QL + Y H + HRDIK ENLLLD++ N+K+SDFG A + NN +
Sbjct: 105 PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER-- 162
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQV 128
L CG+ Y +PE+LK + + D+WS G+VL AM+ G LP+D ++ +
Sbjct: 163 -LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 129 QKRVVF-PESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKED 173
+++ + ++ S+ AL+ IL +P RI + DI++D W +
Sbjct: 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSA-RITIPDIKKDRWYNKP 268
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 2/91 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V+LA + + VA+KI+ +A +D + + +EI + K L H N+++F
Sbjct: 19 AYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPEN-IKKEICINKMLNHENVVKFYGHRRE 76
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ Y+ +EY G L + I + + E A
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 107
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-63
Identities = 56/191 (29%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 4 LLDY------NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFA 57
+LD +A +F QL D ++Y H + +VH+DIK NLLL +K+S G A
Sbjct: 97 MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA 156
Query: 58 RKYSVNNTDYKQNLSETFCGSYAYASPEILKGV-PYTPQQSDIWSMGVVLFAMVYGRLPF 116
D + T GS A+ PEI G+ ++ + DIWS GV L+ + G PF
Sbjct: 157 EALHPFAAD---DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213
Query: 117 DDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKED 173
+ N +L + + K P L+ +L P K R + IRQ W ++
Sbjct: 214 EGDNIYKLFENIGKGSYAIPGD--CGPPLSDLLKGMLEYEPAK-RFSIRQIRQHSWFRKK 270
Query: 174 SNPVGKSKSAP 184
P P
Sbjct: 271 HPPAEAPVPIP 281
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 23/97 (23%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260
SY VK + A+KI+ K ++ + + +EI++++ L+H N+I+ + +
Sbjct: 17 SYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVIQLVDVL 75
Query: 261 --ETTHRVYIIMEYAKNGS--LLEVIRKERYIDEDKA 293
E ++Y++MEY G +L+ + ++R +A
Sbjct: 76 YNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQA 111
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-63
Identities = 59/168 (35%), Positives = 94/168 (55%), Gaps = 8/168 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
A+R+F QL + Y H + HRDIK ENLLLD++ N+K+SDFG A + NN +
Sbjct: 105 PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER-- 162
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQV 128
L CG+ Y +PE+LK + + D+WS G+VL AM+ G LP+D ++ +
Sbjct: 163 -LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221
Query: 129 QKRVVF-PESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKED 173
+++ + ++ S+ AL+ IL +P RI + DI++D W +
Sbjct: 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSA-RITIPDIKKDRWYNKP 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 25/91 (27%), Positives = 46/91 (50%), Gaps = 2/91 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V+LA + + VA+KI+ +A +D + + +EI + K L H N+++F
Sbjct: 19 AYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPEN-IKKEICINKMLNHENVVKFYGHRRE 76
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ Y+ +EY G L + I + + E A
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDA 107
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-62
Identities = 68/166 (40%), Positives = 102/166 (61%), Gaps = 10/166 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D+ RR+F Q+ AI+YCH+ +VHRD+K ENLLLDD N+K++DFG + + N
Sbjct: 108 DEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----- 162
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+T CGS YA+PE++ G Y + D+WS G+VL+ M+ GRLPFDD L K+V
Sbjct: 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV- 220
Query: 130 KRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKED 173
V+ LS ++LI ++ P++ RI +++IR+DPW +
Sbjct: 221 NSCVYVMPDFLSPGAQSLIRRMIVADPMQ-RITIQEIRRDPWFNVN 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 30/91 (32%), Positives = 51/91 (56%), Gaps = 1/91 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ VKLAT + Q VA+K IS+ + + REI +K L+HP++I+ I T
Sbjct: 21 SFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ +++EYA G L + I +++ + ED+
Sbjct: 81 PTDIVMVIEYA-GGELFDYIVEKKRMTEDEG 110
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-61
Identities = 65/169 (38%), Positives = 97/169 (57%), Gaps = 10/169 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
++RR F Q+ +DYCH+ VVHRD+K EN+LLD N K++DFG + N
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDG 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
T CGS YA+PE++ G Y + DIWS GV+L+A++ G LPFDD + L K++
Sbjct: 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI- 228
Query: 130 KRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSNP 176
+F L+ S +L+ ++L P+K R ++DIR+ W K+D
Sbjct: 229 CDGIFYTPQYLNPSVISLLKHMLQVDPMK-RATIKDIREHEWFKQDLPK 276
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 27/92 (29%), Positives = 52/92 (56%), Gaps = 2/92 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQ-APIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261
++ VK+ VA+KI+++ + +D + K + REI+ +K +HP++I+ Q I
Sbjct: 28 TFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIKLYQVIS 86
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
T ++++MEY G L + I K +DE ++
Sbjct: 87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKES 118
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-61
Identities = 54/176 (30%), Positives = 88/176 (50%), Gaps = 16/176 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY--NIKLSDFGFARKYSVNNTDY 67
D+AR +F QL + YCH + HRD+K EN LLD +K+ DFG++ +
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS------KSSV 169
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 127
+ ++ G+ AY +PE+L Y + +D+WS GV L+ M+ G PF+D ++
Sbjct: 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK 229
Query: 128 VQKRVV-----FPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSNP 176
+R++ P+ R+S C LIS I P RI + +I+ W ++
Sbjct: 230 TIQRILSVKYSIPDDIRISPECCHLISRIFVADPAT-RISIPEIKTHSWFLKNLPA 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-19
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ +L + VA+K I + A + ++ REI + L+HPN++RF + I T
Sbjct: 32 NFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINHRSLRHPNIVRFKEVILT 87
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ IIMEYA G L E I ED+A
Sbjct: 88 PTHLAIIMEYASGGELYERICNAGRFSEDEA 118
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-60
Identities = 54/170 (31%), Positives = 92/170 (54%), Gaps = 18/170 (10%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYK 68
+ AR +F Q+ +A+ +CH V+HRDIK EN+L+D ++ +KL DFG K
Sbjct: 149 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-------K 201
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ F G+ Y+ PE ++ Y + + +WS+G++L+ MV G +PF+ + +
Sbjct: 202 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII 256
Query: 129 QKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNP 176
+ +V F R+SS C+ LI L+ P R E+I+ PW+++ P
Sbjct: 257 RGQVFFR--QRVSSECQHLIRWCLALRPSD-RPTFEEIQNHPWMQDVLLP 303
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 19/98 (19%), Positives = 39/98 (39%), Gaps = 8/98 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQ----APIDYLKKFLPREIEVVKGLKH--PNLIRF 256
+ +V + VAIK + K + + + +P E+ ++K + +IR
Sbjct: 55 GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRL 113
Query: 257 LQAIETTHRVYIIMEYAKN-GSLLEVIRKERYIDEDKA 293
L E +I+E + L + I + + E+ A
Sbjct: 114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-60
Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 14/168 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
A F QL A+ Y K ++HRDIK EN+++ + + IKL DFG A +
Sbjct: 130 PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE------RG 183
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
L TFCG+ Y +PE+L G PY + ++WS+GV L+ +V+ PF + L++
Sbjct: 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETV 237
Query: 130 KRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 176
+ +S +L+S +L P + R +E + DPW+ + N
Sbjct: 238 EA-AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNL 284
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 28/130 (21%), Positives = 52/130 (40%), Gaps = 6/130 (4%)
Query: 170 LKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQA 229
L+E V A G + +K + ++ V A +++V +K I K +
Sbjct: 3 LEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKV 62
Query: 230 PIDYLKKF-----LPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS-LLEVIR 283
D + + EI ++ ++H N+I+ L E ++ME +G L I
Sbjct: 63 LEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID 122
Query: 284 KERYIDEDKA 293
+ +DE A
Sbjct: 123 RHPRLDEPLA 132
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-59
Identities = 46/199 (23%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+AR + Q+ Y H+ V+HRD+K NL L++ +K+ DFG A +Y
Sbjct: 141 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDG 195
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ CG+ Y +PE+L ++ + D+WS+G +++ ++ G+ PF+ + E ++
Sbjct: 196 ERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI- 253
Query: 130 KRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNPVGKSKS----A 183
K+ + ++ +LI +L P R + ++ D + P +
Sbjct: 254 KKNEYSIPKHINPVAASLIQKMLQTDPTA-RPTINELLNDEFFTSGYIPARLPITCLTIP 312
Query: 184 PEVGIHKRKLKLIRDKKLS 202
P I L K L+
Sbjct: 313 PRFSIAPSSLDPSNRKPLT 331
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-22
Identities = 20/91 (21%), Positives = 44/91 (48%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+A + A + A KI+ K + ++ + EI + + L H +++ F E
Sbjct: 53 GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
V++++E + SLLE+ ++ + + E +A
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEA 143
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 6e-59
Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 12/175 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
++AR + Q+ + Y H ++HRD+ NLLL NIK++DFG A
Sbjct: 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPH 166
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
T CG+ Y SPEI + +SD+WS+G + + ++ GR PFD L +V
Sbjct: 167 EKHYTLCGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225
Query: 130 K-RVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNPVGKSK 181
P LS K LI +L P R+ + + P++ +S+ K +
Sbjct: 226 LADYEMPSF--LSIEAKDLIHQLLRRNPAD-RLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-20
Identities = 24/92 (26%), Positives = 48/92 (52%), Gaps = 1/92 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+A V A S +VAIK+I K + + + E+++ LKHP+++ E
Sbjct: 23 SFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED 82
Query: 263 THRVYIIMEYAKNGSLLEVIR-KERYIDEDKA 293
++ VY+++E NG + ++ + + E++A
Sbjct: 83 SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA 114
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-58
Identities = 41/169 (24%), Positives = 81/169 (47%), Gaps = 10/169 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+AR + Q+ Y H+ V+HRD+K NL L++ +K+ DFG A +Y
Sbjct: 115 PEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDG 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ CG+ Y +PE+L ++ + D+WS+G +++ ++ G+ PF+ + E ++
Sbjct: 170 ERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI- 227
Query: 130 KRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNP 176
K+ + ++ +LI +L P R + ++ D + P
Sbjct: 228 KKNEYSIPKHINPVAASLIQKMLQTDPTA-RPTINELLNDEFFTSGYIP 275
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-22
Identities = 20/91 (21%), Positives = 44/91 (48%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+A + A + A KI+ K + ++ + EI + + L H +++ F E
Sbjct: 27 GFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 86
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
V++++E + SLLE+ ++ + + E +A
Sbjct: 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEA 117
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-58
Identities = 54/171 (31%), Positives = 84/171 (49%), Gaps = 18/171 (10%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYK 68
+R +F Q+ AI +CH + VVHRDIK EN+L+D + KL DFG
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-------H 191
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
F G+ Y+ PE + Y + +WS+G++L+ MV G +PF+ + +
Sbjct: 192 DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL 246
Query: 129 QKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNPV 177
+ + FP +S C ALI L+ P R +E+I DPW++ + V
Sbjct: 247 EAELHFP--AHVSPDCCALIRRCLAPKPSS-RPSLEEILLDPWMQTPAEDV 294
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 22/100 (22%), Positives = 40/100 (40%), Gaps = 10/100 (10%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQ----APIDYLKKFLPREIEVVK----GLKHPNLI 254
+ TV VAIK+I + + +P+ P E+ ++ G HP +I
Sbjct: 43 GFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKVGAGGGHPGVI 101
Query: 255 RFLQAIETTHRVYIIMEYAKNGS-LLEVIRKERYIDEDKA 293
R L ET +++E L + I ++ + E +
Sbjct: 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS 141
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-55
Identities = 57/171 (33%), Positives = 99/171 (57%), Gaps = 14/171 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
++ + +LADA+ YCH++ V+HRDIK ENLL+ K +K++DFG+ SV+ ++
Sbjct: 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW----SVHAPSLRR 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
T CG+ Y PE+++G + + D+W GV+ + + G PFD +++E +++
Sbjct: 170 R---TMCGTLDYLPPEMIEGKTHDE-KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225
Query: 130 K-RVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSNPV 177
+ FP P LS K LIS +L P + R+ ++ + + PW+K +S V
Sbjct: 226 NVDLKFP--PFLSDGSKDLISKLLRYHPPQ-RLPLKGVMEHPWVKANSRRV 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 26/91 (28%), Positives = 50/91 (54%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V LA ++ +A+K++ K Q + ++ L REIE+ L+HPN++R
Sbjct: 26 KFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
R+Y+++E+A G L + ++K DE ++
Sbjct: 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRS 116
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-54
Identities = 50/175 (28%), Positives = 93/175 (53%), Gaps = 14/175 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + ++LA+A+ YCH K V+HRDIK ENLLL +K++DFG++
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPS 161
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ CG+ Y PE+++G + + D+WS+GV+ + + G+ PF+ Y E K++
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
Query: 130 K-RVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSNPVGKSK 181
+ FP ++ + LIS +L +P + R + ++ + PW+ +S+ +
Sbjct: 221 RVEFTFP--DFVTEGARDLISRLLKHNPSQ-RPMLREVLEHPWITANSSKPSNCQ 272
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 27/91 (29%), Positives = 47/91 (51%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V LA + +A+K++ K Q ++ L RE+E+ L+HPN++R
Sbjct: 21 KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
RVY+I+EYA G++ ++K DE +
Sbjct: 81 ATRVYLILEYAPLGTVYRELQKLSKFDEQRT 111
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-53
Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 32/207 (15%)
Query: 10 DKARRWFSQLADAIDYCH-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 68
+ + ++ Y H +K++ HRD+K N+L+D +KLSDFG S D
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE----SEYMVD-- 204
Query: 69 QNLSETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLK 126
+ G+Y + PE Y + DIWS+G+ L+ M Y +PF + EL
Sbjct: 205 -KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 127 QVQK-RVVFPESPR-----------------LSSSCKALISNILS--PVKFRIQMEDIRQ 166
++ + +P LS+ + L P + RI ED +
Sbjct: 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE-RITSEDALK 322
Query: 167 DPWLKEDSNPVGKSKSAPEVGIHKRKL 193
WL + N + + E+ ++KL
Sbjct: 323 HEWLADT-NIEDLREFSKELYKKRKKL 348
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 24/139 (17%), Positives = 46/139 (33%), Gaps = 18/139 (12%)
Query: 170 LKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHS-QDVAIKIISKVQ 228
L SN + +K E + ++IR + + L + A+K K
Sbjct: 10 LSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC---EKDNKFYALKKYEKSL 66
Query: 229 APIDYLKKFLP--------------REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 274
E++++ +K+ + I VYII EY +
Sbjct: 67 LEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYME 126
Query: 275 NGSLLEVIRKERYIDEDKA 293
N S+L+ +D++
Sbjct: 127 NDSILKFDEYFFVLDKNYT 145
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-51
Identities = 41/188 (21%), Positives = 83/188 (44%), Gaps = 19/188 (10%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + ++ + +A+ H+ +VH D+K N L+ D +KL DFG A + + T
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS--- 182
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQ----------SDIWSMGVVLFAMVYGRLPFDD- 118
+ ++ G+ Y PE +K + + + SD+WS+G +L+ M YG+ PF
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242
Query: 119 -TNYSELLKQVQKRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSN 175
S+L + + ++ L P + RI + ++ P+++ ++
Sbjct: 243 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTH 301
Query: 176 PVGKSKSA 183
PV +
Sbjct: 302 PVNQMAKG 309
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL--IRFLQAI 260
+ V + Q AIK ++ +A L + EI + L+ + IR
Sbjct: 40 GSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHSDKIIRLYDYE 97
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
T +Y++ME N L ++K++ ID +
Sbjct: 98 ITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER 129
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 9e-50
Identities = 41/190 (21%), Positives = 83/190 (43%), Gaps = 19/190 (10%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + ++ + +A+ H+ +VH D+K N L+ D +KL DFG A + + T
Sbjct: 155 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS--- 210
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQ----------SDIWSMGVVLFAMVYGRLPFDD- 118
+ ++ G+ Y PE +K + + + SD+WS+G +L+ M YG+ PF
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 119 -TNYSELLKQVQKRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSN 175
S+L + + ++ L P + RI + ++ P+++ ++
Sbjct: 271 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTH 329
Query: 176 PVGKSKSAPE 185
PV +
Sbjct: 330 PVNQMAKGTT 339
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-16
Identities = 27/130 (20%), Positives = 52/130 (40%), Gaps = 9/130 (6%)
Query: 168 PWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIIS 225
P L D + S + + + R ++ K++ + V + Q AIK ++
Sbjct: 33 PDLGTDDDDKASSSANECISVKGRIYSIL--KQIGSGGSSKVFQVLN-EKKQIYAIKYVN 89
Query: 226 KVQAPIDYLKKFLPREIEVVKGLKHPNL--IRFLQAIETTHRVYIIMEYAKNGSLLEVIR 283
+A L + EI + L+ + IR T +Y++ME N L ++
Sbjct: 90 LEEADNQTLDSYR-NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK 147
Query: 284 KERYIDEDKA 293
K++ ID +
Sbjct: 148 KKKSIDPWER 157
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-49
Identities = 43/223 (19%), Positives = 95/223 (42%), Gaps = 24/223 (10%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + ++ + +A+ H+ +VH D+K N L+ D +KL DFG A + + T
Sbjct: 108 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS--- 163
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQ----------SDIWSMGVVLFAMVYGRLPFDD- 118
+ ++ G+ Y PE +K + + + SD+WS+G +L+ M YG+ PF
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223
Query: 119 -TNYSELLKQVQKRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSN 175
S+L + + ++ L P + RI + ++ P+++ ++
Sbjct: 224 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ-RISIPELLAHPYVQIQTH 282
Query: 176 PVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQD 218
PV + ++K + + + + + +A+ +
Sbjct: 283 PVNQMAKGTT-----EEMKYVLGQLVGLNSPNSILKAAKTLYE 320
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNL--IRFLQAI 260
+ V + Q AIK ++ +A L + EI + L+ + IR
Sbjct: 21 GSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYR-NEIAYLNKLQQHSDKIIRLYDYE 78
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
T +Y++ME N L ++K++ ID +
Sbjct: 79 ITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER 110
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 40/175 (22%), Positives = 78/175 (44%), Gaps = 15/175 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D+ R F Q+ +A+ Y H + ++HRD+K N+ +D+ N+K+ DFG A+ + K
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 70 NLSE---------TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+ + G+ Y + E+L G + ++ D++S+G++ F M+Y
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGME 233
Query: 121 YSELLKQVQK-RVVFPE--SPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
+LK+++ + FP K +I ++ R + WL
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-15
Identities = 23/106 (21%), Positives = 46/106 (43%), Gaps = 18/106 (16%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF------ 256
++ V A +A S+ AIK I + + + E+ ++ L H ++R+
Sbjct: 18 AFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL----SEVMLLASLNHQYVVRYYAAWLE 73
Query: 257 -------LQAIETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKAL 294
+ A++ ++I MEY +NG+L ++I E D+
Sbjct: 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-48
Identities = 52/181 (28%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNN 64
Q+ A+ Y H + + HRDIK EN L + IKL DFG ++++ N
Sbjct: 165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 65 TDYKQNLSETFCGSYAYASPEILKGV--PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
++ T G+ + +PE+L Y P + D WS GV+L ++ G +PF N +
Sbjct: 225 NGEYYGMT-TKAGTPYFVAPEVLNTTNESYGP-KCDAWSAGVLLHLLLMGAVPFPGVNDA 282
Query: 123 ELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVG 178
+ + QV ++ F LS + L+SN+L+ V R Q PW+ + S+ +
Sbjct: 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIY 342
Query: 179 K 179
K
Sbjct: 343 K 343
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 2/128 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF--LPREIEVVKGLKHPNLIRFLQAI 260
SY V++A + AIKI++K + K + E+ ++K L HPN+ R +
Sbjct: 38 SYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSNLSQTFSRCCYQDHIQDLS 320
E + ++ME G LL+ + K + + +
Sbjct: 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGF 157
Query: 321 CFQEQATY 328
Sbjct: 158 RESLDFVQ 165
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 3e-47
Identities = 24/174 (13%), Positives = 54/174 (31%), Gaps = 29/174 (16%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
+ Q+ + H +VH ++ +++LD + + L+ F +
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---------RDGA 258
Query: 72 SETFCGSYAYASPEILK-----------GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
S + PE+ T D W++G+V++ + LP
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTF-SFDAWALGLVIYWIWCADLPITKDA 317
Query: 121 YSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKE 172
+ +F + +AL+ L R+ + P ++
Sbjct: 318 ALGGSEW-----IFRSCKNIPQPVRALLEGFLRYPKED-RLLPLQAMETPEYEQ 365
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 24/164 (14%), Positives = 51/164 (31%), Gaps = 28/164 (17%)
Query: 122 SELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGKSK 181
EL ++ + V S + S+ +L+S L ++E
Sbjct: 25 EELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELG--------------- 69
Query: 182 SAPEVGIHKRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP 239
+R L+R L AT + + + + P K +
Sbjct: 70 --------ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121
Query: 240 REIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIR 283
E+ ++ L+ I+ + + R + K+ ++IR
Sbjct: 122 EEVLRLRLLRG---IKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 162
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-47
Identities = 41/176 (23%), Positives = 80/176 (45%), Gaps = 9/176 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D+ + ++ H K HRD+K N+LL D+ L D G + ++ +Q
Sbjct: 134 DQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 70 NLSE----TFCGSYAYASPEILKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
L+ + +Y +PE+ + +++D+WS+G VL+AM++G P+D
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 124 LLKQ--VQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 176
VQ ++ P+SPR SS+ L++++++ R + + + P
Sbjct: 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 28/134 (20%), Positives = 52/134 (38%), Gaps = 20/134 (14%)
Query: 171 KEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQ 228
+E+ G V I + I +KL ++ V L A+K I
Sbjct: 14 RENLYFQGH-----MVIIDNKHYLFI--QKLGEGGFSYVDLVEGLHDGHFYALKRI-LCH 65
Query: 229 APIDYLKKFLPREIEVVKGLKHPNLIRFLQAI----ETTHRVYIIMEYAKNGSLLEVI-- 282
D ++ RE ++ + HPN++R + H ++++ + K G+L I
Sbjct: 66 EQQD--REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123
Query: 283 --RKERYIDEDKAL 294
K ++ ED+ L
Sbjct: 124 LKDKGNFLTEDQIL 137
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-46
Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 14/170 (8%)
Query: 10 DKARRWFSQLADAIDYCHKK-----SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 64
+ R +QL A+ CH++ +V+HRD+K N+ LD K N+KL DFG AR + +
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+ ++TF G+ Y SPE + + Y ++SDIWS+G +L+ + PF + EL
Sbjct: 171 -----SFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKEL 224
Query: 125 LKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKE 172
++++ R S +I+ +L+ R +E+I ++P + E
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYH-RPSVEEILENPLILE 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 7/98 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-- 260
SY + + + K + + K+ L E+ +++ LKHPN++R+ I
Sbjct: 18 SYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKER----YIDEDKAL 294
T +YI+MEY + G L VI K Y+DE+ L
Sbjct: 77 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 35/209 (16%), Positives = 68/209 (32%), Gaps = 48/209 (22%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNT 65
+ + +++ + +VHR+IK N++ D + KL+DFG AR+ +
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-- 169
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTPQQS-------DIWSMGVVLFAMVYGRLPFDD 118
+ G+ Y P++ + D+WS+GV + G LPF
Sbjct: 170 ----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 119 TNYSELLKQVQKRVV------------------------FPESPRLSSSCKALISNILS- 153
K+V +++ P S LS + L++ +L+
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN 285
Query: 154 -----PVKFRIQMEDIRQDPWLKEDSNPV 177
K + +
Sbjct: 286 ILEADQEK-CWGFDQFFAETSDILHRGNS 313
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 7/97 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE- 261
+ A V + AIK+ + + RE EV+K L H N+++ E
Sbjct: 21 ATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 262 -TTHRVYIIMEYAKNGSLLEVIRKERY---IDEDKAL 294
TT +IME+ GSL V+ + + E + L
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 30/177 (16%), Positives = 48/177 (27%), Gaps = 23/177 (12%)
Query: 9 TDKARRWFS-QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
A + QL K +VH +NL + + L D K
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG------ 245
Query: 68 KQNLSETFCGSYAYASPEIL--KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS--- 122
YA E L +T + W +G+ ++ + LPF
Sbjct: 246 --TRGPASSVPVTYAPREFLNASTATFTH-ALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 123 -----ELLKQVQKRVVFPESPRLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKE 172
L + F L K LI L + R+ + + P +
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR-RLLPLEAMETPEFLQ 358
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 16/123 (13%), Positives = 34/123 (27%), Gaps = 2/123 (1%)
Query: 190 KRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 247
+ + KL + L + V L +D A+K+ + + L
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 248 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSNLSQTF 307
L + + ++ ++ Y + LL + +L F
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 308 SRC 310
S
Sbjct: 179 STL 181
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-43
Identities = 45/190 (23%), Positives = 79/190 (41%), Gaps = 17/190 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
D + F Q A+ + H++ ++HRD+K ENLLL ++ IKL DFG A S
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 68 KQNLSE-------TFCGSYAYASPEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPFD 117
T + Y +PEI+ P + DIW++G +L+ + + + PF+
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGE-KQDIWALGCILYLLCFRQHPFE 254
Query: 118 DTNYSELLKQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNP 176
D L+ V + P + +LI +L + R+ + ++ +
Sbjct: 255 DGA---KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311
Query: 177 VGKSKSAPEV 186
V E+
Sbjct: 312 VNPKSPITEL 321
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 26/137 (18%), Positives = 60/137 (43%), Gaps = 23/137 (16%)
Query: 171 KEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQ 228
++ S+ VG++ V + + +L++ + L+ +A V A ++ A+K +
Sbjct: 13 RDQSDFVGQT-----VELGELRLRVR--RVLAEGGFAFVYEAQDVGSGREYALKRLL-SN 64
Query: 229 APIDYLKKFLPREIEVVKGLK-HPNLIRFLQA-------IETTHRVYIIMEYAKNGSLLE 280
+ + +E+ +K L HPN+++F A +T ++++ G L+E
Sbjct: 65 EEEK--NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE 122
Query: 281 VIRKER---YIDEDKAL 294
++K + D L
Sbjct: 123 FLKKMESRGPLSCDTVL 139
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-43
Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 18/179 (10%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
+ +F Q+ A+ Y H+ ++HRD+K EN+LL + IK++DFG ++
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 168
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDDTNY 121
+ +L T CG+ Y +PE+L V + D WS+GV+LF + G PF +
Sbjct: 169 ----ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224
Query: 122 -SELLKQVQK-RVVFPESP--RLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDS 174
L Q+ + F +S L+ +L P R E+ + PWL+++
Sbjct: 225 QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKA-RFTTEEALRHPWLQDED 282
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF-----LPREIEVVKGLKHPNLIRFL 257
+ VKLA + + VAIKIISK + I ++ + EIE++K L HP +I+
Sbjct: 22 ACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 81
Query: 258 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ YI++E + G L + + + + E
Sbjct: 82 NFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATC 116
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-43
Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
+ A R + A+ YCHK +V HRD+K EN L +KL DFG A ++
Sbjct: 103 FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ + T G+ Y SP++L+G Y P + D WS GV+++ ++ G PF SE
Sbjct: 163 -----KMMR-TKVGTPYYVSPQVLEG-LYGP-ECDEWSAGVMMYVLLCGYPPFSAPTDSE 214
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNIL--SPVKFRIQMEDIRQDPWLKEDSN 175
++ ++++ FPE +S ++LI +L SP + RI + W ++ +
Sbjct: 215 VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ-RITSLQALEHEWFEKQLS 270
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 3/91 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ VK+A A K I K ++ + +F +EIE++K L HPN+IR + E
Sbjct: 21 SWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFK-QEIEIMKSLDHPNIIRLYETFED 77
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+Y++ME G L E + +R E A
Sbjct: 78 NTDIYLVMELCTGGELFERVVHKRVFRESDA 108
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-42
Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 9/165 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D+ WF Q+ A+ + H + ++HRDIK +N+ L ++L DFG AR + + + +
Sbjct: 125 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELAR 183
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
G+ Y SPEI + PY +SDIW++G VL+ + + F+ + L+ ++
Sbjct: 184 ----ACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238
Query: 130 KRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKE 172
P S S ++L+S + P R + I + ++ +
Sbjct: 239 SGSFPPVSLHYSYDLRSLVSQLFKRNPRD-RPSVNSILEKGFIAK 282
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 24/94 (25%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ L S + IK I+ + ++ RE+ V+ +KHPN++++ ++ E
Sbjct: 36 SFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-REVAVLANMKHPNIVQYRESFEE 94
Query: 263 THRVYIIMEYAKNGSLLEVIRKER--YIDEDKAL 294
+YI+M+Y + G L + I ++ ED+ L
Sbjct: 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 15/176 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ + R+ L + I HK ++VHRD+K EN+LLDD NIKL+DFGF+ +
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD----- 175
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQS-----DIWSMGVVLFAMVYGRLPFDDTNY 121
CG+ +Y +PEI++ D+WS GV+++ ++ G PF
Sbjct: 176 -PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234
Query: 122 SELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKED 173
+L+ + F S + K L+S L + R E+ P+ ++
Sbjct: 235 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 17/98 (17%), Positives = 44/98 (44%), Gaps = 7/98 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISK------VQAPIDYLKKFLPREIEVVKGLK-HPNLIR 255
+ V+ ++ A+KII + L++ +E+++++ + HPN+I+
Sbjct: 29 VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 88
Query: 256 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
ET +++ + K G L + + ++ + E +
Sbjct: 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 5e-42
Identities = 22/167 (13%), Positives = 53/167 (31%), Gaps = 16/167 (9%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
+ Q+ + H +VH ++ +++LD + + L+ F + +
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ASAVSP 268
Query: 72 SETFCGSYAYASPEILKGVPYTPQQ----SDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 127
+ +L + P D W++G+ ++ + LP D
Sbjct: 269 IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS-- 326
Query: 128 VQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKE 172
+F + +AL+ L R+ + P ++
Sbjct: 327 ---EWIFRSCKNIPQPVRALLEGFLRYPKED-RLLPLQAMETPEYEQ 369
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 24/201 (11%), Positives = 54/201 (26%), Gaps = 52/201 (25%)
Query: 123 ELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGKSKS 182
EL ++ + V S + S+ +L+S L +S+
Sbjct: 31 ELFNRIPQANVRTTSEYMQSAADSLVSTSLWN-----------------TGQPFRVESEL 73
Query: 183 APEVGIHKRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPR 240
+R L+R L AT + + + + P K +
Sbjct: 74 G------ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 127
Query: 241 EIEVVKGL----------------------KHPNLIRFLQAIETTHRVYIIMEY----AK 274
E+ ++ L K P + ++ ++++ +
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 275 NGSLLEVIRK-ERYIDEDKAL 294
+L + K+L
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSL 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-42
Identities = 55/175 (31%), Positives = 89/175 (50%), Gaps = 14/175 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVN 63
Y+ A Q+ ++I YCH +VHR++K ENLLL K +KL+DFG A + + +
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ F G+ Y SPE+LK PY+ DIW+ GV+L+ ++ G PF D +
Sbjct: 162 -----EAWH-GFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHR 214
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 174
L Q++ +P ++ K+LI ++L+ K RI + + PW+
Sbjct: 215 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 21/91 (23%), Positives = 40/91 (43%), Gaps = 1/91 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+++ V+ + A KII+ + +K RE + + L+HPN++R +I+
Sbjct: 18 AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQE 76
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
Y++ + G L E I + E A
Sbjct: 77 ESFHYLVFDLVTGGELFEDIVAREFYSEADA 107
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-42
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 14/172 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
+ Q+ +A+ Y H + VVH+D+K EN+L D IK+ DFG A + +
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
++ + G+ Y +PE+ K T + DIWS GVV++ ++ G LPF T+ E
Sbjct: 181 -----EHST-NAAGTALYMAPEVFKR-DVTF-KCDIWSAGVVMYFLLTGCLPFTGTSLEE 232
Query: 124 LLKQVQK-RVVFPESPR-LSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 172
+ ++ + R L+ L+ +L+ + R + W K+
Sbjct: 233 VQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-17
Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 7/97 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V L + IK I+K ++ + + + EIEV+K L HPN+I+ + E
Sbjct: 34 AFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFED 91
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSE 299
H +YI+ME + G LLE I + SE
Sbjct: 92 YHNMYIVMETCEGGELLERI-----VSAQARGKALSE 123
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 15/174 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ + R L +A+ + H ++VHRD+K EN+LLDD I+LSDFGF+
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE----- 251
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQS-----DIWSMGVVLFAMVYGRLPFDDTNY 121
CG+ Y +PEILK D+W+ GV+LF ++ G PF
Sbjct: 252 -PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310
Query: 122 SELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
+L+ + + + F SS+ K LIS +L + R+ E Q P+ +
Sbjct: 311 ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 18/136 (13%), Positives = 52/136 (38%), Gaps = 13/136 (9%)
Query: 171 KEDSNPVGKSKSAPEVGIHKRKLKLIRDK-KLS------SYATVKLATSARHSQDVAIKI 223
K N +S + K K + V+ + A+KI
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI 126
Query: 224 ISK-----VQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAKNGS 277
+ ++ +++ RE +++ + HP++I + + E++ ++++ + + G
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 278 LLEVIRKERYIDEDKA 293
L + + ++ + E +
Sbjct: 187 LFDYLTEKVALSEKET 202
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 38/166 (22%), Positives = 72/166 (43%), Gaps = 11/166 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNTD 66
R S ++ A+ Y H+ ++HRD+K EN++L + K+ D G+A++
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD----- 175
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELL 125
+ L F G+ Y +PE+L+ YT D WS G + F + G PF + +
Sbjct: 176 -QGELCTEFVGTLQYLAPELLEQKKYTV-TVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233
Query: 126 KQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLK 171
+V+++ + S++L + + + WL+
Sbjct: 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 18/88 (20%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V + VAIK + +P + ++ EI+++K L HPN++ + +
Sbjct: 26 GFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSAREVPDG 83
Query: 263 ------THRVYIIMEYAKNGSLLEVIRK 284
+ MEY + G L + + +
Sbjct: 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQ 111
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 18/178 (10%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
+ +F Q+ A+ Y H+ ++HRD+K EN+LL + IK++DFG ++
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 293
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+ +L T CG+ Y +PE+L V Y D WS+GV+LF + G PF +
Sbjct: 294 ----ETSLMRTLCGTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPPFSEHR 348
Query: 121 YS-ELLKQVQKRVV-FPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKED 173
L Q+ F +S L+ +L K R E+ + PWL+++
Sbjct: 349 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF-----LPREIEVVKGLKHPNLIRFL 257
+ VKLA + + VAI+IISK + I ++ + EIE++K L HP +I+
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206
Query: 258 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ YI++E + G L + + + + E
Sbjct: 207 NFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATC 241
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-40
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVN 63
Y+ A Q+ ++I YCH +VHR++K ENLLL K +KL+DFG A + + +
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ F G+ Y SPE+LK PY+ DIW+ GV+L+ ++ G PF D +
Sbjct: 185 -----EAWH-GFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHR 237
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGK 179
L Q++ +P ++ K+LI ++L+ K RI + + PW+
Sbjct: 238 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 297
Query: 180 SKSAPEVGIHK-----RKLK 194
V K RKLK
Sbjct: 298 IHRQDTVDCLKKFNARRKLK 317
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 21/91 (23%), Positives = 40/91 (43%), Gaps = 1/91 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+++ V+ + A KII+ + +K RE + + L+HPN++R +I+
Sbjct: 41 AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-REARICRKLQHPNIVRLHDSIQE 99
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
Y++ + G L E I + E A
Sbjct: 100 ESFHYLVFDLVTGGELFEDIVAREFYSEADA 130
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 24/91 (26%), Positives = 39/91 (42%), Gaps = 3/91 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+++ V L + A+K I K A L EI V+K +KH N++ E+
Sbjct: 21 AFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYES 77
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
T Y++M+ G L + I + E A
Sbjct: 78 TTHYYLVMQLVSGGELFDRILERGVYTEKDA 108
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-40
Identities = 37/175 (21%), Positives = 77/175 (44%), Gaps = 13/175 (7%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
A F Q+ +DY H K +++RD+K N+ L D +K+ DFG + N +
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDGKRT 179
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
G+ Y SPE + Y ++ D++++G++L +++ +T+ + ++
Sbjct: 180 ----RSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLR 232
Query: 130 KRVVFPESPRLSSSCKALISNILSPV-KFRIQMEDIRQDPWLKEDSNPVGKSKSA 183
++ S K L+ +LS + R +I + + + S + +A
Sbjct: 233 DGII---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTA 284
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-13
Identities = 21/110 (19%), Positives = 40/110 (36%), Gaps = 25/110 (22%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE- 261
+ V A + IK + Y + RE++ + L H N++ + +
Sbjct: 23 GFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 262 ---------------TTHRVYIIMEYAKNGSLLEVI--RKERYIDEDKAL 294
T ++I ME+ G+L + I R+ +D+ AL
Sbjct: 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 54/175 (30%), Positives = 87/175 (49%), Gaps = 13/175 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVN 63
Y+ A Q+ +A+ +CH+ VVHR++K ENLLL K +KL+DFG A +
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ F G+ Y SPE+L+ PY D+W+ GV+L+ ++ G PF D +
Sbjct: 167 QQAWF-----GFAGTPGYLSPEVLRKDPYGK-PVDLWACGVILYILLVGYPPFWDEDQHR 220
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 174
L +Q++ FP ++ K LI+ +L+ RI + + PW+ S
Sbjct: 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 24/91 (26%), Positives = 39/91 (42%), Gaps = 1/91 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+++ V+ Q+ A II+ + +K RE + + LKHPN++R +I
Sbjct: 23 AFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE-REARICRLLKHPNIVRLHDSISE 81
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
Y+I + G L E I Y E A
Sbjct: 82 EGHHYLIFDLVTGGELFEDIVAREYYSEADA 112
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-39
Identities = 54/176 (30%), Positives = 90/176 (51%), Gaps = 15/176 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
++ A R Q+ I Y HK ++VHRD+K EN+LL+ K +IK+ DFG + + N
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ G+ Y +PE+L+G Y + D+WS GV+L+ ++ G PF N +
Sbjct: 178 -----TKMK-DRIGTAYYIAPEVLRG-TYDE-KCDVWSAGVILYILLSGTPPFYGKNEYD 229
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 175
+LK+V+ + F +S K LI +L+ RI + PW+++ S+
Sbjct: 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 1/91 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V Q+ A+K+I+K A L RE+E++K L HPN+++ + +E
Sbjct: 34 SFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPNIMKLFEILED 92
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ YI+ E G L + I K + E A
Sbjct: 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 35/201 (17%), Positives = 67/201 (33%), Gaps = 48/201 (23%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNT 65
+ + +++ + +VHR+IK N++ D + KL+DFG AR+
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---- 167
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTPQQS-------DIWSMGVVLFAMVYGRLPFDD 118
+ G+ Y P++ + D+WS+GV + G LPF
Sbjct: 168 --DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 119 TNYSELLKQVQKRVV------------------------FPESPRLSSSCKALISNILS- 153
K+V +++ P S LS + L++ +L+
Sbjct: 226 FEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN 285
Query: 154 -----PVKFRIQMEDIRQDPW 169
K + +
Sbjct: 286 ILEADQEK-CWGFDQFFAETS 305
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 7/97 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE- 261
+ A V + AIK+ + + RE EV+K L H N+++ E
Sbjct: 21 ATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 262 -TTHRVYIIMEYAKNGSLLEVIRK---ERYIDEDKAL 294
TT +IME+ GSL V+ + + E + L
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
+N A Q+ + Y HK ++VHRD+K ENLLL+ K IK+ DFG + +
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ G+ Y +PE+L+ Y + D+WS+GV+LF ++ G PF E
Sbjct: 193 KK------MKERLGTAYYIAPEVLRK-KYDE-KCDVWSIGVILFILLAGYPPFGGQTDQE 244
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGK 179
+L++V+K + F +S K LI +L + RI + + PW+KE +
Sbjct: 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKES 304
Query: 180 SKSAPEVGIHKRKLK 194
P + ++
Sbjct: 305 GIELPSLANAIENMR 319
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 36/130 (27%), Positives = 55/130 (42%), Gaps = 9/130 (6%)
Query: 171 KEDSNPVGKSKSAPEVGIHKRKLKLIRD-----KKLS--SYATVKLATSARHSQDVAIKI 223
+E+ G ++ P + I +K + + KKL +Y V L + AIKI
Sbjct: 11 RENLYFQGDLQATPGMFITSKKGH-LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 224 ISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIR 283
I K K L E+ V+K L HPN+++ E Y++ME K G L + I
Sbjct: 70 IRKTSVSTSSNSKLL-EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII 128
Query: 284 KERYIDEDKA 293
+E A
Sbjct: 129 HRMKFNEVDA 138
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
++ A R Q+ I Y HK ++VHRD+K EN+LL+ K +IK+ DFG + + N
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ G+ Y +PE+L+G Y + D+WS GV+L+ ++ G PF N +
Sbjct: 178 TK------MKDRIGTAYYIAPEVLRG-TYDE-KCDVWSAGVILYILLSGTPPFYGKNEYD 229
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGK 179
+LK+V+ + F +S K LI +L+ RI + PW+++ S+
Sbjct: 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289
Query: 180 SKSAPEVGIHKRKLK 194
P + ++
Sbjct: 290 ISDLPSLESAMTNIR 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 1/91 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V Q+ A+K+I+K A L RE+E++K L HPN+++ + +E
Sbjct: 34 SFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REVELLKKLDHPNIMKLFEILED 92
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ YI+ E G L + I K + E A
Sbjct: 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-38
Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 14/176 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVN 63
Y+ A + Q+ +A+ YCH +++HRD+K +LL K N +KL FG A + +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
G+ + +PE++K PY D+W GV+LF ++ G LPF T
Sbjct: 187 GLVAG-----GRVGTPHFMAPEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGTK-ER 239
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 175
L + + K + +S S K L+ +L RI + + PWLKE
Sbjct: 240 LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDR 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 21/99 (21%), Positives = 40/99 (40%), Gaps = 7/99 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260
++ V+ + Q A+KI+ + + L RE + LKHP+++ L+
Sbjct: 36 PFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY 95
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSE 299
+ +Y++ E+ L I + A YSE
Sbjct: 96 SSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSE 129
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-38
Identities = 53/232 (22%), Positives = 100/232 (43%), Gaps = 31/232 (13%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSV 62
++ +A + ++Y H + VVHRD+K N+L + +I++ DFGFA++
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD---DT 119
N T C + + +PE+L+ Y DIWS+GV+L+ M+ G PF D
Sbjct: 173 ENGLLM-----TPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPDD 226
Query: 120 NYSELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 175
E+L ++ + +S + K L+S +L R+ + + PW+
Sbjct: 227 TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD- 285
Query: 176 PVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHS-QDVAIKIISK 226
P+ ++++ K + AT SA + Q ++ + +
Sbjct: 286 ------QLPQYQLNRQDAP--HLVKGAMAATY----SALNRNQSPVLEPVGR 325
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIE 261
SY+ K + + A+KII K K+ EIE++ + +HPN+I +
Sbjct: 34 SYSVCKRCIHKATNMEFAVKIIDKS-------KRDPTEEIEILLRYGQHPNIITLKDVYD 86
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
VY++ E K G LL+ I ++++ E +A
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKFFSEREA 118
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-38
Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
++ A R Q+ I Y HK +VHRD+K ENLLL+ K NI++ DFG + + +
Sbjct: 123 FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ G+ Y +PE+L G Y + D+WS GV+L+ ++ G PF+ N +
Sbjct: 183 KK------MKDKIGTAYYIAPEVLHG-TYDE-KCDVWSTGVILYILLSGCPPFNGANEYD 234
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGK 179
+LK+V+K + F ++S S K LI +L+ RI D W++ + K
Sbjct: 235 ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT----K 290
Query: 180 SKSAPEVGIHKRKLKLIR 197
+ + +V + IR
Sbjct: 291 EQISVDVPSLDNAILNIR 308
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 27/91 (29%), Positives = 44/91 (48%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V L Q+ A+K+ISK Q K+ L RE++++K L HPN+++ + E
Sbjct: 38 SFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED 97
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
Y++ E G L + I + E A
Sbjct: 98 KGYFYLVGEVYTGGELFDEIISRKRFSEVDA 128
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
++ A Q+ I Y HK ++VHRDIK EN+LL++K NIK+ DFG + +S +
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
G+ Y +PE+LK Y + D+WS GV+++ ++ G PF N +
Sbjct: 203 YK------LRDRLGTAYYIAPEVLKK-KYNE-KCDVWSCGVIMYILLCGYPPFGGQNDQD 254
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGK 179
++K+V+K + F + +S K LI +L+ R E+ W+K+ +
Sbjct: 255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA----N 310
Query: 180 SKSAPEVGIHKRKLKLIR 197
+ + + L +R
Sbjct: 311 NINKSDQKTLCGALSNMR 328
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 32/139 (23%), Positives = 55/139 (39%), Gaps = 16/139 (11%)
Query: 171 KEDSNPVGKSKSAPEVGIHKRKLKL----IRDKKLS--SYATVKLATSARHSQDVAIKII 224
++ P + + K++ K+ + +KL +Y V L + AIK+I
Sbjct: 10 GRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVI 69
Query: 225 SK----------VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 274
K I+ + + EI ++K L HPN+I+ E Y++ E+ +
Sbjct: 70 KKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE 129
Query: 275 NGSLLEVIRKERYIDEDKA 293
G L E I DE A
Sbjct: 130 GGELFEQIINRHKFDECDA 148
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 41/177 (23%), Positives = 77/177 (43%), Gaps = 15/177 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARK-------YSV 62
F Q+A+A+++ H K ++HRD+K N+ +K+ DFG +V
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD-DTNY 121
G+ Y SPE + G Y+ + DI+S+G++LF ++Y PF
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMER 233
Query: 122 SELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNP 176
L V+ P + ++ ++LS P++ R + +I ++ ++ P
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPME-RPEAINIIENAVFEDLDFP 289
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 19/100 (19%), Positives = 41/100 (41%), Gaps = 14/100 (14%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V A + + AIK I + ++ + RE++ + L+HP ++R+ A
Sbjct: 17 GFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHPGIVRYFNAWLE 74
Query: 263 THR------------VYIIMEYAKNGSLLEVIRKERYIDE 290
+ +YI M+ + +L + + I+E
Sbjct: 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSV 62
+ ++A + Q+ D ++Y H K + H D+K EN++L DK +IKL DFG A +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
+ ++K G+ + +PEI+ P ++D+WS+GV+ + ++ G PF
Sbjct: 171 DGVEFK-----NIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 123 ELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVG 178
E L + F E + S K I +L + R+ +++ + PW+
Sbjct: 225 ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQA 284
Query: 179 KSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQ 217
+ V + K + +R + S++ V L S
Sbjct: 285 MVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSL 323
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 21/94 (22%), Positives = 42/94 (44%), Gaps = 3/94 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISK---VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 259
+A VK + A K I K + ++ + RE+ +++ + HPN+I
Sbjct: 24 QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV 83
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
E V +I+E G L + + ++ + E++A
Sbjct: 84 YENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVN 63
++ +A +L A+ + H VVHRD+K ENLL D+ IK+ DFGFAR +
Sbjct: 103 FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--- 120
N K T C + YA+PE+L Y D+WS+GV+L+ M+ G++PF +
Sbjct: 163 NQPLK-----TPCFTLHYAAPELLNQNGYDE-SCDLWSLGVILYTMLSGQVPFQSHDRSL 216
Query: 121 ----YSELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 172
E++K+++K F +S K LI +L+ R++M +R + WL++
Sbjct: 217 TCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
Query: 173 DSNPVGKSKSAPEVGIHKRKLKLIRDKK 200
S P++ K
Sbjct: 277 GSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 23/92 (25%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIE 261
S++ + + +Q A+KIISK + +EI +K + HPN+++ +
Sbjct: 23 SFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+++ME G L E I+K+++ E +A
Sbjct: 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEA 108
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 22/236 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVN 63
+ +A + +AI Y H ++ HRD+K ENLL K +KL+DFGFA++ + +
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-- 121
N+ L+ T C + Y +PE+L Y D+WS+GV+++ ++ G PF +
Sbjct: 218 NS-----LT-TPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLA 270
Query: 122 --SELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 175
+ +++ + FP +S K LI N+L R+ + + PW+ +
Sbjct: 271 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS-- 328
Query: 176 PVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI 231
K P K R + + T LAT + + IK I P+
Sbjct: 329 --TKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPL 382
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 24/141 (17%), Positives = 49/141 (34%), Gaps = 27/141 (19%)
Query: 171 KEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLS-------SYATVKLATSARHSQDVAIKI 223
P + + G+ +K +I D K++ V + R + A+K+
Sbjct: 35 PPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM 94
Query: 224 ISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT----HRVYIIMEYAKNGSL 278
+ RE+E+ + P+++R + E + I+ME G L
Sbjct: 95 LQDCPK--------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146
Query: 279 LEVIRKERYIDEDKALLCYSE 299
I +D+ ++E
Sbjct: 147 FSRI-------QDRGDQAFTE 160
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSV 62
+ ++A + Q+ D ++Y H K + H D+K EN++L +IKL DFG A +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE- 170
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
+ ++K G+ + +PEI+ P ++D+WS+GV+ + ++ G PF
Sbjct: 171 DGVEFK-----NIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 123 ELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVG 178
E L + F E S K I +L + R+ +++ + PW+ N
Sbjct: 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA 284
Query: 179 KSKSAPEVGIHKRKLKLIRDKKLSSYATVKLAT 211
+ V + + + +R + S++ V L
Sbjct: 285 MVRRESVVNLENFRKQYVRRRWKLSFSIVSLCN 317
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 20/94 (21%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISK---VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 259
+A VK + A K I K + ++ + RE+ +++ + H N+I
Sbjct: 24 QFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV 83
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
E V +I+E G L + + ++ + E++A
Sbjct: 84 YENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 49/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVN 63
Y+ A Q+ +A+ Y H+ +VHRD+K ENLL +K++DFG ++
Sbjct: 145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-- 202
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYS 122
Q L +T CG+ Y +PEIL+G Y P + D+WS+G++ + ++ G PF D+
Sbjct: 203 ----HQVLMKTVCGTPGYCAPEILRGCAYGP-EVDMWSVGIITYILLCGFEPFYDERGDQ 257
Query: 123 ELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 174
+ +++ F +S + K L+ ++ K R+ Q PW+ +
Sbjct: 258 FMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 31/140 (22%), Positives = 52/140 (37%), Gaps = 13/140 (9%)
Query: 166 QDPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRD-----KKLS--SYATVKLATSARHSQD 218
Q S G + P+ I + D +L + + V +
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKP 80
Query: 219 VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSL 278
A+K++ K KK + EI V+ L HPN+I+ + ET + +++E G L
Sbjct: 81 YALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 279 LEVI-RKERYIDEDKALLCY 297
+ I K Y + D A
Sbjct: 136 FDRIVEKGYYSERDAADAVK 155
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-37
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVN 63
+ +A + AI + H ++ HRD+K ENLL K +KL+DFGFA++
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---- 180
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
QN +T C + Y +PE+L Y D+WS+GV+++ ++ G PF
Sbjct: 181 ---TTQNALQTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGFPPFYSNTGQA 236
Query: 124 LLKQVQKRVV-----FPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 175
+ +++R+ FP +S K LI +L R+ + PW+ +
Sbjct: 237 ISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM- 295
Query: 176 PVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSA 213
P+ +H +++++ K + TSA
Sbjct: 296 ------VVPQTPLH--TARVLQEDKDHWDEVKEEMTSA 325
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 18/102 (17%), Positives = 34/102 (33%), Gaps = 20/102 (19%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE 261
V R Q A+K++ +E++ P+++ L E
Sbjct: 41 VNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQASGGPHIVCILDVYE 92
Query: 262 TTHR----VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSE 299
H + IIME + G L I++ + ++E
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQE-------RGDQAFTE 127
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 43/207 (20%), Positives = 87/207 (42%), Gaps = 14/207 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVN 63
+ + R Q+ + + Y H+ ++VH D+K +N+LL Y +IK+ DFG +RK +
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-H 186
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ + G+ Y +PEIL P T +D+W++G++ + ++ PF + E
Sbjct: 187 ACELR-----EIMGTPEYLAPEILNYDPITT-ATDMWNIGIIAYMLLTHTSPFVGEDNQE 240
Query: 124 LLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGK 179
+ + V + E +S I ++L + R E WL++
Sbjct: 241 TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300
Query: 180 SKSAPEVGIHKRKLKLIRDKKLSSYAT 206
+ + + +S ++
Sbjct: 301 HPEETSSSSQTQDHSVRSSEDKTSKSS 327
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 6/103 (5%)
Query: 196 IRDKKLSS--YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH-PN 252
+ K+L +A V+ S Q+ A K + K + D + L EI V++ K P
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL-HEIAVLELAKSCPR 90
Query: 253 LIRFLQAIETTHRVYIIMEYAKNGSLLEVI--RKERYIDEDKA 293
+I + E T + +I+EYA G + + + E+
Sbjct: 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV 133
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-36
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 16/211 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSV 62
++A + Q+ + + Y H + H D+K EN++L D+ IK+ DFG A K
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 169
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
++K G+ + +PEI+ P ++D+WS+GV+ + ++ G PF
Sbjct: 170 FGNEFK-----NIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQ 223
Query: 123 ELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVG 178
E L V F + S+ K I +L K R+ ++D Q PW+K
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
Query: 179 KSKSAPEVGIHK-RKLKLIRDKKLSSYATVK 208
S+ A V + K +K + S +
Sbjct: 284 LSRKASAVNMEKFKKFAARKKSNNGSGGGLN 314
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 22/94 (23%), Positives = 43/94 (45%), Gaps = 3/94 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISK---VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 259
+A VK A K I K + ++ + RE+ ++K ++HPN+I +
Sbjct: 23 QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 82
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
E V +I+E G L + + ++ + E++A
Sbjct: 83 YENKTDVILILELVAGGELFDFLAEKESLTEEEA 116
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 16/186 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSV 62
D+A ++ Q+ D + Y H K + H D+K EN++L DK IKL DFG A K
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE- 163
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
++K G+ + +PEI+ P ++D+WS+GV+ + ++ G PF
Sbjct: 164 AGNEFK-----NIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGETKQ 217
Query: 123 ELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKED-SNPV 177
E L + F E S K I +L K R+ + + W+K V
Sbjct: 218 ETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
Query: 178 GKSKSA 183
S
Sbjct: 278 RGEDSG 283
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 21/94 (22%), Positives = 44/94 (46%), Gaps = 3/94 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISK---VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 259
+A V+ ++ A K I K + ++ + RE+ +++ ++HPN+I
Sbjct: 17 QFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI 76
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
E V +I+E G L + + ++ + ED+A
Sbjct: 77 FENKTDVVLILELVSGGELFDFLAEKESLTEDEA 110
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNN 64
+ + + Q + + + H+ S+VH DIK EN++ + K ++K+ DFG A K + +
Sbjct: 146 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PD 204
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
K + +A+PEI+ P +D+W++GV+ + ++ G PF + E
Sbjct: 205 EIVK-----VTTATAEFAAPEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDLET 258
Query: 125 LKQVQK-RVVFPES--PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKS 180
L+ V++ F E +S K I N+L + R+ + D + PWLK D
Sbjct: 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD------- 311
Query: 181 KSAPEVGIHKRKLKLIRDKKLSSYATVKLATSA 213
S I + IR K YA A
Sbjct: 312 HSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPA 344
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V + K I+ P+D K + EI ++ L HP LI A E
Sbjct: 63 AFGVVHRCVEKATGRVFVAKFINT-PYPLD--KYTVKNEISIMNQLHHPKLINLHDAFED 119
Query: 263 THRVYIIMEYAKNGSLLEVIRKERY 287
+ + +I+E+ G L + I E Y
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDY 144
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 47/208 (22%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNN 64
+ D+A + Q+ + + H+ + VH D+K EN++ K +KL DFG
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 308
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+ + G+ +A+PE+ +G P +D+WS+GV+ + ++ G PF N E
Sbjct: 309 ---PKQSVKVTTGTAEFAAPEVAEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDET 364
Query: 125 LKQVQK-RVVFPES--PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKS 180
L+ V+ +S +S K I +L R+ + + PWL + P S
Sbjct: 365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 424
Query: 181 KSAPEVGIHKRKLKLIRDKKLSSYATVK 208
+ + + I+ K + +
Sbjct: 425 QIPSSR--YTKIRDSIKTKYDAWPEPLP 450
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 20/85 (23%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V T + A K + D K+ + +EI+ + L+HP L+ A E
Sbjct: 169 AFGVVHRVTERATGNNFAAKFVMT-PHESD--KETVRKEIQTMSVLRHPTLVNLHDAFED 225
Query: 263 THRVYIIMEYAKNGSLLEVIRKERY 287
+ + +I E+ G L E + E
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHN 250
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-35
Identities = 41/171 (23%), Positives = 84/171 (49%), Gaps = 14/171 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
R + +++ A++Y H K ++HRD+K EN+LL++ +I+++DFG A+ S + +
Sbjct: 130 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-V 128
N +F G+ Y SPE+L SD+W++G +++ +V G PF N + ++ +
Sbjct: 190 N---SFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 245
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-------VKFRIQMEDIRQDPWLKE 172
+ FP + + L+ +L + ++ P+ +
Sbjct: 246 KLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-10
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKK--FLPREIEVVKGLKHPNLIRFLQAI 260
S++TV LA S++ AIKI+ K I K ++ RE +V+ L HP ++
Sbjct: 42 SFSTVVLARELATSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF 99
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ ++Y + YAKNG LL+ IRK DE
Sbjct: 100 QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT 132
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-35
Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 12/168 (7%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
++F QL A+++ H + V+HRDIK N+ + +KL D G R +S T
Sbjct: 136 RTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---- 191
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF--DDTNYSELLKQ 127
+ + G+ Y SPE + Y +SDIWS+G +L+ M + PF D N L K+
Sbjct: 192 -AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249
Query: 128 VQKRVVFP-ESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLKE 172
+++ P S S + L++ ++ P K R + +
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEK-RPDVTYVYDVAKRMH 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 22/96 (22%), Positives = 43/96 (44%), Gaps = 4/96 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V A VA+K + + +EI+++K L HPN+I++ +
Sbjct: 44 QFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103
Query: 263 THRVYIIMEYAKNGSLLEVI----RKERYIDEDKAL 294
+ + I++E A G L +I +++R I E
Sbjct: 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 28/196 (14%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVN 63
+N +A +A A+D+ H K + HRD+K EN+L + +K+ DF +N
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 64 N--TDYKQNLSETFCGSYAYASPEILKGVPYTPQ----QSDIWSMGVVLFAMVYGRLPFD 117
+ T CGS Y +PE+++ + D+WS+GV+L+ ++ G PF
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227
Query: 118 DTNYS---------------ELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFR 158
S L + +Q+ + FP+ +S + K LIS +L K R
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQR 287
Query: 159 IQMEDIRQDPWLKEDS 174
+ + Q PW++ +
Sbjct: 288 LSAAQVLQHPWVQGCA 303
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 27/92 (29%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIE 261
++A V+ + SQ+ A+KII K I + + RE+E++ + H N++ ++ E
Sbjct: 25 AHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
R Y++ E + GS+L I K R+ +E +A
Sbjct: 82 EEDRFYLVFEKMRGGSILSHIHKRRHFNELEA 113
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 40/178 (22%), Positives = 75/178 (42%), Gaps = 15/178 (8%)
Query: 4 LLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY--- 60
L D F Q+A+A+++ H K ++HRD+K N+ +K+ DFG
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 61 ----SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
+V G+ Y SPE + G Y+ + DI+S+G++LF ++Y F
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLY---SF 273
Query: 117 D-DTNYSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIRQDPWLK 171
++ V+ + ++ ++LS P + R + DI ++ +
Sbjct: 274 STQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE-RPEATDIIENAIFE 330
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 38/165 (23%), Positives = 70/165 (42%), Gaps = 13/165 (7%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + A+ + H + +VH D+K N+ L + KL DFG +
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG------TA 210
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR-LPFDDTNYSELLKQV 128
E G Y +PE+L+G Y +D++S+G+ + + LP + +L
Sbjct: 211 GAGEVQEGDPRYMAPELLQG-SYGT-AADVFSLGLTILEVACNMELPHGGEGWQQL---R 265
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 172
Q + + LSS ++++ +L P K R E + P L++
Sbjct: 266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 19/94 (20%), Positives = 32/94 (34%), Gaps = 4/94 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE 261
SY V S + A+K + L E+ + + +HP +R QA E
Sbjct: 69 SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQHPCCVRLEQAWE 127
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKAL 294
+Y+ E SL + + E +
Sbjct: 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW 160
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 43/222 (19%), Positives = 92/222 (41%), Gaps = 20/222 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNN 64
N + + Q+ +A+ + H ++ H DI+ EN++ + + IK+ +FG AR+
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PG 157
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+++ + Y +PE+ + + +D+WS+G +++ ++ G PF ++
Sbjct: 158 DNFR-----LLFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQI 211
Query: 125 LKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKS 180
++ + F E +S + +L K R+ + Q PWLK+ V
Sbjct: 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 181 KSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIK 222
+ + L + ++AR S AI+
Sbjct: 272 -------VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIR 306
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 12/92 (13%), Positives = 33/92 (35%), Gaps = 5/92 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V + K + +K +EI ++ +H N++ ++ E+
Sbjct: 17 EFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK----KEISILNIARHRNILHLHESFES 72
Query: 263 THRVYIIMEYAKNGSLLE-VIRKERYIDEDKA 293
+ +I E+ + E + ++E +
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREI 104
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-34
Identities = 42/197 (21%), Positives = 76/197 (38%), Gaps = 34/197 (17%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-------------YNIKLSD 53
Q+A + + H ++HRD+K +N+L+ I +SD
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 54 FGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGV-------PYTPQQSDIWSMGVVL 106
FG +K + ++ NL+ G+ + +PE+L+ T DI+SMG V
Sbjct: 172 FGLCKKLDSGQSSFRTNLN-NPSGTSGWRAPELLEESNNLQTKRRLTR-SIDIFSMGCVF 229
Query: 107 FAMV-YGRLPFDDTNYSELLKQVQK------RVVFPESPRLSSSCKALISNILS--PVKF 157
+ ++ G+ PF D E + + + L + LIS ++ P+K
Sbjct: 230 YYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK- 286
Query: 158 RIQMEDIRQDPWLKEDS 174
R + + P S
Sbjct: 287 RPTAMKVLRHPLFWPKS 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 24/102 (23%), Positives = 42/102 (41%), Gaps = 9/102 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIE 261
S TV S + VA+K + EI+++ HPN+IR+ +
Sbjct: 27 SSGTVVFQGS-FQGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSNL 303
T +YI +E N +L +++ + DE+ L +L
Sbjct: 80 TDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
AR + +++ A+D H +HRD+K +N+LLD ++KL+DFG K +
Sbjct: 168 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV--- 224
Query: 70 NLSETFCGSYAYASPEILKGVP----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 125
+T G+ Y SPE+LK Y + D WS+GV L+ M+ G PF +
Sbjct: 225 -RCDTAVGTPDYISPEVLKSQGGDGYYGR-ECDWWSVGVFLYEMLVGDTPFYADSLVGTY 282
Query: 126 KQV---QKRVVFPESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKE 172
++ + + FP+ +S K LI L+ + R+ +E+I++ + K
Sbjct: 283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 32/180 (17%), Positives = 66/180 (36%), Gaps = 13/180 (7%)
Query: 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-----YNIKLSDFGFARKY 60
+ + Q + + H ++VHRD+K N+L+ +SDFG +K
Sbjct: 114 AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 61 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTP--QQSDIWSMGVVLFAM-VYGRLPFD 117
+V + + G+ + +PE+L DI+S G V + + G PF
Sbjct: 174 AVGRHSFSR--RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 118 DTNYSELLKQVQKRVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 174
+ + + + P + LI +++ + R + + + P+
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 24/119 (20%), Positives = 47/119 (39%), Gaps = 13/119 (10%)
Query: 174 SNPVGKSKSAPEVGIHKR--KLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQA 229
S+P + E K+ L + T+ ++DVA+K I
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF 61
Query: 230 PIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERY 287
F RE+++++ +HPN+IR+ + YI +E +L E + ++ +
Sbjct: 62 ------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDF 113
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-33
Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 18/199 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNN 64
+ Q+ + I + H+ ++H D+K EN+L ++ IK+ DFG AR+Y
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PR 242
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
K G+ + +PE++ + +D+WS+GV+ + ++ G PF N +E
Sbjct: 243 EKLK-----VNFGTPEFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAET 296
Query: 125 LKQVQK-RVVFPES--PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKS 180
L + R + +S K IS +L +RI + + PWL + K
Sbjct: 297 LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH-----KL 351
Query: 181 KSAPEVGIHKRKLKLIRDK 199
S K + +D
Sbjct: 352 HSRLSAQKKKNRGSDAQDF 370
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 3/85 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V +A KII + D K+ + EI V+ L H NLI+ A E+
Sbjct: 101 RFGQVHKCEETATGLKLAAKIIKT-RGMKD--KEEVKNEISVMNQLDHANLIQLYDAFES 157
Query: 263 THRVYIIMEYAKNGSLLEVIRKERY 287
+ + ++MEY G L + I E Y
Sbjct: 158 KNDIVLVMEYVDGGELFDRIIDESY 182
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 42/173 (24%), Positives = 82/173 (47%), Gaps = 20/173 (11%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + + +L A+DY + ++HRD+K +N+LLD+ ++ ++DF A
Sbjct: 115 ETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT-- 172
Query: 70 NLSETFCGSYAYASPEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPF---DDTNYSE 123
T G+ Y +PE+ KG Y+ D WS+GV + ++ GR P+ T+ E
Sbjct: 173 ----TMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227
Query: 124 LLKQVQK-RVVFPESPRLSSSCKALISNILS--PVKFRIQ-MEDIRQDPWLKE 172
++ + V +P S +L+ +L P + R + D++ P++ +
Sbjct: 228 IVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQ-RFSQLSDVQNFPYMND 277
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ AR + +++ AID H+ VHRDIK +N+LLD +I+L+DFG K + T
Sbjct: 162 EMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-- 219
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQS------DIWSMGVVLFAMVYGRLPFDDTNYSE 123
S G+ Y SPEIL+ V P D W++GV + M YG+ PF + +E
Sbjct: 220 --SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277
Query: 124 LLKQV---QKRVVFPESPR-LSSSCKALISNILSPVKFRI---QMEDIRQDPWLKE 172
++ ++ + P + + I +L P + R+ D R P+
Sbjct: 278 TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFG 333
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-31
Identities = 53/175 (30%), Positives = 90/175 (51%), Gaps = 17/175 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ AR + +++ AID H+ VHRDIK +N+L+D +I+L+DFG K +
Sbjct: 175 EMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK----LMEDGT 230
Query: 70 NLSETFCGSYAYASPEILKGVP-----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
S G+ Y SPEIL+ + Y P + D WS+GV ++ M+YG PF + E
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGP-ECDWWSLGVCMYEMLYGETPFYAESLVET 289
Query: 125 LKQV---QKRVVFP-ESPRLSSSCKALISNILSPVKFRI---QMEDIRQDPWLKE 172
++ ++R FP + +S + K LI ++ + R+ +ED ++ P+
Sbjct: 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 54/170 (31%), Positives = 95/170 (55%), Gaps = 18/170 (10%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
A+ + +++ A++Y H K +++RD+K EN+LLD +IK++DFGFA KY + T
Sbjct: 106 PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-KYVPDVTY--- 161
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-V 128
T CG+ Y +PE++ PY + D WS G++++ M+ G PF D+N + ++ +
Sbjct: 162 ----TLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRI-----QMEDIRQDPWLKE 172
+ FP P + K L+S +++ + R+ ED++ PW KE
Sbjct: 217 NAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 5e-04
Identities = 20/98 (20%), Positives = 45/98 (45%), Gaps = 14/98 (14%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-------VVKGLKHPNLIR 255
S+ V L S + + A+K++ K ++ +++E ++ + HP +IR
Sbjct: 18 SFGRVHLIRSRHNGRYYAMKVLKKEIV----VRL---KQVEHTNDERLMLSIVTHPFIIR 70
Query: 256 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ ++++IM+Y + G L ++RK + A
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA 108
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 49/170 (28%), Positives = 84/170 (49%), Gaps = 18/170 (10%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
AR + +Q+ +Y H +++RD+K ENLL+D + I+++DFGFA++ V +
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW-- 196
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-V 128
T CG+ +PEI+ Y + D W++GV+++ M G PF ++ ++ V
Sbjct: 197 ----TLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRI-----QMEDIRQDPWLKE 172
+V FP SS K L+ N+L + R + DI+ W
Sbjct: 252 SGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 20/100 (20%), Positives = 42/100 (42%), Gaps = 4/100 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKF--LPREIEVVKGLKHPNLIRFLQAI 260
S+ V L A+KI+ K + LK+ E +++ + P L++ +
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
+ +Y++MEY G + +R+ E A +++
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-29
Identities = 34/141 (24%), Positives = 60/141 (42%), Gaps = 7/141 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+A Q+ A+D H HRD+K EN+L+ L DFG A + + Q
Sbjct: 134 PRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQ 191
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
G+ Y +PE T ++DI+++ VL+ + G P+ S + +
Sbjct: 192 --LGNTVGTLYYMAPERFSESHATY-RADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN 248
Query: 130 KRVVFPES--PRLSSSCKALI 148
+ + P + P + + A+I
Sbjct: 249 QAIPRPSTVRPGIPVAFDAVI 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 15/91 (16%), Positives = 37/91 (40%), Gaps = 2/91 (2%)
Query: 205 ATVKLATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263
V A + VA+K++ + + + + RE L+ P+++ E
Sbjct: 48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ-REARTAGRLQEPHVVPIHDFGEID 106
Query: 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKAL 294
++Y+ M L ++R++ + +A+
Sbjct: 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAV 137
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-29
Identities = 52/174 (29%), Positives = 89/174 (51%), Gaps = 26/174 (14%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+AR + +++A A+ Y H ++V+RD+K EN+LLD + +I L+DFG K+
Sbjct: 139 PRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC----------KE 188
Query: 70 NLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
N+ TFCG+ Y +PE+L PY + D W +G VL+ M+YG PF N +E+
Sbjct: 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247
Query: 125 LKQ-VQKRVVFPESPRLSSSCKALISNILS--PVKFRI----QMEDIRQDPWLK 171
+ K + P +++S + L+ +L K R+ +I+ +
Sbjct: 248 YDNILNKPLQLK--PNITNSARHLLEGLLQKDRTK-RLGAKDDFMEIKSHVFFS 298
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-29
Identities = 41/144 (28%), Positives = 85/144 (59%), Gaps = 9/144 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D A + ++++ A+ + H+K +++RD+K EN++L+ + ++KL+DFG K S+++
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-KESIHDGT--- 176
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-V 128
++ TFCG+ Y +PEIL + + D WS+G +++ M+ G PF N + + + +
Sbjct: 177 -VTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 129 QKRVVFPESPRLSSSCKALISNIL 152
+ ++ P P L+ + L+ +L
Sbjct: 235 KCKLNLP--PYLTQEARDLLKKLL 256
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 44/149 (29%), Positives = 84/149 (56%), Gaps = 19/149 (12%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + + ++LA A+D+ H +++RD+K EN+LLD++ +IKL+DFG + K+
Sbjct: 126 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS----------KE 175
Query: 70 NLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
++ +FCG+ Y +PE++ +T Q +D WS GV++F M+ G LPF + E
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKET 234
Query: 125 LKQ-VQKRVVFPESPRLSSSCKALISNIL 152
+ ++ ++ P LS ++L+ +
Sbjct: 235 MTMILKAKLGMP--QFLSPEAQSLLRMLF 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 53/176 (30%), Positives = 97/176 (55%), Gaps = 27/176 (15%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
++AR + +++ A++Y H + VV+RDIK ENL+LD +IK++DFG K+
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC----------KE 154
Query: 70 NLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+S+ TFCG+ Y +PE+L+ Y + D W +GVV++ M+ GRLPF + ++ L
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 125 LKQ-VQKRVVFPESPRLSSSCKALISNILS--PVKFRI-----QMEDIRQDPWLKE 172
+ + + + FP LS K+L++ +L P + R+ +++ + +
Sbjct: 214 FELILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQ-RLGGGPSDAKEVMEHRFFLS 266
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 43/217 (19%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVN 63
+ +A + +AI Y H ++ HRD+K ENLL K +KL+DFGFA
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------ 167
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-- 121
E Y D+WS+GV+++ ++ G PF +
Sbjct: 168 --------------------KETTGE-KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLA 205
Query: 122 --SELLKQVQK-RVVFPESP--RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 175
+ +++ + FP +S K LI N+L R+ + + PW+ +
Sbjct: 206 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS-- 263
Query: 176 PVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATS 212
K P K R + + T LAT
Sbjct: 264 --TKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATM 298
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 23/125 (18%), Positives = 47/125 (37%), Gaps = 27/125 (21%)
Query: 187 GIHKRKLKLIRDKKLS-------SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP 239
G+ +K +I D K++ V + R + A+K++
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------AR 58
Query: 240 REIEVVKGL-KHPNLIRFLQAIETTHR----VYIIMEYAKNGSLLEVIRKERYIDEDKAL 294
RE+E+ + P+++R + E + + I+ME G L I +D+
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-------QDRGD 111
Query: 295 LCYSE 299
++E
Sbjct: 112 QAFTE 116
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-28
Identities = 37/142 (26%), Positives = 72/142 (50%), Gaps = 6/142 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+A + A+++ H+ ++HRD+K N+++ +K+ DFG AR + + Q
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQV 128
+ G+ Y SPE +G +SD++S+G VL+ ++ G PF D+ S + V
Sbjct: 176 --TAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232
Query: 129 QKRVVFPES--PRLSSSCKALI 148
++ + P + LS+ A++
Sbjct: 233 REDPIPPSARHEGLSADLDAVV 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 22/95 (23%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 205 ATVKLATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL----QA 259
+ V LA R +DVA+K++ + + + +F RE + L HP ++
Sbjct: 26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-REAQNAAALNHPAIVAVYDTGEAE 84
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKAL 294
YI+MEY +L +++ E + +A+
Sbjct: 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 39/145 (26%), Positives = 77/145 (53%), Gaps = 6/145 (4%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
K Q A +DY H KS++HRD+K N+ L + +K+ DFG A + +
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT---EKSRWSGSH 177
Query: 71 LSETFCGSYAYASPEILKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQ 127
E GS + +PE+++ P QSD+++ G+VL+ ++ G+LP+ + N ++++
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237
Query: 128 VQKRVVFPESPRLSSSCKALISNIL 152
V + + P+ ++ S+C + ++
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRLM 262
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 15/69 (21%), Positives = 34/69 (49%), Gaps = 2/69 (2%)
Query: 218 DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS 277
DVA+K+++ L+ F E+ V++ +H N++ F+ T ++ I+ ++ + S
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 105
Query: 278 LLEVIRKER 286
L +
Sbjct: 106 LYHHLHASE 114
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 54/172 (31%), Positives = 83/172 (48%), Gaps = 23/172 (13%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+A + +++ + + H K +V+RD+K +N+LLD +IK++DFG K+
Sbjct: 118 SRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC----------KE 167
Query: 70 NLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
N+ TFCG+ Y +PEIL G Y D WS GV+L+ M+ G+ PF + EL
Sbjct: 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226
Query: 125 LKQ-VQKRVVFPESPRLSSSCKALISNILS--PVKFRI-QMEDIRQDPWLKE 172
+P L K L+ + P K R+ DIRQ P +E
Sbjct: 227 FHSIRMDNPFYP--RWLEKEAKDLLVKLFVREPEK-RLGVRGDIRQHPLFRE 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 46/143 (32%), Positives = 75/143 (52%), Gaps = 9/143 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D A + +Q+ D I + H +VHRDIK +N+L+D +K+ DFG A+ +++ T Q
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQ 168
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQV 128
+ G+ Y SPE KG +DI+S+G+VL+ M+ G PF+ +T S +K +
Sbjct: 169 --TNHVLGTVQYFSPEQAKGEATDE-CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225
Query: 129 QKRVVFPES---PRLSSSCKALI 148
Q V + + S +I
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVI 248
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 9e-08
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 2/91 (2%)
Query: 205 ATVKLATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263
+TV LA + VAIK I + + LK+F RE+ L H N++ + E
Sbjct: 25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE-REVHNSSQLSHQNIVSMIDVDEED 83
Query: 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKAL 294
Y++MEY + +L E I + D A+
Sbjct: 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAI 114
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 26/176 (14%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+AR + +++ A+ + H K +++RD+K +N+LLD + + KL+DFG K+
Sbjct: 124 ARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC----------KE 173
Query: 70 NLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+ TFCG+ Y +PEIL+ + Y D W+MGV+L+ M+ G PF+ N +L
Sbjct: 174 GICNGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 125 LKQ-VQKRVVFPESPRLSSSCKALISNILS--PVK-----FRIQMEDIRQDPWLKE 172
+ + VV+P L ++ + ++ P + I + P+ KE
Sbjct: 233 FEAILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 43/173 (24%), Positives = 87/173 (50%), Gaps = 17/173 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+A + +Q+ +++ H++++++RD+K EN+LLDD N+++SD G A + T
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT---- 344
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
++ + G+ + +PE+L G Y D +++GV L+ M+ R PF K+++
Sbjct: 345 -KTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 130 KRVVFPE---SPRLSSSCKALISNILS--PVKFRI-----QMEDIRQDPWLKE 172
+RV+ + S + K +L P K R+ + +R P ++
Sbjct: 403 QRVLEQAVTYPDKFSPASKDFCEALLQKDPEK-RLGFRDGSCDGLRTHPLFRD 454
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 24/189 (12%), Positives = 65/189 (34%), Gaps = 22/189 (11%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-----------NIKLSDFGFAR 58
+ ++ I+ H ++H DIK +N +L + + + L D G +
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 59 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-D 117
+ + C + + E+L P+ Q D + + ++ M++G
Sbjct: 232 DMKLFPKG---TIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVK 287
Query: 118 DTNYSELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQ--DPWLKEDSN 175
+ + + +R+ + + + ++ NI ++ +RQ ++
Sbjct: 288 NEGGECKPEGLFRRLPHLD---MWNEFFHVMLNIPDCHH-LPSLDLLRQKLKKVFQQHYT 343
Query: 176 PVGKSKSAP 184
++
Sbjct: 344 NKIRALRNR 352
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 28/163 (17%), Positives = 55/163 (33%), Gaps = 17/163 (10%)
Query: 135 PESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVGIHKRKLK 194
P + LI +LS + + P E + K E + + +
Sbjct: 14 PNFIVGNPWDDKLIFKLLSGLSK-----PVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVY 68
Query: 195 LIRDKKL--SSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG 247
+ L ++A V AT A++ Q +K+ P ++ + +E +K
Sbjct: 69 VH--HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEF--YIGTQLMERLKP 123
Query: 248 LKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDE 290
++F A + ++ E G+LL I + E
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 44/175 (25%), Positives = 86/175 (49%), Gaps = 22/175 (12%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+A + +++ ++ H++ +V+RD+K EN+LLDD +I++SD G A T
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---- 341
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ G+ Y +PE++K YT D W++G +L+ M+ G+ PF ++V+
Sbjct: 342 --IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398
Query: 130 KRVV-----FPESPRLSSSCKALISNILS--PVKFRI-----QMEDIRQDPWLKE 172
+ V + E S ++L S +L P + R+ ++++ P K+
Sbjct: 399 RLVKEVPEEYSER--FSPQARSLCSQLLCKDPAE-RLGCRGGSAREVKEHPLFKK 450
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 44/176 (25%), Positives = 95/176 (53%), Gaps = 20/176 (11%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + + ++ A+++ HK +++RDIK EN+LLD ++ L+DFG + K V + +
Sbjct: 159 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-KEFVADETERA 217
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQS-DIWSMGVVLFAMVYGRLPF----DDTNYSEL 124
FCG+ Y +P+I++G ++ D WS+GV+++ ++ G PF + + +E+
Sbjct: 218 Y---DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
Query: 125 LKQ-VQKRVVFPESPRLSSSCKALISNILS--PVKFRI-----QMEDIRQDPWLKE 172
++ ++ +P +S+ K LI +L P K R+ ++I++ + ++
Sbjct: 275 SRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKK-RLGCGPRDADEIKEHLFFQK 327
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 41/149 (27%), Positives = 80/149 (53%), Gaps = 19/149 (12%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
A + +++A + + K +++RD+K +N++LD + +IK++DFG K+
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC----------KE 170
Query: 70 NLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
N+ + TFCG+ Y +PEI+ PY + D W+ GV+L+ M+ G+ PF+ + EL
Sbjct: 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229
Query: 125 LKQ-VQKRVVFPESPRLSSSCKALISNIL 152
+ ++ V +P +S A+ ++
Sbjct: 230 FQSIMEHNVAYP--KSMSKEAVAICKGLM 256
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 37/146 (25%), Positives = 75/146 (51%), Gaps = 13/146 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY 67
+ +A ++Y H ++ +VHR++K NLL+D KY +K+ DFG +R +
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS- 195
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 127
S++ G+ + +PE+L+ P ++SD++S GV+L+ + + P+ + N + Q
Sbjct: 196 ----SKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPA----Q 246
Query: 128 VQKRVVFP-ESPRLSSSCKALISNIL 152
V V F + + + ++ I+
Sbjct: 247 VVAAVGFKCKRLEIPRNLNPQVAAII 272
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ TV A H DVA+KI+ + + + +FL RE+ ++K L+HPN++ F+ A+
Sbjct: 49 SFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNIVLFMGAVTQ 105
Query: 263 THRVYIIMEYAKNGSLLEVIRKE---RYIDEDKAL 294
+ I+ EY GSL ++ K +DE + L
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 52/145 (35%), Positives = 90/145 (62%), Gaps = 10/145 (6%)
Query: 10 DKARRWFSQLADAIDYCH-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 68
D+AR + +++ A+DY H +K+VV+RD+K ENL+LD +IK++DFG K + +
Sbjct: 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC-KEGIKDGA-- 304
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ- 127
+TFCG+ Y +PE+L+ Y + D W +GVV++ M+ GRLPF + ++ +L +
Sbjct: 305 --TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361
Query: 128 VQKRVVFPESPRLSSSCKALISNIL 152
+ + + FP + L K+L+S +L
Sbjct: 362 LMEEIRFPRT--LGPEAKSLLSGLL 384
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 24/95 (25%), Positives = 42/95 (44%), Gaps = 8/95 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISK----VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 258
++ V L + A+KI+ K + + + E V++ +HP L
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT----ENRVLQNSRHPFLTALKY 215
Query: 259 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ +T R+ +MEYA G L + +ER ED+A
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA 250
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 46/176 (26%), Positives = 91/176 (51%), Gaps = 27/176 (15%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
A + +++A + + K +++RD+K +N++LD + +IK++DFG K+
Sbjct: 442 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC----------KE 491
Query: 70 NLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
N+ + TFCG+ Y +PEI+ PY + D W+ GV+L+ M+ G+ PF+ + EL
Sbjct: 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550
Query: 125 LKQ-VQKRVVFPESPRLSSSCKALISNILS--PVKFRI-----QMEDIRQDPWLKE 172
+ ++ V +P +S A+ +++ P K R+ DI++ + +
Sbjct: 551 FQSIMEHNVAYP--KSMSKEAVAICKGLMTKHPGK-RLGCGPEGERDIKEHAFFRY 603
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 42/175 (24%), Positives = 85/175 (48%), Gaps = 23/175 (13%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
R + +++ +++ H + VV+RD+K N+LLD+ ++++SD G A +S
Sbjct: 292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---- 347
Query: 70 NLSETFCGSYAYASPEIL-KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELL 125
G++ Y +PE+L KGV Y +D +S+G +LF ++ G PF E+
Sbjct: 348 ---HASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
Query: 126 KQV-QKRVVFPESPRLSSSCKALISNILS--PVKFRI-----QMEDIRQDPWLKE 172
+ V P+S S ++L+ +L + R+ +++++ P+ +
Sbjct: 404 RMTLTMAVELPDS--FSPELRSLLEGLLQRDVNR-RLGCLGRGAQEVKESPFFRS 455
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 25/129 (19%), Positives = 60/129 (46%), Gaps = 11/129 (8%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
K R+ ++ + Y H K ++H+D+K +N+ D+ + ++DFG V +++
Sbjct: 131 KTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRRED 189
Query: 71 LSETFCGSYAYASPEILKGV---------PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
G + +PEI++ + P++ + SD++++G + + + PF
Sbjct: 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS-KHSDVFALGTIWYELHAREWPFKTQPA 248
Query: 122 SELLKQVQK 130
++ Q+
Sbjct: 249 EAIIWQMGT 257
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 21/84 (25%), Positives = 37/84 (44%), Gaps = 4/84 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V +VAI++I + D LK F RE+ + +H N++ F+ A +
Sbjct: 45 RFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFK-REVMAYRQTRHENVVLFMGACMS 100
Query: 263 THRVYIIMEYAKNGSLLEVIRKER 286
+ II K +L V+R +
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDAK 124
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 51/185 (27%), Positives = 95/185 (51%), Gaps = 35/185 (18%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ AR + ++++ A++Y H++ +++RD+K +N+LLD + +IKL+D+G K+
Sbjct: 110 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC----------KE 159
Query: 70 NLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-------- 116
L TFCG+ Y +PEIL+G Y D W++GV++F M+ GR PF
Sbjct: 160 GLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
Query: 117 -DDTNYSELLKQ-VQKRVVFPESPRLSSSCKALISNILS--PVK-----FRIQMEDIRQD 167
D L + ++K++ P LS +++ + L+ P + + DI+
Sbjct: 219 PDQNTEDYLFQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276
Query: 168 PWLKE 172
P+ +
Sbjct: 277 PFFRN 281
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 15/156 (9%)
Query: 1 NDILLDYNTDKARRWFSQLADAIDYCHK---KSVVHRDIKCENLLLDDKYN-IKLSDFGF 56
+ L Y A W Q + + Y H K+++HRD+K NLLL +K+ DFG
Sbjct: 93 AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152
Query: 57 ARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
A Q GS A+ +PE+ +G Y+ ++ D++S G++L+ ++ R PF
Sbjct: 153 ACD--------IQTHMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPF 203
Query: 117 DDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL 152
D+ ++ V P L + I +++
Sbjct: 204 DE--IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM 237
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 24/84 (28%), Positives = 40/84 (47%), Gaps = 9/84 (10%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V A ++DVAIK I K F+ E+ + + HPN+++ A
Sbjct: 20 AFGVVCKAK--WRAKDVAIKQIE----SESERKAFI-VELRQLSRVNHPNIVKLYGA--C 70
Query: 263 THRVYIIMEYAKNGSLLEVIRKER 286
+ V ++MEYA+ GSL V+
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHGAE 94
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 28/139 (20%), Positives = 59/139 (42%), Gaps = 19/139 (13%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+A + ++ A+ Y H +V+ D+K EN++L ++ +KL D G +N+
Sbjct: 182 AEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFG--- 235
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
G+ + +PEI++ P T +DI+++G L A+ + + +
Sbjct: 236 ----YLYGTPGFQAPEIVRTGP-TV-ATDIYTVGRTLAALTLDLPTRN----GRYVDGLP 285
Query: 130 KRVVFPESPRLSSSCKALI 148
+ + S L+
Sbjct: 286 ED---DPVLKTYDSYGRLL 301
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 17/85 (20%), Positives = 33/85 (38%), Gaps = 8/85 (9%)
Query: 205 ATVKLATSAR-HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263
+ LA + + V +K + + + E + + + HP++++ +E T
Sbjct: 94 GWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAM-AERQFLAEVVHPSIVQIFNFVEHT 151
Query: 264 HR-----VYIIMEYAKNGSLLEVIR 283
R YI+MEY SL
Sbjct: 152 DRHGDPVGYIVMEYVGGQSLKRSKG 176
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-24
Identities = 26/148 (17%), Positives = 60/148 (40%), Gaps = 19/148 (12%)
Query: 8 NTDKARRWFSQLADAIDYCH--KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 65
+ +A ++ +A + + H + + + ++++D+ ++S +
Sbjct: 109 DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---- 164
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
S + A+ +PE L+ P + +D+WS V+L+ +V +PF D + E
Sbjct: 165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218
Query: 124 LLKQV---QKRVVFPESPRLSSSCKALI 148
+ +V R P +S L+
Sbjct: 219 IGMKVALEGLRPTIPPG--ISPHVSKLM 244
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 16/84 (19%), Positives = 35/84 (41%), Gaps = 5/84 (5%)
Query: 215 HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVYIIMEY 272
D+ +K++ + F E ++ HPN++ L A ++ +I +
Sbjct: 32 QGNDIVVKVLKVRDWSTRKSRDFN-EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90
Query: 273 AKNGSLLEVIRKER--YIDEDKAL 294
GSL V+ + +D+ +A+
Sbjct: 91 MPYGSLYNVLHEGTNFVVDQSQAV 114
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 52/185 (28%), Positives = 96/185 (51%), Gaps = 35/185 (18%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ AR + ++++ A++Y H++ +++RD+K +N+LLD + +IKL+D+G K+
Sbjct: 153 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC----------KE 202
Query: 70 NLSE-----TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-------- 116
L TFCG+ Y +PEIL+G Y D W++GV++F M+ GR PF
Sbjct: 203 GLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
Query: 117 -DDTNYSELLKQ-VQKRVVFPESPRLSSSCKALISNILS--PVK-----FRIQMEDIRQD 167
D L + ++K++ P S LS +++ + L+ P + + DI+
Sbjct: 262 PDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319
Query: 168 PWLKE 172
P+ +
Sbjct: 320 PFFRN 324
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-24
Identities = 41/185 (22%), Positives = 67/185 (36%), Gaps = 18/185 (9%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNL 71
+ Q + ++Y H + ++H D+K +N+LL L DFG A +
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQK 130
+ G+ + +PE++ G P + DIWS ++ M+ G P+ LK +
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDA-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE 271
Query: 131 RVVFPESP-RLSSSCKALISNILS--PVK------------FRIQMEDIRQDPWLKEDSN 175
E P + I L PV +Q + PW E
Sbjct: 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331
Query: 176 PVGKS 180
P G S
Sbjct: 332 PRGNS 336
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-14
Identities = 25/130 (19%), Positives = 50/130 (38%), Gaps = 11/130 (8%)
Query: 165 RQDPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKL---SSYATVKLATSARHSQDVAI 221
R P +++ + K P ++ ++ + + S+ V + A+
Sbjct: 29 RLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88
Query: 222 KIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEV 281
K + L+ F E+ GL P ++ A+ V I ME + GSL ++
Sbjct: 89 KKVR--------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140
Query: 282 IRKERYIDED 291
I++ + ED
Sbjct: 141 IKQMGCLPED 150
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 39/154 (25%), Positives = 75/154 (48%), Gaps = 22/154 (14%)
Query: 10 DKARRWFSQLADAIDYCHKK---SVVHRDIKCENLLLDDKY--------NIKLSDFGFAR 58
D W Q+A ++Y H + ++HRD+K N+L+ K +K++DFG AR
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 59 KYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 118
+ T + G+YA+ +PE+++ ++ + SD+WS GV+L+ ++ G +PF
Sbjct: 165 --EWHRTTKM-----SAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG 216
Query: 119 TNYSELLKQVQKRVVFPESPRLSSSCKALISNIL 152
+ + V + P S+C + ++
Sbjct: 217 IDGLAVAYGVAMNKLALPIP---STCPEPFAKLM 247
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-14
Identities = 21/94 (22%), Positives = 39/94 (41%), Gaps = 6/94 (6%)
Query: 203 SYATVKLATSARHSQDVAIKII--SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260
+ V A +VA+K + ++ +E ++ LKHPN+I
Sbjct: 19 GFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVR-QEAKLFAMLKHPNIIALRGVC 75
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKAL 294
+ ++ME+A+ G L V+ +R I D +
Sbjct: 76 LKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILV 108
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-22
Identities = 27/183 (14%), Positives = 62/183 (33%), Gaps = 34/183 (18%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-------------------DKYNIK 50
+ + Q+ + Y H S+VH DIK N+ + +K K
Sbjct: 115 AELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 51 LSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAM 109
+ D G + S G + + E+L+ + P ++DI+++ + +
Sbjct: 175 IGDLGHVTRISSPQ---------VEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCA 224
Query: 110 VYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILSPV-KFRIQMEDIRQDP 168
+ + ++++ + LS L+ ++ P + R + +
Sbjct: 225 AGAEPLPRN---GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281
Query: 169 WLK 171
L
Sbjct: 282 VLL 284
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 9e-11
Identities = 23/95 (24%), Positives = 35/95 (36%), Gaps = 6/95 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIE 261
+ +V AIK K A + L RE+ L +H +++R+ A
Sbjct: 23 EFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL-REVYAHAVLGQHSHVVRYFSAWA 81
Query: 262 TTHRVYIIMEYAKNGSLLEVI----RKERYIDEDK 292
+ I EY GSL + I R Y E +
Sbjct: 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-22
Identities = 30/149 (20%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 14 RWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDK-----YNIKLSDFGFARKYSVNNTD 66
R +A I+Y ++ +VHRD++ N+ L K++DFG +++
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------- 178
Query: 67 YKQNLSETFCGSYAYASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+ G++ + +PE + YT +++D +S ++L+ ++ G PFD+ +Y ++
Sbjct: 179 -SVHSVSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 125 LKQVQKRVVFP-ESPRLSSSCKALISNIL 152
+ + P + C + N++
Sbjct: 237 --KFINMIREEGLRPTIPEDCPPRLRNVI 263
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 9/98 (9%)
Query: 203 SYATVKLATSARHSQDVAIKII-----SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 257
+ V + VAIK + I+ ++F RE+ ++ L HPN+++
Sbjct: 31 GFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ-REVFIMSNLNHPNIVKLY 89
Query: 258 QAIETTHRVYIIMEYAKNGSLLEVIR-KERYIDEDKAL 294
+ ++ME+ G L + K I L
Sbjct: 90 GL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 26/175 (14%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNL 71
+ Q+ + + Y H +VHRDIK +N+L++ +K+SDFG +++ + N
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-----C 179
Query: 72 SETFCGSYAYASPEILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ETF G+ Y +PEI+ P Y +DIWS+G + M G+ P + EL +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGK-AADIWSLGCTIIEMATGKPP-----FYELGEPQA 233
Query: 130 KRVVF--------PESP-RLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDS 174
+F PE P +S+ KA I P R D+ D +LK S
Sbjct: 234 --AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 3/83 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V + +AIK I + + Y + L EI + K LKH N++++L +
Sbjct: 34 TYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQP-LHEEIALHKHLKHKNIVQYLGSFSE 90
Query: 263 THRVYIIMEYAKNGSLLEVIRKE 285
+ I ME GSL ++R +
Sbjct: 91 NGFIKIFMEQVPGGSLSALLRSK 113
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-21
Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 5/106 (4%)
Query: 20 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79
A+ I++ H+ +HRDIK N+LLD+ + K+SDFG AR + ++ G+
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA---QTVMTSRIVGTT 199
Query: 80 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL 125
AY +PE L+G +SDI+S GVVL ++ G D+ +LL
Sbjct: 200 AYMAPEALRGEITP--KSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 34/169 (20%), Positives = 68/169 (40%), Gaps = 31/169 (18%)
Query: 14 RWFSQLADAIDYCH--------KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 65
R +A + + H K ++ HRD+K +N+L+ ++D G A +S +T
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS-QST 167
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTP-----QQSDIWSMGVVLFAMVYG-------- 112
+ + G+ Y +PE+L ++ DIW+ G+VL+ +
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
Query: 113 --RLPFDDTNYSEL-LKQVQKRVVF----PESPR--LSSSCKALISNIL 152
+ PF D ++ + ++K V P P S ++ ++
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLM 276
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 20/86 (23%), Positives = 39/86 (45%), Gaps = 10/86 (11%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
Y V + ++VA+KI S D F E+ L+H N++ F+ + T
Sbjct: 20 RYGEVWRGS--WQGENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 263 TH----RVYIIMEYAKNGSLLEVIRK 284
+ ++++I Y + GSL + ++
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQL 99
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-21
Identities = 27/110 (24%), Positives = 52/110 (47%), Gaps = 10/110 (9%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK--------- 68
+A + Y H +++HRD+ N L+ + N+ ++DFG AR T +
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 118
+ T G+ + +PE++ G Y ++ D++S G+VL ++ D
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 22/93 (23%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 195 LIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN 252
LI + L + T + + +K + + + + FL +E++V++ L+HPN
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--ETQRTFL-KEVKVMRCLEHPN 68
Query: 253 LIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKE 285
+++F+ + R+ I EY K G+L +I+
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM 101
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 30/168 (17%), Positives = 76/168 (45%), Gaps = 15/168 (8%)
Query: 13 RRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQ 69
R W Q+ + + H ++ ++HRD+KC+N+ + ++K+ D G A
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-------A 184
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQV 128
+ ++ G+ + +PE+ + Y D+++ G+ + M P+ + N +++ ++V
Sbjct: 185 SFAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 129 QKRVVFPESPRLSSS-CKALISNILSP-VKFRIQMEDIRQDPWLKEDS 174
V +++ K +I + R ++D+ + +E++
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 19/92 (20%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL----Q 258
S+ TV + +VA + + ++F E E++KGL+HPN++RF
Sbjct: 38 SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPNIVRFYDSWES 96
Query: 259 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDE 290
++ + ++ E +G+L +++ + +
Sbjct: 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI 128
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-20
Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 13/105 (12%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN---TDYKQ 69
+++ Q+ + I +CH +++HRDIK EN+L+ +KL DFGFAR + D
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA 186
Query: 70 NLSETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVYGR 113
Y +PE+L G V Y D+W++G ++ M G
Sbjct: 187 TR--------WYRAPELLVGDVKYGK-AVDVWAIGCLVTEMFMGE 222
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 9/74 (12%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLIRFLQ 258
SY V + + VAIK K + REI+++K L+H NL+ L+
Sbjct: 37 SYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 259 AIETTHRVYIIMEY 272
+ R Y++ E+
Sbjct: 92 VCKKKKRWYLVFEF 105
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 9/161 (5%)
Query: 18 QLADAIDYCH-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+ + Y K ++HRD+K N+L++ + IKL DFG + + +++ +F
Sbjct: 139 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFV 191
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE 136
G+ +Y SPE L+G Y+ QSDIWSMG+ L M GR P + EL +V
Sbjct: 192 GTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250
Query: 137 SPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPV 177
+ + R M ++ + P
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK 291
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 22/103 (21%), Positives = 43/103 (41%), Gaps = 3/103 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V + +A K+I P + + RE++V+ P ++ F A +
Sbjct: 45 NGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNSPYIVGFYGAFYS 102
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDK-ALLCYSEVSNLS 304
+ I ME+ GSL +V++K I E + + + L+
Sbjct: 103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 145
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-20
Identities = 32/103 (31%), Positives = 45/103 (43%), Gaps = 21/103 (20%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL +D+ H VVHRD+K +N+L+ IKL+DFG AR YS
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA------------ 175
Query: 78 SYA-------YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 113
Y +PE+L Y D+WS+G + M +
Sbjct: 176 -LTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRK 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-20
Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 72
+ Q A+++CHK + +HRD+K EN+L+ IKL DFGFAR + + Y
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY----- 159
Query: 73 ETFCGSYA----YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
Y SPE+L G Y P D+W++G V ++ G
Sbjct: 160 -D---DEVATRWYRSPELLVGDTQYGP-PVDVWAIGCVFAELLSGV 200
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 8e-06
Identities = 24/70 (34%), Positives = 34/70 (48%), Gaps = 1/70 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
SY V + Q VAIK +KK REI ++K LKHPNL+ L+
Sbjct: 15 SYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73
Query: 263 THRVYIIMEY 272
R++++ EY
Sbjct: 74 KRRLHLVFEY 83
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 30/103 (29%), Positives = 44/103 (42%), Gaps = 21/103 (20%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q +D+ H +VHRD+K EN+L+ +KL+DFG AR YS
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA------------ 175
Query: 78 SYA-------YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGR 113
Y +PE+L Y D+WS+G + M +
Sbjct: 176 -LTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRK 216
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 1e-05
Identities = 22/74 (29%), Positives = 40/74 (54%), Gaps = 9/74 (12%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLIRFLQ 258
+Y V A + + VA+K I +D + +P REI ++K L HPN+++ L
Sbjct: 15 TYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 259 AIETTHRVYIIMEY 272
I T +++Y++ E+
Sbjct: 70 VIHTENKLYLVFEF 83
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 27/99 (27%), Positives = 48/99 (48%), Gaps = 7/99 (7%)
Query: 26 CHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85
HK ++ HRDIK +N+LL + ++DFG A K+ + + G+ Y +PE
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH---GQVGTRRYMAPE 203
Query: 86 ILKGVPYTP----QQSDIWSMGVVLFAMVYGRLPFDDTN 120
+L+G + D+++MG+VL+ + D
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 23/119 (19%), Positives = 46/119 (38%), Gaps = 10/119 (8%)
Query: 171 KEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP 230
+ G + L+L+ K + V A ++ VA+KI
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFP----I 57
Query: 231 IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV----YIIMEYAKNGSLLEVIRKE 285
D E+ + G+KH N+++F+ A + V ++I + + GSL + ++
Sbjct: 58 QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN 116
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-19
Identities = 43/191 (22%), Positives = 80/191 (41%), Gaps = 39/191 (20%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL + +CH ++V+HRD+K +NLL++ +KL++FG AR + + Y + +
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW-- 166
Query: 78 SYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPF-------------------- 116
Y P++L G Y+ D+WS G + + P
Sbjct: 167 ---YRPPDVLFGAKLYST-SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 117 -DDT--------NYSELLKQVQKRVVFPESPRLSSSCKALISNILS--PVKFRIQMEDIR 165
++ +Y + P+L+++ + L+ N+L PV+ RI E+
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ-RISAEEAL 281
Query: 166 QDPWLKEDSNP 176
Q P+ + P
Sbjct: 282 QHPYFSDFCPP 292
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 1e-05
Identities = 19/74 (25%), Positives = 38/74 (51%), Gaps = 9/74 (12%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLIRFLQ 258
+Y TV A + + VA+K + +D + +P REI ++K LKH N++R
Sbjct: 14 TYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 259 AIETTHRVYIIMEY 272
+ + ++ ++ E+
Sbjct: 69 VLHSDKKLTLVFEF 82
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 13/105 (12%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN-- 70
+ + QL + YCH++ V+HRD+K +NLL++++ +KL+DFG AR S+ Y
Sbjct: 103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162
Query: 71 -LSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
L Y P+IL G Y+ Q D+W +G + + M GR
Sbjct: 163 TL--------WYRPPDILLGSTDYST-QIDMWGVGCIFYEMATGR 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 21/74 (28%), Positives = 35/74 (47%), Gaps = 10/74 (13%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQA----PIDYLKKFLPREIEVVKGLKHPNLIRFLQ 258
+YATV S VA+K I +++ P + RE+ ++K LKH N++
Sbjct: 14 TYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAI-----REVSLLKDLKHANIVTLHD 67
Query: 259 AIETTHRVYIIMEY 272
I T + ++ EY
Sbjct: 68 IIHTEKSLTLVFEY 81
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 9/100 (9%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE---T 74
L + + Y H+ ++HRD+K N+L+ +KL+DFG AR +S+ + T
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 75 FCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
Y PE+L G Y P D+W G ++ M
Sbjct: 192 LW----YRPPELLLGERDYGP-PIDLWGAGCIMAEMWTRS 226
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 34/149 (22%), Positives = 67/149 (44%), Gaps = 23/149 (15%)
Query: 20 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79
+ + K ++ HRD+K +N+L+ ++D G A ++ + TD G+
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD-SATDTIDIAPNHRVGTK 215
Query: 80 AYASPEILKG------VPYTPQQSDIWSMGVVLFAMVYG----------RLPFDDTNYSE 123
Y +PE+L +++DI++MG+V + + +LP+ D S+
Sbjct: 216 RYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 124 L-LKQVQKRVVF----PESPRLSSSCKAL 147
+++++K V P P SC+AL
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEAL 303
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 9e-09
Identities = 18/87 (20%), Positives = 39/87 (44%), Gaps = 10/87 (11%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V ++VA+KI S + F EI L+H N++ F+ A
Sbjct: 54 RFGEVWRGKW--RGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 263 TH----RVYIIMEYAKNGSLLEVIRKE 285
+ +++++ +Y ++GSL + + +
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY 134
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 32/108 (29%), Positives = 56/108 (51%), Gaps = 12/108 (11%)
Query: 20 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79
A + Y H ++++HRD+K N+LLD+ + K++DFG ++K + + + LS G+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH---LSTVVKGTL 205
Query: 80 AYASPEILKGVPYTPQQ----SDIWSMGVVLFAMVYGRLPFDDTNYSE 123
Y PE + + SD++S GVVLF ++ R + E
Sbjct: 206 GYIDPEY-----FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 41/203 (20%), Positives = 76/203 (37%), Gaps = 49/203 (24%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN-- 70
+ + QL + +CH+ ++HRD+K +NLL++ + +KL DFG AR + + +
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 71 -LSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLK- 126
L Y +P++L G Y+ DIWS G +L M+ G+ F + +L
Sbjct: 171 TL--------WYRAPDVLMGSRTYST-SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221
Query: 127 -------------------------------QVQKRVVFPESPRLSSSCKALISNILS-- 153
+++ + L + + +L
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281
Query: 154 PVKFRIQMEDIRQDPWLKEDSNP 176
P R+ + PW E +
Sbjct: 282 PDM-RLSAKQALHHPWFAEYYHH 303
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 21/74 (28%), Positives = 38/74 (51%), Gaps = 10/74 (13%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQA----PIDYLKKFLPREIEVVKGLKHPNLIRFLQ 258
+YATV + VA+K + K+ + P + REI ++K LKH N++R
Sbjct: 17 TYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAI-----REISLMKELKHENIVRLYD 70
Query: 259 AIETTHRVYIIMEY 272
I T +++ ++ E+
Sbjct: 71 VIHTENKLTLVFEF 84
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 45/195 (23%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN-- 70
+ + QL + +CH+ ++HRD+K +NLL++ +KL+DFG AR + + Y
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV 181
Query: 71 -LSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFD-DTNYSELLKQ 127
L Y +P++L G Y+ DIWS+G + M+ G+ F T+ +L K
Sbjct: 182 TL--------WYRAPDVLMGSKKYST-SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232
Query: 128 VQ-------------------KRVVFPES---------PRLSSSCKALISNILS--PVKF 157
K+ F P L+SN+L P K
Sbjct: 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK- 291
Query: 158 RIQMEDIRQDPWLKE 172
RI D P+ K+
Sbjct: 292 RISARDAMNHPYFKD 306
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 8e-05
Identities = 19/74 (25%), Positives = 35/74 (47%), Gaps = 10/74 (13%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLIRFLQ 258
+Y V A + VA+K I +D + +P REI ++K L HPN++ +
Sbjct: 33 TYGVVYKAKD-SQGRIVALKRIR-----LDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 259 AIETTHRVYIIMEY 272
I + + ++ E+
Sbjct: 87 VIHSERCLTLVFEF 100
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-18
Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 13/105 (12%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN-- 70
+ + QL + I YCH + V+HRD+K +NLL++ + +K++DFG AR + + Y
Sbjct: 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162
Query: 71 -LSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
L Y +P++L G Y+ DIWS+G + MV G
Sbjct: 163 TL--------WYRAPDVLMGSKKYST-TIDIWSVGCIFAEMVNGT 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 6e-05
Identities = 19/74 (25%), Positives = 37/74 (50%), Gaps = 10/74 (13%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLIRFLQ 258
+Y V A + + + A+K I ++ + +P REI ++K LKH N+++
Sbjct: 14 TYGVVYKAQN-NYGETFALKKIR-----LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 259 AIETTHRVYIIMEY 272
I T R+ ++ E+
Sbjct: 68 VIHTKKRLVLVFEH 81
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 30/154 (19%), Positives = 59/154 (38%), Gaps = 26/154 (16%)
Query: 20 ADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79
+ K ++ HRD+K +N+L+ ++D G A K+ ++T+ T G+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI-SDTNEVDIPPNTRVGTK 210
Query: 80 AYASPEILKG------VPYTPQQSDIWSMGVVL---------------FAMVYGRLPFDD 118
Y PE+L +D++S G++L + + Y L D
Sbjct: 211 RYMPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 119 TNYSELLKQV---QKRVVFPESPRLSSSCKALIS 149
+Y ++ + V + R FP + +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGK 303
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 29/136 (21%), Positives = 56/136 (41%), Gaps = 14/136 (10%)
Query: 170 LKEDSNPVGKSKSAPEVG--IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKV 227
L E S G P + +++++++ Y V + + VA+K+
Sbjct: 14 LIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFF-- 69
Query: 228 QAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----RVYIIMEYAKNGSLLEVIR 283
+ F EI ++H N++ F+ A ++Y+I +Y +NGSL + ++
Sbjct: 70 --TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK 127
Query: 284 KERYIDEDKAL-LCYS 298
+D L L YS
Sbjct: 128 S-TTLDAKSMLKLAYS 142
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-18
Identities = 37/127 (29%), Positives = 62/127 (48%), Gaps = 15/127 (11%)
Query: 22 AIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA 80
A+++ H K SV+HRD+K N+L++ +K+ DFG + + + K + G
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAK----DIDAGCKP 174
Query: 81 YASPEILKGVPYTPQ---QSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPE 136
Y +PE + +SDIWS+G+ + + R P+D + LKQ VV
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----VVEEP 230
Query: 137 SPRLSSS 143
SP+L +
Sbjct: 231 SPQLPAD 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 26/108 (24%), Positives = 45/108 (41%), Gaps = 9/108 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIE 261
+Y V+ Q +A+K I + +K L ++++ + + P + F A+
Sbjct: 19 AYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDLDISMRTVDCPFTVTFYGALF 76
Query: 262 TTHRVYIIMEYAKNGSLL----EVIRKERYIDEDK-ALLCYSEVSNLS 304
V+I ME + SL +VI K + I ED + S V L
Sbjct: 77 REGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-18
Identities = 32/99 (32%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+ Y H + V+HRDIK +++LL +KLSDFGF + ++ K+ + G+ +
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ--ISKDVPKRK---SLVGTPYW 207
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+PE++ Y + DIWS+G+++ MV G P+ +
Sbjct: 208 MAPEVISRSLYAT-EVDIWSLGIMVIEMVDGEPPYFSDS 245
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 19/95 (20%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S V LA + VA+K++ + ++ L E+ +++ +H N++ ++
Sbjct: 57 STGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLV 113
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
++++ME+ + G+L +++ + R +E A +C
Sbjct: 114 GEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCE 148
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-18
Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
A+++ H V+HRDIK +N+LL ++KL+DFGF + + K++ T G+ +
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRS---TMVGTPYW 182
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+PE++ Y P + DIWS+G++ M+ G P+ + N
Sbjct: 183 MAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 4/89 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ TV A Q+VAI+ ++ Q P K+ + EI V++ K+PN++ +L +
Sbjct: 32 ASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDED 291
++++MEY GSL +V+ E +DE
Sbjct: 89 GDELWVVMEYLAGGSLTDVV-TETCMDEG 116
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 13/103 (12%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN---L 71
+ ++Y H+ ++HRD+K NLLLD+ +KL+DFG A+ + N Y
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR 176
Query: 72 SETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
Y +PE+L G Y D+W++G +L ++
Sbjct: 177 --------WYRAPELLFGARMYGV-GVDMWAVGCILAELLLRV 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 6e-05
Identities = 22/74 (29%), Positives = 36/74 (48%), Gaps = 6/74 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLIRFLQ 258
+ATV A +Q VAIK I K+ K + REI++++ L HPN+I L
Sbjct: 22 QFATVYKARDKNTNQIVAIKKI-KLGHR-SEAKDGINRTALREIKLLQELSHPNIIGLLD 79
Query: 259 AIETTHRVYIIMEY 272
A + ++ ++
Sbjct: 80 AFGHKSNISLVFDF 93
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
++Y H +HRDIK N+LL+ + + KL+DFG A + + +T K+N T G+ +
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ--LTDTMAKRN---TVIGTPFW 191
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+PE+++ + Y +DIWS+G+ M G+ P+ D +
Sbjct: 192 MAPEVIQEIGYNC-VADIWSLGITAIEMAEGKPPYADIH 229
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 24/97 (24%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
SY +V A Q VAIK + + +K EI +++ P+++++ +
Sbjct: 41 SYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-----EISIMQQCDSPHVVKYYGSYFK 95
Query: 263 THRVYIIMEYAKNGSLLEVIR-KERYIDEDK-ALLCY 297
++I+MEY GS+ ++IR + + + ED+ A +
Sbjct: 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ 132
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 18/110 (16%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-----NIKLSDFGFARKYSVNNTDY 67
+ + QL + +++CH + +HRD+K +NLLL +K+ DFG AR + + +
Sbjct: 135 KSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 68 KQN---LSETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
L Y PEIL G Y+ DIWS+ + M+
Sbjct: 195 THEIITL--------WYRPPEILLGSRHYST-SVDIWSIACIWAEMLMKT 235
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 22/74 (29%), Positives = 39/74 (52%), Gaps = 9/74 (12%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP----REIEVVKGLKHPNLIRFLQ 258
+Y V A ++ VAIK I +++ ++ +P RE+ ++K L+H N+I
Sbjct: 46 TYGEVYKAIDTVTNETVAIKRIR-----LEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 259 AIETTHRVYIIMEY 272
I HR+++I EY
Sbjct: 101 VIHHNHRLHLIFEY 114
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 12/103 (11%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYN----IKLSDFGFARKYSVNNTDYKQNLSE 73
Q+ D I Y H V+HRD+K N+L+ + +K++D GFAR ++
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 74 --TFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
TF Y +PE+L G YT DIW++G + ++
Sbjct: 196 VVTFW----YRAPELLLGARHYTK-AIDIWAIGCIFAELLTSE 233
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 9e-04
Identities = 22/75 (29%), Positives = 37/75 (49%), Gaps = 11/75 (14%)
Query: 204 YATVKLATS--ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261
Y V A + +D A+K I + REI +++ LKHPN+I LQ +
Sbjct: 34 YGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLRELKHPNVIS-LQKVF 87
Query: 262 TTH---RVYIIMEYA 273
+H +V+++ +YA
Sbjct: 88 LSHADRKVWLLFDYA 102
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-17
Identities = 21/129 (16%), Positives = 36/129 (27%), Gaps = 34/129 (26%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
A R LA A D H+ V + + ++ L+
Sbjct: 131 AIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM-------------- 176
Query: 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR 131
A+P+ DI +G L+A++ R P + L ++
Sbjct: 177 --------PDANPQ-----------DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD 217
Query: 132 VV-FPESPR 139
P P
Sbjct: 218 TAGQPIEPA 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 17/80 (21%), Positives = 31/80 (38%), Gaps = 2/80 (2%)
Query: 205 ATVKLATSARHSQDVAIKII-SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263
A + VA+ + + P D L++ L + + P + R L + T
Sbjct: 45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVARVLDVVHTR 103
Query: 264 HRVYIIMEYAKNGSLLEVIR 283
++ E+ + GSL EV
Sbjct: 104 AGGLVVAEWIRGGSLQEVAD 123
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-17
Identities = 31/178 (17%), Positives = 70/178 (39%), Gaps = 39/178 (21%)
Query: 14 RWFSQLADAIDYCH---------KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 64
R + + Y H K ++ HRD+ N+L+ + +SDFG + + + N
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 65 ---TDYKQNLSETFCGSYAYASPEILKGVPYTP------QQSDIWSMGVVL--------- 106
+ N + + G+ Y +PE+L+G +Q D++++G++
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 107 ---------FAMVYGRLPFDDTNYSELLKQV---QKRVVFPESPRLSSSCKALISNIL 152
+ M + + + ++ V ++R FPE+ + +S + +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 15/124 (12%)
Query: 182 SAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPRE 241
+A E + LKL+ Y V + + VA+K+ S + F+ E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSF-----ANRQNFI-NE 55
Query: 242 IEVVK--GLKHPNLIRFLQAIETTHRV-----YIIMEYAKNGSLLEVIRKERYIDEDKAL 294
+ + ++H N+ RF+ E ++MEY NGSL + +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR 115
Query: 295 LCYS 298
L +S
Sbjct: 116 LAHS 119
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 22/133 (16%)
Query: 22 AIDYCH-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARK--YSVNNTDYKQNLSETFCGS 78
A+ Y K V+HRD+K N+LLD++ IKL DFG + + G
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD--------RSAGC 187
Query: 79 YAYASPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRV 132
AY +PE + Y ++D+WS+G+ L + G+ P+ + E+L + V
Sbjct: 188 AAYMAPERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTK----V 242
Query: 133 VFPESPRLSSSCK 145
+ E P L
Sbjct: 243 LQEEPPLLPGHMG 255
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 18/104 (17%), Positives = 37/104 (35%), Gaps = 4/104 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIE 261
+ V + +A+K + + + K + +++VV K P +++
Sbjct: 37 TCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHDCPYIVQCFGTFI 94
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDK-ALLCYSEVSNLS 304
T V+I ME + R + I E + + V L
Sbjct: 95 TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
+DY H + +HRDIK N+LL + +KL+DFG A + + +T K+N TF G+ +
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRN---TFVGTPFW 185
Query: 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+PE++K Y ++DIWS+G+ + G P + +
Sbjct: 186 MAPEVIKQSAYDS-KADIWSLGITAIELARGEPPHSELH 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V R + VAIKII +A + + + +EI V+ P + ++ +
Sbjct: 34 SFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLK 91
Query: 263 THRVYIIMEYAKNGSLLEVIRK----ERYI 288
+++IIMEY GS L+++ E I
Sbjct: 92 DTKLWIIMEYLGGGSALDLLEPGPLDETQI 121
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 32/170 (18%), Positives = 66/170 (38%), Gaps = 23/170 (13%)
Query: 13 RRWFS---------QLADAIDYCHKKSVVHRDIKCENLLL--DDKYNIKLSDFGFARKYS 61
+ S +L DA+++ H+ VH ++ EN+ + +D+ + L+ +GFA +Y
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 62 VNNT--DYKQNLSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLPF 116
+ Y + G + S ++ KG S D+ S+G + +YG LP+
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFISMDLHKGC----GPSRRSDLQSLGYCMLKWLYGFLPW 268
Query: 117 DDTNYSELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQ 166
+ + QK+ + C I + ++ +
Sbjct: 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIR---PSETLQKYLKVVMA 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 27/108 (25%), Positives = 56/108 (51%), Gaps = 10/108 (9%)
Query: 20 ADAIDYCHKKS---VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
A + Y H ++HRD+K N+LLD+++ + DFG A+ +T +++
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----HVTTAVR 196
Query: 77 GSYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
G+ + +PE + G + +++D++ GV+L ++ G+ FD +
Sbjct: 197 GTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 40/129 (31%), Positives = 63/129 (48%), Gaps = 19/129 (14%)
Query: 22 AIDYCH-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARK--YSVNNTDYKQNLSETFCGS 78
A+++ ++HRDIK N+LLD NIKL DFG + + S+ T G
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT--------RDAGC 188
Query: 79 YAYASPEILKGVPYTPQ---QSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVF 134
Y +PE + +SD+WS+G+ L+ + GR P+ + + L QV K
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG--- 245
Query: 135 PESPRLSSS 143
+ P+LS+S
Sbjct: 246 -DPPQLSNS 253
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 17/83 (20%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIE 261
+Y +V Q +A+K I + +K L +++VV + P +++F A+
Sbjct: 34 AYGSVNKMVHKPSGQIMAVKRIRSTVDEKE--QKQLLMDLDVVMRSSDCPYIVQFYGALF 91
Query: 262 TTHRVYIIMEYAKNGSLLEVIRK 284
+I ME + S + +
Sbjct: 92 REGDCWICMELM-STSFDKFYKY 113
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 26/98 (26%), Positives = 52/98 (53%), Gaps = 2/98 (2%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
++Y HK +HRD+K N+LL + +++++DFG + + + + +TF G+ +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 82 ASPE-ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD 118
+PE + + Y ++DIWS G+ + G P+
Sbjct: 193 MAPEVMEQVRGYDF-KADIWSFGITAIELATGAAPYHK 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 24/83 (28%), Positives = 44/83 (53%), Gaps = 6/83 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIIS--KVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260
+ A V+ A A + VAIK I+ K Q +D L K EI+ + HPN++ + +
Sbjct: 27 ATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK----EIQAMSQCHHPNIVSYYTSF 82
Query: 261 ETTHRVYIIMEYAKNGSLLEVIR 283
++++M+ GS+L++I+
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIK 105
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 28/105 (26%), Positives = 47/105 (44%), Gaps = 9/105 (8%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYA- 80
A+DY H VHR +K ++L+ + LS S+ + +Q + F
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN--LSMISHGQRQRVVHDFPKYSVK 197
Query: 81 ---YASPEILK--GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+ SPE+L+ Y +SDI+S+G+ + G +PF D
Sbjct: 198 VLPWLSPEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMP 241
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 17/82 (20%), Positives = 35/82 (42%), Gaps = 1/82 (1%)
Query: 202 SSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261
TV LA + V ++ I+ + + FL E+ V K HPN++ +
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFNHPNIVPYRATFI 96
Query: 262 TTHRVYIIMEYAKNGSLLEVIR 283
+ ++++ + GS ++I
Sbjct: 97 ADNELWVVTSFMAYGSAKDLIC 118
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 30/114 (26%), Positives = 64/114 (56%), Gaps = 6/114 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q++ A++Y KK+ +HR++ N L+ + + +K++DFG +R + Y + F
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKF-- 381
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE L ++ +SD+W+ GV+L+ + YG P+ + S++ + ++K
Sbjct: 382 PIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 30/118 (25%), Positives = 54/118 (45%), Gaps = 8/118 (6%)
Query: 171 KEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQ 228
+ G S + + + + + + KL Y V ++S VA+K + K
Sbjct: 200 RNKPTIYGVSPNYDKWEMERTDITMK--HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED 256
Query: 229 APIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
+++FL +E V+K +KHPNL++ L YII E+ G+LL+ +R+
Sbjct: 257 TM--EVEEFL-KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 311
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 33/114 (28%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A + Y + + VHRD++ N+L+ + K++DFG AR + + +Y F
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF-- 426
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE +T +SD+WS G++L + GR+P+ E+L QV++
Sbjct: 427 PIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 32/166 (19%)
Query: 128 VQKRVVFPESPRL----SSSCKALISNILSPV-KFRIQMEDIRQDPWLKEDSNPVGKSKS 182
+ R F +L S L + + + Q + + +D W
Sbjct: 216 ITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWE------------ 263
Query: 183 APEVGIHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPR 240
I + L+L KL + V + T + VAIK + K + FL +
Sbjct: 264 -----IPRESLRLE--VKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTM--SPEAFL-Q 311
Query: 241 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
E +V+K L+H L++ + + +YI+ EY GSLL+ ++ E
Sbjct: 312 EAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGET 356
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 11/102 (10%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNN--TDYKQNLSET 74
++ A+DYCH ++HRD+K N+++D + ++L D+G A Y
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR------- 190
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116
S + PE+L D+WS+G +L +M++ + PF
Sbjct: 191 -VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 33/114 (28%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A + Y + + VHRD++ N+L+ + K++DFG AR + + +Y F
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF-- 343
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE +T +SD+WS G++L + GR+P+ E+L QV++
Sbjct: 344 PIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 12/113 (10%)
Query: 176 PVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQAPIDY 233
G +K A E I + L+L KL + V + T + VAIK + +
Sbjct: 171 TQGLAKDAWE--IPRESLRLE--VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPE- 224
Query: 234 LKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
FL +E +V+K L+H L++ + + +YI+ EY GSLL+ ++ E
Sbjct: 225 --AFL-QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGET 273
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 34/108 (31%), Positives = 62/108 (57%), Gaps = 11/108 (10%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ +A+++ H K ++HRD+K N+L+ + +I+L+DFG + K T K++ +F G
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRD---SFIG 179
Query: 78 SYAYASPEI-----LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+ + +PE+ +K PY ++DIWS+G+ L M P + N
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELN 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 18/97 (18%), Positives = 44/97 (45%), Gaps = 5/97 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V A + A K+I + EIE++ HP +++ L A
Sbjct: 31 AFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYH 87
Query: 263 THRVYIIMEYAKNGSLLEVIRK-ERYIDEDK-ALLCY 297
+++I++E+ G++ ++ + +R + E + ++C
Sbjct: 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 124
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 35/123 (28%), Positives = 58/123 (47%), Gaps = 17/123 (13%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
W Q+A ++Y + +VHRD+ N+L+ ++K++DFG A+ +Y
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 177
Query: 75 FCGS------YAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQ 127
G A E + YT QSD+WS GV ++ M +G P+D SE+
Sbjct: 178 --GGKVPIKWMA---LESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 128 VQK 130
++K
Sbjct: 232 LEK 234
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 19/73 (26%), Positives = 34/73 (46%), Gaps = 3/73 (4%)
Query: 214 RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 273
+ VAIK + + K+ L E V+ + +P++ R L I T V +I +
Sbjct: 42 KVKIPVAIKEL-REATSPKANKEIL-DEAYVMASVDNPHVCR-LLGICLTSTVQLITQLM 98
Query: 274 KNGSLLEVIRKER 286
G LL+ +R+ +
Sbjct: 99 PFGCLLDYVREHK 111
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 37/127 (29%), Positives = 64/127 (50%), Gaps = 15/127 (11%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
+ + H+ V+HRDIK +N+LL + +KL DFG + + ++ T ++N TF G+ +
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRN---TFIGTPYW 195
Query: 82 ASPEILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE 136
+PE++ Y +SD+WS+G+ M G P D + L + +
Sbjct: 196 MAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----P 250
Query: 137 SPRLSSS 143
+PRL S
Sbjct: 251 APRLKSK 257
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 19/98 (19%), Positives = 42/98 (42%), Gaps = 13/98 (13%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL---- 257
+Y V + Q AIK++ + +K+ EI ++K H N+ +
Sbjct: 36 TYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHRNIATYYGAFI 91
Query: 258 --QAIETTHRVYIIMEYAKNGSLLEVIR--KERYIDED 291
+++++ME+ GS+ ++I+ K + E+
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 30/114 (26%), Positives = 65/114 (57%), Gaps = 6/114 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A+ + + +++ +HRD++ N+L+ K++DFG AR + + +Y F
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFP- 348
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE + +T +SD+WS G++L +V YGR+P+ + E+++ +++
Sbjct: 349 -IKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 10/101 (9%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 245
I + LKL KKL + + V +AT VA+K + K + ++ FL E V+
Sbjct: 185 IPRESLKLE--KKLGAGQFGEVWMAT-YNKHTKVAVKTM-KPGSM--SVEAFL-AEANVM 237
Query: 246 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
K L+H L++ L A+ T +YII E+ GSLL+ ++ +
Sbjct: 238 KTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDE 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 30/114 (26%), Positives = 56/114 (49%), Gaps = 5/114 (4%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
A ++Y K +HRD+ N L+ +K +K+SDFG +R+ + Y +
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQV- 277
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE L Y+ +SD+WS G++L+ G P+ + + + + V+K
Sbjct: 278 PVKWTAPEALNYGRYSS-ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 6e-14
Identities = 28/123 (22%), Positives = 51/123 (41%), Gaps = 6/123 (4%)
Query: 166 QDPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKI 223
Q P K+ + ++ + ++ L L ++ + V + VA+K
Sbjct: 89 QQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVAVKS 146
Query: 224 ISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIR 283
+ P D KFL +E ++K HPN++R + +YI+ME + G L +R
Sbjct: 147 C-RETLPPDLKAKFL-QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR 204
Query: 284 KER 286
E
Sbjct: 205 TEG 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 37/100 (37%), Positives = 50/100 (50%), Gaps = 13/100 (13%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVN--NTDYKQNLSET 74
QL ++ Y H + HRDIK +NLLLD +KL DFG A+ N Y
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY------- 201
Query: 75 FCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
C Y Y +PE++ G YT DIWS G V+ ++ G+
Sbjct: 202 ICSRY-YRAPELIFGATNYTT-NIDIWSTGCVMAELMQGQ 239
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 20/76 (26%), Positives = 36/76 (47%), Gaps = 14/76 (18%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V A S +VAIK KV K+F RE+++++ +KHPN++ +
Sbjct: 52 SFGVVFQAKL-VESDEVAIK---KVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 263 T------HRVYIIMEY 272
+ +++EY
Sbjct: 104 NGDKKDEVFLNLVLEY 119
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 11/105 (10%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLD--DKYNIKLSDFGFARKYSVNNT--DYKQNLSE 73
++ D ++Y H+ VH DIK NLLL+ + + L D+G A +Y Y +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219
Query: 74 TFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 115
G+ + S + GV S D+ +G + + G LP
Sbjct: 220 CHDGTIEFTSIDAHNGV----APSRRGDLEILGYCMIQWLTGHLP 260
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 38/100 (38%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVN--NTDYKQNLSET 74
QL ++ Y H + HRDIK +NLLLD D +KL DFG A++ N Y
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY------- 216
Query: 75 FCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
C Y Y +PE++ G YT D+WS G VL ++ G+
Sbjct: 217 ICSRY-YRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 254
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 19/76 (25%), Positives = 36/76 (47%), Gaps = 13/76 (17%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V A + VAIK KV D K+F RE+++++ L H N++R +
Sbjct: 66 SFGVVYQAKLCDSGELVAIK---KV--LQD--KRFKNRELQIMRKLDHCNIVRLRYFFYS 118
Query: 263 THR------VYIIMEY 272
+ + ++++Y
Sbjct: 119 SGEKKDEVYLNLVLDY 134
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 4/117 (3%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ Q+A+ + Y K +HRD+ NLLL + +K+ DFG R N+ Y
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+A+ +PE LK ++ SD W GV L+ M YG+ P+ N S++L ++ K
Sbjct: 186 V--PFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 29/105 (27%), Positives = 53/105 (50%), Gaps = 10/105 (9%)
Query: 188 IHKRKLKLIRDKKLSS--YATV---KLATSARHSQDVAIKIISK-VQAPIDYLKKFLPRE 241
I ++ L+L+ +KL + V + + + VA+K + V + + + F+ RE
Sbjct: 15 IGEKDLRLL--EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-RE 71
Query: 242 IEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
+ + L H NLIR L + T + ++ E A GSLL+ +RK +
Sbjct: 72 VNAMHSLDHRNLIR-LYGVVLTPPMKMVTELAPLGSLLDRLRKHQ 115
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 30/115 (26%), Positives = 67/115 (58%), Gaps = 6/115 (5%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
+Q+A+ + + +++ +HRD++ N+L+ D + K++DFG AR + + +Y F
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKF- 172
Query: 77 GSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE + +T +SD+WS G++L +V +GR+P+ E+++ +++
Sbjct: 173 -PIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 245
+ + LKL+ +L + + V + VA+K + + D FL E ++
Sbjct: 10 VPRETLKLVE--RLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPD---AFL-AEANLM 62
Query: 246 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
K L+H L+R L A+ T +YII EY +NGSL++ ++
Sbjct: 63 KQLQHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPS 102
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 34/159 (21%), Positives = 64/159 (40%), Gaps = 20/159 (12%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLD--DKYNIKLSDFGFARKYSVNNT--DYKQNLSE 73
++ D ++Y H+ VH DIK NLLL + + L+D+G + +Y N Y++N +
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218
Query: 74 TFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK 130
G+ + S + KGV S D+ +G + + G+LP++ + Q K
Sbjct: 219 GHNGTIEFTSLDAHKGV----ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274
Query: 131 RVVFPESPRLSSS---CKALISNILSPVKFRIQMEDIRQ 166
+ E P+ + + +
Sbjct: 275 TNLLDELPQSVLKWAPSGSS------CCEIAQFLVCAHS 307
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 29/123 (23%), Positives = 56/123 (45%), Gaps = 17/123 (13%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
W Q+A + Y + +VHR++ N+LL ++++DFG A ++ +
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS---- 175
Query: 75 FCGS------YAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQ 127
+ A E + YT QSD+WS GV ++ ++ +G P+ +E+
Sbjct: 176 --EAKTPIKWMA---LESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 229
Query: 128 VQK 130
++K
Sbjct: 230 LEK 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 15/69 (21%), Positives = 33/69 (47%), Gaps = 3/69 (4%)
Query: 218 DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS 277
V IK+I + ++ + + + L H +++R L + + ++ +Y GS
Sbjct: 44 PVCIKVI-EDKSGRQSFQAVT-DHMLAIGSLDHAHIVR-LLGLCPGSSLQLVTQYLPLGS 100
Query: 278 LLEVIRKER 286
LL+ +R+ R
Sbjct: 101 LLDHVRQHR 109
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 16/118 (13%)
Query: 7 YNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDD------KYNIKLSDFGFARK 59
++ QL +DY H++ ++H DIK EN+L++ IK++D G A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 60 YSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD 117
Y + T+ Q + Y SPE+L G P+ +DIWS ++F ++ G F+
Sbjct: 188 YDEHYTNSIQ--------TREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFE 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 29/127 (22%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
++AD + Y + VHRD+ N ++ + + +K+ DFG R + TDY
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDY---------- 193
Query: 78 SYAYA------------SPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSEL 124
Y SPE LK +T SD+WS GVVL+ + P+ + ++
Sbjct: 194 ---YRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 125 LKQVQKR 131
L+ V +
Sbjct: 250 LRFVMEG 256
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 20/82 (24%), Positives = 30/82 (36%), Gaps = 2/82 (2%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264
K VAIK + A + +FL E V+K +++R L +
Sbjct: 44 GVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVSQGQ 101
Query: 265 RVYIIMEYAKNGSLLEVIRKER 286
+IME G L +R R
Sbjct: 102 PTLVIMELMTRGDLKSYLRSLR 123
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 35/123 (28%), Positives = 58/123 (47%), Gaps = 17/123 (13%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
W Q+A ++Y + +VHRD+ N+L+ ++K++DFG A+ +Y
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---- 177
Query: 75 FCGS------YAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQ 127
G A E + YT QSD+WS GV ++ M +G P+D SE+
Sbjct: 178 --GGKVPIKWMA---LESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 128 VQK 130
++K
Sbjct: 232 LEK 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 19/73 (26%), Positives = 34/73 (46%), Gaps = 3/73 (4%)
Query: 214 RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 273
+ VAIK + + K+ L E V+ + +P++ R L I T V +I +
Sbjct: 42 KVKIPVAIKEL-REATSPKANKEIL-DEAYVMASVDNPHVCR-LLGICLTSTVQLITQLM 98
Query: 274 KNGSLLEVIRKER 286
G LL+ +R+ +
Sbjct: 99 PFGCLLDYVREHK 111
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 31/122 (25%), Positives = 54/122 (44%), Gaps = 11/122 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL--DDKYNIKLSDFGFARKYSVNN 64
++ R++ + +D HK ++H D+K EN+LL + IK+ DFG +
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
Y Q S Y +PE++ G Y D+WS+G +L ++ G + +
Sbjct: 257 YTYIQ--------SRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307
Query: 125 LK 126
L
Sbjct: 308 LA 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-14
Identities = 37/127 (29%), Positives = 60/127 (47%), Gaps = 31/127 (24%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QLA ++Y + +HRD+ N+L+ + +K++DFG AR +NN DY
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--INNIDY---------- 212
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
Y +PE + V YT QSD+WS GV+++ + G P+ E
Sbjct: 213 ---YKKTTNGRLPVKWMAPEALFDRV-YTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 124 LLKQVQK 130
L K +++
Sbjct: 268 LFKLLKE 274
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 30/113 (26%), Positives = 50/113 (44%), Gaps = 5/113 (4%)
Query: 204 YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET 262
A + + VA+K++ K A L + E+E++K + KH N+I L A
Sbjct: 55 EAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQ 112
Query: 263 THRVYIIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEVSNLS-QTFSRCCYQ 313
+Y+I+EYA G+L E +R R E + ++ + C YQ
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 32/127 (25%), Positives = 54/127 (42%), Gaps = 31/127 (24%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q++ + Y + +VHRD+ N+L+ + +K+SDFG +R V D
Sbjct: 158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD--VYEEDS---------- 205
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
Y + E + + YT QSD+WS GV+L+ +V G P+
Sbjct: 206 ---YVKRSQGRIPVKWMAIESLFDHI-YTT-QSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 124 LLKQVQK 130
L ++
Sbjct: 261 LFNLLKT 267
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 26/82 (31%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264
AT VA+K++ K A L+ L E V+K + HP++I+ A
Sbjct: 42 ATAFHLKGRAGYTTVAVKML-KENASPSELRDLL-SEFNVLKQVNHPHVIKLYGACSQDG 99
Query: 265 RVYIIMEYAKNGSLLEVIRKER 286
+ +I+EYAK GSL +R+ R
Sbjct: 100 PLLLIVEYAKYGSLRGFLRESR 121
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 16/108 (14%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNT----DYKQN 70
Q+ + +++ H KS +HRDIK +N L+ + + DFG A+KY +T Y++N
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 115
+ G+ YAS G+ +QS D+ S+G VL + G LP
Sbjct: 171 KN--LTGTARYASVNTHLGI----EQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 16/108 (14%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNT----DYKQN 70
Q+ I+Y H K+ +HRD+K +N L+ + + DFG A+KY T Y++N
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 115
+ G+ YAS G+ +QS D+ S+G VL G LP
Sbjct: 173 KN--LTGTARYASINTHLGI----EQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 27/102 (26%), Positives = 49/102 (48%), Gaps = 13/102 (12%)
Query: 22 AIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81
+ Y H +++HRD+K N+LL + +KL DFG A + N +F G+ +
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PAN---SFVGTPYW 216
Query: 82 ASPEI---LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+PE+ + Y + D+WS+G+ + + P + N
Sbjct: 217 MAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMN 257
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 23/90 (25%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V A R+S+ VAIK +S + + + +E+ ++ L+HPN I++
Sbjct: 66 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 125
Query: 263 THRVYIIMEYAKNGSLLEVIR-KERYIDED 291
H +++MEY GS +++ ++ + E
Sbjct: 126 EHTAWLVMEYC-LGSASDLLEVHKKPLQEV 154
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 31/114 (27%), Positives = 64/114 (56%), Gaps = 6/114 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q++ A++Y KK+ +HRD+ N L+ + + +K++DFG +R + Y + F
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKF-- 174
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE L ++ +SD+W+ GV+L+ + YG P+ + S++ + ++K
Sbjct: 175 PIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 8/101 (7%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 245
+ + + + KL Y V ++S VA+K + K +++FL +E V+
Sbjct: 10 MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTM--EVEEFL-KEAAVM 63
Query: 246 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
K +KHPNL++ L YII E+ G+LL+ +R+
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 104
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 37/127 (29%), Positives = 60/127 (47%), Gaps = 31/127 (24%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QLA ++Y + +HRD+ N+L+ + +K++DFG AR +NN DY
Sbjct: 211 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--INNIDY---------- 258
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
Y +PE + V YT QSD+WS GV+++ + G P+ E
Sbjct: 259 ---YKKTTNGRLPVKWMAPEALFDRV-YTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 124 LLKQVQK 130
L K +++
Sbjct: 314 LFKLLKE 320
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 42/199 (21%), Positives = 78/199 (39%), Gaps = 18/199 (9%)
Query: 127 QVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEV 186
++ KR+ +S+ + +++ V+ ++ P L S + P+
Sbjct: 19 KLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEY--ELPEDPKW 76
Query: 187 GIHKRKLKLIRDKKLSS---------YATVKLATSARHSQDVAIKIISKVQAPIDYLKKF 237
+ KL L + L A + + VA+K++ K A L
Sbjct: 77 EFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDL 133
Query: 238 LPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKALL 295
+ E+E++K + KH N+I L A +Y+I+EYA G+L E +R R E +
Sbjct: 134 V-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 296 CYSEVSNLS-QTFSRCCYQ 313
++ + C YQ
Sbjct: 193 NRVPEEQMTFKDLVSCTYQ 211
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 28/114 (24%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
+ + + + +HRD+ N L+D +K+SDFG R V + Y ++ F
Sbjct: 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR--YVLDDQYVSSVGTKF-- 167
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+++PE+ Y+ +SD+W+ G++++ + G++P+D SE++ +V +
Sbjct: 168 PVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-11
Identities = 28/101 (27%), Positives = 51/101 (50%), Gaps = 9/101 (8%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 245
+ + ++ L++ +L S + VKL + DVA+K+I K + + +F +E + +
Sbjct: 5 LKREEITLLK--ELGSGQFGVVKLGK-WKGQYDVAVKMI-KEGSMSE--DEFF-QEAQTM 57
Query: 246 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
L HP L++F + +YI+ EY NG LL +R
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG 98
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 31/128 (24%), Positives = 57/128 (44%), Gaps = 28/128 (21%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ QL+ A+ Y K VHRDI N+L+ +KL DFG +R + ++ Y
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTY------- 171
Query: 75 FCGSYAYAS-----------PEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYS 122
Y + PE + +T SD+W GV ++ ++ +G PF +
Sbjct: 172 ------YKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNN 224
Query: 123 ELLKQVQK 130
+++ +++
Sbjct: 225 DVIGRIEN 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 25/114 (21%), Positives = 48/114 (42%), Gaps = 10/114 (8%)
Query: 178 GKSKSAPEVGIHKRKLKLIRDKKLSS--YATV---KLATSARHSQDVAIKIISKVQAPID 232
S + I + +++L R + + V + + VAIK K
Sbjct: 2 AMGSSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDS 58
Query: 233 YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
+KFL +E ++ HP++++ L + T + V+IIME G L ++ +
Sbjct: 59 VREKFL-QEALTMRQFDHPHIVK-LIGVITENPVWIIMELCTLGELRSFLQVRK 110
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 29/117 (24%), Positives = 64/117 (54%), Gaps = 4/117 (3%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
Q++ + Y +K+ VHRD+ N+LL +++ K+SDFG ++ +++ Y +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 130
+ + +PE + ++ +SD+WS GV ++ A+ YG+ P+ E++ +++
Sbjct: 175 W--PLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 18/69 (26%), Positives = 36/69 (52%), Gaps = 3/69 (4%)
Query: 218 DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGS 277
DVAIK++ K ++ + RE +++ L +P ++R L + + ++ME A G
Sbjct: 39 DVAIKVL-KQGTEKADTEEMM-REAQIMHQLDNPYIVR-LIGVCQAEALMLVMEMAGGGP 95
Query: 278 LLEVIRKER 286
L + + +R
Sbjct: 96 LHKFLVGKR 104
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 35/152 (23%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN--TDYKQNLSETF 75
Q+ I + H ++HRD+K N+++ +K+ DFG AR + T Y
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-------- 223
Query: 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP 135
+ Y +PE++ G+ Y + DIWS+G ++ MV ++ F +Y + +V +++ P
Sbjct: 224 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 136 ESP---RLSSSCKALISNILSPVKFRIQMEDI 164
+L + + + N P + +
Sbjct: 283 CPEFMKKLQPTVRNYVENR--PKYAGLTFPKL 312
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 25/102 (24%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLK 249
++ + ++ + V A A ++VAIK +S+ Q + + RE+ ++K +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVN 119
Query: 250 HPNLIRFL------QAIETTHRVYIIMEYAKNGSLLEVIRKE 285
H N+I L + +E VY++ME + +L +VI+ E
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME 160
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 36/152 (23%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN--TDYKQNLSETF 75
Q+ I + H ++HRD+K N+++ +K+ DFG AR + T Y
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-------- 186
Query: 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP 135
+ Y +PE++ G+ Y + DIWS+G ++ M+ G + F T++ + +V +++ P
Sbjct: 187 VVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 136 ESP---RLSSSCKALISNILSPVKFRIQMEDI 164
+L + + + N P E +
Sbjct: 246 CPEFMKKLQPTVRTYVENR--PKYAGYSFEKL 275
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 10/90 (11%)
Query: 203 SYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI- 260
+ V A A ++VAIK +S+ Q + + RE+ ++K + H N+I L
Sbjct: 37 AQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFT 94
Query: 261 -----ETTHRVYIIMEYAKNGSLLEVIRKE 285
E VYI+ME + +L +VI+ E
Sbjct: 95 PQKSLEEFQDVYIVMELM-DANLCQVIQME 123
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 29/127 (22%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
Q+A ++Y K +HRD+ N+L+ + +K++DFG AR +++ DY
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD--IHHIDY--------- 246
Query: 77 GSYAYA------------SPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
Y +PE L YT QSD+WS GV+L+ + G P+ E
Sbjct: 247 ----YKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 124 LLKQVQK 130
L K +++
Sbjct: 302 LFKLLKE 308
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 24/69 (34%), Positives = 39/69 (56%), Gaps = 3/69 (4%)
Query: 219 VAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNGS 277
VA+K++ K A L + E+E++K + KH N+I L A +Y+I+EYA G+
Sbjct: 104 VAVKML-KSDATEKDLSDLI-SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 278 LLEVIRKER 286
L E ++ R
Sbjct: 162 LREYLQARR 170
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 19/137 (13%)
Query: 4 LLDYNTDKARRWFS---------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDF 54
L+DY + R + +A++Y + VHRD+ N+L+ + K+SDF
Sbjct: 274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 333
Query: 55 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGR 113
G ++ S K + T +PE L+ ++ +SD+WS G++L+ + +GR
Sbjct: 334 GLTKEASSTQDTGKLPVKWT--------APEALREKKFS-TKSDVWSFGILLWEIYSFGR 384
Query: 114 LPFDDTNYSELLKQVQK 130
+P+ +++ +V+K
Sbjct: 385 VPYPRIPLKDVVPRVEK 401
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 30/124 (24%), Positives = 53/124 (42%), Gaps = 14/124 (11%)
Query: 167 DPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKII 224
P + E + ++ ++LKL+ + + + V L VA+K I
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLL--QTIGKGEFGDVMLGDY--RGNKVAVKCI 224
Query: 225 SKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVI 282
K A + FL E V+ L+H NL++ L + + +YI+ EY GSL++ +
Sbjct: 225 -KNDAT---AQAFL-AEASVMTQLRHSNLVQ-LLGVIVEEKGGLYIVTEYMAKGSLVDYL 278
Query: 283 RKER 286
R
Sbjct: 279 RSRG 282
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 31/114 (27%), Positives = 65/114 (57%), Gaps = 6/114 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
+ +A++Y K +HRD+ N L++D+ +K+SDFG +R V + +Y ++ F
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKF-- 183
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
++ PE+L ++ +SDIW+ GV+++ + G++P++ SE + + +
Sbjct: 184 PVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 32/118 (27%), Positives = 52/118 (44%), Gaps = 11/118 (9%)
Query: 171 KEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQ 228
K + G + E I + L ++ +L + + VK R DVAIK+I K
Sbjct: 6 KNAPSTAGLGYGSWE--IDPKDLTFLK--ELGTGQFGVVKYGK-WRGQYDVAIKMI-KEG 59
Query: 229 APIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
+ +F+ E +V+ L H L++ ++II EY NG LL +R+ R
Sbjct: 60 SM--SEDEFI-EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 114
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 30/128 (23%), Positives = 55/128 (42%), Gaps = 28/128 (21%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ Q+ A+ Y + VHRDI N+L+ +KL DFG +R + + DY
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR--YIEDEDY------- 168
Query: 75 FCGSYAYAS-----------PEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYS 122
Y + PE + +T SD+W V ++ ++ +G+ PF
Sbjct: 169 ------YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENK 221
Query: 123 ELLKQVQK 130
+++ ++K
Sbjct: 222 DVIGVLEK 229
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 10/110 (9%)
Query: 182 SAPEVGIHKRKLKLIRDKKLSS--YATV---KLATSARHSQDVAIKIISKVQAPIDYLKK 236
P+ GI + + L R L + V +VA+K K +D +K
Sbjct: 3 GGPQYGIAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEK 59
Query: 237 FLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
F+ E ++K L HP++++ L I +IIME G L + + +
Sbjct: 60 FM-SEAVIMKNLDHPHIVK-LIGIIEEEPTWIIMELYPYGELGHYLERNK 107
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 37/130 (28%), Positives = 57/130 (43%), Gaps = 34/130 (26%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
SQ+A + + K+ +HRD+ N+LL + + K+ DFG AR + N
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD--IMNDSN--------- 219
Query: 77 GSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPF--DDTN 120
Y +PE I V YT QSD+WS G++L+ + G P+ N
Sbjct: 220 ----YIVKGNARLPVKWMAPESIFDCV-YTV-QSDVWSYGILLWEIFSLGLNPYPGILVN 273
Query: 121 YSELLKQVQK 130
S+ K V+
Sbjct: 274 -SKFYKLVKD 282
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 22/96 (22%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 219 VAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAKNGS 277
VA+K++ K A D + + E++++ L +H N++ L A V +I EY G
Sbjct: 79 VAVKML-KSTAHADEKEALM-SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 278 LLEVIRKERYIDEDKALLCYSEVSNLSQTFSRCCYQ 313
LL +R++ + E + + ++ Q
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 30/117 (25%), Positives = 58/117 (49%), Gaps = 6/117 (5%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ QL+ A+ Y K VHRDI N+L+ +KL DFG +R + ++ Y +
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGK 553
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ +PE + +T SD+W GV ++ ++ +G PF ++++ +++
Sbjct: 554 L--PIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 20/78 (25%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 209 LATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268
+ + VAIK K +KFL +E ++ HP++++ L + T + V+I
Sbjct: 411 YMSPENPAMAVAIKTC-KNCTSDSVREKFL-QEALTMRQFDHPHIVK-LIGVITENPVWI 467
Query: 269 IMEYAKNGSLLEVIRKER 286
IME G L ++ +
Sbjct: 468 IMELCTLGELRSFLQVRK 485
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 31/117 (26%), Positives = 60/117 (51%), Gaps = 4/117 (3%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
Q++ + Y + + VHRD+ N+LL ++ K+SDFG ++ + YK
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 130
+ + +PE + ++ +SD+WS GV+++ A YG+ P+ SE+ ++K
Sbjct: 182 W--PVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 26/105 (24%), Positives = 51/105 (48%), Gaps = 7/105 (6%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLAT--SARHSQDVAIKIISKVQAPIDYLKKFLPREIE 243
+ ++ L L DK+L S + TVK + + VA+KI+ + L E
Sbjct: 13 LDRKLLTL-EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEAN 70
Query: 244 VVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYI 288
V++ L +P ++R + I ++ME A+ G L + +++ R++
Sbjct: 71 VMQQLDNPYIVR-MIGICEAESWMLVMEMAELGPLNKYLQQNRHV 114
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 33/128 (25%), Positives = 56/128 (43%), Gaps = 32/128 (25%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A +++ + +HRD+ N+LL +K +K+ DFG AR +
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDPD---------- 203
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPF-DDTNYS 122
Y +PE I V YT QSD+WS GV+L+ + G P+
Sbjct: 204 ---YVRKGDARLPLKWMAPETIFDRV-YTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 123 ELLKQVQK 130
E +++++
Sbjct: 259 EFCRRLKE 266
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 19/113 (16%), Positives = 44/113 (38%), Gaps = 6/113 (5%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA-IET 262
A + VA+K++ K A + + E++++ + H N++ L A +
Sbjct: 46 ADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHIGHHLNVVNLLGACTKP 103
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSNL--SQTFSRCCYQ 313
+ +I+E+ K G+L +R +R + + + +Q
Sbjct: 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 52/253 (20%), Positives = 95/253 (37%), Gaps = 40/253 (15%)
Query: 7 YNTDKARRWFSQLADAIDYCH--KKSVVHRDIKCENLLL--DDKYNIKLSDFGFARKYSV 62
+ + R++ Q+ A+ + + S++H D+K EN+LL + IK+ DFG + +
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
Y Q S Y SPE+L G+PY D+WS+G +L M G F N
Sbjct: 214 RIYQYIQ--------SRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEV 264
Query: 123 ELLKQVQKRVVFPESPRLSSSCKALISNILSPVKFRIQMEDIRQDPWLKEDSNPVGKSKS 182
+ + I +L I + + + ++ + K
Sbjct: 265 DQM--------------------NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKK 304
Query: 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFL---P 239
+ KR+ K +KL + V+ + ++ D + + L P
Sbjct: 305 TKD---GKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361
Query: 240 RE-IEVVKGLKHP 251
+ I+ L+H
Sbjct: 362 KTRIQPYYALQHS 374
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 27/107 (25%), Positives = 51/107 (47%), Gaps = 12/107 (11%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPRE 241
KR LK IR L + V+L + VA+K + K ++ +++ +E
Sbjct: 18 FEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLK-KE 73
Query: 242 IEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKER 286
IE+++ L H N++++ + +IME+ +GSL E + K +
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK 120
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 27/120 (22%), Positives = 46/120 (38%), Gaps = 16/120 (13%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ Q+ +DY + VHRD+ N+L++ ++ +K+ DFG + + Y
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD--- 187
Query: 75 FCGS------YAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQ 127
YA PE L + SD+WS GV L ++ Y +
Sbjct: 188 --DRDSPVFWYA---PECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 50/194 (25%), Positives = 80/194 (41%), Gaps = 49/194 (25%)
Query: 18 QLADAIDYCHKKS--VVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVN--NTDYKQNLS 72
QL +I H S V HRDIK N+L++ +KL DFG A+K S + N Y
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY----- 191
Query: 73 ETFCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR------------------ 113
C Y Y +PE++ G YT DIWS+G + M+ G
Sbjct: 192 --ICSRY-YRAPELIFGNQHYTT-AVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247
Query: 114 --------LPFDDTNYSEL----LKQVQKRVVFPE-SPRLSSSCKALISNIL--SPVKFR 158
L + +++++ K + VF + S + + L+S +L P + R
Sbjct: 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE-R 306
Query: 159 IQMEDIRQDPWLKE 172
++ + P+ E
Sbjct: 307 MKPYEALCHPYFDE 320
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 33/128 (25%), Positives = 53/128 (41%), Gaps = 32/128 (25%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A + + K+ +HRD+ N+LL K+ DFG AR + N
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IKNDSN---------- 200
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDD-TNYS 122
Y +PE I V YT +SD+WS G+ L+ + G P+ S
Sbjct: 201 ---YVVKGNARLPVKWMAPESIFNCV-YT-FESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 123 ELLKQVQK 130
+ K +++
Sbjct: 256 KFYKMIKE 263
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 9e-10
Identities = 22/83 (26%), Positives = 39/83 (46%), Gaps = 3/83 (3%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 263
AT + + VA+K++ K A + + + E++V+ L H N++ L A
Sbjct: 42 ATAYGLIKSDAAMTVAVKML-KPSAHLTEREALM-SELKVLSYLGNHMNIVNLLGACTIG 99
Query: 264 HRVYIIMEYAKNGSLLEVIRKER 286
+I EY G LL +R++R
Sbjct: 100 GPTLVITEYCCYGDLLNFLRRKR 122
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 6e-13
Identities = 32/114 (28%), Positives = 62/114 (54%), Gaps = 6/114 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
+ + + Y + V+HRD+ N L+ + IK+SDFG R V + Y + F
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSSTGTKF-- 167
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ASPE+ Y+ +SD+WS GV+++ + G++P+++ + SE+++ +
Sbjct: 168 PVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-11
Identities = 24/101 (23%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 245
I +L ++ ++ S + V L + VAIK I + A + F+ E EV+
Sbjct: 5 IDPSELTFVQ--EIGSGQFGLVHLGY-WLNKDKVAIKTI-REGAM--SEEDFI-EEAEVM 57
Query: 246 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
L HP L++ + ++ E+ ++G L + +R +R
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR 98
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 28/118 (23%), Positives = 64/118 (54%), Gaps = 4/118 (3%)
Query: 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE 73
Q++ + Y +K+ VHR++ N+LL +++ K+SDFG ++ +++ Y +
Sbjct: 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499
Query: 74 TFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 130
+ + +PE + ++ +SD+WS GV ++ A+ YG+ P+ E++ +++
Sbjct: 500 KW--PLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 5e-12
Identities = 31/137 (22%), Positives = 55/137 (40%), Gaps = 12/137 (8%)
Query: 154 PVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATVKLAT 211
P K R D D + K KR LI D +L + +V+
Sbjct: 302 PDKPRPMPMDTSVFESPFSDPEELKDKKL-----FLKRDNLLIADIELGCGNFGSVRQGV 356
Query: 212 --SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269
+ DVAIK++ K ++ + RE +++ L +P ++R L + + ++
Sbjct: 357 YRMRKKQIDVAIKVL-KQGTEKADTEEMM-REAQIMHQLDNPYIVR-LIGVCQAEALMLV 413
Query: 270 MEYAKNGSLLEVIRKER 286
ME A G L + + +R
Sbjct: 414 MEMAGGGPLHKFLVGKR 430
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 13/100 (13%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVN--NTDYKQNLSET 74
QL A+ + H + HRDIK +NLL++ +KL DFG A+K + + Y
Sbjct: 149 QLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY------- 201
Query: 75 FCGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGR 113
C + Y +PE++ G YTP D+WS+G V ++ G+
Sbjct: 202 ICSRF-YRAPELMLGATEYTP-SIDLWSIGCVFGELILGK 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 26/125 (20%), Positives = 54/125 (43%), Gaps = 27/125 (21%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
+A ++Y ++ +HRD+ N +L + + ++DFG +RK + + DY
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--IYSGDY---------- 192
Query: 78 SYAYAS----------PE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 125
Y E + + YT SD+W+ GV ++ ++ G+ P+ +E+
Sbjct: 193 -YRQGCASKLPVKWLALESLADNL-YTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 126 KQVQK 130
+
Sbjct: 250 NYLIG 254
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 17/85 (20%), Positives = 35/85 (41%), Gaps = 7/85 (8%)
Query: 216 SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL------QAIETTHRVYII 269
VA+K++ +++FL RE +K HP++ + + +A +I
Sbjct: 51 FVKVAVKMLKADIIASSDIEEFL-REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVI 109
Query: 270 MEYAKNGSLLEVIRKERYIDEDKAL 294
+ + K+G L + R + L
Sbjct: 110 LPFMKHGDLHAFLLASRIGENPFNL 134
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-13
Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 18/110 (16%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYN-----IKLSDFGFARKYSVNNT----DYK 68
Q+ + H+KS+V+RDIK +N L+ + I + DFG + Y T Y+
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYR 173
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 115
+ + G+ Y S G +QS D+ ++G V + G LP
Sbjct: 174 EKKN--LSGTARYMSINTHLGR----EQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 32/128 (25%), Positives = 56/128 (43%), Gaps = 32/128 (25%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A +++ KS VHRD+ N+L+ +K+ DFG AR + +
Sbjct: 180 QVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD--IMSDSN---------- 227
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPF-DDTNYS 122
Y +PE + +G+ YT +SD+WS G++L+ + G P+ +
Sbjct: 228 ---YVVRGNARLPVKWMAPESLFEGI-YTI-KSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 123 ELLKQVQK 130
K +Q
Sbjct: 283 NFYKLIQN 290
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 23/83 (27%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 263
AT + S VA+K++ K +A + + E++++ L H N++ L A +
Sbjct: 64 ATAYGISKTGVSIQVAVKML-KEKADSSEREALM-SELKMMTQLGSHENIVNLLGACTLS 121
Query: 264 HRVYIIMEYAKNGSLLEVIRKER 286
+Y+I EY G LL +R +R
Sbjct: 122 GPIYLIFEYCCYGDLLNYLRSKR 144
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 30/127 (23%), Positives = 60/127 (47%), Gaps = 29/127 (22%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y ++ VHRD+ N +LD+ + +K++DFG AR + + +Y
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREY---------- 179
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
Y+ + E + +T +SD+WS GV+L+ ++ G P+ + +
Sbjct: 180 -YSVQQHRHARLPVKWTALESLQTYR-FT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
Query: 124 LLKQVQK 130
L + +
Sbjct: 237 LTHFLAQ 243
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 24/121 (19%), Positives = 54/121 (44%), Gaps = 9/121 (7%)
Query: 172 EDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATV---KLATSARHSQDVAIKIISK 226
D + ++ +V I ++ D+ + + V + A++ AIK +
Sbjct: 1 RDLDSALLAE-VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-S 58
Query: 227 VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA-IETTHRVYIIMEYAKNGSLLEVIRKE 285
+ ++ FL RE +++GL HPN++ + + ++++ Y +G LL+ IR
Sbjct: 59 RITEMQQVEAFL-REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP 117
Query: 286 R 286
+
Sbjct: 118 Q 118
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 25/107 (23%), Positives = 49/107 (45%), Gaps = 13/107 (12%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPRE 241
+R LK I +L + +V+L VA+K + + P D + F RE
Sbjct: 20 FEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGP-DQQRDFQ-RE 74
Query: 242 IEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKER 286
I+++K L ++++ R + ++MEY +G L + +++ R
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR 121
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 16/109 (14%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ SQ+ ++Y + VHRD+ N+L++ + ++K++DFG A+ ++ Y
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE--- 188
Query: 75 FCGS------YAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPF 116
YA PE L ++ +QSD+WS GVVL+ + Y
Sbjct: 189 --PGQSPIFWYA---PESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSC 231
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 38/128 (29%), Positives = 62/128 (48%), Gaps = 31/128 (24%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A ++Y VVH+D+ N+L+ DK N+K+SD G R+ V DY
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAADY---------- 183
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
Y +PE I+ G ++ SDIWS GVVL+ + YG P+ + +
Sbjct: 184 ---YKLLGNSLLPIRWMAPEAIMYGK-FS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 238
Query: 124 LLKQVQKR 131
+++ ++ R
Sbjct: 239 VVEMIRNR 246
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 2/82 (2%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264
+ +Q VAIK + K +A ++F E + L+HPN++ L +
Sbjct: 28 GHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFR-HEAMLRARLQHPNVVCLLGVVTKDQ 85
Query: 265 RVYIIMEYAKNGSLLEVIRKER 286
+ +I Y +G L E +
Sbjct: 86 PLSMIFSYCSHGDLHEFLVMRS 107
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 27/125 (21%), Positives = 52/125 (41%), Gaps = 27/125 (21%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
+A ++Y ++ +HRD+ N +L D + ++DFG ++K + + DY
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--IYSGDY---------- 202
Query: 78 SYAYAS----------PE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 125
Y E + V YT + SD+W+ GV ++ + G P+ E+
Sbjct: 203 -YRQGRIAKMPVKWIAIESLADRV-YTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
Query: 126 KQVQK 130
+
Sbjct: 260 DYLLH 264
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 20/84 (23%), Positives = 36/84 (42%), Gaps = 6/84 (7%)
Query: 216 SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL-----QAIETTHRVYIIM 270
S VA+K + + +++FL E +K HPN+IR L + + + +I+
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFL-SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 271 EYAKNGSLLEVIRKERYIDEDKAL 294
+ K G L + R K +
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHI 144
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 33/137 (24%), Positives = 66/137 (48%), Gaps = 19/137 (13%)
Query: 4 LLDYNTDKARRWFS---------QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDF 54
L+DY + R + +A++Y + VHRD+ N+L+ + K+SDF
Sbjct: 102 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 161
Query: 55 GFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGR 113
G ++ S K + +PE L+ ++ +SD+WS G++L+ + +GR
Sbjct: 162 GLTKEASSTQDTGK------L--PVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGR 212
Query: 114 LPFDDTNYSELLKQVQK 130
+P+ +++ +V+K
Sbjct: 213 VPYPRIPLKDVVPRVEK 229
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 21/74 (28%), Positives = 34/74 (45%), Gaps = 8/74 (10%)
Query: 215 HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR--VYIIMEY 272
VA+K I + FL E V+ L+H NL++ L + + +YI+ EY
Sbjct: 43 RGNKVAVKCIKNDATA----QAFL-AEASVMTQLRHSNLVQ-LLGVIVEEKGGLYIVTEY 96
Query: 273 AKNGSLLEVIRKER 286
GSL++ +R
Sbjct: 97 MAKGSLVDYLRSRG 110
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 12/107 (11%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLA----TSARHSQDVAIKIISKVQAPIDYLKKFLPRE 241
HKR LK IR L + V L T+ + VA+K + K A + + +E
Sbjct: 28 FHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWK-QE 83
Query: 242 IEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKER 286
I++++ L H ++I++ E + ++MEY GSL + + +
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS 130
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 30/137 (21%), Positives = 55/137 (40%), Gaps = 30/137 (21%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ Q+ + + Y H + +HRD+ N+LLD+ +K+ DFG A+ + Y+
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE--- 195
Query: 75 FCGS------YAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGR-------------- 113
YA PE LK + SD+WS GV L+ ++ +
Sbjct: 196 --DGDSPVFWYA---PECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
Query: 114 LPFDDTNYSELLKQVQK 130
+ L + +++
Sbjct: 250 IAQGQMTVLRLTELLER 266
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 34/128 (26%), Positives = 59/128 (46%), Gaps = 31/128 (24%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A + Y + VHRD+ N L+ +K+ DFG +R V +TDY
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--VYSTDY---------- 188
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
Y PE I+ +T +SD+WS GV+L+ + YG+ P+ + +E
Sbjct: 189 ---YRVGGHTMLPIRWMPPESIMYRK-FTT-ESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 124 LLKQVQKR 131
+++ + +
Sbjct: 244 VIECITQG 251
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 18/82 (21%), Positives = 36/82 (43%), Gaps = 3/82 (3%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264
A + + VA+K + + K F RE E++ L+H ++++F
Sbjct: 34 AECYNLSPTKDKMLVAVKALK--DPTLAARKDFQ-REAELLTNLQHEHIVKFYGVCGDGD 90
Query: 265 RVYIIMEYAKNGSLLEVIRKER 286
+ ++ EY K+G L + +R
Sbjct: 91 PLIMVFEYMKHGDLNKFLRAHG 112
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 31/110 (28%), Positives = 52/110 (47%), Gaps = 18/110 (16%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYN-----IKLSDFGFARKYSVNNTD----YK 68
QL ++Y H K++++RD+K EN L+ N I + DF A++Y T Y+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQS---DIWSMGVVLFAMVYGRLP 115
++ S G+ Y S G +QS D+ ++G + + G LP
Sbjct: 173 EHKS--LTGTARYMSINTHLGK----EQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 30/115 (26%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A +++ + +HRD+ N+LL +K +K+ DFG AR + +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDPDYVRKGDARL- 257
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDD-TNYSELLKQVQK 130
+ +PE + YT QSD+WS GV+L+ + G P+ E +++++
Sbjct: 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 18/84 (21%), Positives = 39/84 (46%), Gaps = 4/84 (4%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA-IET 262
A + VA+K++ K A + + E++++ + H N++ L A +
Sbjct: 41 ADAFGIDKTATCRTVAVKML-KEGATHSEHRALM-SELKILIHIGHHLNVVNLLGACTKP 98
Query: 263 THRVYIIMEYAKNGSLLEVIRKER 286
+ +I+E+ K G+L +R +R
Sbjct: 99 GGPLMVIVEFCKFGNLSTYLRSKR 122
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 34/122 (27%), Positives = 62/122 (50%), Gaps = 19/122 (15%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A + Y K VHRD+ N +LD+K+ +K++DFG AR + + +Y ++T
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKT--- 190
Query: 78 SYAYA-------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
A + E + +T +SD+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 191 ---GAKLPVKWMALESLQTQK-FT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
Query: 129 QK 130
+
Sbjct: 246 LQ 247
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 18/72 (25%), Positives = 31/72 (43%), Gaps = 3/72 (4%)
Query: 216 SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-ETTHRVYIIMEYAK 274
A+K + I + +FL E ++K HPN++ L + +++ Y K
Sbjct: 53 KIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 110
Query: 275 NGSLLEVIRKER 286
+G L IR E
Sbjct: 111 HGDLRNFIRNET 122
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 35/128 (27%), Positives = 56/128 (43%), Gaps = 31/128 (24%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A + Y VHRD+ N L+ +K+ DFG +R + +TDY
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD--IYSTDY---------- 213
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
Y PE IL +T +SD+WS GVVL+ + YG+ P+ + +E
Sbjct: 214 ---YRVGGRTMLPIRWMPPESILYRK-FTT-ESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268
Query: 124 LLKQVQKR 131
+ + +
Sbjct: 269 AIDCITQG 276
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 21/110 (19%), Positives = 39/110 (35%), Gaps = 4/110 (3%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264
A + VA+K + + A + F RE E++ L+H +++RF
Sbjct: 60 AECHNLLPEQDKMLVAVKALKE--ASESARQDFQ-REAELLTMLQHQHIVRFFGVCTEGR 116
Query: 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSNLSQT-FSRCCYQ 313
+ ++ EY ++G L +R + A L Q
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 8/111 (7%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H VVHRD+K NL +++ +K+ DFG AR T Y
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY--------VV 185
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ Y +PE++ + Q DIWS+G ++ M+ G+ F +Y + L Q+
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 20/89 (22%), Positives = 38/89 (42%), Gaps = 9/89 (10%)
Query: 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLK 249
+ +Y +V A R + VAIK +S+ Q+ I + + RE+ ++K ++
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQ 81
Query: 250 HPNLIRFLQAIETTHR------VYIIMEY 272
H N+I L Y++M +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPF 110
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 34/128 (26%), Positives = 57/128 (44%), Gaps = 31/128 (24%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A + Y ++ VHRD+ N L+ + +K++DFG +R + + DY
Sbjct: 182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN--IYSADY---------- 229
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
Y PE I YT +SD+W+ GVVL+ + YG P+ + E
Sbjct: 230 ---YKADGNDAIPIRWMPPESIFYNR-YTT-ESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 124 LLKQVQKR 131
++ V+
Sbjct: 285 VIYYVRDG 292
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 19/82 (23%), Positives = 33/82 (40%), Gaps = 2/82 (2%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264
A VA+K++ K +A D F RE ++ +PN+++ L
Sbjct: 66 ARAPGLLPYEPFTMVAVKML-KEEASADMQADFQ-REAALMAEFDNPNIVKLLGVCAVGK 123
Query: 265 RVYIIMEYAKNGSLLEVIRKER 286
+ ++ EY G L E +R
Sbjct: 124 PMCLLFEYMAYGDLNEFLRSMS 145
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 31/111 (27%), Positives = 57/111 (51%), Gaps = 8/111 (7%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H ++HRD+K NL +++ +K+ DFG AR+ T Y
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--------VV 187
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ Y +PE++ Q DIWS+G ++ M+ G+ F +++ + LK++
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 22/114 (19%), Positives = 51/114 (44%), Gaps = 10/114 (8%)
Query: 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLK 249
+ ++ +Y V A R VAIK + + Q+ + + + RE+ ++K ++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMR 82
Query: 250 HPNLIRFL------QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
H N+I L + ++ Y++M + L ++++ E+ ++ L Y
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVY 135
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 30/127 (23%), Positives = 59/127 (46%), Gaps = 29/127 (22%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+A + + K VHRD+ N +LD+K+ +K++DFG AR + + ++
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEF---------- 247
Query: 78 SYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSE 123
+ + E + +T +SD+WS GV+L+ ++ G P+ D N +
Sbjct: 248 -DSVHNKTGAKLPVKWMALESLQTQK-FT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
Query: 124 LLKQVQK 130
+ + +
Sbjct: 305 ITVYLLQ 311
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 19/80 (23%), Positives = 33/80 (41%), Gaps = 3/80 (3%)
Query: 208 KLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-ETTHRV 266
L + A+K + I + +FL E ++K HPN++ L +
Sbjct: 109 TLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSHPNVLSLLGICLRSEGSP 166
Query: 267 YIIMEYAKNGSLLEVIRKER 286
+++ Y K+G L IR E
Sbjct: 167 LVVLPYMKHGDLRNFIRNET 186
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 29/125 (23%), Positives = 52/125 (41%), Gaps = 26/125 (20%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
+ + Y VHRD+ N+L+D K+SDFG +R +
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP------------- 205
Query: 78 SYAYAS-----------PEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELL 125
AY + PE + ++ SD+WS GVV++ + YG P+ + +++
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 126 KQVQK 130
V++
Sbjct: 265 SSVEE 269
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 12/125 (9%)
Query: 167 DPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATV---KLATSARHSQDVAI 221
+P E+ G+S E I ++ + + + S V +L + VAI
Sbjct: 28 EPHTYEEPGRAGRSF-TRE--IEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 222 KIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEV 281
K + K + FL E ++ HPN+IR + I+ EY +NGSL
Sbjct: 83 KAL-KAGYTERQRRDFL-SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 282 IRKER 286
+R
Sbjct: 141 LRTHD 145
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 8/111 (7%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H ++HRD+K NL +++ +K+ DFG AR + T Y
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--------VA 191
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ Y +PEI+ + Q DIWS+G ++ ++ GR F T++ + LK +
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 24/114 (21%), Positives = 53/114 (46%), Gaps = 10/114 (8%)
Query: 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLK 249
+ + + +Y +V A + VA+K +S+ Q+ I + + RE+ ++K +K
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMK 86
Query: 250 HPNLIRFL------QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
H N+I L +++E + VY++ L +++ ++ D+ L Y
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIY 139
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 30/119 (25%), Positives = 61/119 (51%), Gaps = 13/119 (10%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPRE 241
+R LK ++ +L + +V++ + VA+K + + ++L+ F RE
Sbjct: 7 FEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTE-EHLRDFE-RE 61
Query: 242 IEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYS 298
IE++K L+H N++++ + R + +IMEY GSL + ++K + + LL Y+
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 30/138 (21%), Positives = 54/138 (39%), Gaps = 31/138 (22%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ SQ+ ++Y K +HRD+ N+L++++ +K+ DFG + + +K
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE--- 175
Query: 75 FCGS------YAYASPEILKGVPYTPQQSDIWSMGVVL----------------FAMVYG 112
YA PE L ++ SD+WS GVVL F + G
Sbjct: 176 --PGESPIFWYA---PESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 229
Query: 113 RLPFDDTNYSELLKQVQK 130
L++ ++
Sbjct: 230 NDKQGQMIVFHLIELLKN 247
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 31/126 (24%), Positives = 53/126 (42%), Gaps = 28/126 (22%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
+A + Y + VHRD+ N+L++ K+SDFG +R +
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT---------- 204
Query: 78 SYAYAS-----------PE-ILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSEL 124
Y + PE I +T SD+WS G+V++ M YG P+ + + E+
Sbjct: 205 ---YTTSGGKIPIRWTAPEAISYRK-FTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEV 259
Query: 125 LKQVQK 130
+K +
Sbjct: 260 MKAIND 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 29/126 (23%), Positives = 47/126 (37%), Gaps = 13/126 (10%)
Query: 167 DPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATVKLAT----SARHSQDVA 220
+ D N K E IH + + + + + V S + VA
Sbjct: 23 QGAMGSDPNQAV-LKFTTE--IHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVA 77
Query: 221 IKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLE 280
IK + K FL E ++ H N+IR I + II EY +NG+L +
Sbjct: 78 IKTL-KAGYTEKQRVDFL-GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 281 VIRKER 286
+R++
Sbjct: 136 FLREKD 141
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 4/114 (3%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
+A + Y VHRD+ N+L++ K+SDFG R +
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI-- 212
Query: 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLF-AMVYGRLPFDDTNYSELLKQVQK 130
+ SPE + +T SD+WS G+VL+ M YG P+ + + +++K V +
Sbjct: 213 PIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 32/125 (25%), Positives = 53/125 (42%), Gaps = 12/125 (9%)
Query: 167 DPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDKKLSS--YATV---KLATSARHSQDVAI 221
DP ED + A E + + + + + + + V +L ++ VAI
Sbjct: 24 DPHTFEDPTQ-TVHEFAKE--LDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 222 KIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEV 281
K + KV + FL E ++ HPN+IR + + V I+ EY +NGSL
Sbjct: 79 KTL-KVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 282 IRKER 286
+RK
Sbjct: 137 LRKHD 141
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 30/119 (25%), Positives = 61/119 (51%), Gaps = 13/119 (10%)
Query: 188 IHKRKLKLIRDKKLSS--YATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPRE 241
+R LK ++ +L + +V++ + VA+K + + ++L+ F RE
Sbjct: 38 FEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTE-EHLRDFE-RE 92
Query: 242 IEVVKGLKHPNLIRFLQAIETTHR--VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYS 298
IE++K L+H N++++ + R + +IMEY GSL + ++K + + LL Y+
Sbjct: 93 IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 31/138 (22%)
Query: 15 WFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+ SQ+ ++Y K +HRD+ N+L++++ +K+ DFG + + YK
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE--- 206
Query: 75 FCGS------YAYASPEILKGVPYTPQQSDIWSMGVVL----------------FAMVYG 112
YA PE L ++ SD+WS GVVL F + G
Sbjct: 207 --PGESPIFWYA---PESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260
Query: 113 RLPFDDTNYSELLKQVQK 130
L++ ++
Sbjct: 261 NDKQGQMIVFHLIELLKN 278
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 216 SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIMEYAK 274
D AIK + K A D + F E+EV+ L HPN+I L A E +Y+ +EYA
Sbjct: 52 RMDAAIKRM-KEYASKDDHRDFA-GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109
Query: 275 NGSLLEVIRKERYIDEDKALLCYSEVSNL--SQTFSRCCYQ 313
+G+LL+ +RK R ++ D A + ++ SQ
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 31/123 (25%), Positives = 57/123 (46%), Gaps = 24/123 (19%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSE--- 73
+ +A +DY +K +HRD+ N+L+ + Y K++DFG +R + +
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 203
Query: 74 ----TFCGSYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQ 127
+ E + V YT SD+WS GV+L+ +V G P+ +EL ++
Sbjct: 204 PVRWM--------AIESLNYSV-YT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 128 VQK 130
+ +
Sbjct: 254 LPQ 256
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 2/95 (2%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264
V + VA+K + FL E ++ H N++R + +
Sbjct: 49 GQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSL 106
Query: 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSE 299
+I+ME G L +R+ R + L +
Sbjct: 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 34/130 (26%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+A Y + +HRDI N LL K+ DFG AR + Y
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASY------- 198
Query: 75 FCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTN 120
Y PE ++G+ +T + +D WS GV+L+ + G +P+ +
Sbjct: 199 ------YRKGGCAMLPVKWMPPEAFMEGI-FTSK-TDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 121 YSELLKQVQK 130
E+L+ V
Sbjct: 251 NQEVLEFVTS 260
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 16/72 (22%), Positives = 32/72 (44%), Gaps = 3/72 (4%)
Query: 215 HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 274
H +V +K++ K A +Y + F ++ L H +L+ ++ E+ K
Sbjct: 39 HETEVLLKVLDK--AHRNYSESFF-EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVK 95
Query: 275 NGSLLEVIRKER 286
GSL ++K +
Sbjct: 96 FGSLDTYLKKNK 107
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 29/125 (23%), Positives = 50/125 (40%), Gaps = 20/125 (16%)
Query: 17 SQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--------IKLSDFGFARKYSVNNTDYK 68
QLA A+ + + +++H ++ +N+LL + + IKLSD G + +V D
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDIL 177
Query: 69 QNLSETFCGSYAYASPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLK 126
Q + PE I +D WS G L+ + G P + L+
Sbjct: 178 Q-------ERIPWVPPECIENPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229
Query: 127 QVQKR 131
+ R
Sbjct: 230 FYEDR 234
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 10/108 (9%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
Q+ + Y H +V+HRD+K NLLL+ ++K+ DFG AR + D+ L+E
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-PDHDHTGFLTE---- 190
Query: 78 SYA----YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
Y Y +PEI+ + DIWS+G +L M+ R F +Y
Sbjct: 191 -YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 7/87 (8%)
Query: 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH 250
+ + +Y V A + VAIK IS + + REI+++ +H
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRH 84
Query: 251 PNLIRFL-----QAIETTHRVYIIMEY 272
N+I IE VYI+ +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDL 111
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 17/95 (17%), Positives = 33/95 (34%), Gaps = 2/95 (2%)
Query: 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264
V + VA+K + FL E ++ H N++R + +
Sbjct: 90 GQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALIISKFNHQNIVRCIGVSLQSL 147
Query: 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSE 299
+I++E G L +R+ R + L +
Sbjct: 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 34/130 (26%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNTDYKQNLSET 74
+A Y + +HRDI N LL K+ DFG AR + Y
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGY------- 239
Query: 75 FCGSYAYA------------SPE-ILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTN 120
Y PE ++G+ +T + +D WS GV+L+ + G +P+ +
Sbjct: 240 ------YRKGGCAMLPVKWMPPEAFMEGI-FTSK-TDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 121 YSELLKQVQK 130
E+L+ V
Sbjct: 292 NQEVLEFVTS 301
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 7/110 (6%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSET-FC 76
Q A+ H +V+HRD+K NLL++ ++K+ DFG AR + D + +
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 77 GSYA----YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
+ Y +PE++ Y+ + D+WS G +L + R F +Y
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDY 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 24/75 (32%), Positives = 32/75 (42%), Gaps = 7/75 (9%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V AT + VAIK I P+ L+ REI+++K KH N+I
Sbjct: 23 AYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHENIITIFNIQRP 80
Query: 263 THR-----VYIIMEY 272
VYII E
Sbjct: 81 DSFENFNEVYIIQEL 95
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 13/117 (11%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFC 76
QL + Y H +V+HRD+K NL ++ + +K+ DFG AR + +K +LSE
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD-PHYSHKGHLSE--- 183
Query: 77 GSYA----YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
Y SP +L YT + D+W+ G + M+ G+ F + E ++ +
Sbjct: 184 --GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 28/107 (26%), Positives = 48/107 (44%), Gaps = 12/107 (11%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN--TDYKQNLSETF 75
+ + H+ VVHRD+ N+LL D +I + DF AR+ + + T Y
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY-------- 193
Query: 76 CGSYAYASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
Y +PE++ +T + D+WS G V+ M + F + +
Sbjct: 194 VTHRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTF 239
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 33/139 (23%), Positives = 55/139 (39%), Gaps = 28/139 (20%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-------------------KY 47
Y R QL A+ + H+ + H D+K EN+L +
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 48 NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLF 107
+I+++DFG A T ++ + T + Y PE++ + + Q D+WS+G +LF
Sbjct: 180 SIRVADFGSA-------TFDHEHHT-TIVATRHYRPPEVILELGWA-QPCDVWSIGCILF 230
Query: 108 AMVYGRLPFDDTNYSELLK 126
G F E L
Sbjct: 231 EYYRGFTLFQTHENREHLV 249
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 25/109 (22%), Positives = 40/109 (36%), Gaps = 24/109 (22%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
L + Y H ++HRD+K N L++ ++K+ DFG AR Q
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 78 SYA----------------------YASPEILKGVP-YTPQQSDIWSMG 103
Y +PE++ YT + D+WS+G
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIG 271
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 7/94 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL----- 257
SY V A + VAIK I +V + K+ L REI ++ L H ++++ L
Sbjct: 65 SYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVVKVLDIVIP 123
Query: 258 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED 291
+ +E +Y+++E A + ++ R Y+ E
Sbjct: 124 KDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTEL 156
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 33/131 (25%), Positives = 53/131 (40%), Gaps = 18/131 (13%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLS 72
+ + ++ A++Y K S+ H D+K EN+LLDD Y K Y+ +
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 73 E---------TFCGSYAYA--------SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP 115
TF Y + +PE++ + + SD+WS G VL + G L
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLL 258
Query: 116 FDDTNYSELLK 126
F + E L
Sbjct: 259 FRTHEHMEHLA 269
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 18/121 (14%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
QL I Y H ++HRD+K N+LL+ + ++K++DFG +R +
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 78 SYA----------------YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTN 120
+ Y +PEIL G YT + D+WS+G +L ++ G+ F ++
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSS 235
Query: 121 Y 121
Sbjct: 236 T 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 27/127 (21%), Positives = 53/127 (41%), Gaps = 16/127 (12%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCEN-LLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
R+ Q+ ++++ H + H D+K EN L + Y + + ++ N D K +
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK--V 178
Query: 72 ----SETFCGSYAYA--------SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT 119
S T+ + +PE++ + ++ Q D+WS+G +L G F
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTH 237
Query: 120 NYSELLK 126
+ E L
Sbjct: 238 DSKEHLA 244
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 27/116 (23%), Positives = 45/116 (38%), Gaps = 19/116 (16%)
Query: 18 QLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77
L ++ H+ ++HRD+K N LL+ ++K+ DFG AR + N E
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 78 SYA-----------------YASPEILKGVP-YTPQQSDIWSMGVVLFAMVYGRLP 115
Y +PE++ YT + DIWS G + ++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNMLQS 251
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 203 SYATVKLATSARHSQDVAIKIISKV-QAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261
SY V LA ++VAIK ++++ + ID K+ L REI ++ LK +IR I
Sbjct: 38 SYGYVYLAYDKNTEKNVAIKKVNRMFEDLID-CKRIL-REITILNRLKSDYIIRLYDLII 95
Query: 262 TTHR-----VYIIMEYAKNGSLLEVIRKERYIDED 291
+YI++E A + L ++ + ++ E+
Sbjct: 96 PDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEE 129
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 33/158 (20%), Positives = 52/158 (32%), Gaps = 59/158 (37%)
Query: 10 DKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLL------------------------- 43
++ Q+ +DY H K ++H DIK EN+LL
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 44 ------------------------DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79
+K +K++D G A + T+ Q +
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--------TR 257
Query: 80 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFD 117
Y S E+L G Y +DIWS + F + G F+
Sbjct: 258 QYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLFE 294
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 1e-06
Identities = 49/363 (13%), Positives = 108/363 (29%), Gaps = 91/363 (25%)
Query: 24 DYCHKKSVVHRDIKCENLLLDDKYNIKLSDF-GFARKYSVNNTDYKQNL----SETFCGS 78
+ + K+ ++ C+ LL +++DF A ++ + L ++
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 79 YAYAS-----PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV 133
Y E+L P +++ D + K V
Sbjct: 310 YLDCRPQDLPREVLTTNP-------------RRLSII-AESIRDGLATWDNWKHVNC--- 352
Query: 134 FPESPRLSSSCKALISNILSPVKFRIQMEDI---RQD---P-------WLKEDSNPVGKS 180
+L++ ++ + N+L P ++R + + P W + V
Sbjct: 353 ----DKLTTIIESSL-NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV 407
Query: 181 KSAPEVGIHKRKLKLIRDKKLSSYA----TVKLATSARHSQDVAIKIISKVQAP------ 230
+HK L + + K S+ + ++L + + I+ P
Sbjct: 408 ----VNKLHKYSL-VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
Query: 231 ------ID-YLKKFLP------REIEVVKGLKHPNL-IRFLQA-IETTHRVYIIMEYAKN 275
+D Y + E + + L RFL+ I H
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR--HDSTAWNASGSI 520
Query: 276 GSLLEVIRK-ERYIDEDKALLCYSEVSNLSQTFS--------RCCYQDHIQDLSCFQEQA 326
+ L+ ++ + YI ++ Y + N F Y D ++ ++ E
Sbjct: 521 LNTLQQLKFYKPYICDNDPK--YERLVNAILDFLPKIEENLICSKYTDLLR-IALMAEDE 577
Query: 327 TYY 329
+
Sbjct: 578 AIF 580
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 9e-05
Identities = 11/62 (17%), Positives = 22/62 (35%), Gaps = 1/62 (1%)
Query: 8 NTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ A+ QL ++ HRD+ N+LL KL + ++ +
Sbjct: 159 SLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCG 218
Query: 67 YK 68
+
Sbjct: 219 LQ 220
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 347 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.98 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.98 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.98 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.98 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.98 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.98 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.98 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.98 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.98 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.98 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.95 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.95 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.95 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.95 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.95 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.95 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.94 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.94 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.94 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.94 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.94 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.94 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.94 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.94 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.94 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.94 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.94 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.93 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.93 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.93 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.93 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.93 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.93 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.93 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.93 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.93 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.93 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.93 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.93 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.93 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.93 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.93 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.93 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.93 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.93 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.93 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.93 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.93 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.93 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.93 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.93 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.93 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.93 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.93 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.93 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.93 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.93 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.92 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.92 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.92 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.92 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.92 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.92 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.92 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.92 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.92 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.92 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.92 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.92 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.92 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.92 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.92 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.92 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.92 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.92 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.92 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.92 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.92 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.92 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.92 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.92 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.92 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.92 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.92 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.92 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.92 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.92 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.92 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.92 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.92 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.91 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.91 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.91 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.91 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.91 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.91 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.91 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.91 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.91 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.91 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.91 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.91 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.91 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.91 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.91 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.91 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.91 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.91 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.91 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.91 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.91 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.91 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.91 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.91 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.91 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.91 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.91 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.9 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.9 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.9 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.9 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.9 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.9 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.9 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.9 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.9 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.9 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.9 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.9 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.9 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.9 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.9 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.9 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.9 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.89 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.89 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.89 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.89 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.89 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.89 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.89 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.89 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.89 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.88 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.87 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.87 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=309.63 Aligned_cols=167 Identities=25% Similarity=0.536 Sum_probs=145.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .....+++||+.|||||
T Consensus 128 ~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~~~GTp~YmAPE 204 (311)
T 4aw0_A 128 SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK---QARANSFVGTAQYVSPE 204 (311)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT---CCCBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC---cccccCcccCcccCCHH
Confidence 367799999999999999999999999999999999999999999999999987653221 22345679999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH-
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED- 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e- 163 (347)
++.+.+|+ .++|+||+||++|+|++|+.||.+.+..+++.++.+.. ++.+..+|+++++|+++|| .||.+|++++|
T Consensus 205 vl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 205 LLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp HHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred HHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 99998887 68999999999999999999999999999888887653 2334679999999999999 79999999987
Q ss_pred -----HhcCCCCCCCCCCC
Q psy10462 164 -----IRQDPWLKEDSNPV 177 (347)
Q Consensus 164 -----il~~p~~~~~~~~~ 177 (347)
+++||||+...+..
T Consensus 283 ~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 283 EGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp TCHHHHHTSGGGTTCCCTT
T ss_pred cCCHHHHCCCCcCCCCHHH
Confidence 68999998876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=304.66 Aligned_cols=161 Identities=40% Similarity=0.763 Sum_probs=134.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....+.+||+.|||||
T Consensus 108 ~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~------~~~~~~~GT~~Y~APE 181 (275)
T 3hyh_A 108 KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG------NFLKTSCGSPNYAAPE 181 (275)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------------CTTSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC------CccCCeeECcccCChh
Confidence 3678999999999999999999999999999999999999999999999999765432 1234578999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
++.+..+++.++||||+||++|+|+||+.||.+.+..++...+..+. .+.+..+|+++++++++|| .+|.+||+++|+
T Consensus 182 ~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~ei 260 (275)
T 3hyh_A 182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEI 260 (275)
T ss_dssp HHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99998887678999999999999999999999999888888887654 3345679999999999999 799999999999
Q ss_pred hcCCCCCCC
Q psy10462 165 RQDPWLKED 173 (347)
Q Consensus 165 l~~p~~~~~ 173 (347)
++||||+..
T Consensus 261 l~hpw~k~~ 269 (275)
T 3hyh_A 261 MQDDWFKVD 269 (275)
T ss_dssp HHCHHHHTT
T ss_pred HcCcccccC
Confidence 999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=310.79 Aligned_cols=164 Identities=25% Similarity=0.485 Sum_probs=145.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....+.+||+.|||||
T Consensus 166 ~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-----~~~~~~~GTp~YmAPE 240 (346)
T 4fih_A 166 RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-----PRRKSLVGTPYWMAPE 240 (346)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-----CCBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-----CcccccccCcCcCCHH
Confidence 36789999999999999999999999999999999999999999999999998765322 2234678999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
++.+.+|+ .++||||+||++|+|++|+.||.+.+..+++..+..... .+.+..+|+++++|+.+|| .||.+|++++
T Consensus 241 vl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 319 (346)
T 4fih_A 241 LISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAA 319 (346)
T ss_dssp HHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99998887 689999999999999999999999999888888876543 3344678999999999999 7999999999
Q ss_pred HHhcCCCCCCCCC
Q psy10462 163 DIRQDPWLKEDSN 175 (347)
Q Consensus 163 eil~~p~~~~~~~ 175 (347)
|+++||||.+...
T Consensus 320 e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 320 ELLKHPFLAKAGP 332 (346)
T ss_dssp HHTTCGGGGGCCC
T ss_pred HHhcCHhhcCCCC
Confidence 9999999987554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=316.18 Aligned_cols=161 Identities=27% Similarity=0.526 Sum_probs=144.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ......+||+.|||||+
T Consensus 122 ~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-----~~~~~~~GT~~YmAPE~ 196 (350)
T 4b9d_A 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-----ELARACIGTPYYLSPEI 196 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-----HHHHHHHSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-----ccccccCCCccccCHHH
Confidence 4678899999999999999999999999999999999999999999999998654311 12245689999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+.+|+ .++||||+||++|+|+||+.||.+.+..+++.++..+...+.+..+|+++++|+.+|| .+|.+||+++|++
T Consensus 197 l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 275 (350)
T 4b9d_A 197 CENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275 (350)
T ss_dssp HTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 9998887 6899999999999999999999999999999888877666667789999999999999 7999999999999
Q ss_pred cCCCCCCC
Q psy10462 166 QDPWLKED 173 (347)
Q Consensus 166 ~~p~~~~~ 173 (347)
+|||+.+.
T Consensus 276 ~hp~~~~~ 283 (350)
T 4b9d_A 276 EKGFIAKR 283 (350)
T ss_dssp TSHHHHTT
T ss_pred cCHHhhcC
Confidence 99999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=303.36 Aligned_cols=161 Identities=29% Similarity=0.553 Sum_probs=140.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....+.+||+.|||||+
T Consensus 123 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-----~~~~~~~GT~~YmAPE~ 197 (304)
T 3ubd_A 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-----KKAYSFCGTVEYMAPEV 197 (304)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----------CCCCSCCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-----ccccccccCcccCCHHH
Confidence 5779999999999999999999999999999999999999999999999998653321 22346789999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC-----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ----- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~----- 160 (347)
+.+.+|+ .++||||+||++|+|+||+.||.+.+..+++..+.+.. .+.+..+|+++++|+++|| .+|.+|++
T Consensus 198 ~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~ 275 (304)
T 3ubd_A 198 VNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDG 275 (304)
T ss_dssp HHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTT
T ss_pred hccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCC
Confidence 9998887 68999999999999999999999999999888887654 3445679999999999999 79999998
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++|+++||||+...
T Consensus 276 ~~eil~Hp~f~~id 289 (304)
T 3ubd_A 276 VEEIKRHSFFSTID 289 (304)
T ss_dssp HHHHHTSGGGTTCC
T ss_pred HHHHHcCccccCCC
Confidence 58999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=305.26 Aligned_cols=170 Identities=22% Similarity=0.359 Sum_probs=139.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-cEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++++++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....+............+||+.|||||
T Consensus 147 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE 226 (336)
T 4g3f_A 147 LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHH
Confidence 56799999999999999999999999999999999999987 69999999998765432221122234578999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC--CCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF--PESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
++.+.+|+ .++||||+||++|+|+||+.||.+.+..++...+...... ..++.+|+++++++.+|| .+|.+||++.
T Consensus 227 ~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~ 305 (336)
T 4g3f_A 227 VVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAM 305 (336)
T ss_dssp HHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 99998887 6899999999999999999999988777777777654321 235678999999999999 7999999999
Q ss_pred HH-------------hcCCCCCCCCCCC
Q psy10462 163 DI-------------RQDPWLKEDSNPV 177 (347)
Q Consensus 163 ei-------------l~~p~~~~~~~~~ 177 (347)
|+ ++|||+.+...|.
T Consensus 306 el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 306 ELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp HHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred HHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 97 5799998766554
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=310.07 Aligned_cols=163 Identities=25% Similarity=0.489 Sum_probs=144.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... ....+.+||+.|||||+
T Consensus 244 l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-----~~~~~~~GTp~YmAPEv 318 (423)
T 4fie_A 244 MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-----PRRKSLVGTPYWMAPEL 318 (423)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-----CCBCCCEECTTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-----ccccccccCcCcCCHHH
Confidence 6779999999999999999999999999999999999999999999999998765322 22346789999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..|+ .++||||+||++|+|++|+.||.+.+..+.+..+..... .+.+..+|+++++|+.+|| .||.+|++++|
T Consensus 319 l~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e 397 (423)
T 4fie_A 319 ISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 397 (423)
T ss_dssp HTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9998887 689999999999999999999999999888888876543 3445679999999999999 79999999999
Q ss_pred HhcCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSN 175 (347)
Q Consensus 164 il~~p~~~~~~~ 175 (347)
+++||||.+...
T Consensus 398 ll~Hp~~~~~~~ 409 (423)
T 4fie_A 398 LLKHPFLAKAGP 409 (423)
T ss_dssp HTTCGGGGGCCC
T ss_pred HhcCHHhcCCCC
Confidence 999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=298.65 Aligned_cols=158 Identities=19% Similarity=0.493 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~--iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++++++.|+.||+.||+|||++| |+||||||+|||++. ++.+||+|||+|+.... ....+.+||+.|||
T Consensus 126 l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-------~~~~~~~GTp~YmA 198 (290)
T 3fpq_A 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-------SFAKAVIGTPEFMA 198 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-------TSBEESCSSCCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-------CccCCcccCccccC
Confidence 566899999999999999999998 999999999999985 78999999999975322 12346789999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhccCCC-CCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
||++.+ .|+ .++|||||||++|+|+||+.||.+. +..++...+..+...+ .+...++++++|+.+|| .+|.+||+
T Consensus 199 PE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s 276 (290)
T 3fpq_A 199 PEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276 (290)
T ss_dssp GGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcC
Confidence 999976 466 6899999999999999999999765 4555666666554332 23457899999999999 79999999
Q ss_pred HHHHhcCCCCCCC
Q psy10462 161 MEDIRQDPWLKED 173 (347)
Q Consensus 161 ~~eil~~p~~~~~ 173 (347)
++|+++||||++.
T Consensus 277 ~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 277 IKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHTSGGGC--
T ss_pred HHHHhcCccccCC
Confidence 9999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=301.17 Aligned_cols=170 Identities=25% Similarity=0.463 Sum_probs=141.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........ ......+.+||+.|||||
T Consensus 154 ~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~~~GT~~Y~APE 232 (398)
T 4b99_A 154 PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAE-HQYFMTEYVATRWYRAPE 232 (398)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--------CCCCCSSCCCCTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccc-cccccccceeChHhcCHH
Confidence 3678999999999999999999999999999999999999999999999999876432211 122345679999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-----------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------------------------- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------- 136 (347)
++.+..+.+.++||||+||++|+|++|+.||.+.+..+.+..|......|.
T Consensus 233 v~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (398)
T 4b99_A 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWET 312 (398)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHH
T ss_pred HhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHH
Confidence 998876656889999999999999999999999998888877754332221
Q ss_pred -CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 -SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 -~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+.+|+++++|+++|| .||.+|+|++|+++||||.+...+
T Consensus 313 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 313 VYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 1346889999999999 799999999999999999876544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=296.55 Aligned_cols=168 Identities=23% Similarity=0.426 Sum_probs=129.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC-CcEEEeccCCceecccCCccc-----------------
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDY----------------- 67 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~----------------- 67 (347)
.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.........
T Consensus 113 ~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (361)
T 4f9c_A 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNK 192 (361)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccc
Confidence 36789999999999999999999999999999999999876 799999999998654321110
Q ss_pred ------cccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc---------
Q psy10462 68 ------KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKR--------- 131 (347)
Q Consensus 68 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~-~~~~~~~~~i~~~--------- 131 (347)
......+.+||+.|+|||++.+.+..+.++|+||+||++|+|++|+.||.. .+..+.+..|...
T Consensus 193 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~ 272 (361)
T 4f9c_A 193 CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQA 272 (361)
T ss_dssp -------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred ccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhh
Confidence 011123468999999999998876555789999999999999999999954 3333333333210
Q ss_pred --------------------------------------------cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 132 --------------------------------------------VVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 132 --------------------------------------------~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
...+....+|+++++|+++|| .||.+|+|++|+++
T Consensus 273 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 273 AKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 001123467899999999999 79999999999999
Q ss_pred CCCCCCC
Q psy10462 167 DPWLKED 173 (347)
Q Consensus 167 ~p~~~~~ 173 (347)
||||++.
T Consensus 353 Hp~f~~i 359 (361)
T 4f9c_A 353 HPFFKDM 359 (361)
T ss_dssp SGGGTTC
T ss_pred CcccCCC
Confidence 9999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=289.97 Aligned_cols=138 Identities=24% Similarity=0.340 Sum_probs=127.5
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|+++.||+.||+|++++....+....+.+.+|+++|++|+|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999999999999999999865544444456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+||||.++|++.+.++|.+++++++|++ |+.|+|++|||||||||+|||++.++
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g 169 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 169 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC
Confidence 99999999999999989999999999999876 99999999999999999999998876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=283.76 Aligned_cols=157 Identities=20% Similarity=0.331 Sum_probs=131.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....... .......+||+.|||||+
T Consensus 155 l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~---~~~~~~~~gt~~ymAPE~ 231 (329)
T 4aoj_A 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWMPPES 231 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------------CCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCc---ceecCcccccccccChhh
Confidence 56788999999999999999999999999999999999999999999999986543221 112234679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+| |+.||.+.+..++...+.++...+.+..+++++.+++.+|+ .+|.+||+++|+
T Consensus 232 ~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 310 (329)
T 4aoj_A 232 ILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310 (329)
T ss_dssp HTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred hcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence 9998887 78999999999999998 89999999999999999888777777889999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 311 ~~~ 313 (329)
T 4aoj_A 311 HAR 313 (329)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=282.18 Aligned_cols=156 Identities=21% Similarity=0.376 Sum_probs=137.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++.+++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+........ ......+||+.|||||
T Consensus 124 ~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE 200 (299)
T 4asz_A 124 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPE 200 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCE---EETTTEEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCce---eecCceecChhhcCHH
Confidence 3567899999999999999999999999999999999999999999999999865432211 1123456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
++.+..++ .++|||||||++|||+| |+.||.+.+..++...+..+...+.+..+++++.+++.+|+ .+|..||++++
T Consensus 201 ~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~ 279 (299)
T 4asz_A 201 SIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKG 279 (299)
T ss_dssp HHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 99988887 68999999999999998 99999999999999999888777777889999999999999 79999999999
Q ss_pred Hh
Q psy10462 164 IR 165 (347)
Q Consensus 164 il 165 (347)
+.
T Consensus 280 i~ 281 (299)
T 4asz_A 280 IH 281 (299)
T ss_dssp HH
T ss_pred HH
Confidence 84
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.16 Aligned_cols=157 Identities=25% Similarity=0.390 Sum_probs=139.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+....... .......+||+.|||||+
T Consensus 142 l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~---~~~~~~~~gt~~ymAPE~ 218 (308)
T 4gt4_A 142 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY---YKLLGNSLLPIRWMAPEA 218 (308)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGC---BCSSSSSCBCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCc---eeEecccccCCcccCHHH
Confidence 45688999999999999999999999999999999999999999999999986643221 122345679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+| |..||.+.+..++...+..+...|.++..++.+.+++..|+ .+|..||++.++
T Consensus 219 l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei 297 (308)
T 4gt4_A 219 IMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297 (308)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9988887 78999999999999998 89999999999999999888777778889999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
.++
T Consensus 298 ~~~ 300 (308)
T 4gt4_A 298 HSR 300 (308)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=301.63 Aligned_cols=161 Identities=24% Similarity=0.473 Sum_probs=135.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++|+.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... ...+.|||+.|||||
T Consensus 288 ~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-------~~~t~~GTp~YmAPE 360 (689)
T 3v5w_A 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------KPHASVGTHGYMAPE 360 (689)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-------CCCSCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-------CCCCccCCcCccCHH
Confidence 3678999999999999999999999999999999999999999999999999876432 234679999999999
Q ss_pred cccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 86 ILKG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 86 ~~~~-~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
++.+ ..|+ .++|+||+||++|+|++|+.||.+. +..++...+... ..+.+..+|+++++|+.+|| .+|.+|++
T Consensus 361 vl~~~~~y~-~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~ 438 (689)
T 3v5w_A 361 VLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPDSFSPELRSLLEGLLQRDVNRRLG 438 (689)
T ss_dssp HHSTTCCCC-THHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCGGGCTT
T ss_pred HHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CCCCCccCCHHHHHHHHHHccCCHhHCCC
Confidence 9975 4565 7899999999999999999999764 333444444333 23345679999999999999 79999998
Q ss_pred -----HHHHhcCCCCCCCCC
Q psy10462 161 -----MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 -----~~eil~~p~~~~~~~ 175 (347)
++|+++||||+...+
T Consensus 439 ~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 439 CLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp CSSSTHHHHTTSGGGTTCCH
T ss_pred CCCCCHHHHhcCccccCCCH
Confidence 799999999998753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=280.54 Aligned_cols=163 Identities=23% Similarity=0.417 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcccc-------ccCcccccCCcccc
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK-------QNLSETFCGSYAYA 82 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~~gt~~y~ 82 (347)
..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......... .......+||+.||
T Consensus 118 ~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Ym 197 (299)
T 4g31_A 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYM 197 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTS
T ss_pred HHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCcccc
Confidence 55889999999999999999999999999999999999999999999987643221110 11123468999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
|||++.+.+|+ .++||||+||++|||++ ||.+... ...+..+......|.....++.+++|+++|| .+|.+||+
T Consensus 198 APE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps 273 (299)
T 4g31_A 198 SPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE 273 (299)
T ss_dssp CHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC
T ss_pred CHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcC
Confidence 99999998887 68999999999999996 8865322 1223333333222223446778899999999 79999999
Q ss_pred HHHHhcCCCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDSNP 176 (347)
Q Consensus 161 ~~eil~~p~~~~~~~~ 176 (347)
+.|+++|||+++...+
T Consensus 274 ~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 274 AINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHTSGGGCCC---
T ss_pred HHHHhcCHhhCCCCCC
Confidence 9999999999876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.20 Aligned_cols=164 Identities=26% Similarity=0.494 Sum_probs=143.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC--CcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
+++.+++.+++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...... .....+||+.||||
T Consensus 252 l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~------~~~~~~GT~~y~AP 325 (573)
T 3uto_A 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ------SVKVTTGTAEFAAP 325 (573)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS------EEEEECSSGGGCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC------ceeeeEECccccCH
Confidence 5679999999999999999999999999999999999854 889999999998765321 12356899999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCC--CCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPE--SPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~--~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
|++.+.+|+ .++||||+||++|+|++|+.||.+.+..+.+..+..... ++. ...+|+++++||++|| .+|.+|++
T Consensus 326 Ev~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t 404 (573)
T 3uto_A 326 EVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 404 (573)
T ss_dssp HHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC
Confidence 999998887 689999999999999999999999999999888876532 222 3568999999999999 79999999
Q ss_pred HHHHhcCCCCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 161 ~~eil~~p~~~~~~~~~ 177 (347)
++|+++||||+....+.
T Consensus 405 ~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 405 IHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHHHHHSTTTSCCCCTT
T ss_pred HHHHhcCcCcCCCCCCC
Confidence 99999999999876553
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=273.51 Aligned_cols=156 Identities=26% Similarity=0.466 Sum_probs=123.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....... .......+||+.|||||+
T Consensus 129 l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~---~~~~~~~~GT~~ymAPE~ 205 (307)
T 3omv_A 129 FQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG---SQQVEQPTGSVLWMAPEV 205 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------------CCCCTTSCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc---ceeecccccCCCccCHHH
Confidence 56789999999999999999999999999999999999999999999999976543211 112345689999999999
Q ss_pred ccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCCC----CCCCCHHHHHHHHhcc-CCCCC
Q psy10462 87 LKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFPE----SPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 87 ~~~~---~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~----~~~~s~~~~~li~~~l-~~~~~ 157 (347)
+.+. +++ .++|||||||++|||+||+.||.+.+.. .+...+..+...|. +..+++++++++..|+ .+|..
T Consensus 206 l~~~~~~~y~-~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~ 284 (307)
T 3omv_A 206 IRMQDNNPFS-FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEE 284 (307)
T ss_dssp HHCCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTT
T ss_pred hhccCCCCCC-cHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhH
Confidence 9753 354 6899999999999999999999886654 44445555544432 3467899999999999 79999
Q ss_pred CCCHHHHhc
Q psy10462 158 RIQMEDIRQ 166 (347)
Q Consensus 158 R~~~~eil~ 166 (347)
||++.++++
T Consensus 285 RPs~~ei~~ 293 (307)
T 3omv_A 285 RPLFPQILS 293 (307)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=273.49 Aligned_cols=137 Identities=20% Similarity=0.349 Sum_probs=119.2
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
-++|++.+.||+|+||+||+|+++.+|+.||+|++++....+....+.+.+|+++|++++|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999999876655555566788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||| +|+|.++|.+++.++|.+++.+++|++ |+.|+|++||+||||||+|||++.++
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~ 149 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL 149 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC
Confidence 9999 689999999999999999999999877 99999999999999999999998775
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=279.78 Aligned_cols=157 Identities=20% Similarity=0.357 Sum_probs=135.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++++..++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+....+... ......+||+.|||||+
T Consensus 182 l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~ 258 (353)
T 4ase_A 182 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPET 258 (353)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCc---eeeccccccccccCHHH
Confidence 467889999999999999999999999999999999999999999999999866433221 11235678999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCH-HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNY-SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|||||||++|||+| |+.||.+.+. ..+...+..+...+.+...++++.+++..|+ .+|..||++.+
T Consensus 259 l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~e 337 (353)
T 4ase_A 259 IFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 337 (353)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 9988887 78999999999999998 9999998764 4556667777777777889999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
+++|
T Consensus 338 il~~ 341 (353)
T 4ase_A 338 LVEH 341 (353)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=280.27 Aligned_cols=137 Identities=21% Similarity=0.373 Sum_probs=118.1
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
-++|++.+.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+++|++|+|||||+++++|++++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999999999999999998765443 3356678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+||||.++|..+ ..++|.+++.++.|++ |+.|+|++|||||||||+||||++++
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g 162 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG 162 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC
Confidence 9999999999999654 4689999999988876 99999999999999999999998776
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=278.46 Aligned_cols=134 Identities=16% Similarity=0.252 Sum_probs=122.2
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
...|+..+.||+|+||+||+|+++.||+.||||++++.... ..+.+.+|+++|++++|||||+++++|++++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 56789999999999999999999999999999999754322 245678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+||+|.+++.+ +.++|.+++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g 207 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 207 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC
Confidence 999999999999976 5799999999988876 99999999999999999999998776
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=275.03 Aligned_cols=131 Identities=18% Similarity=0.240 Sum_probs=120.3
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
..+.|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+|+.+|++++|||||+++++|++++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3456788889999999999999999999999999997532 23489999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||+||||.++|++.+.++|.+++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g 187 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG 187 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC
Confidence 999999999999999888999999999999876 99999999999999999999998765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=279.60 Aligned_cols=135 Identities=16% Similarity=0.247 Sum_probs=122.8
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
+...|++.+.||+|+||+||+|+++.||+.||||+++..... ..+.+.+|+.+|++++|||||+++++|++++.+||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 457799999999999999999999999999999999754322 24567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||+||+|.++++. +.++|.+++.++.|++ ||.|+|++|||||||||+||||+.++
T Consensus 226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g 284 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 284 (423)
T ss_dssp EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC
T ss_pred EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC
Confidence 9999999999999965 5799999999988876 99999999999999999999998876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=274.19 Aligned_cols=138 Identities=17% Similarity=0.299 Sum_probs=118.5
Q ss_pred hhhhhhhhhhcccccchhhhhhccc---ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSA---RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
..++|++.+.||+|+||+||+|++. .+++.||+|++++...... ....+.+|+++|++++|||||+++++|++++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3478999999999999999999864 4788899999976543322 23456789999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||||+||||.++|++.+.++|.+++.+++|++ |+.|+|++|||||||||+|||+++++
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g 163 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG 163 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC
Confidence 999999999999999999989999999999998876 99999999999999999999998876
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=262.54 Aligned_cols=162 Identities=38% Similarity=0.766 Sum_probs=142.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||+
T Consensus 111 l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~ 184 (328)
T 3fe3_A 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG------KLDAFCGAPPYAAPEL 184 (328)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC------GGGTTSSSGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC------ccccccCCcceeCccc
Confidence 5678999999999999999999999999999999999999999999999997654321 2345689999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..+.+.++|+||+||++|+|++|+.||.+.+..+....+..+. ++.+..+++++.+++++|| .+|.+||++++++
T Consensus 185 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp HHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred ccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 9988877678999999999999999999999999888888877654 3445678999999999999 7999999999999
Q ss_pred cCCCCCCCCC
Q psy10462 166 QDPWLKEDSN 175 (347)
Q Consensus 166 ~~p~~~~~~~ 175 (347)
+|||+.....
T Consensus 264 ~h~~~~~~~~ 273 (328)
T 3fe3_A 264 KDRWINAGHE 273 (328)
T ss_dssp TCTTTTTTCT
T ss_pred cCHhhcCCCc
Confidence 9999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=264.98 Aligned_cols=138 Identities=19% Similarity=0.324 Sum_probs=119.3
Q ss_pred chhhhhhhhhhhcccccchhhhhhccc-----ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
.+.+++|.+.+.||+|+||+||+|++. .+++.||||+++.. .....+.|.+|+++|++++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 356788999999999999999999864 36788999999743 2334566889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHhC-------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRKE-------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~~-------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+++.+|||||||++|||.++|++. ..+++.++..++.|++ |+.|+|+++||||||||+|||++.+.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999753 3699999999999887 99999999999999999999998765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=261.29 Aligned_cols=132 Identities=18% Similarity=0.254 Sum_probs=118.3
Q ss_pred hhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee----CCeEEE
Q psy10462 193 LKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----THRVYI 268 (347)
Q Consensus 193 ~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~i 268 (347)
+++.+.||+|+||+||+|.+..+++.||+|++.+..... ...+.+.+|+++|++|+|||||+++++|++ ++.+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 467778999999999999999999999999997655443 335668899999999999999999999976 356999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcC--ccccCCCCccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRC--CYQDHIQDLSCFQEQ 325 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~--iiHRDlKp~Nil~~~ 325 (347)
|||||+||||.++|++.+.+++..++.++.|++ |+.|+|++| ||||||||+|||++.
T Consensus 107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~ 166 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 166 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC
Confidence 999999999999999889999999999998877 999999998 999999999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=263.76 Aligned_cols=136 Identities=16% Similarity=0.241 Sum_probs=115.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC-----
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 264 (347)
..+|++.+.||+|+||+||+|+++.+|+.||+|+++... .+...+.+.+|+++|++|+|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 356889999999999999999999999999999997543 2334566789999999999999999999997654
Q ss_pred -------eEEEEEEecCCCChHHHHHhCCCC---CHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 -------RVYIIMEYAKNGSLLEVIRKERYI---DEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 -------~~~iv~E~~~~G~L~~~l~~~~~l---~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|||||||+||+|.++++.++.+ ++..++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~ 155 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD 155 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC
Confidence 489999999999999999876654 4566778888776 99999999999999999999998776
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=263.48 Aligned_cols=169 Identities=24% Similarity=0.417 Sum_probs=135.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc----------------cccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD----------------YKQN 70 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------------~~~~ 70 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ....
T Consensus 106 ~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (388)
T 3oz6_A 106 LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185 (388)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-----------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccc
Confidence 566888999999999999999999999999999999999999999999999865321100 0111
Q ss_pred CcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--------------
Q psy10462 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-------------- 136 (347)
Q Consensus 71 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------------- 136 (347)
.....+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+.+..+......|.
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 265 (388)
T 3oz6_A 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKT 265 (388)
T ss_dssp ----CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHH
Confidence 223468999999999998744344789999999999999999999999988777777654433332
Q ss_pred --------------------------------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 137 --------------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 137 --------------------------------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
....++++.+|+++|| .+|.+||+++++++|||+..-..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 266 MIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337 (388)
T ss_dssp HHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred HHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcC
Confidence 1256889999999999 79999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=262.07 Aligned_cols=163 Identities=29% Similarity=0.567 Sum_probs=137.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .......+||+.|+|||
T Consensus 120 ~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~~~~gt~~y~aPE 194 (353)
T 3txo_A 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-----GVTTATFCGTPDYIAPE 194 (353)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--------------CCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-----CccccccCCCcCeEChh
Confidence 4677999999999999999999999999999999999999999999999999753321 12234578999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH---
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM--- 161 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~--- 161 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+..++...+..... ..+..+++++++++++|| .+|.+|++.
T Consensus 195 ~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~ 272 (353)
T 3txo_A 195 ILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQ 272 (353)
T ss_dssp HHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGG
T ss_pred hcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCccc
Confidence 99887776 689999999999999999999999999888888876532 234568999999999999 799999998
Q ss_pred ---HHHhcCCCCCCCCC
Q psy10462 162 ---EDIRQDPWLKEDSN 175 (347)
Q Consensus 162 ---~eil~~p~~~~~~~ 175 (347)
+++++||||+...+
T Consensus 273 ~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 273 GGEHAILRHPFFKEIDW 289 (353)
T ss_dssp TCTHHHHTSGGGTTCCH
T ss_pred CCHHHHhhCCcccCCCH
Confidence 89999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=254.96 Aligned_cols=162 Identities=30% Similarity=0.588 Sum_probs=140.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||
T Consensus 101 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE 175 (337)
T 1o6l_A 101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTPEYLAPE 175 (337)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-----CCBCCCEECGGGCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-----CcccccccChhhCChh
Confidence 36778999999999999999999999999999999999999999999999997543211 1234578999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI----- 159 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~----- 159 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... ...+..+++++++++++|| .+|.+|+
T Consensus 176 ~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~ 253 (337)
T 1o6l_A 176 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253 (337)
T ss_dssp GGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred hhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCC
Confidence 99988776 68999999999999999999999988888877776543 2234578999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ~~~eil~~p~~~~~~ 174 (347)
+++++++||||....
T Consensus 254 ~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 254 DAKEVMEHRFFLSIN 268 (337)
T ss_dssp THHHHHTSGGGTTCC
T ss_pred CHHHHHcCCCcCCCC
Confidence 899999999998765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=258.18 Aligned_cols=160 Identities=28% Similarity=0.529 Sum_probs=138.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC----cEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... .....+||+.|+
T Consensus 112 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~------~~~~~~gt~~y~ 185 (361)
T 2yab_A 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV------EFKNIFGTPEFV 185 (361)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC------CCCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC------ccccCCCCccEE
Confidence 67899999999999999999999999999999999998776 79999999998764321 123567999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCC--CCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPE--SPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~--~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||++.+..++ .++|+||+||++|+|++|..||.+.+..+.+..+..... ++. +..+++.++++++.|| .+|.+|
T Consensus 186 aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 264 (361)
T 2yab_A 186 APEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKR 264 (361)
T ss_dssp CHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred CchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHC
Confidence 99999987776 689999999999999999999999998888888766532 221 2568999999999999 799999
Q ss_pred CCHHHHhcCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKED 173 (347)
Q Consensus 159 ~~~~eil~~p~~~~~ 173 (347)
|+++++++|||+...
T Consensus 265 ~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 265 LTIQEALRHPWITPV 279 (361)
T ss_dssp CCHHHHHTSTTTSCS
T ss_pred cCHHHHhcCcCcCCC
Confidence 999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=263.64 Aligned_cols=166 Identities=31% Similarity=0.509 Sum_probs=142.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....... ......+||+.|+|||
T Consensus 164 ~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~----~~~~~~~gt~~Y~APE 239 (410)
T 3v8s_A 164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM----VRCDTAVGTPDYISPE 239 (410)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE----EECCSCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc----ccccCCcCCccccCHH
Confidence 367789999999999999999999999999999999999999999999999987643221 1123568999999999
Q ss_pred cccCCC----CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 86 ILKGVP----YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 86 ~~~~~~----~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
++.+.. ++ .++|+||+||++|+|++|+.||.+.+..+....+... ..+|....+|+++++|+++|| .+|.+
T Consensus 240 ~l~~~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~r 318 (410)
T 3v8s_A 240 VLKSQGGDGYYG-RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVR 318 (410)
T ss_dssp HHHTTTTTCEEE-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGC
T ss_pred HhhccCCCcCCC-CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhh
Confidence 998754 33 6899999999999999999999999988888887653 456777789999999999999 46666
Q ss_pred --CCCHHHHhcCCCCCCCCCC
Q psy10462 158 --RIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 158 --R~~~~eil~~p~~~~~~~~ 176 (347)
|++++++++||||+...+.
T Consensus 319 lgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 319 LGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp TTSSCHHHHHTSGGGCCSSCC
T ss_pred CCCCCHHHHhcCccccCCCHH
Confidence 8999999999999987643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=258.00 Aligned_cols=140 Identities=15% Similarity=0.194 Sum_probs=121.1
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
...|+++.+++++.+.||+|+||+||+|++.. .||||+++..... ....+.|.+|+++|++++|||||++++++.
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~- 102 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMT- 102 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-
Confidence 34578889999999999999999999998753 4899999754433 334567889999999999999999999875
Q ss_pred CCeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++.+|||||||+||||.++|.. .+.+++.++..++.|++ |+.|+|+++||||||||+||||+.++
T Consensus 103 ~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~ 169 (307)
T 3omv_A 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL 169 (307)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE
T ss_pred CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC
Confidence 4678999999999999999965 46899999999999887 99999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=252.45 Aligned_cols=161 Identities=26% Similarity=0.441 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ......+||+.|+|||+
T Consensus 117 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~ 190 (308)
T 3g33_A 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ------MALTPVVVTLWYRAPEV 190 (308)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC------CCSGGGGCCCSSCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC------cccCCccccccccCchH
Confidence 678999999999999999999999999999999999999999999999999755321 12235678999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC--------------------------CCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE--------------------------SPRL 140 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------------~~~~ 140 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.+....+. .+.+
T Consensus 191 ~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (308)
T 3g33_A 191 LLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEM 269 (308)
T ss_dssp HHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSC
T ss_pred HcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccc
Confidence 9888776 689999999999999999999999888877777654322211 1357
Q ss_pred CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 141 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 141 s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
++.+.+++.+|| .+|.+||+++++++|||+....
T Consensus 270 ~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 270 EESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred cHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 889999999999 7999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=261.27 Aligned_cols=138 Identities=19% Similarity=0.308 Sum_probs=120.6
Q ss_pred chhhhhhhhhhhcccccchhhhhhccc-----ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
.+..+++.+.+.||+|+||+||+|++. .+++.||||+++.. .....+.|.+|+++|++++|||||+++++|.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455678888999999999999999864 46888999999743 2334567889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHhC---------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRKE---------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~~---------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
+++.+|||||||++|||.++|++. +++++.++..++.|++ |+.|+|+++||||||||+||||++
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 999999999999999999999653 3699999999998877 999999999999999999999987
Q ss_pred cc
Q psy10462 326 AT 327 (347)
Q Consensus 326 ~~ 327 (347)
+.
T Consensus 194 ~~ 195 (329)
T 4aoj_A 194 GL 195 (329)
T ss_dssp TT
T ss_pred CC
Confidence 65
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=260.43 Aligned_cols=163 Identities=29% Similarity=0.566 Sum_probs=134.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .......+||+.|+|||
T Consensus 149 ~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-----~~~~~~~~gt~~Y~aPE 223 (396)
T 4dc2_A 149 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-----GDTTSTFCGTPNYIAPE 223 (396)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-----TCCBCCCCBCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-----CCccccccCCcccCCch
Confidence 4677999999999999999999999999999999999999999999999999753221 12234678999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---------NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~ 155 (347)
++.+..++ .++|+||+||++|+|++|+.||... ....+...+... ....+..+++++++++++|| .+|
T Consensus 224 ~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP 301 (396)
T 4dc2_A 224 ILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDP 301 (396)
T ss_dssp HHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSCT
T ss_pred hhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-ccCCCCcCCHHHHHHHHHHhcCCH
Confidence 99998876 6899999999999999999999643 122334444333 23345678999999999999 799
Q ss_pred CCCCCH------HHHhcCCCCCCCCC
Q psy10462 156 KFRIQM------EDIRQDPWLKEDSN 175 (347)
Q Consensus 156 ~~R~~~------~eil~~p~~~~~~~ 175 (347)
.+|+++ +++++||||+...+
T Consensus 302 ~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 302 KERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp TTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred hHcCCCCCCCCHHHHhcCccccCCCH
Confidence 999984 89999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=251.01 Aligned_cols=162 Identities=25% Similarity=0.455 Sum_probs=138.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .....+||+.|+|||+
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE~ 187 (297)
T 3fxz_A 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEV 187 (297)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-----CBCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-----ccCCccCCcCccChhh
Confidence 56789999999999999999999999999999999999999999999999977643221 2335679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR--VVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+... ...+.+..+++.+++++.+|| .+|.+||++++
T Consensus 188 ~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 266 (297)
T 3fxz_A 188 VTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266 (297)
T ss_dssp HHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHH
Confidence 9988876 6899999999999999999999988877666555432 233445678999999999999 79999999999
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
+++|||++...
T Consensus 267 ll~h~~~~~~~ 277 (297)
T 3fxz_A 267 LLQHQFLKIAK 277 (297)
T ss_dssp HTTCGGGGGCC
T ss_pred HhhChhhcccC
Confidence 99999997643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=255.88 Aligned_cols=163 Identities=25% Similarity=0.509 Sum_probs=140.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||
T Consensus 117 ~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE 191 (353)
T 2i0e_A 117 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-----VTTKTFCGTPDYIAPE 191 (353)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-----CCBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-----cccccccCCccccChh
Confidence 36778999999999999999999999999999999999999999999999997543211 1234678999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ---- 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~---- 160 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+..++...+.... ...+..+++++++++++|| .+|.+|++
T Consensus 192 ~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 269 (353)
T 2i0e_A 192 IIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 269 (353)
T ss_dssp HHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTT
T ss_pred hhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCC
Confidence 99988876 68999999999999999999999999888888876643 2334678999999999999 79999994
Q ss_pred -HHHHhcCCCCCCCCC
Q psy10462 161 -MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 -~~eil~~p~~~~~~~ 175 (347)
++++++||||+...+
T Consensus 270 ~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 270 GERDIKEHAFFRYIDW 285 (353)
T ss_dssp HHHHHHTSGGGTTCCH
T ss_pred CHHHHhcCccccCCCH
Confidence 699999999987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=251.38 Aligned_cols=163 Identities=26% Similarity=0.468 Sum_probs=133.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+|||+
T Consensus 116 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~t~~y~aPE~ 190 (311)
T 3niz_A 116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-----SYTHEVVTLWYRAPDV 190 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--------CCCCCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-----cccCCcccCCcCCHHH
Confidence 67789999999999999999999999999999999999999999999999987543211 1234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-----------------------------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-----------------------------S 137 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----------------------------~ 137 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+....+......+. .
T Consensus 191 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (311)
T 3niz_A 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSII 270 (311)
T ss_dssp HTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHS
T ss_pred hcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhC
Confidence 98754444789999999999999999999998776666555543222111 1
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
+.+++++.+++++|| .+|.+||+++++++||||++..
T Consensus 271 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 271 PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 346789999999999 7999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=256.58 Aligned_cols=163 Identities=30% Similarity=0.584 Sum_probs=141.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||
T Consensus 114 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE 188 (345)
T 1xjd_A 114 KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-----AKTNTFCGTPDYIAPE 188 (345)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-----CCBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-----CcccCCCCCcccCChh
Confidence 36778999999999999999999999999999999999999999999999997543211 1234678999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH-H
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME-D 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~-e 163 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+..++...+..... ..+..+++++++++++|| .+|.+|+++. +
T Consensus 189 ~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~ 266 (345)
T 1xjd_A 189 ILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDLLVKLFVREPEKRLGVRGD 266 (345)
T ss_dssp HHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred hhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC-CCCcccCHHHHHHHHHHhcCCHhHcCCChHH
Confidence 99988776 689999999999999999999999998888888766532 234568999999999999 6999999998 9
Q ss_pred HhcCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSN 175 (347)
Q Consensus 164 il~~p~~~~~~~ 175 (347)
+++||||+...+
T Consensus 267 i~~hp~f~~~~w 278 (345)
T 1xjd_A 267 IRQHPLFREINW 278 (345)
T ss_dssp GGGSGGGTTCCH
T ss_pred HHcCccccCCCH
Confidence 999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=258.34 Aligned_cols=139 Identities=14% Similarity=0.226 Sum_probs=119.4
Q ss_pred chhhhhhhhhhhcccccchhhhhhccc-----ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
+++..++++.+.||+|+||+||+|++. .+++.||||+++... .....+.|.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 456778889999999999999999853 467889999996442 2233466889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHhC----------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQE 324 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~~----------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~ 324 (347)
+++.+|||||||++|||.++|..+ ..+++.++..++.|++ |+.|+|+++||||||||+|||++
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999999643 3589999999988877 99999999999999999999998
Q ss_pred ccc
Q psy10462 325 QAT 327 (347)
Q Consensus 325 ~~~ 327 (347)
.+.
T Consensus 180 ~~~ 182 (308)
T 4gt4_A 180 DKL 182 (308)
T ss_dssp GGG
T ss_pred CCC
Confidence 765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=268.10 Aligned_cols=160 Identities=24% Similarity=0.461 Sum_probs=129.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ......+||+.|+|||+
T Consensus 161 l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~ 234 (464)
T 3ttj_A 161 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPEV 234 (464)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C------CCC----CCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC------cccCCCcccccccCHHH
Confidence 677899999999999999999999999999999999999999999999999765421 12345689999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC--------------------C-------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP--------------------R------- 139 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------------------~------- 139 (347)
+.+..++ .++||||+||++|+|++|+.||.+.+..+.+..+.+....|.+. .
T Consensus 235 ~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (464)
T 3ttj_A 235 ILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF 313 (464)
T ss_dssp HTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHS
T ss_pred HcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhC
Confidence 9998877 68999999999999999999999998877776665433222100 0
Q ss_pred --------------CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 140 --------------LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 140 --------------~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
.++++++|+++|| .+|.+||+++|+++||||..-
T Consensus 314 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 314 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 1467899999999 799999999999999999853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=250.87 Aligned_cols=159 Identities=31% Similarity=0.626 Sum_probs=139.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....+||+.|+|||+
T Consensus 103 ~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--------~~~~~~gt~~y~aPE~ 174 (318)
T 1fot_A 103 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VTYTLCGTPDYIAPEV 174 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--------CBCCCCSCTTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--------ccccccCCccccCHhH
Confidence 56789999999999999999999999999999999999999999999999976532 1235689999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... ...+..+++++++++++|| .+|.+|+ +
T Consensus 175 ~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 252 (318)
T 1fot_A 175 VSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 252 (318)
T ss_dssp HTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred hcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCC
Confidence 9988777 67999999999999999999999988888877776543 2334678999999999999 7999999 8
Q ss_pred HHHHhcCCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 ~~eil~~p~~~~~~~ 175 (347)
++++++||||+...+
T Consensus 253 ~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 253 TEDVKNHPWFKEVVW 267 (318)
T ss_dssp THHHHTSGGGSSCCH
T ss_pred HHHHhcCccccCCCH
Confidence 999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=260.00 Aligned_cols=161 Identities=42% Similarity=0.799 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||+
T Consensus 105 l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~------~~~~~~~gt~~y~aPE~ 178 (336)
T 3h4j_B 105 MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG------NFLKTSCGSPNYAAPEV 178 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS------BTTCCCTTSTTTSCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC------cccccccCCcCcCCHHH
Confidence 567899999999999999999999999999999999999999999999999765432 12345679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..+.+.++||||+||++|+|++|+.||.+....+....+... ....+..+++.+++++++|| .+|.+||++++++
T Consensus 179 ~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil 257 (336)
T 3h4j_B 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIR 257 (336)
T ss_dssp SCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHT
T ss_pred HcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 998877557899999999999999999999886654443333322 23345678999999999999 7999999999999
Q ss_pred cCCCCCCCC
Q psy10462 166 QDPWLKEDS 174 (347)
Q Consensus 166 ~~p~~~~~~ 174 (347)
+||||+...
T Consensus 258 ~hp~~~~~~ 266 (336)
T 3h4j_B 258 RDPWFNVNL 266 (336)
T ss_dssp TCHHHHTTC
T ss_pred hChhhccCC
Confidence 999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=255.48 Aligned_cols=159 Identities=18% Similarity=0.268 Sum_probs=115.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK--------SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~--------~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt 78 (347)
++++++.+++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......... .......+||
T Consensus 97 l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~-~~~~~~~~GT 175 (303)
T 3hmm_A 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGT 175 (303)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE-SCC-----CC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCce-eeeccccccc
Confidence 45588899999999999999987 99999999999999999999999999998765432221 1223356899
Q ss_pred ccccccccccCCCC-----CCChhhHHHHHHHHHHHHcCCCCCCC----------C-----CHHHHHHHHHhccCCCCCC
Q psy10462 79 YAYASPEILKGVPY-----TPQQSDIWSMGVVLFAMVYGRLPFDD----------T-----NYSELLKQVQKRVVFPESP 138 (347)
Q Consensus 79 ~~y~aPE~~~~~~~-----~~~~~Dvws~G~~l~~ll~g~~pf~~----------~-----~~~~~~~~i~~~~~~~~~~ 138 (347)
+.|||||++.+... .+.++|||||||++|||+||..||.. . ...+....+......|..+
T Consensus 176 ~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p 255 (303)
T 3hmm_A 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 255 (303)
T ss_dssp GGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred ccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCC
Confidence 99999999976521 12479999999999999999776532 1 2233344443332222221
Q ss_pred -C-----CCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 139 -R-----LSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 139 -~-----~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
. .+..+.+++..|+ .+|..|||+.++.+
T Consensus 256 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1 2246788999999 79999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=280.46 Aligned_cols=141 Identities=12% Similarity=0.149 Sum_probs=123.3
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHH---HHHHHhcCCCcchhhhheeeeeCC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPR---EIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~---E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
+..++|++.+.||+|+||+||+|+++.||+.||+|++++...........+.+ ++.+++.++|||||+++++|++++
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 44678999999999999999999999999999999997654332222223333 466778889999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
.+|||||||+||||.++|.+.+.++|..+++|++|++ |+.|+|++|||||||||+||||+.++.
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~ 330 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC
Confidence 9999999999999999999989999999999999876 999999999999999999999998873
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-32 Score=259.32 Aligned_cols=162 Identities=33% Similarity=0.588 Sum_probs=139.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc---CCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
.+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... ......+||+.|+
T Consensus 106 ~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-----~~~~~~~gt~~Y~ 180 (444)
T 3soa_A 106 YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-----QAWFGFAGTPGYL 180 (444)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC-----CBCCCSCSCGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC-----ceeecccCCcccC
Confidence 367899999999999999999999999999999999998 45789999999997654321 1123467999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CC--CCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FP--ESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~--~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||++.+..++ .++||||+||++|+|++|..||.+.+..+....+..+.. ++ ....+++++++++..|| .+|.+|
T Consensus 181 APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 259 (444)
T 3soa_A 181 SPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKR 259 (444)
T ss_dssp CHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTS
T ss_pred CHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHC
Confidence 99999988777 689999999999999999999999998888888876543 22 33578999999999999 799999
Q ss_pred CCHHHHhcCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKED 173 (347)
Q Consensus 159 ~~~~eil~~p~~~~~ 173 (347)
|++.++++|||+...
T Consensus 260 pta~e~L~hp~~~~~ 274 (444)
T 3soa_A 260 ITAAEALKHPWISHR 274 (444)
T ss_dssp CCHHHHHHSCTTHHH
T ss_pred CCHHHHhcCccccCC
Confidence 999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=247.01 Aligned_cols=163 Identities=26% Similarity=0.530 Sum_probs=133.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... .......||+.|+|||
T Consensus 97 ~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~t~~y~aPE 171 (292)
T 3o0g_A 97 DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-----RCYSAEVVTLWYRPPD 171 (292)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-----SCCCSCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-----ccccCCccccCCcChH
Confidence 36778999999999999999999999999999999999999999999999998654321 1223457899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHHhccCCCC----------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELLKQVQKRVVFPE---------------------------- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~---------------------------- 136 (347)
++.+....+.++|+||+||++|+|++|..| |.+.+..+.+..+.+....+.
T Consensus 172 ~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (292)
T 3o0g_A 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred HHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhc
Confidence 998776444789999999999999988877 566666666666644221111
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
.+.+++.+++++++|| .+|.+||+++|+++||||.+.
T Consensus 252 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1347889999999999 799999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=261.26 Aligned_cols=165 Identities=32% Similarity=0.527 Sum_probs=138.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........ .....+||+.|+|||+
T Consensus 172 l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~----~~~~~~GT~~Y~APE~ 247 (437)
T 4aw2_A 172 LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----QSSVAVGTPDYISPEI 247 (437)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE----ECCSCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc----ccccccCCcCeeChHH
Confidence 667899999999999999999999999999999999999999999999999766432221 1234689999999999
Q ss_pred cc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---ccCCCCC-CCCCHHHHHHHHhcc-CCCC
Q psy10462 87 LK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPES-PRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 87 ~~-----~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~-~~~s~~~~~li~~~l-~~~~ 156 (347)
+. +..++ .++||||+||++|+|++|+.||.+.+..+....+.. ...+|.. ..+++++++|+++|| .++.
T Consensus 248 l~~~~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~ 326 (437)
T 4aw2_A 248 LQAMEGGKGRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH 326 (437)
T ss_dssp HHHHHTSCCEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGG
T ss_pred HhhcccCCCCCC-CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhccccc
Confidence 87 33454 689999999999999999999999998888877754 2344433 468999999999999 4555
Q ss_pred C--CCCHHHHhcCCCCCCCCCC
Q psy10462 157 F--RIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 157 ~--R~~~~eil~~p~~~~~~~~ 176 (347)
+ |++++++++||||+...+.
T Consensus 327 r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 327 RLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp CTTTTTTHHHHTSGGGTTCCTT
T ss_pred ccCCCCHHHHhCCCccCCCCHH
Confidence 5 8999999999999887654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=253.73 Aligned_cols=160 Identities=28% Similarity=0.516 Sum_probs=140.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....+||+.|+|||
T Consensus 137 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--------~~~~~gt~~y~aPE 208 (350)
T 1rdq_E 137 RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--------TWTLCGTPEALAPE 208 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--------BCCCEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--------cccccCCccccCHH
Confidence 3577899999999999999999999999999999999999999999999999865321 23567999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ---- 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~---- 160 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+..+. .+.+..+++++++++++|| .+|.+|++
T Consensus 209 ~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~ 286 (350)
T 1rdq_E 209 IILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKN 286 (350)
T ss_dssp HHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTT
T ss_pred HhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccC
Confidence 99988776 68999999999999999999999999888888887653 2344678999999999999 79999998
Q ss_pred -HHHHhcCCCCCCCCC
Q psy10462 161 -MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 -~~eil~~p~~~~~~~ 175 (347)
++++++||||....+
T Consensus 287 ~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 287 GVNDIKNHKWFATTDW 302 (350)
T ss_dssp TTHHHHTSGGGTTCCH
T ss_pred CHHHHHhCcCcCCCCH
Confidence 999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=247.73 Aligned_cols=160 Identities=32% Similarity=0.654 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......||+.|+|||+
T Consensus 134 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE~ 208 (298)
T 2zv2_A 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-----LLSNTVGTPAFMAPES 208 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-----EECCCCSCGGGCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc-----cccCCcCCccccChhh
Confidence 56799999999999999999999999999999999999999999999999987643221 1234579999999999
Q ss_pred ccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 87 LKGVPY--TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 87 ~~~~~~--~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
+.+... .+.++|+||+||++|+|++|+.||.+.+.......+... ..+|..+.+++++++++.+|| .+|.+||+++
T Consensus 209 ~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~ 288 (298)
T 2zv2_A 209 LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVP 288 (298)
T ss_dssp CCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHH
Confidence 987542 246789999999999999999999998877776666543 345556789999999999999 7999999999
Q ss_pred HHhcCCCCC
Q psy10462 163 DIRQDPWLK 171 (347)
Q Consensus 163 eil~~p~~~ 171 (347)
++++|||+.
T Consensus 289 e~l~hp~~~ 297 (298)
T 2zv2_A 289 EIKLHPWVT 297 (298)
T ss_dssp HHTTCHHHH
T ss_pred HHhcCcccc
Confidence 999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-33 Score=264.93 Aligned_cols=135 Identities=18% Similarity=0.254 Sum_probs=120.6
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee------CC
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------TH 264 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~ 264 (347)
++|++.+.||+|+||+||+|+++.||+.||||++++..... ...+.+.+|+++|+.|+|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 57999999999999999999999999999999997654332 334567799999999999999999998764 36
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|||||||+ |+|.++|.+.+.+++..++.++.|++ ||.|+|++|||||||||+|||++.++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~ 195 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC 195 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC
Confidence 7999999996 68999999889999999999999877 99999999999999999999998776
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=249.54 Aligned_cols=165 Identities=26% Similarity=0.478 Sum_probs=135.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......||+.|+|||+
T Consensus 105 ~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~t~~y~aPE~ 179 (317)
T 2pmi_A 105 LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-----TFSSEVVTLWYRAPDV 179 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-----CCCCCCSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-----cCCCCcccccccCchH
Confidence 66788999999999999999999999999999999999999999999999986543211 1234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------------------------- 135 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------------------------- 135 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+....+.+....+
T Consensus 180 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (317)
T 2pmi_A 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQ 259 (317)
T ss_dssp HTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHG
T ss_pred hhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhc
Confidence 9875433478999999999999999999999988877776664321111
Q ss_pred --CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 136 --ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 136 --~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
....+++++++++.+|| .+|.+||+++++++||||.+....
T Consensus 260 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 260 PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 11257889999999999 799999999999999999876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=247.01 Aligned_cols=162 Identities=28% Similarity=0.471 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......||+.|+|||+
T Consensus 97 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~t~~y~aPE~ 171 (288)
T 1ob3_A 97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-----KYTHEIVTLWYRAPDV 171 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------------CCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-----ccccccccccccCchh
Confidence 56789999999999999999999999999999999999999999999999876532111 1223468999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----------------------------CCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----------------------------ESP 138 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------------------------~~~ 138 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+....+.+....+ ...
T Consensus 172 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
T 1ob3_A 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLK 251 (288)
T ss_dssp HTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCC
T ss_pred eeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhh
Confidence 9875534478999999999999999999999988776666554321110 013
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
.+++++++++++|| .+|.+||+++++++||||++.
T Consensus 252 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 252 GLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp SCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred hcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 47889999999999 799999999999999999763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-32 Score=248.79 Aligned_cols=165 Identities=36% Similarity=0.646 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+||+.|+|||+
T Consensus 102 ~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~ 178 (323)
T 3tki_A 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---ERLLNKMCGTLPYVAPEL 178 (323)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---ECCBCSCCSCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc---ccccCCCccCcCccCcHH
Confidence 56789999999999999999999999999999999999999999999999976543221 122335679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHH-HhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQV-QKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i-~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..+.+.++|+||+||++|+|++|+.||.+.+.. ...... ......+....+++.+.+++.+|| .+|.+||+++|
T Consensus 179 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 258 (323)
T 3tki_A 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 258 (323)
T ss_dssp HHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 988776556899999999999999999999875542 222333 333334445678999999999999 79999999999
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
+++|||+....
T Consensus 259 il~h~~~~~~~ 269 (323)
T 3tki_A 259 IKKDRWYNKPL 269 (323)
T ss_dssp HTTCTTTTCCC
T ss_pred HhhChhhcccc
Confidence 99999998654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-32 Score=255.10 Aligned_cols=165 Identities=27% Similarity=0.381 Sum_probs=136.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc-CCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...... ......||+.|+||
T Consensus 137 ~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~------~~~~~~~t~~y~aP 210 (394)
T 4e7w_A 137 TMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE------PNVSYICSRYYRAP 210 (394)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC------CCCSSCSCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC------CCcccccCcCccCH
Confidence 356788999999999999999999999999999999999 78999999999998764321 12345789999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----------------------------C
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----------------------------E 136 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------------------------~ 136 (347)
|++.+....+.++||||+||++|+|++|+.||.+.+..+.+..+.+....| .
T Consensus 211 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (394)
T 4e7w_A 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF 290 (394)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHS
T ss_pred HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhc
Confidence 999876544478999999999999999999999988776666554422111 1
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
++..++++++|+.+|| .+|..||++.++++||||.+....
T Consensus 291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred cccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 2347889999999999 799999999999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=258.03 Aligned_cols=167 Identities=30% Similarity=0.476 Sum_probs=138.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.++++.++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++........ .....+||+.|+|||
T Consensus 158 ~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~----~~~~~~Gt~~Y~APE 233 (412)
T 2vd5_A 158 RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV----RSLVAVGTPDYLSPE 233 (412)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE----ECSSCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc----ccceeccccCcCCHH
Confidence 3667899999999999999999999999999999999999999999999999876432211 123468999999999
Q ss_pred cccC-------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc---cCCCC-CCCCCHHHHHHHHhccCC
Q psy10462 86 ILKG-------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR---VVFPE-SPRLSSSCKALISNILSP 154 (347)
Q Consensus 86 ~~~~-------~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~-~~~~s~~~~~li~~~l~~ 154 (347)
++.+ ..++ .++|+||+||++|+|++|+.||.+.+..+....+... ..+|. ...+|+++++++++||.+
T Consensus 234 ~l~~~~~~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~ 312 (412)
T 2vd5_A 234 ILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCP 312 (412)
T ss_dssp HHHHHHTCTTCSEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSC
T ss_pred HHhhcccCcCCCCCC-hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCC
Confidence 9873 3454 6899999999999999999999999888887777542 33343 357899999999999988
Q ss_pred CCCC---CCHHHHhcCCCCCCCCCCC
Q psy10462 155 VKFR---IQMEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 155 ~~~R---~~~~eil~~p~~~~~~~~~ 177 (347)
|..| ++++++++||||+...+..
T Consensus 313 p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 313 PETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp GGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred hhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 8777 5999999999999876654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=254.01 Aligned_cols=162 Identities=30% Similarity=0.586 Sum_probs=140.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......+||+.|+|||+
T Consensus 136 ~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-----~~~~~~~~gt~~y~aPE~ 210 (373)
T 2r5t_A 136 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-----NSTTSTFCGTPEYLAPEV 210 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-----CCCCCSBSCCCCCCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-----CCccccccCCccccCHHH
Confidence 667899999999999999999999999999999999999999999999999754321 112346789999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH----
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM---- 161 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~---- 161 (347)
+.+..++ .++|+||+||++|+|++|..||.+.+..+....+.... ...++.++..+++++++|| .+|.+|++.
T Consensus 211 ~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 211 LHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp HTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred hCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 9988776 68999999999999999999999999888888876653 2334678999999999999 699999986
Q ss_pred HHHhcCCCCCCCCC
Q psy10462 162 EDIRQDPWLKEDSN 175 (347)
Q Consensus 162 ~eil~~p~~~~~~~ 175 (347)
+++++||||+...+
T Consensus 289 ~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 289 MEIKSHVFFSLINW 302 (373)
T ss_dssp HHHHTSGGGTTCCH
T ss_pred HHHhCCccccCCCH
Confidence 69999999987653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=257.55 Aligned_cols=169 Identities=25% Similarity=0.430 Sum_probs=127.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----cCCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|......... .......+||+.|+
T Consensus 125 l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~ 202 (405)
T 3rgf_A 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LADLDPVVVTFWYR 202 (405)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC------------------CCCTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcc--cccCCCceecCccc
Confidence 6788999999999999999999999999999999999 67789999999999865432111 11223567999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---------HHHHHHHHhccCCCCCC---------------
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---------SELLKQVQKRVVFPESP--------------- 138 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~--------------- 138 (347)
|||++.+....+.++||||+||++|+|++|+.||.+.+. .+.+..+......|...
T Consensus 203 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 282 (405)
T 3rgf_A 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLM 282 (405)
T ss_dssp CHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHH
T ss_pred CchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhh
Confidence 999998865444789999999999999999999976543 23444443333222211
Q ss_pred ----------------------CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy10462 139 ----------------------RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 139 ----------------------~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~~ 177 (347)
..++.+.+|+++|| .+|.+|||++|+++||||.+...+.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 283 KDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred hhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence 12678899999999 7999999999999999998866543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=248.54 Aligned_cols=165 Identities=30% Similarity=0.532 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......||+.|+|||+
T Consensus 97 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~t~~y~aPE~ 171 (324)
T 3mtl_A 97 INMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-----TYDNEVVTLWYRPPDI 171 (324)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----------------CGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-----ccccccCcccccChhh
Confidence 56788999999999999999999999999999999999999999999999875532211 1234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-----------------------------C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-----------------------------S 137 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-----------------------------~ 137 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+....+.+....|. .
T Consensus 172 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (324)
T 3mtl_A 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHA 251 (324)
T ss_dssp HTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHC
T ss_pred hcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhc
Confidence 98754444789999999999999999999999988877777655332221 1
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
+.+++++++++++|| .+|.+||+++|+++||||......
T Consensus 252 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 252 PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred CCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 346889999999999 799999999999999999875543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-32 Score=249.89 Aligned_cols=170 Identities=22% Similarity=0.342 Sum_probs=138.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ........||+.|+|||
T Consensus 120 ~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE 198 (351)
T 3mi9_A 120 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ-PNRYTNRVVTLWYRPPE 198 (351)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSS-CCCCCSSCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccccc-ccccCCcccccCccCch
Confidence 46789999999999999999999999999999999999999999999999998764322111 12223457899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC---C-----------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP---R----------------------- 139 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---~----------------------- 139 (347)
++.+....+.++||||+||++|+|++|+.||.+.+..+....+......+.+. .
T Consensus 199 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (351)
T 3mi9_A 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 278 (351)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHH
T ss_pred hhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHH
Confidence 99875544478999999999999999999999988877777665432211111 1
Q ss_pred -----CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 140 -----LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 140 -----~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.++.+++++.+|| .+|.+||+++++++||||.....+
T Consensus 279 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 279 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp HHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 2677999999999 799999999999999999876554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=251.93 Aligned_cols=163 Identities=21% Similarity=0.422 Sum_probs=140.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC--CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
.+++.++..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....... ......||+.|+|
T Consensus 98 ~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~a 171 (321)
T 1tki_A 98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD------NFRLLFTAPEYYA 171 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC------EEEEEESCGGGSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC------ccccccCChhhcC
Confidence 4678999999999999999999999999999999999987 7899999999998764321 1234578999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---CCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||++.+..++ .++|+||+||++|+|++|..||.+.+..+....+........ .+.++++++++++.|| .+|..||
T Consensus 172 PE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp 250 (321)
T 1tki_A 172 PEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM 250 (321)
T ss_dssp HHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred cHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCc
Confidence 9999887665 689999999999999999999999988888888766543222 2478999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDSN 175 (347)
Q Consensus 160 ~~~eil~~p~~~~~~~ 175 (347)
+++++++|||+.+...
T Consensus 251 t~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 251 TASEALQHPWLKQKIE 266 (321)
T ss_dssp CHHHHHHSHHHHSCGG
T ss_pred CHHHHhcChhhccCcc
Confidence 9999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.7e-32 Score=258.58 Aligned_cols=169 Identities=21% Similarity=0.361 Sum_probs=124.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc-------------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY------------------- 67 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~------------------- 67 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 153 l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (458)
T 3rp9_A 153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232 (458)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccc
Confidence 6779999999999999999999999999999999999999999999999998654221100
Q ss_pred ---cccCcccccCCccccccccccC-CCCCCChhhHHHHHHHHHHHHc-----------CCCCCCCCCH-----------
Q psy10462 68 ---KQNLSETFCGSYAYASPEILKG-VPYTPQQSDIWSMGVVLFAMVY-----------GRLPFDDTNY----------- 121 (347)
Q Consensus 68 ---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Dvws~G~~l~~ll~-----------g~~pf~~~~~----------- 121 (347)
........+||+.|+|||++.. ..++ .++||||+||++|+|++ |+.+|.+.+.
T Consensus 233 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~ 311 (458)
T 3rp9_A 233 TKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGN 311 (458)
T ss_dssp ------------CCCTTCCHHHHTTCCCCC-THHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---------------
T ss_pred cccccccccCCcccccccChHHhhCCCCCC-cHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccc
Confidence 0012235678999999998754 4454 78999999999999998 7777766431
Q ss_pred ---------HHHHHHHHhccCCC------------------------------CCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 122 ---------SELLKQVQKRVVFP------------------------------ESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 122 ---------~~~~~~i~~~~~~~------------------------------~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
.+.+..+.+....| ..+..++++.+|+++|| .+|.+|+++
T Consensus 312 ~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~ 391 (458)
T 3rp9_A 312 DFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITI 391 (458)
T ss_dssp -----CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred cccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCH
Confidence 12222221111111 12346899999999999 799999999
Q ss_pred HHHhcCCCCCCCCCC
Q psy10462 162 EDIRQDPWLKEDSNP 176 (347)
Q Consensus 162 ~eil~~p~~~~~~~~ 176 (347)
+|+++||||.....+
T Consensus 392 ~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 392 NECLAHPFFKEVRIA 406 (458)
T ss_dssp HHHHHSGGGTTTCCG
T ss_pred HHHhcCHhhhhcCCC
Confidence 999999999886543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.5e-32 Score=249.75 Aligned_cols=162 Identities=30% Similarity=0.580 Sum_probs=134.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||
T Consensus 106 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE 180 (345)
T 3a8x_A 106 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-----DTTSTFCGTPNYIAPE 180 (345)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-----CCBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-----CcccccCCCccccCcc
Confidence 36678999999999999999999999999999999999999999999999997532211 1234568999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---------NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~ 155 (347)
++.+..++ .++|+||+||++|+|++|+.||... ........+... ....+..+++++++++++|| .+|
T Consensus 181 ~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP 258 (345)
T 3a8x_A 181 ILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSLSVKAASVLKSFLNKDP 258 (345)
T ss_dssp HHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSST
T ss_pred ccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhcCCH
Confidence 99988776 6899999999999999999999752 233344444433 22344678999999999999 799
Q ss_pred CCCCCH------HHHhcCCCCCCCC
Q psy10462 156 KFRIQM------EDIRQDPWLKEDS 174 (347)
Q Consensus 156 ~~R~~~------~eil~~p~~~~~~ 174 (347)
.+|+++ +++++||||....
T Consensus 259 ~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 259 KERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp TTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred hHCCCCCCcCCHHHHhcCCccCCCC
Confidence 999985 8999999998765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-32 Score=270.34 Aligned_cols=163 Identities=25% Similarity=0.511 Sum_probs=142.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ......+||+.|+|||
T Consensus 438 ~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-----~~~~~~~GT~~Y~APE 512 (674)
T 3pfq_A 438 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-----VTTKTFCGTPDYIAPE 512 (674)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-----CCBCCCCSCSSSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-----cccccccCCCcccCHh
Confidence 36778999999999999999999999999999999999999999999999998643221 1234678999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH---
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM--- 161 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~--- 161 (347)
++.+..++ .++|+|||||++|+|++|+.||.+.+..++...+.... ...+..+++++++|++.|| .+|.+|+++
T Consensus 513 ~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 590 (674)
T 3pfq_A 513 IIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPE 590 (674)
T ss_dssp HHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTT
T ss_pred hhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCC
Confidence 99988887 68999999999999999999999999988888887653 2334679999999999999 799999997
Q ss_pred --HHHhcCCCCCCCCC
Q psy10462 162 --EDIRQDPWLKEDSN 175 (347)
Q Consensus 162 --~eil~~p~~~~~~~ 175 (347)
+++++||||+...+
T Consensus 591 ~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 591 GERDIKEHAFFRYIDW 606 (674)
T ss_dssp HHHHHHSSGGGSSCCH
T ss_pred cHHHHhcCccccCCCH
Confidence 99999999988654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-32 Score=251.44 Aligned_cols=168 Identities=27% Similarity=0.471 Sum_probs=136.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......+||+.|+|||+
T Consensus 125 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~ 202 (364)
T 3qyz_A 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH--TGFLTEYVATRWYRAPEI 202 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB--CCTTCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc--cccccccccccCCCCCHH
Confidence 567899999999999999999999999999999999999999999999999866432211 112235679999999998
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------------------------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------------------------ 136 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+.+..+......|.
T Consensus 203 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (364)
T 3qyz_A 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL 282 (364)
T ss_dssp HHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred hcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHh
Confidence 76554334789999999999999999999998877666655543221111
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+.+++++.+++.+|| .+|.+||+++++++|||+.+...+
T Consensus 283 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 283 FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 1457889999999999 799999999999999999876443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=246.48 Aligned_cols=161 Identities=29% Similarity=0.531 Sum_probs=137.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC----cEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....... .....+||+.|+
T Consensus 111 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~ 184 (326)
T 2y0a_A 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN------EFKNIFGTPEFV 184 (326)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS------CCCCCCSCTTTC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC------ccccccCCcCcC
Confidence 67799999999999999999999999999999999998877 79999999998764321 123457999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCC--CCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPE--SPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~--~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||++.+..++ .++|+||+||++|+|++|..||.+.+..+....+..... ++. ....++.+++++++|| .+|..|
T Consensus 185 aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 263 (326)
T 2y0a_A 185 APEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263 (326)
T ss_dssp CHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhC
Confidence 99999887776 689999999999999999999999888887777765432 221 2467899999999999 799999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
|+++++++|||+....
T Consensus 264 pt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 264 MTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CCHHHHHHSTTTSCCS
T ss_pred CCHHHHhcCCCccCCc
Confidence 9999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=258.12 Aligned_cols=159 Identities=23% Similarity=0.377 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc--EEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... .....+||+.|+||
T Consensus 197 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~--------~~~~~~gt~~y~aP 268 (429)
T 3kvw_A 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--------RVYTYIQSRFYRAP 268 (429)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC--------CCCSSCSCGGGCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC--------cccccCCCCCccCh
Confidence 677899999999999999999999999999999999999887 99999999965432 12345789999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC----------------------------
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---------------------------- 136 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------- 136 (347)
|++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+.+....|.
T Consensus 269 E~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (429)
T 3kvw_A 269 EVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTL 347 (429)
T ss_dssp HHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECC
T ss_pred HHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccc
Confidence 999988876 689999999999999999999999888777666544322111
Q ss_pred ------------------------------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 137 ------------------------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 137 ------------------------------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
....++.+.+|+++|| .+|.+|||++|+++|||+++..
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp CC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred ccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 0123678999999999 7999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=258.95 Aligned_cols=161 Identities=39% Similarity=0.724 Sum_probs=141.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||+
T Consensus 113 l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~ 186 (476)
T 2y94_A 113 LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG------EFLRTSCGSPNYAAPEV 186 (476)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT------CCBCCCCSCSTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc------ccccccCCCcCeEChhh
Confidence 577999999999999999999999999999999999999999999999999875432 12335689999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..+.+.++|+||+||++|+|++|+.||.+.+..+....+..+.. ..+..+++++++++++|| .+|.+||++++++
T Consensus 187 ~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil 265 (476)
T 2y94_A 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIR 265 (476)
T ss_dssp HTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 99887766789999999999999999999999888888888776643 445678999999999999 7999999999999
Q ss_pred cCCCCCCCC
Q psy10462 166 QDPWLKEDS 174 (347)
Q Consensus 166 ~~p~~~~~~ 174 (347)
+|||+....
T Consensus 266 ~hp~~~~~~ 274 (476)
T 2y94_A 266 EHEWFKQDL 274 (476)
T ss_dssp TCHHHHTTC
T ss_pred hCHHhhhcC
Confidence 999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=251.65 Aligned_cols=160 Identities=34% Similarity=0.643 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC---cEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ......+||+.|+|
T Consensus 125 ~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~------~~~~~~~gt~~y~a 198 (362)
T 2bdw_A 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS------EAWHGFAGTPGYLS 198 (362)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC------CSCCCSCSCTTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC------cccccCCCCccccC
Confidence 67899999999999999999999999999999999998654 5999999999765422 11234679999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCC--CCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPE--SPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~--~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||++.+..++ .++|+||+||++|+|++|..||.+.+..+....+..+.. +|. ...+++++++++.+|| .+|.+||
T Consensus 199 PE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 277 (362)
T 2bdw_A 199 PEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 277 (362)
T ss_dssp HHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCc
Confidence 9999987776 689999999999999999999999988888888766532 332 2468999999999999 7999999
Q ss_pred CHHHHhcCCCCCCC
Q psy10462 160 QMEDIRQDPWLKED 173 (347)
Q Consensus 160 ~~~eil~~p~~~~~ 173 (347)
+++++++|||+...
T Consensus 278 t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 278 TADQALKVPWICNR 291 (362)
T ss_dssp CHHHHTTSHHHHTH
T ss_pred CHHHHhcCcccCCC
Confidence 99999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=246.02 Aligned_cols=161 Identities=25% Similarity=0.556 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||+
T Consensus 118 ~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 192 (327)
T 3a62_A 118 FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-----TVTHTFCGTIEYMAPEI 192 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---------------CTTSSCCTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC-----ccccccCCCcCccCHhh
Confidence 5678899999999999999999999999999999999999999999999987543221 12235679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... .+.++.+++++++++.+|| .+|..|| +
T Consensus 193 ~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~ 270 (327)
T 3a62_A 193 LMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGD 270 (327)
T ss_dssp HTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTT
T ss_pred CcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCC
Confidence 9887776 68999999999999999999999998888877776543 2345678999999999999 7999999 8
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++||||+...
T Consensus 271 ~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 271 AGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHHHSGGGSSCC
T ss_pred HHHHHcCCcccCCC
Confidence 89999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=250.34 Aligned_cols=164 Identities=27% Similarity=0.505 Sum_probs=139.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC--CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
.+++.++..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++....... .....+||+.|+|
T Consensus 145 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~------~~~~~~gt~~y~a 218 (387)
T 1kob_A 145 KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE------IVKVTTATAEFAA 218 (387)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS------CEEEECSSGGGCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc------ceeeeccCCCccC
Confidence 4678999999999999999999999999999999999974 4679999999998764321 1234579999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CC--CCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FP--ESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~--~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||++.+..++ .++|+||+||++|+|++|..||.+.+..+....+..... ++ ....++++++++++.|| .+|..||
T Consensus 219 PE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 297 (387)
T 1kob_A 219 PEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 297 (387)
T ss_dssp HHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred chhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCc
Confidence 9999987776 689999999999999999999999888887777765432 22 23468999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 160 ~~~eil~~p~~~~~~~~ 176 (347)
+++++++|||+......
T Consensus 298 t~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 298 TVHDALEHPWLKGDHSN 314 (387)
T ss_dssp CHHHHHTSTTTSSCCTT
T ss_pred CHHHHhhCccccCCccc
Confidence 99999999999876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=250.53 Aligned_cols=160 Identities=24% Similarity=0.458 Sum_probs=134.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... ....+||+.|+|||+
T Consensus 125 l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~~y~aPE~ 196 (367)
T 1cm8_A 125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--------MTGYVVTRWYRAPEV 196 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--------CCSSCSCGGGCCTHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc--------cCcCcCCCCcCCHHH
Confidence 567889999999999999999999999999999999999999999999999865321 234578999999999
Q ss_pred ccC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC------------------------------
Q psy10462 87 LKG-VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------------------------ 135 (347)
Q Consensus 87 ~~~-~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------------------------ 135 (347)
+.+ ..++ .++|+||+||++|+|++|+.||.+.+..+.+..+.+....|
T Consensus 197 ~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (367)
T 1cm8_A 197 ILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 275 (367)
T ss_dssp HHTTTCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG
T ss_pred HhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHH
Confidence 987 4444 78999999999999999999999988777666554322111
Q ss_pred CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 136 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 136 ~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
..+..++.+.+|+++|| .+|.+||+++++++||||.....
T Consensus 276 ~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 276 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 12356899999999999 79999999999999999987554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=244.35 Aligned_cols=163 Identities=25% Similarity=0.485 Sum_probs=139.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ......||+.|+|||
T Consensus 137 ~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE 211 (321)
T 2c30_A 137 RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-----KRKSLVGTPYWMAPE 211 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-----CBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-----ccccccCCccccCHh
Confidence 367799999999999999999999999999999999999999999999999977643211 123467999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+..++ .++|+||+|+++|+|++|+.||.+.+..+....+..... ......+++.+++++..|| .+|.+||+++
T Consensus 212 ~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 290 (321)
T 2c30_A 212 VISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQ 290 (321)
T ss_dssp HHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99887776 689999999999999999999999888877777765432 2233468899999999999 7999999999
Q ss_pred HHhcCCCCCCCC
Q psy10462 163 DIRQDPWLKEDS 174 (347)
Q Consensus 163 eil~~p~~~~~~ 174 (347)
++++|||+.+..
T Consensus 291 ell~hp~~~~~~ 302 (321)
T 2c30_A 291 ELLDHPFLLQTG 302 (321)
T ss_dssp HHHTSGGGGGCC
T ss_pred HHhcChhhccCC
Confidence 999999997654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=256.27 Aligned_cols=161 Identities=33% Similarity=0.606 Sum_probs=138.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++.+++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|....... ......+||+.|+|||
T Consensus 245 ~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE 319 (446)
T 4ejn_A 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-----ATMKTFCGTPEYLAPE 319 (446)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----------CCSSSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-----cccccccCCccccCHh
Confidence 5678999999999999999998 999999999999999999999999999997543221 1234568999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI----- 159 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~----- 159 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+.... .+.+..+++++++++.+|| .+|..||
T Consensus 320 ~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 397 (446)
T 4ejn_A 320 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 397 (446)
T ss_dssp HHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred hcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHcccCHHHhCCCCCC
Confidence 99888776 68999999999999999999999998888877776543 2334678999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ~~~eil~~p~~~~~~ 174 (347)
+++++++||||....
T Consensus 398 t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 398 DAKEIMQHRFFAGIV 412 (446)
T ss_dssp THHHHHTSGGGTTCC
T ss_pred CHHHHHhCccccCCC
Confidence 999999999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-32 Score=255.60 Aligned_cols=163 Identities=28% Similarity=0.421 Sum_probs=132.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC-CcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+.+.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...... .....+||+.|+|||
T Consensus 153 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~------~~~~~~~t~~y~aPE 226 (420)
T 1j1b_A 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE------PNVSYICSRYYRAPE 226 (420)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC------CCCSCCSCTTSCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC------CceeeeeCCCcCCHH
Confidence 5667899999999999999999999999999999999965 568999999998754321 123457899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc------------------CCCC----------C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV------------------VFPE----------S 137 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~------------------~~~~----------~ 137 (347)
++.+....+.++||||+||++|+|++|+.||.+.+..+.+..+.+.. .+|. +
T Consensus 227 ~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 306 (420)
T 1j1b_A 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 306 (420)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSC
T ss_pred HHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcC
Confidence 99875433478999999999999999999999988766555543321 1111 2
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
+..++++++|+++|| .+|.+|++++|+++||||.....
T Consensus 307 ~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 307 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred CCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 356899999999999 79999999999999999976543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=247.70 Aligned_cols=164 Identities=23% Similarity=0.409 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc-----CCCcEEEeccCCceecccCCccccccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-----DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~-----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y 81 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++........ .....+||+.|
T Consensus 129 ~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~t~~y 203 (329)
T 3gbz_A 129 VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-----QFTHEIITLWY 203 (329)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----------------CCTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc-----ccCCCcCCccc
Confidence 56789999999999999999999999999999999994 455699999999976542211 12345689999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC-----------------------
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP----------------------- 138 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------------------- 138 (347)
+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+......|...
T Consensus 204 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
T 3gbz_A 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTL 283 (329)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCH
T ss_pred cCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccH
Confidence 999999876544478999999999999999999999988877776665433322211
Q ss_pred ------CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 139 ------RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 139 ------~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.+++++++++++|| .+|.+||+++++++||||+....
T Consensus 284 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 284 KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp HHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 16789999999999 79999999999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=250.17 Aligned_cols=162 Identities=24% Similarity=0.404 Sum_probs=126.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....||+.|+|||+
T Consensus 129 l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~ 200 (367)
T 2fst_X 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--------MTGYVATRWYRAPEI 200 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------------------CCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--------CCCcCcCcCccChHH
Confidence 567899999999999999999999999999999999999999999999999764321 234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------------------------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------------------------ 136 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+.+..+.+....|.
T Consensus 201 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (367)
T 2fst_X 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 280 (367)
T ss_dssp HTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred HcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHH
Confidence 98743334789999999999999999999999887776666544222110
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+..++.+.+|+++|| .+|.+||+++++++|||+.+...+
T Consensus 281 ~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 281 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp TTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 1245788999999999 799999999999999999876544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=253.15 Aligned_cols=161 Identities=30% Similarity=0.587 Sum_probs=128.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...... .....+||+.|+|
T Consensus 158 l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~------~~~~~~gt~~y~a 231 (400)
T 1nxk_A 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN------SLTTPCYTPYYVA 231 (400)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------------CTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC------ccccCCCCCCccC
Confidence 678999999999999999999999999999999999997 7889999999998654211 1235678999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhc-cCCC--CCCCCCHHHHHHHHhcc-CCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE----LLKQVQKR-VVFP--ESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~----~~~~i~~~-~~~~--~~~~~s~~~~~li~~~l-~~~ 155 (347)
||++.+..++ .++|||||||++|+|++|+.||.+.+... ....+..+ ..++ ....+++++++|+++|| .+|
T Consensus 232 PE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 310 (400)
T 1nxk_A 232 PEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 310 (400)
T ss_dssp GGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSG
T ss_pred HhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCCh
Confidence 9999887777 68999999999999999999998654321 23333332 2233 33578999999999999 799
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~~~ 174 (347)
.+||+++++++|||+....
T Consensus 311 ~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 311 TQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp GGSCCHHHHHHSHHHHTTT
T ss_pred hHCcCHHHHhcCccccCCC
Confidence 9999999999999997654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=246.60 Aligned_cols=165 Identities=21% Similarity=0.347 Sum_probs=136.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ......+||+.|+|||+
T Consensus 109 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~t~~y~aPE~ 183 (346)
T 1ua2_A 109 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-----RAYTHQVVTRWYRAPEL 183 (346)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-----CCCCCSCCCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-----ccCCcccccccccCchH
Confidence 5668899999999999999999999999999999999999999999999997654321 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---------------------------CCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---------------------------SPR 139 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~ 139 (347)
+.+....+.++|+||+||++|+|++|..||.+.+..+.+..+......+. ...
T Consensus 184 ~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (346)
T 1ua2_A 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 263 (346)
T ss_dssp HTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred hhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhcc
Confidence 97655444789999999999999999999999888777776654322111 134
Q ss_pred CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 140 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 140 ~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.++++++++++|| .+|.+||+++|+++||||.....+
T Consensus 264 ~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 264 AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp CCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 5789999999999 799999999999999999876544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=252.89 Aligned_cols=170 Identities=21% Similarity=0.355 Sum_probs=124.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc-----------------cc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY-----------------KQ 69 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-----------------~~ 69 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......... ..
T Consensus 126 l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (432)
T 3n9x_A 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK 205 (432)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--------------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchh
Confidence 6789999999999999999999999999999999999999999999999998764321110 00
Q ss_pred cCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcC-----------CCCCCCCC-----------------H
Q psy10462 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-----------RLPFDDTN-----------------Y 121 (347)
Q Consensus 70 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g-----------~~pf~~~~-----------------~ 121 (347)
......+||++|+|||++......+.++||||+||++|+|++| ..+|.+.+ .
T Consensus 206 ~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~ 285 (432)
T 3n9x_A 206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSN 285 (432)
T ss_dssp -----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHH
T ss_pred ccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccch
Confidence 1234568999999999875444334789999999999999984 44444332 1
Q ss_pred HHHHHHHHhccCCC-----------------------C-------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCC
Q psy10462 122 SELLKQVQKRVVFP-----------------------E-------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWL 170 (347)
Q Consensus 122 ~~~~~~i~~~~~~~-----------------------~-------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~ 170 (347)
.+.+..+......| . .+.+++++.+|+++|| .+|.+||+++|+++||||
T Consensus 286 ~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 365 (432)
T 3n9x_A 286 RDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365 (432)
T ss_dssp HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence 11222221111111 0 1457999999999999 799999999999999999
Q ss_pred CCCCCC
Q psy10462 171 KEDSNP 176 (347)
Q Consensus 171 ~~~~~~ 176 (347)
.+...+
T Consensus 366 ~~~~~~ 371 (432)
T 3n9x_A 366 KDVRKK 371 (432)
T ss_dssp TTTCCT
T ss_pred hhccCc
Confidence 886554
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=248.13 Aligned_cols=162 Identities=23% Similarity=0.504 Sum_probs=134.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||
T Consensus 111 ~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~------~~~~~~~gt~~Y~aPE 184 (384)
T 4fr4_A 111 HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE------TQITTMAGTKPYMAPE 184 (384)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT------CCBCCCCSCGGGCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC------CceeccCCCccccCCe
Confidence 4678999999999999999999999999999999999999999999999999865432 1234578999999999
Q ss_pred cccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 86 ILKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 86 ~~~~---~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
++.+ ..++ .++|+||+||++|+|++|+.||... ...+....+.... .+.+..+++.+.++++.|| .+|..|
T Consensus 185 ~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R 262 (384)
T 4fr4_A 185 MFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-VTYPSAWSQEMVSLLKKLLEPNPDQR 262 (384)
T ss_dssp GTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred eeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-cCCCCcCCHHHHHHHHHHhcCCHhHh
Confidence 9974 2344 6799999999999999999999753 3344444444332 3445678999999999999 799999
Q ss_pred CC-HHHHhcCCCCCCCCC
Q psy10462 159 IQ-MEDIRQDPWLKEDSN 175 (347)
Q Consensus 159 ~~-~~eil~~p~~~~~~~ 175 (347)
++ ++++++||||....+
T Consensus 263 ~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 263 FSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp CCSHHHHHTSGGGTTCCH
T ss_pred cccHHHHHcChhhhcCCH
Confidence 98 999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-32 Score=250.45 Aligned_cols=161 Identities=32% Similarity=0.686 Sum_probs=124.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc--EEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+||
T Consensus 113 ~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aP 186 (361)
T 3uc3_A 113 FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH------SQPKSTVGTPAYIAP 186 (361)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------------CTTSCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc------CCCCCCcCCCCcCCh
Confidence 667999999999999999999999999999999999987765 999999998743221 112345799999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----SELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~----~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|++.+..+++.++|+||+||++|+|++|+.||.+.+. ......+.. ...+|....+++.+++++++|| .+|..|
T Consensus 187 E~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 266 (361)
T 3uc3_A 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATR 266 (361)
T ss_dssp HHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTS
T ss_pred hhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHC
Confidence 9998887775558999999999999999999987543 333444433 3445666678999999999999 799999
Q ss_pred CCHHHHhcCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKED 173 (347)
Q Consensus 159 ~~~~eil~~p~~~~~ 173 (347)
|+++++++||||...
T Consensus 267 ps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 267 ISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCHHHHHTSHHHHTT
T ss_pred cCHHHHHhCcchhcC
Confidence 999999999999654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=248.61 Aligned_cols=160 Identities=32% Similarity=0.589 Sum_probs=133.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc---EEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++........ .....+||+.|+|
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-----~~~~~~gt~~y~a 201 (351)
T 3c0i_A 127 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-----VAGGRVGTPHFMA 201 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC-----BCCCCCSCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe-----eecCCcCCcCccC
Confidence 678899999999999999999999999999999999986654 99999999987643221 1234579999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---CCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||++.+..++ .++|+||+||++|+|++|..||.+.+ .+....+..+..... ...+++++++++++|| .+|.+||
T Consensus 202 PE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 279 (351)
T 3c0i_A 202 PEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI 279 (351)
T ss_dssp HHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCc
Confidence 9999988776 68999999999999999999998754 455555544432211 2568999999999999 7999999
Q ss_pred CHHHHhcCCCCCCC
Q psy10462 160 QMEDIRQDPWLKED 173 (347)
Q Consensus 160 ~~~eil~~p~~~~~ 173 (347)
++.++++|||+...
T Consensus 280 s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 280 TVYEALNHPWLKER 293 (351)
T ss_dssp CHHHHHTSHHHHTH
T ss_pred CHHHHhcChhhcCC
Confidence 99999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=246.64 Aligned_cols=162 Identities=30% Similarity=0.584 Sum_probs=126.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... ......+||+.|+|
T Consensus 145 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~a 218 (349)
T 2w4o_A 145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ------VLMKTVCGTPGYCA 218 (349)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------------CGGGSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc------cccccccCCCCccC
Confidence 577999999999999999999999999999999999975 789999999999765321 11234679999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhccC-C--CCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE-LLKQVQKRVV-F--PESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~-~~~~i~~~~~-~--~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
||++.+..++ .++|+|||||++|+|++|..||.+....+ ....+..... + +....++.++++++++|| .+|.+|
T Consensus 219 PE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (349)
T 2w4o_A 219 PEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297 (349)
T ss_dssp HHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhC
Confidence 9999987776 68999999999999999999998765444 5555554332 2 223568999999999999 799999
Q ss_pred CCHHHHhcCCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~~ 175 (347)
|++.++++|||+.....
T Consensus 298 pt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 298 LTTFQALQHPWVTGKAA 314 (349)
T ss_dssp CCHHHHHHSTTTTSTTC
T ss_pred cCHHHHhcCcccCCCcc
Confidence 99999999999987553
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-33 Score=254.93 Aligned_cols=142 Identities=17% Similarity=0.275 Sum_probs=120.8
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhcccc-----cccchhheehhccCCchhhhhhchHHHHHHHhcCC-Ccchhhhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSAR-----HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFL 257 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~-----~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~ 257 (347)
..|+++.++|++.+.||+|+||+||+|.+.. +++.||+|+++.... ....+.+.+|+++|+++. |||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 4578899999999999999999999998754 346799999865432 233456779999999995 59999999
Q ss_pred eeeeeC-CeEEEEEEecCCCChHHHHHhC----------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCc
Q psy10462 258 QAIETT-HRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDL 319 (347)
Q Consensus 258 ~~~~~~-~~~~iv~E~~~~G~L~~~l~~~----------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~ 319 (347)
++|.++ +.+|||||||++|||.++|++. ..+++..+..++.|++ |+.|+|+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998664 6799999999999999999752 3589999999988876 999999999999999999
Q ss_pred cccccccc
Q psy10462 320 SCFQEQAT 327 (347)
Q Consensus 320 Nil~~~~~ 327 (347)
|||++.++
T Consensus 215 NILl~~~~ 222 (353)
T 4ase_A 215 NILLSEKN 222 (353)
T ss_dssp GEEECGGG
T ss_pred ceeeCCCC
Confidence 99998765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=249.86 Aligned_cols=161 Identities=25% Similarity=0.393 Sum_probs=134.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc-CCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|....... ......||+.|+|||
T Consensus 138 l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE 211 (383)
T 3eb0_A 138 IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE------PSVAYICSRFYRAPE 211 (383)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS------CCCCCCCCSSCCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC------CCcCcccCCCccCHH
Confidence 56788999999999999999999999999999999998 68899999999998664322 123456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----------------------------CC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----------------------------ES 137 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------------------------~~ 137 (347)
++.+....+.++|+||+||++|+|++|+.||.+.+..+.+..+.+....| .+
T Consensus 212 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (383)
T 3eb0_A 212 LMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291 (383)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred HhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence 99876534478999999999999999999999988777666664322111 13
Q ss_pred CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 138 PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 138 ~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
...++++++++++|| .+|.+||++.|+++||||.+.
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 347889999999999 799999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-31 Score=236.43 Aligned_cols=163 Identities=34% Similarity=0.638 Sum_probs=138.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc---EEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++. +||+|||++....... ......||+.|+|
T Consensus 102 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~y~a 175 (284)
T 3kk8_A 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE------AWHGFAGTPGYLS 175 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC------BCCCSCSCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc------cccCCCCCcCCcC
Confidence 567899999999999999999999999999999999986655 9999999997654321 1234578999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-C--CCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-F--PESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~--~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||.+.+..++ .++|+||+|+++|+|++|+.||.+.+..+....+..... . +....+++++++++..|| .+|..||
T Consensus 176 PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 254 (284)
T 3kk8_A 176 PEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 254 (284)
T ss_dssp HHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred chhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCC
Confidence 9999988776 689999999999999999999999988888877765432 2 233578999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 160 ~~~eil~~p~~~~~~~~ 176 (347)
+++++++|||+......
T Consensus 255 s~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 255 TADQALKVPWICNRERV 271 (284)
T ss_dssp CHHHHTTSHHHHSCCCG
T ss_pred CHHHHhcCccccCChhH
Confidence 99999999999876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=247.28 Aligned_cols=156 Identities=26% Similarity=0.396 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-------------------------CCcEEEeccCCceecc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-------------------------KYNIKLSDFGFARKYS 61 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-------------------------~~~~kl~Dfg~a~~~~ 61 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~ 213 (360)
T 3llt_A 134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecC
Confidence 667899999999999999999999999999999999975 7889999999997643
Q ss_pred cCCccccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-----
Q psy10462 62 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----- 136 (347)
Q Consensus 62 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----- 136 (347)
. ......||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+....+......++
T Consensus 214 ~--------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~ 284 (360)
T 3llt_A 214 D--------YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284 (360)
T ss_dssp S--------CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHH
T ss_pred C--------CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHh
Confidence 2 12345789999999999988877 689999999999999999999998887776666654322111
Q ss_pred ----------------------C------------------CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCC
Q psy10462 137 ----------------------S------------------PRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLK 171 (347)
Q Consensus 137 ----------------------~------------------~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~ 171 (347)
. ...++.+.+++.+|| .+|.+||+++|+++||||+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred hhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 0 012366779999999 7999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=250.09 Aligned_cols=160 Identities=29% Similarity=0.561 Sum_probs=133.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC----CcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK----YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.+++.++.||+.||.|||++||+||||||+|||+... +.+||+|||++....... ......+||+.|+
T Consensus 113 ~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~gt~~y~ 187 (342)
T 2qr7_A 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-----GLLMTPCYTANFV 187 (342)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-----CCBCCSSCCSSCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-----CceeccCCCcccc
Confidence 6789999999999999999999999999999999998543 359999999998764321 1223567999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHhccCC-C--CCCCCCHHHHHHHHhcc-CCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD---TNYSELLKQVQKRVVF-P--ESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~---~~~~~~~~~i~~~~~~-~--~~~~~s~~~~~li~~~l-~~~ 155 (347)
|||++.+..++ .++|+||+||++|+|++|..||.+ .+..++...+..+... + .+..+++++++++++|| .+|
T Consensus 188 aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 266 (342)
T 2qr7_A 188 APEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDP 266 (342)
T ss_dssp CHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSST
T ss_pred CHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCCh
Confidence 99999876666 689999999999999999999985 4556677777654332 2 23568999999999999 799
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~ 172 (347)
.+||++.++++|||+..
T Consensus 267 ~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 267 HQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCCHHHHTTSHHHHT
T ss_pred hHCcCHHHHhcCCeecC
Confidence 99999999999999965
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=246.29 Aligned_cols=162 Identities=27% Similarity=0.487 Sum_probs=131.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....||+.|+|||+
T Consensus 141 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--------~~~~~~t~~y~aPE~ 212 (371)
T 4exu_A 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--------MTGYVVTRWYRAPEV 212 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------------CTTCCCTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--------cCCcccCccccCHHH
Confidence 678999999999999999999999999999999999999999999999999754321 234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------------------------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------------------------ 136 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+.+..+.+....|.
T Consensus 213 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (371)
T 4exu_A 213 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL 292 (371)
T ss_dssp HSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHH
T ss_pred hcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHh
Confidence 98733334689999999999999999999999887776666543221110
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+..++.+++++++|| .+|.+||+++++++||||.....+
T Consensus 293 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 293 FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp STTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred ccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 2356899999999999 799999999999999999865443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=261.25 Aligned_cols=160 Identities=27% Similarity=0.494 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||+
T Consensus 283 l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~------~~~~~~GT~~Y~APEv 356 (576)
T 2acx_A 283 FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ------TIKGRVGTVGYMAPEV 356 (576)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC------CEECCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc------cccccCCCccccCHHH
Confidence 7789999999999999999999999999999999999999999999999998764321 1234589999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC--
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN----YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-- 159 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-- 159 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+ ..++...+... ....+..+++++++++++|| .+|.+|+
T Consensus 357 l~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~ 434 (576)
T 2acx_A 357 VKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYSERFSPQARSLCSQLLCKDPAERLGC 434 (576)
T ss_dssp HTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred HcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-cccCCccCCHHHHHHHHHhccCCHHHcCCC
Confidence 9987776 68999999999999999999998753 34444444433 22334678999999999999 6999999
Q ss_pred ---CHHHHhcCCCCCCCC
Q psy10462 160 ---QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ---~~~eil~~p~~~~~~ 174 (347)
+++++++||||+...
T Consensus 435 ~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 435 RGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp SSSHHHHHHTSGGGTTCC
T ss_pred CCCCHHHHHhChhhccCC
Confidence 789999999998764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=247.12 Aligned_cols=166 Identities=27% Similarity=0.388 Sum_probs=136.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--hCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCH--KKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH--~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+.+..++.++.|++.||.||| ++||+||||||+|||++. ++.+||+|||++....... ......||+.|+|
T Consensus 126 ~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~a 199 (360)
T 3e3p_A 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE------PNVAYICSRYYRA 199 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS------CCCSTTSCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC------CcccccCCcceeC
Confidence 456788999999999999999 999999999999999996 8999999999997654321 1234568999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----------------------------
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP---------------------------- 135 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------------------------- 135 (347)
||++.+....+.++||||+||++|+|++|+.||.+.+..+.+..+.+....|
T Consensus 200 PE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
T 3e3p_A 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNV 279 (360)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHH
T ss_pred HHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccc
Confidence 9999776544478999999999999999999999988877766665422211
Q ss_pred ---CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCCCC
Q psy10462 136 ---ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPVG 178 (347)
Q Consensus 136 ---~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~~~ 178 (347)
.....++++++++..|| .+|.+||++.++++||||.+...+..
T Consensus 280 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 280 FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp TTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred cchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 11225678999999999 79999999999999999988655443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=248.48 Aligned_cols=160 Identities=27% Similarity=0.473 Sum_probs=136.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE--cCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL--DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... .....+||+.|+||
T Consensus 184 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~------~~~~~~gt~~y~aP 257 (373)
T 2x4f_A 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE------KLKVNFGTPEFLAP 257 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC------BCCCCCSSCTTCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc------ccccccCCCcEeCh
Confidence 6678899999999999999999999999999999999 567889999999998764321 12345699999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CC--CCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FP--ESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~--~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
|++.+..++ .++|+|||||++|+|++|+.||.+.+..+.+..+..... ++ ....+++++++++.+|| .+|..||+
T Consensus 258 E~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps 336 (373)
T 2x4f_A 258 EVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS 336 (373)
T ss_dssp HHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred hhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCC
Confidence 999877665 689999999999999999999999988888777765432 22 12568999999999999 79999999
Q ss_pred HHHHhcCCCCCCC
Q psy10462 161 MEDIRQDPWLKED 173 (347)
Q Consensus 161 ~~eil~~p~~~~~ 173 (347)
++++++|||+.+.
T Consensus 337 ~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 337 ASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHSHHHHCH
T ss_pred HHHHhcCcCcCCC
Confidence 9999999998763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=241.58 Aligned_cols=162 Identities=25% Similarity=0.430 Sum_probs=135.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.+++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++....... .....+||+.|+|
T Consensus 128 ~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~------~~~~~~gt~~y~a 201 (327)
T 3lm5_A 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC------ELREIMGTPEYLA 201 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------------CCCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc------ccccccCCcCccC
Confidence 567899999999999999999999999999999999987 7899999999998654321 1234579999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-C--CCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-F--PESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~--~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||++.+..++ .++|+||+|+++|+|++|+.||.+.+..+....+..... + +....+++.+++++..|| .+|..||
T Consensus 202 PE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 280 (327)
T 3lm5_A 202 PEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280 (327)
T ss_dssp HHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc
Confidence 9999887776 689999999999999999999999888877776655332 2 223568999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDSN 175 (347)
Q Consensus 160 ~~~eil~~p~~~~~~~ 175 (347)
+++++++|||++....
T Consensus 281 t~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 281 TAEICLSHSWLQQWDF 296 (327)
T ss_dssp CHHHHTTCGGGCCCCT
T ss_pred CHHHHhCCHhhccccc
Confidence 9999999999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=240.26 Aligned_cols=164 Identities=26% Similarity=0.436 Sum_probs=129.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ......||+.|+|||.
T Consensus 99 ~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 173 (311)
T 4agu_A 99 VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-----YYDDEVATRWYRSPEL 173 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----------------GGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-----ccCCCcCCccccChHH
Confidence 56788999999999999999999999999999999999999999999999976543211 1234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------------CCCC----------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--------------------VFPE---------- 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------~~~~---------- 136 (347)
+.+....+.++|+||+|+++|+|++|+.||.+.+..+....+.+.. ..+.
T Consensus 174 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 4agu_A 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELK 253 (311)
T ss_dssp HHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHH
T ss_pred HhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhh
Confidence 9874433478999999999999999999999988766655543321 1111
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.+.+++++.++++.|| .+|.+||+++++++||||+....
T Consensus 254 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 254 FPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred cccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 1457889999999999 79999999999999999987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=252.66 Aligned_cols=160 Identities=24% Similarity=0.451 Sum_probs=124.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||+
T Consensus 124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~ 197 (371)
T 2xrw_A 124 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPEV 197 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------------CTTCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc------cccCCceecCCccCHHH
Confidence 567889999999999999999999999999999999999999999999999765321 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC--------------------C--------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES--------------------P-------- 138 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--------------------~-------- 138 (347)
+.+..++ .++|+||+||++|+|++|+.||.+.+..+.+..+.+....|.+ .
T Consensus 198 ~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 2xrw_A 198 ILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF 276 (371)
T ss_dssp HTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHS
T ss_pred hcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhc
Confidence 9988776 6899999999999999999999998877776666543322210 0
Q ss_pred -------------CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 139 -------------RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 139 -------------~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
..++++++|+++|| .+|.+||+++++++|||+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 277 PDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 01467899999999 799999999999999998753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=243.32 Aligned_cols=171 Identities=25% Similarity=0.419 Sum_probs=133.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcccc-----ccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK-----QNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-----~~~~~~~~gt~~y 81 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........... .......+||+.|
T Consensus 109 ~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 188 (353)
T 2b9h_A 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccc
Confidence 56789999999999999999999999999999999999999999999999987643211110 1112345789999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-------------------------C
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-------------------------E 136 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------------------------~ 136 (347)
+|||++.+....+.++|+||+||++|+|++|+.||.+.+..+.+..+......| .
T Consensus 189 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (353)
T 2b9h_A 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268 (353)
T ss_dssp CCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCC
T ss_pred cCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCC
Confidence 999988653333478999999999999999999999888766555443211111 0
Q ss_pred ------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy10462 137 ------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 137 ------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~~ 177 (347)
.+.+++++++++.+|| .+|.+||+++++++|||+.....+.
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred cchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 1367899999999999 7999999999999999998765543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=233.40 Aligned_cols=166 Identities=36% Similarity=0.639 Sum_probs=135.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ ........|++.|+|||.
T Consensus 102 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~ 178 (276)
T 2yex_A 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---ERLLNKMCGTLPYVAPEL 178 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---ECCBCCCCSCGGGCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc---hhcccCCccccCccChHH
Confidence 56789999999999999999999999999999999999999999999999976543221 112335678999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..+.+.++|+||+|+++|+|++|+.||...+.. .....+.. ....+....+++.+++++..|| .+|..||++++
T Consensus 179 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2yex_A 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 258 (276)
T ss_dssp GTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence 988766556899999999999999999999876532 22333332 3333444678999999999999 79999999999
Q ss_pred HhcCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSN 175 (347)
Q Consensus 164 il~~p~~~~~~~ 175 (347)
+++|||+.+...
T Consensus 259 il~~~~~~~~~~ 270 (276)
T 2yex_A 259 IKKDRWYNKPLK 270 (276)
T ss_dssp HTTCTTTTCCCC
T ss_pred HhcCccccChhh
Confidence 999999987643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=239.32 Aligned_cols=161 Identities=27% Similarity=0.494 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC----cEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... ......||+.|+
T Consensus 112 ~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~gt~~y~ 185 (321)
T 2a2a_A 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV------EFKNIFGTPEFV 185 (321)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC------CCCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc------cccccCCCCCcc
Confidence 46789999999999999999999999999999999999887 79999999997664321 123456899999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---CCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||++.+..++ .++|+||+|+++|+|++|..||.+.+..+....+.......+ ....++.++++++.|| .+|..|
T Consensus 186 aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 264 (321)
T 2a2a_A 186 APEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKR 264 (321)
T ss_dssp CHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTS
T ss_pred CcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhC
Confidence 99999887776 689999999999999999999999888888877766433221 1467899999999999 799999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
|+++++++|||+....
T Consensus 265 ps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 265 LTIQEALRHPWITPVD 280 (321)
T ss_dssp CCHHHHHHSTTTSCSS
T ss_pred cCHHHHhcCccccCCC
Confidence 9999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=242.17 Aligned_cols=155 Identities=23% Similarity=0.360 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......||+.|+|||+
T Consensus 154 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~ 227 (311)
T 3p1a_A 154 LPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG------AGEVQEGDPRYMAPEL 227 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------------CCCCCGGGCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC------CCcccCCCccccCHhH
Confidence 6778999999999999999999999999999999999999999999999987654321 1234569999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-CCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+ .++ .++||||+||++|+|++|..||.+.. ....+......+ .+..+++++++++..|| .+|.+||+++++
T Consensus 228 ~~~-~~~-~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 302 (311)
T 3p1a_A 228 LQG-SYG-TAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302 (311)
T ss_dssp GGT-CCS-THHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred hcC-CCC-chhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 987 455 68999999999999999977765532 233333332211 23568999999999999 799999999999
Q ss_pred hcCCCCCC
Q psy10462 165 RQDPWLKE 172 (347)
Q Consensus 165 l~~p~~~~ 172 (347)
++|||+++
T Consensus 303 l~hp~~~~ 310 (311)
T 3p1a_A 303 LALPVLRQ 310 (311)
T ss_dssp HTSGGGSC
T ss_pred HhCccccC
Confidence 99999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=245.03 Aligned_cols=163 Identities=35% Similarity=0.625 Sum_probs=116.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC---cEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ......+||+.|+|
T Consensus 103 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~t~~y~a 177 (325)
T 3kn6_A 103 FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-----QPLKTPCFTLHYAA 177 (325)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-----CcccccCCCcCccC
Confidence 67799999999999999999999999999999999997765 79999999997654321 11234578999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhccCCCCC---CCCCHHHHHHHHhcc-
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-------YSELLKQVQKRVVFPES---PRLSSSCKALISNIL- 152 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~---~~~s~~~~~li~~~l- 152 (347)
||++.+..++ .++|+||+||++|+|++|+.||.+.+ ..+....+..+...... ..++++++++++.||
T Consensus 178 PE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 256 (325)
T 3kn6_A 178 PELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLT 256 (325)
T ss_dssp ------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHC
T ss_pred HHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCC
Confidence 9999888776 68999999999999999999998643 34556666554322221 358999999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 153 SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 153 ~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.+|..||+++++++|||+.....
T Consensus 257 ~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 257 VDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp CCTTTCCCTTTSTTCGGGCTTCC
T ss_pred CChhHCCCHHHHhcChhhccCcc
Confidence 79999999999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=243.16 Aligned_cols=156 Identities=32% Similarity=0.599 Sum_probs=131.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....+||+.|+|||
T Consensus 126 ~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE 199 (335)
T 3dls_A 126 RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK------LFYTFCGTIEYCAPE 199 (335)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTC------CBCEECSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCC------ceeccCCCccccChh
Confidence 36778999999999999999999999999999999999999999999999998764321 123457999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
++.+..+.+.++||||+||++|+|++|+.||.+... .. ......+..++++++++++.|| .+|..||+++++
T Consensus 200 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~el 272 (335)
T 3dls_A 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV-EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKL 272 (335)
T ss_dssp HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT-TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH-hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999887755789999999999999999999976321 11 1123345568999999999999 799999999999
Q ss_pred hcCCCCCCCC
Q psy10462 165 RQDPWLKEDS 174 (347)
Q Consensus 165 l~~p~~~~~~ 174 (347)
++|||+.+..
T Consensus 273 l~hp~~~~~~ 282 (335)
T 3dls_A 273 VTDPWVTQPV 282 (335)
T ss_dssp HHCTTTTCCC
T ss_pred hcCccccCCc
Confidence 9999997744
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=237.50 Aligned_cols=161 Identities=30% Similarity=0.673 Sum_probs=136.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ......|++.|+|||
T Consensus 105 ~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-------~~~~~~~~~~y~aPE 177 (279)
T 3fdn_A 105 KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------RRTDLCGTLDYLPPE 177 (279)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---------------CCCCTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-------cccccCCCCCccCHh
Confidence 3567889999999999999999999999999999999999999999999988544321 123457899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
.+.+..++ .++|+||+|+++|+|++|..||.+.+..+....+.... .+.+...++.+++++..|| .+|..||+++++
T Consensus 178 ~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 255 (279)
T 3fdn_A 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREV 255 (279)
T ss_dssp HHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 99887766 67999999999999999999999998888777776543 3345678999999999999 799999999999
Q ss_pred hcCCCCCCCCC
Q psy10462 165 RQDPWLKEDSN 175 (347)
Q Consensus 165 l~~p~~~~~~~ 175 (347)
++|||+.....
T Consensus 256 l~h~~~~~~~~ 266 (279)
T 3fdn_A 256 LEHPWITANSS 266 (279)
T ss_dssp HHCHHHHHHCS
T ss_pred hhCccccCCcc
Confidence 99999986543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=248.68 Aligned_cols=158 Identities=29% Similarity=0.451 Sum_probs=129.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--hCCCeecCCCCCcEEEc--CCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCH--KKSVVHRDIKCENLLLD--DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH--~~~iiH~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.+++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|||++...... .....||+.|+
T Consensus 154 ~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~ 225 (382)
T 2vx3_A 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--------IYQYIQSRFYR 225 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--------CCSSCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc--------cccccCCcccc
Confidence 567899999999999999999 47999999999999994 4778999999999765321 23457899999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC-------------------------
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES------------------------- 137 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------- 137 (347)
|||++.+..++ .++||||+||++|+|++|+.||.+.+..+.+..+.+....|+.
T Consensus 226 aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (382)
T 2vx3_A 226 SPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKK 304 (382)
T ss_dssp CHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECC
T ss_pred ChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccccccccc
Confidence 99999988877 6899999999999999999999998887777666543221110
Q ss_pred ----------C---C-------------------------CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 138 ----------P---R-------------------------LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 138 ----------~---~-------------------------~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
+ . .++++++|+++|| .+|.+|||++++++||||++.
T Consensus 305 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 305 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred ccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 0 0 0137899999999 799999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=242.62 Aligned_cols=167 Identities=29% Similarity=0.490 Sum_probs=133.8
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC--cEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY--NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......... ........||+.|+|||
T Consensus 166 ~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE 244 (345)
T 3hko_A 166 REKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPE 244 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc-cccccccCCCccccCch
Confidence 4577889999999999999999999999999999998766 89999999998654322111 11123457999999999
Q ss_pred cccC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-C--CCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 86 ILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-P--ESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 86 ~~~~--~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~--~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
.+.+ ..++ .++|||||||++|+|++|+.||.+.+..+....+...... + ....+++.+++++.+|| .+|.+||
T Consensus 245 ~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 245 VLNTTNESYG-PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHTCSSSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred hhccCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 9975 3444 6899999999999999999999998888777777654332 2 22347999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 160 ~~~eil~~p~~~~~~~~ 176 (347)
++.++++|||+++....
T Consensus 324 s~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 324 DAMRALQHPWISQFSDK 340 (345)
T ss_dssp CHHHHHHSHHHHTTSSC
T ss_pred CHHHHhcChhhccChHh
Confidence 99999999999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=238.25 Aligned_cols=163 Identities=26% Similarity=0.406 Sum_probs=137.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......||+.|+|||+
T Consensus 117 ~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~ 190 (326)
T 1blx_A 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALTSVVVTLWYRAPEV 190 (326)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG------GGGCCCCCCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC------CCccccccccceeCHHH
Confidence 677899999999999999999999999999999999999999999999999765421 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------------------------CCCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--------------------------ESPRL 140 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------------------------~~~~~ 140 (347)
+.+..++ .++|+||+|+++|+|++|+.||.+.+..+....+......+ ....+
T Consensus 191 ~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 1blx_A 191 LLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 269 (326)
T ss_dssp HTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC
T ss_pred HhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccC
Confidence 9887766 68999999999999999999999988777766665322111 12457
Q ss_pred CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 141 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 141 s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
++.+++++.+|| .+|.+||++.++++|||+.+....
T Consensus 270 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 889999999999 799999999999999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=255.30 Aligned_cols=163 Identities=25% Similarity=0.493 Sum_probs=137.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||
T Consensus 285 ~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-----~~~~~~~GT~~Y~APE 359 (543)
T 3c4z_A 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-----TKTKGYAGTPGFMAPE 359 (543)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-----CCBCCCCSCTTTSCHH
T ss_pred cccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC-----cccccccCCccccChh
Confidence 37789999999999999999999999999999999999999999999999998764321 1123468999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT----NYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
++.+..++ .++|+||+||++|+|++|+.||.+. ...++...+.... ...+..+++.+++++++|| .+|.+||+
T Consensus 360 ~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~ 437 (543)
T 3c4z_A 360 LLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYPDKFSPASKDFCEALLQKDPEKRLG 437 (543)
T ss_dssp HHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-cCCCcccCHHHHHHHHHhccCCHhHCCC
Confidence 99988777 6899999999999999999999875 3455555554432 2334678999999999999 79999996
Q ss_pred -----HHHHhcCCCCCCCCC
Q psy10462 161 -----MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 -----~~eil~~p~~~~~~~ 175 (347)
++++++||||+...+
T Consensus 438 ~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 438 FRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp CBTTBSHHHHTSGGGTTCCH
T ss_pred CcccCHHHHHcCccccCCCH
Confidence 489999999997653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=247.61 Aligned_cols=168 Identities=19% Similarity=0.306 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc--cccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY--KQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~gt~~y~aP 84 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.......... ........+||+.|+||
T Consensus 125 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 204 (389)
T 3gni_B 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204 (389)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCH
Confidence 5678999999999999999999999999999999999999999999999986553322111 11122345789999999
Q ss_pred ccccC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc------------------------------
Q psy10462 85 EILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV------------------------------ 132 (347)
Q Consensus 85 E~~~~--~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~------------------------------ 132 (347)
|++.+ ..++ .++|+||+||++|+|++|+.||.+.+..+....+..+.
T Consensus 205 E~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (389)
T 3gni_B 205 EVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSD 283 (389)
T ss_dssp HHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------------------------
T ss_pred HHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccccc
Confidence 99987 4555 68999999999999999999998765443332221110
Q ss_pred ---------------CCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 133 ---------------VFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 133 ---------------~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
..+.+..+++.+++|+++|| .+|.+||+++++++||||++...
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 284 SLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp ----------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred ccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 01123457889999999999 79999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=248.65 Aligned_cols=165 Identities=23% Similarity=0.461 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......... ......+||+.|+|||+
T Consensus 152 ~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~ 227 (390)
T 2zmd_A 152 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS---VVKDSQVGAVNYMPPEA 227 (390)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------------CCSCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc---ccCCCCCcCCCccChHH
Confidence 46678999999999999999999999999999999996 588999999999866432211 11235679999999999
Q ss_pred ccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-
Q psy10462 87 LKGV-----------PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN-YSELLKQVQK-RVVFPESPRLSSSCKALISNIL- 152 (347)
Q Consensus 87 ~~~~-----------~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~-~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l- 152 (347)
+.+. .++ .++|||||||++|+|++|+.||.+.. ....+..+.. ....+.+...+.++++++..||
T Consensus 228 ~~~~~~~~~~~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 306 (390)
T 2zmd_A 228 IKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLK 306 (390)
T ss_dssp HHCC------------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTC
T ss_pred hhhccccccccccccCCC-ChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcc
Confidence 8752 343 68999999999999999999998753 3333444433 2333344556889999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 153 SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 153 ~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+|..||+++++++|||+.....+
T Consensus 307 ~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 307 RDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp SSTTTSCCHHHHHTSHHHHSCC--
T ss_pred cChhhCCCHHHHhhCcCccccCcc
Confidence 799999999999999999865543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=245.22 Aligned_cols=165 Identities=23% Similarity=0.456 Sum_probs=126.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ .......+||+.|+|||+
T Consensus 105 ~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~ 180 (343)
T 3dbq_A 105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT---SVVKDSQVGTVNYMPPEA 180 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---------------CCCCSSCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc---cccCCCCcCCcCcCCHHH
Confidence 56789999999999999999999999999999999997 57899999999976543221 112234579999999999
Q ss_pred ccC-----------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-
Q psy10462 87 LKG-----------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQK-RVVFPESPRLSSSCKALISNIL- 152 (347)
Q Consensus 87 ~~~-----------~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l- 152 (347)
+.+ ..++ .++||||+||++|+|++|+.||.+... ......+.. ......+...+..+.+++..||
T Consensus 181 ~~~~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 259 (343)
T 3dbq_A 181 IKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLK 259 (343)
T ss_dssp HHHCC-----------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTC
T ss_pred HhhccccccccccccCCC-chhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcC
Confidence 864 3343 689999999999999999999987432 233333332 3333344566789999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 153 SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 153 ~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+|..||++.++++|||+.....+
T Consensus 260 ~dp~~Rpt~~e~l~hp~~~~~~~~ 283 (343)
T 3dbq_A 260 RDPKQRISIPELLAHPYVQIQTHP 283 (343)
T ss_dssp SSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred CChhHCCCHHHHHhCccccccCCc
Confidence 799999999999999999875544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=241.82 Aligned_cols=161 Identities=26% Similarity=0.455 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....||+.|+|||.
T Consensus 123 ~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~t~~y~aPE~ 194 (353)
T 3coi_A 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--------MTGYVVTRWYRAPEV 194 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----------------CCSBCCSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--------ccccccCcCcCCHHH
Confidence 577999999999999999999999999999999999999999999999998754321 224568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC------------------------------CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF------------------------------PE 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~------------------------------~~ 136 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+.+..+.+.... ..
T Consensus 195 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (353)
T 3coi_A 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL 274 (353)
T ss_dssp HSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTT
T ss_pred HhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHh
Confidence 987333346899999999999999999999988876665555331110 11
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.+..++++++++.+|| .+|.+||+++++++||||.....
T Consensus 275 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 275 FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 2457899999999999 79999999999999999986544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=235.02 Aligned_cols=159 Identities=30% Similarity=0.579 Sum_probs=136.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---cCCCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....... ......||+.|+|
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~t~~y~a 176 (277)
T 3f3z_A 103 FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK------MMRTKVGTPYYVS 176 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS------CBCCCCSCTTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc------chhccCCCCCccC
Confidence 5678999999999999999999999999999999999 788899999999997654321 1234568999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCC---CCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPES---PRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||.+.+. ++ .++|+||+|+++|+|++|+.||.+.+..+....+..+....+. ..+++.+++++..|| .+|.+||
T Consensus 177 PE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 254 (277)
T 3f3z_A 177 PQVLEGL-YG-PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI 254 (277)
T ss_dssp HHHHTTC-BC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred hHHhccc-CC-chhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCc
Confidence 9998765 44 6799999999999999999999999888888877765433222 368999999999999 7999999
Q ss_pred CHHHHhcCCCCCCC
Q psy10462 160 QMEDIRQDPWLKED 173 (347)
Q Consensus 160 ~~~eil~~p~~~~~ 173 (347)
++.++++|||+.+.
T Consensus 255 s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 255 TSLQALEHEWFEKQ 268 (277)
T ss_dssp CHHHHTTSHHHHHH
T ss_pred CHHHHhcCHHHhcc
Confidence 99999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=241.76 Aligned_cols=159 Identities=20% Similarity=0.338 Sum_probs=134.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ....+||+.|+|||
T Consensus 150 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---------~~~~~gt~~y~aPE 220 (348)
T 1u5q_A 150 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---------ANSFVGTPYWMAPE 220 (348)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---------BCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---------CCcccCCcceeCHh
Confidence 356788999999999999999999999999999999999999999999999875432 12457999999999
Q ss_pred ccc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 86 ILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 86 ~~~---~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
++. +..++ .++|||||||++|+|++|+.||.+.+..+....+..... .......++.+++++..|| .+|..||+
T Consensus 221 ~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 299 (348)
T 1u5q_A 221 VILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 299 (348)
T ss_dssp HHHTTSSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhccccCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcC
Confidence 985 34455 689999999999999999999998887766666654432 2234568999999999999 79999999
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++|||+....
T Consensus 300 ~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 300 SEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHTTCHHHHSCC
T ss_pred HHHHhhChhhhccC
Confidence 99999999987644
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=242.42 Aligned_cols=160 Identities=33% Similarity=0.570 Sum_probs=135.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... .....+||+.|+|||
T Consensus 196 ~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~------~~~~~~gt~~y~aPE 269 (365)
T 2y7j_A 196 ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE------KLRELCGTPGYLAPE 269 (365)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC------CBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCc------ccccCCCCCCccChh
Confidence 35678899999999999999999999999999999999999999999999998764321 123467999999999
Q ss_pred cccCC------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC---CCCCCCHHHHHHHHhcc-CCC
Q psy10462 86 ILKGV------PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP---ESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 86 ~~~~~------~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~li~~~l-~~~ 155 (347)
++.+. .++ .++|+|||||++|+|++|+.||.+.+..+....+..+.... .+...++.+++++++|| .+|
T Consensus 270 ~~~~~~~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 348 (365)
T 2y7j_A 270 ILKCSMDETHPGYG-KEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDP 348 (365)
T ss_dssp HHHHTTCTTSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSST
T ss_pred hccccccccCcCCC-chhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCCh
Confidence 98632 344 67999999999999999999999988877777776543322 22568899999999999 799
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~ 172 (347)
.+||+++++++||||++
T Consensus 349 ~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 349 EARLTAEQALQHPFFER 365 (365)
T ss_dssp TTSCCHHHHHHSGGGCC
T ss_pred hHCcCHHHHhcCcccCC
Confidence 99999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=248.63 Aligned_cols=129 Identities=12% Similarity=0.172 Sum_probs=114.8
Q ss_pred hhhhhhhhhcccccchhhhhhccc---ccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCe
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSA---RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 265 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 265 (347)
.++|++.+.||+|+||+||+|+++ .+++.||+|.+.+... ...+.+|+++|+.+ +|||||+++++|++++.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 467999999999999999999864 4688899999865421 23456899999998 79999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
+|||||||+||+|.++++ .+++.+++.++.|++ |+.|+|++|||||||||+|||++.+
T Consensus 95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~ 153 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR 153 (361)
T ss_dssp EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT
T ss_pred EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC
Confidence 999999999999999984 599999999998876 9999999999999999999999765
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=235.19 Aligned_cols=168 Identities=29% Similarity=0.522 Sum_probs=140.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ........||+.|+|||
T Consensus 105 ~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE 181 (305)
T 2wtk_C 105 RFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA---DDTCRTSQGSPAFQPPE 181 (305)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS---SCEECCCCSCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcccc---ccccccCCCCCCCcChh
Confidence 367789999999999999999999999999999999999999999999999976542211 11123456899999999
Q ss_pred cccCCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPY-TPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~-~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
++.+... .+.++|+||+|+++|+|++|+.||.+.+..+....+.... .+.+...++.+.++++.|| .+|..||++++
T Consensus 182 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 260 (305)
T 2wtk_C 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQ 260 (305)
T ss_dssp HHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCHHHHHHHHHHccCChhhCCCHHH
Confidence 9986432 2368999999999999999999999988888877776653 3445678999999999999 79999999999
Q ss_pred HhcCCCCCCCCCCC
Q psy10462 164 IRQDPWLKEDSNPV 177 (347)
Q Consensus 164 il~~p~~~~~~~~~ 177 (347)
+++|||+.....+.
T Consensus 261 ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 261 IRQHSWFRKKHPPA 274 (305)
T ss_dssp HHHSHHHHSCCCC-
T ss_pred HhcCcccccCCCCc
Confidence 99999998765543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=234.13 Aligned_cols=160 Identities=32% Similarity=0.656 Sum_probs=137.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ......|++.|+|||.
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~y~aPE~ 183 (284)
T 2vgo_A 111 FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-------RRRTMCGTLDYLPPEM 183 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-------CBCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-------ccccccCCCCcCCHHH
Confidence 567899999999999999999999999999999999999999999999998654321 1234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||+|+++|+|++|..||...+..+....+.... .+.+..++..+++++..|| .+|.+||++++++
T Consensus 184 ~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 261 (284)
T 2vgo_A 184 IEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVM 261 (284)
T ss_dssp HTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHh
Confidence 9987776 67999999999999999999999888777776665532 2344678999999999999 7999999999999
Q ss_pred cCCCCCCCCC
Q psy10462 166 QDPWLKEDSN 175 (347)
Q Consensus 166 ~~p~~~~~~~ 175 (347)
+|||+.....
T Consensus 262 ~h~~~~~~~~ 271 (284)
T 2vgo_A 262 EHPWVKANSR 271 (284)
T ss_dssp TCHHHHHHCC
T ss_pred hCHHHHhhcc
Confidence 9999986543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=241.66 Aligned_cols=165 Identities=22% Similarity=0.388 Sum_probs=128.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......||+.|+|||
T Consensus 130 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~t~~y~aPE 203 (362)
T 3pg1_A 130 VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD------ANKTHYVTHRWYRAPE 203 (362)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------------CGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccc------cccceecccceecCcH
Confidence 3677899999999999999999999999999999999999999999999999754321 1123457899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-----------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------------------------- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------- 136 (347)
++.+....+.++|+||+||++|+|++|+.||.+.+..+....+......|.
T Consensus 204 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
T 3pg1_A 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT 283 (362)
T ss_dssp HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHH
T ss_pred HhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHH
Confidence 998744344789999999999999999999999887776666543221111
Q ss_pred --CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 --SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 --~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+..++.+.+++..|| .+|.+||+++++++||||+....+
T Consensus 284 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 284 AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 2356788999999999 799999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=238.38 Aligned_cols=167 Identities=30% Similarity=0.563 Sum_probs=124.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc---EEEeccCCceecccCCcc--ccccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTD--YKQNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~gt~~y 81 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++......... .........+||+.|
T Consensus 108 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y 187 (316)
T 2ac3_A 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCc
Confidence 567899999999999999999999999999999999988766 999999998765322111 011112345699999
Q ss_pred cccccccC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---------------HHHHHHHHHhccC-CCC--CC
Q psy10462 82 ASPEILKG-----VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---------------YSELLKQVQKRVV-FPE--SP 138 (347)
Q Consensus 82 ~aPE~~~~-----~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~---------------~~~~~~~i~~~~~-~~~--~~ 138 (347)
+|||++.+ ..++ .++|+||+||++|+|++|+.||.+.. .......+..... +|. ..
T Consensus 188 ~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (316)
T 2ac3_A 188 MAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWA 266 (316)
T ss_dssp CCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHT
T ss_pred cChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcc
Confidence 99999875 3344 67999999999999999999998754 2334455544432 222 14
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.+++.+++++++|| .+|.+||+++++++|||+....
T Consensus 267 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 68999999999999 7999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-31 Score=253.57 Aligned_cols=162 Identities=33% Similarity=0.629 Sum_probs=136.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc---CCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... .....+||+.|+
T Consensus 117 ~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~ 190 (486)
T 3mwu_A 117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT------KMKDRIGTAYYI 190 (486)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----------CCTTGGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC------ccCCCcCCCCCC
Confidence 367799999999999999999999999999999999995 45679999999997654321 123457999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---CCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---FPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||++.+. ++ .++||||+||++|+|++|..||.+.+..+....+..+.. .|.+..+|++++++++.|| .+|..|
T Consensus 191 aPE~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 268 (486)
T 3mwu_A 191 APEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR 268 (486)
T ss_dssp CGGGGGSC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTS
T ss_pred CHHHhCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhC
Confidence 99999874 55 689999999999999999999999998888888876543 2334568999999999999 799999
Q ss_pred CCHHHHhcCCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~~ 175 (347)
|++.++++|||+.....
T Consensus 269 ~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 269 ITATQCLEHPWIQKYSS 285 (486)
T ss_dssp CCHHHHHHCHHHHHTCC
T ss_pred cCHHHHhcCHhhccCcc
Confidence 99999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=255.14 Aligned_cols=148 Identities=16% Similarity=0.248 Sum_probs=120.7
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccC
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG 89 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 89 (347)
..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....+| +.|+|||++.+
T Consensus 206 ~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 206 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC--------cccCCCC-cCccChhhhcc
Confidence 56667999999999999999999999999999999999999999999975322 1234567 99999999987
Q ss_pred C-----------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 90 V-----------PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 90 ~-----------~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
. .++ .++|||||||++|+|++|+.||.+.+..+....+ .+....+++++++++..|| .+|..
T Consensus 277 ~~~~~~~~~~~~~~~-~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 277 RATISYHRDRRTLMT-FSFDAWALGLVIYWIWCADLPITKDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HTSTHHHHCCEEECC-HHHHHHHHHHHHHHHHHSSCCC------CCSGGG-----GSSCCCCCHHHHHHHHHHTCSSGGG
T ss_pred cccccccccccccCC-hhhhHHHHHHHHHHHHHCCCCCcccccccchhhh-----hhhccCCCHHHHHHHHHHcCCCchh
Confidence 6 565 7899999999999999999999876543322222 1233678999999999999 79999
Q ss_pred CCCHHHHhcCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKE 172 (347)
Q Consensus 158 R~~~~eil~~p~~~~ 172 (347)
||++.++++||||.+
T Consensus 351 Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 351 RLLPLQAMETPEYEQ 365 (377)
T ss_dssp CCCHHHHHTSHHHHH
T ss_pred CCCHHHHhhChHHHH
Confidence 999999999999865
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=233.06 Aligned_cols=159 Identities=28% Similarity=0.527 Sum_probs=128.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---cCCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
.+++.++..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....... ......||+.|+
T Consensus 120 ~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~t~~y~ 193 (285)
T 3is5_A 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE------HSTNAAGTALYM 193 (285)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------------CTTGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc------cCcCcccccCcC
Confidence 36678899999999999999999999999999999999 456789999999997654321 123456899999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-C-CCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-F-PESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~-~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
|||.+.+ .++ .++|+||+|+++|+|++|+.||.+.+..+....+..... . .....+++.+.++++.|| .+|..||
T Consensus 194 aPE~~~~-~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 271 (285)
T 3is5_A 194 APEVFKR-DVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP 271 (285)
T ss_dssp CHHHHTT-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSC
T ss_pred ChHHhcc-CCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCc
Confidence 9999875 344 689999999999999999999999888777666654322 1 223457899999999999 7999999
Q ss_pred CHHHHhcCCCCCC
Q psy10462 160 QMEDIRQDPWLKE 172 (347)
Q Consensus 160 ~~~eil~~p~~~~ 172 (347)
+++++++||||++
T Consensus 272 s~~e~l~hp~f~~ 284 (285)
T 3is5_A 272 SAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHTSGGGGC
T ss_pred CHHHHhcCHHhhc
Confidence 9999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=238.94 Aligned_cols=159 Identities=23% Similarity=0.401 Sum_probs=130.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-------------------CCcEEEeccCCceecccCCcc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-------------------KYNIKLSDFGFARKYSVNNTD 66 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~~ 66 (347)
.+++.+++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 114 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---- 189 (339)
T 1z57_A 114 PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE---- 189 (339)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS----
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc----
Confidence 4667899999999999999999999999999999999987 66799999999976432
Q ss_pred ccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-C----------
Q psy10462 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-P---------- 135 (347)
Q Consensus 67 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~---------- 135 (347)
......||+.|+|||++.+..++ .++|+||+||++|+|++|..||...+..+....+...... |
T Consensus 190 ----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 264 (339)
T 1z57_A 190 ----HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKR 264 (339)
T ss_dssp ----CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCG
T ss_pred ----ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccch
Confidence 12345789999999999988776 6899999999999999999999988877665554332111 0
Q ss_pred --------------------------------CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 136 --------------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 136 --------------------------------~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
.....++++.+++.+|| .+|.+||+++|+++||||...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 265 KYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred hHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 01122467889999999 799999999999999999763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-32 Score=264.74 Aligned_cols=134 Identities=17% Similarity=0.288 Sum_probs=121.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999997543 23356678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 270 MEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
||||+||||+++|.+ .+.++|.+++.+++|++ ||.|+|++||+||||||+|||++.+
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~ 291 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK 291 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC
Confidence 999999999999964 46899999999999876 9999999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=237.88 Aligned_cols=161 Identities=25% Similarity=0.403 Sum_probs=122.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++.+++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++....... ......||+.|+||
T Consensus 105 ~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~t~~y~aP 178 (290)
T 3fme_A 105 TIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV------AKDIDAGCKPYMAP 178 (290)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------------CCCCCCSCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc------cccccCCCccccCh
Confidence 467789999999999999999998 99999999999999999999999999997654321 12234689999999
Q ss_pred ccc----cCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHH-HhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 85 EIL----KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQV-QKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 85 E~~----~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-~~~~~~~~i-~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
|.+ .+..++ .++|+||+||++|+|++|+.||... ......... ...........+++++++++..|| .+|..
T Consensus 179 E~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 257 (290)
T 3fme_A 179 ERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 257 (290)
T ss_dssp HHHSCCTTC--CC-HHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGG
T ss_pred hhcChhhcCcCCC-cHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhh
Confidence 997 333444 6899999999999999999999863 333333333 333333344578999999999999 79999
Q ss_pred CCCHHHHhcCCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKED 173 (347)
Q Consensus 158 R~~~~eil~~p~~~~~ 173 (347)
||+++++++||||...
T Consensus 258 Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 258 RPTYPELMQHPFFTLH 273 (290)
T ss_dssp SCCHHHHTTSHHHHHH
T ss_pred CcCHHHHHhCcccccC
Confidence 9999999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-32 Score=251.33 Aligned_cols=151 Identities=19% Similarity=0.232 Sum_probs=121.5
Q ss_pred HHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccccC--CC
Q psy10462 14 RWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKG--VP 91 (347)
Q Consensus 14 ~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~ 91 (347)
.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..
T Consensus 198 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 198 ILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--------GPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp HHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--------EEGGGSCGGGCCHHHHTCSEEE
T ss_pred HHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--------ccCccCCcCCcChhhccCCCCC
Confidence 45599999999999999999999999999999999999999999865321 112346799999999987 55
Q ss_pred CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH------HHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 92 YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL--LKQ------VQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 92 ~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~--~~~------i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
++ .++||||+||++|+|++|+.||.+...... ... ......++....+++.+++++.+|| .+|.+||+++
T Consensus 270 ~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 348 (371)
T 3q60_A 270 FT-HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348 (371)
T ss_dssp CC-HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred cC-ccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 65 789999999999999999999987643210 000 0112234444678999999999999 7999999999
Q ss_pred HHhcCCCCCCC
Q psy10462 163 DIRQDPWLKED 173 (347)
Q Consensus 163 eil~~p~~~~~ 173 (347)
++++||||.+.
T Consensus 349 e~l~hp~f~~~ 359 (371)
T 3q60_A 349 EAMETPEFLQL 359 (371)
T ss_dssp HHTTSHHHHHH
T ss_pred HHhcCHHHHHH
Confidence 99999998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-31 Score=241.93 Aligned_cols=160 Identities=24% Similarity=0.369 Sum_probs=131.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE-------------------cCCCcEEEeccCCceecccCCcc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL-------------------DDKYNIKLSDFGFARKYSVNNTD 66 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill-------------------~~~~~~kl~Dfg~a~~~~~~~~~ 66 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 119 ~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--- 195 (355)
T 2eu9_A 119 PYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--- 195 (355)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc---
Confidence 36778999999999999999999999999999999999 56788999999999764321
Q ss_pred ccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----------
Q psy10462 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----------- 135 (347)
Q Consensus 67 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------- 135 (347)
.....||+.|+|||++.+..++ .++|+||+||++|+|++|..||.+.+..+....+.+....+
T Consensus 196 -----~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 269 (355)
T 2eu9_A 196 -----HTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQ 269 (355)
T ss_dssp -----CCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCG
T ss_pred -----ccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccch
Confidence 2345789999999999988776 68999999999999999999999887766655544322110
Q ss_pred --------------------------------CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 136 --------------------------------ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 136 --------------------------------~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.....+.++.+++++|| .+|.+||+++++++||||....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 270 KYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp GGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred hhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 01112457889999999 7999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=238.31 Aligned_cols=166 Identities=19% Similarity=0.337 Sum_probs=130.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......+++.|+|||
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY---RQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------------CCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccc---cccccccCcccccCch
Confidence 4677899999999999999999999999999999999999999999999999765432211 1122344678899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC---
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ--- 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~--- 160 (347)
.+.+..++ .++|+||+||++|+|++ |..||.+.+..+....+......+.+..+++.+.+++..|| .+|.+||+
T Consensus 210 ~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 288 (323)
T 3qup_A 210 SLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288 (323)
T ss_dssp HHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred hhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 99887766 68999999999999999 99999999888888888777777777889999999999999 79999999
Q ss_pred ----HHHHhcCCCCCCCCC
Q psy10462 161 ----MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 ----~~eil~~p~~~~~~~ 175 (347)
++++++|||+.....
T Consensus 289 l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 289 LRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HHHHHHHHHHC--------
T ss_pred HHHHHHHHHHHhhhcCCCC
Confidence 788889999877543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=255.84 Aligned_cols=161 Identities=34% Similarity=0.622 Sum_probs=137.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---cCCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... .....+||+.|+
T Consensus 122 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~ 195 (484)
T 3nyv_A 122 RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK------KMKDKIGTAYYI 195 (484)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC------SHHHHTTGGGTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc------ccccCCCCcccc
Confidence 36779999999999999999999999999999999999 467889999999997654321 123457999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---CCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---PESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||++.+ .++ .++||||+||++|+|++|..||.+.+..+....+..+... |.+..+|+.+++++++|| .+|.+|
T Consensus 196 aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 273 (484)
T 3nyv_A 196 APEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMR 273 (484)
T ss_dssp CHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGS
T ss_pred CceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHC
Confidence 9999987 455 6899999999999999999999999998888888765432 333568999999999999 799999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
|+++++++|||+....
T Consensus 274 ~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 274 ISARDALDHEWIQTYT 289 (484)
T ss_dssp CCHHHHHTSHHHHHHT
T ss_pred cCHHHHhhChhhcccc
Confidence 9999999999997644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=240.72 Aligned_cols=163 Identities=21% Similarity=0.411 Sum_probs=127.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-cEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ......|++.|+||
T Consensus 126 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~~~~y~aP 199 (330)
T 3nsz_A 126 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ------EYNVRVASRYFKGP 199 (330)
T ss_dssp GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC------CCCSCCSCGGGCCH
T ss_pred hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC------ccccccccccccCh
Confidence 356789999999999999999999999999999999999776 89999999998654321 12345789999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHh-------------cc-C----------------
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQK-------------RV-V---------------- 133 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-~~~~~~~~i~~-------------~~-~---------------- 133 (347)
|.+.+....+.++|+||+||++|+|++|+.||... +..+.+..+.. .. .
T Consensus 200 E~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (330)
T 3nsz_A 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 279 (330)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCC
T ss_pred hhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccc
Confidence 99987443447899999999999999999999543 32222222211 00 0
Q ss_pred ------CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 134 ------FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 134 ------~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
......+++++++++++|| .+|.+||+++++++||||....
T Consensus 280 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 280 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp GGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0111237899999999999 7999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=233.64 Aligned_cols=162 Identities=30% Similarity=0.573 Sum_probs=112.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ......||+.|+|||
T Consensus 108 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE 182 (278)
T 3cok_A 108 PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-----KHYTLCGTPNYISPE 182 (278)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-----cceeccCCCCcCCcc
Confidence 367899999999999999999999999999999999999999999999999976542211 122456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
.+.+..++ .++|+||+|+++|+|++|+.||...+..+....+... ....+..++.++++++..|| .+|..||+++++
T Consensus 183 ~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 260 (278)
T 3cok_A 183 IATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260 (278)
T ss_dssp ----------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-ccCCccccCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 99887665 5799999999999999999999877655444433222 22345668999999999999 799999999999
Q ss_pred hcCCCCCCCC
Q psy10462 165 RQDPWLKEDS 174 (347)
Q Consensus 165 l~~p~~~~~~ 174 (347)
++|||+....
T Consensus 261 l~h~~~~~~~ 270 (278)
T 3cok_A 261 LDHPFMSRNS 270 (278)
T ss_dssp TTSTTTC---
T ss_pred hcCccccCCC
Confidence 9999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=250.61 Aligned_cols=159 Identities=35% Similarity=0.617 Sum_probs=136.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC---CcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++....... .....+||+.|+
T Consensus 132 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~------~~~~~~gt~~y~ 205 (494)
T 3lij_A 132 KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK------KMKERLGTAYYI 205 (494)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB------CBCCCCSCTTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc------cccccCCCcCee
Confidence 36778999999999999999999999999999999999764 459999999998764321 123467999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---CCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---PESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||++.+ .++ .++||||+||++|+|++|..||.+.+..+....+..+... +....+++.++++++.|| .+|.+|
T Consensus 206 aPE~l~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 283 (494)
T 3lij_A 206 APEVLRK-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283 (494)
T ss_dssp CHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTS
T ss_pred CHHHHcc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhC
Confidence 9999875 455 6899999999999999999999999998888888765432 223568999999999999 799999
Q ss_pred CCHHHHhcCCCCCC
Q psy10462 159 IQMEDIRQDPWLKE 172 (347)
Q Consensus 159 ~~~~eil~~p~~~~ 172 (347)
|+++++++|||+++
T Consensus 284 ~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 284 ISAQQALEHPWIKE 297 (494)
T ss_dssp CCHHHHHTCHHHHH
T ss_pred ccHHHHhcCccccc
Confidence 99999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=247.37 Aligned_cols=159 Identities=30% Similarity=0.565 Sum_probs=121.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC---cEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ......+||+.|+|
T Consensus 236 ~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~------~~~~~~~gt~~y~a 309 (419)
T 3i6u_A 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET------SLMRTLCGTPTYLA 309 (419)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------------CTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC------ccccccCCCCCccC
Confidence 56799999999999999999999999999999999997544 5999999999765421 12235679999999
Q ss_pred cccccC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCCC---CCCCCHHHHHHHHhcc-CCC
Q psy10462 84 PEILKG---VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFPE---SPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 84 PE~~~~---~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~---~~~~s~~~~~li~~~l-~~~ 155 (347)
||++.+ ..++ .++|+||+||++|+|++|+.||.+.... .....+..+..... ...+++.+++++++|| .+|
T Consensus 310 PE~~~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 388 (419)
T 3i6u_A 310 PEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 388 (419)
T ss_dssp TTTTC----CTTH-HHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred ceeeecCCCCCCC-chhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCCh
Confidence 999864 3333 5899999999999999999999865432 33344444322111 2468999999999999 799
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~ 172 (347)
..||+++++++|||+.+
T Consensus 389 ~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 389 KARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCCHHHHHHSGGGCC
T ss_pred hHCcCHHHHhCCcccCC
Confidence 99999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=232.66 Aligned_cols=161 Identities=40% Similarity=0.715 Sum_probs=131.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... ......|++.|+|||.
T Consensus 108 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~ 181 (276)
T 2h6d_A 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE------FLRTSCGSPNYAAPEV 181 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------------CCTGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc------ceecccCCccccCHHH
Confidence 5678899999999999999999999999999999999999999999999987654321 1234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..+.+.++|+||+|+++|+|++|+.||.+.+..+....+..... +.+..++..+.+++..|| .+|..||++++++
T Consensus 182 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l 260 (276)
T 2h6d_A 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-YIPEYLNRSVATLLMHMLQVDPLKRATIKDIR 260 (276)
T ss_dssp GTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-cCchhcCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 98876654689999999999999999999999888888777766543 345678999999999999 7999999999999
Q ss_pred cCCCCCCCC
Q psy10462 166 QDPWLKEDS 174 (347)
Q Consensus 166 ~~p~~~~~~ 174 (347)
+|||+++..
T Consensus 261 ~h~~~~~~~ 269 (276)
T 2h6d_A 261 EHEWFKQDL 269 (276)
T ss_dssp HSHHHHTTC
T ss_pred hChhhccCc
Confidence 999997653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=250.89 Aligned_cols=162 Identities=33% Similarity=0.580 Sum_probs=139.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC---cEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
.+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... .....+||+.|+
T Consensus 142 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~ 215 (504)
T 3q5i_A 142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY------KLRDRLGTAYYI 215 (504)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS------CBCCCCSCTTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC------ccccccCCcCCC
Confidence 367799999999999999999999999999999999998775 69999999998764321 123457999999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---CCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||++.+ .++ .++|+||+||++|+|++|..||.+.+..+....+..+..... +..+|++++++++.|| .+|.+|
T Consensus 216 aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 293 (504)
T 3q5i_A 216 APEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKR 293 (504)
T ss_dssp CHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTS
T ss_pred CHHHhcc-CCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHC
Confidence 9999875 455 689999999999999999999999999998888877643222 3578999999999999 799999
Q ss_pred CCHHHHhcCCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~~ 175 (347)
|+++++++|||++....
T Consensus 294 ~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 294 CTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHHTSHHHHHTCC
T ss_pred CCHHHHhcCHhhhhchh
Confidence 99999999999987544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=241.23 Aligned_cols=130 Identities=16% Similarity=0.261 Sum_probs=108.5
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC----eE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----RV 266 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~ 266 (347)
++|.+.+.||+|+||+||+|++ +|+.||||+++... ......+.|+..+.+++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4577889999999999999986 58899999996432 11222345666677899999999999998654 68
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhc--------CccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSR--------CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~--------~iiHRDlKp~Nil~~~~~ 327 (347)
|||||||++|||.++|++ ..++++.+..++.|++ |+.|+|++ +||||||||+|||++.++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~ 145 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence 999999999999999976 4688888888888776 99999977 999999999999998875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-31 Score=245.67 Aligned_cols=157 Identities=23% Similarity=0.352 Sum_probs=125.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCC--------------------------------------
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKY-------------------------------------- 47 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~-------------------------------------- 47 (347)
+++.+++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 143 ~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (397)
T 1wak_A 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLV 222 (397)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccc
Confidence 67789999999999999999998 999999999999998775
Q ss_pred -----------cEEEeccCCceecccCCccccccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q psy10462 48 -----------NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF 116 (347)
Q Consensus 48 -----------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf 116 (347)
.+||+|||++...... ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||
T Consensus 223 ~~~~~~~~~~~~~kl~DfG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf 293 (397)
T 1wak_A 223 NPLEPKNAEKLKVKIADLGNACWVHKH--------FTEDIQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLF 293 (397)
T ss_dssp CTTSGGGGGGCCEEECCGGGCEETTBC--------SCSCCSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccceEecccccccccccc--------CccCCCCCcccCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCC
Confidence 7999999999765421 2234689999999999988777 6899999999999999999999
Q ss_pred CCCC------HHHHHHHHHhccCC-----------------------------------------CCCCCCCHHHHHHHH
Q psy10462 117 DDTN------YSELLKQVQKRVVF-----------------------------------------PESPRLSSSCKALIS 149 (347)
Q Consensus 117 ~~~~------~~~~~~~i~~~~~~-----------------------------------------~~~~~~s~~~~~li~ 149 (347)
.+.+ ....+..+.+.... +.+...++.+.+|+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 373 (397)
T 1wak_A 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLL 373 (397)
T ss_dssp CCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHG
T ss_pred CCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHH
Confidence 8654 22222222211100 001223457889999
Q ss_pred hcc-CCCCCCCCHHHHhcCCCCCC
Q psy10462 150 NIL-SPVKFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 150 ~~l-~~~~~R~~~~eil~~p~~~~ 172 (347)
+|| .+|.+||+++++++||||++
T Consensus 374 ~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 374 PMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp GGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred HHhccChhhcCCHHHHhhCccccC
Confidence 999 79999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=234.30 Aligned_cols=160 Identities=30% Similarity=0.590 Sum_probs=137.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---cCCCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...... .....+||+.|+|
T Consensus 103 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~~~y~a 175 (304)
T 2jam_A 103 YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-------IMSTACGTPGYVA 175 (304)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-------TTHHHHSCCCBCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-------ccccccCCCCccC
Confidence 5678999999999999999999999999999999999 77889999999998654321 1234568999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---CCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---PESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||.+.+..++ .++|+||+|+++|+|++|..||.+.+..+....+.++... +....+++.+++++..|| .+|..||
T Consensus 176 PE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 254 (304)
T 2jam_A 176 PEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY 254 (304)
T ss_dssp TTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred hHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCc
Confidence 9999887776 6899999999999999999999998888888877765432 223568999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ~~~eil~~p~~~~~~ 174 (347)
+++++++|||+....
T Consensus 255 s~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 255 TCEKALSHPWIDGNT 269 (304)
T ss_dssp CHHHHHTSHHHHSSC
T ss_pred CHHHHhcCccccCCC
Confidence 999999999997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=239.91 Aligned_cols=161 Identities=21% Similarity=0.379 Sum_probs=124.2
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcccc-------ccCcccccCCccc
Q psy10462 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK-------QNLSETFCGSYAY 81 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~~~~gt~~y 81 (347)
+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........... .......+||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 356889999999999999999999999999999999999999999999987654321110 0122345799999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
+|||++.+..++ .++|+||+||++|+|++|..|+.. ..+....+......+.....++.+++++..|| .+|.+||+
T Consensus 243 ~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 243 MSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp SCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 999999988776 689999999999999998777532 22233333333221122346788899999999 79999999
Q ss_pred HHHHhcCCCCCC
Q psy10462 161 MEDIRQDPWLKE 172 (347)
Q Consensus 161 ~~eil~~p~~~~ 172 (347)
++++++||||++
T Consensus 320 ~~~~l~~~~f~~ 331 (332)
T 3qd2_B 320 ATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHSTTCCC
T ss_pred HHHHhhchhhhc
Confidence 999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-30 Score=231.49 Aligned_cols=163 Identities=25% Similarity=0.554 Sum_probs=139.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ......||+.|+|||.
T Consensus 112 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 186 (294)
T 2rku_A 112 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPNYIAPEV 186 (294)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-----CBCCCCSCCSSCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-----ccccccCCCCcCCcch
Confidence 56789999999999999999999999999999999999999999999999976543221 1234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||+|+++|+|++|+.||.+.+..+....+.... .+.+..+++.+.+++..|| .+|..||++++++
T Consensus 187 ~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 264 (294)
T 2rku_A 187 LSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELL 264 (294)
T ss_dssp HTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred hccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 9887766 68999999999999999999999988877776665543 3445678999999999999 7999999999999
Q ss_pred cCCCCCCCCCC
Q psy10462 166 QDPWLKEDSNP 176 (347)
Q Consensus 166 ~~p~~~~~~~~ 176 (347)
+|||+.....+
T Consensus 265 ~~~~~~~~~~~ 275 (294)
T 2rku_A 265 NDEFFTSGYIP 275 (294)
T ss_dssp GSHHHHTSCCC
T ss_pred hChheecCCcC
Confidence 99999876544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=238.40 Aligned_cols=163 Identities=26% Similarity=0.556 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+||+.|+|||+
T Consensus 156 ~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~gt~~y~aPE~ 231 (355)
T 1vzo_A 156 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET----ERAYDFCGTIEYMAPDI 231 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG----GGGCGGGSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC----CcccCcccCcCccChhh
Confidence 56789999999999999999999999999999999999999999999999976543211 11234679999999999
Q ss_pred ccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-
Q psy10462 87 LKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTN----YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI- 159 (347)
Q Consensus 87 ~~~~~-~~~~~~Dvws~G~~l~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~- 159 (347)
+.+.. ..+.++|||||||++|+|++|+.||...+ ..++...+... ..+.+..++..+++++.+|| .+|.+||
T Consensus 232 ~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~~ 310 (355)
T 1vzo_A 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEMSALAKDLIQRLLMKDPKKRLG 310 (355)
T ss_dssp HTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred hcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-CCCCCcccCHHHHHHHHHHhhhCHHHhcC
Confidence 98632 22368999999999999999999997542 33344443332 23445678999999999999 7999999
Q ss_pred ----CHHHHhcCCCCCCCC
Q psy10462 160 ----QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ----~~~eil~~p~~~~~~ 174 (347)
+++++++|||+....
T Consensus 311 ~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 311 CGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp SSTTTHHHHHTSGGGTTCC
T ss_pred CCCCCHHHHHcCcchhcCC
Confidence 999999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=236.03 Aligned_cols=168 Identities=23% Similarity=0.381 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc-CCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++.+++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||++......... ........+++.|+|||
T Consensus 117 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE 194 (320)
T 2i6l_A 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH--KGHLSEGLVTKWYRSPR 194 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC----------CCCGGGSCCTTCCHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCccc--ccccccccccccccCcH
Confidence 56788999999999999999999999999999999997 5678999999999765422111 11123446789999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC-----------------------------C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP-----------------------------E 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----------------------------~ 136 (347)
.+.+....+.++|+||+||++|+|++|+.||.+.+..+....+......+ .
T Consensus 195 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (320)
T 2i6l_A 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL 274 (320)
T ss_dssp HHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHH
T ss_pred HhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHh
Confidence 98763333478999999999999999999999888766666554332110 0
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
.+.+++++++++++|| .+|.+||+++++++|||+.....+
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 275 LPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp STTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred cchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 1457899999999999 799999999999999999876554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-30 Score=232.26 Aligned_cols=162 Identities=23% Similarity=0.452 Sum_probs=140.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .......||+.|+|||.
T Consensus 116 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 190 (303)
T 3a7i_A 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-----IKRNTFVGTPFWMAPEV 190 (303)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-----CCBCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-----cccCccCCCcCccCHHH
Confidence 5678999999999999999999999999999999999999999999999997664321 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||||+++|+|++|+.||...+..+....+........+..++..+++++..|| .+|..||++++++
T Consensus 191 ~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 269 (303)
T 3a7i_A 191 IKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 269 (303)
T ss_dssp HTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 9887776 6899999999999999999999998887777777665544455678999999999999 7999999999999
Q ss_pred cCCCCCCCC
Q psy10462 166 QDPWLKEDS 174 (347)
Q Consensus 166 ~~p~~~~~~ 174 (347)
+|||+....
T Consensus 270 ~~~~~~~~~ 278 (303)
T 3a7i_A 270 KHKFILRNA 278 (303)
T ss_dssp TCHHHHHHC
T ss_pred hChhhhcCC
Confidence 999986543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=239.39 Aligned_cols=162 Identities=25% Similarity=0.458 Sum_probs=128.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......||+.|+|||.
T Consensus 121 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~t~~y~aPE~ 195 (331)
T 4aaa_A 121 LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-----VYDDEVATRWYRAPEL 195 (331)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCCCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-----ccCCCcCCccccCccc
Confidence 56789999999999999999999999999999999999999999999999976543211 1234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--------------------CCCC----------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--------------------VFPE---------- 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--------------------~~~~---------- 136 (347)
+.+....+.++|+||+||++|+|++|+.||.+.+..+....+.... ..+.
T Consensus 196 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (331)
T 4aaa_A 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERR 275 (331)
T ss_dssp HTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHH
T ss_pred ccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhc
Confidence 9876434478999999999999999999999887766555443211 1111
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
.+.+++.+.+++..|| .+|.+||+++++++||||...
T Consensus 276 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 276 YPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp STTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 1357899999999999 799999999999999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=234.75 Aligned_cols=167 Identities=20% Similarity=0.409 Sum_probs=126.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...................||+.|+|||.
T Consensus 118 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (303)
T 2vwi_A 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197 (303)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHH
Confidence 67789999999999999999999999999999999999999999999999876543221111122234578999999999
Q ss_pred ccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---------CCCCCCCHHHHHHHHhcc-CCC
Q psy10462 87 LKGV-PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---------PESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 87 ~~~~-~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------~~~~~~s~~~~~li~~~l-~~~ 155 (347)
+.+. .++ .++|+||+|+++|+|++|+.||.+.+..+........... .....+++++++++..|| .+|
T Consensus 198 ~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp 276 (303)
T 2vwi_A 198 MEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDP 276 (303)
T ss_dssp HHHHHCCC-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSG
T ss_pred hccccCCC-chhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCCh
Confidence 8753 344 6899999999999999999999987765554443332211 112457889999999999 799
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~~~ 174 (347)
..||+++++++||||....
T Consensus 277 ~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 277 EKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp GGSCCHHHHHTSTTC----
T ss_pred hhCcCHHHHhhChhhhcCC
Confidence 9999999999999998644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-30 Score=230.63 Aligned_cols=158 Identities=19% Similarity=0.489 Sum_probs=128.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEc-CCCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~--iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...... ......||+.|+|
T Consensus 126 ~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~t~~y~a 198 (290)
T 1t4h_A 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-------FAKAVIGTPEFMA 198 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-------SBEESCSSCCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-------ccccccCCcCcCC
Confidence 566889999999999999999999 99999999999997 7889999999998643321 1234568999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhccCCC-CCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
||.+.+. ++ .++|+||+|+++|+|++|+.||.+. +..+....+......+ .+...++++.+++..|| .+|..||+
T Consensus 199 PE~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 276 (290)
T 1t4h_A 199 PEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276 (290)
T ss_dssp GGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHhcc-CC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9998754 44 6899999999999999999999874 4445555554443322 23456789999999999 79999999
Q ss_pred HHHHhcCCCCCCC
Q psy10462 161 MEDIRQDPWLKED 173 (347)
Q Consensus 161 ~~eil~~p~~~~~ 173 (347)
++++++||||++.
T Consensus 277 ~~ell~h~~f~~~ 289 (290)
T 1t4h_A 277 IKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHTSGGGC--
T ss_pred HHHHhhCcccccC
Confidence 9999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-30 Score=229.32 Aligned_cols=156 Identities=17% Similarity=0.241 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-------------------CCcEEEeccCCceecccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-------------------KYNIKLSDFGFARKYSVNNTDY 67 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~~~ 67 (347)
+++.+++.++.||+.||.|||++||+||||||+||+++. ...+||+|||++......
T Consensus 112 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---- 187 (289)
T 1x8b_A 112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---- 187 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS----
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----
Confidence 577899999999999999999999999999999999984 447999999999765431
Q ss_pred cccCcccccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHH
Q psy10462 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKAL 147 (347)
Q Consensus 68 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 147 (347)
....||+.|+|||.+.+....+.++||||+||++|+|++|..|+.... ....+........+..+++.++++
T Consensus 188 -----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l 259 (289)
T 1x8b_A 188 -----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQVLSQEFTEL 259 (289)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCCSSCCCHHHHHH
T ss_pred -----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCCCCcccCHHHHHH
Confidence 223589999999999876444368999999999999999998775543 234444444444556789999999
Q ss_pred HHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 148 ISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 148 i~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
+..|| .+|.+||+++++++|||+....
T Consensus 260 i~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 260 LKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 99999 7999999999999999998643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=239.25 Aligned_cols=157 Identities=22% Similarity=0.370 Sum_probs=135.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .......+|+.|+|||+
T Consensus 200 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~ 276 (370)
T 2psq_A 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEA 276 (370)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTT---CTTTTTTSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccce---ecccCCCcccceECHhH
Confidence 567889999999999999999999999999999999999999999999999865432111 11223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+...+.+..++.++.+++..|| .+|..||+++++
T Consensus 277 ~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 355 (370)
T 2psq_A 277 LFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 355 (370)
T ss_dssp HHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9887776 68999999999999999 99999999888888888777766667789999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 356 l~~ 358 (370)
T 2psq_A 356 VED 358 (370)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-30 Score=235.69 Aligned_cols=163 Identities=25% Similarity=0.554 Sum_probs=139.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ......||+.|+|||+
T Consensus 138 l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE~ 212 (335)
T 2owb_A 138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPNYIAPEV 212 (335)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-----CBCCCCSCCSSCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-----cccccCCCccccCHHH
Confidence 56789999999999999999999999999999999999999999999999986543221 1234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||||+++|+|++|+.||...+..+....+.... ...+..+++.++++++.|| .+|.+||++++++
T Consensus 213 ~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 290 (335)
T 2owb_A 213 LSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELL 290 (335)
T ss_dssp HHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred hccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 9887766 68999999999999999999999988777776665543 3345678999999999999 7999999999999
Q ss_pred cCCCCCCCCCC
Q psy10462 166 QDPWLKEDSNP 176 (347)
Q Consensus 166 ~~p~~~~~~~~ 176 (347)
+|||+.....+
T Consensus 291 ~~~~~~~~~~~ 301 (335)
T 2owb_A 291 NDEFFTSGYIP 301 (335)
T ss_dssp GSHHHHTSCCC
T ss_pred cCccccCCCcc
Confidence 99999876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=236.85 Aligned_cols=161 Identities=27% Similarity=0.486 Sum_probs=134.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++.++..++.||+.||.|||+ +||+||||||+||+++.++.+||+|||++...... ......|++.|+|||
T Consensus 148 ~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE 220 (348)
T 2pml_X 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPE 220 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc-------cccCCCCCcCccCch
Confidence 4678999999999999999999 99999999999999999999999999999765432 123456899999999
Q ss_pred cccCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcc-CCCCC-----------------CCCCHHHH
Q psy10462 86 ILKGV-PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKRV-VFPES-----------------PRLSSSCK 145 (347)
Q Consensus 86 ~~~~~-~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~~~-~~~~~-----------------~~~s~~~~ 145 (347)
.+.+. .+++.++|+||+||++|+|++|+.||...+. .+....+.... .+|.. ..+++.+.
T Consensus 221 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 300 (348)
T 2pml_X 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300 (348)
T ss_dssp GGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHH
T ss_pred hhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHH
Confidence 99887 4443389999999999999999999998766 66666665542 22221 56889999
Q ss_pred HHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 146 ALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 146 ~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
+++..|| .+|..||+++++++||||.+..
T Consensus 301 ~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 301 DFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 9999999 7999999999999999997643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=231.81 Aligned_cols=163 Identities=32% Similarity=0.545 Sum_probs=138.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC-----CeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS-----VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~-----iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y 81 (347)
+++.++..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........ ......|++.|
T Consensus 108 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y 182 (279)
T 2w5a_A 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-----FAKTFVGTPYY 182 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH-----HHHHHHSCCTT
T ss_pred CCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc-----cccccCCCccc
Confidence 677889999999999999999999 99999999999999999999999999876532211 11235689999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
+|||.+.+..++ .++|+||+|+++|+|++|+.||.+.+..+....+..+...+.+..+++++++++..|| .+|..||+
T Consensus 183 ~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 261 (279)
T 2w5a_A 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPS 261 (279)
T ss_dssp CCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred cChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCC
Confidence 999999887766 6899999999999999999999999888888888776655556678999999999999 79999999
Q ss_pred HHHHhcCCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 ~~eil~~p~~~~~~~ 175 (347)
++++++|+|+.+...
T Consensus 262 ~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 262 VEEILENPLILEHHH 276 (279)
T ss_dssp HHHHHTSTTCCGGGS
T ss_pred HHHHHhChhhhhhcc
Confidence 999999999877543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=240.23 Aligned_cols=160 Identities=26% Similarity=0.455 Sum_probs=124.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEc------CCCcEEEeccCCceecccCCccccccCcccccCCc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLD------DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~ 79 (347)
+++.++..++.||+.||.|||++ ||+||||||+|||++ ..+.+||+|||++...... .....||+
T Consensus 128 ~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~ 199 (373)
T 1q8y_A 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--------YTNSIQTR 199 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--------CCSCCSCG
T ss_pred CcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--------CCCCCCCc
Confidence 66788999999999999999998 999999999999994 3447999999999765421 22346899
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhccC--------------------
Q psy10462 80 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY------SELLKQVQKRVV-------------------- 133 (347)
Q Consensus 80 ~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~------~~~~~~i~~~~~-------------------- 133 (347)
.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+. .+.+..+.....
T Consensus 200 ~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 278 (373)
T 1q8y_A 200 EYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR 278 (373)
T ss_dssp GGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC-
T ss_pred cccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCc
Confidence 99999999988776 689999999999999999999986542 222222221110
Q ss_pred ---------------------CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 134 ---------------------FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 134 ---------------------~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
...+...++++++++++|| .+|.+||+++++++||||.+...
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 279 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp -CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred chhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 0111234567889999999 79999999999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=237.47 Aligned_cols=157 Identities=23% Similarity=0.439 Sum_probs=134.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ......||+.|+|||.
T Consensus 114 ~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~t~~y~aPE~ 190 (327)
T 3poz_A 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY---HAEGGKVPIKWMALES 190 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC----------CCCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccc---cccCCCccccccChHH
Confidence 5668899999999999999999999999999999999999999999999998664332211 1223456889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |+.||.+.+..+....+......+.+...+..+.+++..|+ .+|..||++.++
T Consensus 191 ~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 269 (327)
T 3poz_A 191 ILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 269 (327)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred hccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 9887776 68999999999999999 99999998888888888877777778889999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 270 l~~ 272 (327)
T 3poz_A 270 IIE 272 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=228.35 Aligned_cols=162 Identities=31% Similarity=0.538 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... ......|++.|+|||+
T Consensus 121 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~ 194 (298)
T 1phk_A 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE------KLREVCGTPSYLAPEI 194 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC------CBCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCc------ccccccCCccccCHHH
Confidence 5678999999999999999999999999999999999999999999999997654321 1234568999999999
Q ss_pred cc------CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CC--CCCCCCHHHHHHHHhcc-CCCC
Q psy10462 87 LK------GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FP--ESPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 87 ~~------~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~--~~~~~s~~~~~li~~~l-~~~~ 156 (347)
+. ...++ .++|+||+|+++|+|++|+.||.+.+..+....+..... ++ ....++..+++++.+|| .+|.
T Consensus 195 ~~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 273 (298)
T 1phk_A 195 IECSMNDNHPGYG-KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ 273 (298)
T ss_dssp HHHHHCTTSCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGG
T ss_pred hccccccccccCC-cccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcc
Confidence 85 23344 689999999999999999999999888777777765432 22 22468999999999999 7999
Q ss_pred CCCCHHHHhcCCCCCCCCC
Q psy10462 157 FRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 157 ~R~~~~eil~~p~~~~~~~ 175 (347)
.||+++++++||||.+...
T Consensus 274 ~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 274 KRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp GSCCHHHHTTSGGGCTTC-
T ss_pred cCCCHHHHHhChHhhhccc
Confidence 9999999999999987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=235.20 Aligned_cols=157 Identities=20% Similarity=0.355 Sum_probs=133.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ........|++.|+|||.
T Consensus 112 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~~~~y~aPE~ 188 (325)
T 3kex_A 112 LGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK---QLLYSEAKTPIKWMALES 188 (325)
T ss_dssp SCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT---CCC-----CCTTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc---cccccCCCCcccccChHH
Confidence 45578999999999999999999999999999999999999999999999987643221 112234567889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+||++|+|++ |+.||.+.+..+....+......+.+...+.++.+++..|| .+|..||++.++
T Consensus 189 ~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (325)
T 3kex_A 189 IHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267 (325)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHH
T ss_pred hccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9887776 68999999999999999 99999998888888888877666677778999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 268 ~~~ 270 (325)
T 3kex_A 268 ANE 270 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-30 Score=228.44 Aligned_cols=160 Identities=29% Similarity=0.494 Sum_probs=133.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC----cEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.++..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++....... ......|++.|+
T Consensus 105 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~ 178 (283)
T 3bhy_A 105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN------EFKNIFGTPEFV 178 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------------CCCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC------cccccCCCcCcc
Confidence 56789999999999999999999999999999999998877 79999999997654321 122346899999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---CCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||.+.+..++ .++|+||+|+++|+|++|..||.+.+..+....+........ ....++.++++++.|| .+|..|
T Consensus 179 aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (283)
T 3bhy_A 179 APEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 257 (283)
T ss_dssp CHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGS
T ss_pred CcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHC
Confidence 99999887766 689999999999999999999999888877777655432211 2467899999999999 799999
Q ss_pred CCHHHHhcCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKED 173 (347)
Q Consensus 159 ~~~~eil~~p~~~~~ 173 (347)
|++.++++|||+...
T Consensus 258 ps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 258 MTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCHHHHHHCHHHHHH
T ss_pred cCHHHHHhCHHHHHH
Confidence 999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=229.91 Aligned_cols=162 Identities=23% Similarity=0.434 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... ........||+.|+|||.
T Consensus 114 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~ 188 (302)
T 2j7t_A 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-----LQKRDSFIGTPYWMAPEV 188 (302)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-----HHC-----CCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-----ccccccccCChhhcCCee
Confidence 667899999999999999999999999999999999999999999999987543211 011234568999999999
Q ss_pred cc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~-----~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
+. +..++ .++|+||+|+++|+|++|..||...+..+....+..... ...+..++..+++++..|| .+|..|
T Consensus 189 ~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 267 (302)
T 2j7t_A 189 VMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR 267 (302)
T ss_dssp HHHHHTTSTTTT-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred eccccCCCCCCc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhC
Confidence 83 44444 689999999999999999999999887777666655432 2234568899999999999 799999
Q ss_pred CCHHHHhcCCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKEDS 174 (347)
Q Consensus 159 ~~~~eil~~p~~~~~~ 174 (347)
|+++++++|||+....
T Consensus 268 ps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 268 PSAAQLLEHPFVSSIT 283 (302)
T ss_dssp CCHHHHTTSTTTTTCC
T ss_pred CCHHHHhcChHHhhhc
Confidence 9999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-30 Score=233.28 Aligned_cols=158 Identities=19% Similarity=0.337 Sum_probs=134.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... .......+|+.|+|||
T Consensus 147 ~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~t~~y~aPE 224 (325)
T 3kul_A 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA--YTTTGGKIPIRWTAPE 224 (325)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CC--EECC---CCGGGSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccce--eeccCCCCcccccCHh
Confidence 35678999999999999999999999999999999999999999999999998764322111 1122334678899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
++.+..++ .++||||+||++|+|++ |..||.+.+..+....+......+.+..+++.+.+++..|| .+|..||++++
T Consensus 225 ~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 303 (325)
T 3kul_A 225 AIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQ 303 (325)
T ss_dssp HHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHH
Confidence 99877776 68999999999999999 99999999999999988888777778889999999999999 79999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+++
T Consensus 304 il~ 306 (325)
T 3kul_A 304 IVS 306 (325)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=233.81 Aligned_cols=155 Identities=32% Similarity=0.591 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc-CCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++.+++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||++...... ......||+.|+|||
T Consensus 146 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-------~~~~~~gt~~y~aPE 218 (320)
T 3a99_A 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPE 218 (320)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-------CBCCCCSCGGGSCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-------cccCCCCCccCCChH
Confidence 56788999999999999999999999999999999999 7789999999999765421 123456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
++.+..+.+.++|+||||+++|+|++|+.||...+ .+... ....+..+++++++++++|| .+|..||+++++
T Consensus 219 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 291 (320)
T 3a99_A 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291 (320)
T ss_dssp HHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99877665567899999999999999999997642 11122 12334678999999999999 799999999999
Q ss_pred hcCCCCCCCCC
Q psy10462 165 RQDPWLKEDSN 175 (347)
Q Consensus 165 l~~p~~~~~~~ 175 (347)
++|||+.+...
T Consensus 292 l~hp~~~~~~~ 302 (320)
T 3a99_A 292 QNHPWMQDVLL 302 (320)
T ss_dssp HTSGGGSSCCC
T ss_pred hcCHhhcCccC
Confidence 99999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=232.46 Aligned_cols=162 Identities=23% Similarity=0.425 Sum_probs=128.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... .......||+.|+|||+
T Consensus 126 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~ 200 (326)
T 2x7f_A 126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEV 200 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC------------------CCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-----cccccccCCccccChhh
Confidence 5678899999999999999999999999999999999999999999999987653211 11234578999999999
Q ss_pred cc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 87 LK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 87 ~~-----~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
+. +..++ .++|+|||||++|+|++|..||.+.+..+....+..... ......+++.+++++..|| .+|..||
T Consensus 201 ~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 279 (326)
T 2x7f_A 201 IACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP 279 (326)
T ss_dssp HC--------CC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSC
T ss_pred hccccccCcCCC-ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCC
Confidence 87 33444 679999999999999999999998887666655544332 2234568999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ~~~eil~~p~~~~~~ 174 (347)
+++++++|||+.+..
T Consensus 280 s~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 280 ATEQLMKHPFIRDQP 294 (326)
T ss_dssp CHHHHHTSHHHHCCT
T ss_pred CHHHHhhChHHhhCc
Confidence 999999999987643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=234.60 Aligned_cols=157 Identities=22% Similarity=0.421 Sum_probs=130.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .......+|+.|+|||.
T Consensus 114 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~ 190 (327)
T 3lzb_A 114 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE---YHAEGGKVPIKWMALES 190 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------------------CCCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc---ccccCCCccccccCHHH
Confidence 567889999999999999999999999999999999999999999999999765432211 11223456889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++||||+||++|+|++ |..||.+.+..+....+......+.+...+.++.++++.|| .+|..||+++++
T Consensus 191 ~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 191 ILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9887776 68999999999999999 99999999888888888887777778889999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 270 l~~ 272 (327)
T 3lzb_A 270 IIE 272 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-31 Score=249.17 Aligned_cols=149 Identities=17% Similarity=0.266 Sum_probs=123.6
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccccc-
Q psy10462 9 TDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEIL- 87 (347)
Q Consensus 9 ~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~- 87 (347)
+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++
T Consensus 210 ~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~ 280 (413)
T 3dzo_A 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTA 280 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhh
Confidence 3566777899999999999999999999999999999999999999998765321 234567 999999999
Q ss_pred ---------cCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 88 ---------KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 88 ---------~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
.+..++ .++|||||||++|+|++|+.||.+.+..+....+ ++....+++.+++++.+|| .+|.+
T Consensus 281 ~~~~~~~~~~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~ 354 (413)
T 3dzo_A 281 ERMLPFGQHHPTLMT-FAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKED 354 (413)
T ss_dssp HHTSTTGGGCCEEEC-HHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG-----GSSCCCCCHHHHHHHHHHTCSSGGG
T ss_pred ccccccccccCcCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH-----HhhcccCCHHHHHHHHHHccCChhh
Confidence 444444 6899999999999999999999876543322222 2334578899999999999 79999
Q ss_pred CCCHHHHhcCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKE 172 (347)
Q Consensus 158 R~~~~eil~~p~~~~ 172 (347)
||++.++++|||+++
T Consensus 355 Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 355 RLLPLQAMETPEYEQ 369 (413)
T ss_dssp SCCHHHHTTSHHHHH
T ss_pred CcCHHHHHhCHHHHH
Confidence 999999999999865
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=229.37 Aligned_cols=163 Identities=23% Similarity=0.425 Sum_probs=136.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ ......|++.|+|||
T Consensus 121 ~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE 195 (314)
T 3com_A 121 TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-----KRNTVIGTPFWMAPE 195 (314)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-----CBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-----ccCccCCCCCccChh
Confidence 356789999999999999999999999999999999999999999999999976543211 123456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+..++ .++|+||+|+++|+|++|+.||.+.+.......+..... +..+..+++.+.+++..|| .+|..||+++
T Consensus 196 ~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (314)
T 3com_A 196 VIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATAT 274 (314)
T ss_dssp HHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred hcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99887776 679999999999999999999998877665555544322 2334567899999999999 7999999999
Q ss_pred HHhcCCCCCCCC
Q psy10462 163 DIRQDPWLKEDS 174 (347)
Q Consensus 163 eil~~p~~~~~~ 174 (347)
++++|||+....
T Consensus 275 ~ll~~~~~~~~~ 286 (314)
T 3com_A 275 QLLQHPFVRSAK 286 (314)
T ss_dssp HHTTSHHHHTCC
T ss_pred HHHhCHHHhcCC
Confidence 999999997654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=229.74 Aligned_cols=154 Identities=25% Similarity=0.435 Sum_probs=123.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~--iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
+++.++..++.||+.||+|||++| |+||||||+||+++.++.+||+|||++....... .......||+.|+||
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~~gt~~y~aP 208 (309)
T 3p86_A 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-----LSSKSAAGTPEWMAP 208 (309)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------------------CCTTSCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-----cccccCCCCccccCh
Confidence 567889999999999999999999 9999999999999999999999999997543211 112345789999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
|++.+..++ .++||||+||++|+|++|+.||.+.+..+....+.. ....+.+..+++.+.++++.|| .+|..||+++
T Consensus 209 E~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 287 (309)
T 3p86_A 209 EVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFA 287 (309)
T ss_dssp HHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 999988776 689999999999999999999999988887777643 3334456678999999999999 7999999999
Q ss_pred HHhc
Q psy10462 163 DIRQ 166 (347)
Q Consensus 163 eil~ 166 (347)
++++
T Consensus 288 ~ll~ 291 (309)
T 3p86_A 288 TIMD 291 (309)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=236.26 Aligned_cols=157 Identities=22% Similarity=0.377 Sum_probs=137.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .......+|+.|+|||+
T Consensus 188 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~ 264 (382)
T 3tt0_A 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEA 264 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTT---CCCTTCCCGGGGSCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCccccccccccc---ccccCCCCCcceeCHHH
Confidence 678999999999999999999999999999999999999999999999999765432111 11233457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+...+.+..+++++.++++.|| .+|..||+++++
T Consensus 265 ~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 343 (382)
T 3tt0_A 265 LFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343 (382)
T ss_dssp HHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9887766 68999999999999999 99999999999988888887777777889999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 344 l~~ 346 (382)
T 3tt0_A 344 VED 346 (382)
T ss_dssp HHH
T ss_pred HHH
Confidence 865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=234.08 Aligned_cols=163 Identities=23% Similarity=0.402 Sum_probs=129.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... ........||+.|+|||+
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~ 190 (311)
T 3ork_A 113 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS--VTQTAAVIGTAQYLSPEQ 190 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------------------CCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc--cccccccCcCcccCCHHH
Confidence 567899999999999999999999999999999999999999999999999765432211 111234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---CCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
+.+..++ .++|+||+|+++|+|++|+.||.+.+..+...........+. ...+++++++++.+|| .+|..||+..
T Consensus 191 ~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~ 269 (311)
T 3ork_A 191 ARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269 (311)
T ss_dssp HHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred hcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhH
Confidence 9987776 689999999999999999999999888776666554433332 2458999999999999 7999999999
Q ss_pred HHhcCCCCCC
Q psy10462 163 DIRQDPWLKE 172 (347)
Q Consensus 163 eil~~p~~~~ 172 (347)
+++.++|++.
T Consensus 270 ~~l~~~l~~~ 279 (311)
T 3ork_A 270 AEMRADLVRV 279 (311)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=238.96 Aligned_cols=160 Identities=19% Similarity=0.246 Sum_probs=136.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC---cEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY---NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... ........||+.|+|
T Consensus 178 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~~~~t~~y~a 254 (367)
T 3l9p_A 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKWMP 254 (367)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS---CTTCCGGGSCGGGCC
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc---cccCCCcCCcccEEC
Confidence 66788999999999999999999999999999999999555 499999999975432211 111234567899999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+...+.+..+++.+.+++..|| .+|..||++
T Consensus 255 PE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 333 (367)
T 3l9p_A 255 PEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 333 (367)
T ss_dssp HHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCH
Confidence 9999887776 68999999999999998 99999999999998888887766677789999999999999 799999999
Q ss_pred HHHhcCCCC
Q psy10462 162 EDIRQDPWL 170 (347)
Q Consensus 162 ~eil~~p~~ 170 (347)
++++++.|.
T Consensus 334 ~eil~~l~~ 342 (367)
T 3l9p_A 334 AIILERIEY 342 (367)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=237.46 Aligned_cols=161 Identities=28% Similarity=0.544 Sum_probs=109.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
.+++.+++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++...... .....+||+.|+
T Consensus 124 ~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~t~~y~ 196 (336)
T 3fhr_A 124 AFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-------ALQTPCYTPYYV 196 (336)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-------ccccCCCCcCcc
Confidence 3678999999999999999999999999999999999976 455999999999765421 123456899999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHh---ccCCCCCCCCCHHHHHHHHhcc-CC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK----QVQK---RVVFPESPRLSSSCKALISNIL-SP 154 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~----~i~~---~~~~~~~~~~s~~~~~li~~~l-~~ 154 (347)
|||++.+..++ .++|+||+||++|+|++|..||.+.+...... .+.. ....+....+++.+++++..|| .+
T Consensus 197 aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 275 (336)
T 3fhr_A 197 APEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTD 275 (336)
T ss_dssp -------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSS
T ss_pred ChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCC
Confidence 99999877666 68999999999999999999998765443321 1111 1122333578999999999999 79
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q psy10462 155 VKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 155 ~~~R~~~~eil~~p~~~~~~ 174 (347)
|..||+++++++|||+.+..
T Consensus 276 P~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 276 PTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp GGGSCCHHHHHHSHHHHTGG
T ss_pred hhHCcCHHHHhcCccccccc
Confidence 99999999999999998743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=230.49 Aligned_cols=166 Identities=24% Similarity=0.475 Sum_probs=124.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||++++ +.+||+|||++......... .......||+.|+|||.
T Consensus 124 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~ 199 (313)
T 3cek_A 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS---VVKDSQVGTVNYMPPEA 199 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----------------CCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc---ccccCCCCCCCcCCHHH
Confidence 566889999999999999999999999999999999974 88999999999765432211 11234568999999999
Q ss_pred ccCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-
Q psy10462 87 LKGV-----------PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQK-RVVFPESPRLSSSCKALISNIL- 152 (347)
Q Consensus 87 ~~~~-----------~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l- 152 (347)
+.+. .++ .++|+||||+++|+|++|+.||..... ......+.. ....+.+...+..+++++..||
T Consensus 200 ~~~~~~~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 278 (313)
T 3cek_A 200 IKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLK 278 (313)
T ss_dssp HTTCC----------CCC-HHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTC
T ss_pred HhhcccccccccccccCC-chHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHcc
Confidence 8762 333 689999999999999999999987532 233333332 2233344566889999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy10462 153 SPVKFRIQMEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 153 ~~~~~R~~~~eil~~p~~~~~~~~~ 177 (347)
.+|..||+++++++|||+.....+.
T Consensus 279 ~dp~~Rps~~ell~h~~~~~~~~~~ 303 (313)
T 3cek_A 279 RDPKQRISIPELLAHPYVQIQTHPV 303 (313)
T ss_dssp SSTTTSCCHHHHHTSHHHHCC----
T ss_pred CCcccCcCHHHHhcCccccCCCCch
Confidence 7999999999999999998765543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=235.76 Aligned_cols=160 Identities=27% Similarity=0.454 Sum_probs=128.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++...... ......||+.|+|||
T Consensus 128 ~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~gt~~y~aPE 200 (360)
T 3eqc_A 128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------MANSFVGTRSYMSPE 200 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-------C----CCCCTTCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-------cccCCCCCCCeECHH
Confidence 56688999999999999999996 9999999999999999999999999998654321 123457899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------------------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ-------------------------------------- 127 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~-------------------------------------- 127 (347)
++.+..++ .++|+||+||++|+|++|+.||...+..+....
T Consensus 201 ~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
T 3eqc_A 201 RLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE 279 (360)
T ss_dssp HHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHH
T ss_pred HHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchh
Confidence 99987776 689999999999999999999987765443222
Q ss_pred ----HHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 128 ----VQKRVV-FPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 128 ----i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
+..... ......++.++++++++|| .+|.+||+++++++|||++...
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 280 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp HHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred hhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 111111 1122347889999999999 7999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-29 Score=223.39 Aligned_cols=156 Identities=18% Similarity=0.343 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ......+|+.|+|||.
T Consensus 101 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~ 176 (268)
T 3sxs_A 101 LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAPEV 176 (268)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE----ECCSCCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh----cccCCCcCcccCCHHH
Confidence 567899999999999999999999999999999999999999999999999866432211 1123446778999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |+.||...+..+....+........+...++.+.+++..|| .+|..||++.++
T Consensus 177 ~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 255 (268)
T 3sxs_A 177 FHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQL 255 (268)
T ss_dssp HHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9887766 57999999999999999 99999999988888888777666667778999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 256 l~~ 258 (268)
T 3sxs_A 256 LSS 258 (268)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=226.86 Aligned_cols=157 Identities=21% Similarity=0.385 Sum_probs=125.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ......+++.|+|||
T Consensus 112 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE 187 (281)
T 1mp8_A 112 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY----KASKGKLPIKWMAPE 187 (281)
T ss_dssp TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------------------CCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccccc----ccccCCCcccccChh
Confidence 3667889999999999999999999999999999999999999999999999765432111 112345678999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+||+|+++|+|++ |..||.+.+..+....+......+.+..+++.+.+++..|| .+|..||++.+
T Consensus 188 ~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 266 (281)
T 1mp8_A 188 SINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 266 (281)
T ss_dssp HHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99877766 68999999999999996 99999998888888888777666777889999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 267 l~~~ 270 (281)
T 1mp8_A 267 LKAQ 270 (281)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=225.19 Aligned_cols=156 Identities=21% Similarity=0.396 Sum_probs=135.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ........+++.|+|||.
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~ 178 (269)
T 4hcu_A 103 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEV 178 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH----HHSTTSTTCCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc----cccccCcccccccCCHHH
Confidence 5678899999999999999999999999999999999999999999999997653221 111223456788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |+.||.+.+..+....+........+...++.+.+++..|| .+|..||+++++
T Consensus 179 ~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 257 (269)
T 4hcu_A 179 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRL 257 (269)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 9877766 68999999999999999 99999999999988888887666667778999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 258 l~~ 260 (269)
T 4hcu_A 258 LRQ 260 (269)
T ss_dssp HHH
T ss_pred HHH
Confidence 865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=229.53 Aligned_cols=157 Identities=23% Similarity=0.339 Sum_probs=135.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......... ......+++.|+|||.
T Consensus 147 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~ 223 (314)
T 2ivs_A 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV---KRSQGRIPVKWMAIES 223 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE---CSSCCCSCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccce---eccCCCCcccccChhh
Confidence 5678999999999999999999999999999999999999999999999998664322211 1223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+||++|+|++ |..||.+.+..+....+......+.+..+++.+.+++..|| .+|..||+++++
T Consensus 224 ~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 224 LFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp HHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9887766 68999999999999999 99999999888888888777666667789999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=224.89 Aligned_cols=162 Identities=30% Similarity=0.496 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++..+..++.|++.||.|||++|++|+||||+||+++. ++.+||+|||++....... .......|++.|+|||
T Consensus 119 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE 193 (295)
T 2clq_A 119 DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-----PCTETFTGTLQYMAPE 193 (295)
T ss_dssp TCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----------CCCCCCGGGCCHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-----CcccccCCCccccChh
Confidence 456788889999999999999999999999999999987 8999999999997654321 1123457899999999
Q ss_pred cccCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HH-HHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 86 ILKGVP--YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE-LL-KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 86 ~~~~~~--~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~-~~-~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
.+.+.. ++ .++|+||||+++|+|++|+.||...+... .. .........+.+..+++++++++..|| .+|..||+
T Consensus 194 ~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 272 (295)
T 2clq_A 194 IIDKGPRGYG-KAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272 (295)
T ss_dssp HHHHGGGGCS-HHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCC
T ss_pred hhcCCCCCCC-cHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCC
Confidence 987643 33 68999999999999999999997643322 22 221222333345678999999999999 79999999
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++|||+....
T Consensus 273 ~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 273 ANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHTSGGGCC--
T ss_pred HHHHhcChhhhhcc
Confidence 99999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=224.67 Aligned_cols=157 Identities=20% Similarity=0.380 Sum_probs=135.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ........+|+.|+|||
T Consensus 116 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE 191 (283)
T 3gen_A 116 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPE 191 (283)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH----HHSTTSTTSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc----cccccCCccCcccCCHH
Confidence 36678999999999999999999999999999999999999999999999997653221 11122345678899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+||+|+++|+|++ |+.||...+..+....+........+...++.+.+++..|| .+|..||++++
T Consensus 192 ~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 270 (283)
T 3gen_A 192 VLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKI 270 (283)
T ss_dssp HHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHH
Confidence 99877766 68999999999999998 99999999988888888887766667788999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 271 ll~~ 274 (283)
T 3gen_A 271 LLSN 274 (283)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=234.26 Aligned_cols=157 Identities=20% Similarity=0.358 Sum_probs=131.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......||+.|+|||+
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~t~~y~aPE~ 266 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPET 266 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC---EEC--CEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc---hhccccCCCceeEChhh
Confidence 778999999999999999999999999999999999999999999999999765432211 11234568899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYS-ELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|||||||++|+|++ |..||.+.+.. .....+......+.+...++++.+++..|| .+|..||++++
T Consensus 267 ~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 345 (359)
T 3vhe_A 267 IFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 345 (359)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9887776 68999999999999998 99999887643 444555555556666778999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
+++|
T Consensus 346 ll~~ 349 (359)
T 3vhe_A 346 LVEH 349 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9865
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=230.03 Aligned_cols=160 Identities=30% Similarity=0.566 Sum_probs=127.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc---EEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
.+++.+++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++....... ......||+.|+
T Consensus 110 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~gt~~y~ 183 (322)
T 2ycf_A 110 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS------LMRTLCGTPTYL 183 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH------HHHHHHSCCTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc------ccccccCCcCcc
Confidence 3667899999999999999999999999999999999987654 9999999997654211 112456899999
Q ss_pred cccccc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCCC---CCCCCHHHHHHHHhcc-CC
Q psy10462 83 SPEILK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFPE---SPRLSSSCKALISNIL-SP 154 (347)
Q Consensus 83 aPE~~~---~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~---~~~~s~~~~~li~~~l-~~ 154 (347)
|||++. +..++ .++|+||+||++|+|++|..||...... .....+..+..... ...+++.+.+++.+|| .+
T Consensus 184 aPE~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 262 (322)
T 2ycf_A 184 APEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVD 262 (322)
T ss_dssp CHHHHHHTTTTTCT-THHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred CchhhccCCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccC
Confidence 999974 33444 6899999999999999999999865432 33334433322111 2467899999999999 79
Q ss_pred CCCCCCHHHHhcCCCCCC
Q psy10462 155 VKFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 155 ~~~R~~~~eil~~p~~~~ 172 (347)
|..||+++++++|||+..
T Consensus 263 P~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 263 PKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TTTSCCHHHHHTSGGGCC
T ss_pred HhhCCCHHHHhhCcCcCC
Confidence 999999999999999865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=225.11 Aligned_cols=159 Identities=21% Similarity=0.371 Sum_probs=136.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......... .......||+.|+|||+
T Consensus 107 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~ 184 (287)
T 1u59_A 107 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY--TARSAGKWPLKWYAPEC 184 (287)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE--CCCCSSCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee--eccccccccccccCHHH
Confidence 6779999999999999999999999999999999999999999999999998764332211 11223456889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |+.||.+.+..+....+..+...+.+..+++.+.+++..|+ .+|..||+++++
T Consensus 185 ~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 263 (287)
T 1u59_A 185 INFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 263 (287)
T ss_dssp HHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred hccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9877666 68999999999999998 99999998888888888777666666789999999999999 799999999999
Q ss_pred hcCC
Q psy10462 165 RQDP 168 (347)
Q Consensus 165 l~~p 168 (347)
+++.
T Consensus 264 ~~~l 267 (287)
T 1u59_A 264 EQRM 267 (287)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=239.79 Aligned_cols=155 Identities=22% Similarity=0.420 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .......+++.|+|||+
T Consensus 281 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~~~~y~aPE~ 356 (454)
T 1qcf_A 281 QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEA 356 (454)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH----HTTCSSSSCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce----eccCCCcccccccCHHH
Confidence 44578889999999999999999999999999999999999999999999976532111 11123346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |+.||.+.+..++...+..+...+.+..+++++.+++..|+ .+|..||+++++
T Consensus 357 ~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i 435 (454)
T 1qcf_A 357 INFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYI 435 (454)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 9877766 68999999999999999 99999999999998888888877778889999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 436 ~~ 437 (454)
T 1qcf_A 436 QS 437 (454)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-29 Score=223.69 Aligned_cols=159 Identities=18% Similarity=0.270 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc-----EEEeccCCceecccCCcccc--ccCcccccCCc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-----IKLSDFGFARKYSVNNTDYK--QNLSETFCGSY 79 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~-----~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~gt~ 79 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++. +||+|||++........... ........||+
T Consensus 103 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~ 182 (298)
T 1csn_A 103 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCc
Confidence 677899999999999999999999999999999999987766 99999999987654322111 11234567999
Q ss_pred cccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhccC-CC---CCCCCCHHHHHHHHhcc
Q psy10462 80 AYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---NYSELLKQVQKRVV-FP---ESPRLSSSCKALISNIL 152 (347)
Q Consensus 80 ~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~---~~~~~~~~i~~~~~-~~---~~~~~s~~~~~li~~~l 152 (347)
.|+|||++.+..++ .++||||||+++|+|++|+.||.+. ...+....+..... .+ ....+++++++++..|+
T Consensus 183 ~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 261 (298)
T 1csn_A 183 RYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYAR 261 (298)
T ss_dssp TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHH
T ss_pred ccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHh
Confidence 99999999887776 6899999999999999999999874 33444444433211 11 12468899999999999
Q ss_pred -CCCCCCCCHHHHhc
Q psy10462 153 -SPVKFRIQMEDIRQ 166 (347)
Q Consensus 153 -~~~~~R~~~~eil~ 166 (347)
.+|..||+++++.+
T Consensus 262 ~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 262 NLAFDATPDYDYLQG 276 (298)
T ss_dssp HCCTTCCCCHHHHHH
T ss_pred cCCcccCCCHHHHHH
Confidence 79999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=237.63 Aligned_cols=159 Identities=24% Similarity=0.419 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC-------------CcEEEeccCCceecccCCccccccCcccccC
Q psy10462 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK-------------YNIKLSDFGFARKYSVNNTDYKQNLSETFCG 77 (347)
Q Consensus 11 ~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~-------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~g 77 (347)
++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++........... ......+|
T Consensus 116 ~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~-~~~~~~~g 194 (434)
T 2rio_A 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR-TNLNNPSG 194 (434)
T ss_dssp CHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC---------------
T ss_pred hHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccce-eeecCCCC
Confidence 456799999999999999999999999999999754 4799999999987654322111 11234579
Q ss_pred CccccccccccC-------CCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCC-----CCCCHHH
Q psy10462 78 SYAYASPEILKG-------VPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPES-----PRLSSSC 144 (347)
Q Consensus 78 t~~y~aPE~~~~-------~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~-----~~~s~~~ 144 (347)
|+.|+|||++.+ ..++ .++||||+||++|+|++ |..||.+....+ ...+......+.. ..+++++
T Consensus 195 t~~y~aPE~~~~~~~~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~ 272 (434)
T 2rio_A 195 TSGWRAPELLEESNNLQTKRRLT-RSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SNIIRGIFSLDEMKCLHDRSLIAEA 272 (434)
T ss_dssp CCTTSCHHHHSCCCTTSCCCCCC-THHHHHHHHHHHHHHHTTSCCTTCSTTTHH-HHHHHTCCCCCCCTTCCCHHHHHHH
T ss_pred CCCccCHHHhccccccccccCcc-hhhhhHhHHHHHHHHHhCCCCCCCCchhhH-HHHhcCCCCcccccccccccchHHH
Confidence 999999999976 3344 78999999999999999 999998765433 2222222222222 2345789
Q ss_pred HHHHHhcc-CCCCCCCCHHHHhcCCCCCC
Q psy10462 145 KALISNIL-SPVKFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 145 ~~li~~~l-~~~~~R~~~~eil~~p~~~~ 172 (347)
++++..|| .+|..||++.++++|||+..
T Consensus 273 ~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 273 TDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 99999999 79999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=226.58 Aligned_cols=158 Identities=22% Similarity=0.352 Sum_probs=134.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......||+.|+|||
T Consensus 134 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE 210 (322)
T 1p4o_A 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPE 210 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcccccccccccc---ccccCCCCCCCccChh
Confidence 3467889999999999999999999999999999999999999999999999765432111 1122345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+||+|+++|+|++ |..||.+.+..+....+......+.+..+++.+.+++..|| .+|..||++.+
T Consensus 211 ~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 289 (322)
T 1p4o_A 211 SLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE 289 (322)
T ss_dssp HHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 99887766 68999999999999999 89999999888888888776666667788999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 290 ~l~~ 293 (322)
T 1p4o_A 290 IISS 293 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=234.20 Aligned_cols=156 Identities=22% Similarity=0.333 Sum_probs=132.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........ .......+++.|+|||.
T Consensus 210 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~---~~~~~~~~~~~y~aPE~ 286 (377)
T 3cbl_A 210 LRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA---ASGGLRQVPVKWTAPEA 286 (377)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE---CCSSCCEEEGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee---ecCCCCCCCcCcCCHhH
Confidence 556889999999999999999999999999999999999999999999999764321111 11112235678999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+...+.+...++++.+++..|+ .+|..||+++++
T Consensus 287 ~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 365 (377)
T 3cbl_A 287 LNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365 (377)
T ss_dssp HHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 9877766 68999999999999998 99999999988888888887777777788999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 366 ~~ 367 (377)
T 3cbl_A 366 YQ 367 (377)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=235.85 Aligned_cols=139 Identities=21% Similarity=0.249 Sum_probs=124.7
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
..++|++.+.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.+|+.++||||++++++|++.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 35789999999999999999999999999999999975432222334556799999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||+||+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g 142 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 142 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC
Confidence 999999999999998888999999999988776 99999999999999999999998776
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=226.78 Aligned_cols=160 Identities=24% Similarity=0.476 Sum_probs=123.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++.++..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++....... ......||+.|+||
T Consensus 120 ~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aP 193 (318)
T 2dyl_A 120 PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK------AKDRSAGCAAYMAP 193 (318)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------------CCTTCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc------cccccCCCccccCh
Confidence 356788999999999999999995 99999999999999999999999999987654321 12234689999999
Q ss_pred cccc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhccC--CCCCCCCCHHHHHHHHhcc-CCC
Q psy10462 85 EILK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVV--FPESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 85 E~~~-----~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-~~~~~~~~i~~~~~--~~~~~~~s~~~~~li~~~l-~~~ 155 (347)
|++. +..++ .++|+||+|+++|+|++|+.||... +..+....+..... .+....+++++.+++..|| .+|
T Consensus 194 E~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 272 (318)
T 2dyl_A 194 ERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDH 272 (318)
T ss_dssp HHHC--------CC-THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCT
T ss_pred hhcccccccccCCc-cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCCh
Confidence 9985 33344 6899999999999999999999874 44455555544332 3334568999999999999 799
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~ 172 (347)
..||+++++++|||+..
T Consensus 273 ~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 273 RKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp TTSCCHHHHTTSHHHHH
T ss_pred hHCcCHHHHhhCHHHHh
Confidence 99999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=229.69 Aligned_cols=158 Identities=20% Similarity=0.290 Sum_probs=134.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ........||+.|+|||
T Consensus 170 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~t~~y~aPE 246 (343)
T 1luf_A 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKADGNDAIPIRWMPPE 246 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC---BC----CCBCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCcc---ccccCCCcccceecChh
Confidence 466789999999999999999999999999999999999999999999999976532211 11123446789999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
++.+..++ .++|+||||+++|+|++ |..||.+.+..+....+..+...+.+..+++.+.++++.|| .+|..||++.+
T Consensus 247 ~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 247 SIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp HHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 99887766 68999999999999999 99999999988888888777666666788999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 326 ~~~~ 329 (343)
T 1luf_A 326 IHRI 329 (343)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=223.95 Aligned_cols=156 Identities=20% Similarity=0.296 Sum_probs=131.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .......+++.|+|||.
T Consensus 110 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~ 185 (281)
T 3cc6_A 110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY----YKASVTRLPIKWMSPES 185 (281)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-------------CCCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc----cccccCCCCcceeCchh
Confidence 56788999999999999999999999999999999999999999999999876543211 11223456889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |+.||...+..+....+......+.+..+++.+.+++..|| .+|..||++.++
T Consensus 186 ~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 264 (281)
T 3cc6_A 186 INFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL 264 (281)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 9877766 68999999999999998 99999988877777777777666777789999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 265 l~~ 267 (281)
T 3cc6_A 265 VCS 267 (281)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=233.39 Aligned_cols=160 Identities=19% Similarity=0.346 Sum_probs=124.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc--CCCcEEEeccCCceecccCCccc--cccCcccccCCccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD--DKYNIKLSDFGFARKYSVNNTDY--KQNLSETFCGSYAY 81 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~gt~~y 81 (347)
.+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++......... ........+||+.|
T Consensus 148 ~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y 227 (364)
T 3op5_A 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEF 227 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCc
Confidence 367899999999999999999999999999999999999 88999999999998765432111 11122456699999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccC---------CCCCCCCCHHHHHHHHhc
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVV---------FPESPRLSSSCKALISNI 151 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~~~~---------~~~~~~~s~~~~~li~~~ 151 (347)
+|||++.+..++ .++|||||||++|+|++|+.||.+.... ........... .......++++.+++..|
T Consensus 228 ~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 306 (364)
T 3op5_A 228 TSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETV 306 (364)
T ss_dssp CCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHH
T ss_pred cCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHH
Confidence 999999988776 6899999999999999999999863222 21111111100 011256789999999999
Q ss_pred c-CCCCCCCCHHHHhc
Q psy10462 152 L-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 152 l-~~~~~R~~~~eil~ 166 (347)
+ .+|..||+++++.+
T Consensus 307 l~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 307 KLLDYTEKPLYENLRD 322 (364)
T ss_dssp HTCCTTCCCCHHHHHH
T ss_pred hcCCCCCCCCHHHHHH
Confidence 9 79999999998864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=224.97 Aligned_cols=160 Identities=33% Similarity=0.627 Sum_probs=133.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC---CcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK---YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
.+++.++..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++....... ......|++.|+
T Consensus 117 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~y~ 190 (287)
T 2wei_A 117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT------KMKDRIGTAYYI 190 (287)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS------SCSCHHHHHTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC------ccccccCccccc
Confidence 35678999999999999999999999999999999999754 469999999987553221 122345889999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC---CCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF---PESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
|||.+.+. ++ .++|+||+|+++|+|++|..||.+.+..+....+..+... +....++++++++++.|| .+|..|
T Consensus 191 aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 268 (287)
T 2wei_A 191 APEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR 268 (287)
T ss_dssp CHHHHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGS
T ss_pred ChHHhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhC
Confidence 99998874 44 6899999999999999999999999888888877665432 223568999999999999 799999
Q ss_pred CCHHHHhcCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKED 173 (347)
Q Consensus 159 ~~~~eil~~p~~~~~ 173 (347)
|+++++++|||+.+.
T Consensus 269 ps~~ell~hp~~~~~ 283 (287)
T 2wei_A 269 ITATQCLEHPWIQKY 283 (287)
T ss_dssp CCHHHHHHSHHHHHH
T ss_pred cCHHHHhcCHHHhcc
Confidence 999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-29 Score=226.16 Aligned_cols=157 Identities=17% Similarity=0.305 Sum_probs=129.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......+++.|+|||.
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 220 (313)
T 3brb_A 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIES 220 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC-------------------CCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceeccccccc---CcccccCCCccccCchh
Confidence 667899999999999999999999999999999999999999999999999765432111 11223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||||+++|+|++ |..||.+.+..+....+..+...+.+..+++.+.+++..|| .+|..||+++++
T Consensus 221 ~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (313)
T 3brb_A 221 LADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299 (313)
T ss_dssp HHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred hcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9887766 68999999999999999 99999998888888888777666667788999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 300 ~~~ 302 (313)
T 3brb_A 300 RLQ 302 (313)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.8e-30 Score=239.30 Aligned_cols=141 Identities=20% Similarity=0.308 Sum_probs=125.6
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCe
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 265 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 265 (347)
.+..++|++.+.||+|+||+||+|+++.+++.||+|++++.........+.+.+|..+|+++ +|||||+++++|++++.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 34567899999999999999999999999999999999876555555556677999999887 89999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+|||||+||+|.+++.+.+.+++..+++++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g 190 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 190 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC
Confidence 999999999999999999888999999999988876 99999999999999999999998876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=225.94 Aligned_cols=156 Identities=33% Similarity=0.601 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc-CCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++.++..++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...... ......|++.|+|||
T Consensus 136 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE 208 (312)
T 2iwi_A 136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-------PYTDFDGTRVYSPPE 208 (312)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-------CBCCCCSCTTTSCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-------cccccCCcccccCce
Confidence 56788999999999999999999999999999999999 7899999999999866432 123456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
++.+..+.+.++|+||+|+++|+|++|+.||.... + ...... ..+..+++.+++++.+|| .+|..||+++++
T Consensus 209 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~---~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 281 (312)
T 2iwi_A 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--E---ILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281 (312)
T ss_dssp HHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---HHHTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred eeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--H---Hhhhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99876665457999999999999999999997532 1 112222 234678999999999999 799999999999
Q ss_pred hcCCCCCCCCCC
Q psy10462 165 RQDPWLKEDSNP 176 (347)
Q Consensus 165 l~~p~~~~~~~~ 176 (347)
++|||+......
T Consensus 282 l~~~~~~~~~~~ 293 (312)
T 2iwi_A 282 LLDPWMQTPAED 293 (312)
T ss_dssp HHSTTTCC----
T ss_pred hcChhhcCchhc
Confidence 999999876543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=238.11 Aligned_cols=159 Identities=21% Similarity=0.335 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-----CCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-----KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 10 ~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.++..++.||+.||.|||++||+||||||+|||++. ...+||+|||+|.......... ......+||+.|+||
T Consensus 118 ~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~gt~~y~AP 195 (432)
T 3p23_A 118 LEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF--SRRSGVPGTEGWIAP 195 (432)
T ss_dssp SCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------------CCSCTTSCCG
T ss_pred hhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce--eeccccCCCcCccCh
Confidence 467889999999999999999999999999999953 3358899999998764322111 122346799999999
Q ss_pred ccccC---CCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCC---CCCCCCHHHHHHHHhcc-CCCC
Q psy10462 85 EILKG---VPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFP---ESPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 85 E~~~~---~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~li~~~l-~~~~ 156 (347)
|++.+ ..++ .++||||+||++|+|++ |..||........... ......+ .....+..+++++..|| .+|.
T Consensus 196 E~l~~~~~~~~t-~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 273 (432)
T 3p23_A 196 EMLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-LGACSLDCLHPEKHEDVIARELIEKMIAMDPQ 273 (432)
T ss_dssp GGTSCC---CCC-THHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGG
T ss_pred hhhhcccccCCC-cHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-hccCCccccCccccccHHHHHHHHHHHhCCHh
Confidence 99974 2333 58999999999999999 9999976654443322 2222111 12234566899999999 7999
Q ss_pred CCCCHHHHhcCCCCCC
Q psy10462 157 FRIQMEDIRQDPWLKE 172 (347)
Q Consensus 157 ~R~~~~eil~~p~~~~ 172 (347)
.||+++++++||||..
T Consensus 274 ~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 274 KRPSAKHVLKHPFFWS 289 (432)
T ss_dssp GSCCHHHHHTSTTTCC
T ss_pred hCCCHHHHHhCccccC
Confidence 9999999999999965
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-29 Score=223.35 Aligned_cols=154 Identities=27% Similarity=0.441 Sum_probs=120.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ......+||+.|+|||.
T Consensus 108 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~ 183 (294)
T 4eqm_A 108 LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL----TQTNHVLGTVQYFSPEQ 183 (294)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----------------CCSSCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc----cccCccccCccccCHhH
Confidence 56789999999999999999999999999999999999999999999999976542211 11234579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----CCCCCCHHHHHHHHhcc-CCCCCCC-C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----ESPRLSSSCKALISNIL-SPVKFRI-Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~s~~~~~li~~~l-~~~~~R~-~ 160 (347)
+.+..++ .++|+||+|+++|+|++|+.||.+.+..+...........+ .+..+++.+.+++.+|| .+|..|| +
T Consensus 184 ~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~ 262 (294)
T 4eqm_A 184 AKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKT 262 (294)
T ss_dssp HHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSS
T ss_pred hcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHcccc
Confidence 9987776 67999999999999999999999888766554443332211 24568999999999999 7999999 5
Q ss_pred HHHHh
Q psy10462 161 MEDIR 165 (347)
Q Consensus 161 ~~eil 165 (347)
++++.
T Consensus 263 ~~~l~ 267 (294)
T 4eqm_A 263 IQEMK 267 (294)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55444
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=230.39 Aligned_cols=161 Identities=20% Similarity=0.376 Sum_probs=124.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC--cEEEeccCCceecccCCcc--ccccCcccccCCccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY--NIKLSDFGFARKYSVNNTD--YKQNLSETFCGSYAY 81 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~gt~~y 81 (347)
.+++.++..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++........ ..........||+.|
T Consensus 147 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y 226 (345)
T 2v62_A 147 TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF 226 (345)
T ss_dssp BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccc
Confidence 367899999999999999999999999999999999998877 9999999999876432211 111122456799999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhc-cCCC-------CCCCCCHHHHHHHHhc
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT--NYSELLKQVQKR-VVFP-------ESPRLSSSCKALISNI 151 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~--~~~~~~~~i~~~-~~~~-------~~~~~s~~~~~li~~~ 151 (347)
+|||++.+..++ .++|+|||||++|+|++|+.||.+. +........... ...| ....+++++++++..|
T Consensus 227 ~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 305 (345)
T 2v62_A 227 TSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCA 305 (345)
T ss_dssp CCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHH
T ss_pred cCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHH
Confidence 999999987766 6899999999999999999999652 222222111111 1111 1227889999999999
Q ss_pred c-CCCCCCCCHHHHhcC
Q psy10462 152 L-SPVKFRIQMEDIRQD 167 (347)
Q Consensus 152 l-~~~~~R~~~~eil~~ 167 (347)
| .+|..||+++++++.
T Consensus 306 l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 306 HSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HTCCTTCCCCHHHHHHH
T ss_pred hhcCcccCCCHHHHHHH
Confidence 9 799999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=236.88 Aligned_cols=141 Identities=20% Similarity=0.252 Sum_probs=124.5
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCe
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 265 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 265 (347)
.+..++|++.+.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|..+|+.+ +||||++++++|++.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 34567899999999999999999999999999999999765433333455677999999988 79999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+|||||+||+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g 161 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG 161 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC
Confidence 999999999999999998888999999999988876 99999999999999999999998776
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=221.84 Aligned_cols=158 Identities=21% Similarity=0.365 Sum_probs=132.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ..........+++.|+|||.
T Consensus 121 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~ 199 (298)
T 3pls_A 121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY-YSVQQHRHARLPVKWTALES 199 (298)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG-GCSCCSSCTTCGGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc-cccccCcCCCCCccccChhh
Confidence 56688999999999999999999999999999999999999999999999976543211 11222334567899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |..||...+..+....+......+.+...++.+.+++..|| .+|..||+++++
T Consensus 200 ~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 278 (298)
T 3pls_A 200 LQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVL 278 (298)
T ss_dssp HTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHH
Confidence 9887776 68999999999999999 56667777777777777777777777889999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 279 l~ 280 (298)
T 3pls_A 279 VG 280 (298)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-29 Score=223.20 Aligned_cols=157 Identities=20% Similarity=0.328 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........... ......+++.|+|||.
T Consensus 114 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~ 191 (291)
T 1xbb_A 114 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPEC 191 (291)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE--C----CCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc--ccccCCCCceeeChHH
Confidence 56789999999999999999999999999999999999999999999999987643322111 1123346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |+.||.+.+..+....+..+...+.+..+++.+.+++..|+ .+|..||++.++
T Consensus 192 ~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 270 (291)
T 1xbb_A 192 INYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 270 (291)
T ss_dssp HHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9877665 68999999999999999 99999999988888888777666666788999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 271 ~~ 272 (291)
T 1xbb_A 271 EL 272 (291)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=228.76 Aligned_cols=155 Identities=23% Similarity=0.372 Sum_probs=132.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .......+++.|+|||
T Consensus 138 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE 211 (327)
T 1fvr_A 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIE 211 (327)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE------CCC----CCTTTCCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc------ccccCCCCCccccChh
Confidence 4678899999999999999999999999999999999999999999999998743221 1112345688999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+||+||++|+|++ |..||.+.+..+....+..+...+.+..+++.+++++..|| .+|..||++++
T Consensus 212 ~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 212 SLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp HHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99877666 68999999999999998 99999999988888888777666667788999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 291 ll~~ 294 (327)
T 1fvr_A 291 ILVS 294 (327)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=225.64 Aligned_cols=158 Identities=21% Similarity=0.356 Sum_probs=129.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... ........+++.|+|||.
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~ 221 (333)
T 1mqb_A 144 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEA 221 (333)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------------------CCCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc--ccccCCCCccccccCchh
Confidence 567889999999999999999999999999999999999999999999999765432111 111122346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |+.||.+.+..+....+..+...+.+..+++.+.+++..|+ .+|..||++.++
T Consensus 222 ~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 300 (333)
T 1mqb_A 222 ISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 300 (333)
T ss_dssp HHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9887766 68999999999999998 99999999988888888887777777789999999999999 799999999998
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 301 ~~~ 303 (333)
T 1mqb_A 301 VSI 303 (333)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=220.02 Aligned_cols=156 Identities=22% Similarity=0.408 Sum_probs=134.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ......+++.|+|||
T Consensus 105 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE 180 (279)
T 1qpc_A 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT----AREGAKFPIKWTAPE 180 (279)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE----CCTTCCCCTTTSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc----cccCCCCccCccChh
Confidence 3567889999999999999999999999999999999999999999999999876432211 122345678899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|+||+|+++|+|++ |+.||.+.+..+....+..+...+.+..+++.+.+++..|+ .+|..||++++
T Consensus 181 ~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 259 (279)
T 1qpc_A 181 AINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDY 259 (279)
T ss_dssp HHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHH
Confidence 99877666 68999999999999999 99999999888888888777666667788999999999999 79999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+++
T Consensus 260 l~~ 262 (279)
T 1qpc_A 260 LRS 262 (279)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-29 Score=236.70 Aligned_cols=151 Identities=22% Similarity=0.433 Sum_probs=131.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....+++.|+|||+
T Consensus 286 ~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--------~~~~~~~~~y~aPE~ 357 (450)
T 1k9a_A 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--------QDTGKLPVKWTAPEA 357 (450)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------------CCCTTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--------ccCCCCCcceeCHHH
Confidence 466788999999999999999999999999999999999999999999999754321 112356889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |+.||.+.+..++...+..+...+.+..+++.+.+++..|+ .+|..||++.++
T Consensus 358 ~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l 436 (450)
T 1k9a_A 358 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQL 436 (450)
T ss_dssp HHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9887776 68999999999999998 99999998888888888888777777889999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 437 ~~ 438 (450)
T 1k9a_A 437 RE 438 (450)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-29 Score=231.66 Aligned_cols=158 Identities=22% Similarity=0.363 Sum_probs=124.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... .......+++.|+|||
T Consensus 143 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~~y~aPE 220 (373)
T 2qol_A 143 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA--YTTRGGKIPIRWTSPE 220 (373)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------------CTTSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccc--eeccCCCcCCCccChh
Confidence 35678899999999999999999999999999999999999999999999997654321110 0111223567899999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|||||||++|++++ |+.||.+.+..+....+..+...+.+...+..+.+++..|+ .+|..||++++
T Consensus 221 ~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~ 299 (373)
T 2qol_A 221 AIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299 (373)
T ss_dssp HHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHH
Confidence 99887776 68999999999999997 99999999988888888888777777889999999999999 79999999998
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+++
T Consensus 300 i~~ 302 (373)
T 2qol_A 300 IVS 302 (373)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=232.03 Aligned_cols=139 Identities=25% Similarity=0.402 Sum_probs=125.5
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
....+|++.+.||+|+||+||+|++..+|+.||+|++.+..... ...+.+.+|+++|+.++||||+++++++.+++.+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 34568999999999999999999999999999999997654433 33455679999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||++|+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~ 151 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM 151 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC
Confidence 9999999999999998888999999999988876 99999999999999999999998765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=233.16 Aligned_cols=139 Identities=21% Similarity=0.306 Sum_probs=127.0
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 267 (347)
..++|++.+.||+|+||+||+|+++.+++.||+|++++.........+.+.+|..+++++ +|||||+++++|++++.+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 457899999999999999999999999999999999876555555566678999999988 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||+||+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g 147 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 147 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC
Confidence 9999999999999998888999999999988776 99999999999999999999998776
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=222.15 Aligned_cols=159 Identities=22% Similarity=0.365 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---cCCCcEEEeccCCceecccCCcccc--ccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYK--QNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~gt~~y 81 (347)
+++.++..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........... ........||+.|
T Consensus 102 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y 181 (296)
T 4hgt_A 102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181 (296)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccc
Confidence 5778999999999999999999999999999999999 7889999999999987654322110 1122356799999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHh-ccCCC---CCCCCCHHHHHHHHhcc-C
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---ELLKQVQK-RVVFP---ESPRLSSSCKALISNIL-S 153 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~---~~~~~i~~-~~~~~---~~~~~s~~~~~li~~~l-~ 153 (347)
+|||.+.+..++ .++||||+||++|+|++|+.||.+.+.. +....+.. ....+ ....+++++.+++..|+ .
T Consensus 182 ~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 260 (296)
T 4hgt_A 182 ASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSL 260 (296)
T ss_dssp CCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTS
T ss_pred cchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhc
Confidence 999999988766 6899999999999999999999864321 22222221 22222 12567899999999999 7
Q ss_pred CCCCCCCHHHHhc
Q psy10462 154 PVKFRIQMEDIRQ 166 (347)
Q Consensus 154 ~~~~R~~~~eil~ 166 (347)
+|..||+++++++
T Consensus 261 ~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 261 RFDDKPDYSYLRQ 273 (296)
T ss_dssp CTTCCCCHHHHHH
T ss_pred CCCCCCCHHHHHH
Confidence 9999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=226.25 Aligned_cols=157 Identities=22% Similarity=0.370 Sum_probs=135.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......+++.|+|||+
T Consensus 154 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 230 (334)
T 2pvf_A 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEA 230 (334)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSE---ECCSCCCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccc---cccCCCCcccceeChHH
Confidence 567889999999999999999999999999999999999999999999999865432211 11223456889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |..||.+.+..+....+..+...+.+..++..+.+++..|+ .+|..||+++++
T Consensus 231 ~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 309 (334)
T 2pvf_A 231 LFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309 (334)
T ss_dssp HHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9877666 68999999999999999 99999999988888888777666667788999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 310 l~~ 312 (334)
T 2pvf_A 310 VED 312 (334)
T ss_dssp HHH
T ss_pred HHH
Confidence 854
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-30 Score=235.27 Aligned_cols=141 Identities=20% Similarity=0.204 Sum_probs=123.6
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCe
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 265 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 265 (347)
....++|++.+.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|..+++.+ +||||++++++|++++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45568899999999999999999999999999999999764322222344566899999876 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+|||||+||+|.+++++.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 155 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC
Confidence 999999999999999998888999999999988776 99999999999999999999998876
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=231.66 Aligned_cols=159 Identities=21% Similarity=0.344 Sum_probs=123.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ........+++.|+|||.
T Consensus 189 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~-~~~~~~~~~~~~y~aPE~ 267 (373)
T 3c1x_A 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-VHNKTGAKLPVKWMALES 267 (373)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc-ccccCCCCCcccccChHH
Confidence 4568889999999999999999999999999999999999999999999997654321111 111223457789999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+...+.+..+++.+.+++..|+ .+|..||+++++
T Consensus 268 ~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 268 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9887776 68999999999999999 78899887776677777666666666788999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 347 l~~ 349 (373)
T 3c1x_A 347 VSR 349 (373)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=232.06 Aligned_cols=139 Identities=18% Similarity=0.282 Sum_probs=124.8
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
..++|++.+.||+|+||+||+|++..+|+.||+|++++.........+.+.+|+.+++.++||||++++++|++.+.+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 45789999999999999999999999999999999975433222334556789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||+||+|.+++++.+.+++..++.++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g 143 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG 143 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC
Confidence 999999999999999888999999999988776 99999999999999999999998765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=222.70 Aligned_cols=159 Identities=22% Similarity=0.362 Sum_probs=125.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---cCCCcEEEeccCCceecccCCcccc--ccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYK--QNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~gt~~y 81 (347)
+++.++..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........... ........||+.|
T Consensus 102 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y 181 (296)
T 3uzp_A 102 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181 (296)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTT
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccccccc
Confidence 6778999999999999999999999999999999999 4788999999999987654322110 0112456799999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHh-ccCCC---CCCCCCHHHHHHHHhcc-C
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---SELLKQVQK-RVVFP---ESPRLSSSCKALISNIL-S 153 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~---~~~~~~i~~-~~~~~---~~~~~s~~~~~li~~~l-~ 153 (347)
+|||.+.+..++ .++||||+||++|+|++|+.||.+.+. .+....+.. ....+ ....+++++.+++..|| .
T Consensus 182 ~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 260 (296)
T 3uzp_A 182 ASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSL 260 (296)
T ss_dssp CCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTS
T ss_pred CChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhc
Confidence 999999987766 689999999999999999999986432 223333322 22222 12568899999999999 7
Q ss_pred CCCCCCCHHHHhc
Q psy10462 154 PVKFRIQMEDIRQ 166 (347)
Q Consensus 154 ~~~~R~~~~eil~ 166 (347)
+|..||+++++++
T Consensus 261 dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 261 RFDDKPDYSYLRQ 273 (296)
T ss_dssp CTTCCCCHHHHHH
T ss_pred CcCcCCCHHHHHH
Confidence 9999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=241.66 Aligned_cols=140 Identities=15% Similarity=0.251 Sum_probs=125.3
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|++.+.||+|+||+||+|+++.+++.||+|++++...........+.+|..+++.++|||||+++++|++++.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 34678999999999999999999999999999999997643333333455789999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||+||+|.+++.+ .+.+++..++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC
Confidence 99999999999999987 57899999999988776 99999999999999999999998776
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=228.57 Aligned_cols=157 Identities=20% Similarity=0.314 Sum_probs=130.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......||+.|+|||+
T Consensus 169 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~ 245 (344)
T 1rjb_A 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPES 245 (344)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccc---eeccCccCccCccCHHH
Confidence 577889999999999999999999999999999999999999999999999765432211 11233457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSE-LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||||+++|+|+| |..||.+.+..+ ....+......+.+...++++.+++..|| .+|..||++++
T Consensus 246 ~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 246 LFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9887766 68999999999999998 999998876544 34444555555666778999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 325 l~~~ 328 (344)
T 1rjb_A 325 LTSF 328 (344)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=220.28 Aligned_cols=151 Identities=22% Similarity=0.442 Sum_probs=126.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .....+++.|+|||.
T Consensus 114 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--------~~~~~~~~~y~aPE~ 185 (278)
T 1byg_A 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--------QDTGKLPVKWTAPEA 185 (278)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------------CCTTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--------ccCCCccccccCHHH
Confidence 456778999999999999999999999999999999999999999999998754321 123357889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |+.||...+..+....+..+...+.+...++.+.++++.|+ .+|..||++.++
T Consensus 186 ~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 264 (278)
T 1byg_A 186 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264 (278)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 9877766 68999999999999998 99999998888888888777666667788999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 265 ~~ 266 (278)
T 1byg_A 265 RE 266 (278)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=221.99 Aligned_cols=158 Identities=21% Similarity=0.342 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... .........||+.|+|||.
T Consensus 125 ~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~~~y~aPE~ 203 (298)
T 3f66_A 125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY-SVHNKTGAKLPVKWMALES 203 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC-BC-----CCBCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh-ccccccCCCCCccccChHH
Confidence 566889999999999999999999999999999999999999999999999765432211 1112234567889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |..||.+.+..+....+......+.+...++.+.+++..|| .+|..||+++++
T Consensus 204 ~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 282 (298)
T 3f66_A 204 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 282 (298)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9887766 68999999999999999 77788887777777777776666667778999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 283 l~ 284 (298)
T 3f66_A 283 VS 284 (298)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=237.16 Aligned_cols=141 Identities=13% Similarity=0.245 Sum_probs=127.1
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
.+..++|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45578899999999999999999999999999999999754433333345677999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|||||+||+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g 152 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG 152 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC
Confidence 99999999999999999888999999999988776 99999999999999999999998776
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=239.30 Aligned_cols=140 Identities=15% Similarity=0.220 Sum_probs=125.7
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|++.+.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|..++..++||||++++++|++.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 44678999999999999999999999999999999997654333444566889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||+||+|.+++.+. ..+++..+++++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g 199 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG 199 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC
Confidence 999999999999999764 4899999999988776 99999999999999999999998776
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=235.94 Aligned_cols=155 Identities=25% Similarity=0.402 Sum_probs=130.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .......+++.|+|||.
T Consensus 277 ~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~~~~~y~aPE~ 352 (452)
T 1fmk_A 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEA 352 (452)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------------CCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce----ecccCCcccccccCHhH
Confidence 55688999999999999999999999999999999999999999999999976543211 11123346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++||||||+++|+|++ |+.||.+.+..++...+..+...+.+..+++.+.+++..|+ .+|..||+++++
T Consensus 353 ~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 431 (452)
T 1fmk_A 353 ALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 431 (452)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9877766 68999999999999999 99999999999999888888777777889999999999999 799999999999
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 432 ~~ 433 (452)
T 1fmk_A 432 QA 433 (452)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=221.12 Aligned_cols=164 Identities=25% Similarity=0.479 Sum_probs=120.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc---------cccCcccccC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY---------KQNLSETFCG 77 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~~~g 77 (347)
+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......... .........|
T Consensus 113 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (303)
T 1zy4_A 113 QQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192 (303)
T ss_dssp GCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC------------------------
T ss_pred cchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCC
Confidence 3457889999999999999999999999999999999999999999999987653211000 0111234568
Q ss_pred CccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcc-CCC--CCCCCCHHHHHHHHhcc-
Q psy10462 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRV-VFP--ESPRLSSSCKALISNIL- 152 (347)
Q Consensus 78 t~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-~~~~~~~~i~~~~-~~~--~~~~~s~~~~~li~~~l- 152 (347)
|+.|+|||++.+....+.++|+||+||++|+|++ ||... +..+....+.... .+| .+...++.++++++.||
T Consensus 193 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 269 (303)
T 1zy4_A 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLID 269 (303)
T ss_dssp -CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTC
T ss_pred cccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHh
Confidence 9999999999875434478999999999999998 66532 2334444444322 222 22456778999999999
Q ss_pred CCCCCCCCHHHHhcCCCCCCC
Q psy10462 153 SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 153 ~~~~~R~~~~eil~~p~~~~~ 173 (347)
.+|..||+++++++|||+...
T Consensus 270 ~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 270 HDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp SSGGGSCCHHHHHHSSCSCCC
T ss_pred cCcccCcCHHHHhCCCCcCCC
Confidence 799999999999999999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=219.10 Aligned_cols=156 Identities=21% Similarity=0.396 Sum_probs=133.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+++.|+|||+
T Consensus 101 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~y~aPE~ 176 (267)
T 3t9t_A 101 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEV 176 (267)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH----HHSTTSTTCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc----ccccccccccccccChhh
Confidence 5678899999999999999999999999999999999999999999999987653211 111223456788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |+.||.+.+..+....+......+.+...++.+.+++..|+ .+|..||+++++
T Consensus 177 ~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 255 (267)
T 3t9t_A 177 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRL 255 (267)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHH
Confidence 9877766 68999999999999999 99999999988888888777666666778999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 256 l~~ 258 (267)
T 3t9t_A 256 LRQ 258 (267)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=225.14 Aligned_cols=160 Identities=19% Similarity=0.296 Sum_probs=124.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc-----EEEeccCCceecccCCcccc--ccCcccccCC
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN-----IKLSDFGFARKYSVNNTDYK--QNLSETFCGS 78 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~-----~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~gt 78 (347)
.+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||++........... .......+||
T Consensus 101 ~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt 180 (330)
T 2izr_A 101 TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180 (330)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCC
Confidence 3677899999999999999999999999999999999998887 99999999987643322111 1112456899
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcc-CCCCC--CCCCHHHHHHHHhcc
Q psy10462 79 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELLKQVQKRV-VFPES--PRLSSSCKALISNIL 152 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~---~~~~~~~i~~~~-~~~~~--~~~s~~~~~li~~~l 152 (347)
+.|+|||++.+..++ .++|+|||||++|+|++|+.||.+.+ ..+....+.... ..+.. ....+++.+++..|+
T Consensus 181 ~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l 259 (330)
T 2izr_A 181 ARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVR 259 (330)
T ss_dssp TTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHH
T ss_pred ccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHH
Confidence 999999999988776 68999999999999999999998744 334444443221 11111 112349999999999
Q ss_pred -CCCCCCCCHHHHhc
Q psy10462 153 -SPVKFRIQMEDIRQ 166 (347)
Q Consensus 153 -~~~~~R~~~~eil~ 166 (347)
.+|..||+++++.+
T Consensus 260 ~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 260 RLDFFEKPDYDYLRK 274 (330)
T ss_dssp HCCTTCCCCHHHHHH
T ss_pred hCCCCCCCCHHHHHH
Confidence 79999999988864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=222.79 Aligned_cols=157 Identities=20% Similarity=0.353 Sum_probs=123.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ........+++.|+|||.
T Consensus 111 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~ 188 (295)
T 3ugc_A 111 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--FKVKEPGESPIFWYAPES 188 (295)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---------------CTTCGGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcce--eeeccCCCCccceeCcHH
Confidence 567889999999999999999999999999999999999999999999999866432211 111223457788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHHHhccCCCCCCCCCHHHHHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS----------------ELLKQVQKRVVFPESPRLSSSCKALISN 150 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~s~~~~~li~~ 150 (347)
+.+..++ .++||||+|+++|+|++|..||...... .....+......+.+..+++++.++++.
T Consensus 189 ~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 267 (295)
T 3ugc_A 189 LTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE 267 (295)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred hcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHH
Confidence 9887776 6899999999999999999998653211 2334444555666677899999999999
Q ss_pred cc-CCCCCCCCHHHHhc
Q psy10462 151 IL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 151 ~l-~~~~~R~~~~eil~ 166 (347)
|+ .+|..||+++++++
T Consensus 268 ~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 268 CWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HSCSSGGGSCCHHHHHH
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99 79999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=227.77 Aligned_cols=156 Identities=22% Similarity=0.371 Sum_probs=122.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----cCCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.++..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....... ......||+.|+
T Consensus 109 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~------~~~~~~gt~~y~ 182 (319)
T 4euu_A 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE------QFVSLYGTEEYL 182 (319)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC------CBCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC------ceeecccCCCcc
Confidence 6789999999999999999999999999999999999 777889999999998764321 123456899999
Q ss_pred cccccc--------CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhccC-----------------
Q psy10462 83 SPEILK--------GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN----YSELLKQVQKRVV----------------- 133 (347)
Q Consensus 83 aPE~~~--------~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~----~~~~~~~i~~~~~----------------- 133 (347)
|||++. +..++ .++|+||+||++|+|++|+.||.... ..+.+..+..+..
T Consensus 183 aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 261 (319)
T 4euu_A 183 HPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW 261 (319)
T ss_dssp CHHHHHHHTSCCCCCCCBC-TTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEE
T ss_pred CHHHhhhccccccccCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCcccc
Confidence 999986 34454 67999999999999999999997432 2344444433221
Q ss_pred ---CCCCC----CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCC
Q psy10462 134 ---FPESP----RLSSSCKALISNIL-SPVKFRIQMEDIRQDPW 169 (347)
Q Consensus 134 ---~~~~~----~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~ 169 (347)
.+... .++..+.+++++|| .+|.+||+++|+++||-
T Consensus 262 ~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp ESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11112 23457888999999 79999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=218.08 Aligned_cols=154 Identities=25% Similarity=0.532 Sum_probs=124.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---CeecCCCCCcEEEcC--------CCcEEEeccCCceecccCCccccccCccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKS---VVHRDIKCENLLLDD--------KYNIKLSDFGFARKYSVNNTDYKQNLSET 74 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~---iiH~dlkp~Nill~~--------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 74 (347)
.+++.++..++.|++.||.|||++| |+||||||+||+++. ++.+||+|||++....... ...
T Consensus 101 ~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~ 173 (271)
T 3dtc_A 101 RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-------KMS 173 (271)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-------ccC
Confidence 3567899999999999999999999 899999999999986 6789999999997654211 123
Q ss_pred ccCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-
Q psy10462 75 FCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNIL- 152 (347)
Q Consensus 75 ~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l- 152 (347)
..||+.|+|||.+.+..++ .++|+||+|+++|+|++|+.||.+.+.......+.. ....+.+...++.+.+++..|+
T Consensus 174 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 252 (271)
T 3dtc_A 174 AAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWN 252 (271)
T ss_dssp --CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhc
Confidence 4689999999999887766 689999999999999999999999887766665544 3344556778999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q psy10462 153 SPVKFRIQMEDIRQD 167 (347)
Q Consensus 153 ~~~~~R~~~~eil~~ 167 (347)
.+|..||++++++++
T Consensus 253 ~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 253 PDPHSRPSFTNILDQ 267 (271)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCcccCcCHHHHHHH
Confidence 799999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=239.36 Aligned_cols=139 Identities=16% Similarity=0.262 Sum_probs=123.8
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|++.+.||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.+++.++|||||+++++|++++.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 44678999999999999999999999999999999997643333333455779999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||+||+|.+++++ ..+++..+++++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g 205 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 205 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC
Confidence 99999999999999976 4799999999988776 99999999999999999999998776
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-29 Score=232.65 Aligned_cols=139 Identities=15% Similarity=0.236 Sum_probs=125.2
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
..++|++.+.||+|+||+||+|++..+|+.||+|++++.........+.+.+|+.+|+.++||||++++++|.+++.+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999999975433333334567799999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||+||+|.+++.+.+.+++..++.++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g 178 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC
Confidence 999999999999998888999999999988876 99999999999999999999998776
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=219.89 Aligned_cols=156 Identities=28% Similarity=0.538 Sum_probs=116.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ........||+.|+|||.
T Consensus 117 ~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~ 193 (289)
T 3og7_A 117 FEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG---SHQFEQLSGSILWMAPEV 193 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------------------CCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc---cccccccCCCccccCchh
Confidence 56788999999999999999999999999999999999999999999999975532111 111234568999999999
Q ss_pred cc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCCC----CCCCCHHHHHHHHhcc-CCCCC
Q psy10462 87 LK---GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFPE----SPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 87 ~~---~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~----~~~~s~~~~~li~~~l-~~~~~ 157 (347)
+. +..++ .++|+||+|+++|+|++|+.||.+.+.. .....+......+. ...+++.+++++..|| .+|..
T Consensus 194 ~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 272 (289)
T 3og7_A 194 IRMQDSNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDE 272 (289)
T ss_dssp HC----CCSC-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGG
T ss_pred hcccCCCCCC-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhh
Confidence 86 33444 5899999999999999999999876544 44444444433222 2367899999999999 79999
Q ss_pred CCCHHHHhc
Q psy10462 158 RIQMEDIRQ 166 (347)
Q Consensus 158 R~~~~eil~ 166 (347)
||+++++++
T Consensus 273 Rps~~ell~ 281 (289)
T 3og7_A 273 RPSFPRILA 281 (289)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHHH
Confidence 999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-29 Score=232.49 Aligned_cols=149 Identities=15% Similarity=0.254 Sum_probs=129.4
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh---hhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
.+.|++.+.||+|+||+||+|+++.+|+.||+|++++...... ...+.+.+|+.+|+.++||||++++++|++.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 5679999999999999999999999999999999976543211 1235577999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc-ceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY-YSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~-~~~~~~~~~~ 338 (347)
|+|||||+||+|.+++.+.+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++. ...+.++..|
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999998888999999999988876 999999999999999999999977653 3355555544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=222.21 Aligned_cols=157 Identities=20% Similarity=0.335 Sum_probs=130.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......||+.|+|||.
T Consensus 142 ~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 218 (313)
T 1t46_A 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPES 218 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccc---eeccCCCCcceeeChHH
Confidence 678899999999999999999999999999999999999999999999999765432211 11223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSE-LLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+|+++|+|++ |+.||.+.+... ....+......+.+...++.+.+++..|| .+|..||++++
T Consensus 219 ~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 297 (313)
T 1t46_A 219 IFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ 297 (313)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9887766 68999999999999998 999998876543 34444555555556778999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 298 ll~~ 301 (313)
T 1t46_A 298 IVQL 301 (313)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=224.29 Aligned_cols=157 Identities=20% Similarity=0.357 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......||+.|+|||+
T Consensus 145 ~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~ 221 (316)
T 2xir_A 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPET 221 (316)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccc---eeccCCCcceeecCchh
Confidence 567899999999999999999999999999999999999999999999999765432211 11223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCH-HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNY-SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+|+++|+|++ |..||.+.+. ......+..+...+.+...++.+.+++..|| .+|..||++++
T Consensus 222 ~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 300 (316)
T 2xir_A 222 IFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 300 (316)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9887766 68999999999999998 9999987654 3445555555555566778999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 301 ll~~ 304 (316)
T 2xir_A 301 LVEH 304 (316)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.2e-29 Score=227.31 Aligned_cols=159 Identities=26% Similarity=0.426 Sum_probs=108.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++....... ......||+.|+|||
T Consensus 122 ~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE 195 (327)
T 3aln_A 122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI------AKTRDAGCRPYMAPE 195 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------
T ss_pred CcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc------ccccCCCCccccCce
Confidence 56788999999999999999999 99999999999999999999999999997654321 112346899999999
Q ss_pred ccc----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccC--CC--CCCCCCHHHHHHHHhcc-CCC
Q psy10462 86 ILK----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVV--FP--ESPRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 86 ~~~----~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~~~~--~~--~~~~~s~~~~~li~~~l-~~~ 155 (347)
++. +..++ .++|+|||||++|+|++|+.||.+.+.. +....+..+.. .+ ....+++.+.++++.|| .+|
T Consensus 196 ~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 274 (327)
T 3aln_A 196 RIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDE 274 (327)
T ss_dssp ----------CC-SHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSG
T ss_pred eeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCCh
Confidence 983 44454 6899999999999999999999875421 22222111111 11 12357899999999999 799
Q ss_pred CCCCCHHHHhcCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~ 172 (347)
..||++.++++|||+..
T Consensus 275 ~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 275 SKRPKYKELLKHPFILM 291 (327)
T ss_dssp GGSCCHHHHTTSHHHHH
T ss_pred hhCcCHHHHHhChHHHH
Confidence 99999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-29 Score=233.36 Aligned_cols=141 Identities=19% Similarity=0.281 Sum_probs=117.6
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHH-HhcCCCcchhhhheeeeeCCe
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEV-VKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~~~~ 265 (347)
....++|++.+.||+|+||+||+|+++.+++.||+|++++...........+.+|..+ ++.++|||||+++++|++.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3456789999999999999999999999999999999987654444444556678776 567899999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+|||||+||+|.+++.+.+.+++..+++++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g 176 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG 176 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC
Confidence 999999999999999998888999999999988776 99999999999999999999998776
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=220.41 Aligned_cols=155 Identities=21% Similarity=0.345 Sum_probs=134.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... ......+++.|+|||.
T Consensus 108 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~~y~aPE~ 183 (288)
T 3kfa_A 108 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT----AHAGAKFPIKWTAPES 183 (288)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE----EETTEEECGGGCCHHH
T ss_pred ccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc----cccCCccccCcCChhh
Confidence 667889999999999999999999999999999999999999999999999765432211 1123456788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+||+|+++|+|++ |..||.+.+..+....+......+.+..+++.+.++++.|| .+|..||+++++
T Consensus 184 ~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~ 262 (288)
T 3kfa_A 184 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262 (288)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 9887766 68999999999999999 99999998888888888877777777889999999999999 799999999999
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 263 ~~ 264 (288)
T 3kfa_A 263 HQ 264 (288)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=219.70 Aligned_cols=158 Identities=26% Similarity=0.452 Sum_probs=131.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......... .......+++.|+|||+
T Consensus 118 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~ 195 (291)
T 1u46_A 118 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPES 195 (291)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE--EC-----CCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccch--hhhccCCCCceeeCchh
Confidence 5678899999999999999999999999999999999999999999999998764332211 11223457888999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+||+|+++|+|++ |+.||.+.+..+....+... ...+.+..+++.+.+++..|| .+|..||++.+
T Consensus 196 ~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 274 (291)
T 1u46_A 196 LKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 274 (291)
T ss_dssp HHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHH
Confidence 9877665 68999999999999999 99999999888887777553 345556788999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 275 l~~~ 278 (291)
T 1u46_A 275 LRDF 278 (291)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-29 Score=224.62 Aligned_cols=139 Identities=19% Similarity=0.232 Sum_probs=127.0
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
-.++|++.+.||+|+||.||+|++..+++.||+|.+...........+.+.+|+.++++++||||+++++++++++.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 35789999999999999999999999999999999976554455556678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||++||+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~ 148 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK 148 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 999999999999998888999999999988876 99999999999999999999998765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=243.20 Aligned_cols=157 Identities=20% Similarity=0.323 Sum_probs=132.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... .......+|+.|+|||+
T Consensus 466 l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~~~t~~y~APE~ 543 (635)
T 4fl3_A 466 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKWPVKWYAPEC 543 (635)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------------CGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc--ccccCCCCceeeeChhh
Confidence 5678899999999999999999999999999999999999999999999997664322111 11223456788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |+.||.+.+..++...+..+...+.+..+++++.+++..|+ .+|..||+++++
T Consensus 544 ~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 622 (635)
T 4fl3_A 544 INYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 622 (635)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9887776 68999999999999998 99999999999999988888777777889999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 623 ~~ 624 (635)
T 4fl3_A 623 EL 624 (635)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=241.60 Aligned_cols=157 Identities=20% Similarity=0.375 Sum_probs=131.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......... ......+++.|+|||+
T Consensus 433 l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~--~~~~~~~~~~y~APE~ 510 (613)
T 2ozo_A 433 IPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT--ARSAGKWPLKWYAPEC 510 (613)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------------CCTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee--eccCCCCccceeCHhh
Confidence 56789999999999999999999999999999999999999999999999976543221111 1122345688999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |+.||.+.+..++...+..+...+.+..+++++.+++..|+ .+|..||+++++
T Consensus 511 ~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 511 INFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred hcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9877776 68999999999999998 99999999888888888888777777789999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 590 ~~ 591 (613)
T 2ozo_A 590 EQ 591 (613)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=236.72 Aligned_cols=149 Identities=17% Similarity=0.288 Sum_probs=130.2
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
-.++|++.+.||+|+||+||+|.+..+|+.||+|++.+.... ....+.+.+|+.+|+.++|||||+++++|.+++.+|+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 467899999999999999999999999999999999765433 3335567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|||||+||+|.+++..++.+++..+..++.|++ |+.|+|++||+||||||+|||++.......+.++..|
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 999999999999999889999999999988876 9999999999999999999999876555566665544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=230.99 Aligned_cols=149 Identities=15% Similarity=0.278 Sum_probs=131.6
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
-.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.++++++|||||++++++.+++..|+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3578999999999999999999999999999999997654433 234567799999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|||||+||+|.+++..++.+++..+..++.|++ ++.|+|++||+||||||+|||++.++....+.++..|
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 999999999999998888999999999988876 9999999999999999999999887665556655544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-29 Score=232.34 Aligned_cols=140 Identities=19% Similarity=0.206 Sum_probs=124.4
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 266 (347)
...++|++.+.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|..+|+.+ +||||++++++|++.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4567899999999999999999999999999999999765332333345567899999988 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|||||+||+|.+++++.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g 158 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG 158 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC
Confidence 99999999999999998888999999999988876 99999999999999999999998776
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=224.91 Aligned_cols=161 Identities=19% Similarity=0.241 Sum_probs=134.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.||+.||.|||++||+||||||+||+++. +..+||+|||++......... .......|++.|+|
T Consensus 137 ~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~a 213 (327)
T 2yfx_A 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY---RKGGCAMLPVKWMP 213 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC---------CCGGGSCGGGCC
T ss_pred ccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccccccccccc---ccCCCcCCCcceeC
Confidence 667889999999999999999999999999999999984 446999999998754322111 11234467899999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCH
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQM 161 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~ 161 (347)
||.+.+..++ .++|+||||+++|+|++ |..||.+.+..+....+......+.+..+++.+.+++..|| .+|..||++
T Consensus 214 PE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 292 (327)
T 2yfx_A 214 PEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNF 292 (327)
T ss_dssp HHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999877766 68999999999999998 99999999888888888777666667788999999999999 799999999
Q ss_pred HHHhcCCCCC
Q psy10462 162 EDIRQDPWLK 171 (347)
Q Consensus 162 ~eil~~p~~~ 171 (347)
.+++++.|..
T Consensus 293 ~~ll~~l~~~ 302 (327)
T 2yfx_A 293 AIILERIEYC 302 (327)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999887643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-28 Score=219.90 Aligned_cols=160 Identities=16% Similarity=0.292 Sum_probs=124.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...................|++.|+|||+
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 205 (319)
T 2y4i_B 127 LDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205 (319)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHH
Confidence 56789999999999999999999999999999999998 67999999999875432211111222334568999999999
Q ss_pred ccCCC--------CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-CCCCCHHHHHHHHhcc-CCCC
Q psy10462 87 LKGVP--------YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE-SPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 87 ~~~~~--------~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~s~~~~~li~~~l-~~~~ 156 (347)
+.+.. ..+.++|+||||+++|+|++|+.||.+.+..+....+......+. ...++.++.+++..|+ .+|.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 285 (319)
T 2y4i_B 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQE 285 (319)
T ss_dssp HSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTT
T ss_pred hhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChh
Confidence 87521 123689999999999999999999999988888777766544322 3367889999999999 7999
Q ss_pred CCCCHHHHhcC
Q psy10462 157 FRIQMEDIRQD 167 (347)
Q Consensus 157 ~R~~~~eil~~ 167 (347)
.||+++++++.
T Consensus 286 ~Rpt~~~l~~~ 296 (319)
T 2y4i_B 286 ERPTFTKLMDM 296 (319)
T ss_dssp TSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=220.49 Aligned_cols=159 Identities=23% Similarity=0.370 Sum_probs=120.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--------hCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCC
Q psy10462 7 YNTDKARRWFSQLADAIDYCH--------KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH--------~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt 78 (347)
+++.++.+++.|++.||.||| ++||+||||||+|||++.++.+||+|||++.......... ........||
T Consensus 102 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt 180 (301)
T 3q4u_A 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL-DVGNNPRVGT 180 (301)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE-ECCCCCCCCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccc-cccccccccc
Confidence 567899999999999999999 9999999999999999999999999999997665432221 1122345799
Q ss_pred ccccccccccCCCCCC-----ChhhHHHHHHHHHHHHcC----------CCCCCCCC-----HHHHHHHHHhccCCCCCC
Q psy10462 79 YAYASPEILKGVPYTP-----QQSDIWSMGVVLFAMVYG----------RLPFDDTN-----YSELLKQVQKRVVFPESP 138 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~~-----~~~Dvws~G~~l~~ll~g----------~~pf~~~~-----~~~~~~~i~~~~~~~~~~ 138 (347)
+.|+|||++.+..... .++||||+||++|+|++| ..||.+.. .......+......+..+
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (301)
T 3q4u_A 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP 260 (301)
T ss_dssp GGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred cceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCC
Confidence 9999999998763221 479999999999999999 88986532 222222222222222211
Q ss_pred ------CCCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 139 ------RLSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 139 ------~~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
..++.+.+++..|| .+|..||+++++++
T Consensus 261 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 261 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 24467999999999 79999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=236.18 Aligned_cols=155 Identities=20% Similarity=0.340 Sum_probs=134.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ......+++.|+|||+
T Consensus 315 ~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~----~~~~~~~~~~y~aPE~ 390 (495)
T 1opk_A 315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT----AHAGAKFPIKWTAPES 390 (495)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE----CCTTCCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee----ecCCCcCCcceeCHhH
Confidence 556788999999999999999999999999999999999999999999999865432111 1123346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |..||.+.+..++...+......+.+..+++.+.+++..|+ .+|..||++.++
T Consensus 391 ~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el 469 (495)
T 1opk_A 391 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469 (495)
T ss_dssp HHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 9877766 68999999999999999 99999999888888888887777777889999999999999 799999999999
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 470 ~~ 471 (495)
T 1opk_A 470 HQ 471 (495)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=224.76 Aligned_cols=160 Identities=22% Similarity=0.398 Sum_probs=125.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC--cEEEeccCCceecccCCcc--ccccCcccccCCccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY--NIKLSDFGFARKYSVNNTD--YKQNLSETFCGSYAY 81 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~gt~~y 81 (347)
.+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......... ..........||+.|
T Consensus 155 ~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y 234 (352)
T 2jii_A 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEF 234 (352)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccc
Confidence 367799999999999999999999999999999999999988 8999999999766432211 111122345799999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHh---cc-CCC----CCCCCCHHHHHHHHhc
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQK---RV-VFP----ESPRLSSSCKALISNI 151 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~--~~~~~~~i~~---~~-~~~----~~~~~s~~~~~li~~~ 151 (347)
+|||++.+..++ .++|+|||||++|+|++|+.||.+.. .......... .. .++ ....+++.+.+++..|
T Consensus 235 ~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 313 (352)
T 2jii_A 235 ISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVV 313 (352)
T ss_dssp CCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHH
T ss_pred cCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHH
Confidence 999999987766 68999999999999999999998753 3333333221 11 111 1135689999999999
Q ss_pred c-CCCCCCCCHHHHhc
Q psy10462 152 L-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 152 l-~~~~~R~~~~eil~ 166 (347)
| .+|..||+++++++
T Consensus 314 l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 314 MALTYEEKPPYAMLRN 329 (352)
T ss_dssp HTCCTTCCCCHHHHHH
T ss_pred HhCChhhCCCHHHHHH
Confidence 9 79999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=222.35 Aligned_cols=137 Identities=12% Similarity=0.055 Sum_probs=119.8
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
-..+|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++++++||||+++++++++++.+|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34679999999999999999999999999999999986654444455677899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||++||+|.+++++ +. .+.++..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 109 v~e~~~g~~L~~~l~~-~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g 166 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-SP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG 166 (286)
T ss_dssp EEECCCEEEHHHHHTT-CC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS
T ss_pred EEEecCCCCHHHHHhc-CC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC
Confidence 9999999999999954 33 5556666777765 99999999999999999999998765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-28 Score=215.85 Aligned_cols=151 Identities=21% Similarity=0.417 Sum_probs=122.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEcCCCc-----EEEeccCCceecccCCccccccCcccccCCc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYN-----IKLSDFGFARKYSVNNTDYKQNLSETFCGSY 79 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~--iiH~dlkp~Nill~~~~~-----~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~ 79 (347)
+++.++..++.|++.||.|||++| |+||||||+||+++.++. +||+|||++..... ......||+
T Consensus 119 ~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~g~~ 190 (287)
T 4f0f_A 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--------SVSGLLGNF 190 (287)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--------CEECCCCCC
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--------cccccCCCc
Confidence 567889999999999999999999 999999999999988776 99999999874332 123456899
Q ss_pred cccccccccC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHH-hccCCCCCCCCCHHHHHHHHhcc-C
Q psy10462 80 AYASPEILKG--VPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL--LKQVQ-KRVVFPESPRLSSSCKALISNIL-S 153 (347)
Q Consensus 80 ~y~aPE~~~~--~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~--~~~i~-~~~~~~~~~~~s~~~~~li~~~l-~ 153 (347)
.|+|||++.+ ..++ .++|+||+||++|+|++|+.||...+..+. ...+. .....+.+..+++.+.+++..|| .
T Consensus 191 ~y~aPE~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 269 (287)
T 4f0f_A 191 QWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSG 269 (287)
T ss_dssp TTSCGGGSSCSSCEEC-HHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccCchhhccCCCCcC-chhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcC
Confidence 9999999843 3333 689999999999999999999987654332 33333 33334455678999999999999 7
Q ss_pred CCCCCCCHHHHhc
Q psy10462 154 PVKFRIQMEDIRQ 166 (347)
Q Consensus 154 ~~~~R~~~~eil~ 166 (347)
+|..||+++++++
T Consensus 270 dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 270 DPKKRPHFSYIVK 282 (287)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=217.84 Aligned_cols=151 Identities=28% Similarity=0.497 Sum_probs=120.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCCeecCCCCCcEEEcCCCc-EEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK---KSVVHRDIKCENLLLDDKYN-IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~---~~iiH~dlkp~Nill~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.++..++.|++.||.|||+ +||+||||||+||+++.++. +||+|||++...... .....||+.|+
T Consensus 99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~ 170 (307)
T 2eva_A 99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--------MTNNKGSAAWM 170 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------------CCTTSS
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--------cccCCCCCceE
Confidence 5678899999999999999999 89999999999999998886 799999998754321 12345899999
Q ss_pred ccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 83 SPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 83 aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
|||++.+..++ .++||||||+++|+|++|+.||.... .......+......+....+++.+++++.+|| .+|..||
T Consensus 171 aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 249 (307)
T 2eva_A 171 APEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRP 249 (307)
T ss_dssp CHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCc
Confidence 99999987776 68999999999999999999998643 33344444455555556778999999999999 7999999
Q ss_pred CHHHHhc
Q psy10462 160 QMEDIRQ 166 (347)
Q Consensus 160 ~~~eil~ 166 (347)
+++++++
T Consensus 250 s~~ell~ 256 (307)
T 2eva_A 250 SMEEIVK 256 (307)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999976
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=228.69 Aligned_cols=147 Identities=22% Similarity=0.320 Sum_probs=127.6
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
....++|++.+.||+|+||+||+|++..+++.||+|++.+.... .+.+.+|+.+++.++|||||++++++.+++.+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 34567899999999999999999999999999999999754322 34466999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|||||++|+|.+++...+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++.. ++.++..|
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~-~~kl~Dfg 163 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAP-RLKICDFG 163 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSC-CEEECCCC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCc-eEEEeecC
Confidence 99999999999999998888999999999988876 9999999999999999999999765432 24444443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-29 Score=230.95 Aligned_cols=150 Identities=15% Similarity=0.198 Sum_probs=126.8
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCc--hhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP--IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
-.+.|++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+++.++||||++++++|.+++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457899999999999999999999999999999998643211 111245577999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhC----CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKE----RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~----~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|||||+||+|.+++.+. ..+++..+..++.|++ ++.|+|++||+||||||+|||++.++....+.++..|
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999888542 3699999999988776 9999999999999999999999887665555555443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=212.99 Aligned_cols=150 Identities=17% Similarity=0.305 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~--iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
+++.++..++.||+.||.|||++| ++||||||+||+++.++.++|+|||++..... ....||+.|+||
T Consensus 108 ~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----------~~~~~t~~y~aP 177 (271)
T 3kmu_A 108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----------PGRMYAPAWVAP 177 (271)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----------TTCBSCGGGSCH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc----------cCccCCccccCh
Confidence 577899999999999999999999 99999999999999999999999988654221 234689999999
Q ss_pred ccccCCCCCCC--hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 85 EILKGVPYTPQ--QSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 85 E~~~~~~~~~~--~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
|.+.+..+... ++|+||+||++|+|++|+.||.+.+..+....+.. ....+.+..+++++.+++..|| .+|..||+
T Consensus 178 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 257 (271)
T 3kmu_A 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPK 257 (271)
T ss_dssp HHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 99987655432 79999999999999999999999887777665543 3444456678999999999999 79999999
Q ss_pred HHHHhc
Q psy10462 161 MEDIRQ 166 (347)
Q Consensus 161 ~~eil~ 166 (347)
++++++
T Consensus 258 ~~~il~ 263 (271)
T 3kmu_A 258 FDMIVP 263 (271)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=224.08 Aligned_cols=157 Identities=24% Similarity=0.357 Sum_probs=120.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ........||+.|+|||+
T Consensus 136 ~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~ 212 (321)
T 2qkw_B 136 MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ---THLSTVVKGTLGYIDPEY 212 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC---CCCBCCCEEETTTCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccccCCCccccCHHH
Confidence 56789999999999999999999999999999999999999999999999976532211 111234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH----HHHhc-c----CC----CCCCCCCHHHHHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL---LK----QVQKR-V----VF----PESPRLSSSCKALISN 150 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~---~~----~i~~~-~----~~----~~~~~~s~~~~~li~~ 150 (347)
+.+..++ .++|+||+||++|+|++|+.||.+....+. .. ..... . .. ..++..+..+.+++..
T Consensus 213 ~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 291 (321)
T 2qkw_B 213 FIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK 291 (321)
T ss_dssp HHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHH
T ss_pred hcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHH
Confidence 9887776 689999999999999999999976432211 11 11111 0 00 0112234678899999
Q ss_pred cc-CCCCCCCCHHHHhcC
Q psy10462 151 IL-SPVKFRIQMEDIRQD 167 (347)
Q Consensus 151 ~l-~~~~~R~~~~eil~~ 167 (347)
|| .+|..||++.+++++
T Consensus 292 ~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 292 CLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCCcccCcCHHHHHHH
Confidence 99 799999999999865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=222.62 Aligned_cols=157 Identities=20% Similarity=0.317 Sum_probs=120.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC----------CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK----------SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFC 76 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~----------~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 76 (347)
+++.++..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......... ......+
T Consensus 118 ~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~---~~~~~~~ 194 (322)
T 3soc_A 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA---GDTHGQV 194 (322)
T ss_dssp BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCC---CCCTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCc---cccccCc
Confidence 56688999999999999999999 9999999999999999999999999999876533221 1123457
Q ss_pred CCccccccccccCCCCC----CChhhHHHHHHHHHHHHcCCCCCCCCC----------------HHHHHHHHHhccCCCC
Q psy10462 77 GSYAYASPEILKGVPYT----PQQSDIWSMGVVLFAMVYGRLPFDDTN----------------YSELLKQVQKRVVFPE 136 (347)
Q Consensus 77 gt~~y~aPE~~~~~~~~----~~~~Dvws~G~~l~~ll~g~~pf~~~~----------------~~~~~~~i~~~~~~~~ 136 (347)
||+.|+|||++.+.... +.++|||||||++|+|++|+.||.+.. ..+....+......|.
T Consensus 195 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (322)
T 3soc_A 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPV 274 (322)
T ss_dssp CCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCC
T ss_pred cCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCC
Confidence 99999999999874221 146799999999999999999997532 2223333333222222
Q ss_pred CCC------CCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 137 SPR------LSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 137 ~~~------~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
... .++++.+++..|| .+|..||+++++++
T Consensus 275 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 275 LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 2345899999999 79999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=223.88 Aligned_cols=158 Identities=22% Similarity=0.397 Sum_probs=129.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......... .......||+.|+|||.
T Consensus 124 ~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~ 201 (327)
T 3lxl_A 124 LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY--VVREPGQSPIFWYAPES 201 (327)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEE--ECSSCCCSCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccc--eeeccCCccccccCHHH
Confidence 5678899999999999999999999999999999999999999999999998764332211 12234568889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---------------HHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---------------SELLKQVQKRVVFPESPRLSSSCKALISNI 151 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~---------------~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 151 (347)
+.+..++ .++|+||+|+++|+|++|..||..... ......+......+.+..+++.+.+++..|
T Consensus 202 ~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 280 (327)
T 3lxl_A 202 LSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLC 280 (327)
T ss_dssp HHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred hccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHH
Confidence 9887665 689999999999999999999965332 234445555666667778999999999999
Q ss_pred c-CCCCCCCCHHHHhcC
Q psy10462 152 L-SPVKFRIQMEDIRQD 167 (347)
Q Consensus 152 l-~~~~~R~~~~eil~~ 167 (347)
| .+|..||++++++++
T Consensus 281 l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 281 WAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 9 799999999999643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=228.32 Aligned_cols=149 Identities=15% Similarity=0.180 Sum_probs=130.2
Q ss_pred cchhhhhhhhhhhcccc--cchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 186 VGIHKRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G--~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
+.....+|++.+.||+| +||+||+|++..+|+.||+|+++..... ....+.+.+|+.+++.++|||||+++++|.++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 44567889999999999 9999999999999999999999765433 34456778999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+.+|+|||||++|+|.+++... +.+++..++.++.|++ |+.|+|++||+||||||+|||++.++ .+.+...|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~---~~kl~dfg 173 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG---KVYLSGLR 173 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC---CEEECCGG
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC---CEEEcccc
Confidence 9999999999999999999765 6799999999988876 99999999999999999999998765 34444443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=219.42 Aligned_cols=157 Identities=19% Similarity=0.369 Sum_probs=128.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......... .......||+.|+|||.
T Consensus 123 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~ 200 (302)
T 4e5w_A 123 INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY--TVKDDRDSPVFWYAPEC 200 (302)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEE--ECCCCTTCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcce--eccCCCCCCccccCCee
Confidence 5668899999999999999999999999999999999999999999999998765432211 12234568889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT---------------NYSELLKQVQKRVVFPESPRLSSSCKALISNI 151 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~---------------~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 151 (347)
+.+..++ .++|+||+|+++|+|++|..|+... ........+......+.+..+++.+.++++.|
T Consensus 201 ~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 279 (302)
T 4e5w_A 201 LMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKC 279 (302)
T ss_dssp HHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred ecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 9887766 6899999999999999999886432 12334445555666667788999999999999
Q ss_pred c-CCCCCCCCHHHHhc
Q psy10462 152 L-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 152 l-~~~~~R~~~~eil~ 166 (347)
| .+|..||+++++++
T Consensus 280 l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 280 WEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCCHHHHHH
Confidence 9 79999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=225.00 Aligned_cols=150 Identities=16% Similarity=0.223 Sum_probs=129.2
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh---hhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
..+.|++.+.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+|++++||||++++++|.+++.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45779999999999999999999999999999999976543211 124557799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc-ceeEEEEEee
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY-YSTIVVVHLQ 338 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~-~~~~~~~~~~ 338 (347)
+|+|||||++|+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++. ...+.+...|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999998888999999999988876 999999999999999999999987763 3345554443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=221.86 Aligned_cols=156 Identities=20% Similarity=0.312 Sum_probs=121.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcccc---------ccCcccccC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK---------QNLSETFCG 77 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~---------~~~~~~~~g 77 (347)
+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........... .......+|
T Consensus 105 ~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 184 (310)
T 3s95_A 105 YPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184 (310)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCC
Confidence 56688999999999999999999999999999999999999999999999987643221110 011124679
Q ss_pred CccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHhccCCCCCCCCCHHHHHHHHhcc
Q psy10462 78 SYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE-----LLKQVQKRVVFPESPRLSSSCKALISNIL 152 (347)
Q Consensus 78 t~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~s~~~~~li~~~l 152 (347)
|+.|+|||++.+..++ .++||||+|+++|+|++|..||....... ....... ...++.+++.+.+++.+|+
T Consensus 185 t~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l 260 (310)
T 3s95_A 185 NPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD---RYCPPNCPPSFFPITVRCC 260 (310)
T ss_dssp CGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH---HTCCTTCCTTHHHHHHHHT
T ss_pred CcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc---ccCCCCCCHHHHHHHHHHc
Confidence 9999999999988776 68999999999999999999997642211 0111111 1224567889999999999
Q ss_pred -CCCCCCCCHHHHhc
Q psy10462 153 -SPVKFRIQMEDIRQ 166 (347)
Q Consensus 153 -~~~~~R~~~~eil~ 166 (347)
.+|..||+++++++
T Consensus 261 ~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 261 DLDPEKRPSFVKLEH 275 (310)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCChhhCcCHHHHHH
Confidence 79999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=222.75 Aligned_cols=157 Identities=22% Similarity=0.330 Sum_probs=128.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......||+.|+|||+
T Consensus 161 ~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~ 237 (333)
T 2i1m_A 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---IVKGNARLPVKWMAPES 237 (333)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTS---EECSSCEECGGGSCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccce---eecCCCCCCccccCHHH
Confidence 567889999999999999999999999999999999999999999999999765432211 11223457889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL-KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|+|||||++|+|++ |..||.+....... ..+......+.+...++.+.+++..|| .+|..||++++
T Consensus 238 ~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 316 (333)
T 2i1m_A 238 IFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 316 (333)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 9887766 68999999999999998 99999886654433 344445555556678999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 317 l~~~ 320 (333)
T 2i1m_A 317 ICSF 320 (333)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=235.98 Aligned_cols=156 Identities=25% Similarity=0.411 Sum_probs=134.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... . .......++..|+|||+
T Consensus 360 l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~--~~~~~~~~~~~y~aPE~ 435 (535)
T 2h8h_A 360 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--Y--TARQGAKFPIKWTAPEA 435 (535)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--H--HTTCSTTSCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--e--ecccCCcCcccccCHHH
Confidence 5568899999999999999999999999999999999999999999999997653211 1 11123346788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |+.||.+.+..++...+..+...+.+..++..+.+++..|| .+|..||+++++
T Consensus 436 ~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 514 (535)
T 2h8h_A 436 ALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 514 (535)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9877766 68999999999999999 99999999999999988888777777889999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 515 ~~~ 517 (535)
T 2h8h_A 515 QAF 517 (535)
T ss_dssp HHH
T ss_pred HHH
Confidence 763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=219.76 Aligned_cols=136 Identities=24% Similarity=0.319 Sum_probs=121.9
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
....+|+..+.||+|+||+||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence 35678999999999999999999999999999999986543222 345679999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||++|+|.+++.+. .+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~ 153 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC
Confidence 999999999999999764 799999999988776 99999999999999999999998765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=220.51 Aligned_cols=157 Identities=22% Similarity=0.400 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......... .......|++.|+|||.
T Consensus 131 ~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~~y~aPE~ 208 (318)
T 3lxp_A 131 IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY--RVREDGDSPVFWYAPEC 208 (318)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE--EC---CCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccc--ccccCCCCCceeeChHH
Confidence 5678999999999999999999999999999999999999999999999998765432211 12234567889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHHhccCCCCCCCCCHHHHHHHHhc
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS---------------ELLKQVQKRVVFPESPRLSSSCKALISNI 151 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~s~~~~~li~~~ 151 (347)
+.+..++ .++|+||+|+++|+|++|..||...... +....+......+.+..+++.+.++++.|
T Consensus 209 ~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 287 (318)
T 3lxp_A 209 LKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNC 287 (318)
T ss_dssp HHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred hcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHH
Confidence 9887766 6899999999999999999999754221 23334445555666778999999999999
Q ss_pred c-CCCCCCCCHHHHhc
Q psy10462 152 L-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 152 l-~~~~~R~~~~eil~ 166 (347)
| .+|..||+++++++
T Consensus 288 l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 288 WETEASFRPTFENLIP 303 (318)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCCcccCcCHHHHHH
Confidence 9 79999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=219.81 Aligned_cols=140 Identities=14% Similarity=0.255 Sum_probs=125.4
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
...+..++|+..+.||+|+||+||+|.+..+++.||+|.+... .....+.+.+|++++++++||||+++++++.+++
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 3445678999999999999999999999999999999988542 2334566789999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..|+||||+++|+|.++++. .+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~ 145 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK 145 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC
Confidence 99999999999999999977 56899999999988876 99999999999999999999998765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-29 Score=227.73 Aligned_cols=138 Identities=22% Similarity=0.354 Sum_probs=123.1
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
...+|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34679999999999999999999999999999999975433333334567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+ +|+|.+++.+.+.+++.+++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~ 145 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL 145 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC
Confidence 99999 689999998888999999999988876 99999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=218.18 Aligned_cols=160 Identities=18% Similarity=0.341 Sum_probs=119.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC--------CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK--------SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~--------~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt 78 (347)
+++.++..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.......... .......+||
T Consensus 131 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt 209 (337)
T 3mdy_A 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV-DIPPNTRVGT 209 (337)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCSSCSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccc-cCCCCCCccC
Confidence 56688999999999999999999 99999999999999999999999999997664332211 1112345799
Q ss_pred ccccccccccCCCCCCC-----hhhHHHHHHHHHHHHcC----------CCCCCCCC-----HHHHHHHHHhccCCCC-C
Q psy10462 79 YAYASPEILKGVPYTPQ-----QSDIWSMGVVLFAMVYG----------RLPFDDTN-----YSELLKQVQKRVVFPE-S 137 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~~~-----~~Dvws~G~~l~~ll~g----------~~pf~~~~-----~~~~~~~i~~~~~~~~-~ 137 (347)
+.|+|||++.+...... ++|||||||++|+|++| ..||.... .......+......+. +
T Consensus 210 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (337)
T 3mdy_A 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289 (337)
T ss_dssp GGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred cceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCcccc
Confidence 99999999987665533 48999999999999999 77776432 2222222222211111 1
Q ss_pred -----CCCCHHHHHHHHhcc-CCCCCCCCHHHHhcC
Q psy10462 138 -----PRLSSSCKALISNIL-SPVKFRIQMEDIRQD 167 (347)
Q Consensus 138 -----~~~s~~~~~li~~~l-~~~~~R~~~~eil~~ 167 (347)
...++++.+++..|| .+|..||++++++++
T Consensus 290 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 234567899999999 799999999999865
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=230.09 Aligned_cols=159 Identities=20% Similarity=0.343 Sum_probs=125.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE---cCCCcEEEeccCCceecccCCcccc--ccCcccccCCcc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVNNTDYK--QNLSETFCGSYA 80 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~gt~~ 80 (347)
.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......... .......+||+.
T Consensus 99 ~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~ 178 (483)
T 3sv0_A 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178 (483)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCcc
Confidence 36678999999999999999999999999999999999 5788999999999987654322111 112235679999
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhccC-CC---CCCCCCHHHHHHHHhcc-
Q psy10462 81 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY---SELLKQVQKRVV-FP---ESPRLSSSCKALISNIL- 152 (347)
Q Consensus 81 y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~---~~~~~~i~~~~~-~~---~~~~~s~~~~~li~~~l- 152 (347)
|+|||.+.+..++ .++|||||||++|+|++|+.||.+... .+.+..+..... .+ ....++.++.+++..|+
T Consensus 179 Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~ 257 (483)
T 3sv0_A 179 YASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRS 257 (483)
T ss_dssp TCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHT
T ss_pred ccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhc
Confidence 9999999988776 689999999999999999999987543 333333322111 11 12467899999999999
Q ss_pred CCCCCCCCHHHHh
Q psy10462 153 SPVKFRIQMEDIR 165 (347)
Q Consensus 153 ~~~~~R~~~~eil 165 (347)
.+|..||+++++.
T Consensus 258 ~dP~~RPs~~el~ 270 (483)
T 3sv0_A 258 LRFDDKPDYSYLK 270 (483)
T ss_dssp CCTTCCCCHHHHH
T ss_pred CChhhCcCHHHHH
Confidence 7999999998775
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=215.71 Aligned_cols=155 Identities=23% Similarity=0.345 Sum_probs=118.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .......|++.|+|||.
T Consensus 131 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~~y~aPE~ 206 (309)
T 2h34_A 131 LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL----TQLGNTVGTLYYMAPER 206 (309)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------------------CCGGGCCGGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc----ccccccCCCcCccCHHH
Confidence 56788999999999999999999999999999999999999999999999876543211 11224568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--CCCCCCHHHHHHHHhcc-CCCCCCC-CHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--ESPRLSSSCKALISNIL-SPVKFRI-QME 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~s~~~~~li~~~l-~~~~~R~-~~~ 162 (347)
+.+..++ .++|+||||+++|+|++|+.||.+.+.......+......+ .++.+++.+++++.+|| .+|..|| +++
T Consensus 207 ~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~ 285 (309)
T 2h34_A 207 FSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCG 285 (309)
T ss_dssp TCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHH
T ss_pred HcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHH
Confidence 9887766 57999999999999999999999877665555554433222 24568899999999999 7999999 888
Q ss_pred HHhc
Q psy10462 163 DIRQ 166 (347)
Q Consensus 163 eil~ 166 (347)
++++
T Consensus 286 ~l~~ 289 (309)
T 2h34_A 286 DLSA 289 (309)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=224.14 Aligned_cols=142 Identities=19% Similarity=0.285 Sum_probs=118.8
Q ss_pred cchhhhhhhhhhhcccccchhhhhhccc---ccccchhheehhccCCc-hhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~---~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
..+..++|++.+.||+|+||+||+|++. .+|+.||+|++++.... .......+.+|+.+|+.++||||++++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3456788999999999999999999875 68999999999765322 1223445678999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+.+|+|||||+||+|.+++.+.+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~ 158 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG 158 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC
Confidence 9999999999999999999998888999999999988776 99999999999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=217.32 Aligned_cols=150 Identities=21% Similarity=0.309 Sum_probs=121.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc--------EEEeccCCceecccCCccccccCcccccCC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--------IKLSDFGFARKYSVNNTDYKQNLSETFCGS 78 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt 78 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++. +||+|||++..... .....||
T Consensus 110 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---------~~~~~~~ 180 (289)
T 4fvq_A 110 INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---------KDILQER 180 (289)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---------HHHHHHT
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC---------ccccCCc
Confidence 566889999999999999999999999999999999988877 99999999865422 1234578
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCC
Q psy10462 79 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~ 156 (347)
+.|+|||++.+....+.++||||+||++|+|++ |..||...+.............. +...++++++++..|| .+|.
T Consensus 181 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~ 258 (289)
T 4fvq_A 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL--PAPKAAELANLINNCMDYEPD 258 (289)
T ss_dssp TTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCSSCTTHHHHHHHSCSSGG
T ss_pred CcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC--CCCCCHHHHHHHHHHcCCChh
Confidence 899999999873333478999999999999999 56666666665555554444333 3455788999999999 7999
Q ss_pred CCCCHHHHhcC
Q psy10462 157 FRIQMEDIRQD 167 (347)
Q Consensus 157 ~R~~~~eil~~ 167 (347)
.||++++++++
T Consensus 259 ~Rps~~~ll~~ 269 (289)
T 4fvq_A 259 HRPSFRAIIRD 269 (289)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999876
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=235.97 Aligned_cols=151 Identities=22% Similarity=0.283 Sum_probs=132.5
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
.-.++|++.+.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+|++++|||||+++++|++.+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45678999999999999999999999999999999997654433334566789999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+|||||++|+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||++..+....+.++..|
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 9999999999999999888999999999988876 9999999999999999999999766555555555443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=222.77 Aligned_cols=166 Identities=19% Similarity=0.346 Sum_probs=118.4
Q ss_pred CHHHHHHHHHHHHHHHHHHHhC---------CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcc---ccccCcccc
Q psy10462 8 NTDKARRWFSQLADAIDYCHKK---------SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD---YKQNLSETF 75 (347)
Q Consensus 8 ~~~~~~~~~~qi~~gl~~lH~~---------~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~ 75 (347)
++.++.+++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......... .........
T Consensus 109 ~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 188 (336)
T 3g2f_A 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCT
T ss_pred chhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccC
Confidence 4578889999999999999999 9999999999999999999999999999876432111 011122345
Q ss_pred cCCccccccccccCC-------CCCCChhhHHHHHHHHHHHHcCCCCCCCCC------------------HHHHHHHHHh
Q psy10462 76 CGSYAYASPEILKGV-------PYTPQQSDIWSMGVVLFAMVYGRLPFDDTN------------------YSELLKQVQK 130 (347)
Q Consensus 76 ~gt~~y~aPE~~~~~-------~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~------------------~~~~~~~i~~ 130 (347)
+||+.|+|||++.+. .++ .++|||||||++|+|++|..||.... ..+....+..
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (336)
T 3g2f_A 189 VGTIRYMAPEVLEGAVNLRDXESAL-KQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR 267 (336)
T ss_dssp TSCGGGCCHHHHTTCCCGGGHHHHH-HHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTT
T ss_pred CCccceeCchhhcCCcccccccccc-cccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcc
Confidence 799999999999873 222 47899999999999999977764321 1111122222
Q ss_pred ccCCCC-C------CCCCHHHHHHHHhcc-CCCCCCCCHHHHh------cCCCCCCCC
Q psy10462 131 RVVFPE-S------PRLSSSCKALISNIL-SPVKFRIQMEDIR------QDPWLKEDS 174 (347)
Q Consensus 131 ~~~~~~-~------~~~s~~~~~li~~~l-~~~~~R~~~~eil------~~p~~~~~~ 174 (347)
....+. + ...++++.+++..|| .+|..||++++++ .++|.++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 111111 1 113457999999999 7999999999994 478876654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=236.45 Aligned_cols=150 Identities=21% Similarity=0.301 Sum_probs=128.3
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh----------hhhhchHHHHHHHhcCCCcchhhhhe
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID----------YLKKFLPREIEVVKGLKHPNLIRFLQ 258 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~~ 258 (347)
-.++|++.+.||+|+||+||+|.+..+++.||+|++.+...... ...+.+.+|+.+|++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999976543211 23456779999999999999999999
Q ss_pred eeeeCCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEe
Q psy10462 259 AIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHL 337 (347)
Q Consensus 259 ~~~~~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~ 337 (347)
+|++.+.+|+|||||+||+|.+++.+.+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++....+.++..
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999998888999999999988876 999999999999999999999998876556666655
Q ss_pred e
Q psy10462 338 Q 338 (347)
Q Consensus 338 ~ 338 (347)
|
T Consensus 194 g 194 (504)
T 3q5i_A 194 G 194 (504)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=237.57 Aligned_cols=155 Identities=21% Similarity=0.390 Sum_probs=131.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ .......+++.|+|||.
T Consensus 488 l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~----~~~~~~~~t~~y~aPE~ 563 (656)
T 2j0j_A 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY----YKASKGKLPIKWMAPES 563 (656)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--------------CCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc----eeccCCCCCcceeCHHH
Confidence 56688899999999999999999999999999999999999999999999976543211 11123456789999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+...+.++.+++.+.+++..|| .+|..||++.++
T Consensus 564 ~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el 642 (656)
T 2j0j_A 564 INFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642 (656)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9877766 68999999999999997 99999999988888888887777777889999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 643 ~~ 644 (656)
T 2j0j_A 643 KA 644 (656)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=235.59 Aligned_cols=141 Identities=19% Similarity=0.251 Sum_probs=117.6
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
.+..++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34567899999999999999999999999999999999754332333345566899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhh-cCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFS-RCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~-~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|||||++|+|.+++.+.+.+++..++.++.|++ |+.|+|+ +||+||||||+|||++.++
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~ 286 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG 286 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC
Confidence 99999999999999998888999999999988776 9999997 9999999999999998765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=234.42 Aligned_cols=151 Identities=21% Similarity=0.283 Sum_probs=126.6
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
+.-.+.|++.+.||+|+||+||+|++..+++.||+|++.+..... .....+.+|+.+|+.++|||||+++++|++.+.+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 344678999999999999999999999999999999997654322 2245577999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|||||++|+|.+++.+...+++..+..++.|++ |+.|+|++||+||||||+|||++..+....+.++..|
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 99999999999999998888999999999988876 9999999999999999999999876655555555544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=235.92 Aligned_cols=140 Identities=19% Similarity=0.340 Sum_probs=125.6
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
....+|++.+.||+|+||+||+|++..+|+.||+|++++.........+.+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34578999999999999999999999999999999997543322233456789999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||+||+|.+++.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~ 153 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM 153 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC
Confidence 9999999999999998888999999999988876 99999999999999999999998765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=219.64 Aligned_cols=158 Identities=27% Similarity=0.458 Sum_probs=107.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEcCCCcEEEeccCCceecccCCccc-------cccCcccccC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY-------KQNLSETFCG 77 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~--iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~~~~g 77 (347)
+++.++..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.......... .........|
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (337)
T 3ll6_A 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccC
Confidence 677899999999999999999999 9999999999999999999999999997654321110 0011124568
Q ss_pred Cccccccccc---cCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-C
Q psy10462 78 SYAYASPEIL---KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-S 153 (347)
Q Consensus 78 t~~y~aPE~~---~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~ 153 (347)
|+.|+|||++ .+..++ .++|||||||++|+|++|+.||.+...... +......+.....+..+.++++.|| .
T Consensus 213 t~~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~ 288 (337)
T 3ll6_A 213 TPMYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCFRQHPFEDGAKLRI---VNGKYSIPPHDTQYTVFHSLIRAMLQV 288 (337)
T ss_dssp -----------CCTTSCSS-HHHHHHHHHHHHHHHHHSSCCC---------------CCCCTTCCSSGGGHHHHHHHSCS
T ss_pred CCCcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHhCCCCCcchhHHHh---hcCcccCCcccccchHHHHHHHHHccC
Confidence 9999999998 344444 689999999999999999999987554332 2333445556677888999999999 7
Q ss_pred CCCCCCCHHHHhcCC
Q psy10462 154 PVKFRIQMEDIRQDP 168 (347)
Q Consensus 154 ~~~~R~~~~eil~~p 168 (347)
+|.+||++++++++-
T Consensus 289 ~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 289 NPEERLSIAEVVHQL 303 (337)
T ss_dssp SGGGSCCHHHHHHHH
T ss_pred ChhhCcCHHHHHHHH
Confidence 999999999998763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-28 Score=220.01 Aligned_cols=161 Identities=24% Similarity=0.376 Sum_probs=124.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCcccc----ccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK----QNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~~gt~~y~ 82 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........... ........||+.|+
T Consensus 131 ~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 210 (317)
T 2buj_A 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccC
Confidence 67789999999999999999999999999999999999999999999999876432110000 00012345799999
Q ss_pred ccccccCCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCC
Q psy10462 83 SPEILKGVPY--TPQQSDIWSMGVVLFAMVYGRLPFDDTN--YSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 83 aPE~~~~~~~--~~~~~Dvws~G~~l~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~ 157 (347)
|||++.+... .+.++|+||||+++|+|++|+.||.... .......+......|.....++.+.+++..|| .+|..
T Consensus 211 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 290 (317)
T 2buj_A 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQ 290 (317)
T ss_dssp CGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred CHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhh
Confidence 9999876542 1368999999999999999999996421 11223334445556667788999999999999 79999
Q ss_pred CCCHHHHhcC
Q psy10462 158 RIQMEDIRQD 167 (347)
Q Consensus 158 R~~~~eil~~ 167 (347)
||++++++++
T Consensus 291 Rps~~~ll~~ 300 (317)
T 2buj_A 291 RPHIPLLLSQ 300 (317)
T ss_dssp SCCHHHHHHH
T ss_pred CCCHHHHHHH
Confidence 9999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-28 Score=226.67 Aligned_cols=142 Identities=19% Similarity=0.330 Sum_probs=126.3
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
..+.+..++|++.+.||+|+||.||+|++..+++.||+|+++... .....+.+.+|+++|++++|||||++++++.++
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 456778889999999999999999999999899999999987432 233455677999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|+|||||++|+|.++++.. ..+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~ 250 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC
Confidence 9999999999999999999764 4699999999888776 99999999999999999999998765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-28 Score=238.61 Aligned_cols=140 Identities=12% Similarity=0.122 Sum_probs=124.0
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
+..++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++|||||+++++|++.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45677889999999999999999999999999999997644333333455679999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||+||+|.+++...+ .+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g 323 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC
Confidence 9999999999999997654 499999999988776 99999999999999999999998776
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-28 Score=222.00 Aligned_cols=136 Identities=18% Similarity=0.309 Sum_probs=117.8
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-CcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
+.||+|+||+||+|.+..+|+.||+|++.+. ....+.+|+.+++.+. ||||++++++|.+++..|+|||||++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 6799999999999999999999999998643 1344568999999996 99999999999999999999999999
Q ss_pred CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 276 GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 276 G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|.+++.+.+.+++.+++.++.|++ ++.|+|++||+||||||+|||++.++....+.++..|
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 99999999988999999999988876 9999999999999999999999876644455554443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-28 Score=224.11 Aligned_cols=143 Identities=19% Similarity=0.320 Sum_probs=124.0
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 267 (347)
-.++|++.+.||+|+||+||+|.++.+|+.||+|++++.. ....+|+++|.++ +||||++++++|++.+.+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999997542 2344799999887 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc-ccceeEEEEEee
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA-TYYSTIVVVHLQ 338 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~-~~~~~~~~~~~~ 338 (347)
+|||||+||+|.+++.+.+.+++.+++.++.|++ ++.|+|++||+||||||+|||+... +....+.++..|
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999999999888999999999988876 9999999999999999999998544 333345555443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=212.76 Aligned_cols=154 Identities=22% Similarity=0.371 Sum_probs=126.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ......||+.|+|||.
T Consensus 119 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~ 192 (284)
T 2a19_B 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG------KRTRSKGTLRYMSPEQ 192 (284)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS------CCCCCCSCCTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc------cccccCCcccccChhh
Confidence 5678899999999999999999999999999999999999999999999997764321 1224468999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIR 165 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil 165 (347)
+.+..++ .++|+||+|+++|+|++|..||... ......+.... .+..+++.+++++..|| .+|..||++.+++
T Consensus 193 ~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 266 (284)
T 2a19_B 193 ISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266 (284)
T ss_dssp HHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc---ccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9887766 6899999999999999999988532 23333333322 34567899999999999 7999999999999
Q ss_pred cCCCCCC
Q psy10462 166 QDPWLKE 172 (347)
Q Consensus 166 ~~p~~~~ 172 (347)
++.|.-.
T Consensus 267 ~~l~~~~ 273 (284)
T 2a19_B 267 RTLTVWK 273 (284)
T ss_dssp HHHHHHT
T ss_pred HHHHHHh
Confidence 9876443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-28 Score=221.17 Aligned_cols=133 Identities=14% Similarity=0.182 Sum_probs=119.7
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|.+..+++.||+|.+.... .....+.+|+.+|+.++||||++++++|++.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 467889999999999999999999999999999986432 2244577999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 270 MEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
||||+||+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||++..
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~ 138 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR 138 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC
Confidence 9999999999999765 4799999999988876 9999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-28 Score=234.70 Aligned_cols=151 Identities=20% Similarity=0.305 Sum_probs=131.7
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
+.-.++|++.+.||+|+||+||+|++..+++.||+|++.+..... .....+.+|+.+|++++|||||++++++.+.+.+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 445788999999999999999999999999999999986532211 1235567999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+|||||++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++..+....+.++..|
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 99999999999999998888999999999988876 9999999999999999999999877665566665544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-28 Score=225.28 Aligned_cols=149 Identities=13% Similarity=0.172 Sum_probs=124.5
Q ss_pred cchhhhhhhhhhhcccccchhhhhhc-----ccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~-----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
..+..++|++.+.||+|+||+||+|+ +..+++.||+|+++... .......+.+|+.++++++|||||++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34567889999999999999999999 44577889999996432 222344567999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChHHHHHhC-------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeE
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRKE-------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTI 332 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~~-------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~ 332 (347)
.+.+..|+|||||++|+|.++++.. ..+++..+..++.|++ |+.|+|++||+||||||+|||++.++....+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999999754 3599999998888776 9999999999999999999999977655555
Q ss_pred EEEE
Q psy10462 333 VVVH 336 (347)
Q Consensus 333 ~~~~ 336 (347)
.++.
T Consensus 224 kL~D 227 (367)
T 3l9p_A 224 KIGD 227 (367)
T ss_dssp EECC
T ss_pred EECC
Confidence 5543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=218.45 Aligned_cols=146 Identities=21% Similarity=0.295 Sum_probs=126.7
Q ss_pred hhhhhhh-hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEE
Q psy10462 190 KRKLKLI-RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 190 ~~~~~~~-~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 267 (347)
.+.|++. +.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+|+++ +||||+++++++.+++.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4567774 679999999999999999999999999975432 2244567999999985 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+|||||++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++....+.+...|
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 9999999999999998888999999999988876 9999999999999999999999988766556655443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-28 Score=227.02 Aligned_cols=137 Identities=18% Similarity=0.181 Sum_probs=116.3
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCc-----hhhhhhchHHHHHHHhcCC-------------
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP-----IDYLKKFLPREIEVVKGLK------------- 249 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~------------- 249 (347)
+..++|++.+.||+|+||+||+|++ +|+.||+|+++..... .....+.+.+|+.+|++++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4568899999999999999999987 6899999999765321 1122355679999998886
Q ss_pred -------------Ccchhhhheeeee-------------CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-H
Q psy10462 250 -------------HPNLIRFLQAIET-------------THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-N 302 (347)
Q Consensus 250 -------------HpnIv~l~~~~~~-------------~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~ 302 (347)
||||++++++|++ .+.+|||||||++|++.+.+.+ +.+++..++.++.|++ |
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 8888888888876 7899999999999987777744 6799999999998876 9
Q ss_pred HHHHh-hcCccccCCCCccccccccc
Q psy10462 303 LSQTF-SRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 303 ~~~~h-~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.|+| ++||+||||||+|||++.++
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~ 199 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTS 199 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECS
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccC
Confidence 99999 99999999999999998876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-28 Score=223.43 Aligned_cols=136 Identities=19% Similarity=0.277 Sum_probs=120.5
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3678999999999999999999999999999999865432 22245677999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||++|+|.+++...+.+++..++.++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~ 142 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD 142 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC
Confidence 99999999999998888899999999988876 99999999999999999999998765
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-28 Score=222.91 Aligned_cols=139 Identities=18% Similarity=0.257 Sum_probs=124.2
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC----
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 264 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 264 (347)
-.++|++.+.||+|+||.||+|++..+++.||+|+++............+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999999999999999997655445555567889999999999999999999987654
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..|+||||++||+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 153 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN 153 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC
Confidence 3599999999999999998888999999999988876 99999999999999999999997765
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=212.15 Aligned_cols=155 Identities=28% Similarity=0.446 Sum_probs=116.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ......|++.|+|||.
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~ 207 (310)
T 2wqm_A 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-----AAHSLVGTPYYMSPER 207 (310)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----------------------CCSSCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc-----cccccCCCeeEeChHH
Confidence 56788999999999999999999999999999999999999999999999876543211 1224568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHhccCCC-CCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT--NYSELLKQVQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
+.+..++ .++|+||||+++|+|++|..||.+. +..+....+......+ ....+++++++++..|| .+|..||+++
T Consensus 208 ~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 286 (310)
T 2wqm_A 208 IHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVT 286 (310)
T ss_dssp HTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHH
Confidence 9887766 6899999999999999999999764 3344455554433222 23568999999999999 7999999999
Q ss_pred HHhcC
Q psy10462 163 DIRQD 167 (347)
Q Consensus 163 eil~~ 167 (347)
++++.
T Consensus 287 ~il~~ 291 (310)
T 2wqm_A 287 YVYDV 291 (310)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=223.29 Aligned_cols=142 Identities=23% Similarity=0.360 Sum_probs=122.5
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhccc-------ccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSA-------RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIR 255 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~ 255 (347)
+.+.+..++|++.+.||+|+||+||+|++. .++..||+|+++... .....+.+.+|+.+|+++ +|||||+
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~ 151 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 151 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCC
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 345677899999999999999999999864 356679999997542 233345677999999999 8999999
Q ss_pred hheeeeeCCeEEEEEEecCCCChHHHHHhCC----------------CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCC
Q psy10462 256 FLQAIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQD 318 (347)
Q Consensus 256 l~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~----------------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp 318 (347)
++++|.+++.+|+||||+++|+|.++++..+ .+++.++..++.|++ |+.|+|++||+||||||
T Consensus 152 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 231 (370)
T 2psq_A 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231 (370)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 9999999999999999999999999997643 478999998888776 99999999999999999
Q ss_pred ccccccccc
Q psy10462 319 LSCFQEQAT 327 (347)
Q Consensus 319 ~Nil~~~~~ 327 (347)
+|||++.++
T Consensus 232 ~NIll~~~~ 240 (370)
T 2psq_A 232 RNVLVTENN 240 (370)
T ss_dssp GGEEECTTC
T ss_pred hhEEECCCC
Confidence 999998765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=219.45 Aligned_cols=136 Identities=16% Similarity=0.236 Sum_probs=115.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC-----
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 264 (347)
.++|++.+.||+|+||.||+|++..+|+.||+|+++... .....+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 467889999999999999999999999999999997543 2333566789999999999999999999986543
Q ss_pred ----------------------------------------------------eEEEEEEecCCCChHHHHHhCCC---CC
Q psy10462 265 ----------------------------------------------------RVYIIMEYAKNGSLLEVIRKERY---ID 289 (347)
Q Consensus 265 ----------------------------------------------------~~~iv~E~~~~G~L~~~l~~~~~---l~ 289 (347)
.+|+|||||++|+|.+++.+... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987543 55
Q ss_pred HHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 290 EDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 290 e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 201 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD 201 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC
Confidence 666777877776 99999999999999999999998765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=214.85 Aligned_cols=138 Identities=19% Similarity=0.183 Sum_probs=120.5
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 267 (347)
-..+|++.+.||+|+||+||+|.+..+++.||+|++........ ....+.+|+.++..+ +||||+++++++.+++.+|
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35789999999999999999999999999999999975433332 244566899999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhC----CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKE----RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~----~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+||||+++|+|.+++.+. +.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~ 152 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTS 152 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCC
Confidence 999999999999999754 6799999999988876 99999999999999999999998765
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.94 E-value=5.7e-28 Score=235.03 Aligned_cols=140 Identities=11% Similarity=0.080 Sum_probs=123.6
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|+..+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|++++||||++++++|++.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34577888999999999999999999999999999997654333333455779999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhC----CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKE----RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~----~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||+||+|.+++.+. ..+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g 326 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG 326 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC
Confidence 999999999999999763 3799999999988776 99999999999999999999998876
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-28 Score=228.67 Aligned_cols=148 Identities=18% Similarity=0.273 Sum_probs=124.6
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCc-----hhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP-----IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
..++|++.+.||+|+||+||+|.+..+++.||+|++.+.... .......+.+|+.+|++++|||||++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 457899999999999999999999999999999999754321 1222345779999999999999999999985 4
Q ss_pred CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEe
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHL 337 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~ 337 (347)
+.+|+|||||++|+|.+++...+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++....+.+...
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence 56899999999999999998888999999999988876 999999999999999999999987665444555443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=219.08 Aligned_cols=142 Identities=20% Similarity=0.262 Sum_probs=119.1
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
.......++|++.+.||+|+||+||+|.+..+++.||+|+++.... .....+.+.+|+.++++++||||+++++++.++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 3345567889999999999999999999999999999999975432 233345667999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|+|||||++ +|.+++...+.+++..++.++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~ 169 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSD 169 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC--
T ss_pred CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCC
Confidence 999999999985 9999999888999999999988876 99999999999999999999997554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=214.06 Aligned_cols=149 Identities=22% Similarity=0.323 Sum_probs=129.1
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|++.+.||+|+||+||+|.+..+++.+|+|++...... ...+.+.+|+++|++++||||+++++++.+.+.+|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 3467899999999999999999999999999999999754321 12456779999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHh----CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 268 IIMEYAKNGSLLEVIRK----ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~----~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+||||+++|+|.+++.. ...+++..+..++.|++ ++.|+|++||+||||||+|||++..+....+.++..|
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 99999999999999853 36899999999988776 9999999999999999999999876666666666554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=7.4e-28 Score=215.55 Aligned_cols=148 Identities=23% Similarity=0.339 Sum_probs=129.3
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++.+.+..|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 45678999999999999999999999999999999986544333334556789999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+||||+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++ ++.++..|
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~---~~~l~Dfg 154 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG---ELKIADFG 154 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS---CEEECSCC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC---CEEEEecc
Confidence 9999999999999998888999999999988776 99999999999999999999997765 34444443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=215.97 Aligned_cols=157 Identities=20% Similarity=0.372 Sum_probs=126.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......... .......++..|+|||.
T Consensus 142 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~ 219 (326)
T 2w1i_A 142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY--KVKEPGESPIFWYAPES 219 (326)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEE--ECSSCCSCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccccccc--ccccCCCCceeEECchh
Confidence 5678899999999999999999999999999999999999999999999998765332211 11223457788999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----------------HHHHHHHHhccCCCCCCCCCHHHHHHHHh
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY----------------SELLKQVQKRVVFPESPRLSSSCKALISN 150 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~----------------~~~~~~i~~~~~~~~~~~~s~~~~~li~~ 150 (347)
+.+..++ .++|+||+|+++|+|++|..||..... ..+...+......+.+..+++++.++++.
T Consensus 220 ~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 298 (326)
T 2w1i_A 220 LTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE 298 (326)
T ss_dssp HHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred hcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHH
Confidence 9877665 689999999999999999999864311 12223334444556667889999999999
Q ss_pred cc-CCCCCCCCHHHHhc
Q psy10462 151 IL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 151 ~l-~~~~~R~~~~eil~ 166 (347)
|| .+|..||++.++++
T Consensus 299 cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 299 CWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HSCSSGGGSCCHHHHHH
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99 79999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=215.48 Aligned_cols=135 Identities=17% Similarity=0.229 Sum_probs=118.4
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 4688899999999999999999999999999999755432 233455679999999999999999999999999999999
Q ss_pred EecCCCChHHHHH-hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIR-KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~-~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||++ +|.+++. ..+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~ 138 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG 138 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 99986 6666664 467899999999988876 99999999999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=214.71 Aligned_cols=138 Identities=12% Similarity=0.132 Sum_probs=121.7
Q ss_pred hhhhhhhhhhhcccccchhhhhhccccccc-------chhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQ-------DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~-------~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
+..++|++.+.||+|+||+||+|.+..+++ .||+|++.... ....+.+.+|+.++++++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 457889999999999999999999988774 59999986432 23345677999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChHHHHHhCC-CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
.+++..|+||||+++|+|.+++.+.+ .+++..+..++.|++ ++.|+|++||+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 151 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREED 151 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCB
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCc
Confidence 99999999999999999999997755 499999999888776 999999999999999999999988764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=212.35 Aligned_cols=147 Identities=21% Similarity=0.277 Sum_probs=128.7
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
-.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|++++++++||||+++++++.+.+.+|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 4578999999999999999999999999999999987543222 4557799999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||||+++|+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||+..++....+.++..|
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 999999999999998888999999999988876 9999999999999999999999665555556665544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=239.66 Aligned_cols=140 Identities=19% Similarity=0.206 Sum_probs=124.4
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 266 (347)
+...+|++.+.||+|+||+||+|+++.+++.||+|++++.........+.+.+|..+|..+ +||||++++++|++.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4567899999999999999999999999999999999764333333445567899999988 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||||++||+|.+++.+.+.+++..+++++.|++ ||.|+|++|||||||||+|||++.++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g 479 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG 479 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC
Confidence 99999999999999999888999999999988876 99999999999999999999998876
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=213.07 Aligned_cols=148 Identities=16% Similarity=0.280 Sum_probs=131.0
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 467899999999999999999999999999999997654433 2345677999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|||+++|+|.+++..++.+++..+..++.|++ ++.|+|++||+||||||+|||++.++....+.++..|
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 99999999999998888999999999988876 9999999999999999999999887766666665554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=214.43 Aligned_cols=158 Identities=22% Similarity=0.326 Sum_probs=120.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC---CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK---SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~---~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++........ .......||+.|+|
T Consensus 128 ~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~a 203 (326)
T 3uim_A 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT----HVTTAVRGTIGHIA 203 (326)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS----CEECCCCSCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc----cccccccCCcCccC
Confidence 66789999999999999999999 999999999999999999999999999986643221 11234569999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHhccCC-------------CCCCCCCHHHH
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-----NYSELLKQVQKRVVF-------------PESPRLSSSCK 145 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~-------------~~~~~~s~~~~ 145 (347)
||.+.+..++ .++||||+||++|+|++|+.||... ........+...... ..+...+..+.
T Consensus 204 PE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 282 (326)
T 3uim_A 204 PEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLI 282 (326)
T ss_dssp HHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHH
T ss_pred HHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHH
Confidence 9999877766 6899999999999999999999521 111111122111100 00112236788
Q ss_pred HHHHhcc-CCCCCCCCHHHHhcCCC
Q psy10462 146 ALISNIL-SPVKFRIQMEDIRQDPW 169 (347)
Q Consensus 146 ~li~~~l-~~~~~R~~~~eil~~p~ 169 (347)
+++..|| .+|..||++++++++-+
T Consensus 283 ~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 283 QVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHHHHHhCcCCccCCCHHHHHHHhc
Confidence 9999999 79999999999998743
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=214.03 Aligned_cols=156 Identities=26% Similarity=0.434 Sum_probs=120.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... .......||+.|+|||.
T Consensus 130 ~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~ 206 (307)
T 2nru_A 130 LSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT---VMTSRIVGTTAYMAPEA 206 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC---EECSSCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc---ccccccCCCcCcCChHH
Confidence 567889999999999999999999999999999999999999999999999765432111 11234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhcc----------CCCCCCCCCHHHHHHHHhcc
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE----LLKQVQKRV----------VFPESPRLSSSCKALISNIL 152 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~----~~~~i~~~~----------~~~~~~~~s~~~~~li~~~l 152 (347)
+.+. ++ .++|+||+|+++|+|++|..||.+.+..+ ....+.... ..+.+...+..+.+++..||
T Consensus 207 ~~~~-~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 284 (307)
T 2nru_A 207 LRGE-IT-PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCL 284 (307)
T ss_dssp HTTE-EC-THHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHT
T ss_pred hcCC-CC-ccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHc
Confidence 8764 44 68999999999999999999998754322 122221110 01112234567889999999
Q ss_pred -CCCCCCCCHHHHhcC
Q psy10462 153 -SPVKFRIQMEDIRQD 167 (347)
Q Consensus 153 -~~~~~R~~~~eil~~ 167 (347)
.+|..||++++++++
T Consensus 285 ~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 285 HEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSSTTTSCCHHHHHHH
T ss_pred CCCcccCcCHHHHHHH
Confidence 799999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=220.33 Aligned_cols=145 Identities=16% Similarity=0.235 Sum_probs=121.4
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
..+.|++.+.||+|+||+||+|++..+++.||+|+++... ..+.+.+|+.+|++++||||++++++|.+++.+|+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 4567999999999999999999999999999999997532 23456789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||||+++|+|.+++.+.+.+++.++..++.|++ |+.|+|++||+||||||+|||++.......+.++..|
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 999999999999998888999999999988876 9999999999999999999999864444445554443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=217.75 Aligned_cols=139 Identities=16% Similarity=0.173 Sum_probs=122.2
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccc---hhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQD---VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~---~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
.+...+|++.+.||+|+||+||+|.+..+++. ||+|+++... .....+.+.+|+.+|++++||||+++++++.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 45678899999999999999999999866654 9999997432 233456677999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|+||||+++|+|.++++.. +.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 188 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL 188 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC
Confidence 9999999999999999999654 5899999999988876 99999999999999999999997664
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=217.95 Aligned_cols=140 Identities=16% Similarity=0.275 Sum_probs=123.4
Q ss_pred cchhhhhhhhhhhcccccchhhhhhccc-----ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
+.+..++|++.+.||+|+||.||+|++. .+++.||+|+++... .....+.+.+|+.++++++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4567789999999999999999999986 456889999997543 233456678999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChHHHHHhC------------------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccC
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRKE------------------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDH 315 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~~------------------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRD 315 (347)
.+.+.+|+||||+++|+|.+++.+. ..+++.++..++.|++ ++.|+|++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999763 5799999999988876 99999999999999
Q ss_pred CCCccccccccc
Q psy10462 316 IQDLSCFQEQAT 327 (347)
Q Consensus 316 lKp~Nil~~~~~ 327 (347)
|||+|||+++++
T Consensus 200 lkp~NIl~~~~~ 211 (343)
T 1luf_A 200 LATRNCLVGENM 211 (343)
T ss_dssp CSGGGEEECGGG
T ss_pred CCcceEEECCCC
Confidence 999999998765
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=218.13 Aligned_cols=140 Identities=18% Similarity=0.216 Sum_probs=124.6
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh-----hhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID-----YLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
...++|++.+.||+|+||+||+|++..+++.||+|++++...... ...+.+.+|+.+|++++||||++++++|.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 346789999999999999999999999999999999976543221 134467799999999999999999999999
Q ss_pred CCeEEEEEEecCCC-ChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNG-SLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G-~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+++||||+.+| +|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC
Confidence 99999999999877 9999999888999999999988876 99999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=217.58 Aligned_cols=150 Identities=15% Similarity=0.220 Sum_probs=129.2
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh---hhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
-.+.|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 36789999999999999999999999999999999976543211 124557799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccc-eeEEEEEee
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYY-STIVVVHLQ 338 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~-~~~~~~~~~ 338 (347)
+|+||||+++|+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++.. ..+.++..|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999999888999999999988876 9999999999999999999999877632 245554443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=214.73 Aligned_cols=144 Identities=19% Similarity=0.245 Sum_probs=125.1
Q ss_pred CCCccchhhhhhhhhhhcccccchhhhhhccc-----ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhh
Q psy10462 182 SAPEVGIHKRKLKLIRDKKLSSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF 256 (347)
Q Consensus 182 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l 256 (347)
..+.+.+..++|++.+.||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|++++++++||||+++
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~ 91 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKL 91 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeE
Confidence 34567788999999999999999999999873 456889999997542 23334567799999999999999999
Q ss_pred heeeeeCCeEEEEEEecCCCChHHHHHhCCC------------------------CCHHHHHHHHHHHH-HHHHHhhcCc
Q psy10462 257 LQAIETTHRVYIIMEYAKNGSLLEVIRKERY------------------------IDEDKALLCYSEVS-NLSQTFSRCC 311 (347)
Q Consensus 257 ~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~~------------------------l~e~~~~~~~~~~~-~~~~~h~~~i 311 (347)
++++.+.+.+|+||||+++|+|.+++...+. +++..+..++.|++ ++.|+|++||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 171 (314)
T 2ivs_A 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171 (314)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999976443 89999999988876 9999999999
Q ss_pred cccCCCCccccccccc
Q psy10462 312 YQDHIQDLSCFQEQAT 327 (347)
Q Consensus 312 iHRDlKp~Nil~~~~~ 327 (347)
+||||||+|||++.++
T Consensus 172 vH~dikp~NIli~~~~ 187 (314)
T 2ivs_A 172 VHRDLAARNILVAEGR 187 (314)
T ss_dssp ECCCCSGGGEEEETTT
T ss_pred cccccchheEEEcCCC
Confidence 9999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=221.12 Aligned_cols=143 Identities=18% Similarity=0.282 Sum_probs=123.1
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhc-----ccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhh
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRF 256 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~-----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l 256 (347)
...+.+..++|++.+.||+|+||.||+|+ +..+++.||+|+++... .....+.+.+|+++++++ +|||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34677889999999999999999999998 56778999999997542 222345677999999999 89999999
Q ss_pred heeeeeCC-eEEEEEEecCCCChHHHHHhCCC------------------------------------------------
Q psy10462 257 LQAIETTH-RVYIIMEYAKNGSLLEVIRKERY------------------------------------------------ 287 (347)
Q Consensus 257 ~~~~~~~~-~~~iv~E~~~~G~L~~~l~~~~~------------------------------------------------ 287 (347)
++++.+++ .+++|||||++|+|.+++...+.
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998764 59999999999999999976432
Q ss_pred ------------------CCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 288 ------------------IDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 288 ------------------l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~ 230 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 230 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC
Confidence 89999999988876 99999999999999999999998665
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=220.25 Aligned_cols=150 Identities=16% Similarity=0.257 Sum_probs=114.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-----------CCcEEEeccCCceecccCCccccccCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-----------KYNIKLSDFGFARKYSVNNTDYKQNLSETF 75 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 75 (347)
+++.++..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|........ .......
T Consensus 169 l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~ 245 (365)
T 3e7e_A 169 MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK---GTIFTAK 245 (365)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCT---TEEECCS
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCC---Cceeeee
Confidence 667889999999999999999999999999999999988 89999999999976542211 1122356
Q ss_pred cCCccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CC
Q psy10462 76 CGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SP 154 (347)
Q Consensus 76 ~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~ 154 (347)
+||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... ......-.....++...+++..|| .+
T Consensus 246 ~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~~ 319 (365)
T 3e7e_A 246 CETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGE-----CKPEGLFRRLPHLDMWNEFFHVMLNIP 319 (365)
T ss_dssp SCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTE-----EEECSCCTTCSSHHHHHHHHHHHHCCC
T ss_pred cCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCc-----eeechhccccCcHHHHHHHHHHHcCCC
Confidence 799999999999998876 68999999999999999999996432210 000000111234677889999999 56
Q ss_pred CCCCC-CHHHHh
Q psy10462 155 VKFRI-QMEDIR 165 (347)
Q Consensus 155 ~~~R~-~~~eil 165 (347)
|..|+ +++++.
T Consensus 320 p~~r~~~~~~l~ 331 (365)
T 3e7e_A 320 DCHHLPSLDLLR 331 (365)
T ss_dssp CTTCCCCHHHHH
T ss_pred CCCcchHHHHHH
Confidence 76664 455443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=211.66 Aligned_cols=140 Identities=20% Similarity=0.326 Sum_probs=121.3
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
...+.+..++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|++++++++||||+++++++.+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 4567788999999999999999999999875 5667999999755433 2446799999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++.+|+||||+++|+|.+++.. ...+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~ 157 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 157 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC
Confidence 9999999999999999999976 56799999999988876 99999999999999999999998665
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6e-27 Score=226.64 Aligned_cols=140 Identities=19% Similarity=0.287 Sum_probs=125.4
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
..+.+...+|++.+.||+|+||.||+|.+..+++.||+|+++..... .+.+.+|+.+|++++|||||++++++.+.
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 45778889999999999999999999999989999999999754322 34577999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|||||||++|+|.+++++. ..+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 355 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH 355 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC
Confidence 9999999999999999999763 4699999998888776 99999999999999999999997654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=213.14 Aligned_cols=160 Identities=20% Similarity=0.340 Sum_probs=122.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHH--------hCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCC
Q psy10462 7 YNTDKARRWFSQLADAIDYCH--------KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH--------~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt 78 (347)
+++.++..++.|++.||.||| ++||+||||||+||+++.++.+||+|||++.......... ........||
T Consensus 136 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~gt 214 (342)
T 1b6c_B 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGT 214 (342)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEE-EECCCSCCCC
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccccc-ccccccCCcC
Confidence 566889999999999999999 8999999999999999999999999999998765432211 1122345799
Q ss_pred ccccccccccCCCCCC-----ChhhHHHHHHHHHHHHcC----------CCCCCCC-----CHHHHHHHHHhccCCCCCC
Q psy10462 79 YAYASPEILKGVPYTP-----QQSDIWSMGVVLFAMVYG----------RLPFDDT-----NYSELLKQVQKRVVFPESP 138 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~~-----~~~Dvws~G~~l~~ll~g----------~~pf~~~-----~~~~~~~~i~~~~~~~~~~ 138 (347)
+.|+|||++.+..... .++|||||||++|+|++| ..||.+. ........+......+..+
T Consensus 215 ~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (342)
T 1b6c_B 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 294 (342)
T ss_dssp GGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred cccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCc
Confidence 9999999998753221 478999999999999999 8899764 2334444443332222211
Q ss_pred ------CCCHHHHHHHHhcc-CCCCCCCCHHHHhcC
Q psy10462 139 ------RLSSSCKALISNIL-SPVKFRIQMEDIRQD 167 (347)
Q Consensus 139 ------~~s~~~~~li~~~l-~~~~~R~~~~eil~~ 167 (347)
..+..+.+++..|| .+|..||++++++++
T Consensus 295 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 295 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23357889999999 799999999999865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=212.76 Aligned_cols=140 Identities=16% Similarity=0.192 Sum_probs=127.0
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|+..+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34678999999999999999999999999999999997655444555667889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+||||+++|+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 152 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 152 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC
Confidence 9999999999999998888999999999988876 99999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=211.42 Aligned_cols=141 Identities=22% Similarity=0.295 Sum_probs=119.7
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhc----ccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
...+....|+..+.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.++++++||||+++++++
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 344567889999999999999999998 67789999999997543 222345677999999999999999999999
Q ss_pred eeC--CeEEEEEEecCCCChHHHHH-hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 261 ETT--HRVYIIMEYAKNGSLLEVIR-KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 261 ~~~--~~~~iv~E~~~~G~L~~~l~-~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+. ..+|+||||+++|+|.+++. ....+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~ 163 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 163 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC
Confidence 876 67999999999999999994 456799999999988876 99999999999999999999997765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-27 Score=214.66 Aligned_cols=142 Identities=14% Similarity=0.183 Sum_probs=125.6
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
.+...++|++.+.+|+|+||.||+|.+..+++.||+|++......+....+.+.+|+.++++++||||+++++++.+++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 34456789999999999999999999999999999999976544444455678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+||||+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~ 171 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD 171 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC
Confidence 999999999999999998888999999999988876 99999999999999999999998765
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=217.22 Aligned_cols=140 Identities=16% Similarity=0.192 Sum_probs=127.3
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34678999999999999999999999999999999997665444555677889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||++|+|.+++...+.+++.++..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 178 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC
Confidence 9999999999999998888999999999988876 99999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=214.87 Aligned_cols=143 Identities=23% Similarity=0.356 Sum_probs=123.1
Q ss_pred CCCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 182 SAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 182 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
....+.+...+|++.+.||+|+||+||+|++ +|+.||+|++....... ...+.+.+|+++|++++||||+++++++.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3456678889999999999999999999976 57889999997654433 33456779999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHhCCC---CCHHHHHHHHHHHH-HHHHHhhcC--ccccCCCCccccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRKERY---IDEDKALLCYSEVS-NLSQTFSRC--CYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~~~~---l~e~~~~~~~~~~~-~~~~~h~~~--iiHRDlKp~Nil~~~~~ 327 (347)
+.+.+|+|||||++|+|.+++.+.+. +++..+..++.|++ ++.|+|++| |+||||||+|||+++++
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC
Confidence 99999999999999999999987553 99999999888776 999999999 99999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-27 Score=222.33 Aligned_cols=154 Identities=22% Similarity=0.383 Sum_probs=119.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEE----cCCCcEEEeccCCceecccCCccccccCcccccCCcccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL----DDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYA 82 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~ 82 (347)
+++.+++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||++....... .....+||+.|+
T Consensus 109 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~------~~~~~~gt~~y~ 182 (396)
T 4eut_A 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE------QFVSLYGTEEYL 182 (396)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG------GSSCSSSCCTTC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC------ccccccCCcccc
Confidence 6789999999999999999999999999999999999 777889999999998764321 123457999999
Q ss_pred ccccccC--------CCCCCChhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHhccC-----------------
Q psy10462 83 SPEILKG--------VPYTPQQSDIWSMGVVLFAMVYGRLPFDDT----NYSELLKQVQKRVV----------------- 133 (347)
Q Consensus 83 aPE~~~~--------~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~----~~~~~~~~i~~~~~----------------- 133 (347)
|||++.+ ..++ .++|+|||||++|+|++|+.||.+. ...+.+..+..+..
T Consensus 183 aPE~~~~~~~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 261 (396)
T 4eut_A 183 HPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDW 261 (396)
T ss_dssp CHHHHHHHCC--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEE
T ss_pred CHHHhhccccccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCccc
Confidence 9999865 2333 5789999999999999999999642 23444555544321
Q ss_pred ---CCCCCC----CCHHHHHHHHhcc-CCCCCCCCHHHHhcC
Q psy10462 134 ---FPESPR----LSSSCKALISNIL-SPVKFRIQMEDIRQD 167 (347)
Q Consensus 134 ---~~~~~~----~s~~~~~li~~~l-~~~~~R~~~~eil~~ 167 (347)
.|.... ++..+.+++++|| .+|.+|+++++++++
T Consensus 262 ~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp ESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 111122 3456788999999 799999999998643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=219.28 Aligned_cols=139 Identities=15% Similarity=0.201 Sum_probs=121.5
Q ss_pred chhhhhhhhhhhcccccchhhhhhccc---ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSA---RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~---~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
.+...+|++.+.||+|+||.||+|++. .++..||+|.++... .....+.+.+|+.+|++++||||+++++++.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 456778999999999999999999886 567789999996542 233456678999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|+|||||++|+|.+++++. ..+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 184 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL 184 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC
Confidence 9999999999999999999765 4799999998888776 99999999999999999999998765
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=216.43 Aligned_cols=149 Identities=19% Similarity=0.271 Sum_probs=124.3
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCc-----hhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP-----IDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
-.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+|++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 457899999999999999999999999999999999754321 122234577999999999999999999998765
Q ss_pred CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+ +|+||||+++|+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++....+.++..|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 5 899999999999999998888999999998888776 9999999999999999999999887655456565544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=226.87 Aligned_cols=136 Identities=19% Similarity=0.237 Sum_probs=110.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee-----CC
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-----TH 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~ 264 (347)
.++|++.+.||+|+||+||+|++..+|+.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3679999999999999999999999999999999965432 33334567799999999999999999999943 36
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+||||+. |+|.++++..+.+++..++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~ 193 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC 193 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC
Confidence 7999999985 69999999888999999999988876 99999999999999999999998775
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=214.75 Aligned_cols=135 Identities=17% Similarity=0.218 Sum_probs=105.3
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|+..+.||+|+||+||+|.+..+|+.||+|+++... .....+.+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 467899999999999999999999999999999997543 222234567999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhC------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKE------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+ |+|.+++... +.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~ 145 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG 145 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC
Confidence 99998 5999999653 3699999999988776 99999999999999999999998765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=208.69 Aligned_cols=138 Identities=17% Similarity=0.305 Sum_probs=121.1
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
.+.+..++|++.+.+|+|+||+||+|.+. +++.||+|++...... .+.+.+|++++++++||||+++++++.+++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 35677889999999999999999999986 4667999999755433 245679999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+||||+++|+|.+++.. .+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~ 143 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 143 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC
Confidence 99999999999999999965 45699999998888776 99999999999999999999997664
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=221.86 Aligned_cols=134 Identities=17% Similarity=0.254 Sum_probs=120.1
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.+.|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+|+.+|+.++|||||+++++|++.+.+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999987542 22244677999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 270 MEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
||||++|+|.+++... ..+++..+..++.|++ |+.|+|++||+||||||+|||++.+
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~ 185 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC
Confidence 9999999999999764 4799999999988876 9999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=213.46 Aligned_cols=142 Identities=22% Similarity=0.340 Sum_probs=125.7
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
.....++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 34556889999999999999999999999999999999865433233334567799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+||||+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 151 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG 151 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC
Confidence 999999999999999998888999999999988776 99999999999999999999997765
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-27 Score=213.95 Aligned_cols=136 Identities=24% Similarity=0.294 Sum_probs=122.6
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 56888999999999999999999999999999986543 23344566779999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||++|+|.++++..+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 139 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS 139 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC
Confidence 9999999999998888999999999988776 99999999999999999999998765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-27 Score=210.42 Aligned_cols=140 Identities=19% Similarity=0.280 Sum_probs=125.1
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
..+.+..++|++.+.||+|+||.||+|.+..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.++
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4567788999999999999999999999999999999999875322 245567999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|+||||+++|+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~ 148 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH 148 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC
Confidence 9999999999999999999763 4699999999888776 99999999999999999999997665
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-27 Score=218.90 Aligned_cols=137 Identities=14% Similarity=0.127 Sum_probs=117.9
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhh-----cccccccchhheehhccCCchhhhhhchHHHHHHHhcCC---Ccchh
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLA-----TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLI 254 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~-----~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~---HpnIv 254 (347)
...+.+..++|++.+.||+|+||+||+| .+..+++.||+|+++... ...+.+|+++++.++ ||||+
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv 130 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFM 130 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhh
Confidence 4556677889999999999999999999 467789999999986432 234557888888886 99999
Q ss_pred hhheeeeeCCeEEEEEEecCCCChHHHHHh-----CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 255 RFLQAIETTHRVYIIMEYAKNGSLLEVIRK-----ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 255 ~l~~~~~~~~~~~iv~E~~~~G~L~~~l~~-----~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
++++++..++..|+|||||++|+|.+++.. .+.+++..+..++.|++ |+.|+|++|||||||||+|||++.
T Consensus 131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 999999999999999999999999999963 46799999999998877 999999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-27 Score=214.05 Aligned_cols=134 Identities=20% Similarity=0.231 Sum_probs=117.0
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC--eE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--RV 266 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~ 266 (347)
...+|++.+.||+|+||+||+|.+..+|+.||+|+++..... ...+.+.+|+++|++++||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 457899999999999999999999999999999999754321 12345669999999999999999999998765 88
Q ss_pred EEEEEecCCCChHHHHHhCC---CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKER---YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQE 324 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~---~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~ 324 (347)
|+|||||++|+|.+++.... .+++..+..++.|++ ++.|+|++||+||||||+|||+.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 146 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEe
Confidence 99999999999999997643 399999999988876 99999999999999999999983
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=209.81 Aligned_cols=140 Identities=28% Similarity=0.587 Sum_probs=110.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.++..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 114 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--------------------- 172 (299)
T 3m2w_A 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--------------------- 172 (299)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc---------------------
Confidence 677899999999999999999999999999999999998 78899999999864321
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---CCCC----CCCCHHHHHHHHhcc-CCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---FPES----PRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~----~~~s~~~~~li~~~l-~~~ 155 (347)
..++ .++|+||+||++|+|++|+.||.+.+..+....+..... .+.+ ..+++++++++.+|| .+|
T Consensus 173 ------~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 245 (299)
T 3m2w_A 173 ------EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 245 (299)
T ss_dssp ------CGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSST
T ss_pred ------ccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccCh
Confidence 1223 579999999999999999999987654433222222111 1111 467899999999999 799
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~~~ 174 (347)
..||+++++++|||+.+..
T Consensus 246 ~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 246 TQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp TTSCCHHHHHTSHHHHTGG
T ss_pred hhCCCHHHHhcChhhcccc
Confidence 9999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-27 Score=224.09 Aligned_cols=140 Identities=11% Similarity=0.059 Sum_probs=114.0
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHH---HHHhcCCCcchhhhh------
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI---EVVKGLKHPNLIRFL------ 257 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~---~il~~l~HpnIv~l~------ 257 (347)
+...++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+ ++|++++|||||+++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 34467899999999999999999999999999999999865444444456788999 455566899999999
Q ss_pred -eeeeeCC-----------------eEEEEEEecCCCChHHHHHhCCCCCH-------HHHHHHHHHHH-HHHHHhhcCc
Q psy10462 258 -QAIETTH-----------------RVYIIMEYAKNGSLLEVIRKERYIDE-------DKALLCYSEVS-NLSQTFSRCC 311 (347)
Q Consensus 258 -~~~~~~~-----------------~~~iv~E~~~~G~L~~~l~~~~~l~e-------~~~~~~~~~~~-~~~~~h~~~i 311 (347)
+++++++ ..|+||||| +|+|.+++.+.+.+++ ..+..++.|++ |+.|+|++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 6665553 389999999 5799999987655666 66777777766 9999999999
Q ss_pred cccCCCCccccccccc
Q psy10462 312 YQDHIQDLSCFQEQAT 327 (347)
Q Consensus 312 iHRDlKp~Nil~~~~~ 327 (347)
+||||||+|||++.++
T Consensus 228 vHrDikp~NIll~~~~ 243 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRG 243 (377)
T ss_dssp ECSCCCGGGEEECTTC
T ss_pred ecCCCCHHHEEEcCCC
Confidence 9999999999998765
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=7.7e-27 Score=209.17 Aligned_cols=149 Identities=15% Similarity=0.281 Sum_probs=128.1
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh---hhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 5678999999999999999999999999999999976543221 1245677999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc-ceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY-YSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~-~~~~~~~~~~ 338 (347)
|+||||+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++. ...+.+...|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999998888999999999988876 999999999999999999999987763 2244444433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-27 Score=214.20 Aligned_cols=139 Identities=19% Similarity=0.335 Sum_probs=115.9
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCch-----------------------hhhhhchHHHHHH
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI-----------------------DYLKKFLPREIEV 244 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~-----------------------~~~~~~~~~E~~i 244 (347)
...++|++.+.||+|+||.||+|++..+++.||+|++.+..... ....+.+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34578999999999999999999999999999999997543211 1123457799999
Q ss_pred HhcCCCcchhhhheeeee--CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccc
Q psy10462 245 VKGLKHPNLIRFLQAIET--THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSC 321 (347)
Q Consensus 245 l~~l~HpnIv~l~~~~~~--~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Ni 321 (347)
|++++||||+++++++.+ .+.+|+||||+++|+|.+++. .+.+++..+..++.|++ ++.|+|++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 578999999999999988653 46899999999988876 99999999999999999999
Q ss_pred cccccc
Q psy10462 322 FQEQAT 327 (347)
Q Consensus 322 l~~~~~ 327 (347)
|++.++
T Consensus 169 l~~~~~ 174 (298)
T 2zv2_A 169 LVGEDG 174 (298)
T ss_dssp EECTTS
T ss_pred EECCCC
Confidence 998765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-27 Score=212.42 Aligned_cols=138 Identities=21% Similarity=0.350 Sum_probs=120.2
Q ss_pred chhhhhhhhhhhcccccchhhhhhc----ccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
.+..++|++.+.||+|+||+||+|+ +..+++.||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567899999999999999999998 5678999999998643 23334567799999999999999999999865
Q ss_pred --CCeEEEEEEecCCCChHHHHHhCC-CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 --THRVYIIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 --~~~~~iv~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
...+|+|||||++|+|.+++...+ .+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~ 151 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 151 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC
Confidence 356999999999999999997644 599999999988876 99999999999999999999998765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-27 Score=214.63 Aligned_cols=143 Identities=11% Similarity=0.112 Sum_probs=123.4
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~i 268 (347)
..+|++.+.||+|+||+||+|++..+|+.||+|++..... .+.+.+|+.+++++ +||||+++++++.+.+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 4679999999999999999999999999999999864322 34577999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccccee--EEEEEee
Q psy10462 269 IMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYST--IVVVHLQ 338 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~--~~~~~~~ 338 (347)
||||+ +|+|.+++.. .+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++.... +.++..|
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 99999 8999999976 46899999999988876 999999999999999999999988764322 4554443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-27 Score=211.04 Aligned_cols=139 Identities=19% Similarity=0.248 Sum_probs=123.1
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
..++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45679999999999999999999999999999999965432222334567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+++|+|.+++... +.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~ 149 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM 149 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC
Confidence 99999999999999765 6799999999988876 99999999999999999999998765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.3e-27 Score=215.44 Aligned_cols=138 Identities=19% Similarity=0.270 Sum_probs=121.9
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
....|+..+.||+|+||+||+|++..+|+.||+|++...........+.+.+|+++|++++|||||++++++.+++..|+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 34668889999999999999999999999999999976544444445667899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHH-hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIR-KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~-~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||+ |+|.+++. ..+.+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 191 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 191 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC
Confidence 999998 58888885 456899999999888776 99999999999999999999998765
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-27 Score=212.06 Aligned_cols=145 Identities=19% Similarity=0.267 Sum_probs=124.1
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
-.++|++.+.||+|+||.||+|++..+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 35789999999999999999999999999999999975432 123457799999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEE
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVH 336 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~ 336 (347)
||||+++|+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||+...+...++.+..
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~D 152 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITD 152 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEcc
Confidence 999999999999998888999999999988876 99999999999999999999995544444444443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-27 Score=209.95 Aligned_cols=140 Identities=19% Similarity=0.323 Sum_probs=124.6
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
+..++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 34578999999999999999999999899999999986543222233456779999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+||||+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 148 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM 148 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC
Confidence 9999999999999998888999999999988876 89999999999999999999998765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-27 Score=215.96 Aligned_cols=149 Identities=15% Similarity=0.196 Sum_probs=117.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCcEEEcCCC--------------------cEEEeccCCceecccCCc
Q psy10462 7 YNTDKARRWFSQLADAIDYCH-KKSVVHRDIKCENLLLDDKY--------------------NIKLSDFGFARKYSVNNT 65 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH-~~~iiH~dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~ 65 (347)
+++.+++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 158 ~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--- 234 (336)
T 2vuw_A 158 SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--- 234 (336)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---
Confidence 467999999999999999999 99999999999999999887 899999999986542
Q ss_pred cccccCcccccCCccccccccccCCCCCCChhhHHHHHHH-HHHHHcCCCCCCCCCH-HHHHHHHHhccCCCC------C
Q psy10462 66 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVV-LFAMVYGRLPFDDTNY-SELLKQVQKRVVFPE------S 137 (347)
Q Consensus 66 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws~G~~-l~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~------~ 137 (347)
...+||+.|+|||++.+.. + .++||||++++ .+++++|..||.+... ......+......+. +
T Consensus 235 -------~~~~gt~~y~aPE~~~g~~-~-~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (336)
T 2vuw_A 235 -------GIVVFCDVSMDEDLFTGDG-D-YQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAM 305 (336)
T ss_dssp -------TEEECCCCTTCSGGGCCCS-S-HHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHH
T ss_pred -------CcEEEeecccChhhhcCCC-c-cceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhh
Confidence 1347999999999999866 3 68999998777 7788899999965322 222333332222211 1
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCHHHHh-cCCCCC
Q psy10462 138 PRLSSSCKALISNILSPVKFRIQMEDIR-QDPWLK 171 (347)
Q Consensus 138 ~~~s~~~~~li~~~l~~~~~R~~~~eil-~~p~~~ 171 (347)
+.+++++++|+++||..+ +++|++ +||||+
T Consensus 306 ~~~s~~~~dli~~~L~~d----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS----SHHHHHHHCGGGC
T ss_pred hhcCHHHHHHHHHHhccC----CHHHHHhcCCCcC
Confidence 246789999999999632 999999 999984
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-27 Score=218.22 Aligned_cols=143 Identities=22% Similarity=0.355 Sum_probs=123.6
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccc-------cccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchh
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSAR-------HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLI 254 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~-------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv 254 (347)
.+.+.+..++|++.+.||+|+||+||+|++.. +++.||+|++.... .......+.+|+++++++ +|||||
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhh
Confidence 34567788999999999999999999998643 34579999997542 233345677999999999 999999
Q ss_pred hhheeeeeCCeEEEEEEecCCCChHHHHHhCC----------------CCCHHHHHHHHHHHH-HHHHHhhcCccccCCC
Q psy10462 255 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQ 317 (347)
Q Consensus 255 ~l~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~----------------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlK 317 (347)
++++++.+++.+|+|||||++|+|.+++...+ .+++..+..++.|++ |+.|+|++||+|||||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999999999999999999999999997653 499999999988876 9999999999999999
Q ss_pred Cccccccccc
Q psy10462 318 DLSCFQEQAT 327 (347)
Q Consensus 318 p~Nil~~~~~ 327 (347)
|+|||+++++
T Consensus 219 p~NIll~~~~ 228 (382)
T 3tt0_A 219 ARNVLVTEDN 228 (382)
T ss_dssp GGGEEECTTC
T ss_pred cceEEEcCCC
Confidence 9999998765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-27 Score=215.23 Aligned_cols=142 Identities=19% Similarity=0.289 Sum_probs=121.0
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhcc-----cccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 257 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 257 (347)
..+.++.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+|+++ +||||++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 45677889999999999999999999986 3467789999997432 223356678999999999 999999999
Q ss_pred eeeeeCCeEEEEEEecCCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHH-HHHHHhhcCccc
Q psy10462 258 QAIETTHRVYIIMEYAKNGSLLEVIRKER-----------------------YIDEDKALLCYSEVS-NLSQTFSRCCYQ 313 (347)
Q Consensus 258 ~~~~~~~~~~iv~E~~~~G~L~~~l~~~~-----------------------~l~e~~~~~~~~~~~-~~~~~h~~~iiH 313 (347)
+++...+.+|+|||||++|+|.+++...+ .+++..+..++.|++ |+.|+|++||+|
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 99999999999999999999999997643 378999998888776 999999999999
Q ss_pred cCCCCccccccccc
Q psy10462 314 DHIQDLSCFQEQAT 327 (347)
Q Consensus 314 RDlKp~Nil~~~~~ 327 (347)
|||||+|||++.++
T Consensus 196 ~Dikp~NIll~~~~ 209 (344)
T 1rjb_A 196 RDLAARNVLVTHGK 209 (344)
T ss_dssp TTCSGGGEEEETTT
T ss_pred CCCChhhEEEcCCC
Confidence 99999999998765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-27 Score=214.28 Aligned_cols=151 Identities=15% Similarity=0.186 Sum_probs=123.9
Q ss_pred cchhhhhhhhhhhcccccchhhhhhc-----ccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~-----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
..+..++|++.+.||+|+||.||+|+ +..+++.||+|.+.... .......+.+|+.++++++||||+++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 35678899999999999999999998 45678889999996432 223345677999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChHHHHHhCC-------CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeE
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRKER-------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTI 332 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~~~-------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~ 332 (347)
.+.+..|+||||+++|+|.+++...+ .+++..+..++.|++ ++.|+|++||+||||||+|||++.++....+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999997653 489999998888776 9999999999999999999999977665556
Q ss_pred EEEEee
Q psy10462 333 VVVHLQ 338 (347)
Q Consensus 333 ~~~~~~ 338 (347)
.++..|
T Consensus 183 kl~Dfg 188 (327)
T 2yfx_A 183 KIGDFG 188 (327)
T ss_dssp EECCCH
T ss_pred EECccc
Confidence 655443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.5e-27 Score=207.01 Aligned_cols=137 Identities=20% Similarity=0.383 Sum_probs=121.0
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
+.+..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||+++++++.+++.
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 4567889999999999999999999775 5667999999754433 2446799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+||||+++|+|.+++... +.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~ 141 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL 141 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC
Confidence 99999999999999999764 4699999999988876 99999999999999999999998765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=207.92 Aligned_cols=142 Identities=18% Similarity=0.274 Sum_probs=120.8
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhccccc---ccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhhee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 259 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~---~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~ 259 (347)
...+.+..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.++++++||||++++++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 345677889999999999999999999988654 4569999986532 23345667899999999999999999999
Q ss_pred eeeCCeEEEEEEecCCCChHHHHHhCC-CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 260 IETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 260 ~~~~~~~~iv~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+. ++..|+||||+++|+|.+++...+ .+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 153 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND 153 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC
Confidence 84 567899999999999999997654 799999999888776 99999999999999999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=227.70 Aligned_cols=160 Identities=24% Similarity=0.408 Sum_probs=122.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCc---EEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.+++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++....... ......||+.|+|
T Consensus 118 lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~------~~~~~~gt~~Y~A 191 (676)
T 3qa8_A 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE------LCTEFVGTLQYLA 191 (676)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC------CCCCCCSCCTTCS
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc------ccccccCCcccCC
Confidence 566889999999999999999999999999999999997665 8999999997654321 1234678999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------HH------HhccCC----CCC----CCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK---------QV------QKRVVF----PES----PRL 140 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~---------~i------~~~~~~----~~~----~~~ 140 (347)
||.+.+..++ .++|+||+||++|+|++|..||.+......+. .+ .....+ |.+ ..+
T Consensus 192 PE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~l 270 (676)
T 3qa8_A 192 PELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGIL 270 (676)
T ss_dssp SCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGG
T ss_pred hHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhh
Confidence 9999988776 67999999999999999999997653321110 00 000001 111 235
Q ss_pred CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 141 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 141 s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
++.+.+++..|| .+|.+||+++++++||||..-
T Consensus 271 s~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 271 AGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp HHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 678999999999 799999999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=220.35 Aligned_cols=136 Identities=19% Similarity=0.243 Sum_probs=121.2
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC-----C
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 264 (347)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.+... .....+.+.+|+.+|+.++||||+++++++... +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 5789999999999999999999999999999999975432 333345677999999999999999999999776 5
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+|||||+ |+|.++++..+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~ 166 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC 166 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC
Confidence 7999999997 59999999888999999999988876 99999999999999999999998775
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=210.34 Aligned_cols=143 Identities=20% Similarity=0.283 Sum_probs=124.9
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcc-----cccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhh
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRF 256 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l 256 (347)
...+.+..++|++.+.||+|+||+||+|++ ..+++.||+|+++... .....+.+.+|+.+++++ +||||+++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 445778889999999999999999999984 4678899999997543 223356678999999999 99999999
Q ss_pred heeeeeCCeEEEEEEecCCCChHHHHHhCC------------------CCCHHHHHHHHHHHH-HHHHHhhcCccccCCC
Q psy10462 257 LQAIETTHRVYIIMEYAKNGSLLEVIRKER------------------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQ 317 (347)
Q Consensus 257 ~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~------------------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlK 317 (347)
++++.+++..|+||||+++|+|.+++...+ .+++..+..++.|++ ++.|+|++||+|||||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 999999999999999999999999997643 489999999988876 9999999999999999
Q ss_pred Cccccccccc
Q psy10462 318 DLSCFQEQAT 327 (347)
Q Consensus 318 p~Nil~~~~~ 327 (347)
|+|||+++++
T Consensus 173 p~Nil~~~~~ 182 (313)
T 1t46_A 173 ARNILLTHGR 182 (313)
T ss_dssp GGGEEEETTT
T ss_pred cceEEEcCCC
Confidence 9999997664
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=207.50 Aligned_cols=139 Identities=19% Similarity=0.302 Sum_probs=122.2
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
...+|++.+.||+|+||.||+|.+..+|+.||+|+++............+.+|+.++++++||||+++++++.+++.+++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 45679999999999999999999999999999999976544445556677899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh----CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRK----ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~----~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+++|+|.+++.. ...+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~ 173 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG 173 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC
Confidence 9999999999999964 46799999998888776 99999999999999999999998765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=215.50 Aligned_cols=138 Identities=17% Similarity=0.160 Sum_probs=124.4
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
+..++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++.+|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence 44678999999999999999999999999999999997542 2334566789999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhc-CccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSR-CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~-~iiHRDlKp~Nil~~~~~ 327 (347)
+|||||++|+|.+++.+.+.+++..+..++.+++ ++.|+|++ ||+||||||+|||++.++
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~ 169 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 169 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC
Confidence 9999999999999998888999999998888776 99999986 999999999999998765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=212.71 Aligned_cols=144 Identities=22% Similarity=0.357 Sum_probs=123.1
Q ss_pred CCCccchhhhhhhhhhhcccccchhhhhhccc-------ccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcch
Q psy10462 182 SAPEVGIHKRKLKLIRDKKLSSYATVKLATSA-------RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNL 253 (347)
Q Consensus 182 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnI 253 (347)
..+.+.+..++|++.+.||+|+||+||+|++. .+++.||+|+++... .....+.+.+|+.+++++ +||||
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCE
Confidence 34667888999999999999999999999865 467789999997542 223345677999999999 99999
Q ss_pred hhhheeeeeCCeEEEEEEecCCCChHHHHHhCC----------------CCCHHHHHHHHHHHH-HHHHHhhcCccccCC
Q psy10462 254 IRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHI 316 (347)
Q Consensus 254 v~l~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~----------------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDl 316 (347)
+++++++.+++.+|+||||+++|+|.+++...+ .+++..+..++.|++ ++.|+|++||+||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 183 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 999999999999999999999999999997654 389999998888776 999999999999999
Q ss_pred CCccccccccc
Q psy10462 317 QDLSCFQEQAT 327 (347)
Q Consensus 317 Kp~Nil~~~~~ 327 (347)
||+|||++.++
T Consensus 184 kp~NIll~~~~ 194 (334)
T 2pvf_A 184 AARNVLVTENN 194 (334)
T ss_dssp SGGGEEECTTC
T ss_pred ccceEEEcCCC
Confidence 99999998665
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=212.07 Aligned_cols=138 Identities=20% Similarity=0.215 Sum_probs=124.2
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 46789999999999999999999999999999999865433 33345567799999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+++|+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~ 161 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG 161 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC
Confidence 999999999999888778899999999988876 99999999999999999999998765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=209.05 Aligned_cols=134 Identities=16% Similarity=0.218 Sum_probs=117.4
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||+|++ .+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 4688899999999999999998 6788999999965432 2223455679999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||+++ +|.+++... +.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 137 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG 137 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC
Confidence 99986 999999764 6899999998888776 99999999999999999999998765
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=214.24 Aligned_cols=128 Identities=20% Similarity=0.270 Sum_probs=109.0
Q ss_pred hhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecCC
Q psy10462 196 IRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKN 275 (347)
Q Consensus 196 ~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~~ 275 (347)
.+.||+|+||.||+|.+..+|+.||+|+++.... ...+.+.+|+++|++++|||||++++++.+.+.+|+|||||++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 5679999999999999999999999999975432 2345677999999999999999999999999999999999999
Q ss_pred CChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 276 GSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 276 G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
|+|.+++.+. ..+++..+..++.|++ ++.|+|++||+||||||+|||+..+
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 223 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR 223 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC
Confidence 9999999654 4799999998888776 9999999999999999999999543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=206.33 Aligned_cols=139 Identities=14% Similarity=0.214 Sum_probs=121.7
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC--
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-- 263 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-- 263 (347)
.++..++|++.+.+|+|+||.||+|++. ++.||+|++....... ...+.+.+|+.++++++||||+++++++.++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4566789999999999999999999874 7889999997654333 3345678999999999999999999999887
Q ss_pred CeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcC--ccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRC--CYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~--iiHRDlKp~Nil~~~~~ 327 (347)
+.+++||||+++|+|.+++.+.+ .+++..+..++.|++ |+.|+|++| |+||||||+|||+++++
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~ 150 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc
Confidence 78999999999999999998755 599999999988876 999999999 99999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=207.95 Aligned_cols=151 Identities=20% Similarity=0.316 Sum_probs=130.8
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
+.-.++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+.+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 34567899999999999999999999989999999999754332 22245577999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
|+||||+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++....+.++..|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 99999999999999998878999999999988876 9999999999999999999999887655556665544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=208.93 Aligned_cols=143 Identities=16% Similarity=0.216 Sum_probs=124.2
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhccc-----ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhh
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 257 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~ 257 (347)
..++.+..++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .......+.+|+.+++.++||||++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 4567788899999999999999999999876 467889999997543 222344577999999999999999999
Q ss_pred eeeeeCCeEEEEEEecCCCChHHHHHhC----------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 258 QAIETTHRVYIIMEYAKNGSLLEVIRKE----------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 258 ~~~~~~~~~~iv~E~~~~G~L~~~l~~~----------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
+++.+.+..|+||||+++|+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||++++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 9999999999999999999999999652 4679999998888776 9999999999999999999999876
Q ss_pred c
Q psy10462 327 T 327 (347)
Q Consensus 327 ~ 327 (347)
+
T Consensus 175 ~ 175 (322)
T 1p4o_A 175 F 175 (322)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=210.82 Aligned_cols=134 Identities=16% Similarity=0.259 Sum_probs=118.0
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
...|+..+.||+|+||.||+|++..+|+.||+|++...... ..+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 34566677899999999999999889999999998654322 234567999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||+++|+|.+++.+ ..+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 999999999999864 5799999999988876 89999999999999999999998765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=211.71 Aligned_cols=140 Identities=14% Similarity=0.225 Sum_probs=118.4
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
..+.-.++|++.+.||+|+||+||+|++. +|+.||+|++..... .......+.+|++++++++||||+++++++.+++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 34455688999999999999999999985 588999999975432 2333456779999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+|||||++ +|.+++... ..+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~ 156 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG 156 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC
Confidence 99999999985 888888654 4699999999988776 99999999999999999999998765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=207.49 Aligned_cols=139 Identities=15% Similarity=0.108 Sum_probs=116.8
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCe
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 265 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 265 (347)
....++|+..+.||+|+||+||+|++..+|+.||+|++...........+ ..+|+..+.++ +||||++++++|.+.+.
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~-~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHH-HHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHH-HHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 34567899999999999999999999999999999998654433333333 33566655554 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+||||| +|+|.+++.. ...+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~ 194 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG 194 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG
T ss_pred EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC
Confidence 99999999 6699999865 45799999999988876 99999999999999999999997765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=215.60 Aligned_cols=140 Identities=15% Similarity=0.234 Sum_probs=122.0
Q ss_pred hhhhhhhhhhhcccccchhhhhhccc---ccccchhheehhccCCc-hhhhhhchHHHHHHHhcC-CCcchhhhheeeee
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSA---RHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET 262 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~---~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~ 262 (347)
...++|++.+.||+|+||+||+|++. .+|+.||+|++++.... .....+.+.+|+.+|+.+ +||||+++++++.+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34578999999999999999999874 58899999999754321 122244566899999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+|+|||||++|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 196 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 196 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 999999999999999999998888999999999988776 99999999999999999999998765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=218.40 Aligned_cols=140 Identities=15% Similarity=0.188 Sum_probs=116.0
Q ss_pred hhhhhhh-hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhc-CCCcchhhhheeeee----C
Q psy10462 190 KRKLKLI-RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG-LKHPNLIRFLQAIET----T 263 (347)
Q Consensus 190 ~~~~~~~-~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~----~ 263 (347)
.++|.+. +.||+|+||+||+|.+..+|+.||+|+++.. ..+.+|+.++.+ .+||||++++++|+. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4556665 6899999999999999999999999998632 234588888754 599999999999876 5
Q ss_pred CeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEe
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHL 337 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~ 337 (347)
+.+|||||||+||+|.+++...+ .+++..++.++.|++ |+.|+|++||+||||||+|||++..+....+.+...
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 67999999999999999997653 699999999988876 999999999999999999999987543334444433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=219.15 Aligned_cols=137 Identities=20% Similarity=0.312 Sum_probs=119.0
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
..+.+..++|++.+.||+|+||.||+|.+. |+.||+|+++... ..+.+.+|+.+|++++|||||++++++.+.
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 345677889999999999999999999864 7789999997542 245677999999999999999999998765
Q ss_pred C-eEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 H-RVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~-~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+ .+|+|||||++|+|.+++++.+ .+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~ 326 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 326 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC
Confidence 4 7999999999999999997654 379999998888776 99999999999999999999998765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=215.35 Aligned_cols=135 Identities=19% Similarity=0.253 Sum_probs=109.2
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-CcchhhhheeeeeCC--eE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTH--RV 266 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~--~~ 266 (347)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.+..... .....+.+|+.+|+.+. |||||+++++|..++ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 467899999999999999999999999999999996543332 33445669999999996 999999999997544 79
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|||||+ |+|.++++. +.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 146 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC 146 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC
Confidence 99999998 599999976 5899999998888766 99999999999999999999998775
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=210.30 Aligned_cols=143 Identities=15% Similarity=0.232 Sum_probs=111.5
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhccccccc---chhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~---~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
....+..++|++.+.||+|+||+||+|.+..+++ .||+|+++...... ...+.+.+|++++++++||||+++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3455677899999999999999999999887765 79999997543322 2345677999999999999999999999
Q ss_pred eeCCeE------EEEEEecCCCChHHHHHhCC------CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 261 ETTHRV------YIIMEYAKNGSLLEVIRKER------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 261 ~~~~~~------~iv~E~~~~G~L~~~l~~~~------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+.. ++||||+++|+|.+++...+ .+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 877655 99999999999999996432 699999999988876 99999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=217.53 Aligned_cols=134 Identities=20% Similarity=0.231 Sum_probs=116.8
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC--eE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH--RV 266 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~ 266 (347)
...+|++.+.||+|+||+||+|++..+|+.||+|++...... ...+.+.+|+++|++++||||+++++++...+ ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 357899999999999999999999999999999999753321 22345669999999999999999999998765 78
Q ss_pred EEEEEecCCCChHHHHHhCC---CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKER---YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQE 324 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~---~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~ 324 (347)
|+|||||++|+|.+++++.. .+++..+..++.|++ |+.|+|++||+||||||+|||+.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 146 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRV 146 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEe
Confidence 99999999999999996543 399999999988876 99999999999999999999983
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=206.35 Aligned_cols=142 Identities=19% Similarity=0.253 Sum_probs=120.4
Q ss_pred Cccchhhhhhhhhh-hcccccchhhhhh--cccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 184 PEVGIHKRKLKLIR-DKKLSSYATVKLA--TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 184 ~~~~~~~~~~~~~~-~ig~G~fg~V~~~--~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
.++.+...+|++.+ .||+|+||+||+| ....+++.||+|+++... ......+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34556678898888 9999999999999 446678899999997543 2233356678999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..+.+|+||||+++|+|.+++...+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH 154 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC
Confidence 5678999999999999999999888899999999988876 99999999999999999999998765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-27 Score=216.13 Aligned_cols=144 Identities=19% Similarity=0.219 Sum_probs=120.7
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCc--hhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP--IDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
.....-.++|++.+.||+|+||+||+|.+..+++.||+|++.+.... .....+.+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 33445578899999999999999999999999999999998654211 2233456789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHh----------------------------------------CCCCCHHHHHHHHHHHH
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRK----------------------------------------ERYIDEDKALLCYSEVS 301 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~----------------------------------------~~~l~e~~~~~~~~~~~ 301 (347)
+.+.+|+|||||+||+|.+++.. ...+++..++.++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 99999999999999999999852 11246777888888776
Q ss_pred -HHHHHhhcCccccCCCCccccccccc
Q psy10462 302 -NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 302 -~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++.|+|++||+||||||+|||++.++
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~ 205 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNK 205 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSS
T ss_pred HHHHHHHHCCccccCCChhhEEEecCC
Confidence 99999999999999999999998654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=210.66 Aligned_cols=139 Identities=16% Similarity=0.224 Sum_probs=119.6
Q ss_pred CCCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 182 SAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 182 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
..+.+.+..++|++.+.||+|+||+||+|++. ++.||+|++.... .......+|+.+|++++|||||++++++.
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 34667788999999999999999999999764 7889999986432 12334457999999999999999999998
Q ss_pred eCC----eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhc----------CccccCCCCcccccccc
Q psy10462 262 TTH----RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSR----------CCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 262 ~~~----~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~----------~iiHRDlKp~Nil~~~~ 326 (347)
+.. .+|+|||||++|+|.+++++ +.+++..+..++.|++ |+.|+|++ ||+||||||+|||++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 754 48999999999999999976 4699999999988876 99999999 99999999999999776
Q ss_pred c
Q psy10462 327 T 327 (347)
Q Consensus 327 ~ 327 (347)
+
T Consensus 168 ~ 168 (322)
T 3soc_A 168 L 168 (322)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=205.88 Aligned_cols=136 Identities=19% Similarity=0.280 Sum_probs=122.3
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||.||+|.+..+++.||+|+++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 46789999999999999999999999999999998654322 2345677999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||+++|+|.+++.....+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 142 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD 142 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC
Confidence 99999999999998878899999999988776 99999999999999999999998765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=206.63 Aligned_cols=142 Identities=15% Similarity=0.196 Sum_probs=119.5
Q ss_pred hhhhhhhh-hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHH-hcCCCcchhhhheeeee----
Q psy10462 189 HKRKLKLI-RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIET---- 262 (347)
Q Consensus 189 ~~~~~~~~-~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~---- 262 (347)
..++|.+. +.||+|+||.||+|.+..+++.||+|+++.. ..+.+|+.++ +.++||||++++++|..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 34556666 7799999999999999999999999998632 2345899888 55699999999999987
Q ss_pred CCeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
...+|+|||||++|+|.+++.+.+ .+++..+..++.|++ |+.|+|++||+||||||+|||++..+....+.++..|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 678999999999999999997754 799999999988876 9999999999999999999999886544455554433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=209.29 Aligned_cols=141 Identities=16% Similarity=0.262 Sum_probs=121.3
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee-
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET- 262 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~- 262 (347)
..+.+..++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 34556788999999999999999999999999999999998653 22335567799999999999999999999873
Q ss_pred ---CCeEEEEEEecCCCChHHHHHh----CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 ---THRVYIIMEYAKNGSLLEVIRK----ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ---~~~~~iv~E~~~~G~L~~~l~~----~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
....|+||||+++|+|.+++.. ...+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~ 171 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG 171 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC
Confidence 4589999999999999999965 46799999999988876 99999999999999999999997765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-26 Score=209.48 Aligned_cols=138 Identities=21% Similarity=0.303 Sum_probs=119.2
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccch--hheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDV--AIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 264 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~--aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 264 (347)
+..++|++.+.||+|+||.||+|++..+++.+ |+|.+.... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45678999999999999999999998888865 999886432 223345677999999999 9999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCC----------------CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKER----------------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~----------------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+||||+++|+|.+++.+.+ .+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 799999999988876 99999999999999999999997764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-26 Score=207.09 Aligned_cols=138 Identities=12% Similarity=0.231 Sum_probs=122.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCC---c---hhhhhhchHHHHHHHhcCC-Ccchhhhheeeee
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQA---P---IDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET 262 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~---~---~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~ 262 (347)
.++|++.+.+|+|+||.||+|.+..+|+.||+|+++.... . .....+.+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 5789999999999999999999999999999999975431 1 1223456779999999995 9999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++..|+||||+++|+|.+++..+..+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM 161 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC
Confidence 999999999999999999998888999999999988876 99999999999999999999998765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-26 Score=208.67 Aligned_cols=141 Identities=19% Similarity=0.267 Sum_probs=106.4
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
.+.+..++|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.++++++||||+++++++..++
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 456678899999999999999999999998999999999865422 222455679999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHh--------CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRK--------ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~--------~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..|+||||+++|+|.+++.. .+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 158 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG 158 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC
Confidence 99999999999999999963 45699999999988876 99999999999999999999998765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-26 Score=218.36 Aligned_cols=139 Identities=19% Similarity=0.282 Sum_probs=120.8
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
...+.+..++|++.+.||+|+||+||+|.+. +++.||+|+++..... .+.+.+|+.+|++++|||||++++++.
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 4567888999999999999999999999875 4667999999754322 456779999999999999999999986
Q ss_pred CCeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+|+|||||++|+|.++++.. ..+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~ 321 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL 321 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC
Confidence 66899999999999999999753 3789999888888776 99999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.9e-26 Score=204.45 Aligned_cols=139 Identities=13% Similarity=0.205 Sum_probs=119.1
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhh----hhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDY----LKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
+..++|++.+.||+|+||+||+|++..+++.||+|++......... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4568899999999999999999999999999999998654322211 115677999999999999999999999766
Q ss_pred CeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcC--ccccCCCCcccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRC--CYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~--iiHRDlKp~Nil~~~~~~ 328 (347)
. ++||||+++|+|.+++.+. ..+++..+..++.|++ ++.|+|++| |+||||||+|||++.++.
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC
Confidence 5 7999999999999988654 5799999998888776 999999999 999999999999987664
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-26 Score=202.33 Aligned_cols=137 Identities=18% Similarity=0.302 Sum_probs=121.0
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
|.+..++|++.+.+|+|+||.||+|.+. +++.||+|++...... .+.+.+|++++++++||||+++++++.+++.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4567789999999999999999999885 5678999999754432 2456799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+||||+++|+|.+++... +.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~ 141 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 141 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC
Confidence 99999999999999999764 5799999998888776 99999999999999999999997654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-26 Score=217.54 Aligned_cols=139 Identities=17% Similarity=0.287 Sum_probs=121.0
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
...+.+..++|++.+.||+|+||.||+|.+..+ ..||+|+++..... .+.+.+|+++|++++||||+++++++.+
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 456788899999999999999999999998654 56999999754332 3457799999999999999999999876
Q ss_pred CCeEEEEEEecCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|+|||||++|+|.++++. ...+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~ 317 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 317 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC
Confidence 779999999999999999964 35799999999988876 99999999999999999999997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-26 Score=213.20 Aligned_cols=135 Identities=16% Similarity=0.256 Sum_probs=112.3
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC-----
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 264 (347)
.++|+..+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+|+.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4679999999999999999999999999999999965432 3334556779999999999999999999998753
Q ss_pred -eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 -RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 -~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+||||+ +++|.++++. +.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 165 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC 165 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC
Confidence 469999999 7899999976 5799999999888776 99999999999999999999998765
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.9e-26 Score=210.64 Aligned_cols=135 Identities=13% Similarity=0.206 Sum_probs=118.9
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-----Ccchhhhheeee
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-----HPNLIRFLQAIE 261 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~~~~~ 261 (347)
..-.++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+.+|+.+++.+. |||||++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34567899999999999999999999999999999998632 222445568999999986 999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
..+.+|+||||+ +|+|.+++.+.+ .+++..++.++.|++ |+.|+|++||+||||||+|||++..
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDP 173 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccc
Confidence 999999999999 889999997654 599999999988876 9999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-26 Score=211.22 Aligned_cols=134 Identities=18% Similarity=0.198 Sum_probs=115.7
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||+|++..+++.||+|++.... .......+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 46888999999999999999999999999999996543 1222334558999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||++ |+|.+++... ..+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~ 137 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG 137 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC
Confidence 9998 5999999764 4699999999888776 99999999999999999999998775
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-26 Score=208.97 Aligned_cols=142 Identities=20% Similarity=0.293 Sum_probs=123.1
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhccccccc-----chhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQ-----DVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 257 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~-----~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 257 (347)
..+.+..++|++.+.||+|+||+||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.+ +||||++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 3567788999999999999999999999876665 68999986543 223356677999999999 899999999
Q ss_pred eeeeeCCeEEEEEEecCCCChHHHHHhC--------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccc
Q psy10462 258 QAIETTHRVYIIMEYAKNGSLLEVIRKE--------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCF 322 (347)
Q Consensus 258 ~~~~~~~~~~iv~E~~~~G~L~~~l~~~--------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil 322 (347)
+++.+.+.+|+|||||++|+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence 9999999999999999999999999642 3689999999988776 999999999999999999999
Q ss_pred ccccc
Q psy10462 323 QEQAT 327 (347)
Q Consensus 323 ~~~~~ 327 (347)
+++++
T Consensus 197 ~~~~~ 201 (333)
T 2i1m_A 197 LTNGH 201 (333)
T ss_dssp EEGGG
T ss_pred ECCCC
Confidence 97664
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-26 Score=207.72 Aligned_cols=137 Identities=20% Similarity=0.336 Sum_probs=120.5
Q ss_pred hhhhhhhhhhhcccccchhhhhhc----ccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee--
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-- 261 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-- 261 (347)
+..++|++.+.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 567899999999999999999998 5678999999998754 2333456789999999999999999999886
Q ss_pred eCCeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+.+|+||||+++|+|.+++.. ...+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~ 164 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA 164 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC
Confidence 45679999999999999999976 45799999999988876 99999999999999999999997765
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-26 Score=205.02 Aligned_cols=136 Identities=14% Similarity=0.212 Sum_probs=119.1
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
..+.|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 46789999999999999999999999999999999864322 224556799999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+++|+|.+++.+ .+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 154 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG 154 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC
Confidence 9999999999999865 56799999999988876 99999999999999999999998665
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-26 Score=208.53 Aligned_cols=139 Identities=16% Similarity=0.151 Sum_probs=119.7
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccc----cchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHS----QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
.+...+|+..+.||+|+||+||+|.+..++ ..||+|.++... .......+.+|+.++++++||||+++++++.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 456778889999999999999999876553 359999986442 23334567799999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+|+||||+++|+|.+++... +.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~ 184 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL 184 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC
Confidence 99999999999999999999764 6799999999988876 99999999999999999999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.6e-26 Score=213.39 Aligned_cols=138 Identities=15% Similarity=0.182 Sum_probs=119.9
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC--Ccchhhhheeeee
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--HPNLIRFLQAIET 262 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~ 262 (347)
........|++.+.||+|+||+||+|.+.. ++.||+|++...... ....+.+.+|+.+|+++. |||||++++++..
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 344556779999999999999999998865 889999999765433 334566789999999995 5999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
++.+|+||| +.+|+|.+++.+.+.+++.++..++.|++ ++.|+|++||+||||||+|||++.
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~ 190 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD 190 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS
T ss_pred CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC
Confidence 999999999 66789999999888999999998888776 999999999999999999999964
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=6.9e-26 Score=207.70 Aligned_cols=137 Identities=18% Similarity=0.213 Sum_probs=111.8
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccch----hheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDV----AIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~----aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
+..++|+..+.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45688999999999999999999998888776 666654321 222345677999999999999999999999875
Q ss_pred CeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..++||||+++|+|.+++.+ .+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~ 154 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 154 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC
Confidence 47899999999999999976 46799999999988776 99999999999999999999998765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-26 Score=207.84 Aligned_cols=137 Identities=14% Similarity=0.169 Sum_probs=119.0
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
....++|+..+.||+|+||+||+|.+ .+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 33457899999999999999999996 4688999998865432 2245677999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCC----CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKER----YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~----~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+||||+++|+|.+++.... .+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 176 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF 176 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC
Confidence 99999999999999996543 599999998888776 99999999999999999999997764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-26 Score=212.02 Aligned_cols=138 Identities=11% Similarity=0.243 Sum_probs=122.0
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCC--c---hhhhhhchHHHHHHHhcC-CCcchhhhheeeeeC
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQA--P---IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 263 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~--~---~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 263 (347)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++.... . .....+.+.+|+.+++++ +||||++++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 3568888999999999999999998999999999865431 1 122345677999999998 899999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+..|+||||++||+|.+++.....+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM 237 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999998888999999999988876 99999999999999999999998765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-26 Score=218.67 Aligned_cols=134 Identities=19% Similarity=0.236 Sum_probs=115.7
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC------
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 263 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 263 (347)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4679999999999999999999999999999999975432 233345667999999999999999999999654
Q ss_pred CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..+|+|||||++ +|.+.+.. .+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~ 201 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC
Confidence 468999999986 67777753 599999999988876 99999999999999999999998765
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-26 Score=209.98 Aligned_cols=150 Identities=15% Similarity=0.206 Sum_probs=124.9
Q ss_pred hhhhhhhhh-hhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCe
Q psy10462 188 IHKRKLKLI-RDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHR 265 (347)
Q Consensus 188 ~~~~~~~~~-~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~ 265 (347)
.-..+|.+. +.||+|+||+||+|.+..+|+.||+|++.+..... .....+.+|+.+++.+ +||||++++++|.+.+.
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 345556666 88999999999999999999999999997543322 2244567999999999 67999999999999999
Q ss_pred EEEEEEecCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 266 VYIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+|+|||||++|+|.+++.. .+.+++..+..++.|++ ++.|+|++||+||||||+|||++.......+.++..|
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 9999999999999999854 36799999999988876 9999999999999999999999875444455555443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=201.86 Aligned_cols=141 Identities=20% Similarity=0.239 Sum_probs=120.3
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhcccc---cccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSAR---HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
+.+++..++|++.+.+|+|+||+||+|.+.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4567788999999999999999999998643 45569999987543 223356678999999999999999999998
Q ss_pred eeCCeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+ +..|+||||+++|+|.+++.+. ..+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 83 ~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 150 (281)
T 3cc6_A 83 EE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE 150 (281)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT
T ss_pred cC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC
Confidence 75 4579999999999999999664 5699999999888776 99999999999999999999998765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-26 Score=209.00 Aligned_cols=137 Identities=12% Similarity=0.193 Sum_probs=115.1
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccch----hheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDV----AIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~----aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
+..++|++.+.||+|+||+||+|.+..+++.+ |+|.+.... .......+.+|+.++++++||||+++++++. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 45678999999999999999999998888874 555543221 1122345669999999999999999999986 5
Q ss_pred CeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+..++||||+++|+|.+++... +.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~ 152 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS 152 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC
Confidence 6799999999999999999764 5899999999888776 99999999999999999999997765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-26 Score=201.92 Aligned_cols=138 Identities=17% Similarity=0.203 Sum_probs=113.5
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCch-hhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI-DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
++..++|++.+.||+|+||.||+|.+. |+.||+|+++...... ....+.+.+|+++++.++||||+++++++.+++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 345678999999999999999999864 7889999987543222 2224567799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcC---ccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRC---CYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~---iiHRDlKp~Nil~~~~~ 327 (347)
.|+||||+++|+|.+++. .+.+++..+..++.|++ ++.|+|++| |+||||||+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~ 145 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccc
Confidence 999999999999999985 45899999999988776 999999999 99999999999998743
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=203.69 Aligned_cols=137 Identities=20% Similarity=0.248 Sum_probs=121.7
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...+.|+..+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 3567789999999999999999999999999999999754322 22456779999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+||||+++|+|.+++.. +.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 156 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG 156 (303)
T ss_dssp EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC
Confidence 99999999999999865 5799999998888776 99999999999999999999998765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=220.80 Aligned_cols=130 Identities=13% Similarity=0.076 Sum_probs=103.4
Q ss_pred hhhhcccccchhhhhhcccccccchhheehhccCCc-------hhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeE
Q psy10462 195 LIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP-------IDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 195 ~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~-------~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 266 (347)
.....+.|++|.+..++...+|+.||+|++.+.... .+...+.+.+|+++|+++ .||||+++++++++++.+
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 334567888998888888889999999999754321 122345588999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||||+||+|.++|++++++++.. +++|++ ||.|+|++|||||||||+|||++.++
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg 376 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ 376 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHHCCceeccCchHhEEECCCC
Confidence 99999999999999999999998764 556655 99999999999999999999998776
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.9e-26 Score=206.86 Aligned_cols=141 Identities=14% Similarity=0.126 Sum_probs=120.4
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
.+.....++|+..+.||+|+||+||+|.+ .+|+.||+|++...... .....+.+|+++++.++||||+++++++.++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 44556778899999999999999999985 46889999999754321 2233577999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhCC----CCCHHHHHHHHHHHH-HHHHHhhc---CccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKER----YIDEDKALLCYSEVS-NLSQTFSR---CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~----~l~e~~~~~~~~~~~-~~~~~h~~---~iiHRDlKp~Nil~~~~~ 327 (347)
+..++|||||++|+|.+++.... .+++..+..++.|++ ++.|+|++ ||+||||||+|||+++++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 99999999999999999997643 499999999988776 99999999 999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=201.82 Aligned_cols=137 Identities=18% Similarity=0.243 Sum_probs=120.7
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee----
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET---- 262 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~---- 262 (347)
......|++.+.||+|+||.||+|.+..++..||+|.+....... ...+.+.+|+.++++++||||++++++|..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 344566888899999999999999999999999999997654433 335667799999999999999999999876
Q ss_pred CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcC--ccccCCCCcccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRC--CYQDHIQDLSCFQE 324 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~--iiHRDlKp~Nil~~ 324 (347)
...+|+||||+++|+|.+++.+.+.+++..+..++.|++ ++.|+|++| |+||||||+|||++
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~ 165 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE
Confidence 456999999999999999998888999999999988776 999999999 99999999999997
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=222.53 Aligned_cols=139 Identities=19% Similarity=0.253 Sum_probs=116.7
Q ss_pred chhhhhhhhh-hhcccccchhhhhhcc--cccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 187 GIHKRKLKLI-RDKKLSSYATVKLATS--ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 187 ~~~~~~~~~~-~~ig~G~fg~V~~~~~--~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
.+....+.+. +.||+|+||+||+|.+ ..+++.||+|+++... .+....+.+.+|+++|++++|||||++++++++
T Consensus 364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 364 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA- 441 (635)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred cccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3344444443 4799999999999954 5678899999997543 223335667899999999999999999999964
Q ss_pred CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+++|||||++|+|.++++..+.+++..+..++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~ 506 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH 506 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT
T ss_pred CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC
Confidence 56899999999999999999888999999999988876 99999999999999999999998765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.7e-26 Score=201.85 Aligned_cols=132 Identities=18% Similarity=0.250 Sum_probs=116.6
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee------
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------ 262 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------ 262 (347)
-..+|+..+.||+|+||.||+|.+..+|+.||+|.++... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3567899999999999999999999899999999986432 345689999999999999999999865
Q ss_pred ----------CCeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 ----------THRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ----------~~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
...+|+||||+++|+|.+++.+. ..+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence 45699999999999999999653 5799999999988776 99999999999999999999998765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-26 Score=207.24 Aligned_cols=142 Identities=18% Similarity=0.280 Sum_probs=121.2
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhcc-----cccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 257 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 257 (347)
..+.+..++|++.+.||+|+||+||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 35567789999999999999999999984 4678899999997543 223345677999999999 799999999
Q ss_pred eeeeeCC-eEEEEEEecCCCChHHHHHhCCC----------------CCHHHHHHHHHHHH-HHHHHhhcCccccCCCCc
Q psy10462 258 QAIETTH-RVYIIMEYAKNGSLLEVIRKERY----------------IDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDL 319 (347)
Q Consensus 258 ~~~~~~~-~~~iv~E~~~~G~L~~~l~~~~~----------------l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~ 319 (347)
+++..++ .+|+|||||++|+|.+++...+. +++..+..++.|++ ++.|+|++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9987754 59999999999999999976543 89999998888776 999999999999999999
Q ss_pred cccccccc
Q psy10462 320 SCFQEQAT 327 (347)
Q Consensus 320 Nil~~~~~ 327 (347)
|||++.++
T Consensus 178 Nil~~~~~ 185 (316)
T 2xir_A 178 NILLSEKN 185 (316)
T ss_dssp GEEECGGG
T ss_pred eEEECCCC
Confidence 99997654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=204.68 Aligned_cols=137 Identities=21% Similarity=0.314 Sum_probs=116.3
Q ss_pred hhhhhhhhhhhcccccchhhhhh----cccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLA----TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~----~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
+..+.|++.+.||+|+||+||++ .+..+++.||+|+++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 45555699999999999999554 556689999999997542 233456678999999999999999999999884
Q ss_pred --CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 --HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 --~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..+|+||||+++|+|.+++.+. .+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~ 171 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR 171 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC
Confidence 6899999999999999999764 599999999988776 99999999999999999999998765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-26 Score=208.15 Aligned_cols=137 Identities=15% Similarity=0.190 Sum_probs=119.7
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCC--cchhhhheeeeeC
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKH--PNLIRFLQAIETT 263 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~ 263 (347)
..+..+.|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+.+|+.+|++++| |||+++++++.++
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 345567899999999999999999988 46888999999755433 3334567799999999976 9999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
+.+|+||| +.+|+|.+++.+.+.+++.++..++.|++ |+.|+|++||+||||||+|||++.
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~ 143 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD 143 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET
T ss_pred CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC
Confidence 99999999 56789999999989999999999988876 999999999999999999999964
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-26 Score=208.96 Aligned_cols=137 Identities=13% Similarity=0.192 Sum_probs=117.7
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee------
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------ 262 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------ 262 (347)
...+|++.+.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 357899999999999999999999999999999998654322 2223456699999999999999999999987
Q ss_pred --CCeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 --THRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 --~~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+|+|||||++ +|.+.+.. .+.+++..++.++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~ 161 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 161 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC
Confidence 4569999999985 88888765 36799999999998876 99999999999999999999998765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=204.43 Aligned_cols=138 Identities=16% Similarity=0.232 Sum_probs=114.6
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCc--hhhhhhchHHHHHHHhcC---CCcchhhhheeeeeC
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP--IDYLKKFLPREIEVVKGL---KHPNLIRFLQAIETT 263 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~--~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~ 263 (347)
..++|++.+.||+|+||+||+|++..+|+.||+|++...... .......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999999999999999999754321 111223456888888776 499999999999876
Q ss_pred C-----eEEEEEEecCCCChHHHHHhCCC--CCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 H-----RVYIIMEYAKNGSLLEVIRKERY--IDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~-----~~~iv~E~~~~G~L~~~l~~~~~--l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
. .+++||||+. |+|.+++..... +++..++.++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC
Confidence 5 5899999998 599999987543 99999999988876 99999999999999999999997765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=202.55 Aligned_cols=143 Identities=17% Similarity=0.216 Sum_probs=117.7
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhcccc---cccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSAR---HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
..+.+..++|++.+.||+|+||.||+|.+.. +++.||+|.++...... ...+.+.+|+.++++++||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 4556778899999999999999999997754 56689999997554332 3345677999999999999999999999
Q ss_pred eeCC-----eEEEEEEecCCCChHHHHHh------CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 261 ETTH-----RVYIIMEYAKNGSLLEVIRK------ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 261 ~~~~-----~~~iv~E~~~~G~L~~~l~~------~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+ ..|+||||+++|+|.+++.. .+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 8754 46999999999999999942 35799999999988876 99999999999999999999998765
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.2e-26 Score=211.70 Aligned_cols=130 Identities=18% Similarity=0.262 Sum_probs=110.2
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee-----
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----- 262 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----- 262 (347)
....+|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+|+.++|||||+++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34678999999999999999999999999999999986432 233489999999999999999999844
Q ss_pred ---------------------------------CCeEEEEEEecCCCChHHHHH----hCCCCCHHHHHHHHHHHH-HHH
Q psy10462 263 ---------------------------------THRVYIIMEYAKNGSLLEVIR----KERYIDEDKALLCYSEVS-NLS 304 (347)
Q Consensus 263 ---------------------------------~~~~~iv~E~~~~G~L~~~l~----~~~~l~e~~~~~~~~~~~-~~~ 304 (347)
...+++|||||++ +|.+.+. ..+.+++..++.++.|++ |+.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3459999999994 8777764 457899999999988776 999
Q ss_pred HHhhcCccccCCCCccccccc
Q psy10462 305 QTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 305 ~~h~~~iiHRDlKp~Nil~~~ 325 (347)
|+|++||+||||||+|||++.
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~ 176 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNS 176 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEET
T ss_pred HHHHCcCccCccCHHHEEEcC
Confidence 999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-26 Score=209.64 Aligned_cols=139 Identities=17% Similarity=0.225 Sum_probs=113.3
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCch--hhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI--DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
....+|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.++++++||||++++++|.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999999999999999997543221 2223456799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+||||+++ +|.+++... ..+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 149 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG 149 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC
Confidence 9999999986 899998664 4799999998888776 99999999999999999999998765
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=200.80 Aligned_cols=139 Identities=17% Similarity=0.166 Sum_probs=117.0
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
.+..++|++.+.||+|+||+||+|++..+|+.||+|++..... .....+.+..|..+++.++||||+++++++.+++..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4567889999999999999999999999999999999975432 233344454555668888999999999999999999
Q ss_pred EEEEEecCCCChHHHHHh----CCCCCHHHHHHHHHHHH-HHHHHhhc-CccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRK----ERYIDEDKALLCYSEVS-NLSQTFSR-CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~----~~~l~e~~~~~~~~~~~-~~~~~h~~-~iiHRDlKp~Nil~~~~~ 327 (347)
|+||||+++ +|.+++.. .+.+++..+..++.|++ ++.|+|++ ||+||||||+|||++.++
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~ 147 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG 147 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC
Confidence 999999985 88887743 56899999999988876 99999998 999999999999998755
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=202.97 Aligned_cols=134 Identities=21% Similarity=0.302 Sum_probs=117.3
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee-------
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------- 262 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------- 262 (347)
.++|++.+.+|+|+||.||+|++..+|+.||+|+++.. ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 46789999999999999999999999999999998642 2234567799999999999999999998865
Q ss_pred ------CCeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 ------THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ------~~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+|+||||+++|+|.+++... ..+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC
Confidence 46799999999999999999754 4688888888888776 99999999999999999999998765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=219.13 Aligned_cols=139 Identities=17% Similarity=0.287 Sum_probs=121.0
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
...|.+..++|++.+.||+|+||.||+|.+..+ ..||+|+++..... .+.+.+|+++|++++|||||++++++.+
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 456788899999999999999999999998654 56999999754332 3457799999999999999999999876
Q ss_pred CCeEEEEEEecCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|||||||++|+|.++|+. ...+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~ 400 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 400 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC
Confidence 779999999999999999964 35799999999988876 99999999999999999999997654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=201.00 Aligned_cols=145 Identities=14% Similarity=0.086 Sum_probs=124.2
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 266 (347)
...++|++.+.||+|+||+||+|.+..+|+.||+|++.... ..+.+.+|+.+++.+ +||||+++++++.+....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 34678999999999999999999999999999999986432 234567999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc--ceeEEEEEee
Q psy10462 267 YIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY--YSTIVVVHLQ 338 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~--~~~~~~~~~~ 338 (347)
|+||||+ +|+|.+++... +.+++..+..++.|++ |+.|+|++||+||||||+|||++.++. ...+.++..|
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999 89999999764 4699999999988877 999999999999999999999987753 2234444433
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=201.71 Aligned_cols=135 Identities=18% Similarity=0.249 Sum_probs=115.9
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|+..+.||+|+||.||+|++..+|+.||+|+++.... .....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCcc-chhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence 578889999999999999999999999999999975432 2223455679999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||++ |+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 82 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~ 140 (299)
T 2r3i_A 82 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG 140 (299)
T ss_dssp ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred Eccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCC
Confidence 9998 5999999765 5799999998888776 99999999999999999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=200.75 Aligned_cols=138 Identities=19% Similarity=0.316 Sum_probs=119.2
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
.+|.+..++|++.+.||+|+||.||+|.+. +++.||+|.+...... .+.+.+|++++++++||||+++++++. .
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence 357778899999999999999999999864 5667999998754322 345779999999999999999999986 4
Q ss_pred CeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+..|+||||+++|+|.+++.... .+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~ 146 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 146 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC
Confidence 56899999999999999996533 799999999888776 99999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=206.29 Aligned_cols=148 Identities=16% Similarity=0.187 Sum_probs=118.5
Q ss_pred CCccchhhhhhhhhh-hcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHH-HHHhcCCCcchhhhheee
Q psy10462 183 APEVGIHKRKLKLIR-DKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREI-EVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~-~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~l~~~~ 260 (347)
.+....-.++|++.+ .||+|+||+||+|.+..+|+.||+|++.... . ..+|+ ..++.+.||||++++++|
T Consensus 20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~-~~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------K-ARQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------H-HHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------H-HHHHHHHHHHhcCCCChHHHHHHH
Confidence 333344567788855 6999999999999999999999999986421 1 11333 345667999999999999
Q ss_pred ee----CCeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEE
Q psy10462 261 ET----THRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIV 333 (347)
Q Consensus 261 ~~----~~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~ 333 (347)
.. ...+|+|||||++|+|.+++.+.+ .+++..++.++.|++ ++.|+|++||+||||||+|||++.++....+.
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence 76 456999999999999999997653 799999999988876 99999999999999999999998766554555
Q ss_pred EEEee
Q psy10462 334 VVHLQ 338 (347)
Q Consensus 334 ~~~~~ 338 (347)
++..|
T Consensus 172 l~Dfg 176 (336)
T 3fhr_A 172 LTDFG 176 (336)
T ss_dssp ECCCT
T ss_pred Eeccc
Confidence 55443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-25 Score=200.13 Aligned_cols=140 Identities=14% Similarity=0.227 Sum_probs=118.6
Q ss_pred ccchhhhhhhhhh-hcccccchhhhhhccc--ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 185 EVGIHKRKLKLIR-DKKLSSYATVKLATSA--RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 185 ~~~~~~~~~~~~~-~ig~G~fg~V~~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
.+.+..++|.+.. .||+|+||.||+|.+. .+++.||+|+++... .....+.+.+|++++++++||||+++++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 3456677787777 8999999999999754 467789999997542 233456678999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..+.+|+||||+++|+|.+++.. ...+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~ 147 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH 147 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC
Confidence 45679999999999999999965 45799999999988876 99999999999999999999998665
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-25 Score=201.00 Aligned_cols=137 Identities=23% Similarity=0.418 Sum_probs=119.1
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee--eCCeEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE--TTHRVY 267 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~ 267 (347)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ....+.+.+|+.++++++||||+++++++. ..+.+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 56899999999999999999999999999999999765433 334566789999999999999999999885 467899
Q ss_pred EEEEecCCCChHHHHHhC----CCCCHHHHHHHHHHHH-HHHHHhhcC-----ccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKE----RYIDEDKALLCYSEVS-NLSQTFSRC-----CYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~----~~l~e~~~~~~~~~~~-~~~~~h~~~-----iiHRDlKp~Nil~~~~~ 327 (347)
+||||+++|+|.+++... ..+++..+..++.|++ ++.|+|++| |+||||||+|||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC
Confidence 999999999999999653 3599999999988876 999999999 99999999999998665
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=208.99 Aligned_cols=135 Identities=16% Similarity=0.227 Sum_probs=109.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC------
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 263 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 263 (347)
.++|+..+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4679999999999999999999999999999999975432 233345667999999999999999999998654
Q ss_pred CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..+|+||||+ +|+|.++++. +.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~ 169 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 169 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC
Confidence 6689999999 6799999865 6799999999988876 99999999999999999999998765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-25 Score=202.50 Aligned_cols=135 Identities=18% Similarity=0.258 Sum_probs=114.9
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
...+.|++.+.||+|+||.||+|.+..+|+.||+|.+..... .+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 356779999999999999999999999999999999865321 345668999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHH-hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIR-KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~-~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+||||+++|+|.+++. ....+++..+..++.+++ ++.|+|++||+||||||+|||++.++
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 162 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG 162 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC
Confidence 9999999999999996 456899999999988776 99999999999999999999998765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-26 Score=208.36 Aligned_cols=148 Identities=11% Similarity=0.059 Sum_probs=117.1
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccc---cccchhheehhccCCch--------hhhhhchHHHHHHHhcCCCcchhhh
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSAR---HSQDVAIKIISKVQAPI--------DYLKKFLPREIEVVKGLKHPNLIRF 256 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~---~~~~~aiK~i~~~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l 256 (347)
...++|++.+.||+|+||+||+|.+.. +++.+|+|++....... ......+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 456789999999999999999999987 78889999987543211 1112335688999999999999999
Q ss_pred heeeee----CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccccee
Q psy10462 257 LQAIET----THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYST 331 (347)
Q Consensus 257 ~~~~~~----~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~ 331 (347)
++++.+ ...+|+||||| +|+|.+++...+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++.. .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~-~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-Q 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT-S
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC-c
Confidence 999988 78899999999 999999998777999999999988876 9999999999999999999999876532 4
Q ss_pred EEEEEe
Q psy10462 332 IVVVHL 337 (347)
Q Consensus 332 ~~~~~~ 337 (347)
+.++..
T Consensus 192 ~kL~Df 197 (345)
T 2v62_A 192 VYLADY 197 (345)
T ss_dssp EEECCC
T ss_pred EEEEeC
Confidence 444443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-25 Score=200.36 Aligned_cols=138 Identities=14% Similarity=0.155 Sum_probs=114.5
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccc---cchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee-eeC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHS---QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-ETT 263 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~ 263 (347)
.....|++.+.||+|+||+||+|.+..++ ..+|+|.+... ......+.+.+|+.++++++||||+++++++ ..+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 34567888999999999999999875433 35899988653 2333455677999999999999999999985 556
Q ss_pred CeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+..|+||||+++|+|.+++++ ...+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~ 165 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF 165 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC
Confidence 789999999999999999976 45689999998888766 99999999999999999999997764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=198.78 Aligned_cols=138 Identities=19% Similarity=0.184 Sum_probs=117.5
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
......+++.....||+|+||.||+|.+..+++.||+|.++.... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 344455556666789999999999999999999999999875422 22455779999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCC---CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKER---YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~---~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
.+++||||+++|+|.+++.... .+++..+..++.|++ ++.|+|++||+||||||+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 157 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC
Confidence 9999999999999999997642 567888888887766 999999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.6e-26 Score=209.65 Aligned_cols=138 Identities=16% Similarity=0.204 Sum_probs=120.0
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhh--------------hhchHHHHHHHhcCCCcch
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYL--------------KKFLPREIEVVKGLKHPNL 253 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~--------------~~~~~~E~~il~~l~HpnI 253 (347)
...++|++.+.||+|+||.||+|.+ +|+.||+|++.......... .+.+.+|+.++++++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3467899999999999999999998 89999999996543221111 1567899999999999999
Q ss_pred hhhheeeeeCCeEEEEEEecCCCChHHH------HHh--CCCCCHHHHHHHHHHHH-HHHHHhh-cCccccCCCCccccc
Q psy10462 254 IRFLQAIETTHRVYIIMEYAKNGSLLEV------IRK--ERYIDEDKALLCYSEVS-NLSQTFS-RCCYQDHIQDLSCFQ 323 (347)
Q Consensus 254 v~l~~~~~~~~~~~iv~E~~~~G~L~~~------l~~--~~~l~e~~~~~~~~~~~-~~~~~h~-~~iiHRDlKp~Nil~ 323 (347)
+++++++.+++.+|+||||+++|+|.++ +.+ ...+++..+..++.|++ |+.|+|+ +||+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999998 655 57899999999988776 9999998 999999999999999
Q ss_pred cccc
Q psy10462 324 EQAT 327 (347)
Q Consensus 324 ~~~~ 327 (347)
+.++
T Consensus 186 ~~~~ 189 (348)
T 2pml_X 186 DKNG 189 (348)
T ss_dssp CTTS
T ss_pred cCCC
Confidence 7765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-25 Score=200.33 Aligned_cols=136 Identities=17% Similarity=0.241 Sum_probs=114.7
Q ss_pred hhhhhhhhhcccccchhhhhhccccccc---chhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~---~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
.-.|+..+.||+|+||+||+|.+..+++ .||+|.+.... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 3445566899999999999998655444 79999986532 333456677999999999999999999999877655
Q ss_pred -EEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 -YIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 -~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++||||+.+|+|.+++.. .+.+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~ 161 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF 161 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 999999999999999976 46799999998888776 99999999999999999999998765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-25 Score=203.27 Aligned_cols=130 Identities=18% Similarity=0.316 Sum_probs=116.0
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-Ccchhhhheeeee--CCe
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIET--THR 265 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~ 265 (347)
..++|++.+.||+|+||+||+|.+..+++.||+|+++... .+.+.+|+.+++++. ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 4578999999999999999999999999999999986432 345679999999996 9999999999988 678
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.++||||+++|+|.++++ .+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~ 167 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC
Confidence 999999999999999885 499999999988876 99999999999999999999997655
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-25 Score=203.22 Aligned_cols=139 Identities=21% Similarity=0.340 Sum_probs=119.2
Q ss_pred cchhhhhhhhhhhcccccchhhhhhc----ccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLAT----SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~----~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
..+..++|++.+.||+|+||.||+|+ +..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 34567889999999999999999998 56789999999987532 233456779999999999999999999987
Q ss_pred eCC--eEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 262 TTH--RVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ~~~--~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..+ .+++||||+++|+|.+++.+. ..+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 182 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC
Confidence 653 799999999999999999765 4699999998888776 99999999999999999999998765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-25 Score=203.64 Aligned_cols=139 Identities=17% Similarity=0.198 Sum_probs=116.3
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccC--CchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQ--APIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
+...+|++.+.||+|+||+||+|.+..+++.+|+|+..+.. .......+.+.+|+.++++++||||+++++++.++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 45678999999999999999999998888887555432211 112223456779999999999999999999998754
Q ss_pred EEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.++||||+.+|+|.+++.. .+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~ 154 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 154 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC
Confidence 8899999999999999976 46799999999988876 99999999999999999999997765
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-25 Score=202.38 Aligned_cols=137 Identities=20% Similarity=0.260 Sum_probs=114.7
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCch-hhhhhchHHHHHHHhcCCCcchhhhheee--eeCCeE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI-DYLKKFLPREIEVVKGLKHPNLIRFLQAI--ETTHRV 266 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~ 266 (347)
.++|++.+.||+|+||.||+|.+..+++.||+|+++...... ....+.+.+|+.++++++||||+++++++ .+.+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 357889999999999999999999999999999997543211 22345678999999999999999999998 445689
Q ss_pred EEEEEecCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|||||++| |.+++.. .+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~ 146 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG 146 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC
Confidence 9999999986 7888765 45799999998888776 99999999999999999999997764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.1e-25 Score=202.79 Aligned_cols=139 Identities=17% Similarity=0.274 Sum_probs=121.3
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeee-
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIET- 262 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~- 262 (347)
.......+|++.+.||+|+||.||+|++..+|+.||+|++...... .+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344678899999999999999999999999999999998654322 34567999999998 89999999999987
Q ss_pred -----CCeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 -----THRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 -----~~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+|+||||+++|+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC
Confidence 46899999999999999999764 5799999999888776 99999999999999999999997665
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-25 Score=199.44 Aligned_cols=141 Identities=19% Similarity=0.192 Sum_probs=112.0
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccc-cc--cchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSAR-HS--QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~-~~--~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
..+..++|++.+.||+|+||+||+|++.. ++ ..||+|+++..........+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 45567899999999999999999998643 33 3589999976544444455677899999999999999999999987
Q ss_pred CCeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++ .++||||+++|+|.+++.. .+.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD 158 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC
Confidence 65 8999999999999999976 46799999999888776 99999999999999999999998765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-25 Score=218.10 Aligned_cols=139 Identities=14% Similarity=0.232 Sum_probs=116.0
Q ss_pred cchhhhhhhhhh-hcccccchhhhhhccc--ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 186 VGIHKRKLKLIR-DKKLSSYATVKLATSA--RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 186 ~~~~~~~~~~~~-~ig~G~fg~V~~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
+.+..+++.+.. .||+|+||+||+|.+. .++..||+|+++... .....+.+.+|+++|++++|||||++++++.+
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 344455555555 7999999999999775 456679999997542 22234567799999999999999999999976
Q ss_pred CCeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|+|||||++|+|.+++.. ...+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~ 473 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC
Confidence 579999999999999999965 45699999999988876 99999999999999999999998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3e-25 Score=199.68 Aligned_cols=140 Identities=15% Similarity=0.229 Sum_probs=117.0
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
.+..++...+|++.+.||+|+||+||+|++.. .||+|+++..... ....+.+.+|+.++++++||||+++++++ .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 34567889999999999999999999998643 4999999755433 33456678999999999999999999954 5
Q ss_pred CCeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+.+++|||||++|+|.+++.. ...+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~ 157 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN 157 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 6678999999999999999954 45799999999888776 99999999999999999999998765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-25 Score=199.15 Aligned_cols=133 Identities=16% Similarity=0.168 Sum_probs=114.5
Q ss_pred hhhhhhcccccchhhhhhcccccccchhheehhccC-CchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEE
Q psy10462 193 LKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQ-APIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIME 271 (347)
Q Consensus 193 ~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E 271 (347)
+...+.||+|+||.||+|.+ +++.||+|++.... .......+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 34457899999999999986 57889999986532 2233345668899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh---CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 272 YAKNGSLLEVIRK---ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 272 ~~~~G~L~~~l~~---~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+++|+|.+++.. ...+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF 170 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC
Confidence 9999999999963 35699999999988776 99999999999999999999997764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=224.93 Aligned_cols=142 Identities=16% Similarity=0.182 Sum_probs=117.9
Q ss_pred hhhhhhhhhhcccccchhhhhhcccc-cccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe--
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSAR-HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR-- 265 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-- 265 (347)
...+|++.+.||+|+||+||+|.+.. +|+.||+|++.... .......+.+|+.+|++++|||||+++++|...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 35789999999999999999999876 78999999986432 23345567799999999999999999999987665
Q ss_pred ---EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 266 ---VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 266 ---~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
.||||||++||+|.+++.. .+++..+..++.|++ ++.|+|++||+||||||+|||++++ .+.++..|
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~DFG 226 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLIDLG 226 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEECCCT
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEEecc
Confidence 7999999999999998765 799999999988876 9999999999999999999999874 44554433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=205.86 Aligned_cols=134 Identities=19% Similarity=0.233 Sum_probs=116.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC-----
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 264 (347)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4679999999999999999999999999999999975432 2333456779999999999999999999997664
Q ss_pred -eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 -RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 -~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+|||||++ +|.+++. ..+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~ 164 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 164 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC
Confidence 79999999985 8998886 4699999998888776 99999999999999999999998765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-25 Score=199.82 Aligned_cols=137 Identities=20% Similarity=0.310 Sum_probs=116.6
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
..+.+..++|++.+.||+|+||+||+|.+ +|+.||+|+++... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34567789999999999999999999976 48889999986432 235567999999999999999999986544
Q ss_pred -CeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 -HRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 -~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|+||||+++|+|.+++.+.+ .+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 154 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 154 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC
Confidence 57999999999999999997644 389999998888776 99999999999999999999998765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-25 Score=219.34 Aligned_cols=148 Identities=15% Similarity=0.138 Sum_probs=122.8
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee------
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------ 262 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------ 262 (347)
...+|++.+.||.|+||.||+|.+..+|+.||+|++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3478999999999999999999999999999999987542 23345667799999999999999999998765
Q ss_pred CCeEEEEEEecCCCChHHHHHhCC---CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKER---YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~~---~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
.+..|+|||||+||+|.+++...+ .+++..+..++.+++ |+.|+|++||+||||||+|||++.++....+.++..|
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 678999999999999999997644 699999999988776 9999999999999999999999887654444454443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=209.30 Aligned_cols=138 Identities=15% Similarity=0.081 Sum_probs=101.5
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC--CCcchhhhh-------ee
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL--KHPNLIRFL-------QA 259 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~-------~~ 259 (347)
....|+..+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.| +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 355689999999999999999999999999999999876554555566777885544444 799988865 44
Q ss_pred eeeC-----------------CeEEEEEEecCCCChHHHHHhC-CCCCHHHH------HHHHHHHH-HHHHHhhcCcccc
Q psy10462 260 IETT-----------------HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKA------LLCYSEVS-NLSQTFSRCCYQD 314 (347)
Q Consensus 260 ~~~~-----------------~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~------~~~~~~~~-~~~~~h~~~iiHR 314 (347)
+..+ ..+|||||||+ |||.+++... +.+++... ..++.|++ |+.|+|++||+||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 4433 34899999999 8999999763 34555544 46656655 9999999999999
Q ss_pred CCCCccccccccc
Q psy10462 315 HIQDLSCFQEQAT 327 (347)
Q Consensus 315 DlKp~Nil~~~~~ 327 (347)
||||+|||++.++
T Consensus 219 Dikp~NIll~~~~ 231 (371)
T 3q60_A 219 HFTPDNLFIMPDG 231 (371)
T ss_dssp TCSGGGEEECTTS
T ss_pred cCCHHHEEECCCC
Confidence 9999999998775
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.6e-25 Score=199.66 Aligned_cols=132 Identities=20% Similarity=0.256 Sum_probs=110.1
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee--------
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-------- 261 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-------- 261 (347)
.++|+..+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 46789999999999999999999999999999998643 2333456779999999999999999998873
Q ss_pred ------eCCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 262 ------TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 262 ------~~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
+.+.+|+||||++ |+|.+++++ +.+++..++.++.|++ ++.|+|++||+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE 156 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 4478999999998 699999964 6799999998888776 9999999999999999999999744
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-25 Score=204.83 Aligned_cols=134 Identities=17% Similarity=0.219 Sum_probs=117.2
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC-----C
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 264 (347)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+++|++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 467999999999999999999999999999999997432 233345677999999999999999999999765 4
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+||||++ |+|.++++. +.+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~ 165 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 165 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC
Confidence 7999999998 499999976 4799999999988776 99999999999999999999997765
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-25 Score=205.24 Aligned_cols=130 Identities=12% Similarity=0.090 Sum_probs=112.1
Q ss_pred hhhhhhhhhhcccccchhhhhhccccc--------ccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhh----
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARH--------SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRF---- 256 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~--------~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l---- 256 (347)
..++|++.+.||+|+||.||+|++..+ ++.||+|++... +.+.+|++++++++||||+++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhh
Confidence 357899999999999999999999874 889999998643 346699999999999999994
Q ss_pred -----------heeeee-CCeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccc
Q psy10462 257 -----------LQAIET-THRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSC 321 (347)
Q Consensus 257 -----------~~~~~~-~~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Ni 321 (347)
++++.. ++.+|+||||| +|+|.+++... +.+++..+..++.|++ |+.|+|++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 555555 68899999999 99999999875 7899999999988876 99999999999999999999
Q ss_pred cccccc
Q psy10462 322 FQEQAT 327 (347)
Q Consensus 322 l~~~~~ 327 (347)
|++.++
T Consensus 191 l~~~~~ 196 (352)
T 2jii_A 191 FVDPED 196 (352)
T ss_dssp EEETTE
T ss_pred EEcCCC
Confidence 998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-25 Score=206.60 Aligned_cols=136 Identities=15% Similarity=0.162 Sum_probs=113.7
Q ss_pred hhhhhhhhhcccccchhhhhhccccc---ccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee-eCCe
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-TTHR 265 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~---~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~ 265 (347)
...|++.+.||+|+||+||+|.+..+ +..||+|.++... .....+.+.+|+.+|++++||||+++++++. .++.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 34577788999999999999987543 3458999986432 2233566779999999999999999999864 4568
Q ss_pred EEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.|+||||+++|+|.+++++. ..+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 229 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF 229 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC
Confidence 99999999999999999764 4689999888888776 99999999999999999999998765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-25 Score=205.44 Aligned_cols=137 Identities=10% Similarity=0.063 Sum_probs=111.8
Q ss_pred hhhhhhhhhhhcccccchhhhhhccccc-----ccchhheehhccCCchh--------hhhhchHHHHHHHhcCCCcchh
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARH-----SQDVAIKIISKVQAPID--------YLKKFLPREIEVVKGLKHPNLI 254 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~-----~~~~aiK~i~~~~~~~~--------~~~~~~~~E~~il~~l~HpnIv 254 (347)
....+|++.+.||+|+||+||+|.+..+ ++.||+|++........ .......+|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4456899999999999999999988654 57899999865431100 1112234677778888999999
Q ss_pred hhheeeeeC----CeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 255 RFLQAIETT----HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 255 ~l~~~~~~~----~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
++++++... ..+||||||| ||+|.+++... +.+++..+..++.|++ |+.|+|++||+||||||+|||++.
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 999998765 5599999999 99999999765 6899999999988876 999999999999999999999983
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-25 Score=199.65 Aligned_cols=130 Identities=20% Similarity=0.310 Sum_probs=109.9
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhc--CCCcchhhhheeeee----
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG--LKHPNLIRFLQAIET---- 262 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~---- 262 (347)
-.++|++.+.||+|+||+||+|++ +|+.||+|++.... ...+.+|.+++.. ++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 357899999999999999999976 68899999986431 2333467777666 799999999998654
Q ss_pred CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHh--------hcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTF--------SRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h--------~~~iiHRDlKp~Nil~~~~~ 327 (347)
...+|+||||+++|+|.++++. +.+++..+..++.|++ |+.|+| ++||+||||||+|||+++++
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 3569999999999999999954 5799999999888776 999999 99999999999999998765
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-25 Score=209.38 Aligned_cols=130 Identities=18% Similarity=0.215 Sum_probs=110.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC------
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT------ 263 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------ 263 (347)
...|+..+.||+|+||+||+|++..+|+.||||++... .....+|+++|+.++|||||+++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-------chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 45789999999999999999999999999999998643 22344899999999999999999998542
Q ss_pred CeEEEEEEecCCCChHHHHH----hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIR----KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~----~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..+++||||+++ +|.+.++ ....+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~ 193 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 193 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC
Confidence 247899999986 7776664 356899999999888776 99999999999999999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.5e-25 Score=200.75 Aligned_cols=141 Identities=17% Similarity=0.264 Sum_probs=120.8
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-Ccchhhhheeee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIE 261 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~ 261 (347)
...+.+...+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 3456677889999999999999999999999999999999985432 233456779999999995 999999999983
Q ss_pred --------eCCeEEEEEEecCCCChHHHHHh---CCCCCHHHHHHHHHHHH-HHHHHhhcC--ccccCCCCccccccccc
Q psy10462 262 --------TTHRVYIIMEYAKNGSLLEVIRK---ERYIDEDKALLCYSEVS-NLSQTFSRC--CYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 --------~~~~~~iv~E~~~~G~L~~~l~~---~~~l~e~~~~~~~~~~~-~~~~~h~~~--iiHRDlKp~Nil~~~~~ 327 (347)
....+++||||++ |+|.+++.. .+.+++..+..++.|++ ++.|+|++| |+||||||+|||++.++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence 4456999999997 699999864 56799999999988876 999999999 99999999999998765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-25 Score=207.01 Aligned_cols=130 Identities=16% Similarity=0.250 Sum_probs=102.9
Q ss_pred hhhhh-hhhcccccchhhhhhccc--ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee--CCe
Q psy10462 191 RKLKL-IRDKKLSSYATVKLATSA--RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THR 265 (347)
Q Consensus 191 ~~~~~-~~~ig~G~fg~V~~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~ 265 (347)
+.|++ .+.||+|+||+||+|+++ .+++.||+|++..... ...+.+|+.+|++++|||||+++++|.. ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 44554 457999999999999965 5788999999975433 2345689999999999999999999954 678
Q ss_pred EEEEEEecCCCChHHHHHhC---------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKE---------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~---------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
+|+||||+++ +|.+++... ..+++..++.++.|++ |+.|+|++||+||||||+|||+...
T Consensus 95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~ 164 (405)
T 3rgf_A 95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 164 (405)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCS
T ss_pred EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecC
Confidence 9999999985 899888532 2499999999988876 9999999999999999999999543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.6e-25 Score=207.83 Aligned_cols=135 Identities=15% Similarity=0.180 Sum_probs=117.2
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC------CCcchhhhheeeee
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL------KHPNLIRFLQAIET 262 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~ 262 (347)
...+|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+.+|+++++.+ .||||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 356799999999999999999999999999999999643 22234556888888776 67899999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
.+.+|+||||+. |+|.+++...+ .+++..++.++.|++ |+.|+|++||+||||||+|||++.++.
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~ 238 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR 238 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC
Confidence 999999999997 69999997653 599999999988876 999999999999999999999987764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-25 Score=202.19 Aligned_cols=134 Identities=20% Similarity=0.231 Sum_probs=117.1
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC-----C
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 264 (347)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.++++++||||+++++++..+ .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 578999999999999999999999999999999996432 233345567999999999999999999987654 7
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
..|+||||++ |+|.+++.. +.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~ 149 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC 149 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC
Confidence 8999999998 599999976 5799999999988776 99999999999999999999998765
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-25 Score=201.31 Aligned_cols=138 Identities=19% Similarity=0.223 Sum_probs=112.1
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh---hhhhchHHHHHHHhcC----CCcchhhhhee
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGL----KHPNLIRFLQA 259 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l----~HpnIv~l~~~ 259 (347)
..-.++|++.+.||+|+||.||+|.+..+++.||+|+++....... .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3446789999999999999999999999999999999975433211 2234566899999998 89999999999
Q ss_pred eeeCCeEEEEEEe-cCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccc
Q psy10462 260 IETTHRVYIIMEY-AKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQE 324 (347)
Q Consensus 260 ~~~~~~~~iv~E~-~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~ 324 (347)
+.+.+..++|||| +.+|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID 173 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe
Confidence 9999999999999 78999999998888999999999988876 99999999999999999999997
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-25 Score=206.57 Aligned_cols=133 Identities=15% Similarity=0.202 Sum_probs=114.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC--------Ccchhhhheeee
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--------HPNLIRFLQAIE 261 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~--------HpnIv~l~~~~~ 261 (347)
..+|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+|+.+. ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 57899999999999999999999999999999999643 223456679999999885 889999999998
Q ss_pred ----eCCeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhc-CccccCCCCccccccccc
Q psy10462 262 ----TTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSR-CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ----~~~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~-~iiHRDlKp~Nil~~~~~ 327 (347)
+...+|+||||+ +|+|.+++.+. +.+++..++.++.|++ |+.|+|++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 556899999999 56777777543 5799999999988876 99999998 999999999999998765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.6e-25 Score=200.41 Aligned_cols=134 Identities=15% Similarity=0.187 Sum_probs=116.5
Q ss_pred hhhhhhhhhhcccccchhhhhhcc-cccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcc------hhhhheeee
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATS-ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN------LIRFLQAIE 261 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~-~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~~~~~ 261 (347)
-.++|++.+.||+|+||+||+|.+ ..+++.||+|+++.. ....+.+.+|+.+++.++|+| |++++++++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 457899999999999999999987 567889999998642 223456678999999887665 999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+.+|+||||+ +|+|.+++...+ .+++..+..++.|++ |+.|+|++||+||||||+|||+++.+
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCC
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccc
Confidence 999999999999 889999997765 789999999988876 99999999999999999999998755
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=214.66 Aligned_cols=141 Identities=18% Similarity=0.276 Sum_probs=120.1
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhccccc---ccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARH---SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~---~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
..+.+..++|++.+.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+|++++|||||++++++
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34566788899999999999999999987643 4569999886432 233456678999999999999999999998
Q ss_pred eeCCeEEEEEEecCCCChHHHHHhCC-CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
. ++.+|+|||||++|+|.++++.++ .+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~ 528 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND 528 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC
Confidence 5 567899999999999999997654 799999998888776 99999999999999999999998765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-25 Score=204.02 Aligned_cols=134 Identities=18% Similarity=0.235 Sum_probs=116.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE---
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV--- 266 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~--- 266 (347)
.++|...+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3678899999999999999999999999999999975433 333455677999999999999999999999887655
Q ss_pred ---EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 ---YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ---~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+||||++ |+|.+++. ..+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~ 181 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC 181 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC
Confidence 99999998 59988874 3599999999988876 99999999999999999999998765
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=9.7e-25 Score=202.59 Aligned_cols=139 Identities=17% Similarity=0.234 Sum_probs=116.4
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCc--------hhhhhhchHHHHHHHhcCCCcchhhhhe
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP--------IDYLKKFLPREIEVVKGLKHPNLIRFLQ 258 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~--------~~~~~~~~~~E~~il~~l~HpnIv~l~~ 258 (347)
....++|++.+.||+|+||.||+|.+.. |+.||+|++...... +....+.+.+|+.++++++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3446789999999999999999998855 889999998654321 1222356789999999999999999999
Q ss_pred eeee-----CCeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 259 AIET-----THRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 259 ~~~~-----~~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++.. ...+|+||||++ |+|.+++... ..+++..+..++.|++ ++.|+|++||+||||||+|||+++++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 171 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN 171 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC
Confidence 9854 347999999998 5899888654 4799999999988876 99999999999999999999997765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=197.05 Aligned_cols=131 Identities=21% Similarity=0.307 Sum_probs=112.7
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEE
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVY 267 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 267 (347)
+..++|++.+.||+|+||+||+|++. ++.||+|.+... ...+.+.+|++++++++||||+++++++. +..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcE
Confidence 45678999999999999999999864 678999998632 22456779999999999999999999987 4589
Q ss_pred EEEEecCCCChHHHHHhCC---CCCHHHHHHHHHHHH-HHHHHhh---cCccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKER---YIDEDKALLCYSEVS-NLSQTFS---RCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~---~l~e~~~~~~~~~~~-~~~~~h~---~~iiHRDlKp~Nil~~~~~ 327 (347)
+||||+++|+|.+++...+ .+++..+..++.|++ ++.|+|+ +||+||||||+|||++.++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 142 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 142 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC
Confidence 9999999999999997654 478888888888776 9999998 8999999999999998765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=8e-25 Score=199.96 Aligned_cols=139 Identities=16% Similarity=0.162 Sum_probs=121.3
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh---hhhhchHHHHHHHhcCC--Ccchhhhheeee
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLK--HPNLIRFLQAIE 261 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l~--HpnIv~l~~~~~ 261 (347)
....++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++. ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3446789999999999999999999999999999999976543221 12355678999999995 699999999999
Q ss_pred eCCeEEEEEEecCC-CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 262 TTHRVYIIMEYAKN-GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 262 ~~~~~~iv~E~~~~-G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
+++.+++||||+.+ |+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 184 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC
Confidence 99999999999986 89999998888999999999988776 999999999999999999999973
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-25 Score=202.08 Aligned_cols=149 Identities=17% Similarity=0.248 Sum_probs=124.7
Q ss_pred CCCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 182 SAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 182 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
....+.+..++|++.+.||+|+||.||+|.+.. .+|+|+++..... ....+.+.+|+.++++++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 345677888999999999999999999998743 5999998754322 223455678999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHhCC-CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
+++.+++||||+++|+|.+++...+ .+++..+..++.|++ ++.|+|++||+||||||+|||+++. ++.+...|
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~----~~~l~Dfg 174 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG----KVVITDFG 174 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCS
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCC----CEEEeecC
Confidence 9999999999999999999997654 799999999988776 9999999999999999999999732 44454444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=198.79 Aligned_cols=143 Identities=15% Similarity=0.161 Sum_probs=119.8
Q ss_pred CCCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHH-HHhcCCCcchhhhheee
Q psy10462 182 SAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIE-VVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 182 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~ 260 (347)
+...+.+..++|+..+.||+|+||.||+|.+..+|+.||+|+++.... ... ...+.+|+. +++.++||||+++++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKE-QKQLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHH-HHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chH-HHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 345667788999999999999999999999999999999999975432 222 333445665 77778999999999999
Q ss_pred eeCCeEEEEEEecCCCChHHHHHh-----CCCCCHHHHHHHHHHHH-HHHHHhhc-CccccCCCCccccccccc
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRK-----ERYIDEDKALLCYSEVS-NLSQTFSR-CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~-----~~~l~e~~~~~~~~~~~-~~~~~h~~-~iiHRDlKp~Nil~~~~~ 327 (347)
.+++..|+||||+++ +|.+++.. ...+++..+..++.|++ ++.|+|++ ||+||||||+|||++.++
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~ 163 (327)
T 3aln_A 91 FREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG 163 (327)
T ss_dssp ECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT
T ss_pred EeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC
Confidence 999999999999985 88888763 56899999998888776 99999998 999999999999997765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=194.44 Aligned_cols=143 Identities=15% Similarity=0.129 Sum_probs=115.6
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee-eeCCeEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-ETTHRVYI 268 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~i 268 (347)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+|+.+++.+.|+|++..+..+ ...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 467999999999999999999999999999999875432 134567899999999888877766655 66788999
Q ss_pred EEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 269 IMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||||+ +|+|.+++.. .+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++....+.+...|
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 99999 8999999974 56899999999988876 9999999999999999999999544444445554443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=194.15 Aligned_cols=143 Identities=15% Similarity=0.133 Sum_probs=118.0
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee-eeCCeEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-ETTHRVYI 268 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~i 268 (347)
.++|++.+.||+|+||+||+|++..+|+.||+|++..... .+.+.+|+.+++.++|+|++..+..+ ...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4678999999999999999999999999999999864432 23467999999999988877666555 56788999
Q ss_pred EEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 269 IMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||||+ +|+|.+++.. .+.+++..+..++.|++ |+.|+|++||+||||||+|||++.+.....+.+...|
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 99999 8999999974 56899999999988876 9999999999999999999999643333344444433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-25 Score=221.07 Aligned_cols=144 Identities=19% Similarity=0.288 Sum_probs=115.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...... ...+||+.|+|||+
T Consensus 179 l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---------~~~~gt~~y~aPE~ 248 (681)
T 2pzi_A 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---------GYLYGTPGFQAPEI 248 (681)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---------SCCCCCTTTSCTTH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC---------CccCCCccccCHHH
Confidence 5678999999999999999999999999999999999875 8999999999765421 34579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+.. +.++|||||||++|+|++|..||.+.... ... .......++.+.+++.+|| .+|..||+..+.
T Consensus 249 ~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 318 (681)
T 2pzi_A 249 VRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEE 318 (681)
T ss_dssp HHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred HcCCC--CCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCHHHHHHHhhhccCChhhCCCHHHH
Confidence 97754 36899999999999999999998753211 000 0011124678999999999 799999987777
Q ss_pred hcCCCC
Q psy10462 165 RQDPWL 170 (347)
Q Consensus 165 l~~p~~ 170 (347)
+.++|.
T Consensus 319 l~~~l~ 324 (681)
T 2pzi_A 319 MSAQLT 324 (681)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 766654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-24 Score=197.60 Aligned_cols=131 Identities=17% Similarity=0.322 Sum_probs=110.8
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC--CCcchhhhheeeeeC--
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL--KHPNLIRFLQAIETT-- 263 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~~~~~~~-- 263 (347)
...++|++.+.||+|+||.||+|++. |+.||+|++.... .....+|.+++..+ +||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 44678999999999999999999864 8899999985431 12233566666554 999999999999887
Q ss_pred --CeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhc--------CccccCCCCccccccccc
Q psy10462 264 --HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSR--------CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 --~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~--------~iiHRDlKp~Nil~~~~~ 327 (347)
..+|+|||||++|+|.++++.. .+++..+..++.|++ |+.|+|++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 7899999999999999999664 799999998888776 99999988 999999999999998765
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=201.10 Aligned_cols=134 Identities=18% Similarity=0.232 Sum_probs=116.3
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe----
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR---- 265 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~---- 265 (347)
.++|...+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3678899999999999999999999999999999975432 33345567799999999999999999999987654
Q ss_pred --EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 --VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 --~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+||||++ |+|.+++.. .+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~ 163 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC 163 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC
Confidence 599999998 599888743 599999999988876 99999999999999999999998765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=199.77 Aligned_cols=133 Identities=20% Similarity=0.242 Sum_probs=107.4
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHH--HhcCCCcchhhhheeee--
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEV--VKGLKHPNLIRFLQAIE-- 261 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~~~~~-- 261 (347)
..+..++|++.+.||+|+||+||+|++ +++.||+|++.... ...+..|.++ ++.++||||+++++.+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 456678899999999999999999965 68899999986432 1222244444 55689999999998553
Q ss_pred ---eCCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhc---------CccccCCCCccccccccc
Q psy10462 262 ---TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSR---------CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ---~~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~---------~iiHRDlKp~Nil~~~~~ 327 (347)
....+|+|||||++|+|.++++.. ..++..+..++.|++ |+.|+|++ ||+||||||+|||++.++
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 234689999999999999999764 458888888888776 99999999 999999999999998765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-24 Score=196.45 Aligned_cols=137 Identities=14% Similarity=0.181 Sum_probs=115.3
Q ss_pred hhhhhhhhhhcccccchhhhhhccc-ccccchhheehhccCCchhhhhhchHHHHHHHhcC---CCcchhhhheeee---
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSA-RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL---KHPNLIRFLQAIE--- 261 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~--- 261 (347)
..++|++.+.||+|+||.||+|++. .+|+.||+|+++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3578999999999999999999985 67889999999754322 22234556888888776 8999999999987
Q ss_pred --eCCeEEEEEEecCCCChHHHHHhCC--CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 262 --TTHRVYIIMEYAKNGSLLEVIRKER--YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 --~~~~~~iv~E~~~~G~L~~~l~~~~--~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
....+++||||++ |+|.+++.... .+++..+..++.|++ ++.|+|++||+||||||+|||++.++
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC
Confidence 5578999999998 59999997643 599999999988876 99999999999999999999998765
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-24 Score=195.25 Aligned_cols=141 Identities=15% Similarity=0.167 Sum_probs=122.1
Q ss_pred CCCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC--Ccchhhhhee
Q psy10462 182 SAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--HPNLIRFLQA 259 (347)
Q Consensus 182 ~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~ 259 (347)
......+..++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.+++++. ||||++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34456677888999999999999999999885 5888999999755433 333566779999999996 5999999999
Q ss_pred eeeCCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 260 ~~~~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
+.+++.+|+||| +.+|+|.+++.+.+.+++..+..++.|++ ++.|+|++||+||||||+|||+++
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 162 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD 162 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC
Confidence 999999999999 66789999999888999999998888776 999999999999999999999964
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-24 Score=197.10 Aligned_cols=130 Identities=16% Similarity=0.297 Sum_probs=113.4
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhc--CCCcchhhhheeeeeCC--
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG--LKHPNLIRFLQAIETTH-- 264 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~~-- 264 (347)
..++|++.+.||+|+||+||+|++ +|+.||+|++.... ...+.+|.++++. ++||||+++++++...+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 457899999999999999999987 58899999986431 2345688899887 79999999999998876
Q ss_pred --eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHh--------hcCccccCCCCccccccccc
Q psy10462 265 --RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTF--------SRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 --~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h--------~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+||||+++|+|.+++.+ ..+++..+..++.|++ ++.|+| ++||+||||||+|||+++++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 89999999999999999976 4799999998888776 999999 89999999999999998765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-24 Score=202.96 Aligned_cols=127 Identities=17% Similarity=0.203 Sum_probs=106.4
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC----
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH---- 264 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 264 (347)
...+|+..+.||+|+||+||+|++..+++ +|+|++.... ....+|+++|+.++|||||+++++|...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 45679999999999999999999987776 8888875331 23348999999999999999999996543
Q ss_pred --eEEEEEEecCCCChHHHHH----hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccc
Q psy10462 265 --RVYIIMEYAKNGSLLEVIR----KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQE 324 (347)
Q Consensus 265 --~~~iv~E~~~~G~L~~~l~----~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~ 324 (347)
.+|+|||||+++ |.+.+. ..+.+++..++.++.|++ |+.|+|++||+||||||+|||++
T Consensus 110 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 175 (394)
T 4e7w_A 110 EVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD 175 (394)
T ss_dssp CEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc
Confidence 389999999974 444442 356899999999988776 99999999999999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-24 Score=198.48 Aligned_cols=135 Identities=15% Similarity=0.186 Sum_probs=102.2
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
.....++|++.+.||+|+||+||+|++..+|+.||+|++..... ......+|++.++.++||||++++++|...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 44567889999999999999999999999999999998864322 12334577888888999999999999976443
Q ss_pred -------EEEEEEecCCCChHHHH----HhCCCCCHHHHHHHHHHHH-HHHHHh--hcCccccCCCCccccccc
Q psy10462 266 -------VYIIMEYAKNGSLLEVI----RKERYIDEDKALLCYSEVS-NLSQTF--SRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 266 -------~~iv~E~~~~G~L~~~l----~~~~~l~e~~~~~~~~~~~-~~~~~h--~~~iiHRDlKp~Nil~~~ 325 (347)
+++||||+++ +|.+.+ .....+++..+..++.|++ ++.|+| ++||+||||||+|||++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE 166 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC
Confidence 8999999997 555444 3566899999998888776 899999 999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-24 Score=204.05 Aligned_cols=143 Identities=14% Similarity=0.144 Sum_probs=118.1
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCc-chhhhheeeeeCCeEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHP-NLIRFLQAIETTHRVYI 268 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~i 268 (347)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.+.|+ +|..+..++...+..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 4679999999999999999999999999999998764332 23466899999999764 55566666677889999
Q ss_pred EEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 269 IMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||||+ +|+|.+++.. .+.+++..+..++.|++ +|.|+|++||+||||||+|||++..+....+.|+..|
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence 99999 8999999975 56899999999988876 9999999999999999999999654444455555443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-24 Score=199.11 Aligned_cols=135 Identities=19% Similarity=0.243 Sum_probs=116.8
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-----------Ccchhhh
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-----------HPNLIRF 256 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l 256 (347)
+...+|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++++. ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 3567899999999999999999999999999999998643 223455678999999875 8999999
Q ss_pred heeeeeCC----eEEEEEEecCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhc-CccccCCCCccccccccc
Q psy10462 257 LQAIETTH----RVYIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSR-CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 257 ~~~~~~~~----~~~iv~E~~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~-~iiHRDlKp~Nil~~~~~ 327 (347)
++++...+ .+++||||+ +|+|.+++.+ .+.+++..+..++.|++ |+.|+|++ ||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 99998654 799999999 8899999976 34699999999988876 99999998 999999999999997654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-24 Score=202.96 Aligned_cols=135 Identities=17% Similarity=0.183 Sum_probs=111.8
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeC
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT 263 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~ 263 (347)
.+.+...+|+..+.||+|+||+|+. ....+|+.||||++.... ...+.+|+.+|+++ +|||||++++++.+.
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred cEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 3455667789999999999999763 445678899999986432 23456899999999 899999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhCC-CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKER-YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|||||||+ |+|.+++.... .+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~ 155 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCB
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCC
Confidence 99999999997 59999997654 566666677777765 99999999999999999999996544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=190.99 Aligned_cols=142 Identities=12% Similarity=0.092 Sum_probs=111.9
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
..+....++|+..+.||+|+||.||+|.+..+|+.||+|++..... .....+.+..+..+++.++||||+++++++.++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 4556677899999999999999999999999999999999975532 223334454555678888999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhc-CccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSR-CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~-~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|+||||+ ++.+..+... .+.+++..+..++.|++ ++.|+|++ ||+||||||+|||++.++
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~ 162 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG 162 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC
Confidence 9999999999 4455555543 57899999998888776 99999985 999999999999997765
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.6e-24 Score=194.74 Aligned_cols=133 Identities=12% Similarity=0.139 Sum_probs=114.6
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccc-cchhheehhccCCchhhhhhchHHHHHHHhcCCCcc------hhhhheeee
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHS-QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPN------LIRFLQAIE 261 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~-~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~~~~~ 261 (347)
-.++|++.+.||+|+||+||+|.+..++ +.||+|+++.. ....+.+.+|+.+++.+.|+| ++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 4678999999999999999999988776 68999998642 223456678999999987776 899999999
Q ss_pred eCCeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
..+.+|+||||+ +|+|.+++... ..+++..+..++.|++ |+.|+|++||+||||||+|||++..
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecc
Confidence 999999999999 66888888654 4799999999988876 9999999999999999999999654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-23 Score=199.84 Aligned_cols=129 Identities=16% Similarity=0.194 Sum_probs=102.6
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 269 (347)
+.|...+.||+|+||+||.+ ...+|+.||+|++.... .+.+.+|+.+|+++ +|||||++++++.+++.+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 34455678999999999864 45679999999986431 23456899999876 899999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCH-------HHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDE-------DKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e-------~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+ |+|.+++...+...+ ..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~ 152 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSS 152 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCH
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCc
Confidence 99996 699999987554332 23456777665 99999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-23 Score=192.25 Aligned_cols=132 Identities=12% Similarity=0.105 Sum_probs=113.0
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-Cc-----chhhhheeeeeC
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HP-----NLIRFLQAIETT 263 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~~~~~~~ 263 (347)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.. ......+.+|+.+++.+. |+ +|+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 57899999999999999999999999999999999643 222445668889988873 55 489999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHh--hcCccccCCCCcccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTF--SRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h--~~~iiHRDlKp~Nil~~~~ 326 (347)
+.+|+||||++ |+|.+++... +.+++..++.++.|++ ++.|+| +.||+||||||+|||++.+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~ 195 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC
Confidence 99999999997 5999999764 4699999999988876 999999 5799999999999999653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-22 Score=197.78 Aligned_cols=120 Identities=14% Similarity=0.012 Sum_probs=92.0
Q ss_pred hhhcccccchhhhhhcccccccchhheehhccCCch-----hhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 196 IRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI-----DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 196 ~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
.+.||+|+||+||+|. ..++.+|+|......... ....+.+.+|+++|++++||||+++..++...+..||||
T Consensus 341 ~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 5689999999999994 456778888765433221 122445789999999999999997666666778889999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccc
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQ 325 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~ 325 (347)
|||+||+|.+++.+ +..++.|++ ++.|+|++||+||||||+|||+++
T Consensus 419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~ 466 (540)
T 3en9_A 419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK 466 (540)
T ss_dssp ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS
T ss_pred ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC
Confidence 99999999999975 446666665 999999999999999999999987
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 347 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-15 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-14 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-14 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-15 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-15 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-37 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-17 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-37 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-14 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-14 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-15 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-17 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-15 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-10 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-15 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-14 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-11 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-09 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-11 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-32 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-16 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-18 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-14 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-31 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-13 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-11 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-15 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-09 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-30 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-15 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-29 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-11 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-10 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-29 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-11 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-11 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-29 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-11 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-10 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-15 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-13 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-10 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-05 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-13 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-11 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-11 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-12 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-27 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-13 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-10 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-11 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-27 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-13 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-09 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-09 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-09 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-10 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-09 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-09 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-10 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-09 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-06 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-10 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-05 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-10 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-22 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-11 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-21 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-12 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-10 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-19 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-08 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 0.002 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-10 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-44
Identities = 51/170 (30%), Positives = 92/170 (54%), Gaps = 10/170 (5%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ + + ++LA+A+ YCH K V+HRDIK ENLLL +K++DFG++ +
Sbjct: 103 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
T CG+ Y PE+++G + + D+WS+GV+ + + G+ PF+ Y E K
Sbjct: 163 -------TLCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214
Query: 127 QVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 175
++ RV F ++ + LIS +L R + ++ + PW+ +S+
Sbjct: 215 RI-SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.5 bits (175), Expect = 6e-15
Identities = 28/98 (28%), Positives = 50/98 (51%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V LA + +A+K++ K Q ++ L RE+E+ L+HPN++R
Sbjct: 18 KFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
RVY+I+EYA G++ ++K DE + +E+
Sbjct: 78 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 115
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-43
Identities = 61/167 (36%), Positives = 91/167 (54%), Gaps = 6/167 (3%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
A+R+F QL + Y H + HRDIK ENLLLD++ N+K+SDFG A + NN +
Sbjct: 103 PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--- 159
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS--ELLKQ 127
L CG+ Y +PE+LK + + D+WS G+VL AM+ G LP+D + S E
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
Query: 128 VQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKED 173
+K+ ++ S+ AL+ IL RI + DI++D W +
Sbjct: 220 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.4 bits (172), Expect = 1e-14
Identities = 25/98 (25%), Positives = 48/98 (48%), Gaps = 2/98 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V+LA + + VA+KI+ +A +D + +EI + K L H N+++F
Sbjct: 17 AYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIK-KEICINKMLNHENVVKFYGHRRE 74
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
+ Y+ +EY G L + I + + E A + ++
Sbjct: 75 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 112
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-41
Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 14/174 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + Q DA++Y H ++HRD+K N+L +IKL+DFG + K +
Sbjct: 110 SQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD- 168
Query: 70 NLSETFCGSYAYASPEIL-----KGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+F G+ + +PE++ K PY ++D+WS+G+ L M P + N +
Sbjct: 169 ----SFIGTPYWMAPEVVMCETSKDRPYDY-KADVWSLGITLIEMAEIEPPHHELNPMRV 223
Query: 125 LKQVQK--RVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSN 175
L ++ K + R SS+ K + L V R + Q P++ DSN
Sbjct: 224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.8 bits (173), Expect = 2e-14
Identities = 21/93 (22%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V A + S A K+I + L+ ++ EI+++ HPN+++ L A
Sbjct: 24 AFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYM-VEIDILASCDHPNIVKLLDAFYY 80
Query: 263 THRVYIIMEYAKNGSLLEVI-RKERYIDEDKAL 294
+ ++I++E+ G++ V+ ER + E +
Sbjct: 81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQ 113
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-40
Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 12/167 (7%)
Query: 10 DKARRWFSQLADAIDYCHKKS-----VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNN 64
+ R +QL A+ CH++S V+HRD+K N+ LD K N+KL DFG AR + +
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168
Query: 65 TDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
+ ++ F G+ Y SPE + + Y + SDIWS+G +L+ + PF + EL
Sbjct: 169 S-----FAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKEL 222
Query: 125 LKQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWL 170
++++ R S +I+ +L+ R +E+I ++P +
Sbjct: 223 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (176), Expect = 5e-15
Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 7/98 (7%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-- 260
SY + + + K + + + E+ +++ LKHPN++R+ I
Sbjct: 16 SYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHPNIVRYYDRIID 74
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKER----YIDEDKAL 294
T +YI+MEY + G L VI K Y+DE+ L
Sbjct: 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 112
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-38
Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ + + A+++ H V+HRDIK +N+LL ++KL+DFGF + + +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
T G+ + +PE++ Y P + DIWS+G++ M+ G P+ + N L
Sbjct: 173 RS-----TMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 127 QVQKRVV--FPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
+ +LS+ + ++ L V+ R +++ Q +LK
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (176), Expect = 6e-15
Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 179 KSKSAPEVGIHKRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKK 236
K +S VG K+K +K+ + TV A Q+VAI+ ++ Q P K+
Sbjct: 8 KLRSIVSVGDPKKKYTRF--EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKE 62
Query: 237 FLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLC 296
+ EI V++ K+PN++ +L + ++++MEY GSL +V+ + + A +C
Sbjct: 63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 297 Y 297
Sbjct: 123 R 123
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 1e-37
Identities = 37/196 (18%), Positives = 77/196 (39%), Gaps = 13/196 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + Y H +++HRD+K N+LL + +KL DFG A + N
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----- 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 127
+F G+ + +PE++ + + D+WS+G+ + + P + N L
Sbjct: 170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
Query: 128 V-QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPE 185
+ Q +S S + + + L + R E + + ++ + P
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQR 285
Query: 186 VGIHKRKLKLIRDKKL 201
R+L ++ +K+
Sbjct: 286 TKDAVRELDNLQYRKM 301
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 78.5 bits (193), Expect = 3e-17
Identities = 21/92 (22%), Positives = 44/92 (47%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V A R+S+ VAIK +S + + + +E+ ++ L+HPN I++
Sbjct: 27 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKAL 294
H +++MEY + + ++ + E +
Sbjct: 87 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 118
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-37
Identities = 29/168 (17%), Positives = 72/168 (42%), Gaps = 15/168 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLDDK-YNIKLSDFGFARKYSVNNTD 66
R W Q+ + + H ++ ++HRD+KC+N+ + ++K+ D G A
Sbjct: 112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK------ 165
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELL 125
+ + ++ G+ + +PE+ + Y D+++ G+ + M P+ + N +++
Sbjct: 166 -RASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIY 222
Query: 126 KQVQKRVVFPESPR-LSSSCKALISNILSP-VKFRIQMEDIRQDPWLK 171
++V V + K +I + R ++D+ + +
Sbjct: 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (171), Expect = 2e-14
Identities = 21/96 (21%), Positives = 45/96 (46%), Gaps = 5/96 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ TV + +VA + + ++F E E++KGL+HPN++RF + E+
Sbjct: 21 SFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-EEAEMLKGLQHPNIVRFYDSWES 79
Query: 263 T----HRVYIIMEYAKNGSLLEVIRKERYIDEDKAL 294
T + ++ E +G+L +++ + +
Sbjct: 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR 115
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (333), Expect = 4e-37
Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 15/172 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ R+ L + I HK ++VHRD+K EN+LLDD NIKL+DFGF+ +
Sbjct: 110 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-- 167
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQ-----SDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
CG+ +Y +PEI++ D+WS GV+++ ++ G PF +
Sbjct: 168 ----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 223
Query: 125 LKQVQK---RVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 172
L+ + + PE S + K L+S L + R E+ P+ ++
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 69.3 bits (169), Expect = 4e-14
Identities = 17/105 (16%), Positives = 45/105 (42%), Gaps = 7/105 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAP------IDYLKKFLPREIEVVKGLK-HPNLIR 255
+ V+ ++ A+KII + L++ +E+++++ + HPN+I+
Sbjct: 15 VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 74
Query: 256 FLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
ET +++ + K G L + + ++ + E + +
Sbjct: 75 LKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-37
Identities = 45/168 (26%), Positives = 83/168 (49%), Gaps = 11/168 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ K Q A +DY H KS++HRD+K N+ L + +K+ DFG A S +
Sbjct: 101 FEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTP--QQSDIWSMGVVLFAMVYGRLPFDD-TNYSE 123
++ E GS + +PE+++ P QSD+++ G+VL+ ++ G+LP+ + N +
Sbjct: 161 HQ---FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
Query: 124 LLKQVQKRVVFPESPRLSSSC----KALISNILSP-VKFRIQMEDIRQ 166
++ V + + P+ ++ S+C K L++ L R I
Sbjct: 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (176), Expect = 6e-15
Identities = 19/93 (20%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ TV + DVA+K+++ L+ F E+ V++ +H N++ F+ T
Sbjct: 20 SFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFK-NEVGVLRKTRHVNILLFM-GYST 74
Query: 263 THRVYIIMEYAKNGSLLEVIRKER-YIDEDKAL 294
++ I+ ++ + SL + + K +
Sbjct: 75 APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI 107
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-36
Identities = 46/168 (27%), Positives = 88/168 (52%), Gaps = 8/168 (4%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ R + +++ A++Y H K ++HRD+K EN+LL++ +I+++DFG A+ S +
Sbjct: 105 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ N +F G+ Y SPE+L SD+W++G +++ +V G PF N + +
Sbjct: 165 ARAN---SFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220
Query: 127 QVQK-RVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 172
++ K FPE + + L+ +L R+ E++ LK
Sbjct: 221 KIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.7 bits (196), Expect = 1e-17
Identities = 31/98 (31%), Positives = 50/98 (51%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S++TV LA S++ AIKI+ K + ++ RE +V+ L HP ++ +
Sbjct: 20 SFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
++Y + YAKNG LL+ IRK DE +E+
Sbjct: 80 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 132 bits (332), Expect = 3e-36
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 14/214 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNNTDY 67
D+A + Q+ + + H+ + VH D+K EN++ K + +KL DFG +
Sbjct: 124 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 127
G+ +A+PE+ +G P +D+WS+GV+ + ++ G PF N E L+
Sbjct: 184 ------VTTGTAEFAAPEVAEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETLRN 236
Query: 128 VQK---RVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSA 183
V+ + +S K I +L R+ + + PWL + P G+
Sbjct: 237 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP-GRDSQI 295
Query: 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQ 217
P K + + L + +S
Sbjct: 296 PSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSS 329
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 73.2 bits (179), Expect = 4e-15
Identities = 23/93 (24%), Positives = 43/93 (46%), Gaps = 4/93 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V T + A K + P + K+ + +EI+ + L+HP L+ A E
Sbjct: 38 AFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAFED 94
Query: 263 THRVYIIMEYAKNGSLLEVIRKER-YIDEDKAL 294
+ + +I E+ G L E + E + ED+A+
Sbjct: 95 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 127
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 129 bits (324), Expect = 4e-35
Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 13/191 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN--IKLSDFGFARKYSVNNTDY 67
+ + Q + + + H+ S+VH DIK EN++ + K +K+ DFG A K +
Sbjct: 127 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN------ 180
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 127
+ + + +A+PEI+ P D+W++GV+ + ++ G PF + E L+
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239
Query: 128 VQK-RVVFPES--PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSA 183
V++ F E +S K I N+L + R+ + D + PWLK D + + +
Sbjct: 240 VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299
Query: 184 PEVGIHKRKLK 194
++K+K
Sbjct: 300 SRYNKIRQKIK 310
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 75.5 bits (185), Expect = 7e-16
Identities = 23/99 (23%), Positives = 41/99 (41%), Gaps = 4/99 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V + K I+ P+D K + EI ++ L HP LI A E
Sbjct: 41 AFGVVHRCVEKATGRVFVAKFINT-PYPLD--KYTVKNEISIMNQLHHPKLINLHDAFED 97
Query: 263 THRVYIIMEYAKNGSLLEVIRKERY-IDEDKALLCYSEV 300
+ + +I+E+ G L + I E Y + E + + +
Sbjct: 98 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-34
Identities = 55/182 (30%), Positives = 96/182 (52%), Gaps = 20/182 (10%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYK 68
+ AR +F Q+ +A+ +CH V+HRDIK EN+L+D ++ +KL DFG K
Sbjct: 110 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-------K 162
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ F G+ Y+ PE ++ Y + + +WS+G++L+ MV G +PF+ + +
Sbjct: 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII 217
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEVG 187
+ +V F R+SS C+ LI L+ R E+I+ PW+++ P + E+
Sbjct: 218 RGQVFFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP----QETAEIH 271
Query: 188 IH 189
+H
Sbjct: 272 LH 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (137), Expect = 6e-10
Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 6/98 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLK--HPNLIRFL 257
+ +V + VAIK + K + +P E+ ++K + +IR L
Sbjct: 16 GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 75
Query: 258 QAIETTHRVYIIMEYAKNGSLL-EVIRKERYIDEDKAL 294
E +I+E + L + I + + E+ A
Sbjct: 76 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 113
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-34
Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 11/169 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ +A + +++ + + H K +V+RD+K +N+LLD +IK++DFG ++ + +
Sbjct: 100 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
TFCG+ Y +PEIL G Y D WS GV+L+ M+ G+ PF + EL
Sbjct: 160 TN-----TFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 127 QVQK-RVVFPESPRLSSSCKALISNILSP-VKFRIQME-DIRQDPWLKE 172
++ +P L K L+ + + R+ + DIRQ P +E
Sbjct: 214 SIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.8 bits (178), Expect = 4e-15
Identities = 25/99 (25%), Positives = 42/99 (42%), Gaps = 1/99 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV-KGLKHPNLIRFLQAIE 261
S+ V LA + +Q AIK + K +D + E V+ +HP L +
Sbjct: 14 SFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 73
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
T ++ +MEY G L+ I+ D +A +E+
Sbjct: 74 TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 112
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 5e-34
Identities = 42/231 (18%), Positives = 95/231 (41%), Gaps = 15/231 (6%)
Query: 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVN 63
+ N + + Q+ +A+ + H ++ H DI+ EN++ + IK+ +FG AR+
Sbjct: 98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ + Y +PE+ + + +D+WS+G +++ ++ G PF +
Sbjct: 158 DNFR------LLFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQ 210
Query: 124 LLKQVQK-RVVFPES--PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGK 179
+++ + F E +S + +L K R+ + Q PWLK+ V
Sbjct: 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV-S 269
Query: 180 SKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP 230
+K + + LI+ + +++ + ++KV+
Sbjct: 270 TKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVS-VAKVKVA 319
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.9 bits (168), Expect = 8e-14
Identities = 12/95 (12%), Positives = 35/95 (36%), Gaps = 4/95 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V + K + + + +EI ++ +H N++ ++ E+
Sbjct: 17 EFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFES 72
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
+ +I E+ + E I + ++ ++ Y
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (311), Expect = 2e-33
Identities = 50/173 (28%), Positives = 90/173 (52%), Gaps = 18/173 (10%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ A+ + +++ A++Y H K +++RD+K EN+LLD +IK++DFGFA+
Sbjct: 101 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY- 159
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
T CG+ Y +PE++ PY D WS G++++ M+ G PF D+N + +
Sbjct: 160 -------TLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
Query: 127 QVQK-RVVFPESPRLSSSCKALISNILS------PVKFRIQMEDIRQDPWLKE 172
++ + FP P + K L+S +++ + ED++ PW KE
Sbjct: 212 KILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.9 bits (147), Expect = 4e-11
Identities = 22/98 (22%), Positives = 44/98 (44%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V L S + + A+K++ K + E ++ + HP +IR +
Sbjct: 16 SFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 75
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
++++IM+Y + G L ++RK + A +EV
Sbjct: 76 AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 7e-33
Identities = 38/171 (22%), Positives = 72/171 (42%), Gaps = 9/171 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ +Q+A + Y + + VHRD++ N+L+ + K++DFG AR D +
Sbjct: 113 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE----DNEY 168
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ + +PE +T +SD+WS G++L + GR+P+ E+L QV
Sbjct: 169 TARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 227
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ--DPWLKEDSNP 176
++ P P S L+ + R E ++ + +
Sbjct: 228 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (130), Expect = 5e-09
Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 10/101 (9%)
Query: 188 IHKRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 245
I + L+L KL + V + T + VAIK + + +E +V+
Sbjct: 14 IPRESLRLE--VKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFL----QEAQVM 66
Query: 246 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
K L+H L++ A+ + +YI+ EY GSLL+ ++ E
Sbjct: 67 KKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGET 106
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-32
Identities = 59/233 (25%), Positives = 102/233 (43%), Gaps = 22/233 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYN---IKLSDFGFARKYSVNNTD 66
+A + +AI Y H ++ HRD+K ENLL K +KL+DFGFA++ + +N+
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
T C + Y +PE+L Y D+WS+GV+++ ++ G PF + +
Sbjct: 171 T------TPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISP 223
Query: 127 QVQKRVV-------FPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVG 178
++ R+ PE +S K LI N+L R+ + + PW+ + +
Sbjct: 224 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283
Query: 179 KSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI 231
V ++ R + + T LAT + + IK I P+
Sbjct: 284 TPLHTSRVLKEDKE----RWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPL 332
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.3 bits (148), Expect = 3e-11
Identities = 18/105 (17%), Positives = 39/105 (37%), Gaps = 15/105 (14%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEV-VKGLKHPNLIRFLQAIE 261
V + R + A+K++ RE+E+ + + P+++R + E
Sbjct: 24 INGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 262 TTHR----VYIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEV 300
+ + I+ME G L I+ ++ E +A +
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-32
Identities = 44/208 (21%), Positives = 75/208 (36%), Gaps = 53/208 (25%)
Query: 10 DKARRWFSQLADAIDYCH-KKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYK 68
+ + + Y K ++HRD+K N+L++ + IKL DFG + +
Sbjct: 104 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------- 156
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+++ +F G+ +Y SPE L+G Y+ QSDIWSMG+ L M GR P + EL
Sbjct: 157 DSMANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
Query: 129 QKRVVFP-------------------------------------------ESPRLSSSCK 145
+V S S +
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 146 ALISNILSP-VKFRIQMEDIRQDPWLKE 172
++ L R ++ + ++K
Sbjct: 276 DFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.2 bits (187), Expect = 3e-16
Identities = 22/98 (22%), Positives = 39/98 (39%), Gaps = 2/98 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V + +A K+I P + + RE++V+ P ++ F A +
Sbjct: 18 NGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQII-RELQVLHECNSPYIVGFYGAFYS 75
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
+ I ME+ GSL +V++K I E V
Sbjct: 76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (298), Expect = 1e-31
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 14/209 (6%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLL---DDKYNIKLSDFGFARKYSVN 63
Y A R Q+ DA+ Y H +VHRD+K ENLL D+ I +SDFG ++
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163
Query: 64 NTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSE 123
+ T CG+ Y +PE+L PY+ D WS+GV+ + ++ G PF D N ++
Sbjct: 164 SV------LSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAK 216
Query: 124 LLKQVQKRVVFPESPR---LSSSCKALISNILSP-VKFRIQMEDIRQDPWLKEDSNPVGK 179
L +Q+ K +SP +S S K I +++ + R E Q PW+ D+
Sbjct: 217 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
Query: 180 SKSAPEVGIHKRKLKLIRDKKLSSYATVK 208
+ I K K + ++ A V+
Sbjct: 277 IHQSVSEQIKKNFAKSKWKQAFNATAVVR 305
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 81.2 bits (200), Expect = 4e-18
Identities = 27/98 (27%), Positives = 49/98 (50%), Gaps = 2/98 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+++ V LA R + VAIK I+K ++ + + EI V+ +KHPN++ E+
Sbjct: 21 AFSEVILAEDKRTQKLVAIKCIAK--KALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
+Y+IM+ G L + I ++ + E A +V
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 116
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-31
Identities = 36/176 (20%), Positives = 74/176 (42%), Gaps = 8/176 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
Q++ + Y +K+ VHRD+ N+LL +++ K+SDFG ++ +++ Y
Sbjct: 109 SNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ +PE + ++ +SD+WS GV ++ + YG+ P+ E++ +
Sbjct: 169 --RSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ---DPWLKEDSNPVGKS 180
++ P AL+S+ + R + Q + S G
Sbjct: 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.6 bits (167), Expect = 8e-14
Identities = 25/110 (22%), Positives = 51/110 (46%), Gaps = 8/110 (7%)
Query: 190 KRKLKLIRDKKLS--SYATVKLAT--SARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 245
KR LI D +L ++ +V+ + DVAIK++ + D ++ + RE +++
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMM-REAQIM 63
Query: 246 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER-YIDEDKAL 294
L +P ++R + + + ++ME A G L + + +R I
Sbjct: 64 HQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA 112
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-31
Identities = 33/159 (20%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D ++ + +A++Y + VHRD+ N+L+ + K+SDFG ++ S
Sbjct: 103 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---- 158
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
T + +PE L+ ++ +SD+WS G++L+ + +GR+P+ +++ +V
Sbjct: 159 ----TGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 166
+K + ++ N R +R+
Sbjct: 214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.0 bits (163), Expect = 2e-13
Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 10/95 (10%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA-IE 261
+ V L VA+K I + FL E V+ L+H NL++ L +E
Sbjct: 19 EFGDVMLGD--YRGNKVAVKCIKNDAT----AQAFL-AEASVMTQLRHSNLVQLLGVIVE 71
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERY--IDEDKAL 294
+YI+ EY GSL++ +R + D L
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 106
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (291), Expect = 7e-31
Identities = 33/162 (20%), Positives = 69/162 (42%), Gaps = 3/162 (1%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ + +A + Y + VHRD+ N+L++ K+SDFG +R + +D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 125
+ + +PE ++ +T SD+WS G+V++ ++ YG P+ D +++
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 126 KQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 166
+++ P S+ L+ + R + I
Sbjct: 244 NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 60.9 bits (147), Expect = 3e-11
Identities = 22/98 (22%), Positives = 36/98 (36%), Gaps = 5/98 (5%)
Query: 203 SYATVKLATSARHSQD---VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 259
+ V + VAIK + + FL E ++ HPN+I
Sbjct: 38 EFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFL-SEASIMGQFDHPNVIHLEGV 95
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
+ + V II E+ +NGSL +R+ L+
Sbjct: 96 VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 133
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-30
Identities = 34/170 (20%), Positives = 69/170 (40%), Gaps = 7/170 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
Q++ + Y + + VHRD+ N+LL ++ K+SDFG ++ + YK
Sbjct: 107 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ +PE + ++ +SD+WS GV+++ YG+ P+ SE+ +
Sbjct: 167 --QTHGKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ--DPWLKEDSN 175
+K L++ + V+ R + + + N
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.7 bits (175), Expect = 6e-15
Identities = 28/115 (24%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 191 RKLKLIRDKKLS--SYATVKLATSARHS--QDVAIKIISKVQAPIDYLKKFLPREIEVVK 246
RKL + DK+L ++ TVK + VA+KI+ + L E V++
Sbjct: 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-AEANVMQ 63
Query: 247 GLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS 301
L +P ++R + E ++ME A+ G L + +++ R++ + + +VS
Sbjct: 64 QLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-30
Identities = 36/164 (21%), Positives = 74/164 (45%), Gaps = 6/164 (3%)
Query: 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNT 65
+ + W Q+A ++Y + +VHRD+ N+L+ ++K++DFG A+
Sbjct: 107 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166
Query: 66 DYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSEL 124
+Y +E + + E + YT QSD+WS GV ++ ++ +G P+D SE+
Sbjct: 167 EYH---AEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEI 222
Query: 125 LKQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQD 167
++K P+ P + ++ R + ++ +
Sbjct: 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (129), Expect = 7e-09
Identities = 21/97 (21%), Positives = 40/97 (41%), Gaps = 3/97 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKV--QAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260
++ TV + V I + K +A K + E V+ + +P++ R L
Sbjct: 21 AFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 80
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
T V +I + G LL+ +R+ + + LL +
Sbjct: 81 L-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 6e-30
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 16/187 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD----KYNIKLSDFGFARKYSV 62
++A + Q+ + + Y H + H D+K EN++L D K IK+ DFG A K
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 63 NNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS 122
N G+ + +PEI+ P + +D+WS+GV+ + ++ G PF
Sbjct: 170 GNEFKN------IFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQ 222
Query: 123 ELLKQVQKRVVFPES---PRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE-DSNPV 177
E L V E S+ K I +L K R+ ++D Q PW+K D+
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
Query: 178 GKSKSAP 184
S +
Sbjct: 283 LSSAWSH 289
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.7 bits (175), Expect = 8e-15
Identities = 23/119 (19%), Positives = 49/119 (41%), Gaps = 4/119 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQA 259
+A VK A K I K + ++ + RE+ ++K ++HPN+I +
Sbjct: 22 QFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 81
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKAL-LCYSEVSNLSQTFSRCCYQDHIQ 317
E V +I+E G L + + ++ + E++A ++ + S ++
Sbjct: 82 YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 140
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-29
Identities = 47/221 (21%), Positives = 84/221 (38%), Gaps = 33/221 (14%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D + Q+ + Y H +V+HRD+K NLLL+ ++K+ DFG AR ++
Sbjct: 109 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ + Y +PEI+ + DIWS+G +L M+ R F +Y + L +
Sbjct: 169 L--TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226
Query: 130 KRVVFPE------------------------------SPRLSSSCKALISNILSP-VKFR 158
+ P P S L+ +L+ R
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286
Query: 159 IQMEDIRQDPWLKEDSNPVGKSKSAPEVGIHKRKLKLIRDK 199
I++E P+L++ +P + + L ++K
Sbjct: 287 IEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (146), Expect = 6e-11
Identities = 22/118 (18%), Positives = 45/118 (38%), Gaps = 6/118 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V A + VAIK IS + Y ++ L REI+++ +H N+I I
Sbjct: 20 AYGMVCSAYDNVNKVRVAIKKISPFEHQ-TYCQRTL-REIKILLRFRHENIIGINDIIRA 77
Query: 263 ----THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSNLSQTFSRCCYQDHI 316
+ ++ + L ++++ + ++ Y + L S +
Sbjct: 78 PTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDL 135
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (283), Expect = 1e-29
Identities = 34/159 (21%), Positives = 62/159 (38%), Gaps = 6/159 (3%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ Q+A + Y ++ VHRD+ N L+ + +K++DFG +R +
Sbjct: 140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---Y 196
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ PE + YT +SD+W+ GVVL+ + YG P+ + E++ V
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 255
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 166
+ + L+ S R I +
Sbjct: 256 RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.5 bits (143), Expect = 1e-10
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 7/89 (7%)
Query: 203 SYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 257
++ V A + VA+K++ + +A D F RE ++ +PN+++ L
Sbjct: 25 AFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQ-REAALMAEFDNPNIVKLL 82
Query: 258 QAIETTHRVYIIMEYAKNGSLLEVIRKER 286
+ ++ EY G L E +R
Sbjct: 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMS 111
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-29
Identities = 34/158 (21%), Positives = 73/158 (46%), Gaps = 7/158 (4%)
Query: 11 KARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQN 70
K +Q+A+ + + +++ +HRD++ N+L+ D + K++DFG AR D +
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE----DNEYT 165
Query: 71 LSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQ 129
E + +PE + +T +SD+WS G++L +V +GR+P+ E+++ ++
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
Query: 130 KRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 166
+ L+ + R + +R
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (144), Expect = 8e-11
Identities = 27/106 (25%), Positives = 48/106 (45%), Gaps = 10/106 (9%)
Query: 188 IHKRKLKLIRDKKLS--SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVV 245
+ + LKL+ ++L + V + VA+K + + D E ++
Sbjct: 10 VPRETLKLV--ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFL----AEANLM 62
Query: 246 KGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDED 291
K L+H L+R A+ T +YII EY +NGSL++ ++ I
Sbjct: 63 KQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLT 107
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-29
Identities = 51/173 (29%), Positives = 94/173 (54%), Gaps = 15/173 (8%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ ++AR + +++ A++Y H + VV+RDIK ENL+LD +IK++DFG ++ +
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
K FCG+ Y +PE+L+ Y D W +GVV++ M+ GRLPF + ++ L +
Sbjct: 162 MKT-----FCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
Query: 127 QVQK-RVVFPESPRLSSSCKALISNILSP-VKFRIQM-----EDIRQDPWLKE 172
+ + FP + LS K+L++ +L K R+ +++ + +
Sbjct: 216 LILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.9 bits (152), Expect = 1e-11
Identities = 25/98 (25%), Positives = 42/98 (42%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V L + A+KI+ K E V++ +HP L A +T
Sbjct: 17 TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
R+ +MEYA G L + +ER E++A +E+
Sbjct: 77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-29
Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 8/166 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
R+ Q+A+ + Y K +HRD+ NLLL + +K+ DFG R N+ Y
Sbjct: 111 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV- 169
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ E +A+ +PE LK ++ SD W GV L+ M YG+ P+ N S++L ++
Sbjct: 170 -MQEHRKVPFAWCAPESLKTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227
Query: 129 QKR-VVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQDPWLKE 172
K P ++ + + R +R +L E
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLE 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (146), Expect = 4e-11
Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 8/104 (7%)
Query: 188 IHKRKLKLIRDKKLS--SYATVKLAT---SARHSQDVAIKIISKVQAPIDYLKKFLPREI 242
I ++ L+L+ +KL S+ V+ + + VA+K + RE+
Sbjct: 5 IGEKDLRLL--EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 243 EVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
+ L H NLIR + T + ++ E A GSLL+ +RK +
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ 105
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-29
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 34/200 (17%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ + QL + +CH V+HRD+K +NLL++ + IKL+DFG AR + V
Sbjct: 99 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
Y + Y +PEIL G Y DIWS+G + MV R F + + L
Sbjct: 159 YT-----HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
Query: 127 QVQKRVVFPES----------------------------PRLSSSCKALISNILSP-VKF 157
++ + + P+ P L ++L+S +L
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273
Query: 158 RIQMEDIRQDPWLKEDSNPV 177
RI + P+ ++ + PV
Sbjct: 274 RISAKAALAHPFFQDVTKPV 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.6 bits (138), Expect = 4e-10
Identities = 21/95 (22%), Positives = 39/95 (41%), Gaps = 1/95 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V A + + VA+K I + REI ++K L HPN+++ L I T
Sbjct: 14 TYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLDVIHT 72
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
+++Y++ E+ + + Y
Sbjct: 73 ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY 107
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 111 bits (279), Expect = 3e-29
Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 8/163 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+A + A+++ H+ ++HRD+K N+++ +K+ DFG AR + + Q
Sbjct: 111 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ G+ Y SPE +G +SD++S+G VL+ ++ G PF + + Q
Sbjct: 171 --TAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
Query: 130 KRVVFPESPR---LSSSCKALISNILSP-VKFRIQ-MEDIRQD 167
+ P S R LS+ A++ L+ + R Q ++R D
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 74.0 bits (181), Expect = 1e-15
Identities = 23/102 (22%), Positives = 41/102 (40%), Gaps = 4/102 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V LA R +DVA+K++ A RE + L HP ++ E
Sbjct: 19 GMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 78
Query: 263 TH----RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
YI+MEY +L +++ E + +A+ ++
Sbjct: 79 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-29
Identities = 35/195 (17%), Positives = 66/195 (33%), Gaps = 33/195 (16%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + ++Y H+ ++HRD+K NLLLD+ +KL+DFG A+ + N Y
Sbjct: 100 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ Y +PE+L G D+W++G +L ++ + + L ++
Sbjct: 160 -----QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214
Query: 130 KRVVFPES---------------------------PRLSSSCKALISNILSP-VKFRIQM 161
+ + P LI + RI
Sbjct: 215 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
Query: 162 EDIRQDPWLKEDSNP 176
+ + P
Sbjct: 275 TQALKMKYFSNRPGP 289
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 7e-13
Identities = 21/93 (22%), Positives = 39/93 (41%), Gaps = 2/93 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISK--VQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260
+ATV A +Q VAIK I D + + REI++++ L HPN+I L A
Sbjct: 10 QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 69
Query: 261 ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+ ++ ++ + + + +
Sbjct: 70 GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHI 102
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 5e-29
Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 16/172 (9%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ AR + +Q+ +Y H +++RD+K ENLL+D + I+++DFGFA++
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW- 196
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
T CG+ +PEI+ Y D W++GV+++ M G PF ++ +
Sbjct: 197 -------TLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
Query: 127 QVQKRVVFPESPRLSSSCKALISNILS------PVKFRIQMEDIRQDPWLKE 172
++ SS K L+ N+L + + DI+ W
Sbjct: 249 KIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 57.1 bits (137), Expect = 8e-10
Identities = 18/98 (18%), Positives = 40/98 (40%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V L A+KI+ K + + E +++ + P L++ + +
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
+Y++MEY G + +R+ E A +++
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 6e-29
Identities = 42/193 (21%), Positives = 71/193 (36%), Gaps = 34/193 (17%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
T+ + QL +D+ H VVHRD+K +N+L+ IKL+DFG AR YS
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 172
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
+ + Y +PE+L Y D+WS+G + M + F ++ + L
Sbjct: 173 T------SVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225
Query: 127 QVQKRVVFPES--------------------------PRLSSSCKALISNILSP-VKFRI 159
++ + P + K L+ L+ RI
Sbjct: 226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
Query: 160 QMEDIRQDPWLKE 172
P+ ++
Sbjct: 286 SAYSALSHPYFQD 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 3e-05
Identities = 18/113 (15%), Positives = 44/113 (38%), Gaps = 12/113 (10%)
Query: 203 SYATVKLATSARHS-QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK---HPNLIRFLQ 258
+Y V A ++ + VA+K + + RE+ V++ L+ HPN++R
Sbjct: 19 AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLETFEHPNVVRLFD 77
Query: 259 AIETTH-----RVYIIMEYAKNG--SLLEVIRKERYIDEDKALLCYSEVSNLS 304
+ ++ ++ E+ + L+ + + E + + + L
Sbjct: 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 112 bits (280), Expect = 1e-28
Identities = 35/171 (20%), Positives = 79/171 (46%), Gaps = 15/171 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
R + +++ +++ H + VV+RD+K N+LLD+ ++++SD G A +S
Sbjct: 107 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-- 164
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
G++ Y +PE+L+ +D +S+G +LF ++ G PF + + +
Sbjct: 165 -----SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 219
Query: 130 KRVVFPES--PRLSSSCKALISNILSP-VKFRIQM-----EDIRQDPWLKE 172
+ S ++L+ +L V R+ +++++ P+ +
Sbjct: 220 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.8 bits (165), Expect = 2e-13
Identities = 14/95 (14%), Positives = 31/95 (32%), Gaps = 3/95 (3%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPRE---IEVVKGLKHPNLIRFLQA 259
+ V A + A+K + K + + + E + +V P ++ A
Sbjct: 16 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 75
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKAL 294
T ++ I++ G L + + E
Sbjct: 76 FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 110
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-28
Identities = 38/172 (22%), Positives = 68/172 (39%), Gaps = 11/172 (6%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + + +A +DY +K +HRD+ N+L+ + Y K++DFG +R V
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---- 182
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ + E L YT SD+WS GV+L+ +V G P+ +EL +++
Sbjct: 183 --KTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ--DPWLKEDSNPV 177
+ + L+ R I + L+E V
Sbjct: 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (150), Expect = 1e-11
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 203 SYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQA 259
++ V A + D AIK + + + D + F E+EV+ L HPN+I L A
Sbjct: 22 NFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFA-GELEVLCKLGHHPNIINLLGA 79
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSE 299
E +Y+ +EYA +G+LL+ +RK R ++ D A +
Sbjct: 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 1e-28
Identities = 33/160 (20%), Positives = 65/160 (40%), Gaps = 7/160 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + Q+A +++ KS VHRD+ N+L+ +K+ DFG AR +D
Sbjct: 164 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI---MSDSNY 220
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL-KQ 127
+ + +PE L YT +SD+WS G++L+ + G P+ K
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTI-KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
Query: 128 VQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 166
+Q + + ++ + + + R ++
Sbjct: 280 IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (150), Expect = 1e-11
Identities = 23/90 (25%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 203 SYATVKLATSARHSQD-----VAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRF 256
++ V AT+ S+ VA+K++ + +A + + E++++ L H N++
Sbjct: 49 AFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALM-SELKMMTQLGSHENIVNL 106
Query: 257 LQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
L A + +Y+I EY G LL +R +R
Sbjct: 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (270), Expect = 7e-28
Identities = 35/169 (20%), Positives = 73/169 (43%), Gaps = 9/169 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+Q++ A++Y KK+ +HRD+ N L+ + + +K++DFG +R + +
Sbjct: 115 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---- 170
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ +PE L ++ +SD+W+ GV+L+ + YG P+ + S++ + +
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ--DPWLKEDS 174
+K L+ R +I Q + +E S
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 64.7 bits (157), Expect = 1e-12
Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
Y V ++S VA+K + + ++ +E V+K +KHPNL++ L
Sbjct: 29 QYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLLGVCTR 84
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
YII E+ G+LL+ +R+ + +L Y
Sbjct: 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 2e-27
Identities = 33/163 (20%), Positives = 73/163 (44%), Gaps = 7/163 (4%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ T + + +A++Y K +HRD+ N L++D+ +K+SDFG +R D
Sbjct: 97 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LD 152
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 125
+ S ++ PE+L ++ +SDIW+ GV+++ + G++P++ SE
Sbjct: 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETA 211
Query: 126 KQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQD 167
+ + + + S ++ + R + + +
Sbjct: 212 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (158), Expect = 9e-13
Identities = 25/84 (29%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ VK R DVAIK+I + D E +V+ L H L++
Sbjct: 16 QFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEKLVQLYGVCTK 70
Query: 263 THRVYIIMEYAKNGSLLEVIRKER 286
++II EY NG LL +R+ R
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMR 94
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-27
Identities = 37/207 (17%), Positives = 68/207 (32%), Gaps = 33/207 (15%)
Query: 2 DILLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 61
++L+ + + +R L + + Y H+ ++HRD+K N+L+ +KL+DFG AR +S
Sbjct: 109 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168
Query: 62 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
+ + + Y PE+L G D+W G ++ M
Sbjct: 169 LAKNSQPNRYT-NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227
Query: 122 SELLKQVQKRVVFP-------------------------------ESPRLSSSCKALISN 150
L + + ++ LI
Sbjct: 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 287
Query: 151 ILSP-VKFRIQMEDIRQDPWLKEDSNP 176
+L RI +D + D P
Sbjct: 288 LLVLDPAQRIDSDDALNHDFFWSDPMP 314
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.6 bits (138), Expect = 5e-10
Identities = 16/99 (16%), Positives = 39/99 (39%), Gaps = 9/99 (9%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
++ V A + Q VA+K + + L REI++++ LKH N++ ++ T
Sbjct: 22 TFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVNLIEICRT 80
Query: 263 T--------HRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
+Y++ ++ ++ + +
Sbjct: 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 119
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 106 bits (265), Expect = 3e-27
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 34/195 (17%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ A+ + QL + I YCH + V+HRD+K +NLL++ + +K++DFG AR + +
Sbjct: 97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLK 126
Y + Y +P++L G DIWS+G + MV G F + ++ L
Sbjct: 157 YT-----HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211
Query: 127 QVQKRVVFPES----------------------------PRLSSSCKALISNILSP-VKF 157
++ + + P S L S L+S +L
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271
Query: 158 RIQMEDIRQDPWLKE 172
RI + + + KE
Sbjct: 272 RITAKQALEHAYFKE 286
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 61.1 bits (147), Expect = 3e-11
Identities = 20/98 (20%), Positives = 41/98 (41%), Gaps = 2/98 (2%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V A + + + A+K I + + REI ++K LKH N+++ I T
Sbjct: 14 TYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTI-REISILKELKHSNIVKLYDVIHT 71
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
R+ ++ E+ + E ++ A ++
Sbjct: 72 KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 7e-27
Identities = 33/162 (20%), Positives = 73/162 (45%), Gaps = 7/162 (4%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ + + + + Y + V+HRD+ N L+ + IK+SDFG R D
Sbjct: 98 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----D 153
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 125
+ S +ASPE+ Y+ +SD+WS GV+++ + G++P+++ + SE++
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212
Query: 126 KQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 166
+ + + S+ ++++ + R + +
Sbjct: 213 EDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.2 bits (161), Expect = 4e-13
Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+ V L + VAIK I + + F+ E EV+ L HP L++
Sbjct: 17 QFGLVHLGYW-LNKDKVAIKTIREGAMSE---EDFI-EEAEVMMKLSHPKLVQLYGVCLE 71
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
+ ++ E+ ++G L + +R +R + + LL
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGM 106
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 8e-27
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 6/160 (3%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
Q+A ++Y K +HRD+ N+L+ + +K++DFG AR + K
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK- 193
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQV 128
+ + +PE L YT QSD+WS GV+L+ + G P+ EL K +
Sbjct: 194 --TTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 129 QKRVVFPESPRLSSSCKALISNILSPV-KFRIQMEDIRQD 167
++ + ++ ++ + V R + + +D
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (130), Expect = 4e-09
Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 10/92 (10%)
Query: 203 SYATVKLATSARHSQD-------VAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLI 254
++ V LA + +D VA+K++ D L + E+E++K + KH N+I
Sbjct: 25 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLI-SEMEMMKMIGKHKNII 82
Query: 255 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
L A +Y+I+EYA G+L E ++ R
Sbjct: 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARR 114
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-26
Identities = 42/173 (24%), Positives = 92/173 (53%), Gaps = 14/173 (8%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + + ++ A+++ HK +++RDIK EN+LLD ++ L+DFG ++++ + T+
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 188
Query: 70 NLSETFCGSYAYASPEILKGVPYTP-QQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
+ FCG+ Y +P+I++G + D WS+GV+++ ++ G PF ++
Sbjct: 189 D----FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
Query: 129 QKRVV---FPESPRLSSSCKALISNILSP-VKFRIQM-----EDIRQDPWLKE 172
+R++ P +S+ K LI +L K R+ ++I++ + ++
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (131), Expect = 4e-09
Identities = 18/103 (17%), Positives = 41/103 (39%), Gaps = 5/103 (4%)
Query: 203 SYATVKLATSARHSQD---VAIKIISKVQAPIDY-LKKFLPREIEVVKGLKH-PNLIRFL 257
+Y V L A+K++ K + E +V++ ++ P L+
Sbjct: 36 AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 95
Query: 258 QAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
A +T ++++I++Y G L + + E + + E+
Sbjct: 96 YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-26
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 36/197 (18%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYK 68
+ + QL ++ Y H + HRDIK +NLLLD D +KL DFG A++ +
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 180
Query: 69 QNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQV 128
++ S Y +PE++ G D+WS G VL ++ G+ F + + L ++
Sbjct: 181 -----SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 129 QKRVVFPES----------------------------PRLSSSCKALISNILSP-VKFRI 159
K + P PR AL S +L R+
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 160 QMEDIRQDPWLKEDSNP 176
+ + E +P
Sbjct: 296 TPLEACAHSFFDELRDP 312
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 2e-09
Identities = 18/102 (17%), Positives = 40/102 (39%), Gaps = 16/102 (15%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ V A + VAIK + + K+F RE+++++ L H N++R +
Sbjct: 32 SFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFYS 84
Query: 263 THR------VYIIMEYAKNG---SLLEVIRKERYIDEDKALL 295
+ + ++++Y R ++ + L
Sbjct: 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 34/160 (21%), Positives = 68/160 (42%), Gaps = 7/160 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ QL+ A+ Y K VHRDI N+L+ +KL DFG +R D
Sbjct: 108 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTY 163
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAM-VYGRLPFDDTNYSELLKQV 128
+ + +PE + +T SD+W GV ++ + ++G PF ++++ ++
Sbjct: 164 YKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222
Query: 129 QKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQD 167
+ P P + +L++ + R + +++
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (140), Expect = 2e-10
Identities = 23/98 (23%), Positives = 42/98 (42%), Gaps = 6/98 (6%)
Query: 203 SYATVKLATSARHSQD---VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 259
+ V VAIK + +KFL +E ++ HP++++ +
Sbjct: 19 QFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFL-QEALTMRQFDHPHIVKLIGV 76
Query: 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
I T + V+IIME G L ++ +Y + +L+ Y
Sbjct: 77 I-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 34/162 (20%), Positives = 68/162 (41%), Gaps = 5/162 (3%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
++ + +A + Y + VHRD+ N+L++ K+SDFG +R + +
Sbjct: 107 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR--VLEDDP 164
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELL 125
+ + +PE + +T SD+WS G+V++ ++ YG P+ + + E++
Sbjct: 165 EATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223
Query: 126 KQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 166
K + P S+ L+ R + DI
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (129), Expect = 5e-09
Identities = 23/116 (19%), Positives = 41/116 (35%), Gaps = 7/116 (6%)
Query: 203 SYATVKLA----TSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 258
+ V +S + VAIK + FL E ++ H N+IR
Sbjct: 19 EFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFL-GEAGIMGQFSHHNIIRLEG 76
Query: 259 AIETTHRVYIIMEYAKNGSLLEV-IRKERYIDEDKALLCYSEVSNLSQTFSRCCYQ 313
I + II EY +NG+L + K+ + + ++ + + Y
Sbjct: 77 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 132
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 6e-26
Identities = 43/200 (21%), Positives = 83/200 (41%), Gaps = 35/200 (17%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTD 66
+ + + + QL + +CH ++V+HRD+K +NLL++ +KL++FG AR + +
Sbjct: 98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157
Query: 67 YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLP-FDDTNYSELL 125
Y + Y P++L G D+WS G + + P F + + L
Sbjct: 158 YSA-----EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 126 KQVQKRVVFPES----------------------------PRLSSSCKALISNILSP-VK 156
K++ + + P P+L+++ + L+ N+L
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV 272
Query: 157 FRIQMEDIRQDPWLKEDSNP 176
RI E+ Q P+ + P
Sbjct: 273 QRISAEEALQHPYFSDFCPP 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.7 bits (133), Expect = 2e-09
Identities = 19/91 (20%), Positives = 37/91 (40%), Gaps = 1/91 (1%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y TV A + + VA+K + L REI ++K LKH N++R + +
Sbjct: 14 TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKNIVRLHDVLHS 72
Query: 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKA 293
++ ++ E+ +D +
Sbjct: 73 DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIV 103
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 8e-26
Identities = 35/157 (22%), Positives = 67/157 (42%), Gaps = 4/157 (2%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
+ Q+A + + K VHRD+ N +LD+K+ +K++DFG AR D N
Sbjct: 132 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN- 190
Query: 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDTNYSELLKQVQK 130
+ + E L+ +T +SD+WS GV+L+ ++ G P+ D N ++ + +
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 131 RVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ 166
+ ++ P + R ++
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (141), Expect = 2e-10
Identities = 21/99 (21%), Positives = 43/99 (43%), Gaps = 6/99 (6%)
Query: 203 SYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA 259
+ V T + A+K ++++ + +FL E ++K HPN++ L
Sbjct: 39 HFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFL-TEGIIMKDFSHPNVLSLLGI 96
Query: 260 -IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCY 297
+ + +++ Y K+G L IR E + K L+ +
Sbjct: 97 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (251), Expect = 4e-25
Identities = 36/183 (19%), Positives = 68/183 (37%), Gaps = 17/183 (9%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLL---LDDKYNIKLSDFGFARKYSVNNTD 66
Q+ I+Y H K+ +HRD+K +N L + + DFG A+KY T
Sbjct: 103 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 67 --YKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSEL 124
++ G+ YAS G+ + + D+ S+G VL G LP+ +
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 125 LKQVQKRVVFPES-------PRLSSSCKALISNILSP-VKFRIQMEDIRQ---DPWLKED 173
++ ++ S S ++ S + +RQ + + ++
Sbjct: 222 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 174 SNP 176
+
Sbjct: 282 FSY 284
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.8 bits (131), Expect = 3e-09
Identities = 16/99 (16%), Positives = 31/99 (31%), Gaps = 6/99 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
S+ + L T ++VAIK+ L E ++ K ++ I ++
Sbjct: 19 SFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 263 T-HRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
++ME R LL ++
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 112
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 100 bits (249), Expect = 7e-25
Identities = 30/148 (20%), Positives = 56/148 (37%), Gaps = 8/148 (5%)
Query: 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-----NIKLSDFGFARKY- 60
++ Q+ + H+KS+V+RDIK +N L+ I + DFG + Y
Sbjct: 98 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157
Query: 61 -SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT 119
V + G+ Y S G + + D+ ++G V + G LP+
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGL 216
Query: 120 NYSELLKQVQKRVVFPESPRLSSSCKAL 147
+ ++ ++ +S L C
Sbjct: 217 KAATNKQKYERIGEKKQSTPLRELCAGF 244
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.3 bits (109), Expect = 2e-06
Identities = 13/94 (13%), Positives = 27/94 (28%), Gaps = 6/94 (6%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI-E 261
S+ + T+ ++Q VAIK + L E K L I + +
Sbjct: 17 SFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 262 TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALL 295
++++ + R +
Sbjct: 72 EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM 105
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 5e-24
Identities = 40/182 (21%), Positives = 72/182 (39%), Gaps = 12/182 (6%)
Query: 1 NDILLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKY 60
N +L + K + ++AD + Y + VHRD+ N ++ + + +K+ DFG R
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183
Query: 61 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMV-YGRLPFDDT 119
+ K + SPE LK +T D+WS GVVL+ + P+
Sbjct: 184 YETDYYRKGG---KGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGL 239
Query: 120 NYSELLKQVQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ------DPWLKE 172
+ ++L+ V + + + L+ K R +I +P +E
Sbjct: 240 SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
Query: 173 DS 174
S
Sbjct: 300 VS 301
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.1 bits (142), Expect = 1e-10
Identities = 22/116 (18%), Positives = 43/116 (37%), Gaps = 11/116 (9%)
Query: 188 IHKRKLKLIRDKKLS--SYATVKLAT-----SARHSQDVAIKIISKVQAPIDYLKKFLPR 240
+ + K+ + R +L S+ V VAIK +++ + + +
Sbjct: 17 VAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLN 72
Query: 241 EIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLC 296
E V+K +++R L + +IME G L +R R + +L
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 5e-23
Identities = 32/160 (20%), Positives = 64/160 (40%), Gaps = 7/160 (4%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + Q+A +++ + +HRD+ N+LL +K +K+ DFG AR + ++
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQV 128
+ +PE + YT QSD+WS GV+L+ + P+ E +
Sbjct: 194 G---DARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 129 QKRVVFPESPR-LSSSCKALISNILSP-VKFRIQMEDIRQ 166
K +P + + + R ++ +
Sbjct: 250 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 1e-05
Identities = 19/116 (16%), Positives = 43/116 (37%), Gaps = 7/116 (6%)
Query: 203 SYATVKLATSARHSQD-----VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFL 257
++ V A + + VA+K++ + A + + ++ H N++ L
Sbjct: 25 AFGQVIEADAFGIDKTATCRTVAVKMLKE-GATHSEHRALMSELKILIHIGHHLNVVNLL 83
Query: 258 QAI-ETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSNLSQTFSRCCY 312
A + + +I+E+ K G+L +R +R + + CY
Sbjct: 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 9e-23
Identities = 38/198 (19%), Positives = 76/198 (38%), Gaps = 39/198 (19%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
D+ + Q+ + Y H ++HRD+K NL +++ +K+ DFG AR+ T
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---- 176
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ 129
+ + Y +PE++ Q DIWS+G ++ M+ G+ F +++ + LK++
Sbjct: 177 ----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 130 KRVVFPES------------------------------PRLSSSCKALISNILSP-VKFR 158
K P + S L+ +L + R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292
Query: 159 IQMEDIRQDPWLKEDSNP 176
+ + P+ + +
Sbjct: 293 VTAGEALAHPYFESLHDT 310
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (138), Expect = 6e-10
Identities = 23/104 (22%), Positives = 43/104 (41%), Gaps = 9/104 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y V A R VAIK + + + K+ RE+ ++K ++H N+I L
Sbjct: 30 AYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGLLDVFTP 88
Query: 263 THR------VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEV 300
Y++M + G+ L + K + ED+ ++
Sbjct: 89 DETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 3e-22
Identities = 34/192 (17%), Positives = 72/192 (37%), Gaps = 28/192 (14%)
Query: 2 DILLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 61
+ ++ A + + K ++ HRD+K +N+L+ ++D G A ++
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159
Query: 62 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTP-----QQSDIWSMGVVLFAMVYGRLPF 116
+ TD G+ Y +PE+L +++DI++MG+V + +
Sbjct: 160 -SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218
Query: 117 D---------------DTNYSELLKQVQKRVVFPESPRLSSSCKA------LISNILSP- 154
D + E+ K V ++ + P P SC+A ++
Sbjct: 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278
Query: 155 VKFRIQMEDIRQ 166
R+ I++
Sbjct: 279 GAARLTALRIKK 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 3e-12
Identities = 24/117 (20%), Positives = 45/117 (38%), Gaps = 10/117 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE- 261
+ V ++VA+KI S + F EI L+H N++ F+ A
Sbjct: 15 RFGEVWRGK--WRGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 262 ---TTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSNLSQTFSRCCYQDH 315
T +++++ +Y ++GSL + + + E L S S L+
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 4e-22
Identities = 39/196 (19%), Positives = 72/196 (36%), Gaps = 39/196 (19%)
Query: 12 ARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNL 71
+ Q+ + Y H ++HRD+K NL +++ +K+ DFG AR T
Sbjct: 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------ 176
Query: 72 SETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKR 131
+ + Y +PEI+ + Q DIWS+G ++ ++ GR F T++ + LK + +
Sbjct: 177 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 132 VVFPES------------------------------PRLSSSCKALISNILSP-VKFRIQ 160
V P + + L+ +L RI
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 161 MEDIRQDPWLKEDSNP 176
+ + +P
Sbjct: 295 AAQALAHAYFAQYHDP 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.3 bits (145), Expect = 8e-11
Identities = 23/115 (20%), Positives = 47/115 (40%), Gaps = 6/115 (5%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262
+Y +V A + VA+K +S+ I + K+ RE+ ++K +KH N+I L
Sbjct: 30 AYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTP 88
Query: 263 THRV-----YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVSNLSQTFSRCCY 312
+ ++ + L +++ ++ D+ L Y + L S
Sbjct: 89 ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADII 143
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.6 bits (224), Expect = 2e-21
Identities = 32/171 (18%), Positives = 64/171 (37%), Gaps = 9/171 (5%)
Query: 10 DKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQ 69
+ + Q+A + + K+ +HRD+ N+LL K+ DFG AR ++
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-- 202
Query: 70 NLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD--TNYSELLKQ 127
+ + +PE + YT +SD+WS G+ L+ + S+ K
Sbjct: 203 -VKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 128 VQKRVVFPESPRLSSSCKALISNILSP-VKFRIQMEDIRQ--DPWLKEDSN 175
+++ + ++ R + I Q + + E +N
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.1 bits (155), Expect = 4e-12
Identities = 22/90 (24%), Positives = 41/90 (45%), Gaps = 8/90 (8%)
Query: 203 SYATVKLATSARH-----SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRF 256
++ V AT+ + VA+K++ + ++ L E++V+ L H N++
Sbjct: 35 AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNHMNIVNL 92
Query: 257 LQAIETTHRVYIIMEYAKNGSLLEVIRKER 286
L A +I EY G LL +R++R
Sbjct: 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 85.7 bits (211), Expect = 2e-19
Identities = 36/210 (17%), Positives = 72/210 (34%), Gaps = 45/210 (21%)
Query: 2 DILLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKY 60
+ R + ++ A+DYCH ++HRD+K N+++D + ++L D+G A Y
Sbjct: 121 QLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
Query: 61 SVNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF---- 116
S + PE+L D+WS+G +L +M++ + PF
Sbjct: 181 HPGQEYNV------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
Query: 117 ---------------------------------DDTNYSELLKQVQKRVVFPESPRLSSS 143
+D K+ ++ V +S
Sbjct: 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 294
Query: 144 CKALISNILSP-VKFRIQMEDIRQDPWLKE 172
+ +L + R+ + + P+
Sbjct: 295 ALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 56.8 bits (136), Expect = 9e-10
Identities = 18/85 (21%), Positives = 42/85 (49%), Gaps = 9/85 (10%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIE 261
Y+ V A + +++ V +KI+ V+ KK + REI++++ L+ PN+I ++
Sbjct: 47 KYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVK 100
Query: 262 --TTHRVYIIMEYAKNGSLLEVIRK 284
+ ++ E+ N ++ +
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLYQT 125
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 2e-19
Identities = 44/228 (19%), Positives = 89/228 (39%), Gaps = 51/228 (22%)
Query: 2 DILLDYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 61
I ++ + ++ Q+ I + H ++HRD+K N+++ +K+ DFG AR
Sbjct: 111 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
Query: 62 VNNTDYKQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY 121
+ + + Y +PE++ G+ Y DIWS+G ++ MV ++ F +Y
Sbjct: 171 TSFMMTP------YVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDY 223
Query: 122 SELLKQVQKRVVFP-----------------------------------------ESPRL 140
+ +V +++ P +
Sbjct: 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 283
Query: 141 SSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNPVGKSKSAPEV 186
+S + L+S +L P K RI ++D Q P++ +P P++
Sbjct: 284 ASQARDLLSKMLVIDPAK-RISVDDALQHPYINVWYDPAEVEAPPPQI 330
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (124), Expect = 3e-08
Identities = 27/100 (27%), Positives = 47/100 (47%), Gaps = 8/100 (8%)
Query: 203 SYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQA--- 259
+ V A A ++VAIK +S+ + K+ RE+ ++K + H N+I L
Sbjct: 29 AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTP 87
Query: 260 ---IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLC 296
+E VY++ME + +L +VI+ E + LL
Sbjct: 88 QKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLY 126
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 69.7 bits (169), Expect = 6e-14
Identities = 40/218 (18%), Positives = 66/218 (30%), Gaps = 56/218 (25%)
Query: 10 DKARRWFSQLADAIDYCH-KKSVVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDY 67
++ QL +DY H + ++H DIK EN+L++ L A + N +
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD---LGNACW 181
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQ 127
+ Y SPE+L G P+ +DIWS ++F ++ G F+ K
Sbjct: 182 YDEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 128 VQKRVV-----------------------------------------------FPESPRL 140
+ S
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300
Query: 141 SSSCKALISNILS--PVKFRIQMEDIRQDPWLKEDSNP 176
+ +S +L P K R + PWLK+
Sbjct: 301 AKEISDFLSPMLQLDPRK-RADAGGLVNHPWLKDTLGM 337
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 37.7 bits (86), Expect = 0.002
Identities = 11/77 (14%), Positives = 28/77 (36%), Gaps = 7/77 (9%)
Query: 203 SYATVKLATSARHSQDVAIKIISK-------VQAPIDYLKKFLPREIEVVKGLKHPNLIR 255
++TV LA ++ VA+KI+ + I L++ + + ++++
Sbjct: 25 HFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 84
Query: 256 FLQAIETTHRVYIIMEY 272
L + +
Sbjct: 85 LLDHFNHKGPNGVHVVM 101
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 56.7 bits (136), Expect = 3e-10
Identities = 14/94 (14%), Positives = 31/94 (32%), Gaps = 20/94 (21%)
Query: 13 RRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDY----- 67
+ + + + + +VH D+ N+L+ + I + DF + +
Sbjct: 106 DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERD 164
Query: 68 KQNLSETFCGSYAYASPEILKGVPYTPQQSDIWS 101
+N+ F +Y + DI S
Sbjct: 165 VRNIITYFSRTYRT--------------EKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 347 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.98 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.98 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.98 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.98 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.98 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.95 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.95 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.95 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.95 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.94 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.94 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.32 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.16 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.61 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.6 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.0 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 90.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 89.58 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 86.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 85.62 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=294.01 Aligned_cols=164 Identities=36% Similarity=0.649 Sum_probs=136.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......+||+.|||||+
T Consensus 100 l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~---~~~~~~~~GT~~Y~APE~ 176 (271)
T d1nvra_ 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---ERLLNKMCGTLPYVAPEL 176 (271)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---ECCBCCCCSCGGGSCTHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---cccccceeeCcCccCHhH
Confidence 56799999999999999999999999999999999999999999999999987653321 122345689999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHh-ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQK-RVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~-~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+.++++.++||||+||++|+|++|+.||...+.. .....+.. ....+....+|+++++|+++|| .+|.+||+++|
T Consensus 177 ~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp HHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 998887667899999999999999999999765432 23333333 3333445678999999999999 79999999999
Q ss_pred HhcCCCCCCC
Q psy10462 164 IRQDPWLKED 173 (347)
Q Consensus 164 il~~p~~~~~ 173 (347)
+++||||++.
T Consensus 257 il~hpwf~~~ 266 (271)
T d1nvra_ 257 IKKDRWYNKP 266 (271)
T ss_dssp HTTCTTTTCC
T ss_pred HhcCHhhCcC
Confidence 9999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=290.79 Aligned_cols=159 Identities=30% Similarity=0.680 Sum_probs=140.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... .....+||+.|||||
T Consensus 102 ~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-------~~~~~~Gt~~Y~APE 174 (263)
T d2j4za1 102 KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------RRTTLCGTLDYLPPE 174 (263)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-------CCEETTEEGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-------cccccCCCCcccCHH
Confidence 3667999999999999999999999999999999999999999999999999765421 123567999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
++.+.+++ .++||||+||++|+|++|+.||.+.+..+....+.+.. ++.+..+|+++++++.+|| .+|.+||+++|+
T Consensus 175 ~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~t~~ei 252 (263)
T d2j4za1 175 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREV 252 (263)
T ss_dssp HHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 99998887 68999999999999999999999999888888876643 3345678999999999999 799999999999
Q ss_pred hcCCCCCCC
Q psy10462 165 RQDPWLKED 173 (347)
Q Consensus 165 l~~p~~~~~ 173 (347)
++|||+...
T Consensus 253 l~hp~~~~~ 261 (263)
T d2j4za1 253 LEHPWITAN 261 (263)
T ss_dssp HTCHHHHHH
T ss_pred HcCcCcCCc
Confidence 999998653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-39 Score=288.34 Aligned_cols=160 Identities=25% Similarity=0.456 Sum_probs=139.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ......+||+.|+|||+
T Consensus 113 l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-----~~~~~~~gt~~Y~aPE~ 187 (293)
T d1yhwa1 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYWMAPEV 187 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-----CCBCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-----ccccccccCCCccChhh
Confidence 5678999999999999999999999999999999999999999999999998764322 12345679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+.+++ .++||||+||++|+|++|+.||.+.+..+.+..+.... ..+.+..+|+++++|+++|| .+|.+||+++|
T Consensus 188 ~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 266 (293)
T d1yhwa1 188 VTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266 (293)
T ss_dssp HSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9998887 68999999999999999999999988777666664432 23445678999999999999 79999999999
Q ss_pred HhcCCCCCC
Q psy10462 164 IRQDPWLKE 172 (347)
Q Consensus 164 il~~p~~~~ 172 (347)
+++||||+.
T Consensus 267 il~Hp~~~~ 275 (293)
T d1yhwa1 267 LLQHQFLKI 275 (293)
T ss_dssp HTTCGGGGG
T ss_pred HhcCHhhCC
Confidence 999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=285.69 Aligned_cols=158 Identities=32% Similarity=0.550 Sum_probs=131.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC-----CeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS-----VVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~-----iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y 81 (347)
+++++++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+...... ......+||+.|
T Consensus 106 l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-----~~~~~~~gt~~Y 180 (269)
T d2java1 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-----SFAKAFVGTPYY 180 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----------------CCCSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC-----CccccCCCCccc
Confidence 667899999999999999999976 9999999999999999999999999998764321 123356899999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
||||++.+..++ .++||||+||++|+|+||+.||.+.+..++...+..+...+.+..+|+++++++++|| .+|.+||+
T Consensus 181 ~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps 259 (269)
T d2java1 181 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPS 259 (269)
T ss_dssp CCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcC
Confidence 999999988877 6899999999999999999999999999988888777655566789999999999999 79999999
Q ss_pred HHHHhcCCCC
Q psy10462 161 MEDIRQDPWL 170 (347)
Q Consensus 161 ~~eil~~p~~ 170 (347)
++|+++|||+
T Consensus 260 ~~ell~hp~i 269 (269)
T d2java1 260 VEEILENPLI 269 (269)
T ss_dssp HHHHHTSTTC
T ss_pred HHHHHhCCcC
Confidence 9999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=288.39 Aligned_cols=162 Identities=30% Similarity=0.584 Sum_probs=142.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... ......+||+.|+|||
T Consensus 101 ~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-----~~~~~~~GT~~Y~aPE 175 (337)
T d1o6la_ 101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTPEYLAPE 175 (337)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-----CCBCCCEECGGGCCGG
T ss_pred CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-----cccccceeCHHHhhhh
Confidence 46779999999999999999999999999999999999999999999999998654321 1234578999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQ---- 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~---- 160 (347)
++.+.+++ .++|+||+||++|+|++|+.||.+.+..++...+.... .+.+..+|+++++||++|| .+|.+|++
T Consensus 176 ~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~ 253 (337)
T d1o6la_ 176 VLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253 (337)
T ss_dssp GGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred hccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHhhccCCchhhcccccc
Confidence 99999887 68999999999999999999999999988888876654 3445679999999999999 79999994
Q ss_pred -HHHHhcCCCCCCCC
Q psy10462 161 -MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 -~~eil~~p~~~~~~ 174 (347)
++++++||||....
T Consensus 254 ~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 254 DAKEVMEHRFFLSIN 268 (337)
T ss_dssp THHHHHTSGGGTTCC
T ss_pred cHHHHHcCcccccCC
Confidence 89999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=284.61 Aligned_cols=166 Identities=25% Similarity=0.543 Sum_probs=140.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......+||+.|+|||
T Consensus 104 ~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~---~~~~~~~~GT~~Y~APE 180 (288)
T d1uu3a_ 104 SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK---QARANSFVGTAQYVSPE 180 (288)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------------CCCCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc---ccccccccCCccccCce
Confidence 366799999999999999999999999999999999999999999999999987643221 12234568999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH-
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED- 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e- 163 (347)
++.+..++ .++||||+||++|+|++|+.||.+.+..++..++.+.. .+.+..+|+++++|+++|| .+|.+|||++|
T Consensus 181 ~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~ 258 (288)
T d1uu3a_ 181 LLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258 (288)
T ss_dssp HHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred eeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 99998877 68999999999999999999999999888888876653 2334678999999999999 79999999987
Q ss_pred -----HhcCCCCCCCCCC
Q psy10462 164 -----IRQDPWLKEDSNP 176 (347)
Q Consensus 164 -----il~~p~~~~~~~~ 176 (347)
+++||||+...+.
T Consensus 259 ~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 259 EGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp TCHHHHHTSGGGTTCCCT
T ss_pred cCCHHHHcCCccCCCCHH
Confidence 5889999886654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=285.24 Aligned_cols=161 Identities=27% Similarity=0.492 Sum_probs=137.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....... ......+||+.|+|||+
T Consensus 107 l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-----~~~~~~~Gt~~y~APE~ 181 (288)
T d2jfla1 107 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-----QRRDSFIGTPYWMAPEV 181 (288)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-----HHHTCCCSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-----ccccccccccccCCHHH
Confidence 6779999999999999999999999999999999999999999999999997654211 11235679999999999
Q ss_pred cc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc--CCCCCCCCCHHHHHHHHhcc-CCCCCC
Q psy10462 87 LK-----GVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV--VFPESPRLSSSCKALISNIL-SPVKFR 158 (347)
Q Consensus 87 ~~-----~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~s~~~~~li~~~l-~~~~~R 158 (347)
+. +.+++ .++||||+||++|+|++|+.||.+.+..+.+..+.+.. ..+.+..+|+++++|+++|| .+|.+|
T Consensus 182 l~~~~~~~~~y~-~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 260 (288)
T d2jfla1 182 VMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDAR 260 (288)
T ss_dssp HTTCSTTTSSTT-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HhhcccCCCCCC-hhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHC
Confidence 85 33444 68999999999999999999999988888887776653 23345678999999999999 799999
Q ss_pred CCHHHHhcCCCCCCC
Q psy10462 159 IQMEDIRQDPWLKED 173 (347)
Q Consensus 159 ~~~~eil~~p~~~~~ 173 (347)
|+++|+++|||++..
T Consensus 261 ~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 261 WTTSQLLQHPFVTVD 275 (288)
T ss_dssp CCHHHHTTSGGGCCC
T ss_pred cCHHHHhcCcccCCC
Confidence 999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-37 Score=281.58 Aligned_cols=160 Identities=34% Similarity=0.613 Sum_probs=128.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc---CCCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD---DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++.+++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+..... ......+||+.|||
T Consensus 104 l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~------~~~~~~~GT~~y~A 177 (307)
T d1a06a_ 104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG------SVLSTACGTPGYVA 177 (307)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------------CTTSC
T ss_pred CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC------CeeeeeeeCccccC
Confidence 67899999999999999999999999999999999994 5788999999999765432 12235679999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---CCCCCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---FPESPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||++.+.+++ .++||||+||++|+|++|+.||.+.+..+....+.+... .+..+.+|+++++|+++|| .+|..||
T Consensus 178 PE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 256 (307)
T d1a06a_ 178 PEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF 256 (307)
T ss_dssp HHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred cHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCc
Confidence 9999998887 689999999999999999999999998888888766433 2334678999999999999 7999999
Q ss_pred CHHHHhcCCCCCCC
Q psy10462 160 QMEDIRQDPWLKED 173 (347)
Q Consensus 160 ~~~eil~~p~~~~~ 173 (347)
+++|+++|||+...
T Consensus 257 s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 257 TCEQALQHPWIAGD 270 (307)
T ss_dssp CHHHHHHSTTTTSS
T ss_pred CHHHHhcCHhhCCC
Confidence 99999999999764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-37 Score=281.75 Aligned_cols=158 Identities=31% Similarity=0.629 Sum_probs=140.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+++++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... ....+||+.|||||+
T Consensus 101 ~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--------~~~~~Gt~~Y~APE~ 172 (316)
T d1fota_ 101 FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--------TYTLCGTPDYIAPEV 172 (316)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--------BCCCCSCTTTCCHHH
T ss_pred ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--------cccccCcccccCHHH
Confidence 456889999999999999999999999999999999999999999999999875421 235689999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----C
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI-----Q 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-----~ 160 (347)
+.+.+++ .++||||+||++|+|++|+.||.+.+..++..++..+. .+.++.+++++++++++|| .+|.+|+ +
T Consensus 173 l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t 250 (316)
T d1fota_ 173 VSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 250 (316)
T ss_dssp HTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred HcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhhCHHhccccchhh
Confidence 9998887 68999999999999999999999999988888887654 2345678999999999999 7898886 8
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++||||++..
T Consensus 251 ~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 251 TEDVKNHPWFKEVV 264 (316)
T ss_dssp THHHHTSGGGSSCC
T ss_pred HHHHHcCcccccCC
Confidence 99999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-37 Score=286.23 Aligned_cols=159 Identities=28% Similarity=0.534 Sum_probs=140.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... ....+||+.|||||
T Consensus 137 ~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--------~~~~~Gt~~Y~APE 208 (350)
T d1rdqe_ 137 RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--------TWTLCGTPEALAPE 208 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--------BCCCEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--------cccccCccccCCHH
Confidence 3677999999999999999999999999999999999999999999999999876421 23567999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCC-----
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRI----- 159 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~----- 159 (347)
++.+..++ .++||||+||++|+|+||+.||.+.+..+....+..... +.+..++++++++++.|| .+|.+|+
T Consensus 209 ~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~ 286 (350)
T d1rdqe_ 209 IILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKN 286 (350)
T ss_dssp HHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTT
T ss_pred HHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHhhhCHHhccccccc
Confidence 99998887 689999999999999999999999998888888876643 345679999999999999 7888884
Q ss_pred CHHHHhcCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ~~~eil~~p~~~~~~ 174 (347)
+++++++||||+...
T Consensus 287 t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 287 GVNDIKNHKWFATTD 301 (350)
T ss_dssp TTHHHHTSGGGTTCC
T ss_pred cHHHHHcCccccCCC
Confidence 899999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-38 Score=282.63 Aligned_cols=159 Identities=20% Similarity=0.351 Sum_probs=137.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... ....+||+.|||||
T Consensus 111 ~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---------~~~~~GT~~Y~APE 181 (309)
T d1u5ra_ 111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---------ANSFVGTPYWMAPE 181 (309)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---------BCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---------CCccccCccccCHH
Confidence 367899999999999999999999999999999999999999999999999976432 23457999999999
Q ss_pred cccCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCCCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 86 ILKGV---PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 86 ~~~~~---~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
++.+. .++ .++||||+||++|+|++|+.||.+.+..+.+..+..... .+.+..+|+++++|+++|| .+|.+||+
T Consensus 182 ~~~~~~~~~y~-~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 260 (309)
T d1u5ra_ 182 VILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260 (309)
T ss_dssp HHTTTTSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhccCCCCcC-chhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcC
Confidence 98753 355 689999999999999999999999888877777765443 3345568999999999999 79999999
Q ss_pred HHHHhcCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 ~~eil~~p~~~~~~ 174 (347)
++++++|||+....
T Consensus 261 ~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 261 SEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHTTCHHHHSCC
T ss_pred HHHHHhCHHhcCCC
Confidence 99999999997643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-37 Score=284.06 Aligned_cols=162 Identities=27% Similarity=0.513 Sum_probs=141.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEc--CCCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLD--DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|....... .....+||+.|+||
T Consensus 124 l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~------~~~~~~gt~~y~aP 197 (352)
T d1koba_ 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE------IVKVTTATAEFAAP 197 (352)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS------CEEEECSSGGGCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC------ceeeccCcccccCH
Confidence 67899999999999999999999999999999999998 57899999999998765421 23356799999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CC--CCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FP--ESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~--~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
|++.+.+++ .++||||+||++|+|+||+.||.+.+..+.+..+..... ++ ....+|+++++|+++|| .+|.+||+
T Consensus 198 E~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s 276 (352)
T d1koba_ 198 EIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 276 (352)
T ss_dssp HHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC
Confidence 999998887 689999999999999999999999999888888876543 22 23578999999999999 79999999
Q ss_pred HHHHhcCCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDSN 175 (347)
Q Consensus 161 ~~eil~~p~~~~~~~ 175 (347)
++|+++||||+....
T Consensus 277 ~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 277 VHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHTSTTTSSCCT
T ss_pred HHHHhcCHhhCCCcc
Confidence 999999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=275.56 Aligned_cols=156 Identities=19% Similarity=0.484 Sum_probs=130.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCcEEEc-CCCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKS--VVHRDIKCENLLLD-DKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~--iiH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++++++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.... ......+||+.|||
T Consensus 109 ~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-------~~~~~~~GT~~Y~a 181 (270)
T d1t4ha_ 109 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-------SFAKAVIGTPEFMA 181 (270)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-------TSBEESCSSCCCCC
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-------CccCCcccCccccC
Confidence 566899999999999999999998 99999999999996 478999999999975432 12335689999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhccCCC-CCCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDT-NYSELLKQVQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
||++.+ .++ .++||||+||++|+|++|+.||.+. +..++...+..+...+ .+...++++++++++|| .+|++||+
T Consensus 182 PE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s 259 (270)
T d1t4ha_ 182 PEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 259 (270)
T ss_dssp GGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcC
Confidence 999976 465 7899999999999999999999765 4555666666554332 23457899999999999 79999999
Q ss_pred HHHHhcCCCCC
Q psy10462 161 MEDIRQDPWLK 171 (347)
Q Consensus 161 ~~eil~~p~~~ 171 (347)
++|+++||||+
T Consensus 260 ~~ell~Hp~fk 270 (270)
T d1t4ha_ 260 IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHTSGGGC
T ss_pred HHHHhCCcccC
Confidence 99999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=278.90 Aligned_cols=166 Identities=20% Similarity=0.345 Sum_probs=138.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ......+||+.|+|||+
T Consensus 97 l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE~ 171 (299)
T d1ua2a_ 97 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-----RAYTHQVVTRWYRAPEL 171 (299)
T ss_dssp CCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-----CCCCCSCCCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-----ccccceecChhhccHHH
Confidence 5668999999999999999999999999999999999999999999999997654321 12234679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---------------------------CCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---------------------------SPR 139 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~ 139 (347)
+.+....+.++||||+||++|+|++|..||.+.+..+.+..+.+....|. .+.
T Consensus 172 ~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
T d1ua2a_ 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 251 (299)
T ss_dssp HTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTT
T ss_pred HccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhccc
Confidence 87665445789999999999999999999999988887777754322111 124
Q ss_pred CCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy10462 140 LSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 140 ~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~~ 177 (347)
.++++++|+++|| .+|++|||++|+++||||++...+.
T Consensus 252 ~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 252 AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp CCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 6789999999999 7999999999999999998765543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-37 Score=283.42 Aligned_cols=163 Identities=26% Similarity=0.488 Sum_probs=141.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC--CCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD--KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
+++++++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+...... .....+||+.||||
T Consensus 121 l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~------~~~~~~gT~~Y~aP 194 (350)
T d1koaa2 121 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ------SVKVTTGTAEFAAP 194 (350)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS------CEEEECSCTTTCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc------ccceecCcccccCH
Confidence 678999999999999999999999999999999999954 5789999999998765322 22356799999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCC-CC--CCCCCHHHHHHHHhcc-CCCCCCCC
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVF-PE--SPRLSSSCKALISNIL-SPVKFRIQ 160 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~--~~~~s~~~~~li~~~l-~~~~~R~~ 160 (347)
|++.+.+++ .++||||+||++|+|++|+.||.+.+..+.+..+...... +. ...+|+++++|+++|| .+|.+|||
T Consensus 195 Ev~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 273 (350)
T d1koaa2 195 EVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273 (350)
T ss_dssp HHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC
Confidence 999998887 6899999999999999999999999998888888665432 22 2468999999999999 79999999
Q ss_pred HHHHhcCCCCCCCCCC
Q psy10462 161 MEDIRQDPWLKEDSNP 176 (347)
Q Consensus 161 ~~eil~~p~~~~~~~~ 176 (347)
++|+++|||+.+...+
T Consensus 274 ~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 274 IHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHSTTTSCTTCC
T ss_pred HHHHhcCcccCCCCCC
Confidence 9999999999876554
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-37 Score=276.74 Aligned_cols=161 Identities=26% Similarity=0.416 Sum_probs=137.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++++++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||+
T Consensus 113 ~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~------~~~~~~~gT~~Y~APE~ 186 (305)
T d1blxa_ 113 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ------MALTSVVVTLWYRAPEV 186 (305)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG------GGGCCCCCCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc------ccCCCcccChhhcCcch
Confidence 567899999999999999999999999999999999999999999999998754322 22345689999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC--------------------------CCCCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP--------------------------ESPRL 140 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------------------------~~~~~ 140 (347)
+.+.+++ .++||||+||++|+|++|+.||.+.+..+.+..+.+....| ....+
T Consensus 187 ~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (305)
T d1blxa_ 187 LLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 265 (305)
T ss_dssp HTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC
T ss_pred hcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccC
Confidence 9998887 68999999999999999999999998887777664321111 12357
Q ss_pred CHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 141 SSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 141 s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
++.+++|+++|| .+|.+|||++|+++||||++..
T Consensus 266 s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 266 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 889999999999 7999999999999999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-37 Score=283.78 Aligned_cols=161 Identities=22% Similarity=0.431 Sum_probs=133.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+++++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .....+||+.|+|||+
T Consensus 104 ~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-------~~~~~~GT~~y~APE~ 176 (364)
T d1omwa3 104 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------KPHASVGTHGYMAPEV 176 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-------CCCSCCSCGGGCCHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-------cccccccccccchhHH
Confidence 456899999999999999999999999999999999999999999999999876432 1235679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--ccCCCCCCCCCHHHHHHHHhcc-CCCCCCCC---
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK--RVVFPESPRLSSSCKALISNIL-SPVKFRIQ--- 160 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~--- 160 (347)
+.+....+.++||||+||++|+|+||+.||.+.+..+....... ....+.+..+|+++++||.+|| .+|.+||+
T Consensus 177 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~ 256 (364)
T d1omwa3 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256 (364)
T ss_dssp HSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSS
T ss_pred hhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcc
Confidence 97544333789999999999999999999987654333322222 2233445679999999999999 79999999
Q ss_pred --HHHHhcCCCCCCCC
Q psy10462 161 --MEDIRQDPWLKEDS 174 (347)
Q Consensus 161 --~~eil~~p~~~~~~ 174 (347)
++++++||||+...
T Consensus 257 ~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 257 RGAQEVKESPFFRSLD 272 (364)
T ss_dssp STHHHHHTSGGGTTCC
T ss_pred cCHHHHHcCccccCCC
Confidence 79999999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-37 Score=277.66 Aligned_cols=162 Identities=30% Similarity=0.591 Sum_probs=141.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...... ......+||+.|+|||
T Consensus 99 ~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~gt~~y~aPE 173 (320)
T d1xjda_ 99 KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-----AKTNTFCGTPDYIAPE 173 (320)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-----CCBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-----ccccccCCCCCcCCHH
Confidence 36679999999999999999999999999999999999999999999999997654322 2233467999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH-H
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME-D 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~-e 163 (347)
++.+.+++ .++||||+||++|+|++|+.||.+.+..++...+.... ++.+..+|+++++|+++|| .+|.+||+++ +
T Consensus 174 ~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~ 251 (320)
T d1xjda_ 174 ILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGD 251 (320)
T ss_dssp HHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred HHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHhcccCCCCCcCHHHH
Confidence 99998887 68999999999999999999999999999888886653 2345678999999999999 7999999996 8
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
+++||||++..
T Consensus 252 l~~hpff~~~~ 262 (320)
T d1xjda_ 252 IRQHPLFREIN 262 (320)
T ss_dssp GGGSGGGTTCC
T ss_pred HHhCchhccCC
Confidence 99999998643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-37 Score=280.32 Aligned_cols=159 Identities=27% Similarity=0.462 Sum_probs=127.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKK-SVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~-~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
+++.+++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+..... ...+.+||+.|+|||
T Consensus 101 l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-------~~~~~~GT~~Y~APE 173 (322)
T d1s9ja_ 101 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------MANSFVGTRSYMSPE 173 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-------TC---CCSSCCCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-------ccccccCCccccCch
Confidence 66799999999999999999975 9999999999999999999999999999865421 234568999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELL---------------------------------------- 125 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~---------------------------------------- 125 (347)
++.+.+++ .++||||+||++|+|++|+.||.+.+..+..
T Consensus 174 vl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (322)
T d1s9ja_ 174 RLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252 (322)
T ss_dssp HHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHH
T ss_pred HHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHH
Confidence 99998887 6899999999999999999999875432211
Q ss_pred --HHHHhccCCC-CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 126 --KQVQKRVVFP-ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 126 --~~i~~~~~~~-~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
..+....... +...+|+++++|+.+|| .+|.+|||++|+++|||+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp HHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred HHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 1111111101 11246889999999999 799999999999999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=274.46 Aligned_cols=155 Identities=32% Similarity=0.583 Sum_probs=130.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-CCcEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++++++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|...... .....+||+.|+||
T Consensus 106 ~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-------~~~~~~GT~~y~aP 178 (273)
T d1xwsa_ 106 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPP 178 (273)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-------CBCCCCSCGGGSCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc-------cccccccCCCcCCH
Confidence 3677999999999999999999999999999999999985 478999999999765321 23356799999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
|++.+..+.+.++||||+||++|+|++|+.||.+.+ .+.+.. ...+..+|+++++++++|| .+|.+|||++|
T Consensus 179 E~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 251 (273)
T d1xwsa_ 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEE 251 (273)
T ss_dssp HHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc-cCCCCCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 999887776667899999999999999999997632 222222 2344678999999999999 79999999999
Q ss_pred HhcCCCCCCCC
Q psy10462 164 IRQDPWLKEDS 174 (347)
Q Consensus 164 il~~p~~~~~~ 174 (347)
+++|||+++..
T Consensus 252 il~hp~~~~~~ 262 (273)
T d1xwsa_ 252 IQNHPWMQDVL 262 (273)
T ss_dssp HHTSGGGSSCC
T ss_pred HhcCHhhCCCC
Confidence 99999997643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-36 Score=271.90 Aligned_cols=163 Identities=29% Similarity=0.500 Sum_probs=138.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC----cEEEeccCCceecccCCccccccCcccccCCccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY----NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAY 81 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y 81 (347)
.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||+|....... ......||+.|
T Consensus 109 ~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~------~~~~~~~t~~y 182 (293)
T d1jksa_ 109 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN------EFKNIFGTPEF 182 (293)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC------BCSCCCCCGGG
T ss_pred ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc------cccccCCCCcc
Confidence 366799999999999999999999999999999999998776 49999999998764321 12345789999
Q ss_pred cccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC---CCCCCHHHHHHHHhcc-CCCCC
Q psy10462 82 ASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE---SPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 82 ~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~li~~~l-~~~~~ 157 (347)
+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+.+..+.......+ ++.+|+++++|+++|| .+|.+
T Consensus 183 ~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 261 (293)
T d1jksa_ 183 VAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 261 (293)
T ss_dssp CCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGG
T ss_pred cCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhH
Confidence 999999988776 789999999999999999999999999888888876543221 2578999999999999 79999
Q ss_pred CCCHHHHhcCCCCCCCCC
Q psy10462 158 RIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 158 R~~~~eil~~p~~~~~~~ 175 (347)
||+++++++|||++....
T Consensus 262 R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 262 RMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp SCCHHHHHHSTTTCC---
T ss_pred CcCHHHHhcCcccCCCCh
Confidence 999999999999986544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-36 Score=271.06 Aligned_cols=166 Identities=30% Similarity=0.512 Sum_probs=139.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .......||+.|+|||.
T Consensus 99 l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~gt~~y~apE~ 173 (298)
T d1gz8a_ 99 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-----RTYTHEVVTLWYRAPEI 173 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-----BCTTCCBCCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-----ccceeecccceeeehhh
Confidence 6789999999999999999999999999999999999999999999999997654321 22334579999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC----------------------------CC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------------------------SP 138 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------~~ 138 (347)
+....+.+.++|+||+||++|+|++|+.||.+.+..+.+..+.+....+. .+
T Consensus 174 ~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T d1gz8a_ 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVP 253 (298)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHST
T ss_pred hccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhcc
Confidence 88877767899999999999999999999999887776666543211110 13
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNPV 177 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~~ 177 (347)
.+|+++++|+++|| .+|.+|||++|+++||||++...|.
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~ 293 (298)
T d1gz8a_ 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293 (298)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCC
Confidence 56789999999999 7999999999999999998876553
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-36 Score=267.74 Aligned_cols=161 Identities=31% Similarity=0.542 Sum_probs=137.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....+||+.|+|||
T Consensus 106 ~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~------~~~~~~gt~~y~~PE 179 (277)
T d1phka_ 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE------KLREVCGTPSYLAPE 179 (277)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC------CBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCC------ceeeeeccCCCCCHH
Confidence 35679999999999999999999999999999999999999999999999998765321 123467999999999
Q ss_pred cccCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC---CCCCCCCCHHHHHHHHhcc-CCCC
Q psy10462 86 ILKGV-----PYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV---FPESPRLSSSCKALISNIL-SPVK 156 (347)
Q Consensus 86 ~~~~~-----~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~s~~~~~li~~~l-~~~~ 156 (347)
.+.+. ...+.++||||+||++|+|++|+.||.+.+..+....+..+.. .+....+|+++++|+..|| .+|.
T Consensus 180 ~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~ 259 (277)
T d1phka_ 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ 259 (277)
T ss_dssp HHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGG
T ss_pred HhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChh
Confidence 98642 1123689999999999999999999999998888877765432 2233578999999999999 7999
Q ss_pred CCCCHHHHhcCCCCCC
Q psy10462 157 FRIQMEDIRQDPWLKE 172 (347)
Q Consensus 157 ~R~~~~eil~~p~~~~ 172 (347)
+||+++|+++||||++
T Consensus 260 ~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 260 KRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GSCCHHHHTTSGGGCT
T ss_pred HCcCHHHHHcCHHHHH
Confidence 9999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-36 Score=268.86 Aligned_cols=160 Identities=20% Similarity=0.364 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+..................||+.|||||.
T Consensus 125 l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 204 (299)
T d1jpaa_ 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204 (299)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHH
Confidence 56789999999999999999999999999999999999999999999999987654322211111223457899999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+| |+.||.+.+..++...+..+...|.+...++++++++..|| .+|..||++.++
T Consensus 205 ~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei 283 (299)
T d1jpaa_ 205 IQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283 (299)
T ss_dssp HHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9988777 68999999999999998 89999999999999999888888888889999999999999 799999999888
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++.
T Consensus 284 ~~~ 286 (299)
T d1jpaa_ 284 VNT 286 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=277.46 Aligned_cols=161 Identities=30% Similarity=0.603 Sum_probs=130.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
+++++++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+...... .....+||+.|+|
T Consensus 108 l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~------~~~~~~gt~~y~a 181 (335)
T d2ozaa1 108 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN------SLTTPCYTPYYVA 181 (335)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC------CCCCCSCCCSSCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC------ccccccCCcccCC
Confidence 678999999999999999999999999999999999985 4679999999998765322 2235679999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-----CCCCC--CCCCHHHHHHHHhcc-CCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV-----VFPES--PRLSSSCKALISNIL-SPV 155 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~-----~~~~~--~~~s~~~~~li~~~l-~~~ 155 (347)
||++.+..++ .++||||+||++|+|+||+.||.+.+..+....+.... .+|.+ ..+|+++++|+++|| .+|
T Consensus 182 PE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 260 (335)
T d2ozaa1 182 PEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 260 (335)
T ss_dssp CCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSST
T ss_pred cHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCCh
Confidence 9999988887 68999999999999999999998776544444433221 22322 358999999999999 799
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q psy10462 156 KFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 156 ~~R~~~~eil~~p~~~~~~ 174 (347)
.+||+++|+++|||+.+..
T Consensus 261 ~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 261 TQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp TTSCCHHHHHHSHHHHTTT
T ss_pred hHCcCHHHHHcCHHhhCCC
Confidence 9999999999999997644
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-35 Score=267.56 Aligned_cols=169 Identities=27% Similarity=0.463 Sum_probs=137.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......... .......+||+.|+|||
T Consensus 105 ~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~gt~~y~aPE 182 (345)
T d1pmea_ 105 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH--TGFLTEYVATRWYRAPE 182 (345)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB--CCTTCCCCSCGGGCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc--ceeeccccccceechHH
Confidence 4667999999999999999999999999999999999999999999999999876443221 22234567999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC------------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------------------------ 135 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------------------------ 135 (347)
++......+.++|+||+||++|+|++|+.||.+.+..+...........+
T Consensus 183 ~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (345)
T d1pmea_ 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262 (345)
T ss_dssp GTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred HhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHH
Confidence 98766555578999999999999999999999877655444332211111
Q ss_pred CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 136 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 136 ~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
..+.+|+++++|+..|| .||..||+++++++|||+++...+
T Consensus 263 ~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 12457889999999999 799999999999999999866544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-36 Score=273.08 Aligned_cols=157 Identities=20% Similarity=0.308 Sum_probs=132.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+........ ......+||+.|||||+
T Consensus 161 l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~ 237 (325)
T d1rjba_ 161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPES 237 (325)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCce---eeeccccCCCccCChHH
Confidence 566889999999999999999999999999999999999999999999999866443221 11234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL-KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|||||||++|||+| |+.||.+.+..+.+ +.+..+...+.+..+|+++++++..|| .+|..|||++|
T Consensus 238 l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 238 LFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9888877 68999999999999997 89999987655544 444566666677789999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
+++|
T Consensus 317 i~~~ 320 (325)
T d1rjba_ 317 LTSF 320 (325)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.6e-35 Score=264.90 Aligned_cols=161 Identities=28% Similarity=0.470 Sum_probs=132.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.|....... .......|++.|+|||.
T Consensus 97 l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~~~~y~~pE~ 171 (286)
T d1ob3a_ 97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-----RKYTHEIVTLWYRAPDV 171 (286)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------------CCCTTCCHHH
T ss_pred cchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-----cccceecccchhhhHHH
Confidence 6789999999999999999999999999999999999999999999999997654321 11234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC----------------------------CCC
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP----------------------------ESP 138 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------------------------~~~ 138 (347)
+.+..+.+.++|+||+||++|+|++|+.||.+.+..+.+.++......+ ..+
T Consensus 172 ~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (286)
T d1ob3a_ 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLK 251 (286)
T ss_dssp HTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCC
T ss_pred HhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcc
Confidence 9876665689999999999999999999999988777766654321111 123
Q ss_pred CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCC
Q psy10462 139 RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKE 172 (347)
Q Consensus 139 ~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~ 172 (347)
.+++++++|++.|| .||++||+++|+++||||++
T Consensus 252 ~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 252 GLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp SCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 46889999999999 79999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-35 Score=266.06 Aligned_cols=168 Identities=21% Similarity=0.330 Sum_probs=135.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.+++.+++||+.||.|||++||+||||||+|||++.++.+||+|||++.......... .......+||+.|+|||
T Consensus 113 ~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~gT~~Y~aPE 191 (318)
T d3blha1 113 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ-PNRYTNRVVTLWYRPPE 191 (318)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC------CCCCCSCCSCGGGCCHH
T ss_pred ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccc-cccccceecCHHHhhHH
Confidence 46779999999999999999999999999999999999999999999999998765432221 22334567999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCCCC---------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPESP--------------------------- 138 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------------------------- 138 (347)
++.+....+.++|+||+||++|+|++|+.||.+.+..+....+.+....+.+.
T Consensus 192 ~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (318)
T d3blha1 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 271 (318)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHH
T ss_pred HHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhh
Confidence 99876444479999999999999999999999888777766665432211110
Q ss_pred ----CCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 139 ----RLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 139 ----~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
..++.+++|+.+|| .+|++|+|++|+++||||+...
T Consensus 272 ~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 272 LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp HHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred hccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 12567889999999 7999999999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=262.66 Aligned_cols=157 Identities=27% Similarity=0.494 Sum_probs=124.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ........||+.|||||+
T Consensus 101 ~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~ 177 (276)
T d1uwha_ 101 FEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG---SHQFEQLSGSILWMAPEV 177 (276)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------------CCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC---cccccccccCcccCCHHH
Confidence 56789999999999999999999999999999999999999999999999976543211 112345679999999999
Q ss_pred ccCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHhccCCCC----CCCCCHHHHHHHHhcc-CCCCC
Q psy10462 87 LKGVP---YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS-ELLKQVQKRVVFPE----SPRLSSSCKALISNIL-SPVKF 157 (347)
Q Consensus 87 ~~~~~---~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~----~~~~s~~~~~li~~~l-~~~~~ 157 (347)
+.+.. ++ .++|||||||++|||+||+.||.+.+.. .+...+.++...|. +..+++++++++.+|| .+|..
T Consensus 178 l~~~~~~~~~-~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~ 256 (276)
T d1uwha_ 178 IRMQDKNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE 256 (276)
T ss_dssp HTTCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HhcccCCCCC-chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhH
Confidence 97543 44 6899999999999999999999986654 44445555544332 3567899999999999 79999
Q ss_pred CCCHHHHhcC
Q psy10462 158 RIQMEDIRQD 167 (347)
Q Consensus 158 R~~~~eil~~ 167 (347)
||++++++++
T Consensus 257 RPt~~~il~~ 266 (276)
T d1uwha_ 257 RPLFPQILAS 266 (276)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=263.85 Aligned_cols=161 Identities=19% Similarity=0.351 Sum_probs=140.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ .......+||+.|+|||+
T Consensus 106 l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~~gt~~y~aPE~ 183 (285)
T d1u59a_ 106 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPEC 183 (285)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE--ECCCCSSCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc--cccccccccCccccChHH
Confidence 567899999999999999999999999999999999999999999999999877543322 222335578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+| |+.||.+.+..++...+.++...+.++.+++++.+++..|+ .+|.+||++.++
T Consensus 184 ~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i 262 (285)
T d1u59a_ 184 INFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 262 (285)
T ss_dssp HHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9887776 68999999999999998 99999999888888888888777777889999999999999 799999999888
Q ss_pred h---cCCCC
Q psy10462 165 R---QDPWL 170 (347)
Q Consensus 165 l---~~p~~ 170 (347)
. +++|+
T Consensus 263 ~~~L~~~~~ 271 (285)
T d1u59a_ 263 EQRMRACYY 271 (285)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 4 45554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-36 Score=264.53 Aligned_cols=159 Identities=21% Similarity=0.400 Sum_probs=137.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....... .......||+.|+|||+
T Consensus 106 l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~----~~~~~~~gt~~y~APE~ 181 (272)
T d1qpca_ 106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEA 181 (272)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE----ECCTTCCCCTTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc----ccccccCCcccccChHH
Confidence 56788999999999999999999999999999999999999999999999987653221 11234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+|| ..||...+..++...+..+...+.+..+++++++++..|+ .+|.+||+++++
T Consensus 182 ~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei 260 (272)
T d1qpca_ 182 INYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260 (272)
T ss_dssp HHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9887776 689999999999999995 6667778888888888888777777889999999999999 789999999999
Q ss_pred hc--CCCC
Q psy10462 165 RQ--DPWL 170 (347)
Q Consensus 165 l~--~p~~ 170 (347)
++ ++||
T Consensus 261 ~~~L~~~f 268 (272)
T d1qpca_ 261 RSVLEDFF 268 (272)
T ss_dssp HHHHHHHH
T ss_pred HHHhhhhh
Confidence 87 5554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=262.92 Aligned_cols=156 Identities=19% Similarity=0.309 Sum_probs=135.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+........ ........||+.|+|||.
T Consensus 104 l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~~gt~~y~APE~ 181 (277)
T d1xbba_ 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPEC 181 (277)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE--EEC----CCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc--cccccccCCCceecCchh
Confidence 567899999999999999999999999999999999999999999999999876543222 122334578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+| |+.||.+.+..++...+.++...+.+..+++++++++..|+ .+|.+||+++++
T Consensus 182 l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i 260 (277)
T d1xbba_ 182 INYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 260 (277)
T ss_dssp HHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9887776 68999999999999997 89999999999988888888777777889999999999999 799999999998
Q ss_pred h
Q psy10462 165 R 165 (347)
Q Consensus 165 l 165 (347)
.
T Consensus 261 ~ 261 (277)
T d1xbba_ 261 E 261 (277)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-35 Score=268.68 Aligned_cols=164 Identities=27% Similarity=0.408 Sum_probs=135.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-cEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....... .....+||+.|+||
T Consensus 118 ~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~------~~~~~~gt~~y~aP 191 (350)
T d1q5ka_ 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE------PNVSYICSRYYRAP 191 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS------CCCSCCSCTTSCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc------ccccccccccccCh
Confidence 367789999999999999999999999999999999999775 89999999998764321 22346799999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc------------------CCC----------C
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRV------------------VFP----------E 136 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~------------------~~~----------~ 136 (347)
|.+.+....+.++||||+||++|+|++|+.||...+..+.+..+.+.. .++ .
T Consensus 192 E~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (350)
T d1q5ka_ 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF 271 (350)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTS
T ss_pred HHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhc
Confidence 998765544578999999999999999999999888766665553211 111 1
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
.+..++++.+|+++|| .||.+|||++|+++||||.+...
T Consensus 272 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 272 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 2457899999999999 79999999999999999987544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=269.31 Aligned_cols=162 Identities=22% Similarity=0.455 Sum_probs=139.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCC--CcEEEeccCCceecccCCccccccCcccccCCccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDK--YNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYAS 83 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~a 83 (347)
.+++++++.++.||+.||+|||++||+||||||+|||++.+ ..+||+|||++....... .....+||+.|+|
T Consensus 98 ~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~------~~~~~~~t~~y~a 171 (321)
T d1tkia_ 98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD------NFRLLFTAPEYYA 171 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC------EEEEEESCGGGSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC------ccccccccccccc
Confidence 46789999999999999999999999999999999999854 579999999998764321 1234578999999
Q ss_pred cccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccC-CCC--CCCCCHHHHHHHHhcc-CCCCCCC
Q psy10462 84 PEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVV-FPE--SPRLSSSCKALISNIL-SPVKFRI 159 (347)
Q Consensus 84 PE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~--~~~~s~~~~~li~~~l-~~~~~R~ 159 (347)
||.+.+..++ .++||||+||++|+|++|..||.+.+..+++..+.+... ++. .+.+|+++++|+++|| .+|.+||
T Consensus 172 pe~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~ 250 (321)
T d1tkia_ 172 PEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM 250 (321)
T ss_dssp HHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred chhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCc
Confidence 9999988877 689999999999999999999999999888888876543 222 2468999999999999 7999999
Q ss_pred CHHHHhcCCCCCCCC
Q psy10462 160 QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ~~~eil~~p~~~~~~ 174 (347)
+++|+++|||+.+..
T Consensus 251 s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 251 TASEALQHPWLKQKI 265 (321)
T ss_dssp CHHHHHHSHHHHSCG
T ss_pred CHHHHhcCHhhccCc
Confidence 999999999997653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-36 Score=265.75 Aligned_cols=138 Identities=25% Similarity=0.357 Sum_probs=126.6
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
-++|++.+.||+|+||+||+|+++.+|+.||+|++.+....+....+.+.+|+++|++++|||||+++++|++++.+|||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999765444444556678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||++|+|.+++.+.+.++|..++.++.|++ |+.|+|++|||||||||+|||+++++
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~ 143 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 143 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC
Confidence 99999999999999888999999999998877 99999999999999999999998775
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=266.55 Aligned_cols=161 Identities=23% Similarity=0.412 Sum_probs=135.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|...... ....+||+.|+|||
T Consensus 117 ~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~~y~aPE 188 (346)
T d1cm8a_ 117 KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--------MTGYVVTRWYRAPE 188 (346)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--------CCSSCSCGGGCCTH
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc--------cccccccccccCHH
Confidence 4678999999999999999999999999999999999999999999999999865421 23457999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC------------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP------------------------------ 135 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------------------------ 135 (347)
.+.+..+.+.++|+||+||++|+|++|+.||.+.+..+.+..+......+
T Consensus 189 ~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (346)
T d1cm8a_ 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268 (346)
T ss_dssp HHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG
T ss_pred HHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHH
Confidence 99876655578999999999999999999999887766555443321111
Q ss_pred CCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 136 ESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 136 ~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
.....++++++|++.|| .+|.+|||++|+++||||++..
T Consensus 269 ~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 12356899999999999 7999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-36 Score=267.25 Aligned_cols=135 Identities=19% Similarity=0.286 Sum_probs=121.1
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||+|+++.+|+.||+|++++.... ...+.+.+|+++|++++|||||++++++++++.+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 5789999999999999999999999999999999765322 23456789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||+||||.++|.+.+.++|.+++.++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~ 140 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD 140 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC
Confidence 9999999999998888999999999988877 99999999999999999999998765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-35 Score=263.85 Aligned_cols=157 Identities=19% Similarity=0.336 Sum_probs=127.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....... .......+||+.|+|||.
T Consensus 131 l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~ 207 (299)
T d1ywna1 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPET 207 (299)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTT---SCCTTSCCCGGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhcccccc---ccccCceeeCccccchhH
Confidence 56789999999999999999999999999999999999999999999999986543222 112345679999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCH-HHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNY-SELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g-~~pf~~~~~-~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|||||||++|||+|| ..||.+.+. ......+..+...+.+..+++++++++.+|| .+|.+||++++
T Consensus 208 l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 286 (299)
T d1ywna1 208 IFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 286 (299)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9988776 689999999999999986 568877654 3445556667666677789999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
+++|
T Consensus 287 il~~ 290 (299)
T d1ywna1 287 LVEH 290 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-34 Score=257.16 Aligned_cols=157 Identities=20% Similarity=0.344 Sum_probs=128.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+........ ........||+.|+|||+
T Consensus 107 ~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~~gt~~Y~APE~ 184 (283)
T d1mqba_ 107 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAPEA 184 (283)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------------------CCCGGGSCHHH
T ss_pred ccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc--ceEeccCCCCccccCHHH
Confidence 567889999999999999999999999999999999999999999999999876432211 111234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||++| ..||...+..+++..+..+...+.+...++.+++++..|+ .+|..||++.++
T Consensus 185 l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 185 ISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp HHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence 9988877 689999999999999985 5566677888888888888877778889999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 264 l~ 265 (283)
T d1mqba_ 264 VS 265 (283)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-35 Score=256.50 Aligned_cols=156 Identities=21% Similarity=0.395 Sum_probs=126.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.+.+++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||+
T Consensus 98 ~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~ 173 (263)
T d1sm2a_ 98 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----SSTGTKFPVKWASPEV 173 (263)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------------------CTTSCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce----eecceecCcccCChHH
Confidence 456888999999999999999999999999999999999999999999999866432211 1224568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+| |..||.+.+..++...+..+...+.+...++++.+++..|+ .+|.+||+++++
T Consensus 174 l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~i 252 (263)
T d1sm2a_ 174 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252 (263)
T ss_dssp HTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 9988877 68999999999999998 67788888888888888888777777788999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 253 l~~ 255 (263)
T d1sm2a_ 253 LRQ 255 (263)
T ss_dssp HHH
T ss_pred HHH
Confidence 865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-34 Score=253.51 Aligned_cols=156 Identities=21% Similarity=0.381 Sum_probs=137.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+.++.+++.|++.||+|||++||+||||||+||+++.++.+||+|||+++........ ......||+.|+|||.
T Consensus 97 ~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~t~~y~aPE~ 172 (258)
T d1k2pa_ 97 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEV 172 (258)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC----CCCCSCCCGGGCCHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce----eecccCCCCCcCCcHH
Confidence 456889999999999999999999999999999999999999999999999765432211 1224568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+| |+.||.+.+..++...+.++...+.+...++++++++++|+ .+|.+||+++++
T Consensus 173 ~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 251 (258)
T d1k2pa_ 173 LMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251 (258)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred hcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHH
Confidence 9988877 68999999999999998 89999999999999999888777777888999999999999 789999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
++|
T Consensus 252 l~~ 254 (258)
T d1k2pa_ 252 LSN 254 (258)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-36 Score=266.69 Aligned_cols=138 Identities=24% Similarity=0.340 Sum_probs=126.5
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++....+....+.+.+|+++|++++|||||+++++|++++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999765433444456688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+||+|.+++...+.++|..++.++.|++ |+.|+|++|||||||||+|||+++++
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~ 145 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 145 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc
Confidence 99999999999999889999999999998876 99999999999999999999998876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-35 Score=265.12 Aligned_cols=157 Identities=22% Similarity=0.420 Sum_probs=135.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........ .......||+.|+|||.
T Consensus 108 ~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~APE~ 184 (317)
T d1xkka_ 108 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE---YHAEGGKVPIKWMALES 184 (317)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-----------CCTTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc---ccccccccCccccChHH
Confidence 566889999999999999999999999999999999999999999999999876432221 11233468999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+| |..||.+.+..++...+..+...+.++.+++++.+++..|+ .+|..||++.++
T Consensus 185 l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 263 (317)
T d1xkka_ 185 ILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 263 (317)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHH
Confidence 9988876 68999999999999998 89999999888888888888877778889999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 264 l~~ 266 (317)
T d1xkka_ 264 IIE 266 (317)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=270.04 Aligned_cols=139 Identities=21% Similarity=0.249 Sum_probs=126.7
Q ss_pred hhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEE
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 268 (347)
.-++|++.+.||+|+||+||+|+++.||+.||+|++++.........+.+.+|+.+|++++|||||+++++|++++.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 35689999999999999999999999999999999986544333345567799999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||+||+|.+++.+.+.++|..++++++|++ |+.|+|++|||||||||+|||+++++
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g 142 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 142 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC
Confidence 999999999999999989999999999988776 99999999999999999999998876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-35 Score=258.12 Aligned_cols=156 Identities=21% Similarity=0.390 Sum_probs=127.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|+....... .......||+.|+|||.
T Consensus 105 l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~----~~~~~~~gt~~y~apE~ 180 (273)
T d1mp8a_ 105 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY----YKASKGKLPIKWMAPES 180 (273)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------------------CCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc----eeccceecCcccchhhH
Confidence 56789999999999999999999999999999999999999999999999986543211 11234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||++ |..||.+.+..++...+..+...+.++.+|+++++++.+|| .+|.+||+++++
T Consensus 181 l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei 259 (273)
T d1mp8a_ 181 INFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259 (273)
T ss_dssp HHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9988776 68999999999999997 89999999999999999888777788899999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 260 ~~~ 262 (273)
T d1mp8a_ 260 KAQ 262 (273)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-35 Score=265.59 Aligned_cols=138 Identities=17% Similarity=0.217 Sum_probs=126.6
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.+.|+..+.||+|+||+||+|++..+|+.||||++++.........+.+.+|+++|++++|||||+++++|.+++.+|||
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 45689999999999999999999999999999999876655555566788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||++|+|..++..++++++.+++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~ 152 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 152 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC
Confidence 99999999988888888999999999999877 99999999999999999999998765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-35 Score=261.56 Aligned_cols=134 Identities=24% Similarity=0.336 Sum_probs=121.4
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|+++.+|+.||+|+++...... .+.+.+|+.+|++++|||||+++++|++++.+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 567999999999999999999999999999999997543222 45678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+||+|.+++.+ +.+++.+++.+++|++ |+.|+|++|||||||||+|||++.++
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~ 153 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC
Confidence 999999999998865 5799999999998877 99999999999999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-35 Score=263.82 Aligned_cols=147 Identities=20% Similarity=0.234 Sum_probs=123.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.+.|++.+.||+|+||+||+|+++.+|+.||+|++.+..... ....+.+|+.+|++++|||||+++++|++++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 567999999999999999999999999999999997654322 235577999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||||+||||.++|.+.+.++|.+++.++.|++ |+.|+|++||+||||||+|||+........+.++..|
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG 155 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccc
Confidence 99999999999999888999999999998877 9999999999999999999999765444444444433
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-35 Score=268.26 Aligned_cols=139 Identities=17% Similarity=0.157 Sum_probs=125.3
Q ss_pred chhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 187 GIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 187 ~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
++..++|++.+.||+|+||+||+|+++.+|+.||+|++++.. .....+.+.+|+.+|++++|||||+++++|++++.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 345788999999999999999999999999999999997542 233356678999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhc-CccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSR-CCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~-~iiHRDlKp~Nil~~~~~ 327 (347)
|||||||+||||.+++.+.+.+++..++.++.|++ |+.|+|++ ||+||||||+|||++.++
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~ 142 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 142 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC
Confidence 99999999999999998888999999999988776 99999975 999999999999998775
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-34 Score=256.78 Aligned_cols=156 Identities=20% Similarity=0.338 Sum_probs=132.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....+... ......|++.|+|||
T Consensus 111 ~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~----~~~~~~g~~~y~aPE 186 (287)
T d1opja_ 111 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT----AHAGAKFPIKWTAPE 186 (287)
T ss_dssp TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE----EETTEEECGGGCCHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce----eeccccccccccChH
Confidence 3566889999999999999999999999999999999999999999999999865432211 112345789999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCC-CCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRL-PFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
++.+..++ .++|||||||++|||++|.. ||.+.+..++...+..+...+.+..+++++++++.+|| .+|.+||++++
T Consensus 187 ~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 265 (287)
T d1opja_ 187 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 265 (287)
T ss_dssp HHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence 99988877 68999999999999999655 45667777777888777777777889999999999999 79999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+++
T Consensus 266 i~~ 268 (287)
T d1opja_ 266 IHQ 268 (287)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-35 Score=260.94 Aligned_cols=135 Identities=16% Similarity=0.231 Sum_probs=122.4
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.+.|++.+.||+|+||+||+|+++.+|+.||+|++++.. ....+.+.+|+++|++++|||||+++++|.+++.+|||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 467899999999999999999999999999999997542 22356678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+||+|.+++.+ .+.+++.+++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~ 147 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG 147 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC
Confidence 999999999999865 56799999999998876 99999999999999999999998776
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-35 Score=261.10 Aligned_cols=147 Identities=16% Similarity=0.227 Sum_probs=128.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh---hhhhchHHHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++...... ...+.+.+|+.+|++++|||||+++++|++++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999976543221 2345678999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccce-eEEEEE
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYS-TIVVVH 336 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~-~~~~~~ 336 (347)
|||||||+||+|.++|.+.+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++..+ .+.+..
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecc
Confidence 99999999999999998888999999999988876 99999999999999999999998876443 344433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-34 Score=254.00 Aligned_cols=163 Identities=23% Similarity=0.385 Sum_probs=135.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......||+.|+|||.
T Consensus 110 l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~ 185 (285)
T d1fmka3 110 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEA 185 (285)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------------CCGGGSCHHH
T ss_pred chHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc----eeeccccccccccChHH
Confidence 56789999999999999999999999999999999999999999999999986543221 11233568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||++| ..||.+.+..+.+..+.++...+.+..+++++++++.+|| .+|++||+++++
T Consensus 186 ~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 264 (285)
T d1fmka3 186 ALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264 (285)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 9988877 689999999999999995 5566777888888888888777888889999999999999 799999999999
Q ss_pred hc--CCCCCCCC
Q psy10462 165 RQ--DPWLKEDS 174 (347)
Q Consensus 165 l~--~p~~~~~~ 174 (347)
++ ++|+....
T Consensus 265 ~~~L~~~~~~~~ 276 (285)
T d1fmka3 265 QAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHTTTSCSC
T ss_pred HHHHhhhhcCCC
Confidence 87 78886643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-34 Score=258.46 Aligned_cols=140 Identities=19% Similarity=0.286 Sum_probs=126.6
Q ss_pred CccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
..|++..++|++.+.||+|+||+||+|+++.+|+.||||+++..... .+.+.+|+++|++++|||||+++++|.++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 35788899999999999999999999999999999999999754332 34577999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|||||||++|+|.+++.+. ..+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~ 152 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH 152 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC
Confidence 9999999999999999999653 5799999999988876 99999999999999999999998775
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-34 Score=260.95 Aligned_cols=161 Identities=24% Similarity=0.382 Sum_probs=132.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++..... ......||+.|+|||.
T Consensus 118 l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--------~~~~~~g~~~y~apE~ 189 (348)
T d2gfsa1 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--------EMTGYVATRWYRAPEI 189 (348)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--------GGSSSCHHHHTSCHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--------ccccccccccccCchh
Confidence 67899999999999999999999999999999999999999999999999865432 1234578999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC------------------------------
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE------------------------------ 136 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------------------------------ 136 (347)
+.+..+.+.++|+||+||++|+|++|+.||.+.+.......+.+....+.
T Consensus 190 ~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (348)
T d2gfsa1 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 269 (348)
T ss_dssp HTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHH
T ss_pred hcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhh
Confidence 88776666789999999999999999999999887766666543322111
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSN 175 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~ 175 (347)
...+++++++|+++|| .+|.+|+|++|+++||||.+...
T Consensus 270 ~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 270 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 1357899999999999 79999999999999999987544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-34 Score=257.59 Aligned_cols=164 Identities=25% Similarity=0.538 Sum_probs=133.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........ ......|++.|+|||.
T Consensus 126 ~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~----~~~~~~g~~~~~~pe~ 201 (322)
T d1vzoa_ 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE----RAYDFCGTIEYMAPDI 201 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG----GGCGGGSCCTTCCHHH
T ss_pred ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccc----cccccccccccchhHH
Confidence 456889999999999999999999999999999999999999999999999876432221 1235679999999999
Q ss_pred ccCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---ccCCCCCCCCCHHHHHHHHhcc-CCCCCCC--
Q psy10462 87 LKGVP-YTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQK---RVVFPESPRLSSSCKALISNIL-SPVKFRI-- 159 (347)
Q Consensus 87 ~~~~~-~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~s~~~~~li~~~l-~~~~~R~-- 159 (347)
+.+.. +.+.++||||+||++|+|++|+.||.+.+..+....+.+ ....+.+..+|+++++++++|| .+|.+|+
T Consensus 202 ~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp HTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred hhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCC
Confidence 97654 234689999999999999999999987654443333322 2233445679999999999999 7999998
Q ss_pred ---CHHHHhcCCCCCCCC
Q psy10462 160 ---QMEDIRQDPWLKEDS 174 (347)
Q Consensus 160 ---~~~eil~~p~~~~~~ 174 (347)
+++|+++||||++..
T Consensus 282 ~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 282 GPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp STTTHHHHHTSGGGTTCC
T ss_pred CcccHHHHHcCHhhcCCC
Confidence 589999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-33 Score=250.95 Aligned_cols=157 Identities=24% Similarity=0.438 Sum_probs=123.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+......... .......+||+.|+|||
T Consensus 107 ~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~Gt~~Y~aPE 184 (277)
T d1o6ya_ 107 PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS--VTQTAAVIGTAQYLSPE 184 (277)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC------------------TTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccccc--ccccccccCcccccCHH
Confidence 3677999999999999999999999999999999999999999999999998765432211 12234568999999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCC---CCCCCCHHHHHHHHhcc-CCCCCCC-C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFP---ESPRLSSSCKALISNIL-SPVKFRI-Q 160 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~li~~~l-~~~~~R~-~ 160 (347)
++.+..++ .++||||+||++|+|+||+.||.+.+..+...++......+ ..+.+|+++++++++|| .+|.+|| +
T Consensus 185 ~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~s 263 (277)
T d1o6ya_ 185 QARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 263 (277)
T ss_dssp HHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSS
T ss_pred HHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhH
Confidence 99988877 68999999999999999999999988887776665543332 23578999999999999 7999999 6
Q ss_pred HHHHh
Q psy10462 161 MEDIR 165 (347)
Q Consensus 161 ~~eil 165 (347)
+++++
T Consensus 264 a~~l~ 268 (277)
T d1o6ya_ 264 AAEMR 268 (277)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77664
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-34 Score=255.14 Aligned_cols=156 Identities=20% Similarity=0.283 Sum_probs=134.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....... .......+|++.|+|||.
T Consensus 137 l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~---~~~~~~~~~~~~y~aPE~ 213 (301)
T d1lufa_ 137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKADGNDAIPIRWMPPES 213 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC---BC----CCBCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCcc---ccccCCCCcCcCcCCHHH
Confidence 56688999999999999999999999999999999999999999999999976543221 112234678999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCC-CCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGR-LPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||++|. .||.+.+..++...+.++...+.+..+++++.+++.+|+ .+|++||+++++
T Consensus 214 ~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 214 IFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9988887 6899999999999999985 689999999999999888776667789999999999999 799999999998
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
.+
T Consensus 293 ~~ 294 (301)
T d1lufa_ 293 HR 294 (301)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-34 Score=251.70 Aligned_cols=156 Identities=26% Similarity=0.466 Sum_probs=132.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
+++.++.+++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......... .......|++.|+|||.
T Consensus 108 l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~--~~~~~~~~~~~~~aPE~ 185 (273)
T d1u46a_ 108 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPES 185 (273)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEE--EC-----CCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcc--eecCccccCcccCCHHH
Confidence 5678999999999999999999999999999999999999999999999998765432221 12234567889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKR-VVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
+.+..++ .++|||||||++|||+| |+.||.+.+..+....+.+. ...+.+..+++++++++..|+ .+|++||++++
T Consensus 186 ~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 264 (273)
T d1u46a_ 186 LKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 264 (273)
T ss_dssp HHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence 9988776 67999999999999998 89999999999988888654 445566788999999999999 79999999999
Q ss_pred Hh
Q psy10462 164 IR 165 (347)
Q Consensus 164 il 165 (347)
+.
T Consensus 265 i~ 266 (273)
T d1u46a_ 265 LR 266 (273)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-33 Score=251.69 Aligned_cols=157 Identities=22% Similarity=0.372 Sum_probs=139.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++.+++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....... .......+|++.|+|||
T Consensus 131 ~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~y~aPE 207 (299)
T d1fgka_ 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY---YKKTTNGRLPVKWMAPE 207 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCT---TCCCTTSCCGGGGSCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhcccccccc---ccccccCCCChhhhhhh
Confidence 367899999999999999999999999999999999999999999999999987654222 12234567899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|||||||++|+|++ |..||.+.+..++...+..+...+.+..+++++++++..|+ .+|..||++.|
T Consensus 208 ~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~e 286 (299)
T d1fgka_ 208 ALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQ 286 (299)
T ss_dssp HHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHH
Confidence 99988887 68999999999999998 79999999999998888888877778889999999999999 79999999999
Q ss_pred Hhc
Q psy10462 164 IRQ 166 (347)
Q Consensus 164 il~ 166 (347)
+++
T Consensus 287 il~ 289 (299)
T d1fgka_ 287 LVE 289 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-33 Score=255.54 Aligned_cols=163 Identities=22% Similarity=0.417 Sum_probs=129.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCC-cEEEeccCCceecccCCccccccCcccccCCcccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKY-NIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASP 84 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aP 84 (347)
.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|....... .....+||+.|+||
T Consensus 125 ~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~------~~~~~~~t~~y~aP 198 (328)
T d3bqca1 125 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ------EYNVRVASRYFKGP 198 (328)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC------CCCSCCSCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC------cccccccCccccCc
Confidence 467899999999999999999999999999999999998655 59999999998764321 12356789999999
Q ss_pred ccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhc--------------------------------
Q psy10462 85 EILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNY-SELLKQVQKR-------------------------------- 131 (347)
Q Consensus 85 E~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~-~~~~~~i~~~-------------------------------- 131 (347)
|.+.+....+.++|+||+||++|+|++|+.||..... .+....+...
T Consensus 199 E~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (328)
T d3bqca1 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278 (328)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCC
T ss_pred ccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccc
Confidence 9988766545789999999999999999999976532 2221111110
Q ss_pred ----cCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCC
Q psy10462 132 ----VVFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDS 174 (347)
Q Consensus 132 ----~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~ 174 (347)
...+....+|+++++|+++|| .+|.+|+|++|+++||||.+..
T Consensus 279 ~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 279 WERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 000112347889999999999 7999999999999999998743
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-34 Score=261.67 Aligned_cols=134 Identities=13% Similarity=0.193 Sum_probs=121.4
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|.++.||+.||+|++++... ....+.+|+++|++++|||||+++++|++++.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999976432 234577999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCC-CCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKER-YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~-~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+||+|.++|.+.+ .++|.+++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~ 139 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR 139 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC
Confidence 99999999999997655 799999999988876 99999999999999999999997654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-33 Score=249.28 Aligned_cols=163 Identities=25% Similarity=0.515 Sum_probs=132.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+.+.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|........ ......+++.|+|||
T Consensus 97 ~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~~~~~pe 171 (292)
T d1unla_ 97 DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-----CYSAEVVTLWYRPPD 171 (292)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-----CCCSCCSCGGGCCHH
T ss_pred ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-----cceeeccccchhhhh
Confidence 356789999999999999999999999999999999999999999999999987653221 122345788999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHhccCCC----------------------------C
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPF-DDTNYSELLKQVQKRVVFP----------------------------E 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~----------------------------~ 136 (347)
.+.+..+.+.++|+||+||++|+|++|+.|| .+.+..+.+..+......+ .
T Consensus 172 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (292)
T d1unla_ 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred HhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhc
Confidence 9987766557899999999999999999986 4555565555553211110 1
Q ss_pred CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 137 SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 137 ~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
...+++.+++|+++|| .+|.+|||++|+++||||++-
T Consensus 252 ~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 2356789999999999 799999999999999999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-34 Score=254.94 Aligned_cols=138 Identities=12% Similarity=0.214 Sum_probs=124.6
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCch------hhhhhchHHHHHHHhcCC-Ccchhhhheeeee
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI------DYLKKFLPREIEVVKGLK-HPNLIRFLQAIET 262 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~------~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~ 262 (347)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++..... ....+.+.+|+.+|++++ |||||+++++|++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 367899999999999999999999999999999997654321 223456789999999996 9999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++.+|||||||+||||.++|+.+++++|..++.++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM 147 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC
Confidence 999999999999999999999888999999999998877 99999999999999999999998765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-34 Score=261.28 Aligned_cols=138 Identities=18% Similarity=0.285 Sum_probs=125.5
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
-++|++.+.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|+.++|||||+++++|++++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 36799999999999999999999999999999999765433334456678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||+||+|.+++.....+++..++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g 141 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG 141 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC
Confidence 99999999999999999999999999988776 99999999999999999999998776
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-34 Score=255.42 Aligned_cols=139 Identities=18% Similarity=0.251 Sum_probs=125.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC----e
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----R 265 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~ 265 (347)
.++|++.+.||+|+||+||+|++..+|+.||+|++++....+......+.+|+++|++++|||||+++++++.++ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998766555555667889999999999999999999998754 4
Q ss_pred EEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
+|||||||+||+|.+++...+.+++.+++.++.|++ |+.|+|++||+||||||+|||++.++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~ 149 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 149 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc
Confidence 899999999999999998889999999999999877 999999999999999999999977653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-34 Score=262.22 Aligned_cols=134 Identities=17% Similarity=0.257 Sum_probs=120.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++... .....+.+|+++|++++|||||+++++|++++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999975432 2245677999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccc
Q psy10462 270 MEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQA 326 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~ 326 (347)
||||+||+|.+++.+. .+++|.+++.++.|++ |+.|+|++|||||||||+|||++..
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~ 163 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 163 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc
Confidence 9999999999988654 4799999999999877 9999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.98 E-value=5.7e-34 Score=261.21 Aligned_cols=145 Identities=16% Similarity=0.282 Sum_probs=125.4
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
-++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|++++|||||+++++|++++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999997543 23356678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHH-hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 270 MEYAKNGSLLEVIR-KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 270 ~E~~~~G~L~~~l~-~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
||||+||+|.+++. ..+.++|.+++.++.|++ |+.|+|++|||||||||+|||++.+.. ..+.++..|
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~-~~vkL~DFG 171 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS-NELKLIDFG 171 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS-CCEEECCCT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCC-CeEEEeecc
Confidence 99999999999995 456899999999999877 999999999999999999999965432 234444433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.2e-33 Score=255.89 Aligned_cols=161 Identities=24% Similarity=0.462 Sum_probs=125.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++++++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++..... ......+||+.|+|||
T Consensus 115 ~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~------~~~~~~~~t~~y~aPE 188 (355)
T d2b1pa1 115 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS------FMMTPYVVTRYYRAPE 188 (355)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------------CCTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc------cccccccccccccChh
Confidence 4678999999999999999999999999999999999999999999999998765432 1223557899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccCCCC-----------------------------
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQKRVVFPE----------------------------- 136 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----------------------------- 136 (347)
++.+..++ .++|+||+||++|+|++|+.||.+.+.......+......+.
T Consensus 189 ~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (355)
T d2b1pa1 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267 (355)
T ss_dssp HHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHH
T ss_pred hhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccc
Confidence 99998777 579999999999999999999998876665555432211110
Q ss_pred ------------CCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCC
Q psy10462 137 ------------SPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKED 173 (347)
Q Consensus 137 ------------~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~ 173 (347)
....|+++++|+++|| .+|+.|||++|+++|||++..
T Consensus 268 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0113567899999999 799999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.3e-34 Score=250.77 Aligned_cols=137 Identities=22% Similarity=0.402 Sum_probs=115.4
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee--CCeEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET--THRVY 267 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 267 (347)
.++|++.+.||+|+||+||+|+++.||+.||+|+++.....+ ...+.+.+|+++|++++|||||++++++.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 468999999999999999999999999999999998765443 335667899999999999999999999865 46799
Q ss_pred EEEEecCCCChHHHHHh----CCCCCHHHHHHHHHHHH-HHHHHhhcC-----ccccCCCCccccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRK----ERYIDEDKALLCYSEVS-NLSQTFSRC-----CYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~----~~~l~e~~~~~~~~~~~-~~~~~h~~~-----iiHRDlKp~Nil~~~~~ 327 (347)
||||||+||||.+++.+ ++.++|..++.++.|++ |+.|+|++| ||||||||+|||++.++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence 99999999999999853 46899999999999877 999999876 99999999999998775
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=9.6e-34 Score=259.81 Aligned_cols=138 Identities=15% Similarity=0.235 Sum_probs=125.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|+++.||+.||+|++++....+....+.+.+|+++|+.++|||||+++++|.+.+.+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 46899999999999999999999999999999999755433333445677999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||+.||+|.+++.+.+.++|..++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g 178 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC
Confidence 99999999999998888999999999999876 99999999999999999999998776
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.9e-33 Score=247.59 Aligned_cols=133 Identities=18% Similarity=0.244 Sum_probs=118.1
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee----CCeEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET----THRVY 267 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~ 267 (347)
.|++.+.||+|+||+||+|++..+++.||+|.+....... ...+.+.+|+++|++++|||||+++++|++ +..+|
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 3567778999999999999999999999999997654433 335567899999999999999999999975 35699
Q ss_pred EEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcC--ccccCCCCccccccc
Q psy10462 268 IIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRC--CYQDHIQDLSCFQEQ 325 (347)
Q Consensus 268 iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~--iiHRDlKp~Nil~~~ 325 (347)
||||||++|+|.+++++.+.+++.+++.++.|++ |+.|+|+++ |+||||||+|||++.
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~ 149 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG 149 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC
Confidence 9999999999999999888999999999988877 999999998 999999999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.7e-32 Score=247.55 Aligned_cols=156 Identities=22% Similarity=0.347 Sum_probs=136.5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++..++.+++.|++.||.|||+++|+||||||+|||++.++++||+|||+|+........ ......+||+.|+|||.
T Consensus 130 ~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~~t~~y~aPe~ 206 (308)
T d1p4oa_ 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPES 206 (308)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcce---eeccceecccccCCHHH
Confidence 466778999999999999999999999999999999999999999999999866433221 11234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYG-RLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|+|||||++|||+|| ..||.+.+..+.+..+.++...+.+..+++.+.+++..|+ .+|..||+++++
T Consensus 207 l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i 285 (308)
T d1p4oa_ 207 LKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285 (308)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9988776 689999999999999998 5889999999999988887777777889999999999999 799999999999
Q ss_pred hc
Q psy10462 165 RQ 166 (347)
Q Consensus 165 l~ 166 (347)
++
T Consensus 286 l~ 287 (308)
T d1p4oa_ 286 IS 287 (308)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-33 Score=255.21 Aligned_cols=137 Identities=20% Similarity=0.223 Sum_probs=121.3
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHh-cCCCcchhhhheeeeeCCeEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVK-GLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
++|++.+.||+|+||+||+|+++.||+.||+|++++.........+.+.+|..++. .++|||||+++++|++++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999999999999999997643322233344557777765 68999999999999999999999
Q ss_pred EEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||++|+|.+++...+.++|.+++.++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~ 140 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 140 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC
Confidence 99999999999999888999999999998876 99999999999999999999998765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-32 Score=248.69 Aligned_cols=155 Identities=22% Similarity=0.348 Sum_probs=134.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++.+++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...... ......||+.|+|||
T Consensus 123 ~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~------~~~~~~gt~~y~aPE 196 (309)
T d1fvra_ 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIE 196 (309)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC------CC----CCTTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc------cccceecCCcccchH
Confidence 35678899999999999999999999999999999999999999999999997654321 123456899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHcCC-CCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVYGR-LPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMED 163 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~e 163 (347)
.+.+..++ .++|||||||++|||++|. .||.+.+..++...+.++...+.+..+++++++|+.+|+ .+|++||++++
T Consensus 197 ~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e 275 (309)
T d1fvra_ 197 SLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275 (309)
T ss_dssp HHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 99988876 6899999999999999965 689999999999888887777777889999999999999 79999999999
Q ss_pred HhcC
Q psy10462 164 IRQD 167 (347)
Q Consensus 164 il~~ 167 (347)
++++
T Consensus 276 il~~ 279 (309)
T d1fvra_ 276 ILVS 279 (309)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-32 Score=241.73 Aligned_cols=152 Identities=22% Similarity=0.441 Sum_probs=128.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
++++.+.+++.||+.||.|||+++|+||||||+|||++.++.+|++|||+++..... .....+++.|+|||.
T Consensus 100 l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--------~~~~~~~~~y~aPE~ 171 (262)
T d1byga_ 100 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--------QDTGKLPVKWTAPEA 171 (262)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------------CCTTTSCHHH
T ss_pred CCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--------CccccccccCCChHH
Confidence 355788999999999999999999999999999999999999999999999765321 223467889999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++|||||||++|||+| |+.||...+..++...+.++...+.+...+++++++++.|+ .+|.+||++.++
T Consensus 172 l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l 250 (262)
T d1byga_ 172 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250 (262)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 9888776 68999999999999998 79999999888999999888777777889999999999999 799999999998
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 251 ~~~ 253 (262)
T d1byga_ 251 REQ 253 (262)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=2.2e-33 Score=258.79 Aligned_cols=138 Identities=12% Similarity=0.145 Sum_probs=120.5
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchH---HHHHHHhcCCCcchhhhheeeeeCCeE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLP---REIEVVKGLKHPNLIRFLQAIETTHRV 266 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~---~E~~il~~l~HpnIv~l~~~~~~~~~~ 266 (347)
-++|++.+.||+|+||+||+|+++.||+.||+|++.+...........+. +|+++++.++|||||+++++|++++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46799999999999999999999999999999999754432222222233 447778888999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||||||+||+|.++|.+.+.++|..++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g 144 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 144 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC
Confidence 99999999999999999889999999999988776 99999999999999999999998765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=6.7e-33 Score=249.03 Aligned_cols=138 Identities=15% Similarity=0.170 Sum_probs=118.7
Q ss_pred hhhhhhhhhhhcccccchhhhhhccccccc---chhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~---~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
+..++|++.+.||+|+||+||+|+++.+++ .||+|.+.... .....+.+.+|+++|++++|||||++++++.+++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 445778899999999999999999887765 48888886432 2333556789999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+|||||++|+|.+++.. .+.+++.++..++.|++ |+.|+|++|||||||||+|||+++++
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~ 165 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL 165 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC
Confidence 99999999999999999876 45799999999988877 99999999999999999999998775
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-32 Score=242.39 Aligned_cols=133 Identities=17% Similarity=0.320 Sum_probs=118.3
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|++. +++.||||++++.... .+.+.+|+++|++++|||||++++++.+++.+|+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 467889999999999999999875 5667999999765433 34577999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||++|+|.+++... ..+++..+..++.|++ |+.|+|+++|+||||||+|||+++++
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~ 138 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 138 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC
Confidence 9999999999998654 5789999998888877 99999999999999999999998876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-32 Score=243.71 Aligned_cols=139 Identities=19% Similarity=0.308 Sum_probs=120.6
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET 262 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 262 (347)
..+|+++.++|++.+.||+|+||+||+|++. +++.||||+++..... .+.+.+|+++|++++|||||++++++.
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~- 78 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT- 78 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec-
Confidence 3467788899999999999999999999874 6778999999754332 345779999999999999999999875
Q ss_pred CCeEEEEEEecCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 THRVYIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 ~~~~~iv~E~~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++.+|||||||++|+|.+++.. ...+++..+..++.|++ |+.|+|+++|+||||||+|||+++++
T Consensus 79 ~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~ 146 (272)
T d1qpca_ 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 146 (272)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS
T ss_pred cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc
Confidence 4568999999999999998844 33699999999999887 99999999999999999999998765
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-32 Score=243.41 Aligned_cols=138 Identities=14% Similarity=0.198 Sum_probs=119.6
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH 264 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 264 (347)
+|+++.++|++.+.||+|+||+||+|++. ..||||+++...... ...+.+.+|+.+|++++|||||++++++. .+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 46778899999999999999999999764 349999997654333 33566789999999999999999999865 46
Q ss_pred eEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|||||||++|+|.++|.. .+.+++..+..++.|++ |+.|+|++|||||||||+|||+++++
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~ 141 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS
T ss_pred EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC
Confidence 78999999999999999965 45799999999988877 99999999999999999999998775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=242.08 Aligned_cols=159 Identities=19% Similarity=0.295 Sum_probs=129.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCcccccccc
Q psy10462 7 YNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPEI 86 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 86 (347)
....++.+++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++......... ........||+.|+|||.
T Consensus 127 ~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~ 205 (311)
T d1r0pa_ 127 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-VHNKTGAKLPVKWMALES 205 (311)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC-TTCTTCSSCCGGGSCHHH
T ss_pred chHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc-ceecccccccccccChHH
Confidence 3457788999999999999999999999999999999999999999999998765432221 122234568999999999
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHH
Q psy10462 87 LKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDD-TNYSELLKQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQMEDI 164 (347)
Q Consensus 87 ~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ei 164 (347)
+.+..++ .++||||||+++|||+||..||.. .+..+....+..+...+.+...++++.+++.+|+ .+|++||+++|+
T Consensus 206 ~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei 284 (311)
T d1r0pa_ 206 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284 (311)
T ss_dssp HHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 9887776 689999999999999997777754 3445566667777666677788999999999999 799999999999
Q ss_pred hcC
Q psy10462 165 RQD 167 (347)
Q Consensus 165 l~~ 167 (347)
+++
T Consensus 285 ~~~ 287 (311)
T d1r0pa_ 285 VSR 287 (311)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-31 Score=241.52 Aligned_cols=157 Identities=20% Similarity=0.338 Sum_probs=130.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCCccccccc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGSYAYASPE 85 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt~~y~aPE 85 (347)
.+++.++.+++.||+.||+|||+++++||||||+||+++.++.+|++|||+++........ ......+||+.|+|||
T Consensus 141 ~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~---~~~~~~~gt~~y~aPE 217 (311)
T d1t46a_ 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPE 217 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcc---eEeeecccChHHcCHH
Confidence 3667899999999999999999999999999999999999999999999999876432221 1233467899999999
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHHhccCCCCCCCCCHHHHHHHHhcc-CCCCCCCCHH
Q psy10462 86 ILKGVPYTPQQSDIWSMGVVLFAMVY-GRLPFDDTNYSELL-KQVQKRVVFPESPRLSSSCKALISNIL-SPVKFRIQME 162 (347)
Q Consensus 86 ~~~~~~~~~~~~Dvws~G~~l~~ll~-g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~ 162 (347)
.+.+..++ .++|||||||++|+|+| |..||.+.+..+.+ +.+..+...+.+...++.+.+|+..|+ .+|.+||+++
T Consensus 218 ~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 296 (311)
T d1t46a_ 218 SIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296 (311)
T ss_dssp HHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHH
Confidence 99887776 68999999999999998 66667776655544 445566666666778999999999999 7999999999
Q ss_pred HHhc
Q psy10462 163 DIRQ 166 (347)
Q Consensus 163 eil~ 166 (347)
++++
T Consensus 297 ~il~ 300 (311)
T d1t46a_ 297 QIVQ 300 (311)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-32 Score=249.33 Aligned_cols=142 Identities=19% Similarity=0.290 Sum_probs=120.4
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhccccccc-----chhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQ-----DVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 257 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~-----~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 257 (347)
..|+++.++|++.+.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +|||||+++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 4567888999999999999999999999875544 58999886432 223355677999999998 899999999
Q ss_pred eeeeeCCeEEEEEEecCCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHH-HHHHHhhcCccc
Q psy10462 258 QAIETTHRVYIIMEYAKNGSLLEVIRKER-----------------------YIDEDKALLCYSEVS-NLSQTFSRCCYQ 313 (347)
Q Consensus 258 ~~~~~~~~~~iv~E~~~~G~L~~~l~~~~-----------------------~l~e~~~~~~~~~~~-~~~~~h~~~iiH 313 (347)
++|.+++.+|||||||++|||.++|+.++ .+++..+..++.|++ |+.|+|++||||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 99999999999999999999999997542 489999999988877 999999999999
Q ss_pred cCCCCccccccccc
Q psy10462 314 DHIQDLSCFQEQAT 327 (347)
Q Consensus 314 RDlKp~Nil~~~~~ 327 (347)
|||||+|||++.++
T Consensus 188 RDlKp~Nill~~~~ 201 (325)
T d1rjba_ 188 RDLAARNVLVTHGK 201 (325)
T ss_dssp TTCSGGGEEEETTT
T ss_pred ccCchhccccccCC
Confidence 99999999998775
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-32 Score=246.21 Aligned_cols=135 Identities=18% Similarity=0.246 Sum_probs=115.2
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||+|+++.+|+.||+|+++.... .+...+.+.+|+++|++++|||||+++++|++++.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 578999999999999999999999999999999975432 2334566789999999999999999999999999999999
Q ss_pred EecCCCChHHHHH--hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIR--KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~--~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||.+ ++.+++. ..+.++|..++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~ 139 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG 139 (298)
T ss_dssp ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC
Confidence 99986 4555553 345799999999999877 99999999999999999999998765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3e-32 Score=242.07 Aligned_cols=129 Identities=19% Similarity=0.253 Sum_probs=111.3
Q ss_pred hhcccccchhhhhhccc--ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEecC
Q psy10462 197 RDKKLSSYATVKLATSA--RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYAK 274 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~~ 274 (347)
+.||+|+||+||+|.+. .+++.||+|+++... .+....+.+.+|+++|++++|||||++++++++ +.+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 46999999999999754 466789999996543 334445678899999999999999999999965 46799999999
Q ss_pred CCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 275 NGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 275 ~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+|+|.+++++.+.+++..+..++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~ 144 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH 144 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC
Confidence 999999999989999999999998877 99999999999999999999998765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-32 Score=251.41 Aligned_cols=141 Identities=15% Similarity=0.187 Sum_probs=119.4
Q ss_pred hhhhhhhh-hcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhc-CCCcchhhhheeeee----C
Q psy10462 190 KRKLKLIR-DKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKG-LKHPNLIRFLQAIET----T 263 (347)
Q Consensus 190 ~~~~~~~~-~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~----~ 263 (347)
.++|++.. .||+|+||+||+|+++.||+.||||++++. ..+.+|+.++.+ ++|||||+++++|++ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 45788765 599999999999999999999999998642 335589998765 489999999999976 4
Q ss_pred CeEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
..+|||||||+||||.++|+++ ..++|.+++.++.|++ |+.|+|++||+||||||+|||++.+.....+-+...|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 6799999999999999999764 4799999999999877 9999999999999999999999876655555554433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.2e-32 Score=239.68 Aligned_cols=143 Identities=17% Similarity=0.281 Sum_probs=123.8
Q ss_pred CCCCCCccchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhhe
Q psy10462 179 KSKSAPEVGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 258 (347)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~ 258 (347)
.+.....|+++.++|++.+.||+|+||+||+|++..+ +.||||+++..... .+.+.+|+.+|++++|||||++++
T Consensus 5 ~~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g 79 (285)
T d1fmka3 5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 79 (285)
T ss_dssp SSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEE
Confidence 3445567888899999999999999999999998765 46999999755432 345779999999999999999999
Q ss_pred eeeeCCeEEEEEEecCCCChHHHHHh--CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 259 AIETTHRVYIIMEYAKNGSLLEVIRK--ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 259 ~~~~~~~~~iv~E~~~~G~L~~~l~~--~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++.+ +.+|+|||||++|+|..++.. .+.+++.++..++.+++ |+.|+|++||+||||||+|||+++++
T Consensus 80 ~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~ 150 (285)
T d1fmka3 80 VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 150 (285)
T ss_dssp EECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC
Confidence 9854 568999999999999999843 45799999999999877 99999999999999999999998765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.7e-32 Score=240.67 Aligned_cols=138 Identities=14% Similarity=0.201 Sum_probs=116.5
Q ss_pred chhhhhhhhhhh-cccccchhhhhhcccc--cccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 187 GIHKRKLKLIRD-KKLSSYATVKLATSAR--HSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 187 ~~~~~~~~~~~~-ig~G~fg~V~~~~~~~--~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
-+.++++.+... ||+|+||+||+|.++. ++..||||++++.. .....+.+.+|+++|++++|||||++++++++
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 345677777774 9999999999997654 45579999997542 23345667899999999999999999999875
Q ss_pred CeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+|||||||++|+|.+++.. ++.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~ 146 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH 146 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC
Confidence 568999999999999999865 46899999999988887 99999999999999999999998765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-32 Score=246.39 Aligned_cols=132 Identities=17% Similarity=0.191 Sum_probs=112.7
Q ss_pred hhhcccccchhhhhhcccccccchhheehhccCCch--hhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEEEec
Q psy10462 196 IRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPI--DYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIMEYA 273 (347)
Q Consensus 196 ~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~E~~ 273 (347)
.+.||+|+||+||+|+++.+|+.||||+++...... +...+.+.+|+.+|++++|||||+++++|.+++.+|||||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 467999999999999999999999999997554322 223456789999999999999999999999999999999999
Q ss_pred CCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 274 KNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 274 ~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|++..+....+.+++.+++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~ 137 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG 137 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC
Confidence 9988777777677899999999988876 99999999999999999999998765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=2.9e-31 Score=238.47 Aligned_cols=164 Identities=21% Similarity=0.321 Sum_probs=125.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC---CCcEEEeccCCceecccCCcccc--ccCcccccCCcc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD---KYNIKLSDFGFARKYSVNNTDYK--QNLSETFCGSYA 80 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~~~~gt~~ 80 (347)
.+++.++..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+.......... .......+||+.
T Consensus 99 ~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~ 178 (299)
T d1ckia_ 99 KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSS
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCcc
Confidence 4677999999999999999999999999999999999754 45799999999987754332211 122345689999
Q ss_pred ccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----hccCCC---CCCCCCHHHHHHHHhcc-
Q psy10462 81 YASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYSELLKQVQ----KRVVFP---ESPRLSSSCKALISNIL- 152 (347)
Q Consensus 81 y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~~~~~~i~----~~~~~~---~~~~~s~~~~~li~~~l- 152 (347)
|||||.+.+.+++ .++|||||||++|+|+||+.||.+.........+. .....| ....+|+++.+++..|+
T Consensus 179 y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~ 257 (299)
T d1ckia_ 179 YASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRS 257 (299)
T ss_dssp SCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHH
T ss_pred ccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHcc
Confidence 9999999998877 68999999999999999999998765543332221 111122 13568899999999999
Q ss_pred CCCCCCCCHHHH---hcCCCC
Q psy10462 153 SPVKFRIQMEDI---RQDPWL 170 (347)
Q Consensus 153 ~~~~~R~~~~ei---l~~p~~ 170 (347)
.+|..||+++++ ++++|.
T Consensus 258 ~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 258 LRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp SCTTCCCCHHHHHHHHHHHHH
T ss_pred CChhHCcCHHHHHHHHHHHHH
Confidence 799999998755 556553
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.5e-32 Score=239.15 Aligned_cols=138 Identities=16% Similarity=0.175 Sum_probs=121.0
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchh---hhhhchHHHHHHHhcCC--CcchhhhheeeeeCC
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPID---YLKKFLPREIEVVKGLK--HPNLIRFLQAIETTH 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~---~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~ 264 (347)
.++|++.+.||+|+||+||+|++..+|+.||+|++++....+. .....+.+|+.+|++++ |||||+++++|++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 3579999999999999999999999999999999976543321 12344679999999985 999999999999999
Q ss_pred eEEEEEEecCC-CChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKN-GSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~-G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+||||+.+ +++.+++++++.++|.+++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 147 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC
Confidence 99999999986 58899998888999999999988876 99999999999999999999997653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=235.15 Aligned_cols=133 Identities=21% Similarity=0.363 Sum_probs=118.7
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYII 269 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 269 (347)
.++|++.+.||+|+||+||+|++ ++++.||||++++.... .+.+.+|+.++++++|||||+++++|.+++.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 46788999999999999999998 47778999999865443 34577999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 270 MEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 270 ~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||++|+|.+++.. ...+++..+..++.|++ |+.|+|++||+||||||+|||+++++
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~ 137 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 137 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC
Confidence 999999999999754 46799999999988876 99999999999999999999998765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=5.8e-31 Score=242.62 Aligned_cols=162 Identities=25% Similarity=0.413 Sum_probs=123.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCcEEEcCCCc------EEEeccCCceecccCCccccccCcccccCC
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHK-KSVVHRDIKCENLLLDDKYN------IKLSDFGFARKYSVNNTDYKQNLSETFCGS 78 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~-~~iiH~dlkp~Nill~~~~~------~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt 78 (347)
.+.+.+++.++.||+.||+|||+ .||+||||||+|||++.++. ++++|||.+..... .....+||
T Consensus 121 ~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--------~~~~~~gt 192 (362)
T d1q8ya_ 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--------HYTNSIQT 192 (362)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--------CCCSCCSC
T ss_pred CCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--------cccccccc
Confidence 35678999999999999999998 89999999999999986543 89999999876532 12346799
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhcc--------------------
Q psy10462 79 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTNYS------ELLKQVQKRV-------------------- 132 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~~~------~~~~~i~~~~-------------------- 132 (347)
+.|+|||++.+..++ .++|+||+||++++|++|+.||.+.+.. +.+.......
T Consensus 193 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~ 271 (362)
T d1q8ya_ 193 REYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 271 (362)
T ss_dssp GGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC
T ss_pred ccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccccccccccc
Confidence 999999999988887 6899999999999999999999754321 1111110000
Q ss_pred ---------------------CCCCCCCCCHHHHHHHHhcc-CCCCCCCCHHHHhcCCCCCCCCCC
Q psy10462 133 ---------------------VFPESPRLSSSCKALISNIL-SPVKFRIQMEDIRQDPWLKEDSNP 176 (347)
Q Consensus 133 ---------------------~~~~~~~~s~~~~~li~~~l-~~~~~R~~~~eil~~p~~~~~~~~ 176 (347)
........++++++|+.+|| .||.+|||++|+++||||++....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 272 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM 337 (362)
T ss_dssp --CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred chhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCc
Confidence 00011224578999999999 799999999999999999966543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=1e-31 Score=239.89 Aligned_cols=135 Identities=16% Similarity=0.177 Sum_probs=120.8
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||+|+++ +|+.||+|+++.... .+...+.+.+|+.+|++++|||||+++++|.+++..|++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 57889999999999999999985 788999999976532 3334566789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||+.+|++..+.+..+.+++..++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~ 137 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG 137 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC
Confidence 9999888887777788999999999999877 99999999999999999999998875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=235.63 Aligned_cols=140 Identities=19% Similarity=0.268 Sum_probs=120.4
Q ss_pred ccchhhhhhhhhhhcccccchhhhhhcccccc---cchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee
Q psy10462 185 EVGIHKRKLKLIRDKKLSSYATVKLATSARHS---QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE 261 (347)
Q Consensus 185 ~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 261 (347)
+|+++.++|++.+.||+|+||+||+|++..++ ..||+|.++... .....+.+.+|+.+|++++|||||++++++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 36788899999999999999999999886543 458899886432 3344566889999999999999999999996
Q ss_pred eCCeEEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 262 TTHRVYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 262 ~~~~~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++.+|+|||||++|+|.+++.. .+.+++..+..++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~ 145 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND 145 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC
Confidence 5679999999999999998855 55799999999988877 99999999999999999999998765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.8e-31 Score=235.14 Aligned_cols=138 Identities=16% Similarity=0.157 Sum_probs=118.9
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccc----cchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHS----QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT 263 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 263 (347)
+..++|+..+.||+|+||+||+|.++.++ ..||||+++.... +.....+.+|+++|++++|||||++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 44567888999999999999999987654 3699999965432 23345577999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 264 HRVYIIMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 264 ~~~~iv~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+.+++|||||.+|+|.+++... +.+++.++..++.|++ |+.|+|+++|+||||||+|||+++++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~ 147 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL 147 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC
Confidence 9999999999999999988654 6899999999988876 99999999999999999999998875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4e-31 Score=236.56 Aligned_cols=136 Identities=16% Similarity=0.181 Sum_probs=123.6
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCeEEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... .+.....+.+|+.+|+.++|||||+++++|.+++.+++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 478999999999999999999999999999999975543 3344566779999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|++.+++|..++...+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~ 138 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG 138 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC
Confidence 9999999999998889999999999988776 99999999999999999999998765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.8e-31 Score=236.43 Aligned_cols=143 Identities=22% Similarity=0.355 Sum_probs=118.3
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcccccc-------cchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchh
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATSARHS-------QDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLI 254 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~-------~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv 254 (347)
.+.|.++.++|++.+.||+|+||.||+|++..++ ..||+|++++... ......+.+|..++.++ +|||||
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEE
Confidence 4568889999999999999999999999875443 4699999975432 22244566898988888 899999
Q ss_pred hhheeeeeCCeEEEEEEecCCCChHHHHHhCC----------------CCCHHHHHHHHHHHH-HHHHHhhcCccccCCC
Q psy10462 255 RFLQAIETTHRVYIIMEYAKNGSLLEVIRKER----------------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQ 317 (347)
Q Consensus 255 ~l~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~----------------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlK 317 (347)
+++++|.+++.+|+|||||++|+|.++|..++ .+++.++..++.|++ |+.|+|++||||||||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence 99999999999999999999999999997543 589999999999887 9999999999999999
Q ss_pred Cccccccccc
Q psy10462 318 DLSCFQEQAT 327 (347)
Q Consensus 318 p~Nil~~~~~ 327 (347)
|+|||+++++
T Consensus 163 p~NiLl~~~~ 172 (299)
T d1fgka_ 163 ARNVLVTEDN 172 (299)
T ss_dssp GGGEEECTTC
T ss_pred ccceeecCCC
Confidence 9999998875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.7e-31 Score=238.36 Aligned_cols=143 Identities=20% Similarity=0.286 Sum_probs=125.0
Q ss_pred CCccchhhhhhhhhhhcccccchhhhhhcc-----cccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhh
Q psy10462 183 APEVGIHKRKLKLIRDKKLSSYATVKLATS-----ARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRF 256 (347)
Q Consensus 183 ~~~~~~~~~~~~~~~~ig~G~fg~V~~~~~-----~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l 256 (347)
.+.|+++.++|++.+.||+|+||.||+|++ ..+++.||+|++++... ......+.+|+.+++++ +|||||++
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 346888999999999999999999999975 35677899999975432 33355677999999999 79999999
Q ss_pred heeeeeCCeEEEEEEecCCCChHHHHHhCC------------------CCCHHHHHHHHHHHH-HHHHHhhcCccccCCC
Q psy10462 257 LQAIETTHRVYIIMEYAKNGSLLEVIRKER------------------YIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQ 317 (347)
Q Consensus 257 ~~~~~~~~~~~iv~E~~~~G~L~~~l~~~~------------------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlK 317 (347)
++++++++.+|||||||++|+|.++|++.. .+++..+..++.|++ |+.|+|++||||||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 999999999999999999999999997543 589999999999877 9999999999999999
Q ss_pred Cccccccccc
Q psy10462 318 DLSCFQEQAT 327 (347)
Q Consensus 318 p~Nil~~~~~ 327 (347)
|+|||++..+
T Consensus 173 p~NIl~~~~~ 182 (311)
T d1t46a_ 173 ARNILLTHGR 182 (311)
T ss_dssp GGGEEEETTT
T ss_pred cccccccccC
Confidence 9999997665
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=7.7e-30 Score=228.39 Aligned_cols=159 Identities=18% Similarity=0.266 Sum_probs=123.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcC-----CCcEEEeccCCceecccCCccc--cccCcccccCC
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDD-----KYNIKLSDFGFARKYSVNNTDY--KQNLSETFCGS 78 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~-----~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~gt 78 (347)
.++..++..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+......... ........+||
T Consensus 97 ~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT 176 (293)
T d1csna_ 97 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176 (293)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEc
Confidence 3667899999999999999999999999999999999974 5679999999998765432211 11223456899
Q ss_pred ccccccccccCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcc-CCC---CCCCCCHHHHHHHHhc
Q psy10462 79 YAYASPEILKGVPYTPQQSDIWSMGVVLFAMVYGRLPFDDTN---YSELLKQVQKRV-VFP---ESPRLSSSCKALISNI 151 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~~~~~Dvws~G~~l~~ll~g~~pf~~~~---~~~~~~~i~~~~-~~~---~~~~~s~~~~~li~~~ 151 (347)
+.|||||++.+..++ .++|+||+||++|+|++|+.||.+.+ ..+....+.... ..+ ....+++++.+++..|
T Consensus 177 ~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~ 255 (293)
T d1csna_ 177 ARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYA 255 (293)
T ss_dssp TTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHH
T ss_pred hhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHH
Confidence 999999999998877 68999999999999999999998643 333333332211 111 1246789999999999
Q ss_pred c-CCCCCCCCHHHHh
Q psy10462 152 L-SPVKFRIQMEDIR 165 (347)
Q Consensus 152 l-~~~~~R~~~~eil 165 (347)
+ .+|..||..+.+.
T Consensus 256 ~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 256 RNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHCCTTCCCCHHHHH
T ss_pred hcCCcccCcCHHHHH
Confidence 9 7899999876654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=1e-30 Score=235.00 Aligned_cols=140 Identities=16% Similarity=0.277 Sum_probs=122.8
Q ss_pred cchhhhhhhhhhhcccccchhhhhhccc-----ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheee
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAI 260 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 260 (347)
+++++++|++.+.||+|+||+||+|+++ .+++.||||+++... .....+.+.+|+.+|++++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 5667889999999999999999999864 467789999997543 233456678999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChHHHHHhCC------------------------CCCHHHHHHHHHHHH-HHHHHhhcCccccC
Q psy10462 261 ETTHRVYIIMEYAKNGSLLEVIRKER------------------------YIDEDKALLCYSEVS-NLSQTFSRCCYQDH 315 (347)
Q Consensus 261 ~~~~~~~iv~E~~~~G~L~~~l~~~~------------------------~l~e~~~~~~~~~~~-~~~~~h~~~iiHRD 315 (347)
.+.+..++|||||++|+|.++|...+ .+++..+..++.|++ |+.|+|+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999996532 489999999998877 99999999999999
Q ss_pred CCCccccccccc
Q psy10462 316 IQDLSCFQEQAT 327 (347)
Q Consensus 316 lKp~Nil~~~~~ 327 (347)
|||+|||+++++
T Consensus 166 lKp~NILld~~~ 177 (301)
T d1lufa_ 166 LATRNCLVGENM 177 (301)
T ss_dssp CSGGGEEECGGG
T ss_pred EcccceEECCCC
Confidence 999999998765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.3e-31 Score=232.59 Aligned_cols=138 Identities=19% Similarity=0.195 Sum_probs=109.6
Q ss_pred hhhhhhhhhhcccccchhhhhhcccc-cc--cchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 189 HKRKLKLIRDKKLSSYATVKLATSAR-HS--QDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 189 ~~~~~~~~~~ig~G~fg~V~~~~~~~-~~--~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
..++|++.+.||+|+||+||+|++.. ++ ..||||++++.........+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 45779999999999999999998643 33 3689999987655555555678899999999999999999999976 46
Q ss_pred EEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+++|||||++|+|.+++.. .+.+++..+..++.|++ |+.|+|++||+||||||+|||++++.
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~ 148 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD 148 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc
Confidence 7999999999999998854 45799999999988877 99999999999999999999998865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-30 Score=235.07 Aligned_cols=138 Identities=20% Similarity=0.288 Sum_probs=118.0
Q ss_pred hhhhhhhhhhhcccccchhhhhhcccccccc--hhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCC
Q psy10462 188 IHKRKLKLIRDKKLSSYATVKLATSARHSQD--VAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTH 264 (347)
Q Consensus 188 ~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~--~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~ 264 (347)
+..++|++.+.||+|+||+||+|+++.+|.. ||||.++... .....+.+.+|+++|+++ +|||||++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 3457889999999999999999999888775 6778775332 223355678999999999 7999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhC----------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~----------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|||||||++|+|.++|.+. ..+++..+..++.|++ |+.|+|+++|+||||||+|||++.+.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999653 5799999999999877 99999999999999999999998764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.5e-31 Score=240.87 Aligned_cols=130 Identities=16% Similarity=0.167 Sum_probs=110.7
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee------CC
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------TH 264 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~ 264 (347)
-+|+..+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|++++|||||+++++|.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 36888999999999999999999999999999996542 234489999999999999999999854 34
Q ss_pred eEEEEEEecCCCChHHH---HHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEV---IRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~---l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++|||||||++|.+..+ ......+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~ 159 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 159 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC
Confidence 58999999987643332 23456899999999998876 99999999999999999999998765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.6e-31 Score=231.81 Aligned_cols=135 Identities=21% Similarity=0.318 Sum_probs=116.8
Q ss_pred cchhhhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeee-eCC
Q psy10462 186 VGIHKRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIE-TTH 264 (347)
Q Consensus 186 ~~~~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~ 264 (347)
|.+..++|++.+.||+|+||.||+|++ +|+.||+|++++.. ..+.+.+|+++|++++|||||++++++. +++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 567788999999999999999999987 47789999996543 2355779999999999999999999885 456
Q ss_pred eEEEEEEecCCCChHHHHHhC--CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKE--RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~--~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+|||||++|+|.++|.++ ..+++..++.++.|++ |+.|+|+++|+||||||+|||++.++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~ 140 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 140 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC
Confidence 799999999999999999654 3699999999988877 99999999999999999999998876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=238.23 Aligned_cols=137 Identities=15% Similarity=0.180 Sum_probs=117.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeC-----C
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETT-----H 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 264 (347)
.++|++.+.||+|+||+||+|+++.+|+.||||++++...... ..+.+.+|+++|++++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHH-HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChH-HHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3679999999999999999999999999999999986543333 345577999999999999999999998643 3
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCcccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATY 328 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~ 328 (347)
..+++|||+.||||.+++.. +.+++.+++.++.|++ ||.|+|++||+||||||+|||++.++.
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~ 159 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 159 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc
Confidence 44666778889999999854 5799999999998876 999999999999999999999987753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=1.7e-30 Score=236.36 Aligned_cols=129 Identities=18% Similarity=0.302 Sum_probs=114.6
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeC--CeE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETT--HRV 266 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~ 266 (347)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++.. .+.+.+|+.+|+++ +||||++++++|+.+ ..+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999986432 24567999999999 599999999999854 579
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|||||++|+|..+. +.+++.+++.+++|++ ||.|+|++||+||||||+|||++.++
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~ 166 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 166 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC
Confidence 9999999999997764 4699999999999877 99999999999999999999998655
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-30 Score=237.55 Aligned_cols=135 Identities=16% Similarity=0.255 Sum_probs=111.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC-----
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----- 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----- 264 (347)
.++|+..+.||+|+||+||+|.++.+|+.||||++++... .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 5689999999999999999999999999999999976543 3344566779999999999999999999998654
Q ss_pred -eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 -RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 -~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+||||| +++|..+++ .+.+++..++.++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~ 158 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC 158 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc
Confidence 579999999 457777664 46899999999999876 99999999999999999999998776
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.2e-30 Score=236.17 Aligned_cols=134 Identities=15% Similarity=0.169 Sum_probs=111.4
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC----eE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----RV 266 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~ 266 (347)
++|++.+.||+|+||+||+|++..+|+.||||++++.. .....+.+.+|+.+|++++|||||++++++..+. ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46999999999999999999999999999999997543 2333456779999999999999999999997653 23
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
+++|||+.+|||.++++.+ .+++..++.++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~ 146 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 146 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC
T ss_pred EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC
Confidence 4445567789999999764 799999999988876 99999999999999999999998765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.3e-30 Score=232.51 Aligned_cols=142 Identities=17% Similarity=0.280 Sum_probs=116.0
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhccc-----ccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhh
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFL 257 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~ 257 (347)
..|+++.++|++.+.||+|+||+||+|++. .+++.||+|+++.... ....+.+.+|..++.++ +|||||.++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 457788899999999999999999999864 3567899999975432 22234556788887776 799999999
Q ss_pred eeeeeC-CeEEEEEEecCCCChHHHHHhC----------------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCc
Q psy10462 258 QAIETT-HRVYIIMEYAKNGSLLEVIRKE----------------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDL 319 (347)
Q Consensus 258 ~~~~~~-~~~~iv~E~~~~G~L~~~l~~~----------------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~ 319 (347)
+++..+ +.+++|||||++|+|.++|+.. ..+++.++..++.|++ |+.|+|++|||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 987654 5799999999999999999643 2589999999988876 999999999999999999
Q ss_pred cccccccc
Q psy10462 320 SCFQEQAT 327 (347)
Q Consensus 320 Nil~~~~~ 327 (347)
|||++.++
T Consensus 164 NILl~~~~ 171 (299)
T d1ywna1 164 NILLSEKN 171 (299)
T ss_dssp GEEECGGG
T ss_pred ceeECCCC
Confidence 99998765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-30 Score=236.06 Aligned_cols=138 Identities=15% Similarity=0.239 Sum_probs=122.0
Q ss_pred hhhhhhhhhcccccchhhhhhcc---cccccchhheehhccCCc-hhhhhhchHHHHHHHhcCCC-cchhhhheeeeeCC
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATS---ARHSQDVAIKIISKVQAP-IDYLKKFLPREIEVVKGLKH-PNLIRFLQAIETTH 264 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~---~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~ 264 (347)
-++|++.+.||+|+||+||+|++ ..+|+.||+|++++.... +....+.+.+|+++|++++| |||++++++++++.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47799999999999999999976 457899999999765432 22335567799999999955 89999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+|||||.+|+|.+++...+.+++..+..++.|++ |+.|+|++||+||||||+|||++.++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 166 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC
Confidence 9999999999999999999888999999998888776 99999999999999999999998875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=225.88 Aligned_cols=159 Identities=18% Similarity=0.244 Sum_probs=116.2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh--------CCCeecCCCCCcEEEcCCCcEEEeccCCceecccCCccccccCcccccCC
Q psy10462 7 YNTDKARRWFSQLADAIDYCHK--------KSVVHRDIKCENLLLDDKYNIKLSDFGFARKYSVNNTDYKQNLSETFCGS 78 (347)
Q Consensus 7 ~~~~~~~~~~~qi~~gl~~lH~--------~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~gt 78 (347)
++.++..+++.|++.||.|+|+ +||+||||||+|||++.++.+||+|||++.......... ........||
T Consensus 97 l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~-~~~~~~~~gt 175 (303)
T d1vjya_ 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI-DIAPNHRVGT 175 (303)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE-CC----CCSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcce-eccccceecc
Confidence 4567888999999999999996 599999999999999999999999999998775433221 2223456799
Q ss_pred ccccccccccCCCCC-----CChhhHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHHHHHhccCCCCC-
Q psy10462 79 YAYASPEILKGVPYT-----PQQSDIWSMGVVLFAMVYGRLPFDDT---------------NYSELLKQVQKRVVFPES- 137 (347)
Q Consensus 79 ~~y~aPE~~~~~~~~-----~~~~Dvws~G~~l~~ll~g~~pf~~~---------------~~~~~~~~i~~~~~~~~~- 137 (347)
+.|+|||++.+.... +.++|||||||++|||+||..||... ........+......|..
T Consensus 176 ~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 255 (303)
T d1vjya_ 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 255 (303)
T ss_dssp GGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC
T ss_pred cCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCC
Confidence 999999998764321 24789999999999999998877421 122333333222222221
Q ss_pred CC-----CCHHHHHHHHhcc-CCCCCCCCHHHHhc
Q psy10462 138 PR-----LSSSCKALISNIL-SPVKFRIQMEDIRQ 166 (347)
Q Consensus 138 ~~-----~s~~~~~li~~~l-~~~~~R~~~~eil~ 166 (347)
.. ....+.+++.+|+ .+|.+||+++|+++
T Consensus 256 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11 2235789999999 78999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1e-29 Score=229.16 Aligned_cols=142 Identities=16% Similarity=0.216 Sum_probs=123.1
Q ss_pred Cccchhhhhhhhhhhcccccchhhhhhccc-----ccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhhe
Q psy10462 184 PEVGIHKRKLKLIRDKKLSSYATVKLATSA-----RHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQ 258 (347)
Q Consensus 184 ~~~~~~~~~~~~~~~ig~G~fg~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~ 258 (347)
..|.++.++|++.+.||+|+||+||+|.+. .+++.||||++++.. .......+.+|+.++++++|||||++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 468888999999999999999999999875 346789999997543 2233456789999999999999999999
Q ss_pred eeeeCCeEEEEEEecCCCChHHHHHhC----------CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 259 AIETTHRVYIIMEYAKNGSLLEVIRKE----------RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 259 ~~~~~~~~~iv~E~~~~G~L~~~l~~~----------~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++..++..++|||||++|+|.+++... ..+++..+..++.+++ |+.|+|+++|+||||||+|||++.+.
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 999999999999999999999998532 2578889988888876 99999999999999999999998765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.2e-30 Score=231.10 Aligned_cols=135 Identities=18% Similarity=0.208 Sum_probs=110.9
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccc----hhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCCe
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQD----VAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTHR 265 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~----~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 265 (347)
..+|++.+.||+|+||+||+|.+..+|+. ||+|.++.. ......+.+.+|+++|++++|||||++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 35699999999999999999999888875 666666532 2223345678999999999999999999999864 6
Q ss_pred EEEEEEecCCCChHHHHHh-CCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 266 VYIIMEYAKNGSLLEVIRK-ERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 266 ~~iv~E~~~~G~L~~~l~~-~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+++|||+.+|+|.+++.. ...+++..+..++.|++ |+.|+|++|||||||||+|||++.++
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~ 148 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 148 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC
Confidence 7889999999999998865 46899999999988876 99999999999999999999998765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.5e-30 Score=231.11 Aligned_cols=137 Identities=12% Similarity=0.143 Sum_probs=116.3
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee-------
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------- 262 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------- 262 (347)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.... +.....+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 57899999999999999999999999999999999765432 3334556799999999999999999999855
Q ss_pred -CCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 -THRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 -~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
++.+|+|||||.+|++.........+++..++.+++|++ |+.|+|++||+||||||+|||+++++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~ 154 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 154 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC
Confidence 356999999999877776666677899999999999877 99999999999999999999998875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.7e-29 Score=232.22 Aligned_cols=133 Identities=19% Similarity=0.240 Sum_probs=113.2
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee------CC
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET------TH 264 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~ 264 (347)
++|++.+.||+|+||+||+|+++.||+.||||++++.... ......+.+|+.+|++++|||||+++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 5699999999999999999999999999999999765443 3344567799999999999999999999964 46
Q ss_pred eEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 265 RVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 265 ~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
.+|+|||||.+| +.+.+ .+.+++..++.++.|+. |+.|+|++||+||||||+|||++.++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~ 156 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 156 (355)
T ss_dssp EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc
Confidence 899999999764 55555 35699999999998876 99999999999999999999998765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.1e-29 Score=226.77 Aligned_cols=137 Identities=13% Similarity=0.177 Sum_probs=112.7
Q ss_pred hhhhhhhhhcccccchhhhhhccccc-ccchhheehhccCCchhhhhhchHHHHHHHhcC---CCcchhhhheeeee---
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARH-SQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL---KHPNLIRFLQAIET--- 262 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~-~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~--- 262 (347)
.++|++.+.||+|+||+||+|++..+ ++.||||+++..... +.....+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47899999999999999999998765 677999999764332 22334456898888766 79999999999863
Q ss_pred --CCeEEEEEEecCCCChHHHHH-hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 263 --THRVYIIMEYAKNGSLLEVIR-KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 263 --~~~~~iv~E~~~~G~L~~~l~-~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
...+|++||||++|++..... ....+++..++.++.|++ |+.|+|++|||||||||+|||++..+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC
Confidence 357999999999877655443 346799999998888876 99999999999999999999998765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.5e-28 Score=221.52 Aligned_cols=131 Identities=15% Similarity=0.172 Sum_probs=109.4
Q ss_pred hhhhcccccchhhhhhccccccc---chhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeee-CCeEEEEE
Q psy10462 195 LIRDKKLSSYATVKLATSARHSQ---DVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIET-THRVYIIM 270 (347)
Q Consensus 195 ~~~~ig~G~fg~V~~~~~~~~~~---~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~iv~ 270 (347)
+.+.||+|+||+||+|++..++. .||||++++. ......+.+.+|+++|++++|||||++++++.+ ++.+++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 35679999999999999865432 5899998643 233445668899999999999999999999765 56899999
Q ss_pred EecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 271 EYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 271 E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
|||++|+|.+++... ..+++..+..++.|++ |+.|+|+++|+||||||+|||++++.
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~ 167 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF 167 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC
Confidence 999999999999754 4688888888888776 99999999999999999999998754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=4.7e-28 Score=217.29 Aligned_cols=140 Identities=15% Similarity=0.123 Sum_probs=114.2
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchh-hhheeeeeCCeEEEE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLI-RFLQAIETTHRVYII 269 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~iv 269 (347)
++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|+|+| .+.+++.+++..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 469999999999999999999999999999999865321 23466899999999777655 555666788999999
Q ss_pred EEecCCCChHHHHH-hCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEE
Q psy10462 270 MEYAKNGSLLEVIR-KERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVH 336 (347)
Q Consensus 270 ~E~~~~G~L~~~l~-~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~ 336 (347)
||||. |+|.+.+. ..+.+++..+..++.|++ |+.|+|++|||||||||+|||++..+....+.++-
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~D 149 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 149 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeec
Confidence 99995 56666664 466899999999988876 99999999999999999999987665544444443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.94 E-value=6.8e-28 Score=215.59 Aligned_cols=132 Identities=13% Similarity=0.084 Sum_probs=115.8
Q ss_pred hhhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-CcchhhhheeeeeCCeEEE
Q psy10462 190 KRKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-HPNLIRFLQAIETTHRVYI 268 (347)
Q Consensus 190 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~i 268 (347)
..+|++.+.||+|+||+||+|++..+|+.||+|+++.... ...+.+|+++++.|. ||||+.+++++..+...|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3578999999999999999999999999999998864321 345668999999995 5899999999999999999
Q ss_pred EEEecCCCChHHHHHhC-CCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccc
Q psy10462 269 IMEYAKNGSLLEVIRKE-RYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 269 v~E~~~~G~L~~~l~~~-~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~ 327 (347)
||||| +|+|.++++.. +.+++..+..++.|++ ++.|+|++|||||||||+|||+++..
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~ 138 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPN 138 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSS
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcc
Confidence 99999 67999999664 5799999999988876 89999999999999999999997643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4e-28 Score=218.04 Aligned_cols=130 Identities=16% Similarity=0.256 Sum_probs=106.5
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCCCcchhhhheeeeeCC----eE
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLKHPNLIRFLQAIETTH----RV 266 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~ 266 (347)
++|.+.+.||+|+||.||+|++ +|+.||||+++... ......++|+..++.++|||||++++++.+++ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4677888999999999999985 68899999986432 11122234555566789999999999998654 68
Q ss_pred EEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhh--------cCccccCCCCccccccccc
Q psy10462 267 YIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFS--------RCCYQDHIQDLSCFQEQAT 327 (347)
Q Consensus 267 ~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~--------~~iiHRDlKp~Nil~~~~~ 327 (347)
|+|||||++|+|.++|++. .+++.....++.+++ |+.|+|+ +|||||||||+|||++.++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 9999999999999999764 688988888877765 9999996 6999999999999998775
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.88 E-value=7e-24 Score=194.77 Aligned_cols=138 Identities=16% Similarity=0.189 Sum_probs=111.7
Q ss_pred hhhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-----------Ccchhhhhee
Q psy10462 191 RKLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-----------HPNLIRFLQA 259 (347)
Q Consensus 191 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~~~ 259 (347)
.+|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.++ |||||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 45999999999999999999999999999999997542 22345668999988775 5789999988
Q ss_pred eee--CCeEEEEEEecCCCChHHHH---HhCCCCCHHHHHHHHHHHH-HHHHHhh-cCccccCCCCccccccccccceeE
Q psy10462 260 IET--THRVYIIMEYAKNGSLLEVI---RKERYIDEDKALLCYSEVS-NLSQTFS-RCCYQDHIQDLSCFQEQATYYSTI 332 (347)
Q Consensus 260 ~~~--~~~~~iv~E~~~~G~L~~~l---~~~~~l~e~~~~~~~~~~~-~~~~~h~-~~iiHRDlKp~Nil~~~~~~~~~~ 332 (347)
+.. ....+++|+++..++..... .....+++..++.++.|++ |+.|+|+ +||+||||||+|||++..+.....
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 864 46788888888777544433 2345899999999988876 9999996 899999999999999877654433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=9.4e-23 Score=170.41 Aligned_cols=128 Identities=8% Similarity=0.055 Sum_probs=94.9
Q ss_pred hhhhcccccchhhhhhcccccccchhheehhccCCc---------------hhhhhhchHHHHHHHhcCCCcchhhhhee
Q psy10462 195 LIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAP---------------IDYLKKFLPREIEVVKGLKHPNLIRFLQA 259 (347)
Q Consensus 195 ~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~HpnIv~l~~~ 259 (347)
+.+.||+|+||+||+|++. +|+.||+|+++..... .........+|...+.++.|++++..+++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999874 6889999987532111 01112234578899999999999987765
Q ss_pred eeeCCeEEEEEEecCCCChHHHHHhCCCCCHHHHHHHHHHHH-HHHHHhhcCccccCCCCccccccccccceeEEEEEee
Q psy10462 260 IETTHRVYIIMEYAKNGSLLEVIRKERYIDEDKALLCYSEVS-NLSQTFSRCCYQDHIQDLSCFQEQATYYSTIVVVHLQ 338 (347)
Q Consensus 260 ~~~~~~~~iv~E~~~~G~L~~~l~~~~~l~e~~~~~~~~~~~-~~~~~h~~~iiHRDlKp~Nil~~~~~~~~~~~~~~~~ 338 (347)
. ..+++|||++++.+.+ +++..+..++.|+. ++.|+|++||+||||||+|||+++++ ++++-.|
T Consensus 83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~----~~liDFG 147 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFP 147 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE----EEECCCT
T ss_pred c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC----EEEEECC
Confidence 3 2379999999876532 45555667777765 99999999999999999999998643 5555444
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.32 E-value=3.2e-13 Score=111.63 Aligned_cols=55 Identities=15% Similarity=0.255 Sum_probs=48.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCcEEEcCCCcEEEeccCCceecc
Q psy10462 6 DYNTDKARRWFSQLADAIDYCHKKSVVHRDIKCENLLLDDKYNIKLSDFGFARKYS 61 (347)
Q Consensus 6 ~~~~~~~~~~~~qi~~gl~~lH~~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 61 (347)
++..+.+.+++.|++.||.|||++||+||||||+|||+++++ ++|+|||+|....
T Consensus 99 ~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~ 153 (191)
T d1zara2 99 RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG 153 (191)
T ss_dssp GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETT
T ss_pred chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCC
Confidence 345567889999999999999999999999999999999654 8999999997653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.38 E-value=6e-05 Score=63.48 Aligned_cols=84 Identities=15% Similarity=0.070 Sum_probs=53.7
Q ss_pred hhhhhhhcccccchhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcC-CCcchhhhheeeeeCCeEEEEE
Q psy10462 192 KLKLIRDKKLSSYATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGL-KHPNLIRFLQAIETTHRVYIIM 270 (347)
Q Consensus 192 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv~ 270 (347)
.++..+..+-++-+.||+.. ..++.+.+|...... ......+.+|...++.+ .+--+.+++.+..+++..|+||
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~---~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY---KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG---TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc---ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 33434433333446788764 345557788765332 11233466898888776 3434567778888889999999
Q ss_pred EecCCCChHH
Q psy10462 271 EYAKNGSLLE 280 (347)
Q Consensus 271 E~~~~G~L~~ 280 (347)
|+.+|.++.+
T Consensus 90 ~~l~G~~~~~ 99 (263)
T d1j7la_ 90 SEADGVLCSE 99 (263)
T ss_dssp ECCSSEEHHH
T ss_pred Eecccccccc
Confidence 9999977644
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.16 E-value=0.00016 Score=64.98 Aligned_cols=80 Identities=14% Similarity=0.050 Sum_probs=47.0
Q ss_pred hhcccccchhhhhhcccccccchhheehhccCC----chhhhhhchHHHHHHHhcC-CC-c-chhhhheeeeeCCeEEEE
Q psy10462 197 RDKKLSSYATVKLATSARHSQDVAIKIISKVQA----PIDYLKKFLPREIEVVKGL-KH-P-NLIRFLQAIETTHRVYII 269 (347)
Q Consensus 197 ~~ig~G~fg~V~~~~~~~~~~~~aiK~i~~~~~----~~~~~~~~~~~E~~il~~l-~H-p-nIv~l~~~~~~~~~~~iv 269 (347)
+.+|-|....||++....+++.+.+|.-..... ..+...+...+|.+.|+.+ .+ | .+.+++. .+++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 357888999999998877788888886432110 0011122344688888766 22 2 3445543 345567899
Q ss_pred EEecCCCCh
Q psy10462 270 MEYAKNGSL 278 (347)
Q Consensus 270 ~E~~~~G~L 278 (347)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.61 E-value=0.00078 Score=56.01 Aligned_cols=67 Identities=13% Similarity=0.052 Sum_probs=46.2
Q ss_pred hhhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC--CcchhhhheeeeeCCeEEEEEEecCCCCh
Q psy10462 205 ATVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK--HPNLIRFLQAIETTHRVYIIMEYAKNGSL 278 (347)
Q Consensus 205 g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~iv~E~~~~G~L 278 (347)
+.||+... .++..+.+|.-.... ...+.+|...|+.+. .-.+.+++.+..+++..++|||+++|-++
T Consensus 25 ~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 25 AAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 56787654 456667888654321 234567888888762 23356778888888899999999988655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.60 E-value=0.0097 Score=50.87 Aligned_cols=30 Identities=30% Similarity=0.347 Sum_probs=26.6
Q ss_pred CCCeecCCCCCcEEEcCCCcEEEeccCCce
Q psy10462 29 KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 58 (347)
Q Consensus 29 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~ 58 (347)
.|+||+|+.++|++++++...-|.||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.00 E-value=0.067 Score=45.70 Aligned_cols=67 Identities=7% Similarity=0.034 Sum_probs=41.2
Q ss_pred hhhhhcccccccchhheehhccCCchhhhhhchHHHHHHHhcCC-----Ccchhhhh--eeeeeCCeEEEEEEecCCCC
Q psy10462 206 TVKLATSARHSQDVAIKIISKVQAPIDYLKKFLPREIEVVKGLK-----HPNLIRFL--QAIETTHRVYIIMEYAKNGS 277 (347)
Q Consensus 206 ~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~--~~~~~~~~~~iv~E~~~~G~ 277 (347)
.||+++. .+|+.|++|+-+...-+ .+.+..|...|..|. -|..+..- ..++..+..+.++++++|..
T Consensus 37 ~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 37 RVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp EEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 5787765 46888999987643222 233556887777652 22222221 23455678999999998743
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=90.63 E-value=0.053 Score=44.43 Aligned_cols=29 Identities=21% Similarity=0.280 Sum_probs=24.8
Q ss_pred CCeecCCCCCcEEEcCCCcEEEeccCCce
Q psy10462 30 SVVHRDIKCENLLLDDKYNIKLSDFGFAR 58 (347)
Q Consensus 30 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~ 58 (347)
.++|+|+.|.||++++++...|.||+.+.
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEEeeccCcceeecCCceEEEeechhcc
Confidence 37999999999999977666799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=89.58 E-value=0.059 Score=43.90 Aligned_cols=29 Identities=21% Similarity=0.220 Sum_probs=24.8
Q ss_pred CCeecCCCCCcEEEcCCCcEEEeccCCce
Q psy10462 30 SVVHRDIKCENLLLDDKYNIKLSDFGFAR 58 (347)
Q Consensus 30 ~iiH~dlkp~Nill~~~~~~kl~Dfg~a~ 58 (347)
.++|+|+.|.||+++.+..+.|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999987667899998763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=86.19 E-value=0.37 Score=40.74 Aligned_cols=28 Identities=29% Similarity=0.293 Sum_probs=22.8
Q ss_pred CCCeecCCCCCcEEEcCCCcEEEeccCCce
Q psy10462 29 KSVVHRDIKCENLLLDDKYNIKLSDFGFAR 58 (347)
Q Consensus 29 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a~ 58 (347)
.+++|+|+.|.|||++++ ..+.||+-|.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 368999999999999743 4589998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=85.62 E-value=0.18 Score=44.24 Aligned_cols=28 Identities=21% Similarity=0.443 Sum_probs=24.2
Q ss_pred CCCeecCCCCCcEEEcCCCcEEEeccCCc
Q psy10462 29 KSVVHRDIKCENLLLDDKYNIKLSDFGFA 57 (347)
Q Consensus 29 ~~iiH~dlkp~Nill~~~~~~kl~Dfg~a 57 (347)
..++|+|+.|.||++++++ ++|.||..|
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a 250 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFA 250 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTC
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhc
Confidence 3689999999999998764 899999766
|